data_2gzz_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2gzz _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 7.6 mt . . . . . 0 N--CA 1.446 -0.656 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 10.4 t -135.71 158.8 39.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 106.441 -1.688 . . . . 0.0 106.441 -172.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 14.1 mtpt -119.99 125.14 47.66 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 105.793 -1.928 . . . . 0.0 105.793 -177.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -136.65 166.46 23.49 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.485 0.66 . . . . 0.0 111.422 -173.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 22.9 p -132.38 176.23 8.6 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 126.013 1.725 . . . . 0.0 107.819 172.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -53.58 -29.49 37.67 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.859 0.863 . . . . 0.0 112.465 177.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 54.2 mt-30 -66.53 -29.35 69.41 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.048 1.339 . . . . 0.0 112.915 179.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 23.5 p -123.3 -15.65 7.13 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.565 1.146 . . . . 0.0 113.416 -169.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -52.88 -48.15 67.34 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 124.53 1.132 . . . . 0.0 112.048 -172.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.9 m -63.92 -39.38 94.03 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.013 0.525 . . . . 0.0 111.779 -177.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.84 -43.78 87.48 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 178.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -66.08 -43.3 87.76 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 122.425 0.29 . . . . 0.0 110.747 -179.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 37.6 p -77.51 -5.32 49.61 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 -175.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 73.1 m -73.27 -21.88 60.5 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 177.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -87.98 72.18 9.29 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 118.75 0.705 . . . . 0.0 111.527 -169.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 85.09 -151.73 26.2 Favored Glycine 0 C--N 1.336 0.573 0 N-CA-C 110.479 -1.049 . . . . 0.0 110.479 172.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 97.6 t -72.18 132.95 32.69 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 168.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 49.6 t -138.2 143.96 31.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 N-CA-C 105.756 -1.942 . . . . 0.0 105.756 179.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 5.6 tt -122.85 101.6 7.53 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 106.303 -1.74 . . . . 0.0 106.303 -178.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -81.78 147.06 29.6 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.659 -179.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -125.43 93.8 3.96 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 126.588 1.955 . . . . 0.0 107.194 -175.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -75.8 112.79 12.55 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 175.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -149.94 -176.04 5.28 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.432 1.093 . . . . 0.0 108.644 -172.013 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -152.79 147.69 19.52 Favored Pre-proline 0 CA--C 1.531 0.236 0 N-CA-C 106.085 -1.821 . . . . 0.0 106.085 167.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -59.11 -18.29 43.06 Favored 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 121.848 1.699 . . . . 0.0 114.595 177.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 2.0 m95 -75.19 -14.22 60.52 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 118.818 0.735 . . . . 0.0 111.865 176.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 25.0 t -64.32 153.33 38.68 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.499 1.519 . . . . 0.0 111.063 -177.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -103.26 -65.14 0.71 Allowed Glycine 0 CA--C 1.53 0.982 0 CA-C-O 118.424 -1.209 . . . . 0.0 110.514 171.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_exo -53.22 -31.7 56.93 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 123.525 2.816 . . . . 0.0 114.608 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 34.3 m -58.63 -32.59 69.17 Favored 'General case' 0 CA--C 1.537 0.451 0 O-C-N 121.509 -0.744 . . . . 0.0 111.857 176.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.3 mmtp -68.36 -23.83 64.73 Favored 'General case' 0 CA--C 1.531 0.244 0 O-C-N 121.273 -0.892 . . . . 0.0 110.888 179.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 28.9 mtm -71.57 -40.93 69.61 Favored 'General case' 0 C--N 1.339 0.148 0 CA-C-N 118.79 0.723 . . . . 0.0 110.636 176.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 19.2 tt -83.14 -21.37 8.98 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-O 118.918 -0.563 . . . . 0.0 111.529 -176.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -49.79 -50.62 66.46 Favored Pre-proline 0 CA--C 1.55 0.952 0 CA-C-N 120.14 1.336 . . . . 0.0 114.003 177.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -66.46 -26.39 47.59 Favored 'Trans proline' 0 C--N 1.351 0.701 0 CA-C-N 121.688 1.639 . . . . 0.0 112.451 175.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 6.0 t -67.63 -40.08 83.43 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-N 118.907 0.776 . . . . 0.0 109.136 173.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 91.3 mt -64.3 -34.21 77.6 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 119.462 1.028 . . . . 0.0 111.224 172.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -66.32 -38.14 86.99 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 119.606 1.094 . . . . 0.0 111.385 171.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -63.78 -36.09 82.76 Favored 'General case' 0 C--N 1.33 -0.248 0 O-C-N 120.299 -1.501 . . . . 0.0 110.115 172.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 18.7 mt -66.58 -37.25 84.52 Favored 'General case' 0 C--N 1.334 -0.097 0 CA-C-O 117.892 -1.051 . . . . 0.0 112.087 173.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -54.1 -47.05 72.18 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 120.569 1.532 . . . . 0.0 109.65 168.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 44.1 mt-30 -74.49 -13.67 60.72 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 113.283 0.846 . . . . 0.0 113.283 -174.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 61.7 mt-10 -120.93 -24.27 5.67 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 124.417 1.087 . . . . 0.0 113.01 -170.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 17.5 mtp -131.99 -5.2 3.53 Favored 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 -175.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -58.43 -12.17 12.16 Favored Glycine 0 CA--C 1.538 1.472 0 CA-C-N 120.488 1.494 . . . . 0.0 115.393 -172.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -74.83 -25.99 59.39 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.326 1.45 . . . . 0.0 112.226 174.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.458 ' HA ' ' HE3' ' A' ' 49' ' ' LYS . 0.0 OUTLIER -123.67 -18.16 6.19 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 125.575 1.55 . . . . 0.0 112.144 -177.504 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 55.7 tp -118.13 150.71 38.91 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 124.167 0.987 . . . . 0.0 110.552 -169.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -124.02 145.0 49.5 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 104.821 -2.289 . . . . 0.0 104.821 167.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 90.0 mt -120.59 129.32 75.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 104.395 -2.446 . . . . 0.0 104.395 -177.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 98.7 t -126.23 98.45 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 CA-C-N 119.217 0.917 . . . . 0.0 109.403 -170.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -73.47 137.62 44.62 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 176.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 15.1 tt -141.34 125.43 16.79 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 C-N-CA 123.769 0.827 . . . . 0.0 108.79 176.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 60.6 t0 -83.47 104.2 13.42 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 124.62 1.168 . . . . 0.0 108.953 -172.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 30.3 m -58.81 -27.05 33.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 118.713 -0.66 . . . . 0.0 111.959 -174.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -65.57 -17.75 64.81 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 119.346 0.975 . . . . 0.0 112.171 -176.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -120.57 3.44 10.7 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.869 1.268 . . . . 0.0 111.222 178.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 69.0 m-80 -139.11 40.02 2.12 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.43 1.092 . . . . 0.0 109.814 -169.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 51.8 mm-40 -55.46 -32.09 62.49 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.122 0.969 . . . . 0.0 111.257 176.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 36.8 mm-40 -66.25 -48.45 70.47 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 118.493 0.588 . . . . 0.0 110.357 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.15 -39.46 82.63 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 118.408 0.549 . . . . 0.0 109.556 -178.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -58.95 -48.69 80.6 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 121.31 -0.869 . . . . 0.0 110.327 173.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -61.19 -28.66 69.45 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 123.985 0.802 . . . . 0.0 112.202 177.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 44.9 tttp -55.97 -29.24 59.94 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.965 1.306 . . . . 0.0 111.686 179.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -122.88 10.43 9.54 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.705 0.802 . . . . 0.0 111.739 179.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 64.95 28.37 73.41 Favored Glycine 0 CA--C 1.533 1.186 0 CA-C-O 119.39 -0.672 . . . . 0.0 112.892 -177.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 61.4 t -62.27 125.56 18.87 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 171.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 12.0 tpt -136.53 1.28 2.59 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.608 1.163 . . . . 0.0 111.085 -175.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 24.6 m -144.82 163.11 35.07 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 126.626 1.97 . . . . 0.0 107.481 179.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 38.5 pt -142.88 156.26 62.4 Favored Pre-proline 0 CA--C 1.545 0.765 0 C-N-CA 124.574 1.15 . . . . 0.0 108.847 175.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -66.65 138.9 42.11 Favored 'Cis proline' 0 N--CA 1.458 -0.582 0 CA-C-N 120.361 1.164 . . . . 0.0 110.179 -5.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 32.3 m -129.77 142.71 50.65 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 174.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 88.4 mt -123.39 126.52 46.95 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 -168.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -118.41 119.39 34.46 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 103.969 -2.604 . . . . 0.0 103.969 179.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 5.1 t -90.23 123.15 42.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 103.565 -2.754 . . . . 0.0 103.565 171.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.2 mp -111.61 153.64 26.03 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 173.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -136.15 124.32 23.07 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 105.916 -1.883 . . . . 0.0 105.916 174.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 31.9 t70 50.96 34.13 10.06 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.573 1.149 . . . . 0.0 112.251 177.143 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 98.55 0.86 57.84 Favored Glycine 0 CA--C 1.531 1.038 0 CA-C-O 118.227 -1.318 . . . . 0.0 114.956 169.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -128.38 150.32 50.16 Favored 'General case' 0 C--N 1.34 0.153 0 CA-C-N 119.999 1.9 . . . . 0.0 109.916 178.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 47.9 t -62.26 133.24 28.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 176.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.6 p -117.92 -24.73 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 C-N-CA 125.087 1.355 . . . . 0.0 109.58 177.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -158.79 164.98 35.31 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 120.035 1.289 . . . . 0.0 110.506 175.041 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 10.6 m -136.26 150.88 49.14 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.709 1.204 . . . . 0.0 108.891 177.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 62.3 m -150.52 159.3 44.58 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.622 1.569 . . . . 0.0 108.768 169.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 40.7 t -133.77 147.73 30.66 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 -176.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 76.93 -178.03 51.51 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 123.637 0.637 . . . . 0.0 112.423 176.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -64.73 150.29 47.59 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.886 0.874 . . . . 0.0 110.826 178.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -149.02 145.53 19.7 Favored Pre-proline 0 C--O 1.235 0.321 0 C-N-CA 125.677 1.591 . . . . 0.0 106.93 167.529 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -70.84 161.19 46.94 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 122.649 2.233 . . . . 0.0 110.462 174.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 63.5 pttt -58.71 -31.74 68.54 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -175.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -68.02 -45.49 73.85 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 118.244 0.475 . . . . 0.0 109.859 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.7 -40.43 95.36 Favored 'General case' 0 C--O 1.232 0.159 0 O-C-N 122.039 -0.413 . . . . 0.0 110.339 177.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 97.4 mt -64.57 -40.6 95.84 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 122.307 0.243 . . . . 0.0 111.313 176.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 18.9 mt-30 -59.83 -39.3 84.61 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 118.759 -0.638 . . . . 0.0 110.108 175.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -68.14 -40.35 82.45 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 118.941 0.791 . . . . 0.0 110.808 178.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 43.9 tp -60.34 -37.89 82.08 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.312 1.445 . . . . 0.0 111.313 176.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 99.4 t -68.74 -49.75 61.41 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 C-N-CA 123.756 0.823 . . . . 0.0 109.578 170.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -58.09 -39.25 78.11 Favored 'General case' 0 CA--C 1.519 -0.218 0 C-N-CA 125.453 1.501 . . . . 0.0 112.119 -168.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 13.3 ptmm? -65.44 -5.92 9.02 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 113.364 0.876 . . . . 0.0 113.364 -178.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -127.04 -3.48 6.38 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.548 1.139 . . . . 0.0 113.595 175.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 46.9 mt . . . . . 0 C--O 1.248 0.988 0 CA-C-N 119.413 1.006 . . . . 0.0 109.164 170.289 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 7.5 mt . . . . . 0 CA--C 1.536 0.419 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 37.3 t -137.68 164.77 27.91 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 C-N-CA 127.106 2.162 . . . . 0.0 106.2 -179.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 8.1 ttmt -120.14 146.34 46.07 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 107.1 -1.445 . . . . 0.0 107.1 173.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -143.64 169.97 16.73 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.717 0.77 . . . . 0.0 111.029 -178.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 18.6 p -133.77 173.43 11.54 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 127.699 2.4 . . . . 0.0 107.863 176.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -54.93 -31.41 60.32 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 121.578 -0.701 . . . . 0.0 112.547 177.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 59.4 mt-30 -70.77 -27.62 64.06 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.113 1.365 . . . . 0.0 112.959 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 25.5 p -118.89 -18.95 8.74 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.425 1.09 . . . . 0.0 113.524 -168.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -52.99 -46.47 68.32 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 125.014 1.326 . . . . 0.0 111.942 -172.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.0 m -63.79 -38.39 90.92 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 122.79 0.436 . . . . 0.0 111.795 -176.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -68.54 -44.6 74.2 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 177.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 67.6 mm-40 -63.95 -34.46 78.02 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-O 119.545 -0.264 . . . . 0.0 111.223 -178.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 33.3 p -85.79 1.63 48.9 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.012 0.925 . . . . 0.0 113.427 -176.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 70.9 m -101.79 31.52 3.81 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.14 0.976 . . . . 0.0 111.601 -177.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -133.72 65.05 1.59 Allowed 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.44 1.096 . . . . 0.0 110.104 -177.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 89.84 -154.32 23.79 Favored Glycine 0 C--N 1.338 0.661 0 N-CA-C 110.294 -1.123 . . . . 0.0 110.294 175.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 48.5 t -71.71 135.7 27.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 N-CA-C 106.214 -1.772 . . . . 0.0 106.214 168.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 49.2 t -137.62 141.98 37.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 178.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 60.4 tp -122.96 98.79 6.06 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 -177.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -79.39 148.72 31.89 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 178.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -127.98 93.98 3.82 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 126.543 1.937 . . . . 0.0 107.443 -178.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -73.4 112.6 9.62 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 105.735 -1.95 . . . . 0.0 105.735 175.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -148.64 -177.2 5.65 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 124.847 1.259 . . . . 0.0 108.173 -172.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -156.01 149.35 18.69 Favored Pre-proline 0 N--CA 1.453 -0.29 0 N-CA-C 106.154 -1.795 . . . . 0.0 106.154 167.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -68.93 -13.18 36.19 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 CA-C-N 120.866 1.345 . . . . 0.0 113.96 -177.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 46.4 p-90 -69.74 -20.39 63.51 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 120.147 1.34 . . . . 0.0 111.975 169.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 29.1 t -59.17 148.33 31.94 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.06 1.344 . . . . 0.0 111.05 -171.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -97.09 -60.59 0.96 Allowed Glycine 0 CA--C 1.532 1.113 0 CA-C-O 118.722 -1.043 . . . . 0.0 111.335 169.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -66.37 -25.99 48.6 Favored 'Trans proline' 0 C--N 1.349 0.574 0 CA-C-N 120.387 2.093 . . . . 0.0 112.983 -173.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 24.5 m -58.26 -33.98 69.99 Favored 'General case' 0 CA--C 1.534 0.346 0 O-C-N 121.627 -0.671 . . . . 0.0 111.218 174.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.1 mmtp -68.24 -22.87 64.75 Favored 'General case' 0 CA--C 1.531 0.242 0 O-C-N 121.591 -0.693 . . . . 0.0 111.078 -179.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 35.3 mtm -71.34 -44.21 65.51 Favored 'General case' 0 C--N 1.34 0.184 0 CA-C-N 118.863 0.756 . . . . 0.0 110.323 175.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 17.2 tt -83.04 -22.73 8.61 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-O 118.628 -0.701 . . . . 0.0 111.555 -176.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -49.05 -52.04 50.81 Favored Pre-proline 0 CA--C 1.548 0.888 0 CA-C-N 120.28 1.4 . . . . 0.0 114.223 178.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -66.41 -29.9 44.94 Favored 'Trans proline' 0 C--N 1.351 0.667 0 CA-C-N 121.574 1.598 . . . . 0.0 111.985 176.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.0 t -66.49 -40.26 86.04 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-O 118.722 -0.656 . . . . 0.0 109.403 175.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 45.7 mt -64.54 -37.05 86.21 Favored 'General case' 0 C--O 1.224 -0.258 0 CA-C-N 119.507 1.049 . . . . 0.0 110.613 174.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -63.03 -44.47 95.85 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 119.104 0.866 . . . . 0.0 111.083 173.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -63.94 -39.79 94.97 Favored 'General case' 0 CA--C 1.534 0.334 0 O-C-N 121.166 -0.959 . . . . 0.0 110.451 177.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -63.68 -43.28 97.11 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 125.175 1.39 . . . . 0.0 109.641 177.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -58.74 -43.12 90.15 Favored 'General case' 0 CA--C 1.521 -0.143 0 C-N-CA 123.767 0.827 . . . . 0.0 110.917 176.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -70.5 -10.19 58.55 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -106.31 -27.58 10.92 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 125.735 1.614 . . . . 0.0 111.518 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 22.2 mtp -126.14 -2.47 7.01 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 113.51 0.929 . . . . 0.0 113.51 -169.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.82 -7.3 6.17 Favored Glycine 0 CA--C 1.533 1.215 0 CA-C-N 119.591 1.087 . . . . 0.0 115.538 -176.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -75.71 -27.64 58.29 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 118.597 1.198 . . . . 0.0 111.638 171.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 45.0 mmtm -121.03 -20.51 6.81 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 125.514 1.526 . . . . 0.0 112.347 -175.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 48.8 tp -119.83 151.91 38.11 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.131 0.972 . . . . 0.0 111.546 -168.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -120.41 143.84 48.25 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 105.011 -2.218 . . . . 0.0 105.011 166.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 58.6 mt -112.56 140.2 33.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 105.497 -2.038 . . . . 0.0 105.497 173.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 95.1 t -132.75 98.96 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 -172.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 47.6 mtpt -73.9 140.43 45.65 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 175.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 13.0 tt -141.01 126.16 18.57 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 175.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -83.79 101.86 11.9 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 124.728 1.211 . . . . 0.0 108.786 -173.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 24.9 m -59.95 -25.63 33.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 118.667 -0.683 . . . . 0.0 111.961 -174.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -65.05 -18.45 65.31 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 119.464 1.029 . . . . 0.0 112.143 -177.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -120.22 4.02 10.84 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.809 1.244 . . . . 0.0 111.072 177.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -139.2 40.56 2.1 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.607 1.163 . . . . 0.0 109.592 -170.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 48.0 mm-40 -55.84 -32.55 63.7 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.184 0.993 . . . . 0.0 111.257 177.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -65.74 -46.27 79.51 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 118.385 0.539 . . . . 0.0 110.425 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.13 -39.19 79.03 Favored 'General case' 0 C--O 1.223 -0.317 0 CA-C-N 118.457 0.571 . . . . 0.0 109.618 -179.246 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.06 -48.36 81.89 Favored 'General case' 0 CA--C 1.533 0.326 0 O-C-N 121.256 -0.902 . . . . 0.0 110.25 173.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -60.68 -28.75 68.49 Favored Glycine 0 CA--C 1.529 0.938 0 C-N-CA 124.079 0.847 . . . . 0.0 112.36 177.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 47.3 tttp -55.94 -29.32 59.96 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 124.861 1.265 . . . . 0.0 111.709 179.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -123.2 10.63 9.35 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.621 0.768 . . . . 0.0 111.767 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 63.6 31.57 81.21 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 123.641 0.639 . . . . 0.0 112.636 -176.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 55.1 t -65.83 121.87 15.73 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 171.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 98.5 mmm -131.59 2.64 4.14 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.898 1.279 . . . . 0.0 111.382 -178.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 24.5 m -144.83 161.17 39.94 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 126.652 1.981 . . . . 0.0 107.565 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 38.7 pt -142.69 154.36 62.69 Favored Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 124.726 1.211 . . . . 0.0 108.41 176.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -68.26 140.14 53.89 Favored 'Cis proline' 0 C--N 1.349 0.601 0 CA-C-N 120.495 1.212 . . . . 0.0 110.541 -3.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 33.9 m -131.86 142.83 49.81 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 175.067 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 83.0 mt -121.24 127.4 51.39 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 -170.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -120.64 124.63 45.7 Favored 'General case' 0 CA--C 1.508 -0.637 0 N-CA-C 102.851 -3.018 . . . . 0.0 102.851 178.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 1.3 t -106.04 125.87 61.58 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 N-CA-C 103.872 -2.64 . . . . 0.0 103.872 -178.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.7 mp -122.08 152.9 39.34 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 -175.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -135.71 116.71 14.27 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 106.522 -1.659 . . . . 0.0 106.522 178.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.1 t70 49.58 38.42 14.79 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.915 1.286 . . . . 0.0 112.571 176.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 104.14 -2.87 43.99 Favored Glycine 0 CA--C 1.529 0.92 0 CA-C-O 118.056 -1.414 . . . . 0.0 115.418 168.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -126.57 147.17 49.91 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 120.129 1.964 . . . . 0.0 109.995 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 61.0 t -62.58 131.43 27.94 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 174.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 9.9 p -119.3 -20.67 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.732 0 C-N-CA 125.006 1.322 . . . . 0.0 110.093 178.102 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -159.96 166.75 29.46 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 120.58 1.536 . . . . 0.0 110.272 172.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 17.4 m -136.75 151.34 49.1 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.647 1.579 . . . . 0.0 108.798 176.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 46.3 m -148.35 157.4 43.46 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.871 1.669 . . . . 0.0 108.595 169.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 39.4 t -133.8 146.24 32.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 -178.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 79.58 -175.87 54.88 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 123.646 0.641 . . . . 0.0 112.296 176.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -62.46 145.28 54.56 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.577 0.751 . . . . 0.0 110.563 178.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 68.9 mttt -143.72 134.31 12.23 Favored Pre-proline 0 CA--C 1.532 0.258 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 168.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -69.5 160.76 48.56 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.306 2.004 . . . . 0.0 109.907 174.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 49.7 pttt -59.24 -28.3 66.57 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 -176.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -65.54 -47.89 74.35 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 118.444 0.565 . . . . 0.0 109.975 174.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.53 -37.65 88.28 Favored 'General case' 0 CA--C 1.529 0.173 0 O-C-N 121.859 -0.526 . . . . 0.0 110.619 177.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 83.0 mt -65.19 -42.12 93.89 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-O 119.285 -0.388 . . . . 0.0 111.383 176.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 15.8 mt-30 -59.3 -42.87 92.35 Favored 'General case' 0 C--O 1.225 -0.214 0 CA-C-N 118.697 0.681 . . . . 0.0 109.643 175.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -65.99 -38.6 88.91 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 118.017 0.371 . . . . 0.0 110.683 -179.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 65.9 tp -61.15 -47.25 87.06 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 125.025 1.33 . . . . 0.0 110.328 176.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 97.3 t -61.55 -43.26 96.64 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 123.902 0.881 . . . . 0.0 110.045 174.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -61.51 -26.05 67.67 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 125.18 1.392 . . . . 0.0 112.136 -172.088 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 82.3 mttt -55.15 -24.88 28.62 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 118.774 -0.632 . . . . 0.0 112.617 172.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 43.3 m-70 -121.74 -10.67 8.71 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 -167.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 78.7 mt . . . . . 0 C--O 1.249 1.077 0 CA-C-N 118.565 0.62 . . . . 0.0 109.457 172.586 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.9 mt . . . . . 0 CA--C 1.537 0.471 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 29.0 t -136.47 163.97 32.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 C-N-CA 126.724 2.01 . . . . 0.0 106.273 -178.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.52 133.78 49.81 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 104.923 -2.251 . . . . 0.0 104.923 176.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -135.22 175.11 9.89 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 123.875 0.87 . . . . 0.0 111.37 -171.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 31.3 p -137.87 178.56 7.02 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 125.244 1.418 . . . . 0.0 107.779 169.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -49.3 -30.34 7.27 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.895 0.878 . . . . 0.0 112.4 169.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -64.81 -27.47 68.91 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.003 1.321 . . . . 0.0 112.776 -179.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 14.1 p -130.83 -17.55 3.16 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 114.298 1.222 . . . . 0.0 114.298 -167.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 56.8 t80 -52.2 -47.28 65.67 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 124.463 1.105 . . . . 0.0 112.259 -170.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.2 m -64.56 -37.9 89.15 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 122.62 0.368 . . . . 0.0 111.849 -176.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -69.09 -44.56 72.24 Favored 'General case' 0 N--CA 1.452 -0.343 0 O-C-N 122.017 -0.427 . . . . 0.0 109.96 176.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 68.9 mm-40 -63.22 -35.82 81.59 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 122.529 0.331 . . . . 0.0 110.921 -178.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 29.3 p -82.85 0.62 43.22 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 -176.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 70.7 m -102.04 29.21 5.2 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.972 0.909 . . . . 0.0 112.068 -175.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -135.2 55.24 1.89 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.831 0.853 . . . . 0.0 111.387 -173.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 107.39 -152.06 16.91 Favored Glycine 0 C--N 1.337 0.614 0 N-CA-C 109.954 -1.258 . . . . 0.0 109.954 173.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.2 t -74.83 135.75 26.65 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 N-CA-C 104.88 -2.267 . . . . 0.0 104.88 166.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 34.3 t -136.15 139.47 45.61 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 N-CA-C 106.441 -1.688 . . . . 0.0 106.441 178.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.8 tt -124.17 100.11 6.56 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 106.131 -1.803 . . . . 0.0 106.131 -177.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -81.33 145.67 30.75 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.236 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -124.52 94.02 4.08 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 125.899 1.68 . . . . 0.0 107.619 -176.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -74.22 112.51 10.45 Favored 'General case' 0 C--O 1.24 0.58 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 175.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -148.96 -176.51 5.37 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.966 1.306 . . . . 0.0 108.548 -172.581 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -156.44 146.74 15.9 Favored Pre-proline 0 CA--C 1.533 0.296 0 N-CA-C 106.16 -1.793 . . . . 0.0 106.16 168.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -60.76 -17.95 53.04 Favored 'Trans proline' 0 CA--C 1.534 0.495 0 C-N-CA 121.662 1.575 . . . . 0.0 115.799 -178.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 50.5 p-90 -69.23 -20.56 63.95 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 119.99 1.268 . . . . 0.0 112.011 173.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 34.1 t -58.9 146.9 35.99 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 125.055 1.342 . . . . 0.0 111.231 -172.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -95.4 -62.43 0.99 Allowed Glycine 0 CA--C 1.531 1.082 0 CA-C-O 118.647 -1.085 . . . . 0.0 111.163 170.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -64.43 -26.53 62.9 Favored 'Trans proline' 0 C--N 1.35 0.634 0 CA-C-N 120.257 2.029 . . . . 0.0 113.387 -173.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 30.2 m -57.29 -34.7 68.95 Favored 'General case' 0 CA--C 1.537 0.456 0 O-C-N 121.63 -0.669 . . . . 0.0 111.479 174.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.9 mmtp -67.91 -24.49 65.21 Favored 'General case' 0 CA--C 1.531 0.25 0 O-C-N 121.645 -0.659 . . . . 0.0 111.057 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 32.3 mtm -71.25 -44.04 66.07 Favored 'General case' 0 C--N 1.34 0.18 0 CA-C-N 118.654 0.661 . . . . 0.0 110.411 177.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 14.5 tt -82.21 -23.69 9.33 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-O 118.745 -0.645 . . . . 0.0 111.523 -176.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -48.59 -51.46 52.33 Favored Pre-proline 0 CA--C 1.548 0.888 0 CA-C-N 120.062 1.301 . . . . 0.0 114.262 179.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -66.93 -28.08 42.53 Favored 'Trans proline' 0 C--N 1.35 0.649 0 CA-C-N 121.807 1.681 . . . . 0.0 112.407 176.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.6 t -67.8 -37.92 79.32 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 O-C-N 121.584 -0.698 . . . . 0.0 109.313 174.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 95.0 mt -67.16 -35.4 79.6 Favored 'General case' 0 C--N 1.34 0.166 0 CA-C-N 119.516 1.053 . . . . 0.0 111.328 172.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -61.96 -43.07 99.6 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 119.548 1.067 . . . . 0.0 110.755 171.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -63.38 -41.35 98.79 Favored 'General case' 0 CA--C 1.53 0.179 0 O-C-N 121.279 -0.888 . . . . 0.0 110.421 175.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 35.3 tp -60.82 -42.21 97.23 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 123.494 0.718 . . . . 0.0 110.24 177.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -60.54 -43.82 96.79 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 123.347 0.659 . . . . 0.0 110.728 177.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 -71.4 -10.72 60.21 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.29 0.636 . . . . 0.0 112.629 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -105.59 -28.09 10.97 Favored 'General case' 0 C--O 1.232 0.172 0 C-N-CA 125.46 1.504 . . . . 0.0 111.42 -178.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 22.8 mtp -131.44 0.27 4.04 Favored 'General case' 0 N--CA 1.461 0.105 0 N-CA-C 113.658 0.985 . . . . 0.0 113.658 -169.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -55.82 -10.31 3.35 Favored Glycine 0 CA--C 1.535 1.343 0 C-N-CA 124.747 1.165 . . . . 0.0 115.926 -176.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -72.86 -29.14 62.97 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.597 1.159 . . . . 0.0 112.049 172.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 42.3 mmtm -126.37 -14.9 5.79 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 125.732 1.613 . . . . 0.0 112.842 -175.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 58.9 tp -120.3 142.59 48.95 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 124.144 0.978 . . . . 0.0 109.925 -170.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -117.73 145.48 44.43 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 104.899 -2.26 . . . . 0.0 104.899 167.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 73.7 mt -116.19 138.19 47.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 105.399 -2.075 . . . . 0.0 105.399 176.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 93.1 t -132.59 96.47 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -169.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 54.4 mtpt -74.24 139.05 44.07 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 177.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 17.3 tt -141.41 125.62 16.89 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 176.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 39.4 t0 -82.35 104.89 12.99 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 124.737 1.215 . . . . 0.0 108.428 -175.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 30.5 m -60.47 -25.8 35.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 C-N-CA 123.464 0.705 . . . . 0.0 112.194 -173.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -64.83 -26.54 68.38 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 119.188 0.904 . . . . 0.0 111.468 -177.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -108.97 6.38 25.14 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.098 1.359 . . . . 0.0 110.791 -179.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 68.3 m-80 -146.69 39.66 1.06 Allowed 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.536 1.135 . . . . 0.0 110.137 -168.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -57.84 -29.6 65.1 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.448 1.099 . . . . 0.0 110.541 179.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 48.1 mp0 -65.4 -51.35 60.93 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 124.7 1.2 . . . . 0.0 109.923 177.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.12 -38.55 85.79 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.536 0.734 . . . . 0.0 109.748 -178.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.1 -48.62 80.95 Favored 'General case' 0 CA--C 1.534 0.34 0 O-C-N 121.105 -0.997 . . . . 0.0 110.255 172.185 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -60.59 -28.92 68.52 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 123.887 0.756 . . . . 0.0 112.397 177.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 73.7 tttt -55.82 -29.28 59.52 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 125.047 1.339 . . . . 0.0 111.674 179.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -123.64 10.17 9.03 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.647 0.779 . . . . 0.0 111.87 179.288 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 64.37 28.75 73.5 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 123.736 0.684 . . . . 0.0 112.839 -176.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 51.0 t -62.08 125.65 18.81 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 172.054 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 12.0 tpt -137.6 0.71 2.28 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.567 1.147 . . . . 0.0 111.15 -176.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 28.0 m -144.87 162.67 36.24 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 126.594 1.957 . . . . 0.0 107.439 179.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 40.2 pt -142.97 154.44 61.89 Favored Pre-proline 0 CA--C 1.546 0.809 0 C-N-CA 124.502 1.121 . . . . 0.0 108.916 177.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -68.03 138.49 44.33 Favored 'Cis proline' 0 C--N 1.35 0.628 0 CA-C-N 120.427 1.188 . . . . 0.0 110.376 -3.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 26.0 m -129.42 141.55 51.01 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 173.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 86.7 mt -122.82 127.17 48.71 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 -169.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -115.99 123.63 48.5 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 103.683 -2.71 . . . . 0.0 103.683 177.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 6.2 t -99.24 125.13 52.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 103.993 -2.595 . . . . 0.0 103.993 177.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.7 mp -122.5 153.67 38.86 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 4.5 tmtp? -135.19 120.24 18.72 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 106.306 -1.739 . . . . 0.0 106.306 175.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.5 t70 50.69 36.88 15.15 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.901 1.28 . . . . 0.0 112.559 175.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 106.24 -4.26 38.04 Favored Glycine 0 CA--C 1.526 0.779 0 CA-C-O 118.104 -1.387 . . . . 0.0 115.326 168.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -130.87 147.72 52.55 Favored 'General case' 0 C--N 1.339 0.132 0 CA-C-N 120.085 1.942 . . . . 0.0 110.205 -177.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 53.0 t -63.26 132.86 29.24 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 178.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 5.2 p -119.21 -20.39 4.99 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 C-N-CA 124.823 1.249 . . . . 0.0 110.795 174.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -158.23 168.73 26.23 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 120.544 1.52 . . . . 0.0 110.903 173.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 10.3 m -138.26 150.94 47.16 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.399 1.48 . . . . 0.0 108.497 175.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 2.7 m -146.54 157.16 43.69 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 125.761 1.624 . . . . 0.0 108.653 169.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 39.5 t -133.67 147.14 30.92 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 176.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 78.47 -176.94 54.07 Favored Glycine 0 CA--C 1.53 0.973 0 CA-C-O 121.638 0.577 . . . . 0.0 112.406 177.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 60.0 t80 -65.91 145.03 56.4 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.921 0.888 . . . . 0.0 110.896 -179.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -141.93 140.57 19.96 Favored Pre-proline 0 CA--C 1.535 0.37 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 167.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -72.11 162.5 41.55 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 122.68 2.254 . . . . 0.0 110.781 175.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 31.9 pttt -58.91 -30.99 68.23 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 -177.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -66.94 -49.76 64.5 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 118.336 0.516 . . . . 0.0 109.969 176.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.24 -39.4 94.5 Favored 'General case' 0 CA--C 1.529 0.146 0 O-C-N 121.923 -0.486 . . . . 0.0 110.512 179.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 59.3 mt -62.48 -45.22 94.01 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 123.345 0.658 . . . . 0.0 111.013 176.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 19.2 mt-30 -58.79 -42.15 88.39 Favored 'General case' 0 C--O 1.225 -0.214 0 CA-C-N 118.311 0.505 . . . . 0.0 110.262 176.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -66.89 -38.62 86.62 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 118.488 0.586 . . . . 0.0 110.817 -179.079 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 64.8 tp -63.67 -38.32 90.68 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.869 1.267 . . . . 0.0 110.956 176.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 96.4 t -68.54 -46.38 80.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-N 119.083 0.856 . . . . 0.0 109.787 172.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -56.79 -41.96 78.61 Favored 'General case' 0 CA--C 1.519 -0.219 0 C-N-CA 125.449 1.499 . . . . 0.0 111.802 -168.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -68.39 -5.62 20.05 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -175.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 83.5 m-70 -123.72 2.56 8.86 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.311 1.044 . . . . 0.0 112.8 178.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 53.9 mt . . . . . 0 C--O 1.249 1.058 0 CA-C-N 119.306 0.957 . . . . 0.0 109.545 174.449 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.9 mt . . . . . 0 CA--C 1.538 0.497 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 29.5 t -139.53 163.72 25.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 C-N-CA 126.426 1.89 . . . . 0.0 107.138 -174.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -113.74 146.03 40.47 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 174.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -145.25 168.02 21.43 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 123.086 0.554 . . . . 0.0 110.077 175.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 31.7 p -132.42 178.57 6.72 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 168.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -53.29 -28.14 26.51 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.385 0.674 . . . . 0.0 112.292 174.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 -66.05 -29.01 69.28 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.294 1.838 . . . . 0.0 112.832 179.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 16.6 p -129.62 -14.61 4.1 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 -167.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -52.61 -47.03 67.22 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 124.453 1.101 . . . . 0.0 111.987 -172.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.8 m -63.84 -38.88 92.73 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 122.855 0.462 . . . . 0.0 111.787 -177.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -67.56 -44.79 77.4 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 177.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -64.02 -35.76 81.78 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 122.392 0.277 . . . . 0.0 111.062 -178.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 29.0 p -84.12 0.18 49.49 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.868 0.867 . . . . 0.0 113.251 -176.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 70.1 m -99.41 30.0 3.74 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.127 0.971 . . . . 0.0 111.758 -177.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -132.95 56.75 1.83 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.255 1.022 . . . . 0.0 110.543 -176.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 97.14 -155.36 20.66 Favored Glycine 0 C--N 1.336 0.572 0 N-CA-C 110.043 -1.223 . . . . 0.0 110.043 175.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 65.5 t -71.42 133.09 32.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 168.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 46.9 t -137.25 141.59 39.57 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 N-CA-C 105.907 -1.886 . . . . 0.0 105.907 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 3.8 tt -122.81 100.21 6.79 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 106.208 -1.775 . . . . 0.0 106.208 -175.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -82.09 146.22 29.75 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.402 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -125.63 94.2 4.06 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 126.101 1.761 . . . . 0.0 107.323 -178.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -73.54 113.46 10.68 Favored 'General case' 0 C--O 1.24 0.563 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 174.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -149.01 -177.33 5.75 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.842 1.257 . . . . 0.0 108.595 -172.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -156.21 148.3 17.46 Favored Pre-proline 0 CA--C 1.532 0.268 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 167.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -60.61 -18.63 55.97 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 121.796 1.664 . . . . 0.0 115.68 -179.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 50.6 p-90 -69.69 -20.14 63.56 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 119.987 1.267 . . . . 0.0 112.01 173.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 33.7 t -59.56 148.37 33.61 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 124.975 1.31 . . . . 0.0 111.185 -172.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -97.78 -63.36 0.89 Allowed Glycine 0 CA--C 1.529 0.962 0 CA-C-O 118.503 -1.165 . . . . 0.0 110.92 171.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -62.34 -26.57 77.1 Favored 'Trans proline' 0 C--N 1.351 0.704 0 CA-C-N 120.367 2.084 . . . . 0.0 113.73 -174.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 34.3 m -57.08 -35.59 69.57 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 121.653 -0.654 . . . . 0.0 111.513 174.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.0 mmtp -67.32 -25.54 66.07 Favored 'General case' 0 CA--C 1.53 0.208 0 O-C-N 121.63 -0.669 . . . . 0.0 110.977 -179.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 31.4 mtm -70.86 -44.24 66.81 Favored 'General case' 0 C--N 1.341 0.222 0 CA-C-N 118.619 0.645 . . . . 0.0 110.313 177.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 15.4 tt -83.32 -23.65 8.24 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 CA-C-O 118.685 -0.674 . . . . 0.0 111.831 -174.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -48.78 -51.45 53.84 Favored Pre-proline 0 CA--C 1.547 0.843 0 CA-C-N 119.941 1.246 . . . . 0.0 114.072 179.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -66.78 -29.22 42.65 Favored 'Trans proline' 0 C--N 1.35 0.642 0 CA-C-N 121.737 1.656 . . . . 0.0 112.24 176.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.2 t -67.91 -36.83 77.07 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 O-C-N 121.545 -0.722 . . . . 0.0 109.579 175.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 55.2 mt -68.15 -35.25 77.76 Favored 'General case' 0 C--O 1.226 -0.178 0 CA-C-N 119.43 1.014 . . . . 0.0 111.07 173.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -61.96 -42.83 99.56 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 119.196 0.907 . . . . 0.0 110.803 170.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -64.76 -38.71 91.9 Favored 'General case' 0 CA--C 1.532 0.277 0 O-C-N 121.092 -1.005 . . . . 0.0 110.686 176.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 43.5 tp -61.82 -42.92 99.63 Favored 'General case' 0 C--N 1.335 -0.032 0 C-N-CA 123.625 0.77 . . . . 0.0 109.95 175.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -60.23 -42.2 94.7 Favored 'General case' 0 CA--C 1.522 -0.119 0 C-N-CA 123.041 0.536 . . . . 0.0 110.728 178.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 -72.34 -10.92 60.4 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 112.573 0.582 . . . . 0.0 112.573 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -105.36 -32.86 8.38 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 125.353 1.461 . . . . 0.0 111.545 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 82.1 mmm -126.16 -5.7 6.67 Favored 'General case' 0 C--O 1.227 -0.127 0 CA-C-O 118.226 -0.892 . . . . 0.0 113.097 -167.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -57.82 -13.95 14.65 Favored Glycine 0 CA--C 1.532 1.155 0 CA-C-N 120.027 1.285 . . . . 0.0 114.873 -174.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -66.73 -27.32 67.52 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.508 1.123 . . . . 0.0 112.011 172.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.448 ' HA ' ' HE3' ' A' ' 49' ' ' LYS . 0.0 OUTLIER -120.93 -21.61 6.48 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 126.094 1.757 . . . . 0.0 111.84 179.787 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 35.9 tp -109.49 157.67 18.74 Favored 'General case' 0 C--O 1.232 0.169 0 C-N-CA 123.994 0.918 . . . . 0.0 111.428 -169.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -131.27 143.19 50.36 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 103.846 -2.65 . . . . 0.0 103.846 166.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 73.6 mt -116.01 140.38 38.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 105.517 -2.031 . . . . 0.0 105.517 176.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 81.3 t -132.53 98.36 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 -172.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -74.3 140.34 44.83 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 174.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 14.9 tt -142.63 126.91 15.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 N-CA-C 108.679 -0.859 . . . . 0.0 108.679 176.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 62.2 t0 -84.4 105.36 15.18 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 124.609 1.163 . . . . 0.0 109.057 -173.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 31.4 m -59.61 -26.14 33.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 118.664 -0.684 . . . . 0.0 112.023 -175.113 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -65.18 -18.6 65.44 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 119.407 1.003 . . . . 0.0 112.143 -176.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -119.87 3.71 11.03 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.916 1.287 . . . . 0.0 111.173 178.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -139.39 40.29 2.07 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 124.528 1.131 . . . . 0.0 109.82 -169.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 51.4 mm-40 -56.04 -33.05 64.58 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.997 0.919 . . . . 0.0 111.227 178.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -66.08 -46.53 77.37 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 118.509 0.595 . . . . 0.0 110.549 179.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.19 -39.03 78.93 Favored 'General case' 0 C--O 1.223 -0.32 0 O-C-N 121.816 -0.553 . . . . 0.0 109.721 -179.296 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -58.79 -47.95 82.96 Favored 'General case' 0 CA--C 1.534 0.346 0 O-C-N 121.062 -1.024 . . . . 0.0 110.244 172.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -60.38 -28.47 67.26 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 124.171 0.891 . . . . 0.0 112.421 177.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 48.2 tptt -56.2 -29.07 60.42 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.546 1.139 . . . . 0.0 111.491 179.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -123.99 10.26 8.82 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.511 0.724 . . . . 0.0 111.661 -179.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 63.36 30.51 77.77 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 123.693 0.663 . . . . 0.0 112.572 -176.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 61.5 t -61.37 122.34 11.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 173.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 25.8 ptp -129.9 -12.4 4.22 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 124.923 1.289 . . . . 0.0 112.748 -171.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 23.0 m -139.9 165.23 27.87 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 127.396 2.278 . . . . 0.0 108.124 178.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 36.7 pt -142.13 154.79 65.05 Favored Pre-proline 0 CA--C 1.545 0.772 0 C-N-CA 124.845 1.258 . . . . 0.0 108.567 177.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -67.94 139.87 51.34 Favored 'Cis proline' 0 C--N 1.351 0.664 0 CA-C-N 120.481 1.208 . . . . 0.0 110.414 -2.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 22.7 m -130.99 139.12 49.96 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 174.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 85.5 mt -119.46 126.1 50.51 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 106.819 -1.548 . . . . 0.0 106.819 -169.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -117.01 119.28 34.82 Favored 'General case' 0 CA--C 1.511 -0.535 0 N-CA-C 103.755 -2.683 . . . . 0.0 103.755 177.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.4 t -92.34 124.29 44.75 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 N-CA-C 103.582 -2.747 . . . . 0.0 103.582 173.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.3 mp -115.03 155.12 27.58 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 174.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -136.73 123.75 21.53 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 171.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 27.9 t70 49.45 38.03 13.37 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.008 1.323 . . . . 0.0 112.456 177.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 101.64 -2.72 53.05 Favored Glycine 0 CA--C 1.528 0.865 0 CA-C-O 118.108 -1.384 . . . . 0.0 115.395 168.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -131.47 151.74 51.3 Favored 'General case' 0 CA--C 1.528 0.109 0 CA-C-N 120.063 1.931 . . . . 0.0 110.185 -178.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 38.8 t -62.85 133.32 28.7 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.9 p -120.61 -20.28 4.57 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 C-N-CA 125.324 1.45 . . . . 0.0 109.872 177.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -161.02 168.73 23.91 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 120.315 1.416 . . . . 0.0 110.47 171.672 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 10.5 m -140.46 151.03 44.54 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.078 1.351 . . . . 0.0 108.741 175.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 58.7 m -150.45 157.21 42.77 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.283 1.433 . . . . 0.0 108.835 169.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 43.7 t -133.89 144.56 35.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 -178.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 79.24 -175.07 55.21 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 123.434 0.54 . . . . 0.0 112.153 178.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -63.58 148.77 47.97 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.742 0.817 . . . . 0.0 111.031 -179.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 45.6 mttm -144.14 135.54 12.68 Favored Pre-proline 0 C--O 1.233 0.234 0 N-CA-C 106.406 -1.702 . . . . 0.0 106.406 168.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -70.0 162.37 42.46 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 122.154 1.903 . . . . 0.0 110.266 173.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 18.2 ptmt -55.98 -31.02 62.63 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.424 1.09 . . . . 0.0 113.533 -179.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -67.43 -49.69 62.62 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 118.528 0.604 . . . . 0.0 109.767 176.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.04 -39.38 94.56 Favored 'General case' 0 C--N 1.34 0.173 0 C-N-CA 122.896 0.478 . . . . 0.0 110.72 179.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 86.2 mt -62.95 -45.39 92.69 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.111 0.564 . . . . 0.0 111.166 176.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -61.07 -41.14 96.08 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-O 118.944 -0.551 . . . . 0.0 110.353 176.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -63.72 -41.62 98.04 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 118.427 0.558 . . . . 0.0 110.275 179.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 67.8 tp -61.73 -41.49 97.71 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 124.729 1.212 . . . . 0.0 110.98 177.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 75.1 t -62.39 -47.72 91.7 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 CA-C-N 118.757 0.708 . . . . 0.0 109.365 171.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 -61.76 -26.53 68.14 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 125.504 1.522 . . . . 0.0 112.291 -171.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -53.83 -26.87 26.42 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 123.604 0.761 . . . . 0.0 112.416 172.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 72.8 m-70 -123.49 -6.09 8.16 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 113.852 1.056 . . . . 0.0 113.852 -167.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 79.9 mt . . . . . 0 C--O 1.249 1.062 0 CA-C-N 118.814 0.733 . . . . 0.0 109.286 171.851 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.2 mt . . . . . 0 CA--C 1.534 0.359 0 N-CA-C 106.225 -1.769 . . . . 0.0 106.225 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 43.4 t -134.2 163.07 38.01 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 C-N-CA 126.89 2.076 . . . . 0.0 106.0 -178.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 1.4 tmtt? -129.01 131.54 47.41 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 104.247 -2.501 . . . . 0.0 104.247 179.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -142.6 173.46 11.51 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 123.732 0.813 . . . . 0.0 110.973 -169.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 23.6 p -136.91 174.01 11.08 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 125.066 1.347 . . . . 0.0 107.573 169.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -51.13 -27.97 9.79 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.726 1.21 . . . . 0.0 112.976 176.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -57.99 -30.59 66.18 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.103 1.761 . . . . 0.0 112.767 178.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.0 m -139.55 -7.4 1.3 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.837 0.855 . . . . 0.0 113.277 -169.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 69.2 t80 -51.45 -44.0 62.25 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.409 1.084 . . . . 0.0 111.925 -177.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.7 m -63.58 -38.39 90.96 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 122.991 0.516 . . . . 0.0 111.804 -178.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -68.32 -44.82 74.54 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 176.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 67.7 mm-40 -62.43 -36.83 83.62 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 122.67 0.388 . . . . 0.0 111.124 -178.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.7 p -83.13 0.7 43.98 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.072 0.949 . . . . 0.0 113.46 -177.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 68.0 m -105.15 33.33 3.71 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.206 1.002 . . . . 0.0 111.125 -176.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -132.8 60.25 1.71 Allowed 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.253 1.021 . . . . 0.0 109.966 -178.243 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 92.11 -153.71 22.0 Favored Glycine 0 C--N 1.337 0.633 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 177.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 82.9 t -74.06 137.01 24.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 168.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 48.1 t -139.21 145.96 26.54 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 N-CA-C 105.952 -1.87 . . . . 0.0 105.952 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.3 tt -125.01 99.09 5.97 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 106.448 -1.686 . . . . 0.0 106.448 -176.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -79.51 144.63 33.78 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 123.572 0.749 . . . . 0.0 109.17 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -126.92 94.35 4.01 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 126.045 1.738 . . . . 0.0 107.643 -176.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -74.49 113.46 11.76 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 173.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -147.22 -171.47 3.79 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.128 1.371 . . . . 0.0 108.225 -175.449 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -161.32 148.0 11.52 Favored Pre-proline 0 CA--C 1.533 0.306 0 N-CA-C 105.996 -1.853 . . . . 0.0 105.996 166.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -60.58 -18.07 52.47 Favored 'Trans proline' 0 CA--C 1.534 0.477 0 C-N-CA 121.776 1.651 . . . . 0.0 115.745 -178.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 50.7 p-90 -69.76 -20.57 63.49 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 120.029 1.286 . . . . 0.0 111.998 173.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 26.9 t -59.89 148.74 33.8 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 124.902 1.281 . . . . 0.0 111.096 -172.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -100.6 -63.97 0.79 Allowed Glycine 0 CA--C 1.529 0.938 0 CA-C-O 118.501 -1.166 . . . . 0.0 110.492 172.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_exo -53.77 -32.4 65.9 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 123.244 2.629 . . . . 0.0 114.495 -179.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 35.9 m -57.55 -34.82 69.57 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.326 0.651 . . . . 0.0 111.635 176.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.5 mmtp -67.93 -25.49 65.5 Favored 'General case' 0 CA--C 1.531 0.248 0 O-C-N 121.589 -0.694 . . . . 0.0 110.836 -179.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 30.0 mtm -71.25 -42.46 68.79 Favored 'General case' 0 C--N 1.341 0.213 0 CA-C-N 118.67 0.668 . . . . 0.0 110.444 176.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 17.1 tt -84.07 -22.48 8.11 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-O 118.807 -0.616 . . . . 0.0 111.53 -175.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -48.99 -51.21 57.58 Favored Pre-proline 0 CA--C 1.547 0.862 0 CA-C-N 120.028 1.285 . . . . 0.0 113.971 178.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -67.07 -28.37 41.33 Favored 'Trans proline' 0 C--N 1.35 0.614 0 CA-C-N 121.724 1.652 . . . . 0.0 112.303 176.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 13.0 t -66.45 -39.3 83.69 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 174.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 87.4 mt -67.06 -34.7 78.25 Favored 'General case' 0 C--N 1.34 0.165 0 CA-C-N 119.22 0.918 . . . . 0.0 111.323 173.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -62.5 -44.36 96.56 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 119.571 1.078 . . . . 0.0 110.746 171.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -64.42 -38.31 90.6 Favored 'General case' 0 CA--C 1.532 0.271 0 O-C-N 121.233 -0.917 . . . . 0.0 110.7 176.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 61.5 tp -63.22 -44.26 95.79 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.619 0.768 . . . . 0.0 110.015 176.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -59.31 -41.73 89.73 Favored 'General case' 0 CA--C 1.521 -0.153 0 C-N-CA 123.41 0.684 . . . . 0.0 111.009 177.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -72.06 -10.38 59.7 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.075 0.55 . . . . 0.0 112.464 -179.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 -104.77 -33.43 8.44 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 125.208 1.403 . . . . 0.0 111.662 179.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 74.8 mmm -121.29 -4.44 9.43 Favored 'General case' 0 C--O 1.224 -0.242 0 CA-C-O 118.18 -0.914 . . . . 0.0 112.658 -168.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -58.22 -14.09 17.58 Favored Glycine 0 CA--C 1.531 1.075 0 CA-C-N 120.07 1.305 . . . . 0.0 115.23 -173.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -70.14 -25.14 63.33 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 118.533 1.167 . . . . 0.0 111.775 172.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.42 ' HA ' ' HE2' ' A' ' 49' ' ' LYS . 9.7 mmpt? -123.67 -17.43 6.41 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 126.519 1.928 . . . . 0.0 111.628 -175.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 28.0 tp -118.94 159.39 23.9 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 124.718 1.207 . . . . 0.0 111.021 -169.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 37.2 ttmt -134.82 145.2 48.12 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 104.108 -2.552 . . . . 0.0 104.108 167.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 62.3 mt -115.81 141.11 34.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 175.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 69.1 t -132.83 96.81 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 -172.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -75.96 131.91 39.88 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 177.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 15.9 tt -140.34 135.49 36.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -97.78 115.57 28.28 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 123.875 0.87 . . . . 0.0 111.049 -168.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 35.7 m -60.96 -19.62 20.15 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 O-C-N 121.582 -0.699 . . . . 0.0 112.321 -178.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -63.39 -21.75 66.47 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.757 1.223 . . . . 0.0 113.004 179.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -131.79 1.76 4.01 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.655 0.782 . . . . 0.0 112.625 178.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 63.4 m-80 -129.88 39.41 3.7 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.683 0.793 . . . . 0.0 110.896 -170.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.2 mp0 -54.97 -31.88 61.11 Favored 'General case' 0 C--N 1.34 0.178 0 C-N-CA 123.707 0.803 . . . . 0.0 111.896 176.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 27.4 tp10 -67.31 -47.08 71.63 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 123.979 0.912 . . . . 0.0 110.556 -178.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.72 -39.46 76.84 Favored 'General case' 0 CA--C 1.535 0.395 0 O-C-N 121.728 -0.607 . . . . 0.0 109.561 179.316 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.29 -47.45 85.34 Favored 'General case' 0 CA--C 1.533 0.312 0 O-C-N 121.423 -0.798 . . . . 0.0 110.56 174.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -62.66 -27.11 69.3 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 124.055 0.836 . . . . 0.0 111.876 178.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 5.8 tppt? -55.67 -28.44 55.54 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.568 1.147 . . . . 0.0 111.877 177.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -124.22 11.39 8.78 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.81 0.844 . . . . 0.0 111.572 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 63.77 30.48 77.79 Favored Glycine 0 CA--C 1.532 1.094 0 C-N-CA 123.72 0.676 . . . . 0.0 112.761 -177.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 60.9 t -65.86 125.66 23.45 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 172.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 66.8 mtt -136.75 3.98 2.77 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.821 1.249 . . . . 0.0 111.448 -179.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 23.4 m -144.05 162.62 35.75 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 126.676 1.991 . . . . 0.0 107.768 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 44.2 pt -141.72 155.48 66.44 Favored Pre-proline 0 CA--C 1.545 0.78 0 C-N-CA 124.445 1.098 . . . . 0.0 108.796 175.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -67.38 139.62 48.1 Favored 'Cis proline' 0 C--N 1.35 0.607 0 CA-C-N 120.209 1.11 . . . . 0.0 110.209 -5.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 50.9 m -132.65 140.69 48.29 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 174.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 87.8 mt -123.62 129.18 50.76 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 -169.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -120.94 122.9 41.18 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 103.431 -2.803 . . . . 0.0 103.431 177.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 1.8 t -100.22 120.17 49.3 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 N-CA-C 103.899 -2.63 . . . . 0.0 103.899 176.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.3 mp -112.03 155.16 24.24 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 -178.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 57.8 tttp -134.59 115.59 14.04 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 105.785 -1.932 . . . . 0.0 105.785 177.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.0 t70 49.87 39.17 17.72 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.893 1.277 . . . . 0.0 112.374 176.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 104.79 -5.62 43.39 Favored Glycine 0 CA--C 1.529 0.955 0 CA-C-O 118.139 -1.367 . . . . 0.0 115.295 169.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -131.29 149.27 52.63 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 120.054 1.927 . . . . 0.0 110.527 -177.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 39.2 t -63.59 134.49 28.57 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 -179.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 8.7 p -118.94 -26.41 2.51 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 C-N-CA 125.065 1.346 . . . . 0.0 110.504 172.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -149.9 165.28 33.06 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 120.689 1.586 . . . . 0.0 110.046 173.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 17.2 m -140.86 151.18 44.1 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.442 1.497 . . . . 0.0 108.025 178.116 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 37.3 m -151.25 157.06 42.1 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.415 1.486 . . . . 0.0 109.265 169.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 30.6 t -135.62 145.65 31.14 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 -176.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 75.81 -176.75 50.65 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 123.896 0.76 . . . . 0.0 111.893 178.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 47.4 t80 -62.06 137.58 58.27 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 173.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 64.6 tttt -149.94 137.68 11.76 Favored Pre-proline 0 C--O 1.235 0.316 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 -178.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -70.7 153.73 64.45 Favored 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 121.628 1.552 . . . . 0.0 111.959 -172.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 29.2 ttpp -52.18 -45.39 65.11 Favored 'General case' 0 CA--C 1.518 -0.256 0 C-N-CA 125.805 1.642 . . . . 0.0 112.313 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -62.92 -43.31 99.14 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 -176.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.98 -43.1 96.73 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 122.421 0.288 . . . . 0.0 110.499 179.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 76.8 mt -62.32 -44.08 97.32 Favored 'General case' 0 C--O 1.231 0.095 0 CA-C-N 117.535 0.152 . . . . 0.0 110.911 178.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -74.24 -29.27 61.62 Favored 'General case' 0 N--CA 1.451 -0.42 0 O-C-N 122.178 -0.326 . . . . 0.0 110.892 -175.544 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 31.9 tp10 -70.23 -37.72 75.07 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 124.566 1.146 . . . . 0.0 110.543 173.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 53.6 mt -60.86 -50.32 73.89 Favored 'General case' 0 C--O 1.224 -0.246 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 172.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 33.0 t -52.22 -46.33 44.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 122.853 0.461 . . . . 0.0 109.949 173.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -62.77 -38.43 90.56 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 123.974 0.909 . . . . 0.0 112.258 -171.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 16.9 ptmt -67.13 -18.25 65.22 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 118.125 -0.94 . . . . 0.0 112.644 -175.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 25.2 p80 -127.13 -8.41 5.93 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 115.002 1.482 . . . . 0.0 115.002 -174.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 10.2 mt . . . . . 0 C--O 1.248 0.997 0 CA-C-O 118.029 -0.986 . . . . 0.0 109.368 167.433 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.8 mt . . . . . 0 CA--C 1.537 0.459 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 14.7 t -138.53 162.12 29.91 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 126.395 1.878 . . . . 0.0 106.805 -175.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -116.5 144.05 44.82 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 106.03 -1.841 . . . . 0.0 106.03 172.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -144.36 157.66 44.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.385 0.612 . . . . 0.0 111.566 -176.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 16.1 p -105.3 171.07 7.52 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 126.292 1.837 . . . . 0.0 107.646 168.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -47.26 -43.85 22.44 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 124.72 1.208 . . . . 0.0 113.112 176.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 66.9 mm-40 -79.93 -35.04 38.35 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 122.654 0.382 . . . . 0.0 111.533 -175.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.2 m -71.81 -32.38 67.53 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 122.772 0.429 . . . . 0.0 111.315 176.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -52.72 -46.74 67.53 Favored 'General case' 0 N--CA 1.457 -0.116 0 C-N-CA 125.128 1.371 . . . . 0.0 112.245 -169.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 9.5 m -63.75 -38.4 90.98 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 118.105 0.412 . . . . 0.0 111.86 -176.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -68.81 -44.31 73.81 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 176.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 69.0 mm-40 -63.94 -37.21 86.56 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 122.451 0.3 . . . . 0.0 110.925 -178.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 28.8 p -80.52 0.1 35.2 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.992 0.917 . . . . 0.0 113.332 -177.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 70.8 m -98.13 28.76 3.84 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.097 0.959 . . . . 0.0 112.16 -177.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -136.73 81.06 1.85 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.209 1.004 . . . . 0.0 110.023 -178.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 82.64 -156.66 35.17 Favored Glycine 0 C--N 1.338 0.65 0 N-CA-C 110.722 -0.951 . . . . 0.0 110.722 173.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 44.9 t -74.17 135.4 27.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 N-CA-C 106.034 -1.839 . . . . 0.0 106.034 168.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 40.2 t -135.57 136.85 50.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 179.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.2 tt -120.01 111.36 17.8 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 106.198 -1.778 . . . . 0.0 106.198 -179.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -94.31 144.92 25.12 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 123.854 0.862 . . . . 0.0 109.104 -175.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -124.16 93.73 4.0 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 125.56 1.544 . . . . 0.0 107.469 -176.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -73.77 113.44 10.91 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 105.815 -1.92 . . . . 0.0 105.815 174.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -150.41 -176.57 5.53 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.727 1.211 . . . . 0.0 108.227 -171.156 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -152.13 149.15 22.58 Favored Pre-proline 0 C--N 1.331 -0.215 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 167.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -67.95 -12.65 35.95 Favored 'Trans proline' 0 N--CA 1.459 -0.543 0 CA-C-N 121.179 1.457 . . . . 0.0 113.071 -179.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 1.5 m95 -76.27 -12.84 60.15 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.665 0.786 . . . . 0.0 111.876 172.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 29.7 t -64.07 153.62 36.92 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.317 1.447 . . . . 0.0 111.089 -176.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -101.51 -62.98 0.76 Allowed Glycine 0 CA--C 1.532 1.137 0 C-N-CA 124.723 1.154 . . . . 0.0 111.268 170.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -64.88 -25.96 59.72 Favored 'Trans proline' 0 C--N 1.35 0.611 0 CA-C-N 120.472 2.136 . . . . 0.0 113.266 -173.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 25.7 m -57.59 -34.43 69.23 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 121.537 -0.727 . . . . 0.0 111.433 174.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.4 mmtp -67.7 -22.79 65.25 Favored 'General case' 0 CA--C 1.531 0.22 0 O-C-N 121.663 -0.648 . . . . 0.0 111.199 -179.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 34.0 mtm -71.15 -43.64 67.12 Favored 'General case' 0 C--N 1.34 0.179 0 CA-C-N 118.723 0.692 . . . . 0.0 110.359 176.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 13.4 tt -84.21 -23.32 7.78 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-O 118.817 -0.611 . . . . 0.0 111.691 -175.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -48.4 -51.17 53.19 Favored Pre-proline 0 CA--C 1.548 0.889 0 CA-C-N 119.959 1.254 . . . . 0.0 114.27 178.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -66.59 -29.36 44.08 Favored 'Trans proline' 0 C--N 1.351 0.685 0 CA-C-N 121.628 1.617 . . . . 0.0 112.108 176.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 5.1 t -68.06 -36.59 76.01 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 O-C-N 121.585 -0.697 . . . . 0.0 109.751 175.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 74.1 mt -67.21 -36.05 80.9 Favored 'General case' 0 C--N 1.34 0.166 0 CA-C-N 119.518 1.053 . . . . 0.0 111.153 172.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -62.1 -42.66 99.45 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 119.227 0.921 . . . . 0.0 110.808 171.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -63.91 -39.44 94.19 Favored 'General case' 0 CA--C 1.533 0.298 0 O-C-N 121.078 -1.014 . . . . 0.0 110.381 175.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 36.9 tp -62.81 -42.36 99.68 Favored 'General case' 0 CA--C 1.527 0.088 0 C-N-CA 123.754 0.822 . . . . 0.0 110.237 176.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -59.09 -43.15 91.83 Favored 'General case' 0 CA--C 1.522 -0.13 0 C-N-CA 123.363 0.665 . . . . 0.0 110.657 176.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -71.44 -10.67 60.14 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.327 0.651 . . . . 0.0 112.645 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 23.9 mm-40 -106.63 -28.41 10.24 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 125.419 1.487 . . . . 0.0 111.759 -178.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 23.1 mtp -131.73 -1.7 3.79 Favored 'General case' 0 N--CA 1.461 0.118 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 -169.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -54.69 -15.6 6.39 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 124.777 1.179 . . . . 0.0 115.616 -174.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -69.7 -28.91 66.24 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.842 1.257 . . . . 0.0 112.016 175.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 41.7 mmtm -123.88 -16.06 6.73 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 125.757 1.623 . . . . 0.0 112.39 -177.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 58.5 tp -119.28 139.04 52.56 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 123.982 0.913 . . . . 0.0 110.289 -170.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -111.69 145.67 38.87 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 105.009 -2.219 . . . . 0.0 105.009 168.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 90.4 mt -116.99 138.93 46.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 105.747 -1.946 . . . . 0.0 105.747 174.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 98.3 t -132.75 98.87 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 -171.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 54.2 mtpt -74.28 140.25 44.82 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 174.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 14.3 tt -142.71 128.05 16.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 177.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 64.6 t0 -87.57 107.22 18.49 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 124.4 1.08 . . . . 0.0 109.323 -169.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 29.0 m -61.69 -20.81 24.15 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 CA-C-O 118.737 -0.649 . . . . 0.0 112.143 -177.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -69.04 -14.06 62.81 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 119.691 1.132 . . . . 0.0 112.112 178.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -127.06 0.52 6.52 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.1 0.96 . . . . 0.0 111.997 178.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 67.8 m-80 -138.39 41.92 2.21 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.735 0.814 . . . . 0.0 111.104 -169.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 5.4 mp0 -54.62 -31.66 57.57 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.376 0.67 . . . . 0.0 112.104 176.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 -64.72 -46.69 81.23 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 118.471 0.578 . . . . 0.0 110.411 -178.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.6 -38.49 73.99 Favored 'General case' 0 C--O 1.223 -0.303 0 C-N-CA 123.162 0.585 . . . . 0.0 109.503 -178.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -58.09 -47.9 81.8 Favored 'General case' 0 CA--C 1.535 0.376 0 O-C-N 121.28 -0.888 . . . . 0.0 110.236 172.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -61.34 -29.02 70.33 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 124.117 0.865 . . . . 0.0 112.265 177.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 74.3 tttt -55.7 -28.73 57.26 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.774 1.23 . . . . 0.0 111.873 178.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -123.2 9.94 9.28 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.69 0.796 . . . . 0.0 111.956 178.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 63.57 31.71 81.71 Favored Glycine 0 CA--C 1.533 1.218 0 CA-C-O 119.459 -0.634 . . . . 0.0 112.578 -176.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 61.3 t -64.19 124.59 19.26 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 172.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 78.2 mtm -137.06 3.53 2.66 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.924 1.29 . . . . 0.0 111.522 -178.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 39.1 m -141.48 163.87 31.76 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 126.767 2.027 . . . . 0.0 107.532 175.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 41.1 pt -142.99 155.12 62.49 Favored Pre-proline 0 CA--C 1.546 0.806 0 C-N-CA 124.596 1.158 . . . . 0.0 108.626 174.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -67.62 137.68 39.15 Favored 'Cis proline' 0 C--N 1.349 0.587 0 CA-C-N 120.5 1.214 . . . . 0.0 110.204 -4.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 35.9 m -129.96 134.17 47.28 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 106.97 -1.493 . . . . 0.0 106.97 175.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 10.9 mp -114.47 126.54 55.07 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 -169.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -114.73 147.72 39.3 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 104.583 -2.377 . . . . 0.0 104.583 175.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.4 t -126.79 128.79 71.24 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.624 0 N-CA-C 104.706 -2.331 . . . . 0.0 104.706 -177.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.4 mp -130.22 147.89 52.0 Favored 'General case' 0 N--CA 1.445 -0.725 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 -172.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 21.4 tptm -133.74 118.32 17.95 Favored 'General case' 0 CA--C 1.514 -0.439 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 29.2 t70 51.15 33.89 10.17 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.486 1.515 . . . . 0.0 112.55 174.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 110.72 -3.48 29.07 Favored Glycine 0 CA--C 1.527 0.806 0 CA-C-O 118.062 -1.41 . . . . 0.0 114.869 169.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -130.2 144.78 51.56 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 120.027 1.914 . . . . 0.0 110.164 -177.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 13.6 p -65.55 133.23 30.94 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 176.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 8.0 p -126.28 -19.02 2.78 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-O 117.653 -1.165 . . . . 0.0 111.239 -179.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -156.48 169.96 23.42 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 121.116 1.78 . . . . 0.0 111.529 177.538 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 15.6 m -147.11 151.73 37.31 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.454 1.501 . . . . 0.0 108.907 178.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 65.1 m -152.25 157.39 41.35 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 126.18 1.792 . . . . 0.0 108.321 171.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 28.7 t -134.06 142.76 40.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 -176.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.56 -176.81 53.56 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 123.58 0.61 . . . . 0.0 112.44 177.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 66.1 t80 -63.17 150.4 42.98 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.39 1.076 . . . . 0.0 110.939 178.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -146.97 146.14 24.91 Favored Pre-proline 0 N--CA 1.467 0.384 0 C-N-CA 125.355 1.462 . . . . 0.0 107.4 168.034 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -71.24 157.66 56.62 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 122.444 2.096 . . . . 0.0 110.219 170.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 48.5 pttt -58.48 -30.29 66.87 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -178.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -67.18 -45.12 77.92 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 118.508 0.594 . . . . 0.0 109.946 178.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.47 -38.12 89.93 Favored 'General case' 0 CA--C 1.529 0.165 0 O-C-N 121.845 -0.534 . . . . 0.0 110.57 176.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 95.0 mt -64.34 -42.74 96.12 Favored 'General case' 0 C--O 1.226 -0.146 0 CA-C-O 119.26 -0.4 . . . . 0.0 111.327 176.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 15.8 mt-30 -58.11 -42.16 85.13 Favored 'General case' 0 C--O 1.226 -0.139 0 CA-C-N 118.584 0.629 . . . . 0.0 109.971 174.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -65.08 -40.09 94.15 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 118.115 0.416 . . . . 0.0 110.579 -179.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 68.9 tp -61.97 -43.74 98.21 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.44 1.096 . . . . 0.0 110.712 176.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 93.3 t -62.56 -43.44 98.43 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 123.585 0.754 . . . . 0.0 109.743 174.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -60.28 -27.67 67.47 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 125.101 1.36 . . . . 0.0 112.055 -172.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -56.07 -24.07 37.65 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.549 0.74 . . . . 0.0 112.668 174.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 47.4 m-70 -125.37 -3.42 7.39 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 -168.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 84.2 mt . . . . . 0 C--O 1.25 1.083 0 CA-C-N 118.785 0.721 . . . . 0.0 109.184 172.65 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.5 mt . . . . . 0 CA--C 1.537 0.457 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 18.2 t -138.36 161.97 30.62 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 C-N-CA 126.157 1.783 . . . . 0.0 106.887 -175.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 3.7 tppp? -116.33 142.04 47.37 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 106.001 -1.852 . . . . 0.0 106.001 172.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -146.36 166.33 26.66 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.399 0.619 . . . . 0.0 111.053 -177.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 28.5 p -135.47 174.36 10.7 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 126.444 1.897 . . . . 0.0 107.578 170.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -48.53 -29.78 4.57 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.851 1.26 . . . . 0.0 113.149 173.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -59.35 -29.84 67.95 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.071 1.348 . . . . 0.0 113.052 178.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 14.4 m -141.22 -7.1 1.04 Allowed 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 -169.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 77.8 t80 -53.75 -43.64 69.31 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 124.009 0.923 . . . . 0.0 111.772 -174.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.7 m -63.35 -38.91 92.98 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.086 0.554 . . . . 0.0 111.762 -179.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -68.13 -44.26 76.48 Favored 'General case' 0 N--CA 1.453 -0.313 0 O-C-N 122.05 -0.406 . . . . 0.0 109.954 177.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 67.3 mm-40 -63.11 -36.47 83.7 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 122.367 0.267 . . . . 0.0 110.985 -178.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 25.6 p -82.93 1.21 40.75 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.049 0.939 . . . . 0.0 113.367 -177.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 67.4 m -101.63 31.01 3.98 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.204 1.002 . . . . 0.0 111.746 -176.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -132.66 62.09 1.66 Allowed 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.198 0.999 . . . . 0.0 110.206 -178.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 91.54 -156.24 23.86 Favored Glycine 0 C--N 1.339 0.715 0 N-CA-C 109.899 -1.281 . . . . 0.0 109.899 176.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 94.4 t -70.81 135.32 28.32 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 168.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 55.7 t -137.51 142.95 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 N-CA-C 105.742 -1.947 . . . . 0.0 105.742 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.2 tt -122.94 100.87 7.11 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 -176.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -83.29 146.03 28.76 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.376 -179.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -124.46 94.08 4.1 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 125.906 1.682 . . . . 0.0 107.356 -177.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -73.91 112.79 10.37 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 105.891 -1.892 . . . . 0.0 105.891 175.157 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -148.56 -178.91 6.59 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.95 1.3 . . . . 0.0 108.475 -172.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -158.34 147.76 14.91 Favored Pre-proline 0 CA--C 1.531 0.245 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 167.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -62.87 -12.0 27.06 Favored 'Trans proline' 0 CA--C 1.535 0.573 0 CA-C-N 121.53 1.582 . . . . 0.0 116.086 -178.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 54.2 p-90 -70.72 -19.33 62.76 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 120.731 1.605 . . . . 0.0 111.784 171.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 15.3 t -61.2 162.58 7.3 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.41 1.484 . . . . 0.0 111.187 -177.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -119.94 -59.19 0.25 Allowed Glycine 0 CA--C 1.531 1.049 0 CA-C-O 118.513 -1.159 . . . . 0.0 110.694 171.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -54.13 -31.46 65.41 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 123.832 3.021 . . . . 0.0 114.118 179.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 79.8 m -52.37 -37.0 55.14 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.694 1.198 . . . . 0.0 111.915 174.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 75.2 mttt -83.06 -14.69 53.32 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.381 0.672 . . . . 0.0 110.861 -175.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 26.8 mtm -73.1 -43.71 61.39 Favored 'General case' 0 C--N 1.341 0.197 0 CA-C-N 118.886 0.767 . . . . 0.0 109.541 169.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 16.3 tt -80.37 -23.95 11.4 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-O 118.609 -0.71 . . . . 0.0 111.431 -178.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -48.39 -51.16 53.11 Favored Pre-proline 0 CA--C 1.548 0.881 0 CA-C-N 120.359 1.436 . . . . 0.0 114.315 179.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -66.9 -25.76 44.81 Favored 'Trans proline' 0 C--N 1.349 0.59 0 CA-C-N 121.958 1.735 . . . . 0.0 112.597 176.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.5 t -71.4 -35.77 58.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 O-C-N 121.454 -0.779 . . . . 0.0 109.589 174.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 95.7 mt -66.78 -35.26 79.67 Favored 'General case' 0 C--N 1.341 0.202 0 CA-C-N 119.515 1.052 . . . . 0.0 111.233 170.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -63.09 -42.13 99.55 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 119.566 1.075 . . . . 0.0 110.83 171.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -60.73 -44.86 96.11 Favored 'General case' 0 CA--C 1.53 0.174 0 O-C-N 121.505 -0.747 . . . . 0.0 110.021 173.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 34.0 tp -60.7 -41.85 96.02 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.668 0.787 . . . . 0.0 110.355 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -60.97 -43.5 98.7 Favored 'General case' 0 CA--C 1.521 -0.172 0 C-N-CA 123.264 0.626 . . . . 0.0 110.82 177.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -72.41 -10.71 60.13 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.276 0.63 . . . . 0.0 112.502 179.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -104.44 -28.57 11.25 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 125.31 1.444 . . . . 0.0 111.367 -178.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 25.4 mtp -133.69 -2.66 2.98 Favored 'General case' 0 C--N 1.339 0.146 0 N-CA-C 113.966 1.099 . . . . 0.0 113.966 -169.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -55.05 -17.2 9.44 Favored Glycine 0 CA--C 1.534 1.259 0 CA-C-N 120.148 1.34 . . . . 0.0 115.234 -173.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -67.14 -30.7 70.75 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.727 1.211 . . . . 0.0 111.934 174.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 40.3 mmtm -117.21 -17.41 10.22 Favored 'General case' 0 N--CA 1.462 0.149 0 C-N-CA 125.989 1.716 . . . . 0.0 111.938 -178.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 46.8 tp -116.75 154.66 30.27 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.2 1.0 . . . . 0.0 110.599 -169.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -130.12 144.56 51.42 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 104.11 -2.552 . . . . 0.0 104.11 167.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 75.8 mt -117.7 138.27 48.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 105.266 -2.124 . . . . 0.0 105.266 177.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 96.9 t -133.09 98.2 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 -169.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 52.6 mtpt -74.11 139.57 44.67 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 175.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 13.5 tt -141.76 127.16 18.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 176.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -85.27 103.73 14.48 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.615 1.166 . . . . 0.0 108.901 -171.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 29.7 m -59.85 -25.63 33.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 118.614 -0.708 . . . . 0.0 112.003 -174.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -65.41 -17.82 64.83 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 119.494 1.043 . . . . 0.0 112.055 -178.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -120.65 5.31 10.56 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.103 1.361 . . . . 0.0 111.037 178.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 66.5 m-80 -141.39 40.28 1.74 Allowed 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.588 1.155 . . . . 0.0 109.665 -171.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 51.2 mm-40 -55.2 -31.29 61.31 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.854 0.861 . . . . 0.0 110.893 175.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -65.91 -50.42 64.5 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 124.056 0.943 . . . . 0.0 109.941 179.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.9 -38.8 83.42 Favored 'General case' 0 C--O 1.223 -0.299 0 C-N-CA 123.37 0.668 . . . . 0.0 109.643 -178.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -58.99 -48.03 83.05 Favored 'General case' 0 CA--C 1.533 0.299 0 O-C-N 121.061 -1.024 . . . . 0.0 110.305 172.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -60.95 -28.77 69.2 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 123.901 0.762 . . . . 0.0 112.331 177.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 47.8 tptt -56.33 -29.2 60.99 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.723 1.209 . . . . 0.0 111.471 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -124.16 10.91 8.77 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.507 0.723 . . . . 0.0 111.679 -179.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 63.75 31.16 79.85 Favored Glycine 0 CA--C 1.532 1.14 0 C-N-CA 123.643 0.639 . . . . 0.0 112.584 -176.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 49.3 t -65.7 123.78 19.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 171.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 67.1 mtt -136.07 3.64 2.92 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.693 1.197 . . . . 0.0 111.463 -178.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 25.6 m -143.93 161.53 38.46 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 126.849 2.06 . . . . 0.0 107.302 178.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 39.0 pt -143.25 156.11 61.23 Favored Pre-proline 0 CA--C 1.545 0.761 0 C-N-CA 124.636 1.175 . . . . 0.0 108.76 177.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -67.15 139.1 44.69 Favored 'Cis proline' 0 C--N 1.35 0.629 0 CA-C-N 120.347 1.16 . . . . 0.0 110.168 -4.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 26.6 m -130.14 140.76 50.74 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 174.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 89.8 mt -120.08 125.0 47.2 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 106.546 -1.65 . . . . 0.0 106.546 -169.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -114.86 119.83 37.93 Favored 'General case' 0 CA--C 1.512 -0.509 0 N-CA-C 103.663 -2.717 . . . . 0.0 103.663 177.064 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.8 t -90.58 123.18 42.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 103.217 -2.883 . . . . 0.0 103.217 172.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.1 mp -114.66 155.84 25.85 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 173.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -137.91 122.75 18.84 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 173.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.0 t70 49.55 37.33 12.15 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.034 1.334 . . . . 0.0 112.471 176.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 103.91 -4.27 45.66 Favored Glycine 0 CA--C 1.529 0.918 0 CA-C-O 118.217 -1.324 . . . . 0.0 115.202 168.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -131.85 152.81 50.76 Favored 'General case' 0 C--N 1.339 0.137 0 CA-C-N 120.054 1.927 . . . . 0.0 110.209 -177.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 40.8 t -63.14 134.15 28.5 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.5 p -119.02 -20.81 4.8 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 C-N-CA 125.377 1.471 . . . . 0.0 110.006 176.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -161.04 169.15 23.06 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 120.23 1.377 . . . . 0.0 110.685 169.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 8.9 m -136.14 150.83 49.24 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.369 1.468 . . . . 0.0 108.288 173.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 63.7 m -151.07 159.11 44.71 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.483 1.513 . . . . 0.0 108.559 169.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 40.4 t -133.84 148.54 30.38 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 N-CA-C 107.929 -1.138 . . . . 0.0 107.929 -177.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 76.86 -174.88 54.08 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 123.45 0.548 . . . . 0.0 112.404 175.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -64.78 148.62 50.85 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.001 0.92 . . . . 0.0 110.935 -179.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.75 142.18 16.41 Favored Pre-proline 0 CA--C 1.533 0.322 0 C-N-CA 125.455 1.502 . . . . 0.0 107.093 167.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -72.45 161.44 44.23 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 122.747 2.298 . . . . 0.0 110.635 175.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 41.5 pttt -59.25 -29.99 67.95 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 -178.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -66.38 -49.7 65.95 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 118.418 0.554 . . . . 0.0 109.908 176.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.57 -39.96 95.73 Favored 'General case' 0 CA--C 1.528 0.132 0 O-C-N 122.026 -0.421 . . . . 0.0 110.599 179.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 78.4 mt -62.94 -43.55 98.47 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.021 0.528 . . . . 0.0 111.188 177.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -59.16 -41.78 89.19 Favored 'General case' 0 C--O 1.225 -0.189 0 CA-C-N 118.342 0.519 . . . . 0.0 109.981 176.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -66.78 -38.98 87.6 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 118.624 0.647 . . . . 0.0 110.876 -179.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 67.4 tp -62.47 -36.64 83.12 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.842 1.257 . . . . 0.0 110.972 176.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 94.2 t -70.48 -49.32 53.84 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 CA-C-N 119.178 0.899 . . . . 0.0 109.501 171.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -56.46 -40.55 75.03 Favored 'General case' 0 CA--C 1.52 -0.204 0 C-N-CA 125.901 1.68 . . . . 0.0 111.854 -168.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -67.37 -6.21 17.92 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 -176.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 90.4 m-70 -120.89 -7.54 9.49 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.346 1.058 . . . . 0.0 112.686 177.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 60.6 mt . . . . . 0 C--O 1.248 0.99 0 CA-C-N 119.239 0.927 . . . . 0.0 109.15 173.811 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.2 mt . . . . . 0 CA--C 1.536 0.421 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 31.9 t -136.33 163.48 33.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 126.192 1.797 . . . . 0.0 106.877 -175.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -118.05 142.84 46.96 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 105.919 -1.882 . . . . 0.0 105.919 174.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -144.52 166.4 25.26 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.407 0.622 . . . . 0.0 111.027 -177.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 18.3 p -134.09 171.21 14.54 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 126.448 1.899 . . . . 0.0 107.731 171.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -52.73 -29.42 26.88 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.611 1.164 . . . . 0.0 113.046 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 56.7 mt-30 -62.87 -28.98 70.4 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.216 1.406 . . . . 0.0 113.004 179.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.4 m -136.27 -6.63 2.04 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 113.517 0.932 . . . . 0.0 113.517 -169.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -52.19 -43.97 64.44 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.431 1.092 . . . . 0.0 111.677 -178.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.5 m -63.21 -38.95 93.19 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.063 0.545 . . . . 0.0 111.857 -179.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -67.98 -44.35 76.87 Favored 'General case' 0 N--CA 1.452 -0.344 0 O-C-N 122.02 -0.425 . . . . 0.0 110.066 177.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 66.7 mm-40 -63.22 -35.87 81.75 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 122.416 0.286 . . . . 0.0 110.946 -178.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 27.5 p -83.51 1.37 42.22 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.044 0.938 . . . . 0.0 113.377 -177.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 68.1 m -102.02 30.97 4.13 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.18 0.992 . . . . 0.0 111.802 -176.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -132.68 57.79 1.78 Allowed 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.1 0.96 . . . . 0.0 110.526 -177.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 98.65 -153.43 19.88 Favored Glycine 0 C--N 1.337 0.636 0 N-CA-C 110.084 -1.206 . . . . 0.0 110.084 174.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 55.0 t -72.05 135.06 28.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 N-CA-C 105.744 -1.947 . . . . 0.0 105.744 167.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 46.6 t -137.5 142.96 35.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 105.908 -1.886 . . . . 0.0 105.908 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.6 tt -125.27 101.42 6.97 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 106.03 -1.841 . . . . 0.0 106.03 -177.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -82.55 144.64 30.23 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.275 -179.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -121.18 93.79 4.13 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 125.955 1.702 . . . . 0.0 107.166 -178.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -72.7 111.6 7.99 Favored 'General case' 0 C--O 1.239 0.545 0 N-CA-C 105.689 -1.967 . . . . 0.0 105.689 174.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -146.86 -177.46 5.67 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 125.241 1.417 . . . . 0.0 108.168 -171.643 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -155.73 149.59 19.25 Favored Pre-proline 0 C--N 1.33 -0.265 0 N-CA-C 106.405 -1.702 . . . . 0.0 106.405 168.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -68.53 -12.58 35.17 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 121.378 1.386 . . . . 0.0 114.231 -176.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 52.0 p-90 -71.02 -19.69 62.48 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 120.233 1.378 . . . . 0.0 112.192 169.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 27.8 t -60.36 153.25 23.23 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.964 1.306 . . . . 0.0 111.419 -172.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -102.46 -61.2 0.73 Allowed Glycine 0 CA--C 1.533 1.195 0 C-N-CA 124.585 1.088 . . . . 0.0 111.626 171.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -66.95 -25.57 44.63 Favored 'Trans proline' 0 C--N 1.348 0.517 0 CA-C-N 120.46 2.13 . . . . 0.0 112.702 -174.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 24.6 m -56.41 -35.51 67.87 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 121.235 -0.916 . . . . 0.0 111.023 172.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.6 mmtp -69.31 -26.21 64.61 Favored 'General case' 0 CA--C 1.529 0.155 0 O-C-N 121.564 -0.71 . . . . 0.0 111.296 -178.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 5.1 ptt? -85.7 -31.55 22.41 Favored 'General case' 0 C--N 1.34 0.188 0 CA-C-N 118.961 0.8 . . . . 0.0 111.414 -176.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 18.2 tt -77.57 -25.26 14.78 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-O 118.591 -0.718 . . . . 0.0 111.537 170.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -49.71 -49.57 72.23 Favored Pre-proline 0 CA--C 1.547 0.839 0 CA-C-N 120.379 1.445 . . . . 0.0 114.367 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -66.35 -28.88 46.55 Favored 'Trans proline' 0 C--N 1.349 0.601 0 CA-C-N 122.038 1.763 . . . . 0.0 112.122 176.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.1 t -67.82 -37.26 78.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 O-C-N 121.666 -0.646 . . . . 0.0 109.553 174.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 96.1 mt -66.74 -34.82 78.69 Favored 'General case' 0 C--N 1.34 0.175 0 CA-C-N 119.46 1.027 . . . . 0.0 111.422 171.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -63.05 -42.33 99.7 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 119.556 1.071 . . . . 0.0 110.716 171.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -63.94 -39.49 94.27 Favored 'General case' 0 CA--C 1.531 0.24 0 O-C-N 121.243 -0.911 . . . . 0.0 110.421 175.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 42.8 tp -62.4 -43.04 99.77 Favored 'General case' 0 CA--C 1.527 0.077 0 C-N-CA 123.643 0.777 . . . . 0.0 110.205 175.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -60.06 -42.36 94.34 Favored 'General case' 0 CA--C 1.521 -0.137 0 C-N-CA 123.453 0.701 . . . . 0.0 110.805 178.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 -71.98 -10.8 60.28 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.263 0.625 . . . . 0.0 112.481 -179.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -105.54 -32.53 8.46 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 125.265 1.426 . . . . 0.0 111.415 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 71.5 mmm -125.77 -3.14 7.18 Favored 'General case' 0 C--O 1.226 -0.138 0 CA-C-O 118.414 -0.803 . . . . 0.0 113.152 -167.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -57.63 -13.59 12.48 Favored Glycine 0 CA--C 1.533 1.185 0 CA-C-N 119.769 1.168 . . . . 0.0 115.847 -172.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -77.1 -24.98 51.73 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 118.462 1.131 . . . . 0.0 111.721 174.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 51.1 mmtt -117.38 -21.08 8.85 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 125.648 1.579 . . . . 0.0 111.445 -177.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 52.2 tp -122.26 148.45 44.98 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 125.16 1.384 . . . . 0.0 110.223 -169.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -120.64 145.42 47.42 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 105.116 -2.179 . . . . 0.0 105.116 167.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 77.3 mt -115.01 138.01 46.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 105.637 -1.986 . . . . 0.0 105.637 176.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 93.5 t -133.56 98.6 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-N 118.879 0.763 . . . . 0.0 109.236 -170.193 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 52.9 mtpt -73.89 140.37 45.63 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 176.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 13.9 tt -142.72 127.87 16.39 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 176.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 50.6 t0 -84.02 103.43 13.25 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 124.732 1.213 . . . . 0.0 109.004 -172.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 28.3 m -59.36 -28.36 39.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 118.819 -0.61 . . . . 0.0 111.888 -174.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -66.64 -19.3 65.73 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 119.258 0.935 . . . . 0.0 111.846 -177.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -114.62 1.41 14.23 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.547 1.539 . . . . 0.0 110.828 178.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 68.3 m-80 -141.67 42.42 1.72 Allowed 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 124.4 1.08 . . . . 0.0 109.54 -169.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 45.0 mm-40 -55.81 -32.57 63.67 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.041 0.936 . . . . 0.0 111.269 178.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 -66.08 -47.58 73.8 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 118.384 0.538 . . . . 0.0 110.47 179.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.94 -39.41 79.59 Favored 'General case' 0 C--O 1.223 -0.327 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 -178.734 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -58.99 -47.81 83.83 Favored 'General case' 0 CA--C 1.533 0.325 0 O-C-N 121.207 -0.933 . . . . 0.0 110.264 173.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -60.85 -28.72 68.87 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 124.062 0.839 . . . . 0.0 112.405 177.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 24.4 tptp -56.18 -29.21 60.53 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.68 1.192 . . . . 0.0 111.47 179.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -124.27 10.73 8.69 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.557 0.743 . . . . 0.0 111.61 -179.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 63.71 31.36 80.51 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 123.728 0.68 . . . . 0.0 112.588 -177.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 53.7 t -65.55 123.67 18.94 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 172.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 99.0 mtp -135.99 3.49 2.93 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.757 1.223 . . . . 0.0 111.486 -179.121 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 24.5 m -143.89 160.96 39.88 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 126.656 1.983 . . . . 0.0 107.409 178.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 41.9 pt -143.14 154.9 61.89 Favored Pre-proline 0 CA--C 1.545 0.781 0 C-N-CA 124.468 1.107 . . . . 0.0 108.93 177.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -67.1 139.69 47.54 Favored 'Cis proline' 0 C--N 1.35 0.626 0 CA-C-N 120.373 1.169 . . . . 0.0 110.42 -4.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 24.6 m -130.36 140.8 50.59 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 174.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 86.2 mt -121.28 123.57 42.52 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 -169.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -114.06 122.45 46.93 Favored 'General case' 0 CA--C 1.512 -0.513 0 N-CA-C 103.627 -2.731 . . . . 0.0 103.627 178.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.2 t -96.02 127.18 48.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 N-CA-C 104.002 -2.592 . . . . 0.0 104.002 174.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.0 mp -119.66 155.05 33.09 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 177.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -137.05 119.47 15.82 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 106.376 -1.713 . . . . 0.0 106.376 176.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.0 t70 49.52 38.2 14.04 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.97 1.308 . . . . 0.0 112.482 177.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 104.67 -5.1 43.31 Favored Glycine 0 CA--C 1.529 0.944 0 CA-C-O 118.148 -1.362 . . . . 0.0 115.46 168.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -130.81 150.57 51.92 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 120.006 1.903 . . . . 0.0 110.276 -177.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 42.9 t -62.73 133.29 28.6 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.4 p -119.25 -21.03 4.61 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 125.19 1.396 . . . . 0.0 110.36 176.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -158.51 168.59 26.51 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 120.582 1.537 . . . . 0.0 110.317 173.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 18.1 m -146.37 143.31 28.99 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.385 1.074 . . . . 0.0 109.063 175.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 49.5 m -144.62 156.23 44.02 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.561 1.544 . . . . 0.0 108.66 176.213 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 41.2 t -133.76 146.44 31.77 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 -175.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 75.21 -174.25 52.12 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 123.292 0.473 . . . . 0.0 112.271 178.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 67.4 t80 -65.3 148.66 51.31 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.674 0.79 . . . . 0.0 111.347 -178.175 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.29 140.18 14.64 Favored Pre-proline 0 CA--C 1.534 0.349 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 167.383 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -72.05 161.66 44.07 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 122.718 2.279 . . . . 0.0 110.497 175.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 49.3 pttt -58.51 -29.34 66.19 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 113.571 0.952 . . . . 0.0 113.571 -178.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -65.91 -50.34 64.8 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 118.595 0.634 . . . . 0.0 109.559 176.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.53 -39.07 93.46 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 122.721 0.409 . . . . 0.0 110.821 178.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 87.8 mt -63.49 -44.06 95.47 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 122.985 0.514 . . . . 0.0 111.156 176.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 -61.17 -41.95 97.68 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-N 118.426 0.557 . . . . 0.0 110.153 176.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -63.31 -41.18 98.91 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 118.15 0.432 . . . . 0.0 110.238 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 61.3 tp -61.71 -46.01 91.5 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.705 1.202 . . . . 0.0 110.674 176.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 72.8 t -58.32 -44.86 89.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 CA-C-N 118.75 0.705 . . . . 0.0 109.462 173.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -62.59 -25.29 68.0 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.905 1.282 . . . . 0.0 112.153 -174.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -57.61 -22.14 43.42 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 118.506 -0.759 . . . . 0.0 112.452 172.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 70.8 m-70 -124.09 -8.26 7.69 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 -168.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 77.3 mt . . . . . 0 C--O 1.246 0.886 0 CA-C-O 118.363 -0.827 . . . . 0.0 109.416 171.54 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 12.0 mt . . . . . 0 N--CA 1.449 -0.517 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 5.4 t -137.45 160.85 34.87 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 C-N-CA 126.702 2.001 . . . . 0.0 106.472 -174.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.34 133.07 50.12 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 105.358 -2.09 . . . . 0.0 105.358 176.506 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -142.8 174.96 10.19 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 123.611 0.764 . . . . 0.0 111.421 -170.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.3 p -138.14 171.74 13.94 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 126.732 2.013 . . . . 0.0 106.661 168.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -50.45 -27.95 7.42 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 175.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -55.06 -31.33 61.05 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.732 1.613 . . . . 0.0 112.756 177.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.1 m -139.67 -10.1 1.21 Allowed 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 124.035 0.934 . . . . 0.0 113.059 -170.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -53.57 -42.08 67.2 Favored 'General case' 0 C--O 1.231 0.117 0 C-N-CA 124.472 1.109 . . . . 0.0 111.316 -177.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.4 m -63.38 -36.9 85.27 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.16 0.584 . . . . 0.0 112.027 179.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -69.7 -44.25 70.79 Favored 'General case' 0 N--CA 1.453 -0.313 0 O-C-N 121.998 -0.439 . . . . 0.0 110.005 177.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -62.8 -40.88 98.74 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 122.827 0.451 . . . . 0.0 110.463 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 26.0 p -77.3 1.84 17.53 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.867 0.867 . . . . 0.0 113.252 -179.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 63.5 m -105.18 32.76 4.02 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.531 1.132 . . . . 0.0 111.206 179.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -130.97 51.48 2.13 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.2 1.0 . . . . 0.0 110.51 -178.125 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 97.27 -156.7 20.85 Favored Glycine 0 C--N 1.337 0.588 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 179.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 74.4 t -70.94 136.59 25.59 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 168.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 54.6 t -137.84 135.55 45.66 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 N-CA-C 106.039 -1.838 . . . . 0.0 106.039 -179.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.0 tt -113.25 99.95 8.2 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 105.754 -1.943 . . . . 0.0 105.754 -176.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -83.07 146.62 28.6 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 179.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -127.21 94.17 3.93 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 126.236 1.814 . . . . 0.0 107.66 -176.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -74.5 114.07 12.47 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 106.109 -1.811 . . . . 0.0 106.109 175.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -149.99 -177.04 5.68 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.918 1.287 . . . . 0.0 108.778 -171.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -152.86 147.16 18.77 Favored Pre-proline 0 CA--C 1.531 0.245 0 N-CA-C 105.936 -1.875 . . . . 0.0 105.936 167.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -58.81 -18.39 41.4 Favored 'Trans proline' 0 CA--C 1.531 0.36 0 C-N-CA 121.933 1.755 . . . . 0.0 114.844 178.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 1.9 m95 -74.28 -14.65 60.94 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 118.91 0.777 . . . . 0.0 111.908 176.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 34.9 t -63.95 152.54 39.69 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.41 1.484 . . . . 0.0 111.14 -175.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -100.5 -64.4 0.8 Allowed Glycine 0 CA--C 1.53 1.002 0 CA-C-O 118.446 -1.197 . . . . 0.0 110.997 171.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -62.3 -26.28 77.08 Favored 'Trans proline' 0 C--N 1.35 0.646 0 CA-C-N 120.44 2.12 . . . . 0.0 113.675 -174.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 33.7 m -57.01 -34.41 68.15 Favored 'General case' 0 CA--C 1.537 0.446 0 O-C-N 121.577 -0.702 . . . . 0.0 111.627 174.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.2 mmtp -67.53 -24.36 65.55 Favored 'General case' 0 CA--C 1.531 0.226 0 O-C-N 121.529 -0.732 . . . . 0.0 111.118 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 30.8 mtm -72.45 -42.7 64.72 Favored 'General case' 0 C--N 1.34 0.159 0 CA-C-N 118.581 0.628 . . . . 0.0 110.439 177.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 17.1 tt -83.48 -22.12 8.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-O 118.726 -0.654 . . . . 0.0 111.7 -175.117 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -50.24 -52.18 56.3 Favored Pre-proline 0 CA--C 1.549 0.915 0 CA-C-N 120.059 1.3 . . . . 0.0 113.674 177.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -66.84 -27.62 43.71 Favored 'Trans proline' 0 C--N 1.351 0.675 0 CA-C-N 121.606 1.609 . . . . 0.0 112.305 176.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 22.0 t -68.1 -39.19 80.97 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 O-C-N 121.541 -0.724 . . . . 0.0 109.5 175.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 53.2 mt -65.31 -36.3 83.62 Favored 'General case' 0 C--N 1.34 0.16 0 CA-C-N 119.265 0.939 . . . . 0.0 111.085 172.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -63.62 -38.5 91.36 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 118.803 0.729 . . . . 0.0 111.178 172.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -66.63 -35.42 80.15 Favored 'General case' 0 CA--C 1.531 0.244 0 O-C-N 120.35 -1.469 . . . . 0.0 110.691 173.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.58 -44.84 92.88 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.594 0.758 . . . . 0.0 109.733 177.014 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 53.2 t0 -53.66 -48.22 69.64 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 124.972 1.309 . . . . 0.0 110.397 172.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -68.43 -8.11 37.67 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -178.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 77.7 mt-10 -109.6 -36.64 5.9 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.996 1.319 . . . . 0.0 112.265 -176.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 6.2 ptp -145.12 22.96 1.53 Allowed 'General case' 0 C--N 1.341 0.212 0 N-CA-C 114.865 1.432 . . . . 0.0 114.865 178.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -60.84 -5.68 5.69 Favored Glycine 0 CA--C 1.537 1.46 0 CA-C-N 119.996 1.271 . . . . 0.0 115.221 177.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -78.6 -33.17 47.68 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.586 1.154 . . . . 0.0 111.296 170.035 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -95.45 -35.23 11.79 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 124.844 1.258 . . . . 0.0 110.659 178.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 60.8 tp -105.14 153.06 22.03 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.452 1.101 . . . . 0.0 111.745 -169.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 14.4 ttmm -121.85 144.46 48.82 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 104.426 -2.435 . . . . 0.0 104.426 166.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 79.3 mt -120.66 135.62 60.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 104.872 -2.269 . . . . 0.0 104.872 179.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 99.3 t -130.0 98.61 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 -172.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 52.4 mtmt -71.47 138.88 49.36 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 172.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 17.1 tt -142.28 123.59 12.24 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 177.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 59.3 t0 -83.32 106.98 15.53 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 124.282 1.033 . . . . 0.0 108.566 -173.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 31.7 m -60.07 -24.68 30.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 118.551 -0.737 . . . . 0.0 112.043 -175.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -64.75 -19.73 65.95 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 119.659 1.118 . . . . 0.0 112.002 -179.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -116.44 4.44 13.34 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.069 1.347 . . . . 0.0 110.85 178.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 68.4 m-80 -141.35 39.16 1.73 Allowed 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 124.537 1.135 . . . . 0.0 110.169 -169.141 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 53.4 mm-40 -56.48 -34.8 67.26 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.358 0.663 . . . . 0.0 110.851 176.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -65.34 -46.18 81.26 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 122.78 0.432 . . . . 0.0 110.305 177.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.29 -40.62 86.12 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.482 0.713 . . . . 0.0 110.043 -178.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -58.26 -49.49 76.91 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.389 0.675 . . . . 0.0 110.109 172.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -59.67 -29.57 67.31 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 123.958 0.789 . . . . 0.0 112.432 177.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 22.6 ttmt -55.39 -28.91 57.11 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.497 1.519 . . . . 0.0 112.042 178.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -123.61 9.49 8.98 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 123.868 0.867 . . . . 0.0 111.948 178.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 65.14 28.77 73.94 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 123.819 0.723 . . . . 0.0 112.935 -176.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 54.5 t -61.67 128.99 24.07 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 172.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 22.4 ttt -137.93 0.37 2.17 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.573 1.149 . . . . 0.0 111.145 -177.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 25.2 m -145.08 163.95 32.72 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 126.558 1.943 . . . . 0.0 107.612 179.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 39.5 pt -143.41 155.82 60.77 Favored Pre-proline 0 CA--C 1.547 0.832 0 C-N-CA 124.603 1.161 . . . . 0.0 108.85 176.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -67.24 138.66 42.8 Favored 'Cis proline' 0 C--N 1.351 0.671 0 CA-C-N 120.453 1.197 . . . . 0.0 110.288 -4.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 32.8 m -130.22 141.1 50.66 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 175.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 83.0 mt -122.62 128.47 50.71 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 -167.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -122.54 118.36 28.06 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 104.013 -2.588 . . . . 0.0 104.013 -178.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 14.7 t -92.92 119.28 40.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 104.108 -2.553 . . . . 0.0 104.108 173.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.8 mp -109.74 153.91 23.65 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 172.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -134.34 125.06 26.84 Favored 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 170.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.0 t70 48.48 35.02 5.31 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.234 1.414 . . . . 0.0 112.181 173.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 101.69 0.67 52.7 Favored Glycine 0 CA--C 1.532 1.146 0 CA-C-O 117.876 -1.513 . . . . 0.0 115.289 170.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -123.29 146.42 47.9 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 120.491 2.145 . . . . 0.0 109.5 176.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 11.4 p -68.67 132.48 32.89 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 170.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 33.7 m -119.91 -21.0 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 124.439 1.096 . . . . 0.0 110.996 178.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -155.75 162.86 40.45 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 120.44 1.473 . . . . 0.0 110.851 174.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 9.0 m -139.13 151.06 46.36 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.673 1.189 . . . . 0.0 108.708 177.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 48.6 m -151.55 159.32 44.17 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.408 1.483 . . . . 0.0 108.874 169.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 42.7 t -133.93 144.67 34.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 -176.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 77.87 177.97 48.06 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 123.639 0.638 . . . . 0.0 112.494 176.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 55.2 t80 -61.35 145.14 52.53 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 123.866 0.866 . . . . 0.0 111.089 -179.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.37 141.27 14.91 Favored Pre-proline 0 CA--C 1.535 0.403 0 C-N-CA 126.206 1.802 . . . . 0.0 106.843 177.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -72.35 156.79 54.38 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 122.409 2.073 . . . . 0.0 110.722 176.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 42.2 pttt -57.5 -32.54 67.13 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 -175.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -68.77 -43.04 76.59 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 118.5 0.591 . . . . 0.0 109.504 178.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.47 -42.05 98.6 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 118.354 0.525 . . . . 0.0 110.517 176.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 97.1 mt -60.86 -48.84 79.99 Favored 'General case' 0 N--CA 1.461 0.095 0 CA-C-O 121.08 0.467 . . . . 0.0 110.686 178.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -71.57 -28.29 63.74 Favored 'General case' 0 N--CA 1.451 -0.381 0 O-C-N 122.037 -0.414 . . . . 0.0 110.866 -175.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -70.03 -37.25 75.55 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 118.404 0.547 . . . . 0.0 111.355 170.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 8.7 tp -62.79 -34.5 77.4 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.5 1.12 . . . . 0.0 110.274 174.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 48.9 t -69.99 -45.97 74.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 123.836 0.854 . . . . 0.0 110.066 169.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -59.91 -36.58 77.3 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 124.73 1.212 . . . . 0.0 111.937 -172.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 11.0 ptmm? -67.06 -6.25 16.5 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 178.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -123.35 -18.07 6.36 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.136 0.974 . . . . 0.0 113.363 175.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 31.7 mt . . . . . 0 C--O 1.249 1.034 0 CA-C-N 119.913 1.233 . . . . 0.0 109.459 171.784 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.1 mt . . . . . 0 C--O 1.237 0.4 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 44.6 t -138.79 164.03 26.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 126.494 1.917 . . . . 0.0 106.733 -174.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 4.7 mtpt -117.01 142.84 46.45 Favored 'General case' 0 CA--C 1.517 -0.31 0 C-N-CA 125.345 1.458 . . . . 0.0 107.373 173.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -142.81 165.62 26.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.422 0.63 . . . . 0.0 110.525 178.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 17.5 p -132.55 172.25 12.75 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 126.254 1.822 . . . . 0.0 107.664 170.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -52.39 -29.53 24.59 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.238 1.015 . . . . 0.0 113.111 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 56.1 mt-30 -63.47 -28.96 70.32 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.12 1.368 . . . . 0.0 113.174 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.2 m -136.88 -5.49 1.92 Allowed 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 113.842 1.053 . . . . 0.0 113.842 -168.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -52.39 -44.07 65.12 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.166 0.987 . . . . 0.0 111.65 -177.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.5 m -63.23 -38.57 91.68 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.129 0.572 . . . . 0.0 111.849 -179.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -68.1 -44.34 76.45 Favored 'General case' 0 N--CA 1.452 -0.337 0 O-C-N 121.994 -0.442 . . . . 0.0 110.023 177.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 66.1 mm-40 -63.61 -35.76 81.56 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 122.391 0.276 . . . . 0.0 110.979 -178.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 26.4 p -83.91 1.44 43.36 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.029 0.931 . . . . 0.0 113.329 -177.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 69.1 m -100.17 30.27 3.89 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.23 1.012 . . . . 0.0 111.742 -177.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -133.26 61.95 1.67 Allowed 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.297 1.039 . . . . 0.0 110.195 -177.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 92.24 -156.53 23.52 Favored Glycine 0 C--N 1.338 0.694 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 175.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 59.1 t -71.31 134.23 30.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 N-CA-C 106.506 -1.665 . . . . 0.0 106.506 168.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 47.1 t -136.99 141.11 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 105.915 -1.883 . . . . 0.0 105.915 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 3.7 tt -122.19 100.3 6.89 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 106.255 -1.757 . . . . 0.0 106.255 -176.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -83.25 145.42 29.14 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.293 -179.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -123.95 94.12 4.13 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 126.083 1.753 . . . . 0.0 107.196 -177.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -74.13 112.26 10.09 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 105.884 -1.895 . . . . 0.0 105.884 174.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -148.3 -177.12 5.59 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.704 1.201 . . . . 0.0 108.608 -172.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -155.87 146.98 16.55 Favored Pre-proline 0 CA--C 1.531 0.232 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 168.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -60.75 -17.27 48.98 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 121.818 1.679 . . . . 0.0 116.01 -177.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 54.0 p-90 -70.04 -20.12 63.26 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 120.03 1.286 . . . . 0.0 111.914 173.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 29.0 t -59.58 150.97 25.66 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.991 1.316 . . . . 0.0 110.971 -174.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -104.99 -58.61 0.67 Allowed Glycine 0 CA--C 1.531 1.062 0 CA-C-O 118.704 -1.053 . . . . 0.0 110.97 172.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -56.54 -33.08 91.88 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 123.217 2.611 . . . . 0.0 113.712 -179.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 29.7 m -57.82 -34.57 69.81 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.441 0.696 . . . . 0.0 111.403 176.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.4 mmtp -68.38 -24.54 64.79 Favored 'General case' 0 CA--C 1.531 0.22 0 O-C-N 121.5 -0.75 . . . . 0.0 111.063 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 31.1 mtm -70.8 -42.27 70.52 Favored 'General case' 0 C--N 1.34 0.186 0 CA-C-N 118.742 0.701 . . . . 0.0 110.405 176.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 19.1 tt -85.0 -23.76 7.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 CA-C-O 118.53 -0.748 . . . . 0.0 111.782 -175.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -49.38 -50.52 64.55 Favored Pre-proline 0 CA--C 1.548 0.867 0 CA-C-N 120.088 1.313 . . . . 0.0 114.191 178.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -66.93 -27.76 42.83 Favored 'Trans proline' 0 C--N 1.351 0.674 0 CA-C-N 121.779 1.671 . . . . 0.0 112.069 176.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.8 t -68.94 -37.12 76.87 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 O-C-N 121.589 -0.694 . . . . 0.0 109.769 173.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 95.6 mt -65.5 -34.69 78.87 Favored 'General case' 0 C--N 1.339 0.135 0 CA-C-N 119.743 1.156 . . . . 0.0 111.025 172.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -61.97 -43.79 98.1 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 119.376 0.989 . . . . 0.0 110.944 170.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -63.67 -40.18 96.18 Favored 'General case' 0 CA--C 1.531 0.218 0 O-C-N 121.172 -0.955 . . . . 0.0 110.711 175.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 39.8 tp -61.98 -41.96 98.61 Favored 'General case' 0 C--N 1.334 -0.105 0 C-N-CA 124.372 1.069 . . . . 0.0 109.919 178.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -60.82 -42.96 98.73 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 122.949 0.499 . . . . 0.0 110.696 175.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -71.97 -10.4 59.72 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 112.6 0.592 . . . . 0.0 112.6 179.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -105.36 -28.38 10.91 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 125.437 1.495 . . . . 0.0 111.377 -178.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 26.8 mtp -134.3 -1.56 2.88 Favored 'General case' 0 N--CA 1.462 0.146 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 -168.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -56.91 -13.91 9.26 Favored Glycine 0 CA--C 1.532 1.126 0 CA-C-N 119.913 1.233 . . . . 0.0 115.434 -173.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -69.73 -29.93 67.42 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 118.674 1.237 . . . . 0.0 111.73 173.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 45.6 mmtm -115.7 -20.27 10.17 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 125.512 1.525 . . . . 0.0 111.889 -178.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 36.6 tp -112.57 157.17 21.51 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 123.984 0.914 . . . . 0.0 111.41 -168.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -132.34 144.51 50.6 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 103.806 -2.665 . . . . 0.0 103.806 166.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 83.0 mt -118.02 139.43 45.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 105.274 -2.121 . . . . 0.0 105.274 177.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 81.9 t -132.26 98.78 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 -170.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 52.4 mtmt -74.2 136.69 42.79 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 175.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 15.3 tt -139.98 124.82 19.88 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 176.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -82.79 105.08 13.51 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 124.717 1.207 . . . . 0.0 108.784 -174.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 27.7 m -60.37 -27.06 38.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 118.684 -0.674 . . . . 0.0 111.898 -174.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -66.1 -19.83 65.97 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 119.423 1.011 . . . . 0.0 111.773 -177.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -113.83 1.59 14.84 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.534 1.534 . . . . 0.0 110.891 178.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 68.7 m-80 -141.68 41.77 1.72 Allowed 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.27 1.028 . . . . 0.0 109.889 -169.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 46.7 mm-40 -56.03 -32.37 63.96 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.806 0.842 . . . . 0.0 111.262 177.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 35.0 mm-40 -65.72 -47.21 76.1 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 118.407 0.549 . . . . 0.0 110.5 179.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.2 -39.04 78.86 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 121.801 -0.562 . . . . 0.0 109.634 -178.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -58.79 -48.28 81.82 Favored 'General case' 0 CA--C 1.534 0.343 0 O-C-N 121.142 -0.974 . . . . 0.0 110.171 172.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -60.45 -28.67 67.74 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 124.078 0.847 . . . . 0.0 112.438 177.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 47.7 tptt -56.23 -29.28 60.79 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.629 1.171 . . . . 0.0 111.425 179.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -124.0 10.7 8.85 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.671 0.788 . . . . 0.0 111.598 -179.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 64.41 28.52 73.21 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 123.819 0.723 . . . . 0.0 112.802 -177.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 49.1 t -62.86 125.94 20.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 172.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 40.3 ttp -138.49 1.86 2.19 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.487 1.115 . . . . 0.0 111.036 -177.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 24.8 m -144.31 161.98 37.58 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 126.789 2.036 . . . . 0.0 107.374 178.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 40.7 pt -143.13 155.91 61.7 Favored Pre-proline 0 CA--C 1.544 0.721 0 C-N-CA 124.631 1.173 . . . . 0.0 108.768 177.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -67.05 139.54 46.66 Favored 'Cis proline' 0 C--N 1.349 0.588 0 CA-C-N 120.459 1.2 . . . . 0.0 110.26 -4.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 28.1 m -130.81 139.95 50.24 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 174.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 88.0 mt -120.33 124.49 45.69 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 -169.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -115.18 119.7 37.27 Favored 'General case' 0 CA--C 1.512 -0.509 0 N-CA-C 103.578 -2.749 . . . . 0.0 103.578 177.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.2 t -93.1 123.31 45.14 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 N-CA-C 103.432 -2.803 . . . . 0.0 103.432 173.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.1 mp -114.86 155.25 27.16 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 174.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -137.94 123.38 19.55 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 172.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.2 t70 49.36 36.87 10.46 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.084 1.354 . . . . 0.0 112.537 176.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 103.4 -2.83 46.59 Favored Glycine 0 CA--C 1.529 0.92 0 CA-C-O 118.122 -1.377 . . . . 0.0 115.285 168.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -128.62 149.98 50.41 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 120.074 1.937 . . . . 0.0 110.077 -179.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 44.3 t -62.0 131.53 27.25 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 175.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.1 p -117.44 -22.94 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 C-N-CA 125.102 1.361 . . . . 0.0 109.406 179.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -162.3 168.04 22.9 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 120.463 1.483 . . . . 0.0 110.097 169.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 14.0 m -136.56 151.07 48.98 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.363 1.465 . . . . 0.0 108.796 177.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 58.3 m -148.38 157.28 43.38 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.631 1.573 . . . . 0.0 108.649 169.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 42.6 t -133.6 145.33 33.77 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 -178.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 78.27 -176.29 54.24 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 123.553 0.597 . . . . 0.0 111.877 179.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -63.72 148.91 47.91 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.484 0.714 . . . . 0.0 110.41 178.003 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 42.9 mttt -142.4 138.24 16.28 Favored Pre-proline 0 C--O 1.235 0.311 0 N-CA-C 106.352 -1.722 . . . . 0.0 106.352 168.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -66.57 160.03 47.97 Favored 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 121.88 1.72 . . . . 0.0 110.925 178.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 33.7 tttm -48.85 -46.72 42.68 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 126.071 1.748 . . . . 0.0 112.987 -178.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 27.4 mm-40 -72.98 -35.94 66.99 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.207 -176.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.64 -36.6 84.78 Favored 'General case' 0 C--N 1.341 0.233 0 CA-C-N 118.979 0.808 . . . . 0.0 111.054 173.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 87.1 mt -64.53 -45.78 85.72 Favored 'General case' 0 N--CA 1.456 -0.137 0 CA-C-O 119.197 -0.43 . . . . 0.0 110.665 176.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 8.9 mt-30 -57.99 -42.44 85.16 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-N 118.501 0.591 . . . . 0.0 110.787 173.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -64.61 -39.58 93.98 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 118.016 0.371 . . . . 0.0 110.508 -178.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 57.8 tp -61.86 -44.0 97.72 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 124.636 1.174 . . . . 0.0 110.568 176.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 86.6 t -61.22 -44.13 97.78 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-N 118.821 0.737 . . . . 0.0 109.39 173.023 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -60.58 -28.34 68.4 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 125.019 1.328 . . . . 0.0 112.15 -173.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -56.4 -24.12 42.71 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 123.402 0.681 . . . . 0.0 112.498 174.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 72.2 m-70 -123.18 -9.18 8.16 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 -168.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 74.5 mt . . . . . 0 C--O 1.249 1.045 0 CA-C-N 118.948 0.794 . . . . 0.0 109.333 171.298 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.8 mt . . . . . 0 CA--C 1.537 0.472 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 21.5 t -134.88 160.87 41.01 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 C-N-CA 126.68 1.992 . . . . 0.0 106.521 -176.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.23 139.1 50.7 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 105.368 -2.086 . . . . 0.0 105.368 169.284 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -140.68 168.94 18.6 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 121.296 0.569 . . . . 0.0 110.886 -178.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 17.4 p -133.19 169.67 16.54 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 126.334 1.854 . . . . 0.0 107.987 175.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -53.42 -29.31 34.53 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.443 1.097 . . . . 0.0 113.039 -178.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 57.0 mt-30 -61.28 -29.26 69.75 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.164 1.386 . . . . 0.0 112.944 178.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.6 m -136.86 -7.19 1.87 Allowed 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 -169.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -53.25 -43.65 67.52 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.349 1.06 . . . . 0.0 111.516 -177.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.8 m -62.86 -39.87 95.74 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.058 0.543 . . . . 0.0 111.76 179.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.66 -43.38 84.73 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 122.71 0.404 . . . . 0.0 110.074 177.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 68.5 mm-40 -64.09 -42.82 96.8 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 122.265 0.226 . . . . 0.0 110.551 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 35.5 p -77.89 -5.86 52.4 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 124.262 1.025 . . . . 0.0 113.568 -176.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 72.7 m -74.72 -20.26 59.91 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 177.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -87.41 69.23 9.87 Favored 'General case' 0 CA--C 1.537 0.451 0 O-C-N 121.483 -0.761 . . . . 0.0 111.581 -170.012 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 85.28 -151.51 25.75 Favored Glycine 0 C--N 1.337 0.612 0 N-CA-C 109.993 -1.243 . . . . 0.0 109.993 173.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 58.0 t -71.17 137.11 24.43 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 168.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 57.7 t -140.37 146.99 23.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 105.777 -1.935 . . . . 0.0 105.777 179.08 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.5 tt -124.96 99.35 6.09 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 -176.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -81.43 147.86 29.56 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.732 -179.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -126.48 95.21 4.29 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 126.145 1.778 . . . . 0.0 107.27 -178.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -73.81 115.36 13.16 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 174.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -149.16 -178.06 6.17 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.351 1.46 . . . . 0.0 108.553 -173.739 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -156.12 149.65 18.97 Favored Pre-proline 0 CA--C 1.531 0.238 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 167.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_exo -59.62 -19.16 51.51 Favored 'Trans proline' 0 CA--C 1.534 0.504 0 C-N-CA 122.323 2.015 . . . . 0.0 115.775 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 52.4 p-90 -70.85 -20.11 62.57 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 119.933 1.242 . . . . 0.0 112.035 174.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 23.9 t -61.45 152.35 30.13 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 125.025 1.33 . . . . 0.0 111.344 -172.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -101.63 -66.59 0.78 Allowed Glycine 0 CA--C 1.529 0.963 0 CA-C-O 118.424 -1.209 . . . . 0.0 110.528 173.03 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -54.75 -30.42 67.06 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 123.12 2.547 . . . . 0.0 114.275 -179.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 39.4 m -56.26 -34.87 66.82 Favored 'General case' 0 CA--C 1.538 0.495 0 O-C-N 121.467 -0.77 . . . . 0.0 111.551 175.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.4 mmtp -68.94 -29.61 67.89 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 123.427 0.691 . . . . 0.0 110.944 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 5.0 ptt? -85.55 -30.03 23.7 Favored 'General case' 0 C--N 1.34 0.153 0 CA-C-N 118.809 0.731 . . . . 0.0 111.539 -177.002 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 19.5 tt -77.87 -20.77 13.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-O 118.626 -0.702 . . . . 0.0 111.56 169.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -51.7 -49.61 82.14 Favored Pre-proline 0 CA--C 1.548 0.887 0 CA-C-N 120.83 1.65 . . . . 0.0 113.852 178.232 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -66.18 -28.3 48.31 Favored 'Trans proline' 0 C--N 1.35 0.631 0 CA-C-N 121.922 1.722 . . . . 0.0 112.285 175.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 23.9 t -66.93 -39.23 83.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 174.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 95.1 mt -64.6 -37.0 86.08 Favored 'General case' 0 C--N 1.341 0.239 0 CA-C-N 119.531 1.06 . . . . 0.0 111.155 171.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -64.66 -40.79 96.04 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 119.385 0.993 . . . . 0.0 110.857 174.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -63.02 -40.02 96.49 Favored 'General case' 0 CA--C 1.531 0.232 0 O-C-N 121.067 -1.021 . . . . 0.0 110.187 174.158 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.35 -47.28 84.31 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.885 0.874 . . . . 0.0 109.746 175.499 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -59.01 -40.57 85.36 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 123.62 0.768 . . . . 0.0 111.03 179.262 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 -73.92 -10.71 59.93 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.303 0.641 . . . . 0.0 112.377 -179.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -103.44 -33.88 8.91 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 124.954 1.302 . . . . 0.0 111.791 178.292 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 86.6 mmm -125.08 -3.77 7.53 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 113.237 0.829 . . . . 0.0 113.237 -168.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -62.63 -3.57 5.82 Favored Glycine 0 CA--C 1.532 1.147 0 CA-C-N 119.853 1.206 . . . . 0.0 115.342 -175.415 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -73.96 -27.68 61.12 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 118.519 1.16 . . . . 0.0 111.201 169.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.3 -23.07 3.3 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 125.289 1.435 . . . . 0.0 111.59 -171.313 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 45.0 tp -111.24 151.61 28.1 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 124.878 1.271 . . . . 0.0 110.169 -169.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -118.82 144.8 46.12 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 105.541 -2.022 . . . . 0.0 105.541 168.322 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 73.1 mt -116.53 136.96 51.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 105.384 -2.08 . . . . 0.0 105.384 175.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 97.3 t -133.06 97.08 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 -169.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -73.97 139.48 44.86 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 107.648 -1.242 . . . . 0.0 107.648 175.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 11.5 tt -141.05 129.27 23.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.395 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 178.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 61.7 t0 -87.83 105.44 17.41 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 124.809 1.243 . . . . 0.0 110.06 -169.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 27.0 m -62.58 -18.46 20.69 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 CA-C-O 118.539 -0.743 . . . . 0.0 112.449 -177.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -67.54 -15.5 63.69 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 119.863 1.211 . . . . 0.0 112.023 176.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -127.18 1.03 6.45 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.236 1.014 . . . . 0.0 111.89 178.323 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 67.0 m-80 -137.55 41.0 2.4 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.737 0.815 . . . . 0.0 111.209 -169.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 5.3 mp0 -54.11 -32.08 53.94 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.203 0.601 . . . . 0.0 111.76 174.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -66.3 -47.44 73.59 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 118.423 0.556 . . . . 0.0 110.498 -177.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.07 -39.26 79.2 Favored 'General case' 0 CA--C 1.534 0.345 0 O-C-N 121.836 -0.54 . . . . 0.0 109.591 -179.416 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -58.53 -48.45 80.81 Favored 'General case' 0 CA--C 1.534 0.338 0 O-C-N 121.244 -0.91 . . . . 0.0 110.463 173.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -61.92 -28.15 69.83 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 124.179 0.895 . . . . 0.0 112.166 178.015 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 71.7 tttt -55.66 -28.76 57.23 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.853 1.261 . . . . 0.0 111.683 178.057 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -123.17 10.58 9.37 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.775 0.83 . . . . 0.0 111.803 179.252 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 65.38 27.46 72.5 Favored Glycine 0 CA--C 1.534 1.239 0 C-N-CA 123.85 0.738 . . . . 0.0 113.024 -177.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 60.4 t -62.72 127.63 23.17 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 171.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 22.6 ttt -137.16 0.49 2.35 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.612 1.165 . . . . 0.0 111.05 -176.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 25.2 m -144.92 162.51 36.67 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 126.514 1.926 . . . . 0.0 107.719 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 41.1 pt -142.8 156.79 62.47 Favored Pre-proline 0 CA--C 1.544 0.747 0 C-N-CA 124.858 1.263 . . . . 0.0 108.615 177.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -66.74 140.7 51.32 Favored 'Cis proline' 0 C--N 1.349 0.594 0 CA-C-N 120.464 1.201 . . . . 0.0 110.416 -5.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 32.2 m -135.2 135.96 41.41 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 176.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -115.4 132.11 56.72 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 -172.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -120.22 121.87 39.67 Favored 'General case' 0 CA--C 1.513 -0.443 0 N-CA-C 103.545 -2.761 . . . . 0.0 103.545 177.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 8.3 t -92.67 123.36 44.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 103.331 -2.84 . . . . 0.0 103.331 172.227 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.2 mp -113.09 155.7 24.44 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 175.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 60.8 tttp -135.65 124.62 24.2 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 105.854 -1.906 . . . . 0.0 105.854 173.479 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 30.8 t70 50.64 34.73 10.23 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.693 1.197 . . . . 0.0 112.119 176.199 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 100.38 -1.13 55.86 Favored Glycine 0 CA--C 1.529 0.951 0 CA-C-O 118.27 -1.294 . . . . 0.0 114.92 169.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -132.28 152.37 51.39 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 120.072 1.936 . . . . 0.0 110.24 -179.487 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 29.0 t -62.31 135.14 27.17 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 -178.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.9 p -120.59 -25.84 2.44 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 125.16 1.384 . . . . 0.0 110.237 175.135 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.403 ' C ' ' HG1' ' A' ' 86' ' ' THR . 0.7 OUTLIER -155.95 170.24 22.59 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 120.22 1.373 . . . . 0.0 109.792 177.404 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.403 ' HG1' ' C ' ' A' ' 85' ' ' GLU . 30.0 m -152.43 153.73 34.13 Favored 'General case' 0 CA--C 1.541 0.612 0 O-C-N 120.747 -1.221 . . . . 0.0 110.271 -176.197 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 41.7 m -150.22 154.45 37.98 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.561 1.544 . . . . 0.0 108.981 168.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 43.4 t -132.9 141.0 46.06 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 N-CA-C 107.03 -1.471 . . . . 0.0 107.03 -177.113 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 76.67 179.19 47.34 Favored Glycine 0 CA--C 1.53 0.992 0 N-CA-C 111.436 -0.665 . . . . 0.0 111.436 -177.131 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 36.1 t80 -63.18 132.62 52.36 Favored 'General case' 0 C--O 1.231 0.129 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 175.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 13.1 mptt -135.47 147.4 61.65 Favored Pre-proline 0 CA--C 1.536 0.419 0 C-N-CA 126.676 1.99 . . . . 0.0 106.176 174.262 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -71.53 158.07 54.67 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 122.513 2.142 . . . . 0.0 110.521 178.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 20.7 pttp -58.25 -29.25 65.63 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -62.4 -42.84 99.74 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.215 0.606 . . . . 0.0 110.433 176.368 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.62 -47.38 78.78 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 118.544 0.611 . . . . 0.0 110.09 -178.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 10.1 mp -56.09 -47.44 78.03 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.577 0.751 . . . . 0.0 109.912 176.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 14.7 mt-30 -61.73 -39.9 93.18 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-O 118.729 -0.653 . . . . 0.0 112.058 178.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -64.69 -42.83 95.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 119.073 0.852 . . . . 0.0 110.029 178.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 31.0 mt -66.92 -35.3 79.68 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 118.586 0.63 . . . . 0.0 111.562 179.034 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 44.0 t -60.99 -50.99 78.29 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 170.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -61.26 -33.65 73.88 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 125.383 1.473 . . . . 0.0 111.862 -173.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 59.1 mtpt -56.36 -27.93 57.54 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 118.332 -0.842 . . . . 0.0 112.212 174.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -128.92 -5.47 5.06 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 114.688 1.366 . . . . 0.0 114.688 -167.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 17.5 mt . . . . . 0 C--O 1.25 1.082 0 CA-C-N 119.655 1.116 . . . . 0.0 108.725 168.569 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.3 mt . . . . . 0 CA--C 1.538 0.502 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 20.7 t -135.77 161.37 38.54 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 126.696 1.998 . . . . 0.0 106.103 -176.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.62 138.89 50.62 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 105.652 -1.981 . . . . 0.0 105.652 169.149 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -139.2 171.39 14.36 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 123.453 0.701 . . . . 0.0 110.852 -178.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.0 p -136.18 171.66 14.15 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 125.768 1.627 . . . . 0.0 108.454 175.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -38.82 -39.93 0.57 Allowed 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 126.415 1.886 . . . . 0.0 113.525 170.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 43.5 mm-40 -68.62 -26.03 65.14 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.095 0.958 . . . . 0.0 113.088 -173.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.1 m -134.18 -8.95 2.62 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 113.585 0.958 . . . . 0.0 113.585 -169.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 67.4 t80 -54.03 -45.17 71.49 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 124.363 1.065 . . . . 0.0 111.44 -176.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 9.3 m -63.25 -37.42 87.18 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.041 0.536 . . . . 0.0 111.729 -178.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -68.41 -44.77 74.32 Favored 'General case' 0 N--CA 1.454 -0.272 0 O-C-N 122.036 -0.415 . . . . 0.0 110.055 177.143 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 67.0 mm-40 -63.21 -35.78 81.46 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 122.414 0.286 . . . . 0.0 110.955 -178.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.9 p -83.98 1.36 44.04 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.2 1.0 . . . . 0.0 113.496 -177.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 66.5 m -102.15 32.58 3.43 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.099 0.959 . . . . 0.0 111.403 -177.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -132.78 58.18 1.77 Allowed 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.354 1.062 . . . . 0.0 110.155 -178.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 93.97 -154.08 21.42 Favored Glycine 0 C--N 1.339 0.728 0 N-CA-C 110.084 -1.206 . . . . 0.0 110.084 176.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 84.7 t -71.19 134.84 29.24 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 168.142 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 58.8 t -139.07 142.07 34.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 105.639 -1.985 . . . . 0.0 105.639 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 3.4 tt -120.51 99.37 6.52 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 -174.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -81.33 146.83 30.16 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 179.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -126.09 94.14 4.01 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 125.983 1.713 . . . . 0.0 106.961 -177.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -73.95 113.97 11.73 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 106.179 -1.786 . . . . 0.0 106.179 174.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -149.75 -175.85 5.19 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 125.107 1.363 . . . . 0.0 107.883 -172.23 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -155.84 148.36 17.8 Favored Pre-proline 0 N--CA 1.451 -0.376 0 N-CA-C 106.106 -1.813 . . . . 0.0 106.106 167.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -68.35 -12.92 36.34 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 CA-C-N 120.871 1.347 . . . . 0.0 113.923 -178.45 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 42.6 p-90 -69.88 -20.94 63.37 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 120.221 1.373 . . . . 0.0 111.978 169.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 26.8 t -59.3 149.19 29.51 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.117 1.367 . . . . 0.0 111.123 -171.165 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -97.02 -60.39 0.97 Allowed Glycine 0 CA--C 1.533 1.19 0 CA-C-O 118.715 -1.047 . . . . 0.0 111.418 170.016 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -66.77 -25.9 45.7 Favored 'Trans proline' 0 C--N 1.349 0.576 0 CA-C-N 120.444 2.122 . . . . 0.0 112.813 -173.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 22.5 m -58.73 -32.23 69.02 Favored 'General case' 0 CA--C 1.536 0.41 0 O-C-N 121.524 -0.735 . . . . 0.0 111.401 174.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.7 mmtp -69.03 -23.01 64.02 Favored 'General case' 0 CA--C 1.532 0.257 0 O-C-N 121.373 -0.829 . . . . 0.0 111.109 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 34.0 mtm -71.52 -42.65 67.71 Favored 'General case' 0 C--N 1.34 0.194 0 CA-C-N 118.763 0.711 . . . . 0.0 110.404 175.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 16.5 tt -84.0 -22.12 8.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-O 118.741 -0.647 . . . . 0.0 111.599 -176.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -49.39 -51.16 60.38 Favored Pre-proline 0 CA--C 1.547 0.845 0 CA-C-N 120.009 1.277 . . . . 0.0 113.894 177.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -67.59 -25.98 40.29 Favored 'Trans proline' 0 C--N 1.351 0.66 0 CA-C-N 121.828 1.689 . . . . 0.0 112.528 176.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 15.2 t -70.05 -37.01 71.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 O-C-N 121.555 -0.715 . . . . 0.0 109.49 174.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 93.6 mt -67.41 -36.72 81.83 Favored 'General case' 0 C--O 1.226 -0.152 0 CA-C-N 119.576 1.08 . . . . 0.0 111.267 171.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -62.43 -41.59 98.82 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 119.385 0.993 . . . . 0.0 110.686 172.27 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 30.9 mm-40 -60.08 -45.91 91.33 Favored 'General case' 0 N--CA 1.455 -0.18 0 O-C-N 121.401 -0.812 . . . . 0.0 110.139 173.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.13 -44.09 92.03 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.886 0.874 . . . . 0.0 109.576 179.513 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -60.46 -42.78 96.88 Favored 'General case' 0 CA--C 1.522 -0.117 0 C-N-CA 123.559 0.743 . . . . 0.0 111.245 178.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -72.6 -10.22 59.53 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.366 0.666 . . . . 0.0 112.459 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -103.13 -33.75 9.11 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 125.315 1.446 . . . . 0.0 110.723 -179.203 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 88.4 mmm -130.12 -4.05 4.46 Favored 'General case' 0 C--N 1.341 0.203 0 N-CA-C 113.869 1.063 . . . . 0.0 113.869 -167.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.61 -11.41 15.51 Favored Glycine 0 CA--C 1.532 1.095 0 CA-C-N 119.954 1.252 . . . . 0.0 114.993 -173.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -67.05 -28.23 68.04 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 118.434 1.117 . . . . 0.0 111.595 172.012 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -120.8 -25.16 5.5 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 125.56 1.544 . . . . 0.0 111.686 -178.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 35.3 tp -102.58 159.6 15.31 Favored 'General case' 0 C--O 1.232 0.149 0 C-N-CA 124.202 1.001 . . . . 0.0 110.504 -170.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -132.68 143.54 49.71 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 104.326 -2.472 . . . . 0.0 104.326 167.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 67.5 mt -117.09 138.76 46.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 105.28 -2.118 . . . . 0.0 105.28 177.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 97.7 t -132.9 94.22 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 -169.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 27.9 mtpp -73.43 141.07 46.92 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 176.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 11.8 tt -142.73 126.86 15.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 178.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 57.4 t0 -86.25 104.61 15.95 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 124.783 1.233 . . . . 0.0 109.253 -170.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 26.1 m -61.79 -20.74 24.19 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-O 118.625 -0.702 . . . . 0.0 112.271 -176.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -67.6 -13.83 62.41 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 119.723 1.147 . . . . 0.0 111.958 177.345 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -124.23 3.28 8.54 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.666 1.187 . . . . 0.0 111.506 175.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 65.0 m-80 -141.65 41.25 1.72 Allowed 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 124.13 0.972 . . . . 0.0 111.29 -169.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 3.7 mp0 -52.89 -31.55 40.31 Favored 'General case' 0 CA--C 1.531 0.25 0 O-C-N 121.972 -0.455 . . . . 0.0 111.716 172.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -65.05 -50.76 64.92 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 123.905 0.882 . . . . 0.0 109.77 -178.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.34 -36.95 77.42 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.33 0.652 . . . . 0.0 109.839 -178.471 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.41 -45.99 89.96 Favored 'General case' 0 CA--C 1.534 0.365 0 O-C-N 120.834 -1.167 . . . . 0.0 110.669 171.295 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -63.5 -28.12 71.92 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 123.906 0.765 . . . . 0.0 112.189 177.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 74.0 tttt -56.15 -29.17 60.4 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.964 1.306 . . . . 0.0 111.613 179.202 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -123.82 6.17 8.74 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.291 0.636 . . . . 0.0 112.273 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 62.44 41.63 99.76 Favored Glycine 0 CA--C 1.53 0.99 0 N-CA-C 111.698 -0.561 . . . . 0.0 111.698 -175.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 95.2 t -63.38 94.3 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 124.852 1.261 . . . . 0.0 107.963 173.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 1.6 pmm? -73.77 -30.72 62.93 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 125.235 1.414 . . . . 0.0 112.452 -175.325 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 52.0 m -147.42 175.0 11.16 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 126.067 1.747 . . . . 0.0 109.653 -172.221 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 42.8 pt -137.2 154.87 76.02 Favored Pre-proline 0 CA--C 1.546 0.813 0 C-N-CA 125.045 1.338 . . . . 0.0 108.631 175.211 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -67.93 141.54 60.19 Favored 'Cis proline' 0 N--CA 1.458 -0.612 0 CA-C-N 120.467 1.203 . . . . 0.0 110.493 -4.215 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 18.4 m -135.88 137.51 41.51 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 175.016 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -114.79 133.39 55.96 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 -173.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -120.78 116.49 25.34 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 103.18 -2.896 . . . . 0.0 103.18 176.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.4 t -91.79 121.36 42.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 103.723 -2.695 . . . . 0.0 103.723 173.431 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.4 mp -110.51 155.28 22.48 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 175.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 26.4 ttpp -133.7 115.05 14.13 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 105.677 -1.971 . . . . 0.0 105.677 176.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 27.6 t0 50.09 39.98 20.55 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.675 1.19 . . . . 0.0 112.461 176.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 103.59 -4.22 46.82 Favored Glycine 0 CA--C 1.529 0.958 0 CA-C-O 118.184 -1.342 . . . . 0.0 115.345 168.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -132.27 150.2 52.21 Favored 'General case' 0 C--N 1.34 0.155 0 CA-C-N 120.056 1.928 . . . . 0.0 110.32 -178.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 22.1 t -62.99 134.66 28.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 -179.352 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.3 p -117.97 -27.67 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 C-N-CA 125.016 1.326 . . . . 0.0 110.169 174.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 40.8 mm-40 -150.22 163.14 39.01 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 120.201 1.364 . . . . 0.0 110.177 172.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 17.9 m -141.04 145.08 35.4 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.057 1.343 . . . . 0.0 108.44 176.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 20.0 m -144.74 151.99 39.7 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.389 1.476 . . . . 0.0 108.845 175.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 59.2 t -132.44 142.96 41.24 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 -177.059 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 79.14 179.5 52.02 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 123.876 0.751 . . . . 0.0 111.815 -178.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -57.96 144.76 38.29 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 123.391 0.676 . . . . 0.0 110.511 178.219 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -149.64 134.93 9.7 Favored Pre-proline 0 N--CA 1.453 -0.303 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 -175.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -74.39 156.81 45.7 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 122.12 1.88 . . . . 0.0 110.787 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 17.7 ptmt -56.9 -31.77 65.22 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 124.019 0.927 . . . . 0.0 112.266 177.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -66.09 -48.54 70.6 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 118.731 0.696 . . . . 0.0 110.011 179.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.94 -44.36 96.29 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 118.009 0.368 . . . . 0.0 110.335 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 83.3 mt -61.73 -42.68 99.27 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-O 119.465 -0.303 . . . . 0.0 110.505 178.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -61.62 -39.85 92.75 Favored 'General case' 0 C--O 1.222 -0.343 0 CA-C-O 118.132 -0.937 . . . . 0.0 111.268 175.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -64.11 -41.9 97.09 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 119.822 1.192 . . . . 0.0 110.421 178.385 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 88.8 mt -63.54 -38.63 91.87 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 122.904 0.482 . . . . 0.0 111.165 178.129 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 49.7 t -63.33 -51.26 73.26 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 C-N-CA 123.676 0.79 . . . . 0.0 109.542 171.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -59.63 -40.76 88.69 Favored 'General case' 0 C--N 1.332 -0.153 0 C-N-CA 125.907 1.683 . . . . 0.0 111.503 -169.407 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 13.7 ptmm? -69.5 -6.63 31.89 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 118.155 -0.926 . . . . 0.0 113.16 -177.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 93.6 m-70 -124.96 -15.4 6.4 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 177.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 19.7 mt . . . . . 0 C--O 1.249 1.076 0 CA-C-N 119.563 1.074 . . . . 0.0 109.371 169.404 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.6 mt . . . . . 0 C--O 1.236 0.39 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 21.4 t -133.95 159.56 42.31 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 C-N-CA 126.221 1.808 . . . . 0.0 106.498 -176.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -115.2 128.44 56.17 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 105.428 -2.064 . . . . 0.0 105.428 178.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -138.5 166.76 23.48 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 121.576 0.703 . . . . 0.0 112.313 -173.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 36.4 p -137.09 179.24 6.5 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 125.648 1.579 . . . . 0.0 107.715 171.105 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -49.14 -29.8 5.85 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.25 1.02 . . . . 0.0 112.706 170.18 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -63.04 -27.54 69.47 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.007 1.323 . . . . 0.0 112.805 179.341 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 13.6 p -132.08 -20.22 2.48 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 -167.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 56.4 t80 -51.98 -47.52 64.81 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 124.767 1.227 . . . . 0.0 112.534 -169.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.3 m -64.6 -38.57 91.47 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 122.666 0.386 . . . . 0.0 111.665 -175.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -68.04 -45.01 75.12 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 176.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 -62.9 -36.5 83.58 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 119.301 -0.38 . . . . 0.0 111.082 -177.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.8 p -83.75 -0.04 49.24 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 113.526 0.936 . . . . 0.0 113.526 -177.059 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 70.3 m -102.6 31.34 4.14 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.986 0.914 . . . . 0.0 111.494 -175.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -132.35 53.04 2.03 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.181 0.992 . . . . 0.0 110.781 -175.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 99.62 -156.21 19.79 Favored Glycine 0 C--N 1.338 0.655 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 176.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 90.0 t -70.18 136.43 26.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 167.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 60.6 t -139.59 147.13 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 N-CA-C 105.576 -2.009 . . . . 0.0 105.576 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.1 tt -125.17 99.0 5.89 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 -175.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -80.26 147.44 31.19 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 123.258 0.623 . . . . 0.0 109.548 -179.162 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -129.44 93.94 3.66 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 126.126 1.77 . . . . 0.0 108.163 -174.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -75.17 112.58 11.58 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 106.321 -1.733 . . . . 0.0 106.321 174.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -149.46 -176.57 5.44 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.775 1.23 . . . . 0.0 108.218 -173.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -156.67 149.1 17.86 Favored Pre-proline 0 CA--C 1.531 0.239 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 167.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -60.85 -19.13 60.57 Favored 'Trans proline' 0 N--CA 1.46 -0.47 0 C-N-CA 121.568 1.512 . . . . 0.0 115.43 179.134 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 48.5 p-90 -69.72 -20.06 63.54 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 119.926 1.239 . . . . 0.0 111.927 173.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 25.4 t -59.62 147.83 35.88 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.932 1.293 . . . . 0.0 111.072 -172.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -96.91 -63.62 0.92 Allowed Glycine 0 CA--C 1.529 0.94 0 CA-C-O 118.479 -1.178 . . . . 0.0 110.862 171.376 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -62.68 -26.2 75.38 Favored 'Trans proline' 0 C--N 1.349 0.605 0 CA-C-N 120.314 2.057 . . . . 0.0 113.543 -174.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 35.1 m -57.65 -34.34 69.26 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 118.653 0.66 . . . . 0.0 111.471 174.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.9 mmtp -67.88 -25.28 65.44 Favored 'General case' 0 CA--C 1.531 0.236 0 O-C-N 121.553 -0.717 . . . . 0.0 110.921 -179.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 31.0 mtm -71.91 -42.81 66.28 Favored 'General case' 0 C--N 1.34 0.16 0 CA-C-N 118.696 0.68 . . . . 0.0 110.444 176.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 13.5 tt -84.05 -21.73 8.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-O 118.826 -0.607 . . . . 0.0 111.56 -175.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -48.82 -51.8 51.25 Favored Pre-proline 0 CA--C 1.546 0.819 0 CA-C-N 119.994 1.27 . . . . 0.0 113.643 177.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -67.27 -29.0 39.4 Favored 'Trans proline' 0 C--N 1.351 0.682 0 CA-C-N 121.756 1.663 . . . . 0.0 112.555 176.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 31.4 t -65.48 -40.24 87.61 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 174.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 76.9 mt -67.78 -35.54 78.86 Favored 'General case' 0 C--O 1.224 -0.238 0 CA-C-N 119.299 0.954 . . . . 0.0 111.482 173.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -62.38 -42.27 99.28 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 119.549 1.068 . . . . 0.0 110.736 172.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -65.03 -39.38 93.3 Favored 'General case' 0 CA--C 1.532 0.265 0 O-C-N 121.28 -0.887 . . . . 0.0 110.505 175.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.24 -46.37 90.02 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.638 0.775 . . . . 0.0 109.348 175.486 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -58.88 -42.94 90.69 Favored 'General case' 0 CA--C 1.521 -0.144 0 C-N-CA 123.833 0.853 . . . . 0.0 111.279 179.386 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -70.79 -10.47 59.58 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.428 0.691 . . . . 0.0 112.607 179.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 58.2 mt-10 -106.16 -30.62 9.12 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 125.601 1.56 . . . . 0.0 111.46 -177.511 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 91.6 mmm -127.62 -5.38 5.83 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 -171.511 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.81 -10.69 14.21 Favored Glycine 0 CA--C 1.531 1.036 0 CA-C-N 119.828 1.194 . . . . 0.0 114.854 -174.106 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -65.41 -28.48 69.28 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 118.509 1.154 . . . . 0.0 111.51 171.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -123.31 -25.84 4.38 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 125.427 1.491 . . . . 0.0 111.639 -179.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 31.6 tp -100.07 161.61 13.5 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 124.306 1.042 . . . . 0.0 110.385 -170.244 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -135.95 144.6 45.53 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 104.447 -2.427 . . . . 0.0 104.447 168.066 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 59.9 mt -116.65 139.32 43.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 105.489 -2.041 . . . . 0.0 105.489 176.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 93.2 t -132.98 96.31 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 -169.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -74.39 138.02 43.1 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 178.175 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 13.4 tt -141.4 128.73 21.32 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 177.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 64.6 t0 -87.94 106.68 18.27 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.603 1.161 . . . . 0.0 109.797 -169.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 31.3 m -62.08 -19.02 20.92 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 CA-C-O 118.693 -0.67 . . . . 0.0 112.473 -176.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -67.2 -15.72 63.87 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 119.685 1.129 . . . . 0.0 112.105 176.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -127.21 1.86 6.42 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.306 1.042 . . . . 0.0 111.863 179.155 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 63.8 m-80 -137.63 40.52 2.39 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.732 0.813 . . . . 0.0 111.447 -169.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 5.5 mp0 -54.41 -32.58 57.59 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.056 0.542 . . . . 0.0 111.781 174.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 32.9 mm-40 -65.73 -48.96 70.17 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 118.514 0.597 . . . . 0.0 110.136 -179.07 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.39 -37.82 80.76 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.036 0.534 . . . . 0.0 109.927 -178.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.4 -48.59 81.08 Favored 'General case' 0 CA--C 1.535 0.372 0 O-C-N 121.064 -1.022 . . . . 0.0 110.363 172.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -60.62 -27.67 66.58 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 124.225 0.916 . . . . 0.0 112.334 177.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 47.3 tttp -55.52 -29.11 58.29 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.84 1.256 . . . . 0.0 111.726 178.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -123.54 10.8 9.15 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.554 0.742 . . . . 0.0 111.732 179.242 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 64.12 30.44 77.78 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 123.649 0.642 . . . . 0.0 112.629 -176.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 61.5 t -65.44 125.8 23.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 171.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 67.0 mtt -136.36 3.84 2.86 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.811 1.244 . . . . 0.0 111.465 -179.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 24.2 m -144.05 161.79 37.88 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 126.591 1.957 . . . . 0.0 107.697 179.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 42.5 pt -141.56 154.51 66.59 Favored Pre-proline 0 CA--C 1.545 0.774 0 C-N-CA 124.424 1.09 . . . . 0.0 108.811 176.141 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -67.42 140.02 50.34 Favored 'Cis proline' 0 C--N 1.349 0.586 0 CA-C-N 120.356 1.163 . . . . 0.0 110.385 -4.278 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 42.4 m -132.71 142.24 48.96 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 173.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 91.6 mt -125.21 129.46 50.15 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 107.37 -1.345 . . . . 0.0 107.37 -169.259 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -119.84 118.49 30.92 Favored 'General case' 0 CA--C 1.513 -0.476 0 N-CA-C 103.27 -2.863 . . . . 0.0 103.27 178.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 4.5 t -88.6 122.83 40.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 103.007 -2.96 . . . . 0.0 103.007 172.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.2 mp -112.05 157.42 20.78 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 174.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 89.1 tttt -136.42 124.51 22.96 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 106.304 -1.739 . . . . 0.0 106.304 169.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.0 t70 49.22 38.02 12.48 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.909 1.284 . . . . 0.0 112.389 175.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 100.87 -2.4 55.55 Favored Glycine 0 CA--C 1.53 0.979 0 CA-C-O 118.15 -1.361 . . . . 0.0 115.167 169.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -131.96 152.54 51.04 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 120.174 1.987 . . . . 0.0 110.284 -179.15 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 22.0 t -62.92 134.52 28.12 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 -179.252 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.5 p -120.14 -24.23 3.03 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 C-N-CA 125.471 1.508 . . . . 0.0 109.958 176.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -158.79 172.2 18.68 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 120.262 1.392 . . . . 0.0 109.601 173.656 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 26.5 m -148.87 153.15 37.65 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 120.555 -1.34 . . . . 0.0 109.543 -179.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 48.4 m -150.22 154.44 37.95 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.218 1.407 . . . . 0.0 109.051 169.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 40.9 t -133.59 142.17 42.32 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 -177.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 75.69 -177.9 48.92 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 123.43 0.538 . . . . 0.0 111.838 -178.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 59.2 t80 -59.52 143.97 48.62 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 123.238 0.615 . . . . 0.0 110.683 179.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -150.27 137.12 11.23 Favored Pre-proline 0 C--O 1.234 0.267 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 -176.502 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -73.12 153.83 51.97 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 122.009 1.806 . . . . 0.0 110.486 176.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 57.6 pttt -60.79 -31.61 70.97 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 118.897 -0.573 . . . . 0.0 111.818 -178.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -66.45 -42.5 87.53 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.279 0.632 . . . . 0.0 110.438 -179.179 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.18 -44.48 88.32 Favored 'General case' 0 C--O 1.232 0.16 0 O-C-N 121.961 -0.462 . . . . 0.0 109.898 179.148 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 92.0 mt -62.61 -40.22 96.25 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.582 177.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -60.4 -41.19 93.34 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-O 118.577 -0.725 . . . . 0.0 111.498 174.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -63.39 -42.71 98.83 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 118.924 0.784 . . . . 0.0 110.007 176.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 40.7 mt -63.65 -41.62 98.19 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 118.739 0.699 . . . . 0.0 111.382 177.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 43.1 t -57.51 -49.34 80.68 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 C-N-CA 123.546 0.738 . . . . 0.0 109.239 171.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -63.05 -31.44 72.58 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.403 1.481 . . . . 0.0 111.964 -173.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -58.67 -24.73 61.83 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 118.236 -0.888 . . . . 0.0 112.213 174.397 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 82.3 m-70 -125.69 -14.56 6.23 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 113.863 1.06 . . . . 0.0 113.863 -168.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 23.8 mt . . . . . 0 C--O 1.247 0.964 0 CA-C-N 119.692 1.133 . . . . 0.0 109.125 168.975 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 7.6 mt . . . . . 0 CA--C 1.536 0.405 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 38.7 t -135.0 164.1 34.68 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 C-N-CA 127.065 2.146 . . . . 0.0 106.082 -179.291 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 6.2 ttmt -120.85 146.22 46.79 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 175.016 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -146.48 167.78 22.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.335 0.588 . . . . 0.0 111.104 -176.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 16.0 p -132.57 170.62 14.91 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 126.394 1.878 . . . . 0.0 107.896 171.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -52.97 -29.76 30.95 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.034 0.933 . . . . 0.0 113.125 -179.096 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 56.6 mt-30 -62.47 -28.98 70.19 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.124 1.37 . . . . 0.0 112.933 179.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.6 m -136.33 -5.89 2.04 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 113.517 0.932 . . . . 0.0 113.517 -169.191 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 81.9 t80 -53.43 -44.01 68.46 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.174 0.99 . . . . 0.0 111.281 -178.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.2 m -62.89 -39.06 93.33 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.252 0.621 . . . . 0.0 111.935 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.77 -43.89 82.82 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 122.697 0.399 . . . . 0.0 109.993 178.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -64.53 -41.54 96.31 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 122.235 0.214 . . . . 0.0 110.709 -179.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 36.3 p -79.47 -3.65 47.59 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 124.308 1.043 . . . . 0.0 113.544 -176.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 74.7 m -75.07 -21.4 59.01 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 176.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -88.02 71.74 9.32 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 121.55 -0.719 . . . . 0.0 111.586 -169.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 84.13 -152.75 28.58 Favored Glycine 0 C--N 1.336 0.566 0 N-CA-C 110.304 -1.118 . . . . 0.0 110.304 173.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 63.2 t -70.7 134.36 30.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 169.114 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 61.6 t -139.09 138.81 41.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 105.786 -1.931 . . . . 0.0 105.786 179.34 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.9 tt -117.37 104.31 11.0 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 -177.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -89.45 147.1 24.2 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 -177.308 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -127.42 94.13 3.9 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 125.551 1.54 . . . . 0.0 107.333 -175.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -74.46 112.77 10.96 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 105.68 -1.971 . . . . 0.0 105.68 174.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -149.41 -174.94 4.81 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 124.911 1.284 . . . . 0.0 108.095 -172.056 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -152.77 148.78 20.95 Favored Pre-proline 0 N--CA 1.453 -0.285 0 N-CA-C 105.83 -1.915 . . . . 0.0 105.83 167.174 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -68.21 -11.89 33.39 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 CA-C-N 121.101 1.429 . . . . 0.0 112.855 178.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 1.3 m95 -77.22 -12.34 59.94 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.775 0.83 . . . . 0.0 111.814 172.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 17.4 t -64.65 160.95 18.69 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.353 1.461 . . . . 0.0 110.834 -178.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -115.52 -58.02 0.34 Allowed Glycine 0 CA--C 1.531 1.046 0 CA-C-O 118.631 -1.094 . . . . 0.0 111.069 171.436 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -56.22 -33.63 91.29 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 123.506 2.804 . . . . 0.0 113.395 178.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 23.0 m -58.4 -33.71 69.94 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 121.705 -0.622 . . . . 0.0 111.555 176.34 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.5 mmtp -68.5 -22.24 64.55 Favored 'General case' 0 CA--C 1.531 0.238 0 O-C-N 121.499 -0.75 . . . . 0.0 111.086 -179.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 35.3 mtm -70.15 -43.27 71.23 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-N 118.731 0.696 . . . . 0.0 110.298 175.346 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 18.2 tt -85.2 -23.7 7.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-O 118.379 -0.82 . . . . 0.0 111.701 -176.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -49.04 -50.19 64.47 Favored Pre-proline 0 CA--C 1.549 0.914 0 CA-C-N 120.407 1.458 . . . . 0.0 114.516 179.038 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -66.13 -30.64 46.6 Favored 'Trans proline' 0 C--N 1.351 0.666 0 CA-C-N 121.636 1.62 . . . . 0.0 111.682 176.449 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.6 t -66.03 -39.81 85.55 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-O 118.305 -0.855 . . . . 0.0 109.449 174.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 94.7 mt -62.53 -37.66 86.95 Favored 'General case' 0 C--N 1.34 0.185 0 CA-C-N 119.916 1.235 . . . . 0.0 110.874 173.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -63.02 -45.4 92.5 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 119.411 1.005 . . . . 0.0 110.978 173.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 50.8 mm-40 -65.26 -37.33 86.87 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 120.923 -1.111 . . . . 0.0 110.83 178.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -63.94 -42.99 97.19 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 125.154 1.382 . . . . 0.0 109.392 176.156 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -58.5 -43.59 89.14 Favored 'General case' 0 CA--C 1.521 -0.137 0 C-N-CA 123.941 0.896 . . . . 0.0 111.203 176.014 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -70.26 -12.8 61.84 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -179.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -102.25 -33.38 9.64 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 125.228 1.411 . . . . 0.0 111.088 -179.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 79.5 mmm -119.49 -5.61 10.29 Favored 'General case' 0 N--CA 1.461 0.117 0 CA-C-O 118.584 -0.722 . . . . 0.0 112.837 -168.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -61.4 -8.01 11.86 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 124.583 1.087 . . . . 0.0 115.574 -173.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -75.53 -26.41 58.04 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 118.736 1.268 . . . . 0.0 111.365 171.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 50.8 mmtt -118.15 -24.29 7.04 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 125.503 1.521 . . . . 0.0 111.684 -176.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 47.4 tp -116.4 152.99 32.85 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 124.379 1.072 . . . . 0.0 112.056 -167.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -119.41 142.15 48.47 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 104.986 -2.227 . . . . 0.0 104.986 166.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 75.8 mt -110.94 140.28 30.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 105.667 -1.975 . . . . 0.0 105.667 172.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 97.3 t -131.79 98.35 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -175.095 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -75.09 140.48 43.48 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 174.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 13.7 tt -142.88 124.77 12.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 178.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -82.68 105.31 13.61 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 124.594 1.158 . . . . 0.0 108.832 -173.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 31.0 m -60.12 -25.58 33.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 118.536 -0.745 . . . . 0.0 111.959 -175.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -65.71 -18.01 65.02 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 119.597 1.089 . . . . 0.0 112.047 -177.252 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -118.69 3.51 11.68 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.893 1.277 . . . . 0.0 111.132 177.392 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -139.81 40.46 2.0 Allowed 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 124.563 1.145 . . . . 0.0 109.758 -170.179 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 50.5 mm-40 -55.54 -32.42 62.93 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.907 0.883 . . . . 0.0 111.024 176.388 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 33.1 mm-40 -65.33 -48.27 73.61 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 118.411 0.551 . . . . 0.0 110.255 178.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.43 -40.27 85.48 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.235 0.614 . . . . 0.0 109.927 -178.561 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.98 -47.33 86.27 Favored 'General case' 0 CA--C 1.533 0.293 0 O-C-N 121.541 -0.725 . . . . 0.0 110.76 173.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -62.9 -29.01 72.87 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 123.554 0.597 . . . . 0.0 111.944 177.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 17.9 ttmt -55.6 -29.87 59.9 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 125.837 1.655 . . . . 0.0 111.999 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -123.67 7.9 8.85 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 123.491 0.717 . . . . 0.0 112.197 -179.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 63.09 41.41 99.78 Favored Glycine 0 CA--C 1.53 0.996 0 CA-C-N 118.329 0.513 . . . . 0.0 111.857 -176.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 88.3 t -66.07 91.52 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 C-N-CA 124.71 1.204 . . . . 0.0 107.774 174.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 25.1 ptt? -73.57 -28.12 61.68 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 124.707 1.203 . . . . 0.0 112.94 -176.138 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 34.4 m -146.72 174.85 11.08 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 125.973 1.709 . . . . 0.0 109.491 -170.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 41.6 pt -139.49 156.56 71.42 Favored Pre-proline 0 CA--C 1.545 0.752 0 C-N-CA 125.169 1.388 . . . . 0.0 108.669 174.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -67.46 138.97 44.99 Favored 'Cis proline' 0 C--N 1.349 0.561 0 CA-C-N 120.577 1.242 . . . . 0.0 110.13 -5.08 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 23.4 m -132.91 135.23 45.43 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 176.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 10.8 mp -114.81 125.68 53.96 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 -169.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -115.41 122.63 46.4 Favored 'General case' 0 CA--C 1.515 -0.393 0 N-CA-C 103.708 -2.701 . . . . 0.0 103.708 177.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 4.3 t -92.87 125.7 45.41 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.481 0 N-CA-C 103.655 -2.72 . . . . 0.0 103.655 169.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.2 mp -114.08 152.17 31.44 Favored 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 172.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -137.96 126.16 23.03 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 174.414 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 32.2 t70 50.86 33.17 8.21 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.976 1.31 . . . . 0.0 112.264 178.139 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 100.65 0.06 55.41 Favored Glycine 0 CA--C 1.531 1.059 0 CA-C-O 118.207 -1.33 . . . . 0.0 114.965 169.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -128.51 150.46 50.16 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 120.002 1.901 . . . . 0.0 109.929 179.218 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 47.1 t -62.09 132.62 27.87 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 175.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.6 p -119.53 -21.75 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 C-N-CA 125.129 1.372 . . . . 0.0 109.79 178.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -159.65 165.01 33.57 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 120.184 1.356 . . . . 0.0 110.751 171.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 10.7 m -136.32 150.82 49.05 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.255 1.422 . . . . 0.0 108.916 176.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 73.3 m -150.67 156.83 42.12 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.885 1.674 . . . . 0.0 108.696 170.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 47.5 t -133.49 145.3 33.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 -176.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 79.43 178.32 51.06 Favored Glycine 0 CA--C 1.53 1.025 0 C-N-CA 123.928 0.775 . . . . 0.0 112.706 175.253 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -60.06 148.35 36.05 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 123.798 0.839 . . . . 0.0 111.017 179.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -149.29 136.7 11.15 Favored Pre-proline 0 CA--C 1.534 0.334 0 C-N-CA 125.492 1.517 . . . . 0.0 107.084 -178.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -69.3 158.98 55.52 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 122.019 1.813 . . . . 0.0 111.04 177.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -55.06 -43.19 73.64 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 124.799 1.24 . . . . 0.0 112.739 -178.031 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -61.49 -44.08 97.72 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.009 0.524 . . . . 0.0 110.257 178.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.49 -36.51 82.92 Favored 'General case' 0 CA--C 1.528 0.129 0 O-C-N 121.865 -0.522 . . . . 0.0 111.017 178.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 92.4 mt -62.98 -42.11 99.74 Favored 'General case' 0 N--CA 1.456 -0.14 0 O-C-N 122.134 -0.353 . . . . 0.0 110.91 173.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -60.55 -39.8 89.27 Favored 'General case' 0 C--O 1.224 -0.284 0 CA-C-O 118.712 -0.661 . . . . 0.0 110.178 175.18 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -65.75 -40.9 92.56 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 119.02 0.827 . . . . 0.0 110.601 178.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 60.4 tp -60.44 -37.51 81.18 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 125.406 1.482 . . . . 0.0 110.958 177.22 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 92.9 t -69.38 -51.63 40.64 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 123.509 0.724 . . . . 0.0 109.698 171.321 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -58.27 -38.14 76.37 Favored 'General case' 0 C--N 1.334 -0.101 0 C-N-CA 125.939 1.695 . . . . 0.0 112.099 -168.135 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -65.42 -8.49 19.11 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 113.342 0.867 . . . . 0.0 113.342 -178.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -120.91 -10.46 9.1 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 124.293 1.037 . . . . 0.0 113.062 178.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 55.8 mt . . . . . 0 C--O 1.248 0.996 0 CA-C-N 119.204 0.911 . . . . 0.0 109.314 173.562 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.9 mt . . . . . 0 CA--C 1.538 0.5 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 40.8 t -138.07 163.88 28.71 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 126.284 1.834 . . . . 0.0 107.345 -174.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -115.29 146.07 41.86 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 174.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -147.94 167.57 24.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.31 0.576 . . . . 0.0 111.253 -179.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 18.0 p -136.25 172.26 13.27 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 126.253 1.821 . . . . 0.0 106.98 168.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -49.88 -28.53 6.68 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.824 0.85 . . . . 0.0 113.073 174.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -56.86 -31.98 65.36 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.619 1.568 . . . . 0.0 112.933 178.447 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 14.8 m -142.26 -4.78 1.0 Allowed 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -169.223 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -54.35 -41.67 69.39 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.98 0.912 . . . . 0.0 111.724 -176.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.2 p -59.96 -45.73 91.72 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 124.01 0.924 . . . . 0.0 111.747 177.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.2 -43.72 94.17 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 122.719 0.408 . . . . 0.0 110.284 178.069 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -63.4 -35.85 81.77 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 119.475 -0.298 . . . . 0.0 111.076 -179.255 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 29.1 p -85.5 3.58 39.72 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.094 0.957 . . . . 0.0 113.253 -176.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 60.5 m -106.43 30.78 5.69 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.165 0.986 . . . . 0.0 111.684 -176.344 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -132.5 37.91 3.48 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.573 0.749 . . . . 0.0 112.313 -174.149 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 121.04 -153.52 16.6 Favored Glycine 0 C--N 1.335 0.52 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 175.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 53.5 t -74.45 133.95 30.5 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 N-CA-C 105.011 -2.218 . . . . 0.0 105.011 166.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 43.2 t -137.03 133.81 47.76 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 N-CA-C 105.896 -1.89 . . . . 0.0 105.896 -178.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 5.1 tt -116.89 101.18 8.31 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 106.138 -1.801 . . . . 0.0 106.138 -177.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -81.82 145.8 30.22 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.342 179.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -126.15 94.17 4.02 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 125.918 1.687 . . . . 0.0 107.444 -177.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -73.1 112.85 9.52 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 105.936 -1.875 . . . . 0.0 105.936 174.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -149.38 -176.68 5.48 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.88 1.272 . . . . 0.0 108.403 -172.207 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -151.95 147.92 20.7 Favored Pre-proline 0 C--O 1.233 0.213 0 N-CA-C 105.545 -2.02 . . . . 0.0 105.545 167.228 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -68.03 -11.64 32.67 Favored 'Trans proline' 0 CA--C 1.534 0.498 0 CA-C-N 121.1 1.429 . . . . 0.0 113.276 -178.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 1.6 m95 -75.77 -13.7 60.3 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.637 0.775 . . . . 0.0 111.803 172.35 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 23.0 t -63.4 158.21 21.21 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.438 1.495 . . . . 0.0 110.971 -178.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -113.22 -57.82 0.41 Allowed Glycine 0 CA--C 1.531 1.065 0 CA-C-O 118.581 -1.121 . . . . 0.0 111.05 171.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -55.96 -33.76 90.06 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 123.366 2.711 . . . . 0.0 113.575 178.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 23.4 m -58.04 -34.15 69.76 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.271 0.628 . . . . 0.0 111.537 176.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.4 mmtp -68.5 -22.6 64.53 Favored 'General case' 0 CA--C 1.531 0.242 0 O-C-N 121.471 -0.768 . . . . 0.0 111.094 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 33.4 mtm -71.07 -42.85 68.84 Favored 'General case' 0 C--N 1.34 0.172 0 CA-C-N 118.841 0.746 . . . . 0.0 110.33 176.339 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 16.6 tt -85.29 -24.64 6.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-O 118.557 -0.735 . . . . 0.0 111.701 -175.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -48.85 -50.27 62.47 Favored Pre-proline 0 CA--C 1.549 0.912 0 CA-C-N 120.062 1.301 . . . . 0.0 114.219 178.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -67.08 -28.94 40.68 Favored 'Trans proline' 0 C--N 1.35 0.626 0 CA-C-N 121.774 1.669 . . . . 0.0 111.977 176.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.1 t -66.43 -40.89 87.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 CA-C-O 118.614 -0.708 . . . . 0.0 109.27 173.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 94.6 mt -63.23 -37.27 86.59 Favored 'General case' 0 C--N 1.34 0.188 0 CA-C-N 119.504 1.047 . . . . 0.0 110.855 174.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -62.37 -43.78 98.01 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 119.356 0.98 . . . . 0.0 111.107 173.02 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -62.74 -39.04 92.86 Favored 'General case' 0 CA--C 1.535 0.374 0 O-C-N 121.185 -0.947 . . . . 0.0 110.286 175.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.96 -43.65 98.22 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 124.556 1.142 . . . . 0.0 110.069 177.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -59.43 -42.71 92.51 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 123.679 0.792 . . . . 0.0 110.842 176.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -71.49 -10.61 60.04 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -179.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -106.6 -28.35 10.3 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 125.517 1.527 . . . . 0.0 111.651 -178.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 23.0 mtp -130.48 1.76 4.55 Favored 'General case' 0 N--CA 1.462 0.156 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -169.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -56.93 -11.63 6.09 Favored Glycine 0 CA--C 1.533 1.19 0 N-CA-C 115.993 1.157 . . . . 0.0 115.993 -175.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -78.58 -25.99 45.43 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 118.893 1.347 . . . . 0.0 111.778 173.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 52.1 mmtt -117.13 -19.8 9.54 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 125.468 1.507 . . . . 0.0 111.734 -176.031 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 57.1 tp -124.97 144.85 50.15 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 124.68 1.192 . . . . 0.0 110.668 -168.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -116.75 145.87 43.2 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 105.183 -2.154 . . . . 0.0 105.183 167.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 68.1 mt -115.83 140.24 38.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 105.768 -1.938 . . . . 0.0 105.768 175.179 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 80.8 t -132.84 98.23 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 -171.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -74.17 140.33 45.08 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 174.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 13.6 tt -143.49 124.97 11.09 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 178.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 61.0 t0 -83.89 106.63 15.71 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 124.401 1.08 . . . . 0.0 108.883 -172.331 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 33.0 m -59.81 -25.11 31.28 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 CA-C-O 118.444 -0.788 . . . . 0.0 112.072 -175.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -65.29 -18.6 65.44 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 119.646 1.112 . . . . 0.0 112.026 -178.556 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -118.7 4.53 11.6 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.041 1.337 . . . . 0.0 110.948 177.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 68.6 m-80 -140.5 38.72 1.87 Allowed 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 124.383 1.073 . . . . 0.0 110.151 -169.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 55.1 mm-40 -56.05 -33.27 64.83 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.295 0.638 . . . . 0.0 110.849 174.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -66.52 -47.93 71.36 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 118.3 0.5 . . . . 0.0 110.284 178.127 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.96 -40.86 91.68 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 118.65 0.659 . . . . 0.0 110.0 -179.236 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.35 -50.35 74.29 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.361 0.664 . . . . 0.0 110.1 174.08 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -60.37 -28.39 67.11 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 123.879 0.752 . . . . 0.0 112.334 177.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 21.9 ttmt -55.05 -29.48 57.56 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 125.565 1.546 . . . . 0.0 111.898 178.16 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -124.12 11.07 8.82 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.846 0.858 . . . . 0.0 111.71 178.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 67.38 24.42 73.63 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 123.914 0.768 . . . . 0.0 113.214 -177.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 48.9 t -63.65 129.62 27.53 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 171.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 35.0 ttm -142.64 4.37 1.52 Allowed 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.269 1.028 . . . . 0.0 111.278 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 22.8 m -142.6 161.58 37.7 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 126.697 1.999 . . . . 0.0 107.539 178.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 43.0 pt -143.0 156.45 61.95 Favored Pre-proline 0 CA--C 1.545 0.76 0 C-N-CA 124.588 1.155 . . . . 0.0 108.921 178.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -66.9 139.18 44.28 Favored 'Cis proline' 0 C--N 1.348 0.547 0 CA-C-N 120.423 1.187 . . . . 0.0 110.18 -5.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 33.1 m -131.37 139.1 49.42 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 174.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 83.7 mt -119.82 128.55 53.8 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 -169.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -117.86 124.32 48.04 Favored 'General case' 0 CA--C 1.516 -0.354 0 N-CA-C 103.973 -2.603 . . . . 0.0 103.973 177.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 15.9 t -96.38 122.68 48.12 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 N-CA-C 104.118 -2.549 . . . . 0.0 104.118 173.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.9 mp -116.16 152.45 33.67 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 175.317 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 57.8 tttp -135.02 121.83 20.97 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 173.123 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.4 t70 48.66 37.13 8.83 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.889 1.275 . . . . 0.0 112.264 175.469 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 99.07 2.1 57.02 Favored Glycine 0 CA--C 1.53 0.971 0 CA-C-O 117.954 -1.47 . . . . 0.0 115.283 169.539 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -122.1 145.55 48.06 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 120.292 2.046 . . . . 0.0 109.323 175.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 58.5 t -65.79 130.85 31.47 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 170.218 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 35.4 m -119.45 -19.27 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 CA-C-O 117.717 -1.135 . . . . 0.0 111.314 175.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -155.21 167.93 28.75 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 120.444 1.475 . . . . 0.0 111.191 173.345 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 14.3 m -141.84 151.11 42.45 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.767 1.627 . . . . 0.0 108.698 177.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 58.8 m -150.16 156.27 41.31 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.514 1.525 . . . . 0.0 108.57 169.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 42.3 t -133.62 144.91 34.54 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 -178.237 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 78.22 -175.86 54.43 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 123.695 0.664 . . . . 0.0 111.817 179.102 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -62.56 147.17 49.9 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.371 0.669 . . . . 0.0 110.415 177.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 58.6 mttt -142.22 138.0 16.25 Favored Pre-proline 0 C--O 1.234 0.281 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 168.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -68.6 165.09 30.54 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 122.134 1.889 . . . . 0.0 111.029 177.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -53.77 -44.04 69.72 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 125.531 1.532 . . . . 0.0 112.698 -178.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -63.78 -43.71 95.53 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.097 177.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.77 -38.49 86.66 Favored 'General case' 0 C--N 1.339 0.12 0 O-C-N 121.776 -0.577 . . . . 0.0 110.58 -179.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 51.9 mt -62.22 -45.87 91.42 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 123.511 0.724 . . . . 0.0 110.746 175.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 11.3 mt-30 -58.92 -41.0 86.26 Favored 'General case' 0 C--O 1.225 -0.19 0 CA-C-N 118.383 0.538 . . . . 0.0 110.769 175.214 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -65.9 -39.92 91.03 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 118.875 0.761 . . . . 0.0 110.81 179.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 67.8 tp -62.54 -36.38 82.42 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.339 1.456 . . . . 0.0 111.181 177.096 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 84.2 t -69.11 -47.88 72.36 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-N 118.572 0.623 . . . . 0.0 109.857 169.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -57.18 -40.6 77.66 Favored 'General case' 0 CA--C 1.521 -0.155 0 C-N-CA 125.498 1.519 . . . . 0.0 111.893 -168.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -65.52 -6.44 10.75 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 -178.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -126.59 0.4 6.84 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 124.526 1.13 . . . . 0.0 113.426 176.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 54.7 mt . . . . . 0 C--O 1.247 0.955 0 CA-C-N 119.462 1.028 . . . . 0.0 109.004 171.35 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.6 mt . . . . . 0 CA--C 1.539 0.547 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 47.3 t -140.34 164.3 22.36 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 C-N-CA 127.049 2.14 . . . . 0.0 106.99 -173.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 3.7 tppp? -113.87 147.37 38.57 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 175.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -146.85 168.91 20.25 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 123.109 0.564 . . . . 0.0 110.535 175.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 33.2 p -136.03 177.73 7.61 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 125.929 1.691 . . . . 0.0 107.961 170.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -42.75 -37.85 1.9 Allowed 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.3 1.44 . . . . 0.0 112.836 169.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 50.8 mm-40 -73.88 -26.24 60.45 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.805 0.842 . . . . 0.0 113.03 -174.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 14.3 p -121.74 -19.77 6.68 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 -169.413 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -53.82 -45.85 70.97 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 124.54 1.136 . . . . 0.0 111.925 -171.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.6 m -65.7 -23.96 66.88 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 112.937 0.717 . . . . 0.0 112.937 -177.14 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -90.66 -28.68 18.21 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 124.086 0.954 . . . . 0.0 111.443 176.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 68.9 mm-40 -70.81 -32.63 69.77 Favored 'General case' 0 N--CA 1.453 -0.325 0 O-C-N 121.797 -0.564 . . . . 0.0 110.829 173.266 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 22.9 p -88.71 4.56 46.9 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 113.847 1.055 . . . . 0.0 113.847 -170.277 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 30.4 p -108.67 29.16 7.68 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.336 1.054 . . . . 0.0 112.339 -174.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -129.32 50.73 2.12 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.218 1.007 . . . . 0.0 110.954 -174.357 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 103.68 -155.37 17.82 Favored Glycine 0 C--N 1.337 0.625 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 178.26 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 45.1 t -71.53 138.22 22.12 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 N-CA-C 105.694 -1.965 . . . . 0.0 105.694 167.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 47.3 t -138.22 139.25 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 N-CA-C 105.739 -1.949 . . . . 0.0 105.739 179.316 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 61.1 tp -122.6 101.72 7.64 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 106.703 -1.592 . . . . 0.0 106.703 -176.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -83.27 151.28 25.68 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 179.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -130.4 94.21 3.62 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 126.482 1.913 . . . . 0.0 107.242 -178.51 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -74.2 114.46 12.57 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 105.704 -1.962 . . . . 0.0 105.704 174.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -149.46 -177.63 5.96 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.094 1.357 . . . . 0.0 108.521 -172.856 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -155.63 147.94 17.59 Favored Pre-proline 0 CA--C 1.532 0.255 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 168.062 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -61.2 -18.06 56.21 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 121.649 1.566 . . . . 0.0 115.72 -178.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 49.7 p-90 -69.02 -20.68 64.14 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 119.963 1.256 . . . . 0.0 111.878 173.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 30.6 t -59.22 146.33 39.56 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 125.146 1.379 . . . . 0.0 111.054 -172.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -95.22 -60.26 1.07 Allowed Glycine 0 CA--C 1.531 1.064 0 CA-C-O 118.795 -1.003 . . . . 0.0 111.36 169.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -66.04 -26.25 50.88 Favored 'Trans proline' 0 C--N 1.35 0.656 0 CA-C-N 120.293 2.047 . . . . 0.0 113.101 -172.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 30.8 m -57.53 -35.14 69.89 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 121.699 -0.625 . . . . 0.0 111.295 174.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.0 mmtp -67.3 -26.09 66.36 Favored 'General case' 0 CA--C 1.53 0.207 0 O-C-N 121.673 -0.642 . . . . 0.0 110.928 -179.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 29.8 mtm -71.85 -44.17 64.28 Favored 'General case' 0 C--N 1.34 0.173 0 CA-C-N 118.585 0.63 . . . . 0.0 110.426 177.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 15.5 tt -79.86 -22.16 11.95 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-O 118.574 -0.727 . . . . 0.0 111.351 -177.201 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -48.93 -52.32 47.71 Favored Pre-proline 0 CA--C 1.549 0.942 0 CA-C-N 120.424 1.466 . . . . 0.0 114.241 179.125 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -66.71 -26.92 45.29 Favored 'Trans proline' 0 C--N 1.35 0.607 0 CA-C-N 121.748 1.66 . . . . 0.0 112.454 176.512 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 6.1 t -69.82 -37.86 74.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 O-C-N 121.688 -0.633 . . . . 0.0 109.454 174.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 43.2 mt -65.66 -36.72 84.49 Favored 'General case' 0 C--O 1.224 -0.267 0 CA-C-N 119.286 0.948 . . . . 0.0 110.517 172.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -63.34 -43.73 96.89 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 119.198 0.908 . . . . 0.0 111.079 173.013 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -60.61 -44.98 95.68 Favored 'General case' 0 CA--C 1.531 0.241 0 O-C-N 121.243 -0.911 . . . . 0.0 110.186 175.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -62.16 -41.88 98.73 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 124.846 1.258 . . . . 0.0 109.942 179.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -60.24 -42.85 96.14 Favored 'General case' 0 CA--C 1.521 -0.168 0 C-N-CA 123.879 0.872 . . . . 0.0 110.905 176.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -71.54 -10.46 59.8 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 122.976 0.51 . . . . 0.0 112.337 -179.202 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -103.59 -34.0 8.8 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 125.205 1.402 . . . . 0.0 111.234 178.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 74.6 mmm -121.86 -5.63 9.08 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 113.364 0.876 . . . . 0.0 113.364 -168.512 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -57.83 -15.11 18.37 Favored Glycine 0 CA--C 1.532 1.133 0 CA-C-N 119.718 1.145 . . . . 0.0 115.135 -173.203 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -69.71 -30.48 68.12 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 118.441 1.12 . . . . 0.0 111.728 173.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 45.9 mmtm -112.82 -19.69 11.89 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 125.456 1.502 . . . . 0.0 111.676 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 30.1 tp -117.55 157.15 26.83 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.412 1.085 . . . . 0.0 111.214 -169.232 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 37.4 ttmt -128.3 141.32 51.48 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 103.893 -2.632 . . . . 0.0 103.893 166.453 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 62.2 mt -108.15 141.53 23.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 105.925 -1.88 . . . . 0.0 105.925 175.04 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 84.7 t -132.69 98.44 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 -173.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt -74.31 140.49 44.93 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 174.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 15.0 tt -142.35 126.81 16.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 176.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 49.2 t0 -83.42 103.49 12.83 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.795 1.238 . . . . 0.0 109.067 -173.076 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 28.2 m -60.1 -27.15 38.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 118.766 -0.635 . . . . 0.0 112.028 -174.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -66.31 -19.54 65.84 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 119.321 0.964 . . . . 0.0 111.73 -177.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -114.13 1.78 14.69 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.558 1.543 . . . . 0.0 110.893 178.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 69.0 m-80 -141.98 42.52 1.68 Allowed 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.387 1.075 . . . . 0.0 109.79 -169.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 45.2 mm-40 -56.22 -33.07 65.01 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.794 0.838 . . . . 0.0 111.236 178.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 36.0 mm-40 -65.78 -46.72 77.68 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 118.379 0.536 . . . . 0.0 110.389 179.074 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.45 -38.51 77.81 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 121.798 -0.564 . . . . 0.0 109.778 -178.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -58.78 -47.54 84.36 Favored 'General case' 0 CA--C 1.535 0.376 0 O-C-N 120.978 -1.076 . . . . 0.0 110.241 171.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -59.97 -28.93 66.9 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 124.087 0.851 . . . . 0.0 112.506 176.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 50.1 tptt -56.27 -29.05 60.61 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.602 1.161 . . . . 0.0 111.551 179.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -123.34 10.39 9.24 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.568 0.747 . . . . 0.0 111.664 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 62.31 33.31 85.72 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 123.558 0.599 . . . . 0.0 112.427 -176.176 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 57.5 t -64.94 121.06 13.29 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 173.001 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 26.1 mmt -132.45 2.64 3.85 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.96 1.304 . . . . 0.0 111.465 -179.009 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 30.0 m -144.82 161.48 39.17 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 126.953 2.101 . . . . 0.0 107.062 178.242 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 34.5 pt -144.21 155.18 58.18 Favored Pre-proline 0 CA--C 1.545 0.788 0 C-N-CA 124.772 1.229 . . . . 0.0 108.451 177.406 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -68.54 139.54 51.47 Favored 'Cis proline' 0 C--N 1.35 0.624 0 CA-C-N 120.651 1.268 . . . . 0.0 110.53 -2.474 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 32.0 m -132.89 132.57 42.21 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 177.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 6.9 mp -110.52 131.17 55.28 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 -171.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -122.38 128.35 50.86 Favored 'General case' 0 CA--C 1.508 -0.638 0 N-CA-C 103.388 -2.819 . . . . 0.0 103.388 179.132 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 1.5 t -110.61 127.13 67.86 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.751 0 N-CA-C 104.337 -2.468 . . . . 0.0 104.337 -176.255 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.3 mp -126.08 152.05 46.37 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 -174.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -138.04 125.47 21.94 Favored 'General case' 0 CA--C 1.513 -0.479 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 175.221 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 29.2 t70 49.84 33.12 6.02 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.959 1.303 . . . . 0.0 112.348 173.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 99.41 4.59 56.14 Favored Glycine 0 CA--C 1.53 1.018 0 CA-C-O 118.018 -1.434 . . . . 0.0 114.551 170.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -122.0 144.89 48.62 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 120.101 1.951 . . . . 0.0 109.043 174.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 14.3 p -68.74 129.71 33.43 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 169.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 27.7 m -115.62 -20.87 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 CA-C-O 117.577 -1.201 . . . . 0.0 111.052 179.586 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -159.42 166.36 31.19 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 120.734 1.606 . . . . 0.0 111.402 176.343 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 13.3 m -136.34 151.18 49.31 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.991 1.716 . . . . 0.0 108.519 175.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 74.1 m -150.26 158.11 43.81 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.882 1.673 . . . . 0.0 108.671 171.206 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 39.2 t -133.97 148.21 30.32 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 -177.01 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.68 177.24 51.86 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 123.973 0.797 . . . . 0.0 112.705 171.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 47.6 t80 -62.55 135.46 57.42 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.352 0.661 . . . . 0.0 109.59 175.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 13.0 mptt -136.05 136.2 22.58 Favored Pre-proline 0 CA--C 1.533 0.324 0 C-N-CA 126.429 1.892 . . . . 0.0 105.995 175.389 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -70.61 160.19 50.28 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 122.493 2.128 . . . . 0.0 110.591 176.18 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 41.5 pttt -59.34 -28.9 67.25 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -177.108 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -65.86 -48.86 70.15 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 122.839 0.456 . . . . 0.0 110.037 173.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.6 -37.9 89.06 Favored 'General case' 0 CA--C 1.529 0.162 0 O-C-N 121.898 -0.501 . . . . 0.0 110.711 178.296 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 79.3 mt -64.97 -41.56 95.34 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 119.355 -0.355 . . . . 0.0 111.255 176.267 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 15.6 mt-30 -59.32 -41.05 88.17 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 118.824 0.738 . . . . 0.0 110.086 174.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -64.77 -40.82 95.9 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 118.199 0.454 . . . . 0.0 110.365 178.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 63.3 tp -61.03 -43.77 98.4 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.733 1.213 . . . . 0.0 110.755 177.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 78.5 t -61.42 -46.43 96.61 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 123.651 0.78 . . . . 0.0 109.37 173.125 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -61.91 -25.73 67.75 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 125.017 1.327 . . . . 0.0 112.239 -173.086 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 49.2 mtpt -55.86 -24.58 37.73 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 118.658 -0.687 . . . . 0.0 112.576 172.327 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 80.9 m-70 -123.34 -8.2 8.13 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 -168.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 82.1 mt . . . . . 0 C--O 1.248 0.975 0 CA-C-N 119.155 0.889 . . . . 0.0 109.327 171.512 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.3 mt . . . . . 0 CA--C 1.534 0.351 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 41.3 t -135.32 163.72 35.05 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 C-N-CA 126.353 1.861 . . . . 0.0 106.251 -177.127 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 6.2 ttmt -118.99 144.83 46.28 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 174.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -145.12 166.49 25.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.393 0.615 . . . . 0.0 110.976 -177.027 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.9 p -133.09 169.92 16.15 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 126.254 1.822 . . . . 0.0 107.779 171.29 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -52.63 -29.71 27.61 Favored 'General case' 0 CA--C 1.535 0.365 0 C-N-CA 124.499 1.12 . . . . 0.0 113.23 -178.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 82.6 mm-40 -63.54 -29.0 70.33 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.788 1.235 . . . . 0.0 113.103 179.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.6 m -135.17 -6.85 2.31 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 -169.295 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -52.14 -42.98 63.8 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.439 1.096 . . . . 0.0 111.722 -178.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.6 m -62.74 -39.15 93.19 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.111 0.564 . . . . 0.0 111.83 -179.02 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -68.54 -43.89 75.7 Favored 'General case' 0 N--CA 1.452 -0.329 0 O-C-N 122.011 -0.431 . . . . 0.0 110.079 177.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 67.1 mm-40 -63.05 -34.52 77.76 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-O 119.618 -0.229 . . . . 0.0 111.085 -179.068 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 27.4 p -85.65 3.66 39.94 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 113.524 0.935 . . . . 0.0 113.524 -176.507 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 69.6 m -105.4 30.05 5.99 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.053 0.941 . . . . 0.0 112.07 -175.515 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -132.83 37.46 3.45 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.455 0.702 . . . . 0.0 112.702 -173.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 123.11 -152.47 16.93 Favored Glycine 0 N--CA 1.465 0.593 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 174.022 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 67.4 t -73.09 133.72 31.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 104.528 -2.397 . . . . 0.0 104.528 165.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 40.7 t -136.26 130.19 47.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.8 tt -110.9 99.49 8.39 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 105.865 -1.902 . . . . 0.0 105.865 -178.106 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -80.07 143.16 34.23 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 178.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -123.91 94.05 4.11 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 125.806 1.642 . . . . 0.0 107.159 -176.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -73.88 113.15 10.72 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 105.791 -1.929 . . . . 0.0 105.791 174.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -148.86 -177.05 5.58 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.785 1.234 . . . . 0.0 108.354 -173.125 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -156.07 149.06 18.27 Favored Pre-proline 0 CA--C 1.531 0.224 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 167.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -61.44 -18.17 57.83 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 121.707 1.605 . . . . 0.0 115.61 179.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 52.6 p-90 -70.56 -19.44 62.88 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 120.002 1.274 . . . . 0.0 111.901 173.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 19.5 t -60.03 151.99 25.08 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 124.944 1.298 . . . . 0.0 110.844 -174.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -105.88 -58.0 0.64 Allowed Glycine 0 CA--C 1.531 1.058 0 CA-C-O 118.842 -0.976 . . . . 0.0 111.017 171.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -56.91 -33.16 94.53 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 123.28 2.653 . . . . 0.0 113.518 -179.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 31.4 m -58.11 -34.05 69.77 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.202 0.601 . . . . 0.0 111.423 176.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.2 mmtp -68.42 -24.85 64.79 Favored 'General case' 0 CA--C 1.53 0.184 0 O-C-N 121.534 -0.729 . . . . 0.0 110.927 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 31.0 mtm -70.65 -43.21 69.65 Favored 'General case' 0 C--N 1.34 0.153 0 CA-C-N 118.735 0.698 . . . . 0.0 110.357 176.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 17.5 tt -83.08 -22.74 8.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-O 118.61 -0.709 . . . . 0.0 111.616 -176.355 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -49.28 -51.08 60.4 Favored Pre-proline 0 CA--C 1.547 0.853 0 CA-C-N 120.234 1.379 . . . . 0.0 114.261 178.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -66.49 -28.97 45.33 Favored 'Trans proline' 0 C--N 1.351 0.675 0 CA-C-N 121.675 1.634 . . . . 0.0 112.028 176.378 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.2 t -68.27 -36.67 76.0 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 O-C-N 121.645 -0.659 . . . . 0.0 109.703 175.08 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 87.9 mt -66.39 -36.06 81.89 Favored 'General case' 0 C--N 1.341 0.212 0 CA-C-N 119.654 1.115 . . . . 0.0 111.144 171.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -62.45 -42.94 99.83 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 119.376 0.989 . . . . 0.0 110.799 171.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -63.92 -39.98 95.41 Favored 'General case' 0 CA--C 1.532 0.272 0 O-C-N 121.199 -0.938 . . . . 0.0 110.466 176.273 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 44.8 tp -62.05 -42.96 99.74 Favored 'General case' 0 CA--C 1.528 0.098 0 C-N-CA 123.867 0.867 . . . . 0.0 109.992 176.295 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -60.39 -42.45 95.9 Favored 'General case' 0 CA--C 1.52 -0.185 0 C-N-CA 123.275 0.63 . . . . 0.0 110.845 178.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -71.69 -10.8 60.31 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.319 0.648 . . . . 0.0 112.511 -179.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -105.52 -31.98 8.72 Favored 'General case' 0 C--O 1.232 0.15 0 C-N-CA 125.486 1.514 . . . . 0.0 111.458 -179.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 80.0 mmm -125.47 -3.32 7.34 Favored 'General case' 0 N--CA 1.46 0.06 0 CA-C-O 118.407 -0.806 . . . . 0.0 113.113 -167.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -57.85 -10.91 7.18 Favored Glycine 0 CA--C 1.534 1.226 0 C-N-CA 124.826 1.203 . . . . 0.0 115.919 -173.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -75.22 -24.57 57.75 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 118.502 1.151 . . . . 0.0 111.881 173.458 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 50.6 mtmt -128.26 -16.01 4.54 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 125.757 1.623 . . . . 0.0 111.887 -173.014 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 58.9 tp -123.0 144.23 49.4 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 124.816 1.246 . . . . 0.0 110.283 -172.227 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -116.25 145.39 43.18 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 105.256 -2.127 . . . . 0.0 105.256 167.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 82.6 mt -115.12 137.9 47.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 105.298 -2.112 . . . . 0.0 105.298 175.477 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 95.2 t -132.06 96.9 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 -171.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -74.96 137.03 41.34 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 176.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 13.3 tt -140.43 126.73 21.47 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 178.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -83.63 106.53 15.42 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 124.462 1.105 . . . . 0.0 109.098 -172.355 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 34.6 m -58.97 -27.7 36.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 118.643 -0.694 . . . . 0.0 111.99 -176.03 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -65.69 -17.23 64.46 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 119.347 0.976 . . . . 0.0 112.204 -176.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -121.96 4.16 9.92 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.927 1.291 . . . . 0.0 111.225 179.484 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 68.7 m-80 -141.28 40.47 1.76 Allowed 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.197 0.999 . . . . 0.0 109.785 -170.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 53.7 mm-40 -54.42 -30.84 53.69 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.097 0.959 . . . . 0.0 111.09 175.375 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -66.16 -50.18 64.83 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 123.99 0.916 . . . . 0.0 110.167 -179.273 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.77 -38.96 80.4 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 -178.428 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -58.62 -48.29 81.5 Favored 'General case' 0 CA--C 1.534 0.342 0 O-C-N 121.298 -0.876 . . . . 0.0 110.357 172.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -61.23 -28.76 69.71 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 123.905 0.764 . . . . 0.0 112.213 177.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 19.9 tptm -56.19 -29.3 60.69 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.697 1.199 . . . . 0.0 111.509 179.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -123.73 10.82 9.03 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.552 0.741 . . . . 0.0 111.627 -179.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 64.35 30.81 78.88 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 123.616 0.627 . . . . 0.0 112.582 -177.226 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 61.0 t -65.96 122.44 16.92 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 171.06 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 26.1 mmt -132.65 3.5 3.84 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.784 1.233 . . . . 0.0 111.381 -178.312 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 23.7 m -144.66 162.23 37.19 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 126.652 1.981 . . . . 0.0 107.621 179.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 17.7 pt -142.42 155.14 64.31 Favored Pre-proline 0 CA--C 1.544 0.731 0 C-N-CA 124.663 1.185 . . . . 0.0 108.689 175.195 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -67.99 138.32 43.39 Favored 'Cis proline' 0 C--N 1.35 0.63 0 CA-C-N 120.469 1.203 . . . . 0.0 110.399 -3.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 44.9 m -131.33 140.61 49.77 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 174.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 83.4 mt -122.32 127.73 50.18 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 -169.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -117.84 125.4 50.46 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 103.984 -2.599 . . . . 0.0 103.984 178.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 10.0 t -97.05 123.58 49.45 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 N-CA-C 104.145 -2.539 . . . . 0.0 104.145 172.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.9 mp -115.19 151.69 33.96 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 175.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 21.0 tptm -133.55 119.37 19.41 Favored 'General case' 0 CA--C 1.516 -0.363 0 N-CA-C 106.229 -1.767 . . . . 0.0 106.229 174.402 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.2 t70 50.83 37.59 17.52 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.626 1.17 . . . . 0.0 112.483 175.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 103.73 -2.35 45.42 Favored Glycine 0 CA--C 1.527 0.826 0 CA-C-O 118.087 -1.396 . . . . 0.0 115.582 168.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -128.41 145.25 51.14 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 120.033 1.917 . . . . 0.0 109.773 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 61.4 t -61.63 132.52 27.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 173.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.4 p -119.49 -21.85 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.77 0 C-N-CA 124.413 1.085 . . . . 0.0 110.372 174.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -157.62 165.56 35.17 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 120.552 1.524 . . . . 0.0 111.053 175.269 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 11.7 m -137.57 151.21 48.12 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.219 1.408 . . . . 0.0 109.004 179.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 58.4 m -148.47 157.23 43.34 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 126.022 1.729 . . . . 0.0 108.561 169.399 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 36.6 t -133.71 146.71 31.38 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 -179.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 79.41 -175.97 54.86 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 123.504 0.573 . . . . 0.0 112.19 177.135 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -63.17 146.55 53.1 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.579 0.752 . . . . 0.0 110.618 178.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 66.7 mttt -143.9 136.17 13.29 Favored Pre-proline 0 CA--C 1.532 0.284 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 168.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -70.42 160.42 49.59 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 122.408 2.072 . . . . 0.0 110.086 174.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 49.0 pttt -58.4 -28.59 65.34 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 113.569 0.952 . . . . 0.0 113.569 -177.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -65.25 -50.34 66.17 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 118.61 0.641 . . . . 0.0 109.741 174.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.81 -39.84 95.53 Favored 'General case' 0 C--N 1.34 0.165 0 C-N-CA 122.89 0.476 . . . . 0.0 110.627 178.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 92.3 mt -64.08 -42.54 96.92 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 122.74 0.416 . . . . 0.0 111.344 177.276 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -61.8 -40.07 93.94 Favored 'General case' 0 C--O 1.223 -0.29 0 CA-C-N 118.592 0.633 . . . . 0.0 110.197 176.469 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -65.5 -41.92 92.7 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 118.729 0.695 . . . . 0.0 110.302 178.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 58.3 tp -60.55 -38.29 84.03 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.744 1.618 . . . . 0.0 111.22 177.115 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 71.5 t -68.01 -49.92 63.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 C-N-CA 123.822 0.849 . . . . 0.0 109.545 171.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 -58.63 -40.68 84.02 Favored 'General case' 0 C--N 1.333 -0.122 0 C-N-CA 125.344 1.458 . . . . 0.0 111.821 -168.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.408 ' HG3' ' CD2' ' A' ' 103' ' ' HIS . 22.0 ptmt -65.75 -8.31 20.45 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 -177.542 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . 0.408 ' CD2' ' HG3' ' A' ' 102' ' ' LYS . 94.7 m-70 -124.14 1.9 8.56 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 124.413 1.085 . . . . 0.0 113.695 179.605 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 55.8 mt . . . . . 0 C--O 1.248 1.025 0 CA-C-N 119.386 0.994 . . . . 0.0 109.227 172.519 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.8 mt . . . . . 0 CA--C 1.536 0.428 0 N-CA-C 106.97 -1.493 . . . . 0.0 106.97 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 20.2 t -138.59 163.95 27.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 126.621 1.968 . . . . 0.0 106.856 -176.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.25 136.49 53.59 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 105.618 -1.993 . . . . 0.0 105.618 177.011 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -141.3 176.2 9.04 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 123.631 0.772 . . . . 0.0 112.473 -169.542 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.4 p -130.08 173.12 11.04 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 127.646 2.378 . . . . 0.0 107.924 175.094 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -45.95 -39.9 9.52 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 124.643 1.177 . . . . 0.0 113.521 177.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 80.8 mm-40 -90.43 -38.02 13.56 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 122.921 0.489 . . . . 0.0 111.727 -174.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 11.4 m -67.83 -33.63 75.15 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 118.143 0.429 . . . . 0.0 110.927 177.34 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 33.4 t80 -50.77 -45.96 59.24 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 126.143 1.777 . . . . 0.0 111.217 -176.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 9.7 m -64.86 -37.8 88.85 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 118.601 0.637 . . . . 0.0 111.876 -175.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -68.53 -45.68 71.56 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 175.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -64.21 -36.75 85.09 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 122.486 0.314 . . . . 0.0 111.252 -176.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 36.8 p -81.17 -4.1 54.3 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 124.071 0.948 . . . . 0.0 113.031 -176.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 70.0 m -94.66 28.64 2.57 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.937 0.895 . . . . 0.0 111.754 -177.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -134.01 66.84 1.53 Allowed 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.541 1.137 . . . . 0.0 110.229 -177.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 88.13 -156.56 27.37 Favored Glycine 0 C--N 1.337 0.59 0 N-CA-C 110.373 -1.091 . . . . 0.0 110.373 174.205 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 97.9 t -71.41 132.85 32.82 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 N-CA-C 106.889 -1.522 . . . . 0.0 106.889 168.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 47.2 t -136.46 146.34 29.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 179.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 5.0 tt -128.06 100.56 5.93 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 -176.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -81.97 146.27 29.83 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.256 -179.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -124.56 94.42 4.19 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 126.113 1.765 . . . . 0.0 107.458 -176.394 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -74.44 112.42 10.6 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 106.05 -1.833 . . . . 0.0 106.05 175.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -149.24 -177.22 5.71 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.668 1.187 . . . . 0.0 108.575 -174.087 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -155.65 146.96 16.71 Favored Pre-proline 0 CA--C 1.532 0.277 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 167.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_exo -60.29 -18.21 51.2 Favored 'Trans proline' 0 N--CA 1.461 -0.439 0 C-N-CA 121.821 1.68 . . . . 0.0 115.86 -178.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 51.3 p-90 -69.35 -20.43 63.85 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 119.949 1.25 . . . . 0.0 111.937 173.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 34.2 t -59.31 148.21 33.05 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 125.065 1.346 . . . . 0.0 111.199 -172.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -97.61 -63.28 0.89 Allowed Glycine 0 CA--C 1.53 0.971 0 CA-C-O 118.403 -1.22 . . . . 0.0 110.974 171.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -62.24 -26.52 77.53 Favored 'Trans proline' 0 C--N 1.35 0.613 0 CA-C-N 120.424 2.112 . . . . 0.0 113.679 -174.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 33.8 m -57.39 -34.98 69.43 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 121.582 -0.698 . . . . 0.0 111.515 174.464 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.8 mmtp -67.53 -24.94 65.6 Favored 'General case' 0 CA--C 1.53 0.182 0 O-C-N 121.602 -0.686 . . . . 0.0 111.021 -179.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 31.3 mtm -71.22 -43.41 67.4 Favored 'General case' 0 C--N 1.34 0.182 0 CA-C-N 118.68 0.673 . . . . 0.0 110.421 176.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 14.1 tt -84.18 -23.48 7.76 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-O 118.705 -0.664 . . . . 0.0 111.727 -174.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -48.88 -51.47 54.44 Favored Pre-proline 0 CA--C 1.548 0.877 0 CA-C-N 119.911 1.232 . . . . 0.0 114.076 178.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -66.57 -29.67 43.8 Favored 'Trans proline' 0 C--N 1.35 0.65 0 CA-C-N 121.611 1.611 . . . . 0.0 112.194 176.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 5.4 t -66.46 -39.92 85.24 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 175.218 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 67.9 mt -64.99 -38.23 90.26 Favored 'General case' 0 C--N 1.34 0.169 0 CA-C-N 119.317 0.962 . . . . 0.0 110.858 174.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -61.6 -43.9 97.99 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 119.011 0.823 . . . . 0.0 111.122 172.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -62.34 -38.5 89.75 Favored 'General case' 0 CA--C 1.533 0.327 0 O-C-N 121.393 -0.817 . . . . 0.0 110.223 175.609 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.77 -44.48 96.08 Favored 'General case' 0 C--N 1.333 -0.114 0 C-N-CA 124.074 0.95 . . . . 0.0 110.391 177.097 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -60.24 -41.89 94.1 Favored 'General case' 0 CA--C 1.521 -0.165 0 C-N-CA 123.24 0.616 . . . . 0.0 110.92 177.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 -72.01 -11.03 60.58 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 -179.075 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -106.45 -32.69 7.99 Favored 'General case' 0 C--O 1.232 0.133 0 C-N-CA 125.226 1.411 . . . . 0.0 111.639 -179.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 87.4 mmm -125.75 -4.18 7.08 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-O 118.357 -0.83 . . . . 0.0 113.022 -168.284 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -58.39 -11.77 10.8 Favored Glycine 0 CA--C 1.533 1.188 0 CA-C-N 119.835 1.198 . . . . 0.0 114.811 -175.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -65.98 -27.95 68.53 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 118.418 1.109 . . . . 0.0 111.83 171.378 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.442 ' HA ' ' HE3' ' A' ' 49' ' ' LYS . 0.0 OUTLIER -121.28 -24.87 5.36 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 125.954 1.701 . . . . 0.0 111.81 179.333 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 45.9 tp -103.0 157.76 16.76 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 124.144 0.977 . . . . 0.0 111.036 -169.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -133.88 144.41 48.88 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 103.957 -2.608 . . . . 0.0 103.957 166.65 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 66.2 mt -118.56 140.54 41.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 105.61 -1.996 . . . . 0.0 105.61 178.305 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 74.0 t -133.0 97.21 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 -170.205 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 51.3 mtmt -74.35 134.46 42.5 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 177.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 20.2 tt -137.92 126.8 33.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 178.167 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 62.9 t0 -87.84 103.97 16.15 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 114.727 -1.124 . . . . 0.0 108.419 -171.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 23.0 m -61.7 -23.2 30.29 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 CA-C-O 118.766 -0.635 . . . . 0.0 112.208 -174.339 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -65.34 -22.67 66.84 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 119.25 0.932 . . . . 0.0 111.562 -179.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -117.28 1.71 12.47 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.926 1.29 . . . . 0.0 111.323 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 66.6 m-80 -139.36 43.34 2.02 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 125.167 1.387 . . . . 0.0 108.798 -171.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -60.64 -35.44 76.21 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.034 0.934 . . . . 0.0 109.825 -175.451 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 -62.64 -44.49 96.15 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 123.674 0.79 . . . . 0.0 110.218 179.174 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -66.7 -40.86 88.65 Favored 'General case' 0 C--O 1.225 -0.188 0 C-N-CA 123.467 0.707 . . . . 0.0 110.082 -178.061 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.38 -50.06 75.41 Favored 'General case' 0 CA--C 1.532 0.283 0 O-C-N 121.742 -0.598 . . . . 0.0 110.058 173.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -58.43 -29.77 63.96 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 123.558 0.599 . . . . 0.0 112.55 176.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 9.8 ttpt -58.05 -26.61 62.7 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 125.758 1.623 . . . . 0.0 111.994 -178.35 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -123.61 11.04 9.13 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.886 0.874 . . . . 0.0 111.944 176.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 65.89 29.05 74.24 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 123.567 0.603 . . . . 0.0 112.765 -177.173 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 61.8 t -65.65 125.26 22.37 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 170.14 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 98.7 mtp -135.25 3.41 3.11 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.747 1.219 . . . . 0.0 111.515 -179.131 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 24.0 m -144.1 162.05 37.26 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 126.588 1.955 . . . . 0.0 107.743 179.228 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 38.6 pt -142.11 154.39 64.64 Favored Pre-proline 0 CA--C 1.545 0.767 0 C-N-CA 124.534 1.134 . . . . 0.0 108.685 176.332 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -67.71 140.07 51.63 Favored 'Cis proline' 0 C--N 1.351 0.692 0 CA-C-N 120.437 1.192 . . . . 0.0 110.429 -3.149 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 35.8 m -131.74 143.52 50.3 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 173.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 88.3 mt -123.9 126.84 47.08 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 -169.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -115.87 121.71 43.18 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 103.17 -2.9 . . . . 0.0 103.17 177.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 4.6 t -94.21 129.14 44.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 103.641 -2.726 . . . . 0.0 103.641 174.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.7 mp -122.89 154.81 37.83 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 178.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -138.33 123.32 19.0 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 174.12 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.0 t70 49.86 37.41 13.45 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.07 1.348 . . . . 0.0 112.647 176.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 105.1 -4.23 41.29 Favored Glycine 0 CA--C 1.529 0.916 0 CA-C-O 118.184 -1.342 . . . . 0.0 115.271 168.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -131.92 150.68 52.08 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 120.056 1.928 . . . . 0.0 110.374 -177.221 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 44.6 t -62.2 132.14 27.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 178.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.8 p -120.44 -21.75 3.94 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 C-N-CA 125.436 1.494 . . . . 0.0 109.926 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -159.84 172.21 18.05 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 120.121 1.328 . . . . 0.0 109.873 174.034 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 25.9 m -146.53 151.41 37.29 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.708 1.203 . . . . 0.0 109.246 177.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 4.2 m -147.13 156.87 43.35 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 125.507 1.523 . . . . 0.0 109.14 170.174 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 35.5 t -134.85 143.32 37.82 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 -177.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 76.17 -173.89 53.65 Favored Glycine 0 CA--C 1.531 1.052 0 CA-C-O 121.509 0.505 . . . . 0.0 111.862 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 65.4 t80 -63.56 149.2 46.86 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.483 0.713 . . . . 0.0 110.871 179.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 27.4 mttp -144.71 136.92 13.2 Favored Pre-proline 0 CA--C 1.534 0.342 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 168.247 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -70.44 161.3 46.52 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 122.32 2.013 . . . . 0.0 110.228 174.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 46.5 pttt -59.15 -29.53 67.49 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 -177.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -64.86 -50.13 67.81 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 118.951 0.796 . . . . 0.0 109.737 175.096 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.62 -39.47 94.44 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 122.73 0.412 . . . . 0.0 110.821 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 77.1 mt -63.68 -44.46 93.66 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 122.949 0.5 . . . . 0.0 111.249 176.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 12.4 mt-30 -61.4 -39.44 90.73 Favored 'General case' 0 C--O 1.224 -0.243 0 CA-C-O 118.704 -0.665 . . . . 0.0 110.371 176.358 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -65.6 -40.46 92.69 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 118.915 0.78 . . . . 0.0 110.439 178.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 68.9 tp -62.93 -35.73 81.07 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.634 1.574 . . . . 0.0 111.451 177.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 76.9 t -69.04 -50.96 48.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 C-N-CA 123.638 0.775 . . . . 0.0 109.584 169.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -58.27 -38.5 77.08 Favored 'General case' 0 CA--C 1.522 -0.117 0 C-N-CA 126.013 1.725 . . . . 0.0 112.196 -168.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -64.68 -6.96 8.92 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 -179.096 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -123.25 -5.9 8.31 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 124.395 1.078 . . . . 0.0 113.276 176.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 57.6 mt . . . . . 0 C--O 1.246 0.911 0 CA-C-N 119.319 0.963 . . . . 0.0 109.223 172.678 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.1 mp . . . . . 0 N--CA 1.448 -0.557 0 N-CA-C 105.134 -2.172 . . . . 0.0 105.134 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 46.8 t -132.91 164.4 35.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 C-N-CA 127.165 2.186 . . . . 0.0 105.904 -175.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 6.3 ttmt -121.67 147.2 46.19 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 177.007 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -147.35 168.32 22.11 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 123.279 0.632 . . . . 0.0 110.449 179.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 33.8 p -134.68 179.78 6.08 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 125.595 1.558 . . . . 0.0 107.371 169.314 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -49.17 -29.74 5.9 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.842 0.857 . . . . 0.0 112.685 170.167 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -65.18 -27.15 68.5 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.265 1.426 . . . . 0.0 113.138 179.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.9 p -134.43 -16.9 2.06 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 114.66 1.356 . . . . 0.0 114.66 -167.097 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -55.11 -45.13 75.48 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 124.442 1.097 . . . . 0.0 111.85 -170.091 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.7 m -63.26 -39.0 93.35 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 122.747 0.419 . . . . 0.0 111.613 -178.014 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -68.43 -44.49 74.87 Favored 'General case' 0 N--CA 1.452 -0.361 0 O-C-N 122.119 -0.363 . . . . 0.0 110.076 177.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -63.34 -34.6 78.06 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-O 119.33 -0.367 . . . . 0.0 111.108 -178.442 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 35.0 p -86.83 3.48 45.12 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.192 0.997 . . . . 0.0 113.268 -176.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 69.5 m -105.36 32.29 4.36 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.252 1.021 . . . . 0.0 111.562 -177.035 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -132.3 53.74 1.98 Allowed 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.197 0.999 . . . . 0.0 110.798 -176.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 97.55 -157.17 20.79 Favored Glycine 0 C--N 1.339 0.703 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 177.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 91.1 t -70.17 137.11 24.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 167.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 61.9 t -138.16 144.94 29.42 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 N-CA-C 105.479 -2.045 . . . . 0.0 105.479 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 41.8 tp -122.97 99.42 6.37 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 106.611 -1.625 . . . . 0.0 106.611 -177.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -78.52 149.95 33.0 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 109.319 -0.622 . . . . 0.0 109.319 177.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -129.15 94.38 3.8 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 126.761 2.024 . . . . 0.0 106.821 -179.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -73.25 114.51 11.52 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 105.882 -1.896 . . . . 0.0 105.882 174.253 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -147.38 -177.85 5.92 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 125.507 1.523 . . . . 0.0 108.301 -171.154 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -155.72 148.69 18.19 Favored Pre-proline 0 C--O 1.235 0.303 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 168.058 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -67.56 -13.25 38.4 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 121.656 1.571 . . . . 0.0 114.469 -175.206 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 53.4 p-90 -71.1 -20.26 62.36 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 120.194 1.361 . . . . 0.0 112.283 170.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 34.7 t -61.0 153.66 24.63 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.078 1.351 . . . . 0.0 111.523 -172.117 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -103.26 -65.53 0.72 Allowed Glycine 0 CA--C 1.53 0.983 0 CA-C-O 118.385 -1.23 . . . . 0.0 110.91 174.479 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_exo -55.77 -30.03 74.38 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.965 2.444 . . . . 0.0 114.118 179.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 33.2 m -58.18 -30.34 66.33 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 121.321 -0.862 . . . . 0.0 111.977 175.222 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.5 mmtp -72.68 -38.26 67.64 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 123.314 0.646 . . . . 0.0 110.014 178.046 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 5.8 ptt? -72.76 -31.52 64.97 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 118.817 0.735 . . . . 0.0 111.639 -176.327 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 15.9 tt -78.26 -19.1 13.53 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-O 118.925 -0.56 . . . . 0.0 111.969 174.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -54.94 -49.33 92.59 Favored Pre-proline 0 CA--C 1.545 0.77 0 CA-C-N 120.272 1.397 . . . . 0.0 113.655 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -66.53 -26.58 46.94 Favored 'Trans proline' 0 C--N 1.351 0.696 0 CA-C-N 121.95 1.732 . . . . 0.0 112.344 175.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 11.7 t -67.19 -39.7 83.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 174.11 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 96.3 mt -67.02 -34.34 77.51 Favored 'General case' 0 C--N 1.339 0.122 0 CA-C-N 119.013 0.824 . . . . 0.0 111.579 173.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -64.68 -42.26 95.47 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 119.338 0.972 . . . . 0.0 110.859 172.318 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -62.64 -37.77 87.66 Favored 'General case' 0 CA--C 1.531 0.235 0 O-C-N 120.884 -1.135 . . . . 0.0 110.457 173.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 42.9 tp -63.99 -42.42 97.19 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 123.114 0.566 . . . . 0.0 110.314 177.361 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -57.8 -44.47 86.34 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 118.983 0.81 . . . . 0.0 110.881 173.418 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -68.99 -8.87 48.91 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -177.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -112.2 -30.05 7.35 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 125.787 1.635 . . . . 0.0 111.973 -179.096 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 87.1 mmm -129.1 -7.66 4.86 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -169.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -58.48 -15.93 26.74 Favored Glycine 0 CA--C 1.529 0.949 0 CA-C-N 119.906 1.23 . . . . 0.0 114.674 -171.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -65.75 -26.2 67.62 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.297 1.039 . . . . 0.0 111.653 174.221 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.448 ' HA ' ' HE3' ' A' ' 49' ' ' LYS . 0.0 OUTLIER -122.91 -19.91 5.99 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.932 1.693 . . . . 0.0 111.884 179.761 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 36.0 tp -110.37 154.5 23.46 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 124.113 0.965 . . . . 0.0 111.144 -169.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 36.1 ttmt -130.96 144.28 51.36 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 104.6 -2.37 . . . . 0.0 104.6 167.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 94.1 mt -115.75 136.54 52.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 105.305 -2.109 . . . . 0.0 105.305 179.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 95.8 t -132.35 98.77 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-N 119.11 0.868 . . . . 0.0 109.23 -169.252 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 29.6 mtpp -74.57 139.99 44.1 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 175.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 13.0 tt -141.61 128.08 19.76 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 176.632 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 60.4 t0 -85.21 104.6 15.23 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 124.554 1.142 . . . . 0.0 109.196 -171.232 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 31.1 m -58.91 -26.46 32.55 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-O 118.593 -0.718 . . . . 0.0 112.017 -175.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -65.29 -18.57 65.42 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 119.454 1.024 . . . . 0.0 112.18 -177.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -119.8 4.39 11.02 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.921 1.289 . . . . 0.0 111.071 177.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 68.0 m-80 -139.24 39.92 2.09 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 124.456 1.102 . . . . 0.0 109.642 -170.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 49.9 mm-40 -55.67 -33.32 64.01 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.929 0.892 . . . . 0.0 111.112 177.523 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 -66.29 -49.04 68.43 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 118.353 0.524 . . . . 0.0 110.189 179.093 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.52 -39.66 88.75 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.351 0.661 . . . . 0.0 109.846 -179.006 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.64 -49.05 79.28 Favored 'General case' 0 CA--C 1.533 0.292 0 O-C-N 121.149 -0.97 . . . . 0.0 110.322 173.344 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -60.46 -28.49 67.5 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 123.916 0.77 . . . . 0.0 112.262 177.257 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 72.2 tttt -56.13 -29.03 60.14 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 125.068 1.347 . . . . 0.0 111.698 179.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -123.47 10.64 9.18 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.63 0.772 . . . . 0.0 111.703 179.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 64.1 31.15 79.87 Favored Glycine 0 CA--C 1.532 1.14 0 C-N-CA 123.708 0.67 . . . . 0.0 112.617 -176.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 61.8 t -65.94 121.6 15.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 171.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 26.1 mmt -132.47 2.17 3.8 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.797 1.239 . . . . 0.0 111.514 -178.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 31.5 m -145.65 161.74 39.16 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 126.789 2.036 . . . . 0.0 107.401 179.372 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 41.6 pt -142.62 156.79 63.03 Favored Pre-proline 0 CA--C 1.545 0.773 0 C-N-CA 124.734 1.214 . . . . 0.0 108.739 177.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -65.48 142.69 55.56 Favored 'Cis proline' 0 C--N 1.35 0.627 0 CA-C-N 120.413 1.183 . . . . 0.0 110.231 -5.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 18.6 m -135.62 132.86 37.61 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 175.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -110.02 134.59 51.97 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 -174.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -121.98 125.75 47.02 Favored 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 102.593 -3.114 . . . . 0.0 102.593 177.022 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 1.9 t -103.67 122.3 56.17 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 N-CA-C 103.605 -2.739 . . . . 0.0 103.605 -179.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.7 mp -119.45 155.8 31.37 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 -175.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -136.81 126.2 24.99 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 170.214 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.2 t70 48.36 36.02 6.5 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.93 1.292 . . . . 0.0 112.294 172.366 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 98.31 2.53 57.84 Favored Glycine 0 CA--C 1.533 1.189 0 CA-C-O 117.925 -1.486 . . . . 0.0 115.108 171.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -121.42 145.88 47.47 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 120.364 2.082 . . . . 0.0 109.569 175.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 67.6 t -66.32 130.03 31.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 169.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 35.5 m -114.42 -21.92 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 CA-C-O 117.666 -1.159 . . . . 0.0 110.985 174.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -156.36 168.23 27.98 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 120.605 1.548 . . . . 0.0 111.023 173.609 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 14.1 m -143.72 151.0 39.49 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.597 1.559 . . . . 0.0 109.186 -177.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 13.0 m -152.61 153.95 34.39 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.375 1.47 . . . . 0.0 109.221 168.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 61.0 t -132.69 142.33 42.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 -172.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 75.84 -172.32 54.12 Favored Glycine 0 CA--C 1.529 0.913 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 -173.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -60.08 148.86 34.3 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.566 0.698 . . . . 0.0 110.303 174.615 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 39.5 tptt -149.14 122.44 4.53 Favored Pre-proline 0 N--CA 1.45 -0.431 0 N-CA-C 105.717 -1.956 . . . . 0.0 105.717 -173.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -68.5 155.67 68.23 Favored 'Trans proline' 0 N--CA 1.454 -0.807 0 C-N-CA 121.369 1.379 . . . . 0.0 111.101 -174.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -52.26 -46.88 65.97 Favored 'General case' 0 N--CA 1.461 0.121 0 C-N-CA 125.205 1.402 . . . . 0.0 112.021 -179.357 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -62.26 -40.39 96.04 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 122.95 0.5 . . . . 0.0 110.672 -179.104 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -69.45 -37.51 77.38 Favored 'General case' 0 N--CA 1.456 -0.162 0 O-C-N 121.796 -0.565 . . . . 0.0 110.798 179.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 98.5 mt -60.43 -43.4 96.82 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-O 119.285 -0.388 . . . . 0.0 110.18 173.389 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 65.4 mt-30 -62.11 -37.05 83.64 Favored 'General case' 0 N--CA 1.461 0.103 0 CA-C-N 118.431 0.56 . . . . 0.0 111.732 176.017 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -61.79 -48.74 79.26 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 118.429 0.559 . . . . 0.0 109.781 175.219 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 34.9 mt -62.47 -36.69 83.27 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 118.381 0.537 . . . . 0.0 111.431 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 56.1 t -61.48 -51.81 68.46 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 172.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -69.2 -22.04 63.92 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 -172.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 65.2 mttm -57.65 -26.36 61.51 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 118.213 -0.899 . . . . 0.0 111.548 170.115 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -126.13 -18.05 5.1 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 113.645 0.98 . . . . 0.0 113.645 -169.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 33.4 mt . . . . . 0 C--O 1.247 0.926 0 CA-C-N 119.935 1.243 . . . . 0.0 109.156 169.097 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.3 mt . . . . . 0 CA--C 1.537 0.48 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 23.4 t -136.55 162.99 34.41 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 C-N-CA 126.271 1.829 . . . . 0.0 106.94 -174.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.21 132.77 55.49 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 105.128 -2.175 . . . . 0.0 105.128 173.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -136.25 169.7 17.22 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 123.309 0.644 . . . . 0.0 110.976 -177.218 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.9 p -135.91 171.98 13.68 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 125.597 1.559 . . . . 0.0 107.505 169.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -51.79 -27.8 13.47 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.502 1.121 . . . . 0.0 112.946 178.061 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -57.97 -32.37 67.78 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 126.256 1.823 . . . . 0.0 112.809 178.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.0 m -141.22 -3.73 1.19 Allowed 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 113.383 0.883 . . . . 0.0 113.383 -169.166 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 78.3 t80 -53.51 -41.6 66.48 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.172 0.989 . . . . 0.0 111.633 -178.069 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.1 p -60.67 -45.5 93.89 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 124.045 0.938 . . . . 0.0 111.774 177.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.03 -43.62 95.02 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 122.737 0.415 . . . . 0.0 110.284 178.175 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 65.4 mm-40 -63.4 -37.24 86.53 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-O 119.414 -0.326 . . . . 0.0 110.962 -179.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 31.6 p -83.98 3.26 35.04 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.221 1.008 . . . . 0.0 113.277 -177.26 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 63.4 m -104.13 31.47 4.55 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.296 1.038 . . . . 0.0 111.459 -177.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -134.51 64.02 1.61 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.297 1.039 . . . . 0.0 110.229 -177.486 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 88.89 -158.33 28.13 Favored Glycine 0 C--N 1.337 0.603 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 177.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 59.1 t -69.94 135.5 28.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 168.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 46.8 t -137.35 140.17 42.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 N-CA-C 105.763 -1.94 . . . . 0.0 105.763 179.26 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 52.3 tp -118.98 99.58 6.82 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 106.622 -1.622 . . . . 0.0 106.622 -178.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -79.67 149.35 31.27 Favored 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 178.025 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -130.43 93.99 3.57 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 126.532 1.933 . . . . 0.0 107.596 -177.02 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -74.44 113.82 12.11 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 105.821 -1.918 . . . . 0.0 105.821 175.275 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -149.9 -175.82 5.19 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 124.667 1.187 . . . . 0.0 108.455 -172.28 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -151.82 147.74 20.53 Favored Pre-proline 0 C--O 1.233 0.199 0 N-CA-C 105.64 -1.985 . . . . 0.0 105.64 167.19 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -67.1 -13.05 38.39 Favored 'Trans proline' 0 CA--C 1.535 0.533 0 CA-C-N 121.093 1.426 . . . . 0.0 113.104 -179.073 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 1.3 m95 -76.4 -13.51 60.12 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.841 0.856 . . . . 0.0 111.907 173.074 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 31.4 t -63.87 154.37 33.9 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 125.387 1.475 . . . . 0.0 111.076 -176.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -104.74 -65.4 0.68 Allowed Glycine 0 CA--C 1.53 0.997 0 CA-C-O 118.324 -1.265 . . . . 0.0 110.589 172.213 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -53.26 -32.02 58.78 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 123.4 2.733 . . . . 0.0 114.633 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 33.2 m -57.91 -34.37 69.77 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 121.574 -0.704 . . . . 0.0 111.721 176.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.0 mmtp -67.76 -23.17 65.2 Favored 'General case' 0 CA--C 1.53 0.188 0 O-C-N 121.492 -0.755 . . . . 0.0 111.074 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 32.2 mtm -70.83 -43.52 68.39 Favored 'General case' 0 C--N 1.339 0.143 0 CA-C-N 118.784 0.72 . . . . 0.0 110.357 176.018 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 17.3 tt -83.61 -22.61 8.33 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-O 118.75 -0.643 . . . . 0.0 111.698 -176.387 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -48.94 -51.43 55.29 Favored Pre-proline 0 CA--C 1.547 0.861 0 CA-C-N 120.032 1.287 . . . . 0.0 114.035 178.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -67.56 -25.16 41.16 Favored 'Trans proline' 0 C--N 1.351 0.688 0 CA-C-N 121.78 1.672 . . . . 0.0 112.367 176.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.4 t -72.07 -35.1 52.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 O-C-N 121.506 -0.746 . . . . 0.0 109.613 175.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 69.6 mt -67.97 -35.98 79.28 Favored 'General case' 0 C--N 1.338 0.095 0 CA-C-N 119.329 0.968 . . . . 0.0 111.036 170.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -62.4 -41.61 98.8 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 119.058 0.845 . . . . 0.0 110.818 170.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -61.99 -42.38 99.08 Favored 'General case' 0 C--N 1.331 -0.23 0 O-C-N 121.182 -0.948 . . . . 0.0 110.27 174.185 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 46.3 tp -61.62 -40.65 95.61 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.993 0.917 . . . . 0.0 110.642 178.586 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -60.98 -41.47 96.47 Favored 'General case' 0 C--N 1.334 -0.099 0 C-N-CA 123.108 0.563 . . . . 0.0 110.821 174.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -75.55 -11.08 59.95 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.023 0.529 . . . . 0.0 112.362 178.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -91.44 -50.45 5.79 Favored 'General case' 0 C--O 1.232 0.15 0 C-N-CA 124.928 1.291 . . . . 0.0 109.636 178.117 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 24.9 mtm -140.49 21.3 2.37 Favored 'General case' 0 N--CA 1.465 0.275 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -170.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -56.34 -11.7 5.28 Favored Glycine 0 CA--C 1.538 1.473 0 CA-C-N 120.197 1.362 . . . . 0.0 114.591 174.16 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -72.77 -28.7 62.76 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 118.694 1.247 . . . . 0.0 111.723 171.454 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -107.9 -24.92 11.45 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 125.922 1.689 . . . . 0.0 111.302 -179.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 48.8 tp -114.42 157.54 22.75 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 124.498 1.119 . . . . 0.0 111.307 -168.664 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -128.7 143.42 50.93 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 104.214 -2.513 . . . . 0.0 104.214 166.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 82.3 mt -117.44 138.5 47.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 105.367 -2.086 . . . . 0.0 105.367 178.199 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 98.8 t -132.59 98.74 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 -170.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 52.6 mtmt -70.93 141.6 51.11 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 107.848 -1.168 . . . . 0.0 107.848 173.323 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 16.5 tt -144.05 125.2 9.73 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 174.221 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 54.1 t0 -83.82 105.65 14.89 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.362 1.065 . . . . 0.0 108.629 -173.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 30.9 m -59.31 -26.25 33.25 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-O 118.538 -0.744 . . . . 0.0 111.939 -174.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -65.11 -18.27 65.16 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 119.453 1.024 . . . . 0.0 112.179 -177.401 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -119.69 3.82 11.11 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.915 1.286 . . . . 0.0 111.134 178.046 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 68.2 m-80 -139.5 39.82 2.05 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.438 1.095 . . . . 0.0 109.761 -170.453 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 52.1 mm-40 -55.41 -32.61 62.82 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.75 0.82 . . . . 0.0 111.092 176.37 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 33.4 mm-40 -65.99 -47.67 73.78 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 118.373 0.533 . . . . 0.0 110.324 178.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.49 -39.83 85.2 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 118.581 0.628 . . . . 0.0 109.993 -178.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.49 -49.39 77.96 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 121.621 -0.674 . . . . 0.0 110.453 173.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -61.75 -28.67 70.4 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 123.764 0.697 . . . . 0.0 112.131 178.367 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 17.2 ttmt -54.97 -29.47 56.9 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 125.772 1.629 . . . . 0.0 112.009 178.346 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -123.65 10.5 9.05 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.794 0.837 . . . . 0.0 111.831 178.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 65.25 28.27 73.37 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 123.825 0.726 . . . . 0.0 112.94 -177.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 56.7 t -62.35 127.49 22.45 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 172.084 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 42.3 ttp -137.29 0.79 2.36 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.532 1.133 . . . . 0.0 110.966 -176.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 24.4 m -144.95 162.74 36.15 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 126.535 1.934 . . . . 0.0 107.634 179.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 41.0 pt -143.29 156.55 60.92 Favored Pre-proline 0 CA--C 1.545 0.754 0 C-N-CA 124.897 1.279 . . . . 0.0 108.583 176.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -66.89 139.6 46.36 Favored 'Cis proline' 0 C--N 1.349 0.575 0 CA-C-N 120.522 1.222 . . . . 0.0 110.207 -5.097 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 31.9 m -132.11 138.59 48.16 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 176.198 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 88.5 mt -116.09 128.5 55.73 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 -171.367 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -119.23 125.54 49.41 Favored 'General case' 0 CA--C 1.509 -0.626 0 N-CA-C 102.551 -3.129 . . . . 0.0 102.551 177.459 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 1.7 t -105.64 122.6 59.31 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 N-CA-C 103.609 -2.737 . . . . 0.0 103.609 -179.387 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.8 mp -120.23 153.52 36.2 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 -176.57 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -136.63 124.97 23.28 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 171.501 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.5 t70 48.62 36.04 7.04 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.016 1.327 . . . . 0.0 112.284 174.026 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 99.8 2.34 56.23 Favored Glycine 0 CA--C 1.532 1.113 0 CA-C-O 117.92 -1.489 . . . . 0.0 114.98 170.055 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -122.36 146.75 47.04 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 120.273 2.037 . . . . 0.0 109.571 176.122 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 62.0 t -66.82 130.01 31.83 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 N-CA-C 107.405 -1.332 . . . . 0.0 107.405 170.216 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 30.7 m -118.29 -17.19 7.36 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 C-N-CA 124.641 1.177 . . . . 0.0 111.338 176.21 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -156.4 167.55 30.09 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 120.547 1.521 . . . . 0.0 110.61 172.477 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 19.1 m -146.42 142.62 28.35 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.589 1.156 . . . . 0.0 108.706 174.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 49.5 m -144.58 156.71 44.27 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.025 1.33 . . . . 0.0 108.734 176.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 39.8 t -134.23 146.38 31.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 -174.657 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 76.32 -175.95 52.36 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 123.532 0.587 . . . . 0.0 112.436 177.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -63.29 148.78 47.31 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.989 0.915 . . . . 0.0 111.286 -179.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -148.84 142.13 15.85 Favored Pre-proline 0 CA--C 1.534 0.335 0 C-N-CA 125.626 1.57 . . . . 0.0 107.24 167.816 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -72.26 160.8 46.23 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 122.871 2.381 . . . . 0.0 110.787 175.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 40.5 pttt -59.31 -30.12 68.12 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 -176.275 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -65.22 -49.72 68.62 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 118.355 0.525 . . . . 0.0 109.639 174.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.74 -37.86 88.93 Favored 'General case' 0 CA--C 1.528 0.118 0 O-C-N 122.063 -0.398 . . . . 0.0 110.853 179.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 84.5 mt -63.77 -44.62 92.88 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 122.722 0.409 . . . . 0.0 111.289 175.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -60.7 -41.95 96.23 Favored 'General case' 0 C--O 1.223 -0.291 0 CA-C-O 118.903 -0.57 . . . . 0.0 109.838 176.07 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -64.24 -40.93 97.05 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 118.383 0.538 . . . . 0.0 110.777 -179.535 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 56.3 tp -61.0 -44.89 96.75 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 124.965 1.306 . . . . 0.0 110.715 176.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 75.4 t -62.15 -43.83 98.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 123.602 0.761 . . . . 0.0 109.621 173.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -62.6 -24.05 67.37 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 125.186 1.395 . . . . 0.0 112.203 -173.296 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -54.85 -26.1 33.08 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 118.611 -0.709 . . . . 0.0 112.222 171.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 86.1 m-70 -123.8 -11.62 7.67 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 113.423 0.897 . . . . 0.0 113.423 -168.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 70.4 mt . . . . . 0 C--O 1.249 1.045 0 CA-C-N 119.16 0.891 . . . . 0.0 109.292 171.678 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.1 ttm . . . . . 0 N--CA 1.484 1.247 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -68.64 -20.89 64.49 Favored 'General case' 0 CA--C 1.509 -0.611 0 N-CA-C 115.699 1.74 . . . . 0.0 115.699 -175.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 7.6 mt -87.55 133.63 29.83 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 -172.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 10.4 t -135.71 158.8 39.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 106.441 -1.688 . . . . 0.0 106.441 -172.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 14.1 mtpt -119.99 125.14 47.66 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 105.793 -1.928 . . . . 0.0 105.793 -177.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -136.65 166.46 23.49 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.485 0.66 . . . . 0.0 111.422 -173.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 22.9 p -132.38 176.23 8.6 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 126.013 1.725 . . . . 0.0 107.819 172.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -53.58 -29.49 37.67 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.859 0.863 . . . . 0.0 112.465 177.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 54.2 mt-30 -66.53 -29.35 69.41 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.048 1.339 . . . . 0.0 112.915 179.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 23.5 p -123.3 -15.65 7.13 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.565 1.146 . . . . 0.0 113.416 -169.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -52.88 -48.15 67.34 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 124.53 1.132 . . . . 0.0 112.048 -172.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.9 m -63.92 -39.38 94.03 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.013 0.525 . . . . 0.0 111.779 -177.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.84 -43.78 87.48 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 178.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -66.08 -43.3 87.76 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 122.425 0.29 . . . . 0.0 110.747 -179.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 37.6 p -77.51 -5.32 49.61 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 -175.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 73.1 m -73.27 -21.88 60.5 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 177.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -87.98 72.18 9.29 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 118.75 0.705 . . . . 0.0 111.527 -169.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 85.09 -151.73 26.2 Favored Glycine 0 C--N 1.336 0.573 0 N-CA-C 110.479 -1.049 . . . . 0.0 110.479 172.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 97.6 t -72.18 132.95 32.69 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 168.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 49.6 t -138.2 143.96 31.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 N-CA-C 105.756 -1.942 . . . . 0.0 105.756 179.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 5.6 tt -122.85 101.6 7.53 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 106.303 -1.74 . . . . 0.0 106.303 -178.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -81.78 147.06 29.6 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.659 -179.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -125.43 93.8 3.96 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 126.588 1.955 . . . . 0.0 107.194 -175.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -75.8 112.79 12.55 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 175.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -149.94 -176.04 5.28 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.432 1.093 . . . . 0.0 108.644 -172.013 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -152.79 147.69 19.52 Favored Pre-proline 0 CA--C 1.531 0.236 0 N-CA-C 106.085 -1.821 . . . . 0.0 106.085 167.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -59.11 -18.29 43.06 Favored 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 121.848 1.699 . . . . 0.0 114.595 177.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 2.0 m95 -75.19 -14.22 60.52 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 118.818 0.735 . . . . 0.0 111.865 176.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 25.0 t -64.32 153.33 38.68 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.499 1.519 . . . . 0.0 111.063 -177.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -103.26 -65.14 0.71 Allowed Glycine 0 CA--C 1.53 0.982 0 CA-C-O 118.424 -1.209 . . . . 0.0 110.514 171.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_exo -53.22 -31.7 56.93 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 123.525 2.816 . . . . 0.0 114.608 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 34.3 m -58.63 -32.59 69.17 Favored 'General case' 0 CA--C 1.537 0.451 0 O-C-N 121.509 -0.744 . . . . 0.0 111.857 176.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.3 mmtp -68.36 -23.83 64.73 Favored 'General case' 0 CA--C 1.531 0.244 0 O-C-N 121.273 -0.892 . . . . 0.0 110.888 179.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 28.9 mtm -71.57 -40.93 69.61 Favored 'General case' 0 C--N 1.339 0.148 0 CA-C-N 118.79 0.723 . . . . 0.0 110.636 176.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 19.2 tt -83.14 -21.37 8.98 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-O 118.918 -0.563 . . . . 0.0 111.529 -176.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -49.79 -50.62 66.46 Favored Pre-proline 0 CA--C 1.55 0.952 0 CA-C-N 120.14 1.336 . . . . 0.0 114.003 177.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -66.46 -26.39 47.59 Favored 'Trans proline' 0 C--N 1.351 0.701 0 CA-C-N 121.688 1.639 . . . . 0.0 112.451 175.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 6.0 t -67.63 -40.08 83.43 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-N 118.907 0.776 . . . . 0.0 109.136 173.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 91.3 mt -64.3 -34.21 77.6 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 119.462 1.028 . . . . 0.0 111.224 172.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -66.32 -38.14 86.99 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 119.606 1.094 . . . . 0.0 111.385 171.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -63.78 -36.09 82.76 Favored 'General case' 0 C--N 1.33 -0.248 0 O-C-N 120.299 -1.501 . . . . 0.0 110.115 172.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 18.7 mt -66.58 -37.25 84.52 Favored 'General case' 0 C--N 1.334 -0.097 0 CA-C-O 117.892 -1.051 . . . . 0.0 112.087 173.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -54.1 -47.05 72.18 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 120.569 1.532 . . . . 0.0 109.65 168.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 44.1 mt-30 -74.49 -13.67 60.72 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 113.283 0.846 . . . . 0.0 113.283 -174.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 61.7 mt-10 -120.93 -24.27 5.67 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 124.417 1.087 . . . . 0.0 113.01 -170.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 17.5 mtp -131.99 -5.2 3.53 Favored 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 -175.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -58.43 -12.17 12.16 Favored Glycine 0 CA--C 1.538 1.472 0 CA-C-N 120.488 1.494 . . . . 0.0 115.393 -172.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -74.83 -25.99 59.39 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.326 1.45 . . . . 0.0 112.226 174.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.458 ' HA ' ' HE3' ' A' ' 49' ' ' LYS . 0.0 OUTLIER -123.67 -18.16 6.19 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 125.575 1.55 . . . . 0.0 112.144 -177.504 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 55.7 tp -118.13 150.71 38.91 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 124.167 0.987 . . . . 0.0 110.552 -169.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -124.02 145.0 49.5 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 104.821 -2.289 . . . . 0.0 104.821 167.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 90.0 mt -120.59 129.32 75.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 104.395 -2.446 . . . . 0.0 104.395 -177.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 98.7 t -126.23 98.45 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 CA-C-N 119.217 0.917 . . . . 0.0 109.403 -170.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -73.47 137.62 44.62 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 176.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 15.1 tt -141.34 125.43 16.79 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 C-N-CA 123.769 0.827 . . . . 0.0 108.79 176.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 60.6 t0 -83.47 104.2 13.42 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 124.62 1.168 . . . . 0.0 108.953 -172.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 30.3 m -58.81 -27.05 33.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 118.713 -0.66 . . . . 0.0 111.959 -174.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -65.57 -17.75 64.81 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 119.346 0.975 . . . . 0.0 112.171 -176.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -120.57 3.44 10.7 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.869 1.268 . . . . 0.0 111.222 178.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 69.0 m-80 -139.11 40.02 2.12 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.43 1.092 . . . . 0.0 109.814 -169.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 51.8 mm-40 -55.46 -32.09 62.49 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.122 0.969 . . . . 0.0 111.257 176.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 36.8 mm-40 -66.25 -48.45 70.47 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 118.493 0.588 . . . . 0.0 110.357 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.15 -39.46 82.63 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 118.408 0.549 . . . . 0.0 109.556 -178.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -58.95 -48.69 80.6 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 121.31 -0.869 . . . . 0.0 110.327 173.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -61.19 -28.66 69.45 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 123.985 0.802 . . . . 0.0 112.202 177.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 44.9 tttp -55.97 -29.24 59.94 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.965 1.306 . . . . 0.0 111.686 179.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -122.88 10.43 9.54 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.705 0.802 . . . . 0.0 111.739 179.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 64.95 28.37 73.41 Favored Glycine 0 CA--C 1.533 1.186 0 CA-C-O 119.39 -0.672 . . . . 0.0 112.892 -177.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 61.4 t -62.27 125.56 18.87 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 171.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 12.0 tpt -136.53 1.28 2.59 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.608 1.163 . . . . 0.0 111.085 -175.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 24.6 m -144.82 163.11 35.07 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 126.626 1.97 . . . . 0.0 107.481 179.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 38.5 pt -142.88 156.26 62.4 Favored Pre-proline 0 CA--C 1.545 0.765 0 C-N-CA 124.574 1.15 . . . . 0.0 108.847 175.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -66.65 138.9 42.11 Favored 'Cis proline' 0 N--CA 1.458 -0.582 0 CA-C-N 120.361 1.164 . . . . 0.0 110.179 -5.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 32.3 m -129.77 142.71 50.65 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 174.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 88.4 mt -123.39 126.52 46.95 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 -168.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -118.41 119.39 34.46 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 103.969 -2.604 . . . . 0.0 103.969 179.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 5.1 t -90.23 123.15 42.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 103.565 -2.754 . . . . 0.0 103.565 171.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.2 mp -111.61 153.64 26.03 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 173.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -136.15 124.32 23.07 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 105.916 -1.883 . . . . 0.0 105.916 174.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 31.9 t70 50.96 34.13 10.06 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.573 1.149 . . . . 0.0 112.251 177.143 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 98.55 0.86 57.84 Favored Glycine 0 CA--C 1.531 1.038 0 CA-C-O 118.227 -1.318 . . . . 0.0 114.956 169.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -128.38 150.32 50.16 Favored 'General case' 0 C--N 1.34 0.153 0 CA-C-N 119.999 1.9 . . . . 0.0 109.916 178.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 47.9 t -62.26 133.24 28.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 176.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.6 p -117.92 -24.73 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 C-N-CA 125.087 1.355 . . . . 0.0 109.58 177.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -158.79 164.98 35.31 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 120.035 1.289 . . . . 0.0 110.506 175.041 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 10.6 m -136.26 150.88 49.14 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.709 1.204 . . . . 0.0 108.891 177.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 62.3 m -150.52 159.3 44.58 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.622 1.569 . . . . 0.0 108.768 169.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 40.7 t -133.77 147.73 30.66 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 -176.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 76.93 -178.03 51.51 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 123.637 0.637 . . . . 0.0 112.423 176.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -64.73 150.29 47.59 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.886 0.874 . . . . 0.0 110.826 178.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -149.02 145.53 19.7 Favored Pre-proline 0 C--O 1.235 0.321 0 C-N-CA 125.677 1.591 . . . . 0.0 106.93 167.529 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -70.84 161.19 46.94 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 122.649 2.233 . . . . 0.0 110.462 174.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 63.5 pttt -58.71 -31.74 68.54 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -175.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -68.02 -45.49 73.85 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 118.244 0.475 . . . . 0.0 109.859 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.7 -40.43 95.36 Favored 'General case' 0 C--O 1.232 0.159 0 O-C-N 122.039 -0.413 . . . . 0.0 110.339 177.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 97.4 mt -64.57 -40.6 95.84 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 122.307 0.243 . . . . 0.0 111.313 176.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 18.9 mt-30 -59.83 -39.3 84.61 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 118.759 -0.638 . . . . 0.0 110.108 175.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -68.14 -40.35 82.45 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 118.941 0.791 . . . . 0.0 110.808 178.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 43.9 tp -60.34 -37.89 82.08 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.312 1.445 . . . . 0.0 111.313 176.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 99.4 t -68.74 -49.75 61.41 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 C-N-CA 123.756 0.823 . . . . 0.0 109.578 170.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -58.09 -39.25 78.11 Favored 'General case' 0 CA--C 1.519 -0.218 0 C-N-CA 125.453 1.501 . . . . 0.0 112.119 -168.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 13.3 ptmm? -65.44 -5.92 9.02 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 113.364 0.876 . . . . 0.0 113.364 -178.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -127.04 -3.48 6.38 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.548 1.139 . . . . 0.0 113.595 175.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 46.9 mt . . . . . 0 C--O 1.248 0.988 0 CA-C-N 119.413 1.006 . . . . 0.0 109.164 170.289 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 43.5 tpp . . . . . 0 N--CA 1.483 1.196 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -144.73 -174.09 4.24 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.535 1.134 . . . . 0.0 110.476 -170.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 7.5 mt -70.05 147.27 11.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 168.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 37.3 t -137.68 164.77 27.91 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 C-N-CA 127.106 2.162 . . . . 0.0 106.2 -179.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 8.1 ttmt -120.14 146.34 46.07 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 107.1 -1.445 . . . . 0.0 107.1 173.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -143.64 169.97 16.73 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.717 0.77 . . . . 0.0 111.029 -178.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 18.6 p -133.77 173.43 11.54 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 127.699 2.4 . . . . 0.0 107.863 176.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -54.93 -31.41 60.32 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 121.578 -0.701 . . . . 0.0 112.547 177.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 59.4 mt-30 -70.77 -27.62 64.06 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.113 1.365 . . . . 0.0 112.959 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 25.5 p -118.89 -18.95 8.74 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.425 1.09 . . . . 0.0 113.524 -168.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -52.99 -46.47 68.32 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 125.014 1.326 . . . . 0.0 111.942 -172.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.0 m -63.79 -38.39 90.92 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 122.79 0.436 . . . . 0.0 111.795 -176.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -68.54 -44.6 74.2 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 177.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 67.6 mm-40 -63.95 -34.46 78.02 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-O 119.545 -0.264 . . . . 0.0 111.223 -178.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 33.3 p -85.79 1.63 48.9 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.012 0.925 . . . . 0.0 113.427 -176.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 70.9 m -101.79 31.52 3.81 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.14 0.976 . . . . 0.0 111.601 -177.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -133.72 65.05 1.59 Allowed 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.44 1.096 . . . . 0.0 110.104 -177.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 89.84 -154.32 23.79 Favored Glycine 0 C--N 1.338 0.661 0 N-CA-C 110.294 -1.123 . . . . 0.0 110.294 175.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 48.5 t -71.71 135.7 27.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 N-CA-C 106.214 -1.772 . . . . 0.0 106.214 168.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 49.2 t -137.62 141.98 37.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 178.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 60.4 tp -122.96 98.79 6.06 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 -177.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -79.39 148.72 31.89 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 178.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -127.98 93.98 3.82 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 126.543 1.937 . . . . 0.0 107.443 -178.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -73.4 112.6 9.62 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 105.735 -1.95 . . . . 0.0 105.735 175.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -148.64 -177.2 5.65 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 124.847 1.259 . . . . 0.0 108.173 -172.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -156.01 149.35 18.69 Favored Pre-proline 0 N--CA 1.453 -0.29 0 N-CA-C 106.154 -1.795 . . . . 0.0 106.154 167.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -68.93 -13.18 36.19 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 CA-C-N 120.866 1.345 . . . . 0.0 113.96 -177.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 46.4 p-90 -69.74 -20.39 63.51 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 120.147 1.34 . . . . 0.0 111.975 169.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 29.1 t -59.17 148.33 31.94 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.06 1.344 . . . . 0.0 111.05 -171.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -97.09 -60.59 0.96 Allowed Glycine 0 CA--C 1.532 1.113 0 CA-C-O 118.722 -1.043 . . . . 0.0 111.335 169.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -66.37 -25.99 48.6 Favored 'Trans proline' 0 C--N 1.349 0.574 0 CA-C-N 120.387 2.093 . . . . 0.0 112.983 -173.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 24.5 m -58.26 -33.98 69.99 Favored 'General case' 0 CA--C 1.534 0.346 0 O-C-N 121.627 -0.671 . . . . 0.0 111.218 174.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.1 mmtp -68.24 -22.87 64.75 Favored 'General case' 0 CA--C 1.531 0.242 0 O-C-N 121.591 -0.693 . . . . 0.0 111.078 -179.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 35.3 mtm -71.34 -44.21 65.51 Favored 'General case' 0 C--N 1.34 0.184 0 CA-C-N 118.863 0.756 . . . . 0.0 110.323 175.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 17.2 tt -83.04 -22.73 8.61 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-O 118.628 -0.701 . . . . 0.0 111.555 -176.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -49.05 -52.04 50.81 Favored Pre-proline 0 CA--C 1.548 0.888 0 CA-C-N 120.28 1.4 . . . . 0.0 114.223 178.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -66.41 -29.9 44.94 Favored 'Trans proline' 0 C--N 1.351 0.667 0 CA-C-N 121.574 1.598 . . . . 0.0 111.985 176.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.0 t -66.49 -40.26 86.04 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-O 118.722 -0.656 . . . . 0.0 109.403 175.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 45.7 mt -64.54 -37.05 86.21 Favored 'General case' 0 C--O 1.224 -0.258 0 CA-C-N 119.507 1.049 . . . . 0.0 110.613 174.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -63.03 -44.47 95.85 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 119.104 0.866 . . . . 0.0 111.083 173.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -63.94 -39.79 94.97 Favored 'General case' 0 CA--C 1.534 0.334 0 O-C-N 121.166 -0.959 . . . . 0.0 110.451 177.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -63.68 -43.28 97.11 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 125.175 1.39 . . . . 0.0 109.641 177.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -58.74 -43.12 90.15 Favored 'General case' 0 CA--C 1.521 -0.143 0 C-N-CA 123.767 0.827 . . . . 0.0 110.917 176.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -70.5 -10.19 58.55 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -106.31 -27.58 10.92 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 125.735 1.614 . . . . 0.0 111.518 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 22.2 mtp -126.14 -2.47 7.01 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 113.51 0.929 . . . . 0.0 113.51 -169.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.82 -7.3 6.17 Favored Glycine 0 CA--C 1.533 1.215 0 CA-C-N 119.591 1.087 . . . . 0.0 115.538 -176.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -75.71 -27.64 58.29 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 118.597 1.198 . . . . 0.0 111.638 171.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 45.0 mmtm -121.03 -20.51 6.81 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 125.514 1.526 . . . . 0.0 112.347 -175.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 48.8 tp -119.83 151.91 38.11 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.131 0.972 . . . . 0.0 111.546 -168.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -120.41 143.84 48.25 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 105.011 -2.218 . . . . 0.0 105.011 166.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 58.6 mt -112.56 140.2 33.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 105.497 -2.038 . . . . 0.0 105.497 173.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 95.1 t -132.75 98.96 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 -172.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 47.6 mtpt -73.9 140.43 45.65 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 175.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 13.0 tt -141.01 126.16 18.57 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 175.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -83.79 101.86 11.9 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 124.728 1.211 . . . . 0.0 108.786 -173.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 24.9 m -59.95 -25.63 33.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 118.667 -0.683 . . . . 0.0 111.961 -174.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -65.05 -18.45 65.31 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 119.464 1.029 . . . . 0.0 112.143 -177.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -120.22 4.02 10.84 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.809 1.244 . . . . 0.0 111.072 177.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -139.2 40.56 2.1 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.607 1.163 . . . . 0.0 109.592 -170.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 48.0 mm-40 -55.84 -32.55 63.7 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.184 0.993 . . . . 0.0 111.257 177.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -65.74 -46.27 79.51 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 118.385 0.539 . . . . 0.0 110.425 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.13 -39.19 79.03 Favored 'General case' 0 C--O 1.223 -0.317 0 CA-C-N 118.457 0.571 . . . . 0.0 109.618 -179.246 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.06 -48.36 81.89 Favored 'General case' 0 CA--C 1.533 0.326 0 O-C-N 121.256 -0.902 . . . . 0.0 110.25 173.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -60.68 -28.75 68.49 Favored Glycine 0 CA--C 1.529 0.938 0 C-N-CA 124.079 0.847 . . . . 0.0 112.36 177.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 47.3 tttp -55.94 -29.32 59.96 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 124.861 1.265 . . . . 0.0 111.709 179.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -123.2 10.63 9.35 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.621 0.768 . . . . 0.0 111.767 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 63.6 31.57 81.21 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 123.641 0.639 . . . . 0.0 112.636 -176.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 55.1 t -65.83 121.87 15.73 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 171.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 98.5 mmm -131.59 2.64 4.14 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.898 1.279 . . . . 0.0 111.382 -178.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 24.5 m -144.83 161.17 39.94 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 126.652 1.981 . . . . 0.0 107.565 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 38.7 pt -142.69 154.36 62.69 Favored Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 124.726 1.211 . . . . 0.0 108.41 176.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -68.26 140.14 53.89 Favored 'Cis proline' 0 C--N 1.349 0.601 0 CA-C-N 120.495 1.212 . . . . 0.0 110.541 -3.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 33.9 m -131.86 142.83 49.81 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 175.067 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 83.0 mt -121.24 127.4 51.39 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 -170.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -120.64 124.63 45.7 Favored 'General case' 0 CA--C 1.508 -0.637 0 N-CA-C 102.851 -3.018 . . . . 0.0 102.851 178.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 1.3 t -106.04 125.87 61.58 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 N-CA-C 103.872 -2.64 . . . . 0.0 103.872 -178.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.7 mp -122.08 152.9 39.34 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 -175.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -135.71 116.71 14.27 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 106.522 -1.659 . . . . 0.0 106.522 178.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.1 t70 49.58 38.42 14.79 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.915 1.286 . . . . 0.0 112.571 176.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 104.14 -2.87 43.99 Favored Glycine 0 CA--C 1.529 0.92 0 CA-C-O 118.056 -1.414 . . . . 0.0 115.418 168.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -126.57 147.17 49.91 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 120.129 1.964 . . . . 0.0 109.995 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 61.0 t -62.58 131.43 27.94 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 174.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 9.9 p -119.3 -20.67 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.732 0 C-N-CA 125.006 1.322 . . . . 0.0 110.093 178.102 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -159.96 166.75 29.46 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 120.58 1.536 . . . . 0.0 110.272 172.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 17.4 m -136.75 151.34 49.1 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.647 1.579 . . . . 0.0 108.798 176.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 46.3 m -148.35 157.4 43.46 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.871 1.669 . . . . 0.0 108.595 169.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 39.4 t -133.8 146.24 32.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 -178.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 79.58 -175.87 54.88 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 123.646 0.641 . . . . 0.0 112.296 176.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -62.46 145.28 54.56 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.577 0.751 . . . . 0.0 110.563 178.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 68.9 mttt -143.72 134.31 12.23 Favored Pre-proline 0 CA--C 1.532 0.258 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 168.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -69.5 160.76 48.56 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.306 2.004 . . . . 0.0 109.907 174.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 49.7 pttt -59.24 -28.3 66.57 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 -176.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -65.54 -47.89 74.35 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 118.444 0.565 . . . . 0.0 109.975 174.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.53 -37.65 88.28 Favored 'General case' 0 CA--C 1.529 0.173 0 O-C-N 121.859 -0.526 . . . . 0.0 110.619 177.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 83.0 mt -65.19 -42.12 93.89 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-O 119.285 -0.388 . . . . 0.0 111.383 176.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 15.8 mt-30 -59.3 -42.87 92.35 Favored 'General case' 0 C--O 1.225 -0.214 0 CA-C-N 118.697 0.681 . . . . 0.0 109.643 175.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -65.99 -38.6 88.91 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 118.017 0.371 . . . . 0.0 110.683 -179.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 65.9 tp -61.15 -47.25 87.06 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 125.025 1.33 . . . . 0.0 110.328 176.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 97.3 t -61.55 -43.26 96.64 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 123.902 0.881 . . . . 0.0 110.045 174.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -61.51 -26.05 67.67 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 125.18 1.392 . . . . 0.0 112.136 -172.088 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 82.3 mttt -55.15 -24.88 28.62 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 118.774 -0.632 . . . . 0.0 112.617 172.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 43.3 m-70 -121.74 -10.67 8.71 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 -167.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 78.7 mt . . . . . 0 C--O 1.249 1.077 0 CA-C-N 118.565 0.62 . . . . 0.0 109.457 172.586 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.0 mmt . . . . . 0 N--CA 1.485 1.281 0 CA-C-O 120.766 0.317 . . . . 0.0 110.148 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -150.44 -176.98 5.7 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.135 1.374 . . . . 0.0 109.201 -175.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.9 mt -73.79 144.93 12.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 167.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 29.0 t -136.47 163.97 32.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 C-N-CA 126.724 2.01 . . . . 0.0 106.273 -178.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.52 133.78 49.81 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 104.923 -2.251 . . . . 0.0 104.923 176.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -135.22 175.11 9.89 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 123.875 0.87 . . . . 0.0 111.37 -171.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 31.3 p -137.87 178.56 7.02 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 125.244 1.418 . . . . 0.0 107.779 169.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -49.3 -30.34 7.27 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.895 0.878 . . . . 0.0 112.4 169.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -64.81 -27.47 68.91 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.003 1.321 . . . . 0.0 112.776 -179.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 14.1 p -130.83 -17.55 3.16 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 114.298 1.222 . . . . 0.0 114.298 -167.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 56.8 t80 -52.2 -47.28 65.67 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 124.463 1.105 . . . . 0.0 112.259 -170.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.2 m -64.56 -37.9 89.15 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 122.62 0.368 . . . . 0.0 111.849 -176.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -69.09 -44.56 72.24 Favored 'General case' 0 N--CA 1.452 -0.343 0 O-C-N 122.017 -0.427 . . . . 0.0 109.96 176.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 68.9 mm-40 -63.22 -35.82 81.59 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 122.529 0.331 . . . . 0.0 110.921 -178.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 29.3 p -82.85 0.62 43.22 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 -176.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 70.7 m -102.04 29.21 5.2 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.972 0.909 . . . . 0.0 112.068 -175.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -135.2 55.24 1.89 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.831 0.853 . . . . 0.0 111.387 -173.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 107.39 -152.06 16.91 Favored Glycine 0 C--N 1.337 0.614 0 N-CA-C 109.954 -1.258 . . . . 0.0 109.954 173.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.2 t -74.83 135.75 26.65 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 N-CA-C 104.88 -2.267 . . . . 0.0 104.88 166.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 34.3 t -136.15 139.47 45.61 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 N-CA-C 106.441 -1.688 . . . . 0.0 106.441 178.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.8 tt -124.17 100.11 6.56 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 106.131 -1.803 . . . . 0.0 106.131 -177.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -81.33 145.67 30.75 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.236 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -124.52 94.02 4.08 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 125.899 1.68 . . . . 0.0 107.619 -176.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -74.22 112.51 10.45 Favored 'General case' 0 C--O 1.24 0.58 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 175.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -148.96 -176.51 5.37 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.966 1.306 . . . . 0.0 108.548 -172.581 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -156.44 146.74 15.9 Favored Pre-proline 0 CA--C 1.533 0.296 0 N-CA-C 106.16 -1.793 . . . . 0.0 106.16 168.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -60.76 -17.95 53.04 Favored 'Trans proline' 0 CA--C 1.534 0.495 0 C-N-CA 121.662 1.575 . . . . 0.0 115.799 -178.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 50.5 p-90 -69.23 -20.56 63.95 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 119.99 1.268 . . . . 0.0 112.011 173.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 34.1 t -58.9 146.9 35.99 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 125.055 1.342 . . . . 0.0 111.231 -172.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -95.4 -62.43 0.99 Allowed Glycine 0 CA--C 1.531 1.082 0 CA-C-O 118.647 -1.085 . . . . 0.0 111.163 170.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -64.43 -26.53 62.9 Favored 'Trans proline' 0 C--N 1.35 0.634 0 CA-C-N 120.257 2.029 . . . . 0.0 113.387 -173.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 30.2 m -57.29 -34.7 68.95 Favored 'General case' 0 CA--C 1.537 0.456 0 O-C-N 121.63 -0.669 . . . . 0.0 111.479 174.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.9 mmtp -67.91 -24.49 65.21 Favored 'General case' 0 CA--C 1.531 0.25 0 O-C-N 121.645 -0.659 . . . . 0.0 111.057 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 32.3 mtm -71.25 -44.04 66.07 Favored 'General case' 0 C--N 1.34 0.18 0 CA-C-N 118.654 0.661 . . . . 0.0 110.411 177.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 14.5 tt -82.21 -23.69 9.33 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-O 118.745 -0.645 . . . . 0.0 111.523 -176.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -48.59 -51.46 52.33 Favored Pre-proline 0 CA--C 1.548 0.888 0 CA-C-N 120.062 1.301 . . . . 0.0 114.262 179.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -66.93 -28.08 42.53 Favored 'Trans proline' 0 C--N 1.35 0.649 0 CA-C-N 121.807 1.681 . . . . 0.0 112.407 176.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.6 t -67.8 -37.92 79.32 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 O-C-N 121.584 -0.698 . . . . 0.0 109.313 174.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 95.0 mt -67.16 -35.4 79.6 Favored 'General case' 0 C--N 1.34 0.166 0 CA-C-N 119.516 1.053 . . . . 0.0 111.328 172.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -61.96 -43.07 99.6 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 119.548 1.067 . . . . 0.0 110.755 171.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -63.38 -41.35 98.79 Favored 'General case' 0 CA--C 1.53 0.179 0 O-C-N 121.279 -0.888 . . . . 0.0 110.421 175.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 35.3 tp -60.82 -42.21 97.23 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 123.494 0.718 . . . . 0.0 110.24 177.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -60.54 -43.82 96.79 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 123.347 0.659 . . . . 0.0 110.728 177.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 -71.4 -10.72 60.21 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.29 0.636 . . . . 0.0 112.629 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -105.59 -28.09 10.97 Favored 'General case' 0 C--O 1.232 0.172 0 C-N-CA 125.46 1.504 . . . . 0.0 111.42 -178.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 22.8 mtp -131.44 0.27 4.04 Favored 'General case' 0 N--CA 1.461 0.105 0 N-CA-C 113.658 0.985 . . . . 0.0 113.658 -169.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -55.82 -10.31 3.35 Favored Glycine 0 CA--C 1.535 1.343 0 C-N-CA 124.747 1.165 . . . . 0.0 115.926 -176.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -72.86 -29.14 62.97 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.597 1.159 . . . . 0.0 112.049 172.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 42.3 mmtm -126.37 -14.9 5.79 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 125.732 1.613 . . . . 0.0 112.842 -175.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 58.9 tp -120.3 142.59 48.95 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 124.144 0.978 . . . . 0.0 109.925 -170.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -117.73 145.48 44.43 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 104.899 -2.26 . . . . 0.0 104.899 167.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 73.7 mt -116.19 138.19 47.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 105.399 -2.075 . . . . 0.0 105.399 176.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 93.1 t -132.59 96.47 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -169.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 54.4 mtpt -74.24 139.05 44.07 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 177.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 17.3 tt -141.41 125.62 16.89 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 176.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 39.4 t0 -82.35 104.89 12.99 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 124.737 1.215 . . . . 0.0 108.428 -175.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 30.5 m -60.47 -25.8 35.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 C-N-CA 123.464 0.705 . . . . 0.0 112.194 -173.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -64.83 -26.54 68.38 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 119.188 0.904 . . . . 0.0 111.468 -177.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -108.97 6.38 25.14 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.098 1.359 . . . . 0.0 110.791 -179.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 68.3 m-80 -146.69 39.66 1.06 Allowed 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.536 1.135 . . . . 0.0 110.137 -168.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -57.84 -29.6 65.1 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.448 1.099 . . . . 0.0 110.541 179.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 48.1 mp0 -65.4 -51.35 60.93 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 124.7 1.2 . . . . 0.0 109.923 177.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.12 -38.55 85.79 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.536 0.734 . . . . 0.0 109.748 -178.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.1 -48.62 80.95 Favored 'General case' 0 CA--C 1.534 0.34 0 O-C-N 121.105 -0.997 . . . . 0.0 110.255 172.185 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -60.59 -28.92 68.52 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 123.887 0.756 . . . . 0.0 112.397 177.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 73.7 tttt -55.82 -29.28 59.52 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 125.047 1.339 . . . . 0.0 111.674 179.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -123.64 10.17 9.03 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.647 0.779 . . . . 0.0 111.87 179.288 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 64.37 28.75 73.5 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 123.736 0.684 . . . . 0.0 112.839 -176.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 51.0 t -62.08 125.65 18.81 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 172.054 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 12.0 tpt -137.6 0.71 2.28 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.567 1.147 . . . . 0.0 111.15 -176.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 28.0 m -144.87 162.67 36.24 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 126.594 1.957 . . . . 0.0 107.439 179.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 40.2 pt -142.97 154.44 61.89 Favored Pre-proline 0 CA--C 1.546 0.809 0 C-N-CA 124.502 1.121 . . . . 0.0 108.916 177.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -68.03 138.49 44.33 Favored 'Cis proline' 0 C--N 1.35 0.628 0 CA-C-N 120.427 1.188 . . . . 0.0 110.376 -3.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 26.0 m -129.42 141.55 51.01 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 173.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 86.7 mt -122.82 127.17 48.71 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 -169.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -115.99 123.63 48.5 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 103.683 -2.71 . . . . 0.0 103.683 177.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 6.2 t -99.24 125.13 52.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 103.993 -2.595 . . . . 0.0 103.993 177.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.7 mp -122.5 153.67 38.86 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 4.5 tmtp? -135.19 120.24 18.72 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 106.306 -1.739 . . . . 0.0 106.306 175.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.5 t70 50.69 36.88 15.15 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.901 1.28 . . . . 0.0 112.559 175.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 106.24 -4.26 38.04 Favored Glycine 0 CA--C 1.526 0.779 0 CA-C-O 118.104 -1.387 . . . . 0.0 115.326 168.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -130.87 147.72 52.55 Favored 'General case' 0 C--N 1.339 0.132 0 CA-C-N 120.085 1.942 . . . . 0.0 110.205 -177.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 53.0 t -63.26 132.86 29.24 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 178.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 5.2 p -119.21 -20.39 4.99 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 C-N-CA 124.823 1.249 . . . . 0.0 110.795 174.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -158.23 168.73 26.23 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 120.544 1.52 . . . . 0.0 110.903 173.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 10.3 m -138.26 150.94 47.16 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.399 1.48 . . . . 0.0 108.497 175.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 2.7 m -146.54 157.16 43.69 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 125.761 1.624 . . . . 0.0 108.653 169.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 39.5 t -133.67 147.14 30.92 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 176.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 78.47 -176.94 54.07 Favored Glycine 0 CA--C 1.53 0.973 0 CA-C-O 121.638 0.577 . . . . 0.0 112.406 177.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 60.0 t80 -65.91 145.03 56.4 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.921 0.888 . . . . 0.0 110.896 -179.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -141.93 140.57 19.96 Favored Pre-proline 0 CA--C 1.535 0.37 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 167.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -72.11 162.5 41.55 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 122.68 2.254 . . . . 0.0 110.781 175.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 31.9 pttt -58.91 -30.99 68.23 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 -177.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -66.94 -49.76 64.5 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 118.336 0.516 . . . . 0.0 109.969 176.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.24 -39.4 94.5 Favored 'General case' 0 CA--C 1.529 0.146 0 O-C-N 121.923 -0.486 . . . . 0.0 110.512 179.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 59.3 mt -62.48 -45.22 94.01 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 123.345 0.658 . . . . 0.0 111.013 176.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 19.2 mt-30 -58.79 -42.15 88.39 Favored 'General case' 0 C--O 1.225 -0.214 0 CA-C-N 118.311 0.505 . . . . 0.0 110.262 176.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -66.89 -38.62 86.62 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 118.488 0.586 . . . . 0.0 110.817 -179.079 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 64.8 tp -63.67 -38.32 90.68 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.869 1.267 . . . . 0.0 110.956 176.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 96.4 t -68.54 -46.38 80.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-N 119.083 0.856 . . . . 0.0 109.787 172.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -56.79 -41.96 78.61 Favored 'General case' 0 CA--C 1.519 -0.219 0 C-N-CA 125.449 1.499 . . . . 0.0 111.802 -168.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -68.39 -5.62 20.05 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -175.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 83.5 m-70 -123.72 2.56 8.86 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.311 1.044 . . . . 0.0 112.8 178.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 53.9 mt . . . . . 0 C--O 1.249 1.058 0 CA-C-N 119.306 0.957 . . . . 0.0 109.545 174.449 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.455 ' HG3' ' H ' ' A' ' 2' ' ' ALA 0.252 20.8 ptm . . . . . 0 N--CA 1.48 1.067 0 CA-C-O 118.778 -0.63 . . . . 0.0 112.033 . . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.455 ' H ' ' HG3' ' A' ' 1' ' ' MET . . . -158.33 -176.31 5.83 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 125.264 1.426 . . . . 0.0 109.034 -170.12 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.9 mt -75.56 145.63 10.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 167.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 29.5 t -139.53 163.72 25.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 C-N-CA 126.426 1.89 . . . . 0.0 107.138 -174.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -113.74 146.03 40.47 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 174.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -145.25 168.02 21.43 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 123.086 0.554 . . . . 0.0 110.077 175.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 31.7 p -132.42 178.57 6.72 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 168.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -53.29 -28.14 26.51 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.385 0.674 . . . . 0.0 112.292 174.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 -66.05 -29.01 69.28 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.294 1.838 . . . . 0.0 112.832 179.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 16.6 p -129.62 -14.61 4.1 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 -167.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -52.61 -47.03 67.22 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 124.453 1.101 . . . . 0.0 111.987 -172.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.8 m -63.84 -38.88 92.73 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 122.855 0.462 . . . . 0.0 111.787 -177.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -67.56 -44.79 77.4 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 177.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -64.02 -35.76 81.78 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 122.392 0.277 . . . . 0.0 111.062 -178.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 29.0 p -84.12 0.18 49.49 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.868 0.867 . . . . 0.0 113.251 -176.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 70.1 m -99.41 30.0 3.74 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.127 0.971 . . . . 0.0 111.758 -177.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -132.95 56.75 1.83 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.255 1.022 . . . . 0.0 110.543 -176.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 97.14 -155.36 20.66 Favored Glycine 0 C--N 1.336 0.572 0 N-CA-C 110.043 -1.223 . . . . 0.0 110.043 175.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 65.5 t -71.42 133.09 32.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 168.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 46.9 t -137.25 141.59 39.57 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 N-CA-C 105.907 -1.886 . . . . 0.0 105.907 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 3.8 tt -122.81 100.21 6.79 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 106.208 -1.775 . . . . 0.0 106.208 -175.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -82.09 146.22 29.75 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.402 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -125.63 94.2 4.06 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 126.101 1.761 . . . . 0.0 107.323 -178.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -73.54 113.46 10.68 Favored 'General case' 0 C--O 1.24 0.563 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 174.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -149.01 -177.33 5.75 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.842 1.257 . . . . 0.0 108.595 -172.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -156.21 148.3 17.46 Favored Pre-proline 0 CA--C 1.532 0.268 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 167.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -60.61 -18.63 55.97 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 121.796 1.664 . . . . 0.0 115.68 -179.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 50.6 p-90 -69.69 -20.14 63.56 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 119.987 1.267 . . . . 0.0 112.01 173.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 33.7 t -59.56 148.37 33.61 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 124.975 1.31 . . . . 0.0 111.185 -172.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -97.78 -63.36 0.89 Allowed Glycine 0 CA--C 1.529 0.962 0 CA-C-O 118.503 -1.165 . . . . 0.0 110.92 171.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -62.34 -26.57 77.1 Favored 'Trans proline' 0 C--N 1.351 0.704 0 CA-C-N 120.367 2.084 . . . . 0.0 113.73 -174.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 34.3 m -57.08 -35.59 69.57 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 121.653 -0.654 . . . . 0.0 111.513 174.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.0 mmtp -67.32 -25.54 66.07 Favored 'General case' 0 CA--C 1.53 0.208 0 O-C-N 121.63 -0.669 . . . . 0.0 110.977 -179.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 31.4 mtm -70.86 -44.24 66.81 Favored 'General case' 0 C--N 1.341 0.222 0 CA-C-N 118.619 0.645 . . . . 0.0 110.313 177.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 15.4 tt -83.32 -23.65 8.24 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 CA-C-O 118.685 -0.674 . . . . 0.0 111.831 -174.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -48.78 -51.45 53.84 Favored Pre-proline 0 CA--C 1.547 0.843 0 CA-C-N 119.941 1.246 . . . . 0.0 114.072 179.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -66.78 -29.22 42.65 Favored 'Trans proline' 0 C--N 1.35 0.642 0 CA-C-N 121.737 1.656 . . . . 0.0 112.24 176.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.2 t -67.91 -36.83 77.07 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 O-C-N 121.545 -0.722 . . . . 0.0 109.579 175.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 55.2 mt -68.15 -35.25 77.76 Favored 'General case' 0 C--O 1.226 -0.178 0 CA-C-N 119.43 1.014 . . . . 0.0 111.07 173.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -61.96 -42.83 99.56 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 119.196 0.907 . . . . 0.0 110.803 170.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -64.76 -38.71 91.9 Favored 'General case' 0 CA--C 1.532 0.277 0 O-C-N 121.092 -1.005 . . . . 0.0 110.686 176.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 43.5 tp -61.82 -42.92 99.63 Favored 'General case' 0 C--N 1.335 -0.032 0 C-N-CA 123.625 0.77 . . . . 0.0 109.95 175.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -60.23 -42.2 94.7 Favored 'General case' 0 CA--C 1.522 -0.119 0 C-N-CA 123.041 0.536 . . . . 0.0 110.728 178.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 -72.34 -10.92 60.4 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 112.573 0.582 . . . . 0.0 112.573 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -105.36 -32.86 8.38 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 125.353 1.461 . . . . 0.0 111.545 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 82.1 mmm -126.16 -5.7 6.67 Favored 'General case' 0 C--O 1.227 -0.127 0 CA-C-O 118.226 -0.892 . . . . 0.0 113.097 -167.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -57.82 -13.95 14.65 Favored Glycine 0 CA--C 1.532 1.155 0 CA-C-N 120.027 1.285 . . . . 0.0 114.873 -174.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -66.73 -27.32 67.52 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.508 1.123 . . . . 0.0 112.011 172.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.448 ' HA ' ' HE3' ' A' ' 49' ' ' LYS . 0.0 OUTLIER -120.93 -21.61 6.48 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 126.094 1.757 . . . . 0.0 111.84 179.787 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 35.9 tp -109.49 157.67 18.74 Favored 'General case' 0 C--O 1.232 0.169 0 C-N-CA 123.994 0.918 . . . . 0.0 111.428 -169.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -131.27 143.19 50.36 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 103.846 -2.65 . . . . 0.0 103.846 166.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 73.6 mt -116.01 140.38 38.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 105.517 -2.031 . . . . 0.0 105.517 176.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 81.3 t -132.53 98.36 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 -172.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -74.3 140.34 44.83 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 174.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 14.9 tt -142.63 126.91 15.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 N-CA-C 108.679 -0.859 . . . . 0.0 108.679 176.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 62.2 t0 -84.4 105.36 15.18 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 124.609 1.163 . . . . 0.0 109.057 -173.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 31.4 m -59.61 -26.14 33.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 118.664 -0.684 . . . . 0.0 112.023 -175.113 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -65.18 -18.6 65.44 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 119.407 1.003 . . . . 0.0 112.143 -176.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -119.87 3.71 11.03 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.916 1.287 . . . . 0.0 111.173 178.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -139.39 40.29 2.07 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 124.528 1.131 . . . . 0.0 109.82 -169.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 51.4 mm-40 -56.04 -33.05 64.58 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.997 0.919 . . . . 0.0 111.227 178.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -66.08 -46.53 77.37 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 118.509 0.595 . . . . 0.0 110.549 179.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.19 -39.03 78.93 Favored 'General case' 0 C--O 1.223 -0.32 0 O-C-N 121.816 -0.553 . . . . 0.0 109.721 -179.296 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -58.79 -47.95 82.96 Favored 'General case' 0 CA--C 1.534 0.346 0 O-C-N 121.062 -1.024 . . . . 0.0 110.244 172.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -60.38 -28.47 67.26 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 124.171 0.891 . . . . 0.0 112.421 177.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 48.2 tptt -56.2 -29.07 60.42 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.546 1.139 . . . . 0.0 111.491 179.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -123.99 10.26 8.82 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.511 0.724 . . . . 0.0 111.661 -179.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 63.36 30.51 77.77 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 123.693 0.663 . . . . 0.0 112.572 -176.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 61.5 t -61.37 122.34 11.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 173.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 25.8 ptp -129.9 -12.4 4.22 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 124.923 1.289 . . . . 0.0 112.748 -171.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 23.0 m -139.9 165.23 27.87 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 127.396 2.278 . . . . 0.0 108.124 178.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 36.7 pt -142.13 154.79 65.05 Favored Pre-proline 0 CA--C 1.545 0.772 0 C-N-CA 124.845 1.258 . . . . 0.0 108.567 177.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -67.94 139.87 51.34 Favored 'Cis proline' 0 C--N 1.351 0.664 0 CA-C-N 120.481 1.208 . . . . 0.0 110.414 -2.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 22.7 m -130.99 139.12 49.96 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 174.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 85.5 mt -119.46 126.1 50.51 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 106.819 -1.548 . . . . 0.0 106.819 -169.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -117.01 119.28 34.82 Favored 'General case' 0 CA--C 1.511 -0.535 0 N-CA-C 103.755 -2.683 . . . . 0.0 103.755 177.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.4 t -92.34 124.29 44.75 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 N-CA-C 103.582 -2.747 . . . . 0.0 103.582 173.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.3 mp -115.03 155.12 27.58 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 174.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -136.73 123.75 21.53 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 171.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 27.9 t70 49.45 38.03 13.37 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.008 1.323 . . . . 0.0 112.456 177.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 101.64 -2.72 53.05 Favored Glycine 0 CA--C 1.528 0.865 0 CA-C-O 118.108 -1.384 . . . . 0.0 115.395 168.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -131.47 151.74 51.3 Favored 'General case' 0 CA--C 1.528 0.109 0 CA-C-N 120.063 1.931 . . . . 0.0 110.185 -178.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 38.8 t -62.85 133.32 28.7 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.9 p -120.61 -20.28 4.57 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 C-N-CA 125.324 1.45 . . . . 0.0 109.872 177.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -161.02 168.73 23.91 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 120.315 1.416 . . . . 0.0 110.47 171.672 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 10.5 m -140.46 151.03 44.54 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.078 1.351 . . . . 0.0 108.741 175.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 58.7 m -150.45 157.21 42.77 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.283 1.433 . . . . 0.0 108.835 169.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 43.7 t -133.89 144.56 35.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 -178.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 79.24 -175.07 55.21 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 123.434 0.54 . . . . 0.0 112.153 178.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -63.58 148.77 47.97 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.742 0.817 . . . . 0.0 111.031 -179.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 45.6 mttm -144.14 135.54 12.68 Favored Pre-proline 0 C--O 1.233 0.234 0 N-CA-C 106.406 -1.702 . . . . 0.0 106.406 168.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -70.0 162.37 42.46 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 122.154 1.903 . . . . 0.0 110.266 173.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 18.2 ptmt -55.98 -31.02 62.63 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.424 1.09 . . . . 0.0 113.533 -179.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -67.43 -49.69 62.62 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 118.528 0.604 . . . . 0.0 109.767 176.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.04 -39.38 94.56 Favored 'General case' 0 C--N 1.34 0.173 0 C-N-CA 122.896 0.478 . . . . 0.0 110.72 179.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 86.2 mt -62.95 -45.39 92.69 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.111 0.564 . . . . 0.0 111.166 176.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -61.07 -41.14 96.08 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-O 118.944 -0.551 . . . . 0.0 110.353 176.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -63.72 -41.62 98.04 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 118.427 0.558 . . . . 0.0 110.275 179.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 67.8 tp -61.73 -41.49 97.71 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 124.729 1.212 . . . . 0.0 110.98 177.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 75.1 t -62.39 -47.72 91.7 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 CA-C-N 118.757 0.708 . . . . 0.0 109.365 171.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 -61.76 -26.53 68.14 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 125.504 1.522 . . . . 0.0 112.291 -171.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -53.83 -26.87 26.42 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 123.604 0.761 . . . . 0.0 112.416 172.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 72.8 m-70 -123.49 -6.09 8.16 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 113.852 1.056 . . . . 0.0 113.852 -167.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 79.9 mt . . . . . 0 C--O 1.249 1.062 0 CA-C-N 118.814 0.733 . . . . 0.0 109.286 171.851 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.7 tpt . . . . . 0 N--CA 1.479 1.007 0 CA-C-O 118.949 -0.548 . . . . 0.0 110.248 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -163.87 -174.46 3.64 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.541 1.537 . . . . 0.0 108.205 -172.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.2 mt -75.3 142.62 14.31 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 N-CA-C 106.225 -1.769 . . . . 0.0 106.225 166.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 43.4 t -134.2 163.07 38.01 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 C-N-CA 126.89 2.076 . . . . 0.0 106.0 -178.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 1.4 tmtt? -129.01 131.54 47.41 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 104.247 -2.501 . . . . 0.0 104.247 179.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -142.6 173.46 11.51 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 123.732 0.813 . . . . 0.0 110.973 -169.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 23.6 p -136.91 174.01 11.08 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 125.066 1.347 . . . . 0.0 107.573 169.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -51.13 -27.97 9.79 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.726 1.21 . . . . 0.0 112.976 176.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -57.99 -30.59 66.18 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.103 1.761 . . . . 0.0 112.767 178.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.0 m -139.55 -7.4 1.3 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.837 0.855 . . . . 0.0 113.277 -169.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 69.2 t80 -51.45 -44.0 62.25 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.409 1.084 . . . . 0.0 111.925 -177.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.7 m -63.58 -38.39 90.96 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 122.991 0.516 . . . . 0.0 111.804 -178.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -68.32 -44.82 74.54 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 176.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 67.7 mm-40 -62.43 -36.83 83.62 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 122.67 0.388 . . . . 0.0 111.124 -178.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.7 p -83.13 0.7 43.98 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.072 0.949 . . . . 0.0 113.46 -177.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 68.0 m -105.15 33.33 3.71 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.206 1.002 . . . . 0.0 111.125 -176.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -132.8 60.25 1.71 Allowed 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.253 1.021 . . . . 0.0 109.966 -178.243 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 92.11 -153.71 22.0 Favored Glycine 0 C--N 1.337 0.633 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 177.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 82.9 t -74.06 137.01 24.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 168.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 48.1 t -139.21 145.96 26.54 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 N-CA-C 105.952 -1.87 . . . . 0.0 105.952 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.3 tt -125.01 99.09 5.97 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 106.448 -1.686 . . . . 0.0 106.448 -176.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -79.51 144.63 33.78 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 123.572 0.749 . . . . 0.0 109.17 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -126.92 94.35 4.01 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 126.045 1.738 . . . . 0.0 107.643 -176.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -74.49 113.46 11.76 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 173.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -147.22 -171.47 3.79 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.128 1.371 . . . . 0.0 108.225 -175.449 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -161.32 148.0 11.52 Favored Pre-proline 0 CA--C 1.533 0.306 0 N-CA-C 105.996 -1.853 . . . . 0.0 105.996 166.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -60.58 -18.07 52.47 Favored 'Trans proline' 0 CA--C 1.534 0.477 0 C-N-CA 121.776 1.651 . . . . 0.0 115.745 -178.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 50.7 p-90 -69.76 -20.57 63.49 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 120.029 1.286 . . . . 0.0 111.998 173.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 26.9 t -59.89 148.74 33.8 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 124.902 1.281 . . . . 0.0 111.096 -172.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -100.6 -63.97 0.79 Allowed Glycine 0 CA--C 1.529 0.938 0 CA-C-O 118.501 -1.166 . . . . 0.0 110.492 172.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_exo -53.77 -32.4 65.9 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 123.244 2.629 . . . . 0.0 114.495 -179.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 35.9 m -57.55 -34.82 69.57 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.326 0.651 . . . . 0.0 111.635 176.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.5 mmtp -67.93 -25.49 65.5 Favored 'General case' 0 CA--C 1.531 0.248 0 O-C-N 121.589 -0.694 . . . . 0.0 110.836 -179.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 30.0 mtm -71.25 -42.46 68.79 Favored 'General case' 0 C--N 1.341 0.213 0 CA-C-N 118.67 0.668 . . . . 0.0 110.444 176.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 17.1 tt -84.07 -22.48 8.11 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-O 118.807 -0.616 . . . . 0.0 111.53 -175.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -48.99 -51.21 57.58 Favored Pre-proline 0 CA--C 1.547 0.862 0 CA-C-N 120.028 1.285 . . . . 0.0 113.971 178.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -67.07 -28.37 41.33 Favored 'Trans proline' 0 C--N 1.35 0.614 0 CA-C-N 121.724 1.652 . . . . 0.0 112.303 176.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 13.0 t -66.45 -39.3 83.69 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 174.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 87.4 mt -67.06 -34.7 78.25 Favored 'General case' 0 C--N 1.34 0.165 0 CA-C-N 119.22 0.918 . . . . 0.0 111.323 173.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -62.5 -44.36 96.56 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 119.571 1.078 . . . . 0.0 110.746 171.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -64.42 -38.31 90.6 Favored 'General case' 0 CA--C 1.532 0.271 0 O-C-N 121.233 -0.917 . . . . 0.0 110.7 176.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 61.5 tp -63.22 -44.26 95.79 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.619 0.768 . . . . 0.0 110.015 176.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -59.31 -41.73 89.73 Favored 'General case' 0 CA--C 1.521 -0.153 0 C-N-CA 123.41 0.684 . . . . 0.0 111.009 177.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -72.06 -10.38 59.7 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.075 0.55 . . . . 0.0 112.464 -179.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 -104.77 -33.43 8.44 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 125.208 1.403 . . . . 0.0 111.662 179.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 74.8 mmm -121.29 -4.44 9.43 Favored 'General case' 0 C--O 1.224 -0.242 0 CA-C-O 118.18 -0.914 . . . . 0.0 112.658 -168.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -58.22 -14.09 17.58 Favored Glycine 0 CA--C 1.531 1.075 0 CA-C-N 120.07 1.305 . . . . 0.0 115.23 -173.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -70.14 -25.14 63.33 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 118.533 1.167 . . . . 0.0 111.775 172.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.42 ' HA ' ' HE2' ' A' ' 49' ' ' LYS . 9.7 mmpt? -123.67 -17.43 6.41 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 126.519 1.928 . . . . 0.0 111.628 -175.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 28.0 tp -118.94 159.39 23.9 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 124.718 1.207 . . . . 0.0 111.021 -169.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 37.2 ttmt -134.82 145.2 48.12 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 104.108 -2.552 . . . . 0.0 104.108 167.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 62.3 mt -115.81 141.11 34.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 175.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 69.1 t -132.83 96.81 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 -172.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -75.96 131.91 39.88 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 177.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 15.9 tt -140.34 135.49 36.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -97.78 115.57 28.28 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 123.875 0.87 . . . . 0.0 111.049 -168.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 35.7 m -60.96 -19.62 20.15 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 O-C-N 121.582 -0.699 . . . . 0.0 112.321 -178.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -63.39 -21.75 66.47 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.757 1.223 . . . . 0.0 113.004 179.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -131.79 1.76 4.01 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.655 0.782 . . . . 0.0 112.625 178.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 63.4 m-80 -129.88 39.41 3.7 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.683 0.793 . . . . 0.0 110.896 -170.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.2 mp0 -54.97 -31.88 61.11 Favored 'General case' 0 C--N 1.34 0.178 0 C-N-CA 123.707 0.803 . . . . 0.0 111.896 176.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 27.4 tp10 -67.31 -47.08 71.63 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 123.979 0.912 . . . . 0.0 110.556 -178.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.72 -39.46 76.84 Favored 'General case' 0 CA--C 1.535 0.395 0 O-C-N 121.728 -0.607 . . . . 0.0 109.561 179.316 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.29 -47.45 85.34 Favored 'General case' 0 CA--C 1.533 0.312 0 O-C-N 121.423 -0.798 . . . . 0.0 110.56 174.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -62.66 -27.11 69.3 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 124.055 0.836 . . . . 0.0 111.876 178.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 5.8 tppt? -55.67 -28.44 55.54 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.568 1.147 . . . . 0.0 111.877 177.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -124.22 11.39 8.78 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.81 0.844 . . . . 0.0 111.572 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 63.77 30.48 77.79 Favored Glycine 0 CA--C 1.532 1.094 0 C-N-CA 123.72 0.676 . . . . 0.0 112.761 -177.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 60.9 t -65.86 125.66 23.45 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 172.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 66.8 mtt -136.75 3.98 2.77 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.821 1.249 . . . . 0.0 111.448 -179.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 23.4 m -144.05 162.62 35.75 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 126.676 1.991 . . . . 0.0 107.768 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 44.2 pt -141.72 155.48 66.44 Favored Pre-proline 0 CA--C 1.545 0.78 0 C-N-CA 124.445 1.098 . . . . 0.0 108.796 175.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -67.38 139.62 48.1 Favored 'Cis proline' 0 C--N 1.35 0.607 0 CA-C-N 120.209 1.11 . . . . 0.0 110.209 -5.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 50.9 m -132.65 140.69 48.29 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 174.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 87.8 mt -123.62 129.18 50.76 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 -169.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -120.94 122.9 41.18 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 103.431 -2.803 . . . . 0.0 103.431 177.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 1.8 t -100.22 120.17 49.3 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 N-CA-C 103.899 -2.63 . . . . 0.0 103.899 176.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.3 mp -112.03 155.16 24.24 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 -178.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 57.8 tttp -134.59 115.59 14.04 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 105.785 -1.932 . . . . 0.0 105.785 177.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.0 t70 49.87 39.17 17.72 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.893 1.277 . . . . 0.0 112.374 176.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 104.79 -5.62 43.39 Favored Glycine 0 CA--C 1.529 0.955 0 CA-C-O 118.139 -1.367 . . . . 0.0 115.295 169.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -131.29 149.27 52.63 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 120.054 1.927 . . . . 0.0 110.527 -177.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 39.2 t -63.59 134.49 28.57 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 -179.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 8.7 p -118.94 -26.41 2.51 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 C-N-CA 125.065 1.346 . . . . 0.0 110.504 172.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -149.9 165.28 33.06 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 120.689 1.586 . . . . 0.0 110.046 173.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 17.2 m -140.86 151.18 44.1 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.442 1.497 . . . . 0.0 108.025 178.116 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 37.3 m -151.25 157.06 42.1 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.415 1.486 . . . . 0.0 109.265 169.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 30.6 t -135.62 145.65 31.14 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 -176.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 75.81 -176.75 50.65 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 123.896 0.76 . . . . 0.0 111.893 178.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 47.4 t80 -62.06 137.58 58.27 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 173.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 64.6 tttt -149.94 137.68 11.76 Favored Pre-proline 0 C--O 1.235 0.316 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 -178.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -70.7 153.73 64.45 Favored 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 121.628 1.552 . . . . 0.0 111.959 -172.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 29.2 ttpp -52.18 -45.39 65.11 Favored 'General case' 0 CA--C 1.518 -0.256 0 C-N-CA 125.805 1.642 . . . . 0.0 112.313 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -62.92 -43.31 99.14 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 -176.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.98 -43.1 96.73 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 122.421 0.288 . . . . 0.0 110.499 179.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 76.8 mt -62.32 -44.08 97.32 Favored 'General case' 0 C--O 1.231 0.095 0 CA-C-N 117.535 0.152 . . . . 0.0 110.911 178.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -74.24 -29.27 61.62 Favored 'General case' 0 N--CA 1.451 -0.42 0 O-C-N 122.178 -0.326 . . . . 0.0 110.892 -175.544 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 31.9 tp10 -70.23 -37.72 75.07 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 124.566 1.146 . . . . 0.0 110.543 173.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 53.6 mt -60.86 -50.32 73.89 Favored 'General case' 0 C--O 1.224 -0.246 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 172.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 33.0 t -52.22 -46.33 44.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 122.853 0.461 . . . . 0.0 109.949 173.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -62.77 -38.43 90.56 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 123.974 0.909 . . . . 0.0 112.258 -171.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 16.9 ptmt -67.13 -18.25 65.22 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 118.125 -0.94 . . . . 0.0 112.644 -175.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 25.2 p80 -127.13 -8.41 5.93 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 115.002 1.482 . . . . 0.0 115.002 -174.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 10.2 mt . . . . . 0 C--O 1.248 0.997 0 CA-C-O 118.029 -0.986 . . . . 0.0 109.368 167.433 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.6 ttm . . . . . 0 N--CA 1.483 1.212 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -157.23 -163.62 1.42 Allowed 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.311 1.444 . . . . 0.0 108.828 -172.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.8 mt -72.82 145.58 11.75 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 166.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 14.7 t -138.53 162.12 29.91 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 126.395 1.878 . . . . 0.0 106.805 -175.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -116.5 144.05 44.82 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 106.03 -1.841 . . . . 0.0 106.03 172.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -144.36 157.66 44.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.385 0.612 . . . . 0.0 111.566 -176.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 16.1 p -105.3 171.07 7.52 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 126.292 1.837 . . . . 0.0 107.646 168.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -47.26 -43.85 22.44 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 124.72 1.208 . . . . 0.0 113.112 176.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 66.9 mm-40 -79.93 -35.04 38.35 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 122.654 0.382 . . . . 0.0 111.533 -175.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.2 m -71.81 -32.38 67.53 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 122.772 0.429 . . . . 0.0 111.315 176.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -52.72 -46.74 67.53 Favored 'General case' 0 N--CA 1.457 -0.116 0 C-N-CA 125.128 1.371 . . . . 0.0 112.245 -169.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 9.5 m -63.75 -38.4 90.98 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 118.105 0.412 . . . . 0.0 111.86 -176.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -68.81 -44.31 73.81 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 176.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 69.0 mm-40 -63.94 -37.21 86.56 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 122.451 0.3 . . . . 0.0 110.925 -178.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 28.8 p -80.52 0.1 35.2 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.992 0.917 . . . . 0.0 113.332 -177.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 70.8 m -98.13 28.76 3.84 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.097 0.959 . . . . 0.0 112.16 -177.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -136.73 81.06 1.85 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.209 1.004 . . . . 0.0 110.023 -178.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 82.64 -156.66 35.17 Favored Glycine 0 C--N 1.338 0.65 0 N-CA-C 110.722 -0.951 . . . . 0.0 110.722 173.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 44.9 t -74.17 135.4 27.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 N-CA-C 106.034 -1.839 . . . . 0.0 106.034 168.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 40.2 t -135.57 136.85 50.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 179.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.2 tt -120.01 111.36 17.8 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 106.198 -1.778 . . . . 0.0 106.198 -179.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -94.31 144.92 25.12 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 123.854 0.862 . . . . 0.0 109.104 -175.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -124.16 93.73 4.0 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 125.56 1.544 . . . . 0.0 107.469 -176.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -73.77 113.44 10.91 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 105.815 -1.92 . . . . 0.0 105.815 174.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -150.41 -176.57 5.53 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.727 1.211 . . . . 0.0 108.227 -171.156 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -152.13 149.15 22.58 Favored Pre-proline 0 C--N 1.331 -0.215 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 167.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -67.95 -12.65 35.95 Favored 'Trans proline' 0 N--CA 1.459 -0.543 0 CA-C-N 121.179 1.457 . . . . 0.0 113.071 -179.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 1.5 m95 -76.27 -12.84 60.15 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.665 0.786 . . . . 0.0 111.876 172.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 29.7 t -64.07 153.62 36.92 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.317 1.447 . . . . 0.0 111.089 -176.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -101.51 -62.98 0.76 Allowed Glycine 0 CA--C 1.532 1.137 0 C-N-CA 124.723 1.154 . . . . 0.0 111.268 170.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -64.88 -25.96 59.72 Favored 'Trans proline' 0 C--N 1.35 0.611 0 CA-C-N 120.472 2.136 . . . . 0.0 113.266 -173.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 25.7 m -57.59 -34.43 69.23 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 121.537 -0.727 . . . . 0.0 111.433 174.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.4 mmtp -67.7 -22.79 65.25 Favored 'General case' 0 CA--C 1.531 0.22 0 O-C-N 121.663 -0.648 . . . . 0.0 111.199 -179.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 34.0 mtm -71.15 -43.64 67.12 Favored 'General case' 0 C--N 1.34 0.179 0 CA-C-N 118.723 0.692 . . . . 0.0 110.359 176.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 13.4 tt -84.21 -23.32 7.78 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-O 118.817 -0.611 . . . . 0.0 111.691 -175.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -48.4 -51.17 53.19 Favored Pre-proline 0 CA--C 1.548 0.889 0 CA-C-N 119.959 1.254 . . . . 0.0 114.27 178.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -66.59 -29.36 44.08 Favored 'Trans proline' 0 C--N 1.351 0.685 0 CA-C-N 121.628 1.617 . . . . 0.0 112.108 176.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 5.1 t -68.06 -36.59 76.01 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 O-C-N 121.585 -0.697 . . . . 0.0 109.751 175.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 74.1 mt -67.21 -36.05 80.9 Favored 'General case' 0 C--N 1.34 0.166 0 CA-C-N 119.518 1.053 . . . . 0.0 111.153 172.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -62.1 -42.66 99.45 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 119.227 0.921 . . . . 0.0 110.808 171.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -63.91 -39.44 94.19 Favored 'General case' 0 CA--C 1.533 0.298 0 O-C-N 121.078 -1.014 . . . . 0.0 110.381 175.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 36.9 tp -62.81 -42.36 99.68 Favored 'General case' 0 CA--C 1.527 0.088 0 C-N-CA 123.754 0.822 . . . . 0.0 110.237 176.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -59.09 -43.15 91.83 Favored 'General case' 0 CA--C 1.522 -0.13 0 C-N-CA 123.363 0.665 . . . . 0.0 110.657 176.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -71.44 -10.67 60.14 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.327 0.651 . . . . 0.0 112.645 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 23.9 mm-40 -106.63 -28.41 10.24 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 125.419 1.487 . . . . 0.0 111.759 -178.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 23.1 mtp -131.73 -1.7 3.79 Favored 'General case' 0 N--CA 1.461 0.118 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 -169.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -54.69 -15.6 6.39 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 124.777 1.179 . . . . 0.0 115.616 -174.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -69.7 -28.91 66.24 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.842 1.257 . . . . 0.0 112.016 175.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 41.7 mmtm -123.88 -16.06 6.73 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 125.757 1.623 . . . . 0.0 112.39 -177.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 58.5 tp -119.28 139.04 52.56 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 123.982 0.913 . . . . 0.0 110.289 -170.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -111.69 145.67 38.87 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 105.009 -2.219 . . . . 0.0 105.009 168.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 90.4 mt -116.99 138.93 46.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 105.747 -1.946 . . . . 0.0 105.747 174.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 98.3 t -132.75 98.87 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 -171.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 54.2 mtpt -74.28 140.25 44.82 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 174.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 14.3 tt -142.71 128.05 16.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 177.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 64.6 t0 -87.57 107.22 18.49 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 124.4 1.08 . . . . 0.0 109.323 -169.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 29.0 m -61.69 -20.81 24.15 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 CA-C-O 118.737 -0.649 . . . . 0.0 112.143 -177.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -69.04 -14.06 62.81 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 119.691 1.132 . . . . 0.0 112.112 178.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -127.06 0.52 6.52 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.1 0.96 . . . . 0.0 111.997 178.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 67.8 m-80 -138.39 41.92 2.21 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.735 0.814 . . . . 0.0 111.104 -169.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 5.4 mp0 -54.62 -31.66 57.57 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.376 0.67 . . . . 0.0 112.104 176.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 -64.72 -46.69 81.23 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 118.471 0.578 . . . . 0.0 110.411 -178.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.6 -38.49 73.99 Favored 'General case' 0 C--O 1.223 -0.303 0 C-N-CA 123.162 0.585 . . . . 0.0 109.503 -178.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -58.09 -47.9 81.8 Favored 'General case' 0 CA--C 1.535 0.376 0 O-C-N 121.28 -0.888 . . . . 0.0 110.236 172.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -61.34 -29.02 70.33 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 124.117 0.865 . . . . 0.0 112.265 177.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 74.3 tttt -55.7 -28.73 57.26 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.774 1.23 . . . . 0.0 111.873 178.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -123.2 9.94 9.28 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.69 0.796 . . . . 0.0 111.956 178.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 63.57 31.71 81.71 Favored Glycine 0 CA--C 1.533 1.218 0 CA-C-O 119.459 -0.634 . . . . 0.0 112.578 -176.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 61.3 t -64.19 124.59 19.26 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 172.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 78.2 mtm -137.06 3.53 2.66 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.924 1.29 . . . . 0.0 111.522 -178.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 39.1 m -141.48 163.87 31.76 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 126.767 2.027 . . . . 0.0 107.532 175.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 41.1 pt -142.99 155.12 62.49 Favored Pre-proline 0 CA--C 1.546 0.806 0 C-N-CA 124.596 1.158 . . . . 0.0 108.626 174.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -67.62 137.68 39.15 Favored 'Cis proline' 0 C--N 1.349 0.587 0 CA-C-N 120.5 1.214 . . . . 0.0 110.204 -4.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 35.9 m -129.96 134.17 47.28 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 106.97 -1.493 . . . . 0.0 106.97 175.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 10.9 mp -114.47 126.54 55.07 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 -169.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -114.73 147.72 39.3 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 104.583 -2.377 . . . . 0.0 104.583 175.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.4 t -126.79 128.79 71.24 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.624 0 N-CA-C 104.706 -2.331 . . . . 0.0 104.706 -177.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.4 mp -130.22 147.89 52.0 Favored 'General case' 0 N--CA 1.445 -0.725 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 -172.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 21.4 tptm -133.74 118.32 17.95 Favored 'General case' 0 CA--C 1.514 -0.439 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 29.2 t70 51.15 33.89 10.17 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.486 1.515 . . . . 0.0 112.55 174.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 110.72 -3.48 29.07 Favored Glycine 0 CA--C 1.527 0.806 0 CA-C-O 118.062 -1.41 . . . . 0.0 114.869 169.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -130.2 144.78 51.56 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 120.027 1.914 . . . . 0.0 110.164 -177.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 13.6 p -65.55 133.23 30.94 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 176.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 8.0 p -126.28 -19.02 2.78 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-O 117.653 -1.165 . . . . 0.0 111.239 -179.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -156.48 169.96 23.42 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 121.116 1.78 . . . . 0.0 111.529 177.538 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 15.6 m -147.11 151.73 37.31 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.454 1.501 . . . . 0.0 108.907 178.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 65.1 m -152.25 157.39 41.35 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 126.18 1.792 . . . . 0.0 108.321 171.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 28.7 t -134.06 142.76 40.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 -176.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.56 -176.81 53.56 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 123.58 0.61 . . . . 0.0 112.44 177.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 66.1 t80 -63.17 150.4 42.98 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.39 1.076 . . . . 0.0 110.939 178.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -146.97 146.14 24.91 Favored Pre-proline 0 N--CA 1.467 0.384 0 C-N-CA 125.355 1.462 . . . . 0.0 107.4 168.034 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -71.24 157.66 56.62 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 122.444 2.096 . . . . 0.0 110.219 170.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 48.5 pttt -58.48 -30.29 66.87 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -178.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -67.18 -45.12 77.92 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 118.508 0.594 . . . . 0.0 109.946 178.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.47 -38.12 89.93 Favored 'General case' 0 CA--C 1.529 0.165 0 O-C-N 121.845 -0.534 . . . . 0.0 110.57 176.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 95.0 mt -64.34 -42.74 96.12 Favored 'General case' 0 C--O 1.226 -0.146 0 CA-C-O 119.26 -0.4 . . . . 0.0 111.327 176.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 15.8 mt-30 -58.11 -42.16 85.13 Favored 'General case' 0 C--O 1.226 -0.139 0 CA-C-N 118.584 0.629 . . . . 0.0 109.971 174.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -65.08 -40.09 94.15 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 118.115 0.416 . . . . 0.0 110.579 -179.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 68.9 tp -61.97 -43.74 98.21 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.44 1.096 . . . . 0.0 110.712 176.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 93.3 t -62.56 -43.44 98.43 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 123.585 0.754 . . . . 0.0 109.743 174.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -60.28 -27.67 67.47 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 125.101 1.36 . . . . 0.0 112.055 -172.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -56.07 -24.07 37.65 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.549 0.74 . . . . 0.0 112.668 174.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 47.4 m-70 -125.37 -3.42 7.39 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 -168.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 84.2 mt . . . . . 0 C--O 1.25 1.083 0 CA-C-N 118.785 0.721 . . . . 0.0 109.184 172.65 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.199 0 CA-C-O 118.391 -0.814 . . . . 0.0 113.017 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -152.07 177.98 9.94 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 119.888 1.222 . . . . 0.0 109.952 -172.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.5 mt -75.64 147.46 8.09 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 167.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 18.2 t -138.36 161.97 30.62 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 C-N-CA 126.157 1.783 . . . . 0.0 106.887 -175.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 3.7 tppp? -116.33 142.04 47.37 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 106.001 -1.852 . . . . 0.0 106.001 172.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -146.36 166.33 26.66 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.399 0.619 . . . . 0.0 111.053 -177.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 28.5 p -135.47 174.36 10.7 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 126.444 1.897 . . . . 0.0 107.578 170.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -48.53 -29.78 4.57 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.851 1.26 . . . . 0.0 113.149 173.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -59.35 -29.84 67.95 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.071 1.348 . . . . 0.0 113.052 178.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 14.4 m -141.22 -7.1 1.04 Allowed 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 -169.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 77.8 t80 -53.75 -43.64 69.31 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 124.009 0.923 . . . . 0.0 111.772 -174.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.7 m -63.35 -38.91 92.98 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.086 0.554 . . . . 0.0 111.762 -179.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -68.13 -44.26 76.48 Favored 'General case' 0 N--CA 1.453 -0.313 0 O-C-N 122.05 -0.406 . . . . 0.0 109.954 177.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 67.3 mm-40 -63.11 -36.47 83.7 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 122.367 0.267 . . . . 0.0 110.985 -178.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 25.6 p -82.93 1.21 40.75 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.049 0.939 . . . . 0.0 113.367 -177.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 67.4 m -101.63 31.01 3.98 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.204 1.002 . . . . 0.0 111.746 -176.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -132.66 62.09 1.66 Allowed 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.198 0.999 . . . . 0.0 110.206 -178.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 91.54 -156.24 23.86 Favored Glycine 0 C--N 1.339 0.715 0 N-CA-C 109.899 -1.281 . . . . 0.0 109.899 176.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 94.4 t -70.81 135.32 28.32 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 168.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 55.7 t -137.51 142.95 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 N-CA-C 105.742 -1.947 . . . . 0.0 105.742 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.2 tt -122.94 100.87 7.11 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 -176.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -83.29 146.03 28.76 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.376 -179.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -124.46 94.08 4.1 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 125.906 1.682 . . . . 0.0 107.356 -177.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -73.91 112.79 10.37 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 105.891 -1.892 . . . . 0.0 105.891 175.157 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -148.56 -178.91 6.59 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.95 1.3 . . . . 0.0 108.475 -172.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -158.34 147.76 14.91 Favored Pre-proline 0 CA--C 1.531 0.245 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 167.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -62.87 -12.0 27.06 Favored 'Trans proline' 0 CA--C 1.535 0.573 0 CA-C-N 121.53 1.582 . . . . 0.0 116.086 -178.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 54.2 p-90 -70.72 -19.33 62.76 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 120.731 1.605 . . . . 0.0 111.784 171.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 15.3 t -61.2 162.58 7.3 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.41 1.484 . . . . 0.0 111.187 -177.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -119.94 -59.19 0.25 Allowed Glycine 0 CA--C 1.531 1.049 0 CA-C-O 118.513 -1.159 . . . . 0.0 110.694 171.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -54.13 -31.46 65.41 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 123.832 3.021 . . . . 0.0 114.118 179.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 79.8 m -52.37 -37.0 55.14 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.694 1.198 . . . . 0.0 111.915 174.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 75.2 mttt -83.06 -14.69 53.32 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.381 0.672 . . . . 0.0 110.861 -175.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 26.8 mtm -73.1 -43.71 61.39 Favored 'General case' 0 C--N 1.341 0.197 0 CA-C-N 118.886 0.767 . . . . 0.0 109.541 169.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 16.3 tt -80.37 -23.95 11.4 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-O 118.609 -0.71 . . . . 0.0 111.431 -178.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -48.39 -51.16 53.11 Favored Pre-proline 0 CA--C 1.548 0.881 0 CA-C-N 120.359 1.436 . . . . 0.0 114.315 179.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -66.9 -25.76 44.81 Favored 'Trans proline' 0 C--N 1.349 0.59 0 CA-C-N 121.958 1.735 . . . . 0.0 112.597 176.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.5 t -71.4 -35.77 58.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 O-C-N 121.454 -0.779 . . . . 0.0 109.589 174.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 95.7 mt -66.78 -35.26 79.67 Favored 'General case' 0 C--N 1.341 0.202 0 CA-C-N 119.515 1.052 . . . . 0.0 111.233 170.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -63.09 -42.13 99.55 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 119.566 1.075 . . . . 0.0 110.83 171.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -60.73 -44.86 96.11 Favored 'General case' 0 CA--C 1.53 0.174 0 O-C-N 121.505 -0.747 . . . . 0.0 110.021 173.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 34.0 tp -60.7 -41.85 96.02 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.668 0.787 . . . . 0.0 110.355 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -60.97 -43.5 98.7 Favored 'General case' 0 CA--C 1.521 -0.172 0 C-N-CA 123.264 0.626 . . . . 0.0 110.82 177.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -72.41 -10.71 60.13 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.276 0.63 . . . . 0.0 112.502 179.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -104.44 -28.57 11.25 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 125.31 1.444 . . . . 0.0 111.367 -178.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 25.4 mtp -133.69 -2.66 2.98 Favored 'General case' 0 C--N 1.339 0.146 0 N-CA-C 113.966 1.099 . . . . 0.0 113.966 -169.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -55.05 -17.2 9.44 Favored Glycine 0 CA--C 1.534 1.259 0 CA-C-N 120.148 1.34 . . . . 0.0 115.234 -173.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -67.14 -30.7 70.75 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.727 1.211 . . . . 0.0 111.934 174.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 40.3 mmtm -117.21 -17.41 10.22 Favored 'General case' 0 N--CA 1.462 0.149 0 C-N-CA 125.989 1.716 . . . . 0.0 111.938 -178.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 46.8 tp -116.75 154.66 30.27 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.2 1.0 . . . . 0.0 110.599 -169.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -130.12 144.56 51.42 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 104.11 -2.552 . . . . 0.0 104.11 167.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 75.8 mt -117.7 138.27 48.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 105.266 -2.124 . . . . 0.0 105.266 177.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 96.9 t -133.09 98.2 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 -169.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 52.6 mtpt -74.11 139.57 44.67 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 175.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 13.5 tt -141.76 127.16 18.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 176.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -85.27 103.73 14.48 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.615 1.166 . . . . 0.0 108.901 -171.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 29.7 m -59.85 -25.63 33.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 118.614 -0.708 . . . . 0.0 112.003 -174.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -65.41 -17.82 64.83 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 119.494 1.043 . . . . 0.0 112.055 -178.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -120.65 5.31 10.56 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.103 1.361 . . . . 0.0 111.037 178.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 66.5 m-80 -141.39 40.28 1.74 Allowed 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.588 1.155 . . . . 0.0 109.665 -171.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 51.2 mm-40 -55.2 -31.29 61.31 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.854 0.861 . . . . 0.0 110.893 175.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -65.91 -50.42 64.5 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 124.056 0.943 . . . . 0.0 109.941 179.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.9 -38.8 83.42 Favored 'General case' 0 C--O 1.223 -0.299 0 C-N-CA 123.37 0.668 . . . . 0.0 109.643 -178.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -58.99 -48.03 83.05 Favored 'General case' 0 CA--C 1.533 0.299 0 O-C-N 121.061 -1.024 . . . . 0.0 110.305 172.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -60.95 -28.77 69.2 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 123.901 0.762 . . . . 0.0 112.331 177.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 47.8 tptt -56.33 -29.2 60.99 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.723 1.209 . . . . 0.0 111.471 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -124.16 10.91 8.77 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.507 0.723 . . . . 0.0 111.679 -179.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 63.75 31.16 79.85 Favored Glycine 0 CA--C 1.532 1.14 0 C-N-CA 123.643 0.639 . . . . 0.0 112.584 -176.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 49.3 t -65.7 123.78 19.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 171.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 67.1 mtt -136.07 3.64 2.92 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.693 1.197 . . . . 0.0 111.463 -178.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 25.6 m -143.93 161.53 38.46 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 126.849 2.06 . . . . 0.0 107.302 178.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 39.0 pt -143.25 156.11 61.23 Favored Pre-proline 0 CA--C 1.545 0.761 0 C-N-CA 124.636 1.175 . . . . 0.0 108.76 177.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -67.15 139.1 44.69 Favored 'Cis proline' 0 C--N 1.35 0.629 0 CA-C-N 120.347 1.16 . . . . 0.0 110.168 -4.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 26.6 m -130.14 140.76 50.74 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 174.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 89.8 mt -120.08 125.0 47.2 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 106.546 -1.65 . . . . 0.0 106.546 -169.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -114.86 119.83 37.93 Favored 'General case' 0 CA--C 1.512 -0.509 0 N-CA-C 103.663 -2.717 . . . . 0.0 103.663 177.064 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.8 t -90.58 123.18 42.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 103.217 -2.883 . . . . 0.0 103.217 172.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.1 mp -114.66 155.84 25.85 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 173.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -137.91 122.75 18.84 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 173.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.0 t70 49.55 37.33 12.15 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.034 1.334 . . . . 0.0 112.471 176.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 103.91 -4.27 45.66 Favored Glycine 0 CA--C 1.529 0.918 0 CA-C-O 118.217 -1.324 . . . . 0.0 115.202 168.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -131.85 152.81 50.76 Favored 'General case' 0 C--N 1.339 0.137 0 CA-C-N 120.054 1.927 . . . . 0.0 110.209 -177.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 40.8 t -63.14 134.15 28.5 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.5 p -119.02 -20.81 4.8 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 C-N-CA 125.377 1.471 . . . . 0.0 110.006 176.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -161.04 169.15 23.06 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 120.23 1.377 . . . . 0.0 110.685 169.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 8.9 m -136.14 150.83 49.24 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.369 1.468 . . . . 0.0 108.288 173.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 63.7 m -151.07 159.11 44.71 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.483 1.513 . . . . 0.0 108.559 169.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 40.4 t -133.84 148.54 30.38 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 N-CA-C 107.929 -1.138 . . . . 0.0 107.929 -177.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 76.86 -174.88 54.08 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 123.45 0.548 . . . . 0.0 112.404 175.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -64.78 148.62 50.85 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.001 0.92 . . . . 0.0 110.935 -179.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.75 142.18 16.41 Favored Pre-proline 0 CA--C 1.533 0.322 0 C-N-CA 125.455 1.502 . . . . 0.0 107.093 167.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -72.45 161.44 44.23 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 122.747 2.298 . . . . 0.0 110.635 175.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 41.5 pttt -59.25 -29.99 67.95 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 -178.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -66.38 -49.7 65.95 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 118.418 0.554 . . . . 0.0 109.908 176.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.57 -39.96 95.73 Favored 'General case' 0 CA--C 1.528 0.132 0 O-C-N 122.026 -0.421 . . . . 0.0 110.599 179.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 78.4 mt -62.94 -43.55 98.47 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.021 0.528 . . . . 0.0 111.188 177.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -59.16 -41.78 89.19 Favored 'General case' 0 C--O 1.225 -0.189 0 CA-C-N 118.342 0.519 . . . . 0.0 109.981 176.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -66.78 -38.98 87.6 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 118.624 0.647 . . . . 0.0 110.876 -179.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 67.4 tp -62.47 -36.64 83.12 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.842 1.257 . . . . 0.0 110.972 176.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 94.2 t -70.48 -49.32 53.84 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 CA-C-N 119.178 0.899 . . . . 0.0 109.501 171.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -56.46 -40.55 75.03 Favored 'General case' 0 CA--C 1.52 -0.204 0 C-N-CA 125.901 1.68 . . . . 0.0 111.854 -168.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -67.37 -6.21 17.92 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 -176.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 90.4 m-70 -120.89 -7.54 9.49 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.346 1.058 . . . . 0.0 112.686 177.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 60.6 mt . . . . . 0 C--O 1.248 0.99 0 CA-C-N 119.239 0.927 . . . . 0.0 109.15 173.811 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.8 mpp? . . . . . 0 N--CA 1.482 1.151 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -149.93 -173.38 4.41 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.518 1.527 . . . . 0.0 108.805 -177.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.2 mt -75.25 145.09 11.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 167.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 31.9 t -136.33 163.48 33.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 126.192 1.797 . . . . 0.0 106.877 -175.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -118.05 142.84 46.96 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 105.919 -1.882 . . . . 0.0 105.919 174.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -144.52 166.4 25.26 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.407 0.622 . . . . 0.0 111.027 -177.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 18.3 p -134.09 171.21 14.54 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 126.448 1.899 . . . . 0.0 107.731 171.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -52.73 -29.42 26.88 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.611 1.164 . . . . 0.0 113.046 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 56.7 mt-30 -62.87 -28.98 70.4 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.216 1.406 . . . . 0.0 113.004 179.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.4 m -136.27 -6.63 2.04 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 113.517 0.932 . . . . 0.0 113.517 -169.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -52.19 -43.97 64.44 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.431 1.092 . . . . 0.0 111.677 -178.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.5 m -63.21 -38.95 93.19 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.063 0.545 . . . . 0.0 111.857 -179.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -67.98 -44.35 76.87 Favored 'General case' 0 N--CA 1.452 -0.344 0 O-C-N 122.02 -0.425 . . . . 0.0 110.066 177.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 66.7 mm-40 -63.22 -35.87 81.75 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 122.416 0.286 . . . . 0.0 110.946 -178.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 27.5 p -83.51 1.37 42.22 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.044 0.938 . . . . 0.0 113.377 -177.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 68.1 m -102.02 30.97 4.13 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.18 0.992 . . . . 0.0 111.802 -176.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -132.68 57.79 1.78 Allowed 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.1 0.96 . . . . 0.0 110.526 -177.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 98.65 -153.43 19.88 Favored Glycine 0 C--N 1.337 0.636 0 N-CA-C 110.084 -1.206 . . . . 0.0 110.084 174.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 55.0 t -72.05 135.06 28.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 N-CA-C 105.744 -1.947 . . . . 0.0 105.744 167.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 46.6 t -137.5 142.96 35.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 105.908 -1.886 . . . . 0.0 105.908 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.6 tt -125.27 101.42 6.97 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 106.03 -1.841 . . . . 0.0 106.03 -177.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -82.55 144.64 30.23 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.275 -179.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -121.18 93.79 4.13 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 125.955 1.702 . . . . 0.0 107.166 -178.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -72.7 111.6 7.99 Favored 'General case' 0 C--O 1.239 0.545 0 N-CA-C 105.689 -1.967 . . . . 0.0 105.689 174.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -146.86 -177.46 5.67 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 125.241 1.417 . . . . 0.0 108.168 -171.643 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -155.73 149.59 19.25 Favored Pre-proline 0 C--N 1.33 -0.265 0 N-CA-C 106.405 -1.702 . . . . 0.0 106.405 168.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -68.53 -12.58 35.17 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 121.378 1.386 . . . . 0.0 114.231 -176.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 52.0 p-90 -71.02 -19.69 62.48 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 120.233 1.378 . . . . 0.0 112.192 169.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 27.8 t -60.36 153.25 23.23 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.964 1.306 . . . . 0.0 111.419 -172.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -102.46 -61.2 0.73 Allowed Glycine 0 CA--C 1.533 1.195 0 C-N-CA 124.585 1.088 . . . . 0.0 111.626 171.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -66.95 -25.57 44.63 Favored 'Trans proline' 0 C--N 1.348 0.517 0 CA-C-N 120.46 2.13 . . . . 0.0 112.702 -174.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 24.6 m -56.41 -35.51 67.87 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 121.235 -0.916 . . . . 0.0 111.023 172.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.6 mmtp -69.31 -26.21 64.61 Favored 'General case' 0 CA--C 1.529 0.155 0 O-C-N 121.564 -0.71 . . . . 0.0 111.296 -178.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 5.1 ptt? -85.7 -31.55 22.41 Favored 'General case' 0 C--N 1.34 0.188 0 CA-C-N 118.961 0.8 . . . . 0.0 111.414 -176.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 18.2 tt -77.57 -25.26 14.78 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-O 118.591 -0.718 . . . . 0.0 111.537 170.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -49.71 -49.57 72.23 Favored Pre-proline 0 CA--C 1.547 0.839 0 CA-C-N 120.379 1.445 . . . . 0.0 114.367 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -66.35 -28.88 46.55 Favored 'Trans proline' 0 C--N 1.349 0.601 0 CA-C-N 122.038 1.763 . . . . 0.0 112.122 176.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.1 t -67.82 -37.26 78.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 O-C-N 121.666 -0.646 . . . . 0.0 109.553 174.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 96.1 mt -66.74 -34.82 78.69 Favored 'General case' 0 C--N 1.34 0.175 0 CA-C-N 119.46 1.027 . . . . 0.0 111.422 171.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -63.05 -42.33 99.7 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 119.556 1.071 . . . . 0.0 110.716 171.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -63.94 -39.49 94.27 Favored 'General case' 0 CA--C 1.531 0.24 0 O-C-N 121.243 -0.911 . . . . 0.0 110.421 175.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 42.8 tp -62.4 -43.04 99.77 Favored 'General case' 0 CA--C 1.527 0.077 0 C-N-CA 123.643 0.777 . . . . 0.0 110.205 175.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -60.06 -42.36 94.34 Favored 'General case' 0 CA--C 1.521 -0.137 0 C-N-CA 123.453 0.701 . . . . 0.0 110.805 178.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 -71.98 -10.8 60.28 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.263 0.625 . . . . 0.0 112.481 -179.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -105.54 -32.53 8.46 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 125.265 1.426 . . . . 0.0 111.415 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 71.5 mmm -125.77 -3.14 7.18 Favored 'General case' 0 C--O 1.226 -0.138 0 CA-C-O 118.414 -0.803 . . . . 0.0 113.152 -167.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -57.63 -13.59 12.48 Favored Glycine 0 CA--C 1.533 1.185 0 CA-C-N 119.769 1.168 . . . . 0.0 115.847 -172.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -77.1 -24.98 51.73 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 118.462 1.131 . . . . 0.0 111.721 174.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 51.1 mmtt -117.38 -21.08 8.85 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 125.648 1.579 . . . . 0.0 111.445 -177.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 52.2 tp -122.26 148.45 44.98 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 125.16 1.384 . . . . 0.0 110.223 -169.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -120.64 145.42 47.42 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 105.116 -2.179 . . . . 0.0 105.116 167.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 77.3 mt -115.01 138.01 46.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 105.637 -1.986 . . . . 0.0 105.637 176.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 93.5 t -133.56 98.6 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-N 118.879 0.763 . . . . 0.0 109.236 -170.193 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 52.9 mtpt -73.89 140.37 45.63 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 176.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 13.9 tt -142.72 127.87 16.39 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 176.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 50.6 t0 -84.02 103.43 13.25 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 124.732 1.213 . . . . 0.0 109.004 -172.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 28.3 m -59.36 -28.36 39.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 118.819 -0.61 . . . . 0.0 111.888 -174.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -66.64 -19.3 65.73 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 119.258 0.935 . . . . 0.0 111.846 -177.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -114.62 1.41 14.23 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.547 1.539 . . . . 0.0 110.828 178.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 68.3 m-80 -141.67 42.42 1.72 Allowed 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 124.4 1.08 . . . . 0.0 109.54 -169.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 45.0 mm-40 -55.81 -32.57 63.67 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.041 0.936 . . . . 0.0 111.269 178.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 -66.08 -47.58 73.8 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 118.384 0.538 . . . . 0.0 110.47 179.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.94 -39.41 79.59 Favored 'General case' 0 C--O 1.223 -0.327 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 -178.734 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -58.99 -47.81 83.83 Favored 'General case' 0 CA--C 1.533 0.325 0 O-C-N 121.207 -0.933 . . . . 0.0 110.264 173.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -60.85 -28.72 68.87 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 124.062 0.839 . . . . 0.0 112.405 177.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 24.4 tptp -56.18 -29.21 60.53 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.68 1.192 . . . . 0.0 111.47 179.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -124.27 10.73 8.69 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.557 0.743 . . . . 0.0 111.61 -179.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 63.71 31.36 80.51 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 123.728 0.68 . . . . 0.0 112.588 -177.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 53.7 t -65.55 123.67 18.94 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 172.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 99.0 mtp -135.99 3.49 2.93 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.757 1.223 . . . . 0.0 111.486 -179.121 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 24.5 m -143.89 160.96 39.88 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 126.656 1.983 . . . . 0.0 107.409 178.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 41.9 pt -143.14 154.9 61.89 Favored Pre-proline 0 CA--C 1.545 0.781 0 C-N-CA 124.468 1.107 . . . . 0.0 108.93 177.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -67.1 139.69 47.54 Favored 'Cis proline' 0 C--N 1.35 0.626 0 CA-C-N 120.373 1.169 . . . . 0.0 110.42 -4.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 24.6 m -130.36 140.8 50.59 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 174.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 86.2 mt -121.28 123.57 42.52 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 -169.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -114.06 122.45 46.93 Favored 'General case' 0 CA--C 1.512 -0.513 0 N-CA-C 103.627 -2.731 . . . . 0.0 103.627 178.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.2 t -96.02 127.18 48.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 N-CA-C 104.002 -2.592 . . . . 0.0 104.002 174.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.0 mp -119.66 155.05 33.09 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 177.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -137.05 119.47 15.82 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 106.376 -1.713 . . . . 0.0 106.376 176.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.0 t70 49.52 38.2 14.04 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.97 1.308 . . . . 0.0 112.482 177.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 104.67 -5.1 43.31 Favored Glycine 0 CA--C 1.529 0.944 0 CA-C-O 118.148 -1.362 . . . . 0.0 115.46 168.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -130.81 150.57 51.92 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 120.006 1.903 . . . . 0.0 110.276 -177.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 42.9 t -62.73 133.29 28.6 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.4 p -119.25 -21.03 4.61 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 125.19 1.396 . . . . 0.0 110.36 176.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -158.51 168.59 26.51 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 120.582 1.537 . . . . 0.0 110.317 173.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 18.1 m -146.37 143.31 28.99 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.385 1.074 . . . . 0.0 109.063 175.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 49.5 m -144.62 156.23 44.02 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.561 1.544 . . . . 0.0 108.66 176.213 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 41.2 t -133.76 146.44 31.77 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 -175.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 75.21 -174.25 52.12 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 123.292 0.473 . . . . 0.0 112.271 178.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 67.4 t80 -65.3 148.66 51.31 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.674 0.79 . . . . 0.0 111.347 -178.175 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.29 140.18 14.64 Favored Pre-proline 0 CA--C 1.534 0.349 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 167.383 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -72.05 161.66 44.07 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 122.718 2.279 . . . . 0.0 110.497 175.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 49.3 pttt -58.51 -29.34 66.19 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 113.571 0.952 . . . . 0.0 113.571 -178.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -65.91 -50.34 64.8 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 118.595 0.634 . . . . 0.0 109.559 176.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.53 -39.07 93.46 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 122.721 0.409 . . . . 0.0 110.821 178.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 87.8 mt -63.49 -44.06 95.47 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 122.985 0.514 . . . . 0.0 111.156 176.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 -61.17 -41.95 97.68 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-N 118.426 0.557 . . . . 0.0 110.153 176.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -63.31 -41.18 98.91 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 118.15 0.432 . . . . 0.0 110.238 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 61.3 tp -61.71 -46.01 91.5 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.705 1.202 . . . . 0.0 110.674 176.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 72.8 t -58.32 -44.86 89.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 CA-C-N 118.75 0.705 . . . . 0.0 109.462 173.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -62.59 -25.29 68.0 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.905 1.282 . . . . 0.0 112.153 -174.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -57.61 -22.14 43.42 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 118.506 -0.759 . . . . 0.0 112.452 172.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 70.8 m-70 -124.09 -8.26 7.69 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 -168.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 77.3 mt . . . . . 0 C--O 1.246 0.886 0 CA-C-O 118.363 -0.827 . . . . 0.0 109.416 171.54 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.3 mtt . . . . . 0 N--CA 1.483 1.19 0 CA-C-O 118.985 -0.531 . . . . 0.0 111.154 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -67.2 -20.62 65.73 Favored 'General case' 0 CA--C 1.51 -0.581 0 N-CA-C 116.844 2.164 . . . . 0.0 116.844 -169.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 12.0 mt -82.12 137.61 20.84 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.192 0 CA-C-N 114.312 -1.313 . . . . 0.0 108.901 -168.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 5.4 t -137.45 160.85 34.87 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 C-N-CA 126.702 2.001 . . . . 0.0 106.472 -174.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.34 133.07 50.12 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 105.358 -2.09 . . . . 0.0 105.358 176.506 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -142.8 174.96 10.19 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 123.611 0.764 . . . . 0.0 111.421 -170.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.3 p -138.14 171.74 13.94 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 126.732 2.013 . . . . 0.0 106.661 168.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -50.45 -27.95 7.42 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 175.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -55.06 -31.33 61.05 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.732 1.613 . . . . 0.0 112.756 177.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.1 m -139.67 -10.1 1.21 Allowed 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 124.035 0.934 . . . . 0.0 113.059 -170.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -53.57 -42.08 67.2 Favored 'General case' 0 C--O 1.231 0.117 0 C-N-CA 124.472 1.109 . . . . 0.0 111.316 -177.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.4 m -63.38 -36.9 85.27 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.16 0.584 . . . . 0.0 112.027 179.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -69.7 -44.25 70.79 Favored 'General case' 0 N--CA 1.453 -0.313 0 O-C-N 121.998 -0.439 . . . . 0.0 110.005 177.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -62.8 -40.88 98.74 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 122.827 0.451 . . . . 0.0 110.463 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 26.0 p -77.3 1.84 17.53 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.867 0.867 . . . . 0.0 113.252 -179.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 63.5 m -105.18 32.76 4.02 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.531 1.132 . . . . 0.0 111.206 179.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -130.97 51.48 2.13 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.2 1.0 . . . . 0.0 110.51 -178.125 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 97.27 -156.7 20.85 Favored Glycine 0 C--N 1.337 0.588 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 179.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 74.4 t -70.94 136.59 25.59 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 168.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 54.6 t -137.84 135.55 45.66 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 N-CA-C 106.039 -1.838 . . . . 0.0 106.039 -179.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.0 tt -113.25 99.95 8.2 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 105.754 -1.943 . . . . 0.0 105.754 -176.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -83.07 146.62 28.6 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 179.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -127.21 94.17 3.93 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 126.236 1.814 . . . . 0.0 107.66 -176.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -74.5 114.07 12.47 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 106.109 -1.811 . . . . 0.0 106.109 175.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -149.99 -177.04 5.68 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.918 1.287 . . . . 0.0 108.778 -171.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -152.86 147.16 18.77 Favored Pre-proline 0 CA--C 1.531 0.245 0 N-CA-C 105.936 -1.875 . . . . 0.0 105.936 167.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -58.81 -18.39 41.4 Favored 'Trans proline' 0 CA--C 1.531 0.36 0 C-N-CA 121.933 1.755 . . . . 0.0 114.844 178.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 1.9 m95 -74.28 -14.65 60.94 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 118.91 0.777 . . . . 0.0 111.908 176.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 34.9 t -63.95 152.54 39.69 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.41 1.484 . . . . 0.0 111.14 -175.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -100.5 -64.4 0.8 Allowed Glycine 0 CA--C 1.53 1.002 0 CA-C-O 118.446 -1.197 . . . . 0.0 110.997 171.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -62.3 -26.28 77.08 Favored 'Trans proline' 0 C--N 1.35 0.646 0 CA-C-N 120.44 2.12 . . . . 0.0 113.675 -174.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 33.7 m -57.01 -34.41 68.15 Favored 'General case' 0 CA--C 1.537 0.446 0 O-C-N 121.577 -0.702 . . . . 0.0 111.627 174.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.2 mmtp -67.53 -24.36 65.55 Favored 'General case' 0 CA--C 1.531 0.226 0 O-C-N 121.529 -0.732 . . . . 0.0 111.118 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 30.8 mtm -72.45 -42.7 64.72 Favored 'General case' 0 C--N 1.34 0.159 0 CA-C-N 118.581 0.628 . . . . 0.0 110.439 177.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 17.1 tt -83.48 -22.12 8.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-O 118.726 -0.654 . . . . 0.0 111.7 -175.117 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -50.24 -52.18 56.3 Favored Pre-proline 0 CA--C 1.549 0.915 0 CA-C-N 120.059 1.3 . . . . 0.0 113.674 177.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -66.84 -27.62 43.71 Favored 'Trans proline' 0 C--N 1.351 0.675 0 CA-C-N 121.606 1.609 . . . . 0.0 112.305 176.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 22.0 t -68.1 -39.19 80.97 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 O-C-N 121.541 -0.724 . . . . 0.0 109.5 175.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 53.2 mt -65.31 -36.3 83.62 Favored 'General case' 0 C--N 1.34 0.16 0 CA-C-N 119.265 0.939 . . . . 0.0 111.085 172.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -63.62 -38.5 91.36 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 118.803 0.729 . . . . 0.0 111.178 172.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -66.63 -35.42 80.15 Favored 'General case' 0 CA--C 1.531 0.244 0 O-C-N 120.35 -1.469 . . . . 0.0 110.691 173.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.58 -44.84 92.88 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.594 0.758 . . . . 0.0 109.733 177.014 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 53.2 t0 -53.66 -48.22 69.64 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 124.972 1.309 . . . . 0.0 110.397 172.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -68.43 -8.11 37.67 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -178.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 77.7 mt-10 -109.6 -36.64 5.9 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.996 1.319 . . . . 0.0 112.265 -176.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 6.2 ptp -145.12 22.96 1.53 Allowed 'General case' 0 C--N 1.341 0.212 0 N-CA-C 114.865 1.432 . . . . 0.0 114.865 178.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -60.84 -5.68 5.69 Favored Glycine 0 CA--C 1.537 1.46 0 CA-C-N 119.996 1.271 . . . . 0.0 115.221 177.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -78.6 -33.17 47.68 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.586 1.154 . . . . 0.0 111.296 170.035 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -95.45 -35.23 11.79 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 124.844 1.258 . . . . 0.0 110.659 178.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 60.8 tp -105.14 153.06 22.03 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.452 1.101 . . . . 0.0 111.745 -169.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 14.4 ttmm -121.85 144.46 48.82 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 104.426 -2.435 . . . . 0.0 104.426 166.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 79.3 mt -120.66 135.62 60.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 104.872 -2.269 . . . . 0.0 104.872 179.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 99.3 t -130.0 98.61 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 -172.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 52.4 mtmt -71.47 138.88 49.36 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 172.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 17.1 tt -142.28 123.59 12.24 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 177.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 59.3 t0 -83.32 106.98 15.53 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 124.282 1.033 . . . . 0.0 108.566 -173.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 31.7 m -60.07 -24.68 30.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 118.551 -0.737 . . . . 0.0 112.043 -175.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -64.75 -19.73 65.95 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 119.659 1.118 . . . . 0.0 112.002 -179.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -116.44 4.44 13.34 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.069 1.347 . . . . 0.0 110.85 178.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 68.4 m-80 -141.35 39.16 1.73 Allowed 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 124.537 1.135 . . . . 0.0 110.169 -169.141 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 53.4 mm-40 -56.48 -34.8 67.26 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.358 0.663 . . . . 0.0 110.851 176.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -65.34 -46.18 81.26 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 122.78 0.432 . . . . 0.0 110.305 177.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.29 -40.62 86.12 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.482 0.713 . . . . 0.0 110.043 -178.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -58.26 -49.49 76.91 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.389 0.675 . . . . 0.0 110.109 172.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -59.67 -29.57 67.31 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 123.958 0.789 . . . . 0.0 112.432 177.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 22.6 ttmt -55.39 -28.91 57.11 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.497 1.519 . . . . 0.0 112.042 178.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -123.61 9.49 8.98 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 123.868 0.867 . . . . 0.0 111.948 178.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 65.14 28.77 73.94 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 123.819 0.723 . . . . 0.0 112.935 -176.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 54.5 t -61.67 128.99 24.07 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 172.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 22.4 ttt -137.93 0.37 2.17 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.573 1.149 . . . . 0.0 111.145 -177.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 25.2 m -145.08 163.95 32.72 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 126.558 1.943 . . . . 0.0 107.612 179.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 39.5 pt -143.41 155.82 60.77 Favored Pre-proline 0 CA--C 1.547 0.832 0 C-N-CA 124.603 1.161 . . . . 0.0 108.85 176.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -67.24 138.66 42.8 Favored 'Cis proline' 0 C--N 1.351 0.671 0 CA-C-N 120.453 1.197 . . . . 0.0 110.288 -4.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 32.8 m -130.22 141.1 50.66 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 175.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 83.0 mt -122.62 128.47 50.71 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 -167.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -122.54 118.36 28.06 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 104.013 -2.588 . . . . 0.0 104.013 -178.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 14.7 t -92.92 119.28 40.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 104.108 -2.553 . . . . 0.0 104.108 173.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.8 mp -109.74 153.91 23.65 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 172.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -134.34 125.06 26.84 Favored 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 170.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.0 t70 48.48 35.02 5.31 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.234 1.414 . . . . 0.0 112.181 173.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 101.69 0.67 52.7 Favored Glycine 0 CA--C 1.532 1.146 0 CA-C-O 117.876 -1.513 . . . . 0.0 115.289 170.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -123.29 146.42 47.9 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 120.491 2.145 . . . . 0.0 109.5 176.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 11.4 p -68.67 132.48 32.89 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 170.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 33.7 m -119.91 -21.0 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 124.439 1.096 . . . . 0.0 110.996 178.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -155.75 162.86 40.45 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 120.44 1.473 . . . . 0.0 110.851 174.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 9.0 m -139.13 151.06 46.36 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.673 1.189 . . . . 0.0 108.708 177.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 48.6 m -151.55 159.32 44.17 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.408 1.483 . . . . 0.0 108.874 169.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 42.7 t -133.93 144.67 34.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 -176.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 77.87 177.97 48.06 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 123.639 0.638 . . . . 0.0 112.494 176.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 55.2 t80 -61.35 145.14 52.53 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 123.866 0.866 . . . . 0.0 111.089 -179.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.37 141.27 14.91 Favored Pre-proline 0 CA--C 1.535 0.403 0 C-N-CA 126.206 1.802 . . . . 0.0 106.843 177.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -72.35 156.79 54.38 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 122.409 2.073 . . . . 0.0 110.722 176.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 42.2 pttt -57.5 -32.54 67.13 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 -175.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -68.77 -43.04 76.59 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 118.5 0.591 . . . . 0.0 109.504 178.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.47 -42.05 98.6 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 118.354 0.525 . . . . 0.0 110.517 176.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 97.1 mt -60.86 -48.84 79.99 Favored 'General case' 0 N--CA 1.461 0.095 0 CA-C-O 121.08 0.467 . . . . 0.0 110.686 178.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -71.57 -28.29 63.74 Favored 'General case' 0 N--CA 1.451 -0.381 0 O-C-N 122.037 -0.414 . . . . 0.0 110.866 -175.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -70.03 -37.25 75.55 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 118.404 0.547 . . . . 0.0 111.355 170.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 8.7 tp -62.79 -34.5 77.4 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.5 1.12 . . . . 0.0 110.274 174.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 48.9 t -69.99 -45.97 74.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 123.836 0.854 . . . . 0.0 110.066 169.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -59.91 -36.58 77.3 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 124.73 1.212 . . . . 0.0 111.937 -172.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 11.0 ptmm? -67.06 -6.25 16.5 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 178.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -123.35 -18.07 6.36 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.136 0.974 . . . . 0.0 113.363 175.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 31.7 mt . . . . . 0 C--O 1.249 1.034 0 CA-C-N 119.913 1.233 . . . . 0.0 109.459 171.784 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.5 ttt . . . . . 0 N--CA 1.479 0.993 0 CA-C-O 119.082 -0.485 . . . . 0.0 110.076 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -165.23 -175.62 3.72 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 126.096 1.759 . . . . 0.0 107.876 -171.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.1 mt -76.15 142.67 14.09 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 165.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 44.6 t -138.79 164.03 26.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 126.494 1.917 . . . . 0.0 106.733 -174.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 4.7 mtpt -117.01 142.84 46.45 Favored 'General case' 0 CA--C 1.517 -0.31 0 C-N-CA 125.345 1.458 . . . . 0.0 107.373 173.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -142.81 165.62 26.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.422 0.63 . . . . 0.0 110.525 178.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 17.5 p -132.55 172.25 12.75 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 126.254 1.822 . . . . 0.0 107.664 170.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -52.39 -29.53 24.59 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.238 1.015 . . . . 0.0 113.111 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 56.1 mt-30 -63.47 -28.96 70.32 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.12 1.368 . . . . 0.0 113.174 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.2 m -136.88 -5.49 1.92 Allowed 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 113.842 1.053 . . . . 0.0 113.842 -168.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -52.39 -44.07 65.12 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.166 0.987 . . . . 0.0 111.65 -177.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.5 m -63.23 -38.57 91.68 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.129 0.572 . . . . 0.0 111.849 -179.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -68.1 -44.34 76.45 Favored 'General case' 0 N--CA 1.452 -0.337 0 O-C-N 121.994 -0.442 . . . . 0.0 110.023 177.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 66.1 mm-40 -63.61 -35.76 81.56 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 122.391 0.276 . . . . 0.0 110.979 -178.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 26.4 p -83.91 1.44 43.36 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.029 0.931 . . . . 0.0 113.329 -177.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 69.1 m -100.17 30.27 3.89 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.23 1.012 . . . . 0.0 111.742 -177.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -133.26 61.95 1.67 Allowed 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.297 1.039 . . . . 0.0 110.195 -177.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 92.24 -156.53 23.52 Favored Glycine 0 C--N 1.338 0.694 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 175.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 59.1 t -71.31 134.23 30.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 N-CA-C 106.506 -1.665 . . . . 0.0 106.506 168.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 47.1 t -136.99 141.11 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 105.915 -1.883 . . . . 0.0 105.915 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 3.7 tt -122.19 100.3 6.89 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 106.255 -1.757 . . . . 0.0 106.255 -176.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -83.25 145.42 29.14 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.293 -179.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -123.95 94.12 4.13 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 126.083 1.753 . . . . 0.0 107.196 -177.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -74.13 112.26 10.09 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 105.884 -1.895 . . . . 0.0 105.884 174.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -148.3 -177.12 5.59 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.704 1.201 . . . . 0.0 108.608 -172.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -155.87 146.98 16.55 Favored Pre-proline 0 CA--C 1.531 0.232 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 168.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -60.75 -17.27 48.98 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 121.818 1.679 . . . . 0.0 116.01 -177.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 54.0 p-90 -70.04 -20.12 63.26 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 120.03 1.286 . . . . 0.0 111.914 173.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 29.0 t -59.58 150.97 25.66 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.991 1.316 . . . . 0.0 110.971 -174.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -104.99 -58.61 0.67 Allowed Glycine 0 CA--C 1.531 1.062 0 CA-C-O 118.704 -1.053 . . . . 0.0 110.97 172.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -56.54 -33.08 91.88 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 123.217 2.611 . . . . 0.0 113.712 -179.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 29.7 m -57.82 -34.57 69.81 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.441 0.696 . . . . 0.0 111.403 176.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.4 mmtp -68.38 -24.54 64.79 Favored 'General case' 0 CA--C 1.531 0.22 0 O-C-N 121.5 -0.75 . . . . 0.0 111.063 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 31.1 mtm -70.8 -42.27 70.52 Favored 'General case' 0 C--N 1.34 0.186 0 CA-C-N 118.742 0.701 . . . . 0.0 110.405 176.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 19.1 tt -85.0 -23.76 7.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 CA-C-O 118.53 -0.748 . . . . 0.0 111.782 -175.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -49.38 -50.52 64.55 Favored Pre-proline 0 CA--C 1.548 0.867 0 CA-C-N 120.088 1.313 . . . . 0.0 114.191 178.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -66.93 -27.76 42.83 Favored 'Trans proline' 0 C--N 1.351 0.674 0 CA-C-N 121.779 1.671 . . . . 0.0 112.069 176.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.8 t -68.94 -37.12 76.87 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 O-C-N 121.589 -0.694 . . . . 0.0 109.769 173.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 95.6 mt -65.5 -34.69 78.87 Favored 'General case' 0 C--N 1.339 0.135 0 CA-C-N 119.743 1.156 . . . . 0.0 111.025 172.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -61.97 -43.79 98.1 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 119.376 0.989 . . . . 0.0 110.944 170.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -63.67 -40.18 96.18 Favored 'General case' 0 CA--C 1.531 0.218 0 O-C-N 121.172 -0.955 . . . . 0.0 110.711 175.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 39.8 tp -61.98 -41.96 98.61 Favored 'General case' 0 C--N 1.334 -0.105 0 C-N-CA 124.372 1.069 . . . . 0.0 109.919 178.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -60.82 -42.96 98.73 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 122.949 0.499 . . . . 0.0 110.696 175.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -71.97 -10.4 59.72 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 112.6 0.592 . . . . 0.0 112.6 179.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -105.36 -28.38 10.91 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 125.437 1.495 . . . . 0.0 111.377 -178.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 26.8 mtp -134.3 -1.56 2.88 Favored 'General case' 0 N--CA 1.462 0.146 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 -168.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -56.91 -13.91 9.26 Favored Glycine 0 CA--C 1.532 1.126 0 CA-C-N 119.913 1.233 . . . . 0.0 115.434 -173.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -69.73 -29.93 67.42 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 118.674 1.237 . . . . 0.0 111.73 173.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 45.6 mmtm -115.7 -20.27 10.17 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 125.512 1.525 . . . . 0.0 111.889 -178.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 36.6 tp -112.57 157.17 21.51 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 123.984 0.914 . . . . 0.0 111.41 -168.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -132.34 144.51 50.6 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 103.806 -2.665 . . . . 0.0 103.806 166.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 83.0 mt -118.02 139.43 45.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 105.274 -2.121 . . . . 0.0 105.274 177.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 81.9 t -132.26 98.78 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 -170.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 52.4 mtmt -74.2 136.69 42.79 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 175.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 15.3 tt -139.98 124.82 19.88 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 176.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -82.79 105.08 13.51 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 124.717 1.207 . . . . 0.0 108.784 -174.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 27.7 m -60.37 -27.06 38.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 118.684 -0.674 . . . . 0.0 111.898 -174.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -66.1 -19.83 65.97 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 119.423 1.011 . . . . 0.0 111.773 -177.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -113.83 1.59 14.84 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.534 1.534 . . . . 0.0 110.891 178.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 68.7 m-80 -141.68 41.77 1.72 Allowed 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.27 1.028 . . . . 0.0 109.889 -169.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 46.7 mm-40 -56.03 -32.37 63.96 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.806 0.842 . . . . 0.0 111.262 177.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 35.0 mm-40 -65.72 -47.21 76.1 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 118.407 0.549 . . . . 0.0 110.5 179.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.2 -39.04 78.86 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 121.801 -0.562 . . . . 0.0 109.634 -178.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -58.79 -48.28 81.82 Favored 'General case' 0 CA--C 1.534 0.343 0 O-C-N 121.142 -0.974 . . . . 0.0 110.171 172.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -60.45 -28.67 67.74 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 124.078 0.847 . . . . 0.0 112.438 177.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 47.7 tptt -56.23 -29.28 60.79 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.629 1.171 . . . . 0.0 111.425 179.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -124.0 10.7 8.85 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.671 0.788 . . . . 0.0 111.598 -179.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 64.41 28.52 73.21 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 123.819 0.723 . . . . 0.0 112.802 -177.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 49.1 t -62.86 125.94 20.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 172.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 40.3 ttp -138.49 1.86 2.19 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.487 1.115 . . . . 0.0 111.036 -177.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 24.8 m -144.31 161.98 37.58 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 126.789 2.036 . . . . 0.0 107.374 178.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 40.7 pt -143.13 155.91 61.7 Favored Pre-proline 0 CA--C 1.544 0.721 0 C-N-CA 124.631 1.173 . . . . 0.0 108.768 177.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -67.05 139.54 46.66 Favored 'Cis proline' 0 C--N 1.349 0.588 0 CA-C-N 120.459 1.2 . . . . 0.0 110.26 -4.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 28.1 m -130.81 139.95 50.24 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 174.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 88.0 mt -120.33 124.49 45.69 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 -169.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -115.18 119.7 37.27 Favored 'General case' 0 CA--C 1.512 -0.509 0 N-CA-C 103.578 -2.749 . . . . 0.0 103.578 177.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.2 t -93.1 123.31 45.14 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 N-CA-C 103.432 -2.803 . . . . 0.0 103.432 173.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.1 mp -114.86 155.25 27.16 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 174.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -137.94 123.38 19.55 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 172.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.2 t70 49.36 36.87 10.46 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.084 1.354 . . . . 0.0 112.537 176.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 103.4 -2.83 46.59 Favored Glycine 0 CA--C 1.529 0.92 0 CA-C-O 118.122 -1.377 . . . . 0.0 115.285 168.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -128.62 149.98 50.41 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 120.074 1.937 . . . . 0.0 110.077 -179.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 44.3 t -62.0 131.53 27.25 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 175.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.1 p -117.44 -22.94 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 C-N-CA 125.102 1.361 . . . . 0.0 109.406 179.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -162.3 168.04 22.9 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 120.463 1.483 . . . . 0.0 110.097 169.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 14.0 m -136.56 151.07 48.98 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.363 1.465 . . . . 0.0 108.796 177.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 58.3 m -148.38 157.28 43.38 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.631 1.573 . . . . 0.0 108.649 169.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 42.6 t -133.6 145.33 33.77 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 -178.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 78.27 -176.29 54.24 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 123.553 0.597 . . . . 0.0 111.877 179.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -63.72 148.91 47.91 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.484 0.714 . . . . 0.0 110.41 178.003 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 42.9 mttt -142.4 138.24 16.28 Favored Pre-proline 0 C--O 1.235 0.311 0 N-CA-C 106.352 -1.722 . . . . 0.0 106.352 168.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -66.57 160.03 47.97 Favored 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 121.88 1.72 . . . . 0.0 110.925 178.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 33.7 tttm -48.85 -46.72 42.68 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 126.071 1.748 . . . . 0.0 112.987 -178.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 27.4 mm-40 -72.98 -35.94 66.99 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.207 -176.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.64 -36.6 84.78 Favored 'General case' 0 C--N 1.341 0.233 0 CA-C-N 118.979 0.808 . . . . 0.0 111.054 173.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 87.1 mt -64.53 -45.78 85.72 Favored 'General case' 0 N--CA 1.456 -0.137 0 CA-C-O 119.197 -0.43 . . . . 0.0 110.665 176.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 8.9 mt-30 -57.99 -42.44 85.16 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-N 118.501 0.591 . . . . 0.0 110.787 173.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -64.61 -39.58 93.98 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 118.016 0.371 . . . . 0.0 110.508 -178.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 57.8 tp -61.86 -44.0 97.72 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 124.636 1.174 . . . . 0.0 110.568 176.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 86.6 t -61.22 -44.13 97.78 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-N 118.821 0.737 . . . . 0.0 109.39 173.023 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -60.58 -28.34 68.4 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 125.019 1.328 . . . . 0.0 112.15 -173.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -56.4 -24.12 42.71 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 123.402 0.681 . . . . 0.0 112.498 174.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 72.2 m-70 -123.18 -9.18 8.16 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 -168.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 74.5 mt . . . . . 0 C--O 1.249 1.045 0 CA-C-N 118.948 0.794 . . . . 0.0 109.333 171.298 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 46.4 tpp . . . . . 0 N--CA 1.484 1.235 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -143.58 -179.26 6.33 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.728 1.211 . . . . 0.0 110.353 -172.465 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.8 mt -72.26 148.8 9.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 168.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 21.5 t -134.88 160.87 41.01 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 C-N-CA 126.68 1.992 . . . . 0.0 106.521 -176.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.23 139.1 50.7 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 105.368 -2.086 . . . . 0.0 105.368 169.284 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -140.68 168.94 18.6 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 121.296 0.569 . . . . 0.0 110.886 -178.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 17.4 p -133.19 169.67 16.54 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 126.334 1.854 . . . . 0.0 107.987 175.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -53.42 -29.31 34.53 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.443 1.097 . . . . 0.0 113.039 -178.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 57.0 mt-30 -61.28 -29.26 69.75 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.164 1.386 . . . . 0.0 112.944 178.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.6 m -136.86 -7.19 1.87 Allowed 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 -169.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -53.25 -43.65 67.52 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.349 1.06 . . . . 0.0 111.516 -177.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.8 m -62.86 -39.87 95.74 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.058 0.543 . . . . 0.0 111.76 179.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.66 -43.38 84.73 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 122.71 0.404 . . . . 0.0 110.074 177.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 68.5 mm-40 -64.09 -42.82 96.8 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 122.265 0.226 . . . . 0.0 110.551 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 35.5 p -77.89 -5.86 52.4 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 124.262 1.025 . . . . 0.0 113.568 -176.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 72.7 m -74.72 -20.26 59.91 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 177.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -87.41 69.23 9.87 Favored 'General case' 0 CA--C 1.537 0.451 0 O-C-N 121.483 -0.761 . . . . 0.0 111.581 -170.012 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 85.28 -151.51 25.75 Favored Glycine 0 C--N 1.337 0.612 0 N-CA-C 109.993 -1.243 . . . . 0.0 109.993 173.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 58.0 t -71.17 137.11 24.43 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 168.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 57.7 t -140.37 146.99 23.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 105.777 -1.935 . . . . 0.0 105.777 179.08 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.5 tt -124.96 99.35 6.09 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 -176.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -81.43 147.86 29.56 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.732 -179.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -126.48 95.21 4.29 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 126.145 1.778 . . . . 0.0 107.27 -178.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -73.81 115.36 13.16 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 174.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -149.16 -178.06 6.17 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.351 1.46 . . . . 0.0 108.553 -173.739 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -156.12 149.65 18.97 Favored Pre-proline 0 CA--C 1.531 0.238 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 167.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_exo -59.62 -19.16 51.51 Favored 'Trans proline' 0 CA--C 1.534 0.504 0 C-N-CA 122.323 2.015 . . . . 0.0 115.775 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 52.4 p-90 -70.85 -20.11 62.57 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 119.933 1.242 . . . . 0.0 112.035 174.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 23.9 t -61.45 152.35 30.13 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 125.025 1.33 . . . . 0.0 111.344 -172.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -101.63 -66.59 0.78 Allowed Glycine 0 CA--C 1.529 0.963 0 CA-C-O 118.424 -1.209 . . . . 0.0 110.528 173.03 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -54.75 -30.42 67.06 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 123.12 2.547 . . . . 0.0 114.275 -179.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 39.4 m -56.26 -34.87 66.82 Favored 'General case' 0 CA--C 1.538 0.495 0 O-C-N 121.467 -0.77 . . . . 0.0 111.551 175.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.4 mmtp -68.94 -29.61 67.89 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 123.427 0.691 . . . . 0.0 110.944 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 5.0 ptt? -85.55 -30.03 23.7 Favored 'General case' 0 C--N 1.34 0.153 0 CA-C-N 118.809 0.731 . . . . 0.0 111.539 -177.002 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 19.5 tt -77.87 -20.77 13.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-O 118.626 -0.702 . . . . 0.0 111.56 169.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -51.7 -49.61 82.14 Favored Pre-proline 0 CA--C 1.548 0.887 0 CA-C-N 120.83 1.65 . . . . 0.0 113.852 178.232 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -66.18 -28.3 48.31 Favored 'Trans proline' 0 C--N 1.35 0.631 0 CA-C-N 121.922 1.722 . . . . 0.0 112.285 175.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 23.9 t -66.93 -39.23 83.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 174.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 95.1 mt -64.6 -37.0 86.08 Favored 'General case' 0 C--N 1.341 0.239 0 CA-C-N 119.531 1.06 . . . . 0.0 111.155 171.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -64.66 -40.79 96.04 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 119.385 0.993 . . . . 0.0 110.857 174.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -63.02 -40.02 96.49 Favored 'General case' 0 CA--C 1.531 0.232 0 O-C-N 121.067 -1.021 . . . . 0.0 110.187 174.158 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.35 -47.28 84.31 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.885 0.874 . . . . 0.0 109.746 175.499 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -59.01 -40.57 85.36 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 123.62 0.768 . . . . 0.0 111.03 179.262 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 -73.92 -10.71 59.93 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.303 0.641 . . . . 0.0 112.377 -179.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -103.44 -33.88 8.91 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 124.954 1.302 . . . . 0.0 111.791 178.292 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 86.6 mmm -125.08 -3.77 7.53 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 113.237 0.829 . . . . 0.0 113.237 -168.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -62.63 -3.57 5.82 Favored Glycine 0 CA--C 1.532 1.147 0 CA-C-N 119.853 1.206 . . . . 0.0 115.342 -175.415 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -73.96 -27.68 61.12 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 118.519 1.16 . . . . 0.0 111.201 169.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.3 -23.07 3.3 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 125.289 1.435 . . . . 0.0 111.59 -171.313 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 45.0 tp -111.24 151.61 28.1 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 124.878 1.271 . . . . 0.0 110.169 -169.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -118.82 144.8 46.12 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 105.541 -2.022 . . . . 0.0 105.541 168.322 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 73.1 mt -116.53 136.96 51.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 105.384 -2.08 . . . . 0.0 105.384 175.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 97.3 t -133.06 97.08 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 -169.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -73.97 139.48 44.86 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 107.648 -1.242 . . . . 0.0 107.648 175.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 11.5 tt -141.05 129.27 23.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.395 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 178.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 61.7 t0 -87.83 105.44 17.41 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 124.809 1.243 . . . . 0.0 110.06 -169.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 27.0 m -62.58 -18.46 20.69 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 CA-C-O 118.539 -0.743 . . . . 0.0 112.449 -177.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -67.54 -15.5 63.69 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 119.863 1.211 . . . . 0.0 112.023 176.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -127.18 1.03 6.45 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.236 1.014 . . . . 0.0 111.89 178.323 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 67.0 m-80 -137.55 41.0 2.4 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.737 0.815 . . . . 0.0 111.209 -169.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 5.3 mp0 -54.11 -32.08 53.94 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.203 0.601 . . . . 0.0 111.76 174.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -66.3 -47.44 73.59 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 118.423 0.556 . . . . 0.0 110.498 -177.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.07 -39.26 79.2 Favored 'General case' 0 CA--C 1.534 0.345 0 O-C-N 121.836 -0.54 . . . . 0.0 109.591 -179.416 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -58.53 -48.45 80.81 Favored 'General case' 0 CA--C 1.534 0.338 0 O-C-N 121.244 -0.91 . . . . 0.0 110.463 173.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -61.92 -28.15 69.83 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 124.179 0.895 . . . . 0.0 112.166 178.015 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 71.7 tttt -55.66 -28.76 57.23 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.853 1.261 . . . . 0.0 111.683 178.057 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -123.17 10.58 9.37 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.775 0.83 . . . . 0.0 111.803 179.252 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 65.38 27.46 72.5 Favored Glycine 0 CA--C 1.534 1.239 0 C-N-CA 123.85 0.738 . . . . 0.0 113.024 -177.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 60.4 t -62.72 127.63 23.17 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 171.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 22.6 ttt -137.16 0.49 2.35 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.612 1.165 . . . . 0.0 111.05 -176.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 25.2 m -144.92 162.51 36.67 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 126.514 1.926 . . . . 0.0 107.719 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 41.1 pt -142.8 156.79 62.47 Favored Pre-proline 0 CA--C 1.544 0.747 0 C-N-CA 124.858 1.263 . . . . 0.0 108.615 177.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -66.74 140.7 51.32 Favored 'Cis proline' 0 C--N 1.349 0.594 0 CA-C-N 120.464 1.201 . . . . 0.0 110.416 -5.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 32.2 m -135.2 135.96 41.41 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 176.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -115.4 132.11 56.72 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 -172.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -120.22 121.87 39.67 Favored 'General case' 0 CA--C 1.513 -0.443 0 N-CA-C 103.545 -2.761 . . . . 0.0 103.545 177.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 8.3 t -92.67 123.36 44.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 103.331 -2.84 . . . . 0.0 103.331 172.227 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.2 mp -113.09 155.7 24.44 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 175.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 60.8 tttp -135.65 124.62 24.2 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 105.854 -1.906 . . . . 0.0 105.854 173.479 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 30.8 t70 50.64 34.73 10.23 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.693 1.197 . . . . 0.0 112.119 176.199 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 100.38 -1.13 55.86 Favored Glycine 0 CA--C 1.529 0.951 0 CA-C-O 118.27 -1.294 . . . . 0.0 114.92 169.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -132.28 152.37 51.39 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 120.072 1.936 . . . . 0.0 110.24 -179.487 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 29.0 t -62.31 135.14 27.17 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 -178.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.9 p -120.59 -25.84 2.44 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 125.16 1.384 . . . . 0.0 110.237 175.135 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.403 ' C ' ' HG1' ' A' ' 86' ' ' THR . 0.7 OUTLIER -155.95 170.24 22.59 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 120.22 1.373 . . . . 0.0 109.792 177.404 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.403 ' HG1' ' C ' ' A' ' 85' ' ' GLU . 30.0 m -152.43 153.73 34.13 Favored 'General case' 0 CA--C 1.541 0.612 0 O-C-N 120.747 -1.221 . . . . 0.0 110.271 -176.197 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 41.7 m -150.22 154.45 37.98 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.561 1.544 . . . . 0.0 108.981 168.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 43.4 t -132.9 141.0 46.06 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 N-CA-C 107.03 -1.471 . . . . 0.0 107.03 -177.113 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 76.67 179.19 47.34 Favored Glycine 0 CA--C 1.53 0.992 0 N-CA-C 111.436 -0.665 . . . . 0.0 111.436 -177.131 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 36.1 t80 -63.18 132.62 52.36 Favored 'General case' 0 C--O 1.231 0.129 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 175.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 13.1 mptt -135.47 147.4 61.65 Favored Pre-proline 0 CA--C 1.536 0.419 0 C-N-CA 126.676 1.99 . . . . 0.0 106.176 174.262 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -71.53 158.07 54.67 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 122.513 2.142 . . . . 0.0 110.521 178.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 20.7 pttp -58.25 -29.25 65.63 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -62.4 -42.84 99.74 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.215 0.606 . . . . 0.0 110.433 176.368 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.62 -47.38 78.78 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 118.544 0.611 . . . . 0.0 110.09 -178.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 10.1 mp -56.09 -47.44 78.03 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.577 0.751 . . . . 0.0 109.912 176.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 14.7 mt-30 -61.73 -39.9 93.18 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-O 118.729 -0.653 . . . . 0.0 112.058 178.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -64.69 -42.83 95.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 119.073 0.852 . . . . 0.0 110.029 178.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 31.0 mt -66.92 -35.3 79.68 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 118.586 0.63 . . . . 0.0 111.562 179.034 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 44.0 t -60.99 -50.99 78.29 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 170.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -61.26 -33.65 73.88 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 125.383 1.473 . . . . 0.0 111.862 -173.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 59.1 mtpt -56.36 -27.93 57.54 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 118.332 -0.842 . . . . 0.0 112.212 174.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -128.92 -5.47 5.06 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 114.688 1.366 . . . . 0.0 114.688 -167.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 17.5 mt . . . . . 0 C--O 1.25 1.082 0 CA-C-N 119.655 1.116 . . . . 0.0 108.725 168.569 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.8 tpp . . . . . 0 N--CA 1.478 0.973 0 CA-C-O 118.912 -0.566 . . . . 0.0 110.251 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -164.56 -175.57 3.92 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 125.588 1.555 . . . . 0.0 108.366 -173.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.3 mt -75.92 143.78 12.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 166.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 20.7 t -135.77 161.37 38.54 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 126.696 1.998 . . . . 0.0 106.103 -176.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.62 138.89 50.62 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 105.652 -1.981 . . . . 0.0 105.652 169.149 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -139.2 171.39 14.36 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 123.453 0.701 . . . . 0.0 110.852 -178.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.0 p -136.18 171.66 14.15 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 125.768 1.627 . . . . 0.0 108.454 175.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -38.82 -39.93 0.57 Allowed 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 126.415 1.886 . . . . 0.0 113.525 170.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 43.5 mm-40 -68.62 -26.03 65.14 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.095 0.958 . . . . 0.0 113.088 -173.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.1 m -134.18 -8.95 2.62 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 113.585 0.958 . . . . 0.0 113.585 -169.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 67.4 t80 -54.03 -45.17 71.49 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 124.363 1.065 . . . . 0.0 111.44 -176.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 9.3 m -63.25 -37.42 87.18 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.041 0.536 . . . . 0.0 111.729 -178.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -68.41 -44.77 74.32 Favored 'General case' 0 N--CA 1.454 -0.272 0 O-C-N 122.036 -0.415 . . . . 0.0 110.055 177.143 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 67.0 mm-40 -63.21 -35.78 81.46 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 122.414 0.286 . . . . 0.0 110.955 -178.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.9 p -83.98 1.36 44.04 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.2 1.0 . . . . 0.0 113.496 -177.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 66.5 m -102.15 32.58 3.43 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.099 0.959 . . . . 0.0 111.403 -177.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -132.78 58.18 1.77 Allowed 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.354 1.062 . . . . 0.0 110.155 -178.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 93.97 -154.08 21.42 Favored Glycine 0 C--N 1.339 0.728 0 N-CA-C 110.084 -1.206 . . . . 0.0 110.084 176.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 84.7 t -71.19 134.84 29.24 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 168.142 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 58.8 t -139.07 142.07 34.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 105.639 -1.985 . . . . 0.0 105.639 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 3.4 tt -120.51 99.37 6.52 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 -174.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -81.33 146.83 30.16 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 179.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -126.09 94.14 4.01 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 125.983 1.713 . . . . 0.0 106.961 -177.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -73.95 113.97 11.73 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 106.179 -1.786 . . . . 0.0 106.179 174.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -149.75 -175.85 5.19 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 125.107 1.363 . . . . 0.0 107.883 -172.23 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -155.84 148.36 17.8 Favored Pre-proline 0 N--CA 1.451 -0.376 0 N-CA-C 106.106 -1.813 . . . . 0.0 106.106 167.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -68.35 -12.92 36.34 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 CA-C-N 120.871 1.347 . . . . 0.0 113.923 -178.45 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 42.6 p-90 -69.88 -20.94 63.37 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 120.221 1.373 . . . . 0.0 111.978 169.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 26.8 t -59.3 149.19 29.51 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.117 1.367 . . . . 0.0 111.123 -171.165 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -97.02 -60.39 0.97 Allowed Glycine 0 CA--C 1.533 1.19 0 CA-C-O 118.715 -1.047 . . . . 0.0 111.418 170.016 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -66.77 -25.9 45.7 Favored 'Trans proline' 0 C--N 1.349 0.576 0 CA-C-N 120.444 2.122 . . . . 0.0 112.813 -173.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 22.5 m -58.73 -32.23 69.02 Favored 'General case' 0 CA--C 1.536 0.41 0 O-C-N 121.524 -0.735 . . . . 0.0 111.401 174.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.7 mmtp -69.03 -23.01 64.02 Favored 'General case' 0 CA--C 1.532 0.257 0 O-C-N 121.373 -0.829 . . . . 0.0 111.109 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 34.0 mtm -71.52 -42.65 67.71 Favored 'General case' 0 C--N 1.34 0.194 0 CA-C-N 118.763 0.711 . . . . 0.0 110.404 175.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 16.5 tt -84.0 -22.12 8.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-O 118.741 -0.647 . . . . 0.0 111.599 -176.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -49.39 -51.16 60.38 Favored Pre-proline 0 CA--C 1.547 0.845 0 CA-C-N 120.009 1.277 . . . . 0.0 113.894 177.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -67.59 -25.98 40.29 Favored 'Trans proline' 0 C--N 1.351 0.66 0 CA-C-N 121.828 1.689 . . . . 0.0 112.528 176.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 15.2 t -70.05 -37.01 71.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 O-C-N 121.555 -0.715 . . . . 0.0 109.49 174.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 93.6 mt -67.41 -36.72 81.83 Favored 'General case' 0 C--O 1.226 -0.152 0 CA-C-N 119.576 1.08 . . . . 0.0 111.267 171.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -62.43 -41.59 98.82 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 119.385 0.993 . . . . 0.0 110.686 172.27 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 30.9 mm-40 -60.08 -45.91 91.33 Favored 'General case' 0 N--CA 1.455 -0.18 0 O-C-N 121.401 -0.812 . . . . 0.0 110.139 173.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.13 -44.09 92.03 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.886 0.874 . . . . 0.0 109.576 179.513 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -60.46 -42.78 96.88 Favored 'General case' 0 CA--C 1.522 -0.117 0 C-N-CA 123.559 0.743 . . . . 0.0 111.245 178.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -72.6 -10.22 59.53 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.366 0.666 . . . . 0.0 112.459 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -103.13 -33.75 9.11 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 125.315 1.446 . . . . 0.0 110.723 -179.203 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 88.4 mmm -130.12 -4.05 4.46 Favored 'General case' 0 C--N 1.341 0.203 0 N-CA-C 113.869 1.063 . . . . 0.0 113.869 -167.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.61 -11.41 15.51 Favored Glycine 0 CA--C 1.532 1.095 0 CA-C-N 119.954 1.252 . . . . 0.0 114.993 -173.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -67.05 -28.23 68.04 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 118.434 1.117 . . . . 0.0 111.595 172.012 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -120.8 -25.16 5.5 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 125.56 1.544 . . . . 0.0 111.686 -178.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 35.3 tp -102.58 159.6 15.31 Favored 'General case' 0 C--O 1.232 0.149 0 C-N-CA 124.202 1.001 . . . . 0.0 110.504 -170.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -132.68 143.54 49.71 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 104.326 -2.472 . . . . 0.0 104.326 167.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 67.5 mt -117.09 138.76 46.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 105.28 -2.118 . . . . 0.0 105.28 177.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 97.7 t -132.9 94.22 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 -169.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 27.9 mtpp -73.43 141.07 46.92 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 176.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 11.8 tt -142.73 126.86 15.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 178.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 57.4 t0 -86.25 104.61 15.95 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 124.783 1.233 . . . . 0.0 109.253 -170.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 26.1 m -61.79 -20.74 24.19 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-O 118.625 -0.702 . . . . 0.0 112.271 -176.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -67.6 -13.83 62.41 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 119.723 1.147 . . . . 0.0 111.958 177.345 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -124.23 3.28 8.54 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.666 1.187 . . . . 0.0 111.506 175.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 65.0 m-80 -141.65 41.25 1.72 Allowed 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 124.13 0.972 . . . . 0.0 111.29 -169.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 3.7 mp0 -52.89 -31.55 40.31 Favored 'General case' 0 CA--C 1.531 0.25 0 O-C-N 121.972 -0.455 . . . . 0.0 111.716 172.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -65.05 -50.76 64.92 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 123.905 0.882 . . . . 0.0 109.77 -178.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.34 -36.95 77.42 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.33 0.652 . . . . 0.0 109.839 -178.471 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.41 -45.99 89.96 Favored 'General case' 0 CA--C 1.534 0.365 0 O-C-N 120.834 -1.167 . . . . 0.0 110.669 171.295 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -63.5 -28.12 71.92 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 123.906 0.765 . . . . 0.0 112.189 177.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 74.0 tttt -56.15 -29.17 60.4 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.964 1.306 . . . . 0.0 111.613 179.202 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -123.82 6.17 8.74 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.291 0.636 . . . . 0.0 112.273 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 62.44 41.63 99.76 Favored Glycine 0 CA--C 1.53 0.99 0 N-CA-C 111.698 -0.561 . . . . 0.0 111.698 -175.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 95.2 t -63.38 94.3 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 124.852 1.261 . . . . 0.0 107.963 173.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 1.6 pmm? -73.77 -30.72 62.93 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 125.235 1.414 . . . . 0.0 112.452 -175.325 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 52.0 m -147.42 175.0 11.16 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 126.067 1.747 . . . . 0.0 109.653 -172.221 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 42.8 pt -137.2 154.87 76.02 Favored Pre-proline 0 CA--C 1.546 0.813 0 C-N-CA 125.045 1.338 . . . . 0.0 108.631 175.211 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -67.93 141.54 60.19 Favored 'Cis proline' 0 N--CA 1.458 -0.612 0 CA-C-N 120.467 1.203 . . . . 0.0 110.493 -4.215 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 18.4 m -135.88 137.51 41.51 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 175.016 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -114.79 133.39 55.96 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 -173.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -120.78 116.49 25.34 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 103.18 -2.896 . . . . 0.0 103.18 176.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.4 t -91.79 121.36 42.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 103.723 -2.695 . . . . 0.0 103.723 173.431 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.4 mp -110.51 155.28 22.48 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 175.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 26.4 ttpp -133.7 115.05 14.13 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 105.677 -1.971 . . . . 0.0 105.677 176.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 27.6 t0 50.09 39.98 20.55 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.675 1.19 . . . . 0.0 112.461 176.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 103.59 -4.22 46.82 Favored Glycine 0 CA--C 1.529 0.958 0 CA-C-O 118.184 -1.342 . . . . 0.0 115.345 168.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -132.27 150.2 52.21 Favored 'General case' 0 C--N 1.34 0.155 0 CA-C-N 120.056 1.928 . . . . 0.0 110.32 -178.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 22.1 t -62.99 134.66 28.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 -179.352 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.3 p -117.97 -27.67 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 C-N-CA 125.016 1.326 . . . . 0.0 110.169 174.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 40.8 mm-40 -150.22 163.14 39.01 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 120.201 1.364 . . . . 0.0 110.177 172.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 17.9 m -141.04 145.08 35.4 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.057 1.343 . . . . 0.0 108.44 176.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 20.0 m -144.74 151.99 39.7 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.389 1.476 . . . . 0.0 108.845 175.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 59.2 t -132.44 142.96 41.24 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 -177.059 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 79.14 179.5 52.02 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 123.876 0.751 . . . . 0.0 111.815 -178.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -57.96 144.76 38.29 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 123.391 0.676 . . . . 0.0 110.511 178.219 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -149.64 134.93 9.7 Favored Pre-proline 0 N--CA 1.453 -0.303 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 -175.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -74.39 156.81 45.7 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 122.12 1.88 . . . . 0.0 110.787 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 17.7 ptmt -56.9 -31.77 65.22 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 124.019 0.927 . . . . 0.0 112.266 177.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -66.09 -48.54 70.6 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 118.731 0.696 . . . . 0.0 110.011 179.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.94 -44.36 96.29 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 118.009 0.368 . . . . 0.0 110.335 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 83.3 mt -61.73 -42.68 99.27 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-O 119.465 -0.303 . . . . 0.0 110.505 178.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -61.62 -39.85 92.75 Favored 'General case' 0 C--O 1.222 -0.343 0 CA-C-O 118.132 -0.937 . . . . 0.0 111.268 175.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -64.11 -41.9 97.09 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 119.822 1.192 . . . . 0.0 110.421 178.385 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 88.8 mt -63.54 -38.63 91.87 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 122.904 0.482 . . . . 0.0 111.165 178.129 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 49.7 t -63.33 -51.26 73.26 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 C-N-CA 123.676 0.79 . . . . 0.0 109.542 171.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -59.63 -40.76 88.69 Favored 'General case' 0 C--N 1.332 -0.153 0 C-N-CA 125.907 1.683 . . . . 0.0 111.503 -169.407 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 13.7 ptmm? -69.5 -6.63 31.89 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 118.155 -0.926 . . . . 0.0 113.16 -177.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 93.6 m-70 -124.96 -15.4 6.4 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 177.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 19.7 mt . . . . . 0 C--O 1.249 1.076 0 CA-C-N 119.563 1.074 . . . . 0.0 109.371 169.404 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.0 mtt . . . . . 0 N--CA 1.479 1.004 0 CA-C-O 118.981 -0.533 . . . . 0.0 109.907 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -161.17 -172.43 3.42 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.607 1.563 . . . . 0.0 108.436 -174.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.6 mt -74.95 143.54 13.23 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 166.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 21.4 t -133.95 159.56 42.31 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 C-N-CA 126.221 1.808 . . . . 0.0 106.498 -176.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -115.2 128.44 56.17 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 105.428 -2.064 . . . . 0.0 105.428 178.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -138.5 166.76 23.48 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 121.576 0.703 . . . . 0.0 112.313 -173.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 36.4 p -137.09 179.24 6.5 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 125.648 1.579 . . . . 0.0 107.715 171.105 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -49.14 -29.8 5.85 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.25 1.02 . . . . 0.0 112.706 170.18 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -63.04 -27.54 69.47 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.007 1.323 . . . . 0.0 112.805 179.341 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 13.6 p -132.08 -20.22 2.48 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 -167.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 56.4 t80 -51.98 -47.52 64.81 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 124.767 1.227 . . . . 0.0 112.534 -169.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.3 m -64.6 -38.57 91.47 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 122.666 0.386 . . . . 0.0 111.665 -175.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -68.04 -45.01 75.12 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 176.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 -62.9 -36.5 83.58 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 119.301 -0.38 . . . . 0.0 111.082 -177.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.8 p -83.75 -0.04 49.24 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 113.526 0.936 . . . . 0.0 113.526 -177.059 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 70.3 m -102.6 31.34 4.14 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.986 0.914 . . . . 0.0 111.494 -175.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -132.35 53.04 2.03 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.181 0.992 . . . . 0.0 110.781 -175.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 99.62 -156.21 19.79 Favored Glycine 0 C--N 1.338 0.655 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 176.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 90.0 t -70.18 136.43 26.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 167.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 60.6 t -139.59 147.13 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 N-CA-C 105.576 -2.009 . . . . 0.0 105.576 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.1 tt -125.17 99.0 5.89 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 -175.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -80.26 147.44 31.19 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 123.258 0.623 . . . . 0.0 109.548 -179.162 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -129.44 93.94 3.66 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 126.126 1.77 . . . . 0.0 108.163 -174.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -75.17 112.58 11.58 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 106.321 -1.733 . . . . 0.0 106.321 174.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -149.46 -176.57 5.44 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.775 1.23 . . . . 0.0 108.218 -173.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -156.67 149.1 17.86 Favored Pre-proline 0 CA--C 1.531 0.239 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 167.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -60.85 -19.13 60.57 Favored 'Trans proline' 0 N--CA 1.46 -0.47 0 C-N-CA 121.568 1.512 . . . . 0.0 115.43 179.134 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 48.5 p-90 -69.72 -20.06 63.54 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 119.926 1.239 . . . . 0.0 111.927 173.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 25.4 t -59.62 147.83 35.88 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.932 1.293 . . . . 0.0 111.072 -172.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -96.91 -63.62 0.92 Allowed Glycine 0 CA--C 1.529 0.94 0 CA-C-O 118.479 -1.178 . . . . 0.0 110.862 171.376 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -62.68 -26.2 75.38 Favored 'Trans proline' 0 C--N 1.349 0.605 0 CA-C-N 120.314 2.057 . . . . 0.0 113.543 -174.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 35.1 m -57.65 -34.34 69.26 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 118.653 0.66 . . . . 0.0 111.471 174.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.9 mmtp -67.88 -25.28 65.44 Favored 'General case' 0 CA--C 1.531 0.236 0 O-C-N 121.553 -0.717 . . . . 0.0 110.921 -179.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 31.0 mtm -71.91 -42.81 66.28 Favored 'General case' 0 C--N 1.34 0.16 0 CA-C-N 118.696 0.68 . . . . 0.0 110.444 176.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 13.5 tt -84.05 -21.73 8.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-O 118.826 -0.607 . . . . 0.0 111.56 -175.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -48.82 -51.8 51.25 Favored Pre-proline 0 CA--C 1.546 0.819 0 CA-C-N 119.994 1.27 . . . . 0.0 113.643 177.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -67.27 -29.0 39.4 Favored 'Trans proline' 0 C--N 1.351 0.682 0 CA-C-N 121.756 1.663 . . . . 0.0 112.555 176.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 31.4 t -65.48 -40.24 87.61 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 174.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 76.9 mt -67.78 -35.54 78.86 Favored 'General case' 0 C--O 1.224 -0.238 0 CA-C-N 119.299 0.954 . . . . 0.0 111.482 173.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -62.38 -42.27 99.28 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 119.549 1.068 . . . . 0.0 110.736 172.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -65.03 -39.38 93.3 Favored 'General case' 0 CA--C 1.532 0.265 0 O-C-N 121.28 -0.887 . . . . 0.0 110.505 175.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.24 -46.37 90.02 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.638 0.775 . . . . 0.0 109.348 175.486 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -58.88 -42.94 90.69 Favored 'General case' 0 CA--C 1.521 -0.144 0 C-N-CA 123.833 0.853 . . . . 0.0 111.279 179.386 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -70.79 -10.47 59.58 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.428 0.691 . . . . 0.0 112.607 179.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 58.2 mt-10 -106.16 -30.62 9.12 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 125.601 1.56 . . . . 0.0 111.46 -177.511 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 91.6 mmm -127.62 -5.38 5.83 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 -171.511 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.81 -10.69 14.21 Favored Glycine 0 CA--C 1.531 1.036 0 CA-C-N 119.828 1.194 . . . . 0.0 114.854 -174.106 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -65.41 -28.48 69.28 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 118.509 1.154 . . . . 0.0 111.51 171.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -123.31 -25.84 4.38 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 125.427 1.491 . . . . 0.0 111.639 -179.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 31.6 tp -100.07 161.61 13.5 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 124.306 1.042 . . . . 0.0 110.385 -170.244 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -135.95 144.6 45.53 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 104.447 -2.427 . . . . 0.0 104.447 168.066 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 59.9 mt -116.65 139.32 43.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 105.489 -2.041 . . . . 0.0 105.489 176.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 93.2 t -132.98 96.31 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 -169.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -74.39 138.02 43.1 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 178.175 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 13.4 tt -141.4 128.73 21.32 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 177.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 64.6 t0 -87.94 106.68 18.27 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.603 1.161 . . . . 0.0 109.797 -169.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 31.3 m -62.08 -19.02 20.92 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 CA-C-O 118.693 -0.67 . . . . 0.0 112.473 -176.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -67.2 -15.72 63.87 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 119.685 1.129 . . . . 0.0 112.105 176.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -127.21 1.86 6.42 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.306 1.042 . . . . 0.0 111.863 179.155 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 63.8 m-80 -137.63 40.52 2.39 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.732 0.813 . . . . 0.0 111.447 -169.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 5.5 mp0 -54.41 -32.58 57.59 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.056 0.542 . . . . 0.0 111.781 174.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 32.9 mm-40 -65.73 -48.96 70.17 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 118.514 0.597 . . . . 0.0 110.136 -179.07 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.39 -37.82 80.76 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.036 0.534 . . . . 0.0 109.927 -178.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.4 -48.59 81.08 Favored 'General case' 0 CA--C 1.535 0.372 0 O-C-N 121.064 -1.022 . . . . 0.0 110.363 172.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -60.62 -27.67 66.58 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 124.225 0.916 . . . . 0.0 112.334 177.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 47.3 tttp -55.52 -29.11 58.29 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.84 1.256 . . . . 0.0 111.726 178.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -123.54 10.8 9.15 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.554 0.742 . . . . 0.0 111.732 179.242 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 64.12 30.44 77.78 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 123.649 0.642 . . . . 0.0 112.629 -176.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 61.5 t -65.44 125.8 23.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 171.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 67.0 mtt -136.36 3.84 2.86 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.811 1.244 . . . . 0.0 111.465 -179.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 24.2 m -144.05 161.79 37.88 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 126.591 1.957 . . . . 0.0 107.697 179.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 42.5 pt -141.56 154.51 66.59 Favored Pre-proline 0 CA--C 1.545 0.774 0 C-N-CA 124.424 1.09 . . . . 0.0 108.811 176.141 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -67.42 140.02 50.34 Favored 'Cis proline' 0 C--N 1.349 0.586 0 CA-C-N 120.356 1.163 . . . . 0.0 110.385 -4.278 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 42.4 m -132.71 142.24 48.96 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 173.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 91.6 mt -125.21 129.46 50.15 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 107.37 -1.345 . . . . 0.0 107.37 -169.259 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -119.84 118.49 30.92 Favored 'General case' 0 CA--C 1.513 -0.476 0 N-CA-C 103.27 -2.863 . . . . 0.0 103.27 178.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 4.5 t -88.6 122.83 40.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 103.007 -2.96 . . . . 0.0 103.007 172.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.2 mp -112.05 157.42 20.78 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 174.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 89.1 tttt -136.42 124.51 22.96 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 106.304 -1.739 . . . . 0.0 106.304 169.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.0 t70 49.22 38.02 12.48 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.909 1.284 . . . . 0.0 112.389 175.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 100.87 -2.4 55.55 Favored Glycine 0 CA--C 1.53 0.979 0 CA-C-O 118.15 -1.361 . . . . 0.0 115.167 169.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -131.96 152.54 51.04 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 120.174 1.987 . . . . 0.0 110.284 -179.15 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 22.0 t -62.92 134.52 28.12 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 -179.252 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.5 p -120.14 -24.23 3.03 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 C-N-CA 125.471 1.508 . . . . 0.0 109.958 176.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -158.79 172.2 18.68 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 120.262 1.392 . . . . 0.0 109.601 173.656 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 26.5 m -148.87 153.15 37.65 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 120.555 -1.34 . . . . 0.0 109.543 -179.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 48.4 m -150.22 154.44 37.95 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.218 1.407 . . . . 0.0 109.051 169.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 40.9 t -133.59 142.17 42.32 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 -177.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 75.69 -177.9 48.92 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 123.43 0.538 . . . . 0.0 111.838 -178.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 59.2 t80 -59.52 143.97 48.62 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 123.238 0.615 . . . . 0.0 110.683 179.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -150.27 137.12 11.23 Favored Pre-proline 0 C--O 1.234 0.267 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 -176.502 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -73.12 153.83 51.97 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 122.009 1.806 . . . . 0.0 110.486 176.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 57.6 pttt -60.79 -31.61 70.97 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 118.897 -0.573 . . . . 0.0 111.818 -178.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -66.45 -42.5 87.53 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.279 0.632 . . . . 0.0 110.438 -179.179 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.18 -44.48 88.32 Favored 'General case' 0 C--O 1.232 0.16 0 O-C-N 121.961 -0.462 . . . . 0.0 109.898 179.148 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 92.0 mt -62.61 -40.22 96.25 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.582 177.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -60.4 -41.19 93.34 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-O 118.577 -0.725 . . . . 0.0 111.498 174.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -63.39 -42.71 98.83 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 118.924 0.784 . . . . 0.0 110.007 176.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 40.7 mt -63.65 -41.62 98.19 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 118.739 0.699 . . . . 0.0 111.382 177.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 43.1 t -57.51 -49.34 80.68 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 C-N-CA 123.546 0.738 . . . . 0.0 109.239 171.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -63.05 -31.44 72.58 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.403 1.481 . . . . 0.0 111.964 -173.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -58.67 -24.73 61.83 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 118.236 -0.888 . . . . 0.0 112.213 174.397 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 82.3 m-70 -125.69 -14.56 6.23 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 113.863 1.06 . . . . 0.0 113.863 -168.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 23.8 mt . . . . . 0 C--O 1.247 0.964 0 CA-C-N 119.692 1.133 . . . . 0.0 109.125 168.975 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 44.7 tpp . . . . . 0 N--CA 1.483 1.185 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -143.82 -173.73 4.06 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.536 1.134 . . . . 0.0 110.527 -170.001 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 7.6 mt -69.95 145.6 12.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 168.34 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 38.7 t -135.0 164.1 34.68 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 C-N-CA 127.065 2.146 . . . . 0.0 106.082 -179.291 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 6.2 ttmt -120.85 146.22 46.79 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 175.016 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -146.48 167.78 22.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.335 0.588 . . . . 0.0 111.104 -176.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 16.0 p -132.57 170.62 14.91 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 126.394 1.878 . . . . 0.0 107.896 171.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -52.97 -29.76 30.95 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.034 0.933 . . . . 0.0 113.125 -179.096 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 56.6 mt-30 -62.47 -28.98 70.19 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.124 1.37 . . . . 0.0 112.933 179.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.6 m -136.33 -5.89 2.04 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 113.517 0.932 . . . . 0.0 113.517 -169.191 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 81.9 t80 -53.43 -44.01 68.46 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.174 0.99 . . . . 0.0 111.281 -178.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.2 m -62.89 -39.06 93.33 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.252 0.621 . . . . 0.0 111.935 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.77 -43.89 82.82 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 122.697 0.399 . . . . 0.0 109.993 178.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -64.53 -41.54 96.31 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 122.235 0.214 . . . . 0.0 110.709 -179.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 36.3 p -79.47 -3.65 47.59 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 124.308 1.043 . . . . 0.0 113.544 -176.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 74.7 m -75.07 -21.4 59.01 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 176.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -88.02 71.74 9.32 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 121.55 -0.719 . . . . 0.0 111.586 -169.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 84.13 -152.75 28.58 Favored Glycine 0 C--N 1.336 0.566 0 N-CA-C 110.304 -1.118 . . . . 0.0 110.304 173.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 63.2 t -70.7 134.36 30.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 169.114 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 61.6 t -139.09 138.81 41.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 105.786 -1.931 . . . . 0.0 105.786 179.34 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.9 tt -117.37 104.31 11.0 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 -177.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -89.45 147.1 24.2 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 -177.308 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -127.42 94.13 3.9 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 125.551 1.54 . . . . 0.0 107.333 -175.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -74.46 112.77 10.96 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 105.68 -1.971 . . . . 0.0 105.68 174.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -149.41 -174.94 4.81 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 124.911 1.284 . . . . 0.0 108.095 -172.056 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -152.77 148.78 20.95 Favored Pre-proline 0 N--CA 1.453 -0.285 0 N-CA-C 105.83 -1.915 . . . . 0.0 105.83 167.174 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -68.21 -11.89 33.39 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 CA-C-N 121.101 1.429 . . . . 0.0 112.855 178.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 1.3 m95 -77.22 -12.34 59.94 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.775 0.83 . . . . 0.0 111.814 172.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 17.4 t -64.65 160.95 18.69 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.353 1.461 . . . . 0.0 110.834 -178.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -115.52 -58.02 0.34 Allowed Glycine 0 CA--C 1.531 1.046 0 CA-C-O 118.631 -1.094 . . . . 0.0 111.069 171.436 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -56.22 -33.63 91.29 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 123.506 2.804 . . . . 0.0 113.395 178.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 23.0 m -58.4 -33.71 69.94 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 121.705 -0.622 . . . . 0.0 111.555 176.34 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.5 mmtp -68.5 -22.24 64.55 Favored 'General case' 0 CA--C 1.531 0.238 0 O-C-N 121.499 -0.75 . . . . 0.0 111.086 -179.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 35.3 mtm -70.15 -43.27 71.23 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-N 118.731 0.696 . . . . 0.0 110.298 175.346 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 18.2 tt -85.2 -23.7 7.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-O 118.379 -0.82 . . . . 0.0 111.701 -176.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -49.04 -50.19 64.47 Favored Pre-proline 0 CA--C 1.549 0.914 0 CA-C-N 120.407 1.458 . . . . 0.0 114.516 179.038 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -66.13 -30.64 46.6 Favored 'Trans proline' 0 C--N 1.351 0.666 0 CA-C-N 121.636 1.62 . . . . 0.0 111.682 176.449 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.6 t -66.03 -39.81 85.55 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-O 118.305 -0.855 . . . . 0.0 109.449 174.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 94.7 mt -62.53 -37.66 86.95 Favored 'General case' 0 C--N 1.34 0.185 0 CA-C-N 119.916 1.235 . . . . 0.0 110.874 173.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -63.02 -45.4 92.5 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 119.411 1.005 . . . . 0.0 110.978 173.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 50.8 mm-40 -65.26 -37.33 86.87 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 120.923 -1.111 . . . . 0.0 110.83 178.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -63.94 -42.99 97.19 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 125.154 1.382 . . . . 0.0 109.392 176.156 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -58.5 -43.59 89.14 Favored 'General case' 0 CA--C 1.521 -0.137 0 C-N-CA 123.941 0.896 . . . . 0.0 111.203 176.014 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -70.26 -12.8 61.84 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -179.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -102.25 -33.38 9.64 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 125.228 1.411 . . . . 0.0 111.088 -179.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 79.5 mmm -119.49 -5.61 10.29 Favored 'General case' 0 N--CA 1.461 0.117 0 CA-C-O 118.584 -0.722 . . . . 0.0 112.837 -168.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -61.4 -8.01 11.86 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 124.583 1.087 . . . . 0.0 115.574 -173.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -75.53 -26.41 58.04 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 118.736 1.268 . . . . 0.0 111.365 171.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 50.8 mmtt -118.15 -24.29 7.04 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 125.503 1.521 . . . . 0.0 111.684 -176.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 47.4 tp -116.4 152.99 32.85 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 124.379 1.072 . . . . 0.0 112.056 -167.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -119.41 142.15 48.47 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 104.986 -2.227 . . . . 0.0 104.986 166.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 75.8 mt -110.94 140.28 30.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 105.667 -1.975 . . . . 0.0 105.667 172.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 97.3 t -131.79 98.35 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -175.095 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -75.09 140.48 43.48 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 174.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 13.7 tt -142.88 124.77 12.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 178.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -82.68 105.31 13.61 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 124.594 1.158 . . . . 0.0 108.832 -173.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 31.0 m -60.12 -25.58 33.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 118.536 -0.745 . . . . 0.0 111.959 -175.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -65.71 -18.01 65.02 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 119.597 1.089 . . . . 0.0 112.047 -177.252 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -118.69 3.51 11.68 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.893 1.277 . . . . 0.0 111.132 177.392 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -139.81 40.46 2.0 Allowed 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 124.563 1.145 . . . . 0.0 109.758 -170.179 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 50.5 mm-40 -55.54 -32.42 62.93 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.907 0.883 . . . . 0.0 111.024 176.388 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 33.1 mm-40 -65.33 -48.27 73.61 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 118.411 0.551 . . . . 0.0 110.255 178.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.43 -40.27 85.48 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.235 0.614 . . . . 0.0 109.927 -178.561 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.98 -47.33 86.27 Favored 'General case' 0 CA--C 1.533 0.293 0 O-C-N 121.541 -0.725 . . . . 0.0 110.76 173.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -62.9 -29.01 72.87 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 123.554 0.597 . . . . 0.0 111.944 177.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 17.9 ttmt -55.6 -29.87 59.9 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 125.837 1.655 . . . . 0.0 111.999 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -123.67 7.9 8.85 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 123.491 0.717 . . . . 0.0 112.197 -179.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 63.09 41.41 99.78 Favored Glycine 0 CA--C 1.53 0.996 0 CA-C-N 118.329 0.513 . . . . 0.0 111.857 -176.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 88.3 t -66.07 91.52 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 C-N-CA 124.71 1.204 . . . . 0.0 107.774 174.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 25.1 ptt? -73.57 -28.12 61.68 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 124.707 1.203 . . . . 0.0 112.94 -176.138 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 34.4 m -146.72 174.85 11.08 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 125.973 1.709 . . . . 0.0 109.491 -170.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 41.6 pt -139.49 156.56 71.42 Favored Pre-proline 0 CA--C 1.545 0.752 0 C-N-CA 125.169 1.388 . . . . 0.0 108.669 174.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -67.46 138.97 44.99 Favored 'Cis proline' 0 C--N 1.349 0.561 0 CA-C-N 120.577 1.242 . . . . 0.0 110.13 -5.08 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 23.4 m -132.91 135.23 45.43 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 176.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 10.8 mp -114.81 125.68 53.96 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 -169.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -115.41 122.63 46.4 Favored 'General case' 0 CA--C 1.515 -0.393 0 N-CA-C 103.708 -2.701 . . . . 0.0 103.708 177.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 4.3 t -92.87 125.7 45.41 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.481 0 N-CA-C 103.655 -2.72 . . . . 0.0 103.655 169.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.2 mp -114.08 152.17 31.44 Favored 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 172.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -137.96 126.16 23.03 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 174.414 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 32.2 t70 50.86 33.17 8.21 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.976 1.31 . . . . 0.0 112.264 178.139 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 100.65 0.06 55.41 Favored Glycine 0 CA--C 1.531 1.059 0 CA-C-O 118.207 -1.33 . . . . 0.0 114.965 169.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -128.51 150.46 50.16 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 120.002 1.901 . . . . 0.0 109.929 179.218 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 47.1 t -62.09 132.62 27.87 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 175.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.6 p -119.53 -21.75 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 C-N-CA 125.129 1.372 . . . . 0.0 109.79 178.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -159.65 165.01 33.57 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 120.184 1.356 . . . . 0.0 110.751 171.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 10.7 m -136.32 150.82 49.05 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.255 1.422 . . . . 0.0 108.916 176.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 73.3 m -150.67 156.83 42.12 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.885 1.674 . . . . 0.0 108.696 170.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 47.5 t -133.49 145.3 33.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 -176.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 79.43 178.32 51.06 Favored Glycine 0 CA--C 1.53 1.025 0 C-N-CA 123.928 0.775 . . . . 0.0 112.706 175.253 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -60.06 148.35 36.05 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 123.798 0.839 . . . . 0.0 111.017 179.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -149.29 136.7 11.15 Favored Pre-proline 0 CA--C 1.534 0.334 0 C-N-CA 125.492 1.517 . . . . 0.0 107.084 -178.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -69.3 158.98 55.52 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 122.019 1.813 . . . . 0.0 111.04 177.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -55.06 -43.19 73.64 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 124.799 1.24 . . . . 0.0 112.739 -178.031 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -61.49 -44.08 97.72 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.009 0.524 . . . . 0.0 110.257 178.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.49 -36.51 82.92 Favored 'General case' 0 CA--C 1.528 0.129 0 O-C-N 121.865 -0.522 . . . . 0.0 111.017 178.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 92.4 mt -62.98 -42.11 99.74 Favored 'General case' 0 N--CA 1.456 -0.14 0 O-C-N 122.134 -0.353 . . . . 0.0 110.91 173.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -60.55 -39.8 89.27 Favored 'General case' 0 C--O 1.224 -0.284 0 CA-C-O 118.712 -0.661 . . . . 0.0 110.178 175.18 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -65.75 -40.9 92.56 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 119.02 0.827 . . . . 0.0 110.601 178.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 60.4 tp -60.44 -37.51 81.18 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 125.406 1.482 . . . . 0.0 110.958 177.22 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 92.9 t -69.38 -51.63 40.64 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 123.509 0.724 . . . . 0.0 109.698 171.321 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -58.27 -38.14 76.37 Favored 'General case' 0 C--N 1.334 -0.101 0 C-N-CA 125.939 1.695 . . . . 0.0 112.099 -168.135 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -65.42 -8.49 19.11 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 113.342 0.867 . . . . 0.0 113.342 -178.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -120.91 -10.46 9.1 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 124.293 1.037 . . . . 0.0 113.062 178.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 55.8 mt . . . . . 0 C--O 1.248 0.996 0 CA-C-N 119.204 0.911 . . . . 0.0 109.314 173.562 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.1 mmt . . . . . 0 N--CA 1.484 1.233 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -151.97 -174.59 4.91 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.041 1.336 . . . . 0.0 109.211 -174.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.9 mt -75.67 143.79 12.77 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 167.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 40.8 t -138.07 163.88 28.71 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 126.284 1.834 . . . . 0.0 107.345 -174.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -115.29 146.07 41.86 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 174.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -147.94 167.57 24.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.31 0.576 . . . . 0.0 111.253 -179.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 18.0 p -136.25 172.26 13.27 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 126.253 1.821 . . . . 0.0 106.98 168.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -49.88 -28.53 6.68 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.824 0.85 . . . . 0.0 113.073 174.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -56.86 -31.98 65.36 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.619 1.568 . . . . 0.0 112.933 178.447 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 14.8 m -142.26 -4.78 1.0 Allowed 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -169.223 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -54.35 -41.67 69.39 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.98 0.912 . . . . 0.0 111.724 -176.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.2 p -59.96 -45.73 91.72 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 124.01 0.924 . . . . 0.0 111.747 177.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.2 -43.72 94.17 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 122.719 0.408 . . . . 0.0 110.284 178.069 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -63.4 -35.85 81.77 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 119.475 -0.298 . . . . 0.0 111.076 -179.255 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 29.1 p -85.5 3.58 39.72 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.094 0.957 . . . . 0.0 113.253 -176.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 60.5 m -106.43 30.78 5.69 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.165 0.986 . . . . 0.0 111.684 -176.344 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -132.5 37.91 3.48 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.573 0.749 . . . . 0.0 112.313 -174.149 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 121.04 -153.52 16.6 Favored Glycine 0 C--N 1.335 0.52 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 175.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 53.5 t -74.45 133.95 30.5 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 N-CA-C 105.011 -2.218 . . . . 0.0 105.011 166.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 43.2 t -137.03 133.81 47.76 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 N-CA-C 105.896 -1.89 . . . . 0.0 105.896 -178.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 5.1 tt -116.89 101.18 8.31 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 106.138 -1.801 . . . . 0.0 106.138 -177.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -81.82 145.8 30.22 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.342 179.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -126.15 94.17 4.02 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 125.918 1.687 . . . . 0.0 107.444 -177.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -73.1 112.85 9.52 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 105.936 -1.875 . . . . 0.0 105.936 174.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -149.38 -176.68 5.48 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.88 1.272 . . . . 0.0 108.403 -172.207 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -151.95 147.92 20.7 Favored Pre-proline 0 C--O 1.233 0.213 0 N-CA-C 105.545 -2.02 . . . . 0.0 105.545 167.228 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -68.03 -11.64 32.67 Favored 'Trans proline' 0 CA--C 1.534 0.498 0 CA-C-N 121.1 1.429 . . . . 0.0 113.276 -178.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 1.6 m95 -75.77 -13.7 60.3 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.637 0.775 . . . . 0.0 111.803 172.35 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 23.0 t -63.4 158.21 21.21 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.438 1.495 . . . . 0.0 110.971 -178.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -113.22 -57.82 0.41 Allowed Glycine 0 CA--C 1.531 1.065 0 CA-C-O 118.581 -1.121 . . . . 0.0 111.05 171.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -55.96 -33.76 90.06 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 123.366 2.711 . . . . 0.0 113.575 178.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 23.4 m -58.04 -34.15 69.76 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.271 0.628 . . . . 0.0 111.537 176.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.4 mmtp -68.5 -22.6 64.53 Favored 'General case' 0 CA--C 1.531 0.242 0 O-C-N 121.471 -0.768 . . . . 0.0 111.094 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 33.4 mtm -71.07 -42.85 68.84 Favored 'General case' 0 C--N 1.34 0.172 0 CA-C-N 118.841 0.746 . . . . 0.0 110.33 176.339 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 16.6 tt -85.29 -24.64 6.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-O 118.557 -0.735 . . . . 0.0 111.701 -175.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -48.85 -50.27 62.47 Favored Pre-proline 0 CA--C 1.549 0.912 0 CA-C-N 120.062 1.301 . . . . 0.0 114.219 178.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -67.08 -28.94 40.68 Favored 'Trans proline' 0 C--N 1.35 0.626 0 CA-C-N 121.774 1.669 . . . . 0.0 111.977 176.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.1 t -66.43 -40.89 87.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 CA-C-O 118.614 -0.708 . . . . 0.0 109.27 173.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 94.6 mt -63.23 -37.27 86.59 Favored 'General case' 0 C--N 1.34 0.188 0 CA-C-N 119.504 1.047 . . . . 0.0 110.855 174.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -62.37 -43.78 98.01 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 119.356 0.98 . . . . 0.0 111.107 173.02 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -62.74 -39.04 92.86 Favored 'General case' 0 CA--C 1.535 0.374 0 O-C-N 121.185 -0.947 . . . . 0.0 110.286 175.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.96 -43.65 98.22 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 124.556 1.142 . . . . 0.0 110.069 177.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -59.43 -42.71 92.51 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 123.679 0.792 . . . . 0.0 110.842 176.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -71.49 -10.61 60.04 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -179.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -106.6 -28.35 10.3 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 125.517 1.527 . . . . 0.0 111.651 -178.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 23.0 mtp -130.48 1.76 4.55 Favored 'General case' 0 N--CA 1.462 0.156 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -169.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -56.93 -11.63 6.09 Favored Glycine 0 CA--C 1.533 1.19 0 N-CA-C 115.993 1.157 . . . . 0.0 115.993 -175.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -78.58 -25.99 45.43 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 118.893 1.347 . . . . 0.0 111.778 173.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 52.1 mmtt -117.13 -19.8 9.54 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 125.468 1.507 . . . . 0.0 111.734 -176.031 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 57.1 tp -124.97 144.85 50.15 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 124.68 1.192 . . . . 0.0 110.668 -168.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -116.75 145.87 43.2 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 105.183 -2.154 . . . . 0.0 105.183 167.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 68.1 mt -115.83 140.24 38.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 105.768 -1.938 . . . . 0.0 105.768 175.179 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 80.8 t -132.84 98.23 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 -171.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -74.17 140.33 45.08 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 174.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 13.6 tt -143.49 124.97 11.09 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 178.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 61.0 t0 -83.89 106.63 15.71 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 124.401 1.08 . . . . 0.0 108.883 -172.331 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 33.0 m -59.81 -25.11 31.28 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 CA-C-O 118.444 -0.788 . . . . 0.0 112.072 -175.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -65.29 -18.6 65.44 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 119.646 1.112 . . . . 0.0 112.026 -178.556 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -118.7 4.53 11.6 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.041 1.337 . . . . 0.0 110.948 177.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 68.6 m-80 -140.5 38.72 1.87 Allowed 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 124.383 1.073 . . . . 0.0 110.151 -169.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 55.1 mm-40 -56.05 -33.27 64.83 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.295 0.638 . . . . 0.0 110.849 174.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -66.52 -47.93 71.36 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 118.3 0.5 . . . . 0.0 110.284 178.127 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.96 -40.86 91.68 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 118.65 0.659 . . . . 0.0 110.0 -179.236 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.35 -50.35 74.29 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.361 0.664 . . . . 0.0 110.1 174.08 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -60.37 -28.39 67.11 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 123.879 0.752 . . . . 0.0 112.334 177.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 21.9 ttmt -55.05 -29.48 57.56 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 125.565 1.546 . . . . 0.0 111.898 178.16 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -124.12 11.07 8.82 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.846 0.858 . . . . 0.0 111.71 178.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 67.38 24.42 73.63 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 123.914 0.768 . . . . 0.0 113.214 -177.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 48.9 t -63.65 129.62 27.53 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 171.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 35.0 ttm -142.64 4.37 1.52 Allowed 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.269 1.028 . . . . 0.0 111.278 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 22.8 m -142.6 161.58 37.7 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 126.697 1.999 . . . . 0.0 107.539 178.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 43.0 pt -143.0 156.45 61.95 Favored Pre-proline 0 CA--C 1.545 0.76 0 C-N-CA 124.588 1.155 . . . . 0.0 108.921 178.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -66.9 139.18 44.28 Favored 'Cis proline' 0 C--N 1.348 0.547 0 CA-C-N 120.423 1.187 . . . . 0.0 110.18 -5.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 33.1 m -131.37 139.1 49.42 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 174.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 83.7 mt -119.82 128.55 53.8 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 -169.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -117.86 124.32 48.04 Favored 'General case' 0 CA--C 1.516 -0.354 0 N-CA-C 103.973 -2.603 . . . . 0.0 103.973 177.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 15.9 t -96.38 122.68 48.12 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 N-CA-C 104.118 -2.549 . . . . 0.0 104.118 173.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.9 mp -116.16 152.45 33.67 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 175.317 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 57.8 tttp -135.02 121.83 20.97 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 173.123 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.4 t70 48.66 37.13 8.83 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.889 1.275 . . . . 0.0 112.264 175.469 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 99.07 2.1 57.02 Favored Glycine 0 CA--C 1.53 0.971 0 CA-C-O 117.954 -1.47 . . . . 0.0 115.283 169.539 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -122.1 145.55 48.06 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 120.292 2.046 . . . . 0.0 109.323 175.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 58.5 t -65.79 130.85 31.47 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 170.218 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 35.4 m -119.45 -19.27 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 CA-C-O 117.717 -1.135 . . . . 0.0 111.314 175.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -155.21 167.93 28.75 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 120.444 1.475 . . . . 0.0 111.191 173.345 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 14.3 m -141.84 151.11 42.45 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.767 1.627 . . . . 0.0 108.698 177.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 58.8 m -150.16 156.27 41.31 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.514 1.525 . . . . 0.0 108.57 169.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 42.3 t -133.62 144.91 34.54 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 -178.237 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 78.22 -175.86 54.43 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 123.695 0.664 . . . . 0.0 111.817 179.102 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -62.56 147.17 49.9 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.371 0.669 . . . . 0.0 110.415 177.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 58.6 mttt -142.22 138.0 16.25 Favored Pre-proline 0 C--O 1.234 0.281 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 168.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -68.6 165.09 30.54 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 122.134 1.889 . . . . 0.0 111.029 177.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -53.77 -44.04 69.72 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 125.531 1.532 . . . . 0.0 112.698 -178.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -63.78 -43.71 95.53 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.097 177.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.77 -38.49 86.66 Favored 'General case' 0 C--N 1.339 0.12 0 O-C-N 121.776 -0.577 . . . . 0.0 110.58 -179.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 51.9 mt -62.22 -45.87 91.42 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 123.511 0.724 . . . . 0.0 110.746 175.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 11.3 mt-30 -58.92 -41.0 86.26 Favored 'General case' 0 C--O 1.225 -0.19 0 CA-C-N 118.383 0.538 . . . . 0.0 110.769 175.214 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -65.9 -39.92 91.03 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 118.875 0.761 . . . . 0.0 110.81 179.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 67.8 tp -62.54 -36.38 82.42 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.339 1.456 . . . . 0.0 111.181 177.096 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 84.2 t -69.11 -47.88 72.36 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-N 118.572 0.623 . . . . 0.0 109.857 169.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -57.18 -40.6 77.66 Favored 'General case' 0 CA--C 1.521 -0.155 0 C-N-CA 125.498 1.519 . . . . 0.0 111.893 -168.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -65.52 -6.44 10.75 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 -178.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -126.59 0.4 6.84 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 124.526 1.13 . . . . 0.0 113.426 176.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 54.7 mt . . . . . 0 C--O 1.247 0.955 0 CA-C-N 119.462 1.028 . . . . 0.0 109.004 171.35 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.4 ptt? . . . . . 0 N--CA 1.481 1.104 0 CA-C-O 118.563 -0.732 . . . . 0.0 112.762 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -158.04 -175.64 5.47 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 119.799 1.181 . . . . 0.0 109.413 -169.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.6 mt -75.89 144.34 12.05 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 167.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 47.3 t -140.34 164.3 22.36 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 C-N-CA 127.049 2.14 . . . . 0.0 106.99 -173.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 3.7 tppp? -113.87 147.37 38.57 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 175.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -146.85 168.91 20.25 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 123.109 0.564 . . . . 0.0 110.535 175.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 33.2 p -136.03 177.73 7.61 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 125.929 1.691 . . . . 0.0 107.961 170.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -42.75 -37.85 1.9 Allowed 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.3 1.44 . . . . 0.0 112.836 169.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 50.8 mm-40 -73.88 -26.24 60.45 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.805 0.842 . . . . 0.0 113.03 -174.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 14.3 p -121.74 -19.77 6.68 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 -169.413 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -53.82 -45.85 70.97 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 124.54 1.136 . . . . 0.0 111.925 -171.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.6 m -65.7 -23.96 66.88 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 112.937 0.717 . . . . 0.0 112.937 -177.14 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -90.66 -28.68 18.21 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 124.086 0.954 . . . . 0.0 111.443 176.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 68.9 mm-40 -70.81 -32.63 69.77 Favored 'General case' 0 N--CA 1.453 -0.325 0 O-C-N 121.797 -0.564 . . . . 0.0 110.829 173.266 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 22.9 p -88.71 4.56 46.9 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 113.847 1.055 . . . . 0.0 113.847 -170.277 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 30.4 p -108.67 29.16 7.68 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.336 1.054 . . . . 0.0 112.339 -174.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -129.32 50.73 2.12 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.218 1.007 . . . . 0.0 110.954 -174.357 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 103.68 -155.37 17.82 Favored Glycine 0 C--N 1.337 0.625 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 178.26 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 45.1 t -71.53 138.22 22.12 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 N-CA-C 105.694 -1.965 . . . . 0.0 105.694 167.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 47.3 t -138.22 139.25 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 N-CA-C 105.739 -1.949 . . . . 0.0 105.739 179.316 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 61.1 tp -122.6 101.72 7.64 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 106.703 -1.592 . . . . 0.0 106.703 -176.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -83.27 151.28 25.68 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 179.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -130.4 94.21 3.62 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 126.482 1.913 . . . . 0.0 107.242 -178.51 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -74.2 114.46 12.57 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 105.704 -1.962 . . . . 0.0 105.704 174.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -149.46 -177.63 5.96 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.094 1.357 . . . . 0.0 108.521 -172.856 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -155.63 147.94 17.59 Favored Pre-proline 0 CA--C 1.532 0.255 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 168.062 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -61.2 -18.06 56.21 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 121.649 1.566 . . . . 0.0 115.72 -178.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 49.7 p-90 -69.02 -20.68 64.14 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 119.963 1.256 . . . . 0.0 111.878 173.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 30.6 t -59.22 146.33 39.56 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 125.146 1.379 . . . . 0.0 111.054 -172.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -95.22 -60.26 1.07 Allowed Glycine 0 CA--C 1.531 1.064 0 CA-C-O 118.795 -1.003 . . . . 0.0 111.36 169.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -66.04 -26.25 50.88 Favored 'Trans proline' 0 C--N 1.35 0.656 0 CA-C-N 120.293 2.047 . . . . 0.0 113.101 -172.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 30.8 m -57.53 -35.14 69.89 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 121.699 -0.625 . . . . 0.0 111.295 174.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.0 mmtp -67.3 -26.09 66.36 Favored 'General case' 0 CA--C 1.53 0.207 0 O-C-N 121.673 -0.642 . . . . 0.0 110.928 -179.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 29.8 mtm -71.85 -44.17 64.28 Favored 'General case' 0 C--N 1.34 0.173 0 CA-C-N 118.585 0.63 . . . . 0.0 110.426 177.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 15.5 tt -79.86 -22.16 11.95 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-O 118.574 -0.727 . . . . 0.0 111.351 -177.201 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -48.93 -52.32 47.71 Favored Pre-proline 0 CA--C 1.549 0.942 0 CA-C-N 120.424 1.466 . . . . 0.0 114.241 179.125 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -66.71 -26.92 45.29 Favored 'Trans proline' 0 C--N 1.35 0.607 0 CA-C-N 121.748 1.66 . . . . 0.0 112.454 176.512 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 6.1 t -69.82 -37.86 74.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 O-C-N 121.688 -0.633 . . . . 0.0 109.454 174.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 43.2 mt -65.66 -36.72 84.49 Favored 'General case' 0 C--O 1.224 -0.267 0 CA-C-N 119.286 0.948 . . . . 0.0 110.517 172.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -63.34 -43.73 96.89 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 119.198 0.908 . . . . 0.0 111.079 173.013 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -60.61 -44.98 95.68 Favored 'General case' 0 CA--C 1.531 0.241 0 O-C-N 121.243 -0.911 . . . . 0.0 110.186 175.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -62.16 -41.88 98.73 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 124.846 1.258 . . . . 0.0 109.942 179.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -60.24 -42.85 96.14 Favored 'General case' 0 CA--C 1.521 -0.168 0 C-N-CA 123.879 0.872 . . . . 0.0 110.905 176.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -71.54 -10.46 59.8 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 122.976 0.51 . . . . 0.0 112.337 -179.202 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -103.59 -34.0 8.8 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 125.205 1.402 . . . . 0.0 111.234 178.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 74.6 mmm -121.86 -5.63 9.08 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 113.364 0.876 . . . . 0.0 113.364 -168.512 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -57.83 -15.11 18.37 Favored Glycine 0 CA--C 1.532 1.133 0 CA-C-N 119.718 1.145 . . . . 0.0 115.135 -173.203 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -69.71 -30.48 68.12 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 118.441 1.12 . . . . 0.0 111.728 173.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 45.9 mmtm -112.82 -19.69 11.89 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 125.456 1.502 . . . . 0.0 111.676 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 30.1 tp -117.55 157.15 26.83 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.412 1.085 . . . . 0.0 111.214 -169.232 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 37.4 ttmt -128.3 141.32 51.48 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 103.893 -2.632 . . . . 0.0 103.893 166.453 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 62.2 mt -108.15 141.53 23.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 105.925 -1.88 . . . . 0.0 105.925 175.04 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 84.7 t -132.69 98.44 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 -173.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt -74.31 140.49 44.93 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 174.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 15.0 tt -142.35 126.81 16.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 176.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 49.2 t0 -83.42 103.49 12.83 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.795 1.238 . . . . 0.0 109.067 -173.076 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 28.2 m -60.1 -27.15 38.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 118.766 -0.635 . . . . 0.0 112.028 -174.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -66.31 -19.54 65.84 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 119.321 0.964 . . . . 0.0 111.73 -177.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -114.13 1.78 14.69 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.558 1.543 . . . . 0.0 110.893 178.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 69.0 m-80 -141.98 42.52 1.68 Allowed 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.387 1.075 . . . . 0.0 109.79 -169.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 45.2 mm-40 -56.22 -33.07 65.01 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.794 0.838 . . . . 0.0 111.236 178.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 36.0 mm-40 -65.78 -46.72 77.68 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 118.379 0.536 . . . . 0.0 110.389 179.074 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.45 -38.51 77.81 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 121.798 -0.564 . . . . 0.0 109.778 -178.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -58.78 -47.54 84.36 Favored 'General case' 0 CA--C 1.535 0.376 0 O-C-N 120.978 -1.076 . . . . 0.0 110.241 171.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -59.97 -28.93 66.9 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 124.087 0.851 . . . . 0.0 112.506 176.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 50.1 tptt -56.27 -29.05 60.61 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.602 1.161 . . . . 0.0 111.551 179.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -123.34 10.39 9.24 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.568 0.747 . . . . 0.0 111.664 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 62.31 33.31 85.72 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 123.558 0.599 . . . . 0.0 112.427 -176.176 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 57.5 t -64.94 121.06 13.29 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 173.001 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 26.1 mmt -132.45 2.64 3.85 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.96 1.304 . . . . 0.0 111.465 -179.009 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 30.0 m -144.82 161.48 39.17 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 126.953 2.101 . . . . 0.0 107.062 178.242 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 34.5 pt -144.21 155.18 58.18 Favored Pre-proline 0 CA--C 1.545 0.788 0 C-N-CA 124.772 1.229 . . . . 0.0 108.451 177.406 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -68.54 139.54 51.47 Favored 'Cis proline' 0 C--N 1.35 0.624 0 CA-C-N 120.651 1.268 . . . . 0.0 110.53 -2.474 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 32.0 m -132.89 132.57 42.21 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 177.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 6.9 mp -110.52 131.17 55.28 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 -171.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -122.38 128.35 50.86 Favored 'General case' 0 CA--C 1.508 -0.638 0 N-CA-C 103.388 -2.819 . . . . 0.0 103.388 179.132 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 1.5 t -110.61 127.13 67.86 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.751 0 N-CA-C 104.337 -2.468 . . . . 0.0 104.337 -176.255 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.3 mp -126.08 152.05 46.37 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 -174.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -138.04 125.47 21.94 Favored 'General case' 0 CA--C 1.513 -0.479 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 175.221 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 29.2 t70 49.84 33.12 6.02 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.959 1.303 . . . . 0.0 112.348 173.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 99.41 4.59 56.14 Favored Glycine 0 CA--C 1.53 1.018 0 CA-C-O 118.018 -1.434 . . . . 0.0 114.551 170.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -122.0 144.89 48.62 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 120.101 1.951 . . . . 0.0 109.043 174.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 14.3 p -68.74 129.71 33.43 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 169.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 27.7 m -115.62 -20.87 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 CA-C-O 117.577 -1.201 . . . . 0.0 111.052 179.586 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -159.42 166.36 31.19 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 120.734 1.606 . . . . 0.0 111.402 176.343 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 13.3 m -136.34 151.18 49.31 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.991 1.716 . . . . 0.0 108.519 175.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 74.1 m -150.26 158.11 43.81 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.882 1.673 . . . . 0.0 108.671 171.206 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 39.2 t -133.97 148.21 30.32 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 -177.01 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.68 177.24 51.86 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 123.973 0.797 . . . . 0.0 112.705 171.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 47.6 t80 -62.55 135.46 57.42 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.352 0.661 . . . . 0.0 109.59 175.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 13.0 mptt -136.05 136.2 22.58 Favored Pre-proline 0 CA--C 1.533 0.324 0 C-N-CA 126.429 1.892 . . . . 0.0 105.995 175.389 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -70.61 160.19 50.28 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 122.493 2.128 . . . . 0.0 110.591 176.18 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 41.5 pttt -59.34 -28.9 67.25 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -177.108 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -65.86 -48.86 70.15 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 122.839 0.456 . . . . 0.0 110.037 173.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.6 -37.9 89.06 Favored 'General case' 0 CA--C 1.529 0.162 0 O-C-N 121.898 -0.501 . . . . 0.0 110.711 178.296 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 79.3 mt -64.97 -41.56 95.34 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 119.355 -0.355 . . . . 0.0 111.255 176.267 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 15.6 mt-30 -59.32 -41.05 88.17 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 118.824 0.738 . . . . 0.0 110.086 174.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -64.77 -40.82 95.9 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 118.199 0.454 . . . . 0.0 110.365 178.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 63.3 tp -61.03 -43.77 98.4 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.733 1.213 . . . . 0.0 110.755 177.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 78.5 t -61.42 -46.43 96.61 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 123.651 0.78 . . . . 0.0 109.37 173.125 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -61.91 -25.73 67.75 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 125.017 1.327 . . . . 0.0 112.239 -173.086 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 49.2 mtpt -55.86 -24.58 37.73 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 118.658 -0.687 . . . . 0.0 112.576 172.327 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 80.9 m-70 -123.34 -8.2 8.13 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 -168.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 82.1 mt . . . . . 0 C--O 1.248 0.975 0 CA-C-N 119.155 0.889 . . . . 0.0 109.327 171.512 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.8 mmt . . . . . 0 N--CA 1.483 1.224 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -151.74 -175.47 5.22 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 125.006 1.322 . . . . 0.0 109.373 -174.548 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.3 mt -75.34 142.12 14.96 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 166.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 41.3 t -135.32 163.72 35.05 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 C-N-CA 126.353 1.861 . . . . 0.0 106.251 -177.127 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 6.2 ttmt -118.99 144.83 46.28 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 174.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -145.12 166.49 25.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.393 0.615 . . . . 0.0 110.976 -177.027 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.9 p -133.09 169.92 16.15 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 126.254 1.822 . . . . 0.0 107.779 171.29 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -52.63 -29.71 27.61 Favored 'General case' 0 CA--C 1.535 0.365 0 C-N-CA 124.499 1.12 . . . . 0.0 113.23 -178.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 82.6 mm-40 -63.54 -29.0 70.33 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.788 1.235 . . . . 0.0 113.103 179.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.6 m -135.17 -6.85 2.31 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 -169.295 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -52.14 -42.98 63.8 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.439 1.096 . . . . 0.0 111.722 -178.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.6 m -62.74 -39.15 93.19 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.111 0.564 . . . . 0.0 111.83 -179.02 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -68.54 -43.89 75.7 Favored 'General case' 0 N--CA 1.452 -0.329 0 O-C-N 122.011 -0.431 . . . . 0.0 110.079 177.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 67.1 mm-40 -63.05 -34.52 77.76 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-O 119.618 -0.229 . . . . 0.0 111.085 -179.068 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 27.4 p -85.65 3.66 39.94 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 113.524 0.935 . . . . 0.0 113.524 -176.507 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 69.6 m -105.4 30.05 5.99 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.053 0.941 . . . . 0.0 112.07 -175.515 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -132.83 37.46 3.45 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.455 0.702 . . . . 0.0 112.702 -173.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 123.11 -152.47 16.93 Favored Glycine 0 N--CA 1.465 0.593 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 174.022 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 67.4 t -73.09 133.72 31.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 104.528 -2.397 . . . . 0.0 104.528 165.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 40.7 t -136.26 130.19 47.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.8 tt -110.9 99.49 8.39 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 105.865 -1.902 . . . . 0.0 105.865 -178.106 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -80.07 143.16 34.23 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 178.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -123.91 94.05 4.11 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 125.806 1.642 . . . . 0.0 107.159 -176.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -73.88 113.15 10.72 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 105.791 -1.929 . . . . 0.0 105.791 174.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -148.86 -177.05 5.58 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.785 1.234 . . . . 0.0 108.354 -173.125 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -156.07 149.06 18.27 Favored Pre-proline 0 CA--C 1.531 0.224 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 167.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -61.44 -18.17 57.83 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 121.707 1.605 . . . . 0.0 115.61 179.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 52.6 p-90 -70.56 -19.44 62.88 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 120.002 1.274 . . . . 0.0 111.901 173.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 19.5 t -60.03 151.99 25.08 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 124.944 1.298 . . . . 0.0 110.844 -174.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -105.88 -58.0 0.64 Allowed Glycine 0 CA--C 1.531 1.058 0 CA-C-O 118.842 -0.976 . . . . 0.0 111.017 171.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -56.91 -33.16 94.53 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 123.28 2.653 . . . . 0.0 113.518 -179.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 31.4 m -58.11 -34.05 69.77 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.202 0.601 . . . . 0.0 111.423 176.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.2 mmtp -68.42 -24.85 64.79 Favored 'General case' 0 CA--C 1.53 0.184 0 O-C-N 121.534 -0.729 . . . . 0.0 110.927 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 31.0 mtm -70.65 -43.21 69.65 Favored 'General case' 0 C--N 1.34 0.153 0 CA-C-N 118.735 0.698 . . . . 0.0 110.357 176.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 17.5 tt -83.08 -22.74 8.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-O 118.61 -0.709 . . . . 0.0 111.616 -176.355 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -49.28 -51.08 60.4 Favored Pre-proline 0 CA--C 1.547 0.853 0 CA-C-N 120.234 1.379 . . . . 0.0 114.261 178.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -66.49 -28.97 45.33 Favored 'Trans proline' 0 C--N 1.351 0.675 0 CA-C-N 121.675 1.634 . . . . 0.0 112.028 176.378 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.2 t -68.27 -36.67 76.0 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 O-C-N 121.645 -0.659 . . . . 0.0 109.703 175.08 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 87.9 mt -66.39 -36.06 81.89 Favored 'General case' 0 C--N 1.341 0.212 0 CA-C-N 119.654 1.115 . . . . 0.0 111.144 171.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -62.45 -42.94 99.83 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 119.376 0.989 . . . . 0.0 110.799 171.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -63.92 -39.98 95.41 Favored 'General case' 0 CA--C 1.532 0.272 0 O-C-N 121.199 -0.938 . . . . 0.0 110.466 176.273 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 44.8 tp -62.05 -42.96 99.74 Favored 'General case' 0 CA--C 1.528 0.098 0 C-N-CA 123.867 0.867 . . . . 0.0 109.992 176.295 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -60.39 -42.45 95.9 Favored 'General case' 0 CA--C 1.52 -0.185 0 C-N-CA 123.275 0.63 . . . . 0.0 110.845 178.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -71.69 -10.8 60.31 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.319 0.648 . . . . 0.0 112.511 -179.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -105.52 -31.98 8.72 Favored 'General case' 0 C--O 1.232 0.15 0 C-N-CA 125.486 1.514 . . . . 0.0 111.458 -179.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 80.0 mmm -125.47 -3.32 7.34 Favored 'General case' 0 N--CA 1.46 0.06 0 CA-C-O 118.407 -0.806 . . . . 0.0 113.113 -167.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -57.85 -10.91 7.18 Favored Glycine 0 CA--C 1.534 1.226 0 C-N-CA 124.826 1.203 . . . . 0.0 115.919 -173.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -75.22 -24.57 57.75 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 118.502 1.151 . . . . 0.0 111.881 173.458 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 50.6 mtmt -128.26 -16.01 4.54 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 125.757 1.623 . . . . 0.0 111.887 -173.014 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 58.9 tp -123.0 144.23 49.4 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 124.816 1.246 . . . . 0.0 110.283 -172.227 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -116.25 145.39 43.18 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 105.256 -2.127 . . . . 0.0 105.256 167.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 82.6 mt -115.12 137.9 47.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 105.298 -2.112 . . . . 0.0 105.298 175.477 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 95.2 t -132.06 96.9 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 -171.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -74.96 137.03 41.34 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 176.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 13.3 tt -140.43 126.73 21.47 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 178.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -83.63 106.53 15.42 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 124.462 1.105 . . . . 0.0 109.098 -172.355 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 34.6 m -58.97 -27.7 36.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 118.643 -0.694 . . . . 0.0 111.99 -176.03 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -65.69 -17.23 64.46 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 119.347 0.976 . . . . 0.0 112.204 -176.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -121.96 4.16 9.92 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.927 1.291 . . . . 0.0 111.225 179.484 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 68.7 m-80 -141.28 40.47 1.76 Allowed 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.197 0.999 . . . . 0.0 109.785 -170.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 53.7 mm-40 -54.42 -30.84 53.69 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.097 0.959 . . . . 0.0 111.09 175.375 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -66.16 -50.18 64.83 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 123.99 0.916 . . . . 0.0 110.167 -179.273 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.77 -38.96 80.4 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 -178.428 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -58.62 -48.29 81.5 Favored 'General case' 0 CA--C 1.534 0.342 0 O-C-N 121.298 -0.876 . . . . 0.0 110.357 172.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -61.23 -28.76 69.71 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 123.905 0.764 . . . . 0.0 112.213 177.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 19.9 tptm -56.19 -29.3 60.69 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.697 1.199 . . . . 0.0 111.509 179.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -123.73 10.82 9.03 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.552 0.741 . . . . 0.0 111.627 -179.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 64.35 30.81 78.88 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 123.616 0.627 . . . . 0.0 112.582 -177.226 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 61.0 t -65.96 122.44 16.92 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 171.06 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 26.1 mmt -132.65 3.5 3.84 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.784 1.233 . . . . 0.0 111.381 -178.312 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 23.7 m -144.66 162.23 37.19 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 126.652 1.981 . . . . 0.0 107.621 179.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 17.7 pt -142.42 155.14 64.31 Favored Pre-proline 0 CA--C 1.544 0.731 0 C-N-CA 124.663 1.185 . . . . 0.0 108.689 175.195 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -67.99 138.32 43.39 Favored 'Cis proline' 0 C--N 1.35 0.63 0 CA-C-N 120.469 1.203 . . . . 0.0 110.399 -3.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 44.9 m -131.33 140.61 49.77 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 174.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 83.4 mt -122.32 127.73 50.18 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 -169.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -117.84 125.4 50.46 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 103.984 -2.599 . . . . 0.0 103.984 178.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 10.0 t -97.05 123.58 49.45 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 N-CA-C 104.145 -2.539 . . . . 0.0 104.145 172.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.9 mp -115.19 151.69 33.96 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 175.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 21.0 tptm -133.55 119.37 19.41 Favored 'General case' 0 CA--C 1.516 -0.363 0 N-CA-C 106.229 -1.767 . . . . 0.0 106.229 174.402 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.2 t70 50.83 37.59 17.52 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.626 1.17 . . . . 0.0 112.483 175.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 103.73 -2.35 45.42 Favored Glycine 0 CA--C 1.527 0.826 0 CA-C-O 118.087 -1.396 . . . . 0.0 115.582 168.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -128.41 145.25 51.14 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 120.033 1.917 . . . . 0.0 109.773 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 61.4 t -61.63 132.52 27.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 173.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.4 p -119.49 -21.85 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.77 0 C-N-CA 124.413 1.085 . . . . 0.0 110.372 174.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -157.62 165.56 35.17 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 120.552 1.524 . . . . 0.0 111.053 175.269 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 11.7 m -137.57 151.21 48.12 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.219 1.408 . . . . 0.0 109.004 179.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 58.4 m -148.47 157.23 43.34 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 126.022 1.729 . . . . 0.0 108.561 169.399 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 36.6 t -133.71 146.71 31.38 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 -179.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 79.41 -175.97 54.86 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 123.504 0.573 . . . . 0.0 112.19 177.135 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -63.17 146.55 53.1 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.579 0.752 . . . . 0.0 110.618 178.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 66.7 mttt -143.9 136.17 13.29 Favored Pre-proline 0 CA--C 1.532 0.284 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 168.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -70.42 160.42 49.59 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 122.408 2.072 . . . . 0.0 110.086 174.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 49.0 pttt -58.4 -28.59 65.34 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 113.569 0.952 . . . . 0.0 113.569 -177.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -65.25 -50.34 66.17 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 118.61 0.641 . . . . 0.0 109.741 174.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.81 -39.84 95.53 Favored 'General case' 0 C--N 1.34 0.165 0 C-N-CA 122.89 0.476 . . . . 0.0 110.627 178.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 92.3 mt -64.08 -42.54 96.92 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 122.74 0.416 . . . . 0.0 111.344 177.276 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -61.8 -40.07 93.94 Favored 'General case' 0 C--O 1.223 -0.29 0 CA-C-N 118.592 0.633 . . . . 0.0 110.197 176.469 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -65.5 -41.92 92.7 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 118.729 0.695 . . . . 0.0 110.302 178.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 58.3 tp -60.55 -38.29 84.03 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.744 1.618 . . . . 0.0 111.22 177.115 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 71.5 t -68.01 -49.92 63.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 C-N-CA 123.822 0.849 . . . . 0.0 109.545 171.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 -58.63 -40.68 84.02 Favored 'General case' 0 C--N 1.333 -0.122 0 C-N-CA 125.344 1.458 . . . . 0.0 111.821 -168.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.408 ' HG3' ' CD2' ' A' ' 103' ' ' HIS . 22.0 ptmt -65.75 -8.31 20.45 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 -177.542 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . 0.408 ' CD2' ' HG3' ' A' ' 102' ' ' LYS . 94.7 m-70 -124.14 1.9 8.56 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 124.413 1.085 . . . . 0.0 113.695 179.605 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 55.8 mt . . . . . 0 C--O 1.248 1.025 0 CA-C-N 119.386 0.994 . . . . 0.0 109.227 172.519 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.2 tmm? . . . . . 0 N--CA 1.48 1.031 0 CA-C-O 118.628 -0.701 . . . . 0.0 109.877 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -163.62 -173.58 3.35 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.622 1.569 . . . . 0.0 108.386 -178.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.8 mt -75.2 146.32 9.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 N-CA-C 106.97 -1.493 . . . . 0.0 106.97 166.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 20.2 t -138.59 163.95 27.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 126.621 1.968 . . . . 0.0 106.856 -176.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.25 136.49 53.59 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 105.618 -1.993 . . . . 0.0 105.618 177.011 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -141.3 176.2 9.04 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 123.631 0.772 . . . . 0.0 112.473 -169.542 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.4 p -130.08 173.12 11.04 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 127.646 2.378 . . . . 0.0 107.924 175.094 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -45.95 -39.9 9.52 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 124.643 1.177 . . . . 0.0 113.521 177.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 80.8 mm-40 -90.43 -38.02 13.56 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 122.921 0.489 . . . . 0.0 111.727 -174.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 11.4 m -67.83 -33.63 75.15 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 118.143 0.429 . . . . 0.0 110.927 177.34 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 33.4 t80 -50.77 -45.96 59.24 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 126.143 1.777 . . . . 0.0 111.217 -176.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 9.7 m -64.86 -37.8 88.85 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 118.601 0.637 . . . . 0.0 111.876 -175.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -68.53 -45.68 71.56 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 175.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -64.21 -36.75 85.09 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 122.486 0.314 . . . . 0.0 111.252 -176.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 36.8 p -81.17 -4.1 54.3 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 124.071 0.948 . . . . 0.0 113.031 -176.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 70.0 m -94.66 28.64 2.57 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.937 0.895 . . . . 0.0 111.754 -177.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -134.01 66.84 1.53 Allowed 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.541 1.137 . . . . 0.0 110.229 -177.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 88.13 -156.56 27.37 Favored Glycine 0 C--N 1.337 0.59 0 N-CA-C 110.373 -1.091 . . . . 0.0 110.373 174.205 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 97.9 t -71.41 132.85 32.82 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 N-CA-C 106.889 -1.522 . . . . 0.0 106.889 168.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 47.2 t -136.46 146.34 29.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 179.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 5.0 tt -128.06 100.56 5.93 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 -176.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -81.97 146.27 29.83 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.256 -179.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -124.56 94.42 4.19 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 126.113 1.765 . . . . 0.0 107.458 -176.394 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -74.44 112.42 10.6 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 106.05 -1.833 . . . . 0.0 106.05 175.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -149.24 -177.22 5.71 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.668 1.187 . . . . 0.0 108.575 -174.087 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -155.65 146.96 16.71 Favored Pre-proline 0 CA--C 1.532 0.277 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 167.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_exo -60.29 -18.21 51.2 Favored 'Trans proline' 0 N--CA 1.461 -0.439 0 C-N-CA 121.821 1.68 . . . . 0.0 115.86 -178.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 51.3 p-90 -69.35 -20.43 63.85 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 119.949 1.25 . . . . 0.0 111.937 173.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 34.2 t -59.31 148.21 33.05 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 125.065 1.346 . . . . 0.0 111.199 -172.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -97.61 -63.28 0.89 Allowed Glycine 0 CA--C 1.53 0.971 0 CA-C-O 118.403 -1.22 . . . . 0.0 110.974 171.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -62.24 -26.52 77.53 Favored 'Trans proline' 0 C--N 1.35 0.613 0 CA-C-N 120.424 2.112 . . . . 0.0 113.679 -174.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 33.8 m -57.39 -34.98 69.43 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 121.582 -0.698 . . . . 0.0 111.515 174.464 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.8 mmtp -67.53 -24.94 65.6 Favored 'General case' 0 CA--C 1.53 0.182 0 O-C-N 121.602 -0.686 . . . . 0.0 111.021 -179.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 31.3 mtm -71.22 -43.41 67.4 Favored 'General case' 0 C--N 1.34 0.182 0 CA-C-N 118.68 0.673 . . . . 0.0 110.421 176.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 14.1 tt -84.18 -23.48 7.76 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-O 118.705 -0.664 . . . . 0.0 111.727 -174.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -48.88 -51.47 54.44 Favored Pre-proline 0 CA--C 1.548 0.877 0 CA-C-N 119.911 1.232 . . . . 0.0 114.076 178.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -66.57 -29.67 43.8 Favored 'Trans proline' 0 C--N 1.35 0.65 0 CA-C-N 121.611 1.611 . . . . 0.0 112.194 176.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 5.4 t -66.46 -39.92 85.24 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 175.218 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 67.9 mt -64.99 -38.23 90.26 Favored 'General case' 0 C--N 1.34 0.169 0 CA-C-N 119.317 0.962 . . . . 0.0 110.858 174.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -61.6 -43.9 97.99 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 119.011 0.823 . . . . 0.0 111.122 172.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -62.34 -38.5 89.75 Favored 'General case' 0 CA--C 1.533 0.327 0 O-C-N 121.393 -0.817 . . . . 0.0 110.223 175.609 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.77 -44.48 96.08 Favored 'General case' 0 C--N 1.333 -0.114 0 C-N-CA 124.074 0.95 . . . . 0.0 110.391 177.097 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -60.24 -41.89 94.1 Favored 'General case' 0 CA--C 1.521 -0.165 0 C-N-CA 123.24 0.616 . . . . 0.0 110.92 177.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 -72.01 -11.03 60.58 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 -179.075 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -106.45 -32.69 7.99 Favored 'General case' 0 C--O 1.232 0.133 0 C-N-CA 125.226 1.411 . . . . 0.0 111.639 -179.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 87.4 mmm -125.75 -4.18 7.08 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-O 118.357 -0.83 . . . . 0.0 113.022 -168.284 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -58.39 -11.77 10.8 Favored Glycine 0 CA--C 1.533 1.188 0 CA-C-N 119.835 1.198 . . . . 0.0 114.811 -175.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -65.98 -27.95 68.53 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 118.418 1.109 . . . . 0.0 111.83 171.378 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.442 ' HA ' ' HE3' ' A' ' 49' ' ' LYS . 0.0 OUTLIER -121.28 -24.87 5.36 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 125.954 1.701 . . . . 0.0 111.81 179.333 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 45.9 tp -103.0 157.76 16.76 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 124.144 0.977 . . . . 0.0 111.036 -169.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -133.88 144.41 48.88 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 103.957 -2.608 . . . . 0.0 103.957 166.65 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 66.2 mt -118.56 140.54 41.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 105.61 -1.996 . . . . 0.0 105.61 178.305 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 74.0 t -133.0 97.21 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 -170.205 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 51.3 mtmt -74.35 134.46 42.5 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 177.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 20.2 tt -137.92 126.8 33.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 178.167 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 62.9 t0 -87.84 103.97 16.15 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 114.727 -1.124 . . . . 0.0 108.419 -171.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 23.0 m -61.7 -23.2 30.29 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 CA-C-O 118.766 -0.635 . . . . 0.0 112.208 -174.339 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -65.34 -22.67 66.84 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 119.25 0.932 . . . . 0.0 111.562 -179.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -117.28 1.71 12.47 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.926 1.29 . . . . 0.0 111.323 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 66.6 m-80 -139.36 43.34 2.02 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 125.167 1.387 . . . . 0.0 108.798 -171.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -60.64 -35.44 76.21 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.034 0.934 . . . . 0.0 109.825 -175.451 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 -62.64 -44.49 96.15 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 123.674 0.79 . . . . 0.0 110.218 179.174 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -66.7 -40.86 88.65 Favored 'General case' 0 C--O 1.225 -0.188 0 C-N-CA 123.467 0.707 . . . . 0.0 110.082 -178.061 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.38 -50.06 75.41 Favored 'General case' 0 CA--C 1.532 0.283 0 O-C-N 121.742 -0.598 . . . . 0.0 110.058 173.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -58.43 -29.77 63.96 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 123.558 0.599 . . . . 0.0 112.55 176.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 9.8 ttpt -58.05 -26.61 62.7 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 125.758 1.623 . . . . 0.0 111.994 -178.35 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -123.61 11.04 9.13 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.886 0.874 . . . . 0.0 111.944 176.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 65.89 29.05 74.24 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 123.567 0.603 . . . . 0.0 112.765 -177.173 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 61.8 t -65.65 125.26 22.37 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 170.14 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 98.7 mtp -135.25 3.41 3.11 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.747 1.219 . . . . 0.0 111.515 -179.131 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 24.0 m -144.1 162.05 37.26 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 126.588 1.955 . . . . 0.0 107.743 179.228 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 38.6 pt -142.11 154.39 64.64 Favored Pre-proline 0 CA--C 1.545 0.767 0 C-N-CA 124.534 1.134 . . . . 0.0 108.685 176.332 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -67.71 140.07 51.63 Favored 'Cis proline' 0 C--N 1.351 0.692 0 CA-C-N 120.437 1.192 . . . . 0.0 110.429 -3.149 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 35.8 m -131.74 143.52 50.3 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 173.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 88.3 mt -123.9 126.84 47.08 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 -169.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -115.87 121.71 43.18 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 103.17 -2.9 . . . . 0.0 103.17 177.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 4.6 t -94.21 129.14 44.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 103.641 -2.726 . . . . 0.0 103.641 174.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.7 mp -122.89 154.81 37.83 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 178.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -138.33 123.32 19.0 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 174.12 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.0 t70 49.86 37.41 13.45 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.07 1.348 . . . . 0.0 112.647 176.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 105.1 -4.23 41.29 Favored Glycine 0 CA--C 1.529 0.916 0 CA-C-O 118.184 -1.342 . . . . 0.0 115.271 168.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -131.92 150.68 52.08 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 120.056 1.928 . . . . 0.0 110.374 -177.221 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 44.6 t -62.2 132.14 27.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 178.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.8 p -120.44 -21.75 3.94 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 C-N-CA 125.436 1.494 . . . . 0.0 109.926 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -159.84 172.21 18.05 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 120.121 1.328 . . . . 0.0 109.873 174.034 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 25.9 m -146.53 151.41 37.29 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.708 1.203 . . . . 0.0 109.246 177.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 4.2 m -147.13 156.87 43.35 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 125.507 1.523 . . . . 0.0 109.14 170.174 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 35.5 t -134.85 143.32 37.82 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 -177.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 76.17 -173.89 53.65 Favored Glycine 0 CA--C 1.531 1.052 0 CA-C-O 121.509 0.505 . . . . 0.0 111.862 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 65.4 t80 -63.56 149.2 46.86 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.483 0.713 . . . . 0.0 110.871 179.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 27.4 mttp -144.71 136.92 13.2 Favored Pre-proline 0 CA--C 1.534 0.342 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 168.247 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -70.44 161.3 46.52 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 122.32 2.013 . . . . 0.0 110.228 174.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 46.5 pttt -59.15 -29.53 67.49 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 -177.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -64.86 -50.13 67.81 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 118.951 0.796 . . . . 0.0 109.737 175.096 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.62 -39.47 94.44 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 122.73 0.412 . . . . 0.0 110.821 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 77.1 mt -63.68 -44.46 93.66 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 122.949 0.5 . . . . 0.0 111.249 176.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 12.4 mt-30 -61.4 -39.44 90.73 Favored 'General case' 0 C--O 1.224 -0.243 0 CA-C-O 118.704 -0.665 . . . . 0.0 110.371 176.358 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -65.6 -40.46 92.69 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 118.915 0.78 . . . . 0.0 110.439 178.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 68.9 tp -62.93 -35.73 81.07 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.634 1.574 . . . . 0.0 111.451 177.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 76.9 t -69.04 -50.96 48.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 C-N-CA 123.638 0.775 . . . . 0.0 109.584 169.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -58.27 -38.5 77.08 Favored 'General case' 0 CA--C 1.522 -0.117 0 C-N-CA 126.013 1.725 . . . . 0.0 112.196 -168.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -64.68 -6.96 8.92 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 -179.096 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -123.25 -5.9 8.31 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 124.395 1.078 . . . . 0.0 113.276 176.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 57.6 mt . . . . . 0 C--O 1.246 0.911 0 CA-C-N 119.319 0.963 . . . . 0.0 109.223 172.678 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 78.5 mtm . . . . . 0 N--CA 1.481 1.12 0 CA-C-O 120.399 0.143 . . . . 0.0 110.884 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 68.87 167.14 0.27 Allowed 'General case' 0 C--O 1.237 0.42 0 C-N-CA 128.776 2.831 . . . . 0.0 114.756 169.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.1 mp -87.01 141.88 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 N-CA-C 105.134 -2.172 . . . . 0.0 105.134 169.301 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 46.8 t -132.91 164.4 35.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 C-N-CA 127.165 2.186 . . . . 0.0 105.904 -175.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 6.3 ttmt -121.67 147.2 46.19 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 177.007 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -147.35 168.32 22.11 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 123.279 0.632 . . . . 0.0 110.449 179.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 33.8 p -134.68 179.78 6.08 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 125.595 1.558 . . . . 0.0 107.371 169.314 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -49.17 -29.74 5.9 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.842 0.857 . . . . 0.0 112.685 170.167 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -65.18 -27.15 68.5 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.265 1.426 . . . . 0.0 113.138 179.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.9 p -134.43 -16.9 2.06 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 114.66 1.356 . . . . 0.0 114.66 -167.097 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -55.11 -45.13 75.48 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 124.442 1.097 . . . . 0.0 111.85 -170.091 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.7 m -63.26 -39.0 93.35 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 122.747 0.419 . . . . 0.0 111.613 -178.014 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -68.43 -44.49 74.87 Favored 'General case' 0 N--CA 1.452 -0.361 0 O-C-N 122.119 -0.363 . . . . 0.0 110.076 177.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -63.34 -34.6 78.06 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-O 119.33 -0.367 . . . . 0.0 111.108 -178.442 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 35.0 p -86.83 3.48 45.12 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.192 0.997 . . . . 0.0 113.268 -176.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 69.5 m -105.36 32.29 4.36 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.252 1.021 . . . . 0.0 111.562 -177.035 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -132.3 53.74 1.98 Allowed 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.197 0.999 . . . . 0.0 110.798 -176.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 97.55 -157.17 20.79 Favored Glycine 0 C--N 1.339 0.703 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 177.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 91.1 t -70.17 137.11 24.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 167.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 61.9 t -138.16 144.94 29.42 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 N-CA-C 105.479 -2.045 . . . . 0.0 105.479 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 41.8 tp -122.97 99.42 6.37 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 106.611 -1.625 . . . . 0.0 106.611 -177.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -78.52 149.95 33.0 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 109.319 -0.622 . . . . 0.0 109.319 177.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -129.15 94.38 3.8 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 126.761 2.024 . . . . 0.0 106.821 -179.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -73.25 114.51 11.52 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 105.882 -1.896 . . . . 0.0 105.882 174.253 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -147.38 -177.85 5.92 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 125.507 1.523 . . . . 0.0 108.301 -171.154 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -155.72 148.69 18.19 Favored Pre-proline 0 C--O 1.235 0.303 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 168.058 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -67.56 -13.25 38.4 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 121.656 1.571 . . . . 0.0 114.469 -175.206 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 53.4 p-90 -71.1 -20.26 62.36 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 120.194 1.361 . . . . 0.0 112.283 170.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 34.7 t -61.0 153.66 24.63 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.078 1.351 . . . . 0.0 111.523 -172.117 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -103.26 -65.53 0.72 Allowed Glycine 0 CA--C 1.53 0.983 0 CA-C-O 118.385 -1.23 . . . . 0.0 110.91 174.479 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_exo -55.77 -30.03 74.38 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.965 2.444 . . . . 0.0 114.118 179.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 33.2 m -58.18 -30.34 66.33 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 121.321 -0.862 . . . . 0.0 111.977 175.222 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.5 mmtp -72.68 -38.26 67.64 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 123.314 0.646 . . . . 0.0 110.014 178.046 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 5.8 ptt? -72.76 -31.52 64.97 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 118.817 0.735 . . . . 0.0 111.639 -176.327 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 15.9 tt -78.26 -19.1 13.53 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-O 118.925 -0.56 . . . . 0.0 111.969 174.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -54.94 -49.33 92.59 Favored Pre-proline 0 CA--C 1.545 0.77 0 CA-C-N 120.272 1.397 . . . . 0.0 113.655 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -66.53 -26.58 46.94 Favored 'Trans proline' 0 C--N 1.351 0.696 0 CA-C-N 121.95 1.732 . . . . 0.0 112.344 175.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 11.7 t -67.19 -39.7 83.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 174.11 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 96.3 mt -67.02 -34.34 77.51 Favored 'General case' 0 C--N 1.339 0.122 0 CA-C-N 119.013 0.824 . . . . 0.0 111.579 173.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -64.68 -42.26 95.47 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 119.338 0.972 . . . . 0.0 110.859 172.318 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -62.64 -37.77 87.66 Favored 'General case' 0 CA--C 1.531 0.235 0 O-C-N 120.884 -1.135 . . . . 0.0 110.457 173.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 42.9 tp -63.99 -42.42 97.19 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 123.114 0.566 . . . . 0.0 110.314 177.361 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -57.8 -44.47 86.34 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 118.983 0.81 . . . . 0.0 110.881 173.418 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -68.99 -8.87 48.91 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -177.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -112.2 -30.05 7.35 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 125.787 1.635 . . . . 0.0 111.973 -179.096 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 87.1 mmm -129.1 -7.66 4.86 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -169.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -58.48 -15.93 26.74 Favored Glycine 0 CA--C 1.529 0.949 0 CA-C-N 119.906 1.23 . . . . 0.0 114.674 -171.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -65.75 -26.2 67.62 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.297 1.039 . . . . 0.0 111.653 174.221 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.448 ' HA ' ' HE3' ' A' ' 49' ' ' LYS . 0.0 OUTLIER -122.91 -19.91 5.99 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.932 1.693 . . . . 0.0 111.884 179.761 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 36.0 tp -110.37 154.5 23.46 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 124.113 0.965 . . . . 0.0 111.144 -169.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 36.1 ttmt -130.96 144.28 51.36 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 104.6 -2.37 . . . . 0.0 104.6 167.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 94.1 mt -115.75 136.54 52.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 105.305 -2.109 . . . . 0.0 105.305 179.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 95.8 t -132.35 98.77 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-N 119.11 0.868 . . . . 0.0 109.23 -169.252 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 29.6 mtpp -74.57 139.99 44.1 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 175.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 13.0 tt -141.61 128.08 19.76 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 176.632 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 60.4 t0 -85.21 104.6 15.23 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 124.554 1.142 . . . . 0.0 109.196 -171.232 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 31.1 m -58.91 -26.46 32.55 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-O 118.593 -0.718 . . . . 0.0 112.017 -175.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -65.29 -18.57 65.42 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 119.454 1.024 . . . . 0.0 112.18 -177.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -119.8 4.39 11.02 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.921 1.289 . . . . 0.0 111.071 177.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 68.0 m-80 -139.24 39.92 2.09 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 124.456 1.102 . . . . 0.0 109.642 -170.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 49.9 mm-40 -55.67 -33.32 64.01 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.929 0.892 . . . . 0.0 111.112 177.523 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 -66.29 -49.04 68.43 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 118.353 0.524 . . . . 0.0 110.189 179.093 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.52 -39.66 88.75 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.351 0.661 . . . . 0.0 109.846 -179.006 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.64 -49.05 79.28 Favored 'General case' 0 CA--C 1.533 0.292 0 O-C-N 121.149 -0.97 . . . . 0.0 110.322 173.344 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -60.46 -28.49 67.5 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 123.916 0.77 . . . . 0.0 112.262 177.257 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 72.2 tttt -56.13 -29.03 60.14 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 125.068 1.347 . . . . 0.0 111.698 179.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -123.47 10.64 9.18 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.63 0.772 . . . . 0.0 111.703 179.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 64.1 31.15 79.87 Favored Glycine 0 CA--C 1.532 1.14 0 C-N-CA 123.708 0.67 . . . . 0.0 112.617 -176.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 61.8 t -65.94 121.6 15.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 171.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 26.1 mmt -132.47 2.17 3.8 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.797 1.239 . . . . 0.0 111.514 -178.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 31.5 m -145.65 161.74 39.16 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 126.789 2.036 . . . . 0.0 107.401 179.372 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 41.6 pt -142.62 156.79 63.03 Favored Pre-proline 0 CA--C 1.545 0.773 0 C-N-CA 124.734 1.214 . . . . 0.0 108.739 177.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -65.48 142.69 55.56 Favored 'Cis proline' 0 C--N 1.35 0.627 0 CA-C-N 120.413 1.183 . . . . 0.0 110.231 -5.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 18.6 m -135.62 132.86 37.61 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 175.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -110.02 134.59 51.97 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 -174.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -121.98 125.75 47.02 Favored 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 102.593 -3.114 . . . . 0.0 102.593 177.022 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 1.9 t -103.67 122.3 56.17 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 N-CA-C 103.605 -2.739 . . . . 0.0 103.605 -179.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.7 mp -119.45 155.8 31.37 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 -175.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -136.81 126.2 24.99 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 170.214 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.2 t70 48.36 36.02 6.5 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.93 1.292 . . . . 0.0 112.294 172.366 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 98.31 2.53 57.84 Favored Glycine 0 CA--C 1.533 1.189 0 CA-C-O 117.925 -1.486 . . . . 0.0 115.108 171.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -121.42 145.88 47.47 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 120.364 2.082 . . . . 0.0 109.569 175.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 67.6 t -66.32 130.03 31.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 169.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 35.5 m -114.42 -21.92 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 CA-C-O 117.666 -1.159 . . . . 0.0 110.985 174.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -156.36 168.23 27.98 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 120.605 1.548 . . . . 0.0 111.023 173.609 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 14.1 m -143.72 151.0 39.49 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.597 1.559 . . . . 0.0 109.186 -177.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 13.0 m -152.61 153.95 34.39 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.375 1.47 . . . . 0.0 109.221 168.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 61.0 t -132.69 142.33 42.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 -172.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 75.84 -172.32 54.12 Favored Glycine 0 CA--C 1.529 0.913 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 -173.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -60.08 148.86 34.3 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.566 0.698 . . . . 0.0 110.303 174.615 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 39.5 tptt -149.14 122.44 4.53 Favored Pre-proline 0 N--CA 1.45 -0.431 0 N-CA-C 105.717 -1.956 . . . . 0.0 105.717 -173.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -68.5 155.67 68.23 Favored 'Trans proline' 0 N--CA 1.454 -0.807 0 C-N-CA 121.369 1.379 . . . . 0.0 111.101 -174.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -52.26 -46.88 65.97 Favored 'General case' 0 N--CA 1.461 0.121 0 C-N-CA 125.205 1.402 . . . . 0.0 112.021 -179.357 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -62.26 -40.39 96.04 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 122.95 0.5 . . . . 0.0 110.672 -179.104 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -69.45 -37.51 77.38 Favored 'General case' 0 N--CA 1.456 -0.162 0 O-C-N 121.796 -0.565 . . . . 0.0 110.798 179.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 98.5 mt -60.43 -43.4 96.82 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-O 119.285 -0.388 . . . . 0.0 110.18 173.389 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 65.4 mt-30 -62.11 -37.05 83.64 Favored 'General case' 0 N--CA 1.461 0.103 0 CA-C-N 118.431 0.56 . . . . 0.0 111.732 176.017 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -61.79 -48.74 79.26 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 118.429 0.559 . . . . 0.0 109.781 175.219 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 34.9 mt -62.47 -36.69 83.27 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 118.381 0.537 . . . . 0.0 111.431 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 56.1 t -61.48 -51.81 68.46 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 172.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -69.2 -22.04 63.92 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 -172.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 65.2 mttm -57.65 -26.36 61.51 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 118.213 -0.899 . . . . 0.0 111.548 170.115 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -126.13 -18.05 5.1 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 113.645 0.98 . . . . 0.0 113.645 -169.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 33.4 mt . . . . . 0 C--O 1.247 0.926 0 CA-C-N 119.935 1.243 . . . . 0.0 109.156 169.097 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.3 mpt? . . . . . 0 N--CA 1.478 0.962 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -162.47 -175.3 4.43 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 126.137 1.775 . . . . 0.0 107.805 -177.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.3 mt -76.02 144.37 11.97 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 166.058 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 23.4 t -136.55 162.99 34.41 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 C-N-CA 126.271 1.829 . . . . 0.0 106.94 -174.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.21 132.77 55.49 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 105.128 -2.175 . . . . 0.0 105.128 173.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -136.25 169.7 17.22 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 123.309 0.644 . . . . 0.0 110.976 -177.218 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.9 p -135.91 171.98 13.68 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 125.597 1.559 . . . . 0.0 107.505 169.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -51.79 -27.8 13.47 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.502 1.121 . . . . 0.0 112.946 178.061 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -57.97 -32.37 67.78 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 126.256 1.823 . . . . 0.0 112.809 178.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.0 m -141.22 -3.73 1.19 Allowed 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 113.383 0.883 . . . . 0.0 113.383 -169.166 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 78.3 t80 -53.51 -41.6 66.48 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.172 0.989 . . . . 0.0 111.633 -178.069 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.1 p -60.67 -45.5 93.89 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 124.045 0.938 . . . . 0.0 111.774 177.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.03 -43.62 95.02 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 122.737 0.415 . . . . 0.0 110.284 178.175 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 65.4 mm-40 -63.4 -37.24 86.53 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-O 119.414 -0.326 . . . . 0.0 110.962 -179.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 31.6 p -83.98 3.26 35.04 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.221 1.008 . . . . 0.0 113.277 -177.26 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 63.4 m -104.13 31.47 4.55 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.296 1.038 . . . . 0.0 111.459 -177.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -134.51 64.02 1.61 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.297 1.039 . . . . 0.0 110.229 -177.486 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 88.89 -158.33 28.13 Favored Glycine 0 C--N 1.337 0.603 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 177.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 59.1 t -69.94 135.5 28.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 168.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 46.8 t -137.35 140.17 42.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 N-CA-C 105.763 -1.94 . . . . 0.0 105.763 179.26 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 52.3 tp -118.98 99.58 6.82 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 106.622 -1.622 . . . . 0.0 106.622 -178.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -79.67 149.35 31.27 Favored 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 178.025 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -130.43 93.99 3.57 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 126.532 1.933 . . . . 0.0 107.596 -177.02 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -74.44 113.82 12.11 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 105.821 -1.918 . . . . 0.0 105.821 175.275 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -149.9 -175.82 5.19 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 124.667 1.187 . . . . 0.0 108.455 -172.28 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -151.82 147.74 20.53 Favored Pre-proline 0 C--O 1.233 0.199 0 N-CA-C 105.64 -1.985 . . . . 0.0 105.64 167.19 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -67.1 -13.05 38.39 Favored 'Trans proline' 0 CA--C 1.535 0.533 0 CA-C-N 121.093 1.426 . . . . 0.0 113.104 -179.073 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 1.3 m95 -76.4 -13.51 60.12 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.841 0.856 . . . . 0.0 111.907 173.074 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 31.4 t -63.87 154.37 33.9 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 125.387 1.475 . . . . 0.0 111.076 -176.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -104.74 -65.4 0.68 Allowed Glycine 0 CA--C 1.53 0.997 0 CA-C-O 118.324 -1.265 . . . . 0.0 110.589 172.213 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -53.26 -32.02 58.78 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 123.4 2.733 . . . . 0.0 114.633 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 33.2 m -57.91 -34.37 69.77 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 121.574 -0.704 . . . . 0.0 111.721 176.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.0 mmtp -67.76 -23.17 65.2 Favored 'General case' 0 CA--C 1.53 0.188 0 O-C-N 121.492 -0.755 . . . . 0.0 111.074 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 32.2 mtm -70.83 -43.52 68.39 Favored 'General case' 0 C--N 1.339 0.143 0 CA-C-N 118.784 0.72 . . . . 0.0 110.357 176.018 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 17.3 tt -83.61 -22.61 8.33 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-O 118.75 -0.643 . . . . 0.0 111.698 -176.387 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -48.94 -51.43 55.29 Favored Pre-proline 0 CA--C 1.547 0.861 0 CA-C-N 120.032 1.287 . . . . 0.0 114.035 178.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -67.56 -25.16 41.16 Favored 'Trans proline' 0 C--N 1.351 0.688 0 CA-C-N 121.78 1.672 . . . . 0.0 112.367 176.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.4 t -72.07 -35.1 52.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 O-C-N 121.506 -0.746 . . . . 0.0 109.613 175.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 69.6 mt -67.97 -35.98 79.28 Favored 'General case' 0 C--N 1.338 0.095 0 CA-C-N 119.329 0.968 . . . . 0.0 111.036 170.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -62.4 -41.61 98.8 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 119.058 0.845 . . . . 0.0 110.818 170.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -61.99 -42.38 99.08 Favored 'General case' 0 C--N 1.331 -0.23 0 O-C-N 121.182 -0.948 . . . . 0.0 110.27 174.185 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 46.3 tp -61.62 -40.65 95.61 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.993 0.917 . . . . 0.0 110.642 178.586 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -60.98 -41.47 96.47 Favored 'General case' 0 C--N 1.334 -0.099 0 C-N-CA 123.108 0.563 . . . . 0.0 110.821 174.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -75.55 -11.08 59.95 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.023 0.529 . . . . 0.0 112.362 178.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -91.44 -50.45 5.79 Favored 'General case' 0 C--O 1.232 0.15 0 C-N-CA 124.928 1.291 . . . . 0.0 109.636 178.117 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 24.9 mtm -140.49 21.3 2.37 Favored 'General case' 0 N--CA 1.465 0.275 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -170.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -56.34 -11.7 5.28 Favored Glycine 0 CA--C 1.538 1.473 0 CA-C-N 120.197 1.362 . . . . 0.0 114.591 174.16 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -72.77 -28.7 62.76 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 118.694 1.247 . . . . 0.0 111.723 171.454 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -107.9 -24.92 11.45 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 125.922 1.689 . . . . 0.0 111.302 -179.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 48.8 tp -114.42 157.54 22.75 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 124.498 1.119 . . . . 0.0 111.307 -168.664 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -128.7 143.42 50.93 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 104.214 -2.513 . . . . 0.0 104.214 166.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 82.3 mt -117.44 138.5 47.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 105.367 -2.086 . . . . 0.0 105.367 178.199 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 98.8 t -132.59 98.74 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 -170.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 52.6 mtmt -70.93 141.6 51.11 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 107.848 -1.168 . . . . 0.0 107.848 173.323 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 16.5 tt -144.05 125.2 9.73 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 174.221 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 54.1 t0 -83.82 105.65 14.89 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.362 1.065 . . . . 0.0 108.629 -173.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 30.9 m -59.31 -26.25 33.25 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-O 118.538 -0.744 . . . . 0.0 111.939 -174.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -65.11 -18.27 65.16 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 119.453 1.024 . . . . 0.0 112.179 -177.401 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -119.69 3.82 11.11 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.915 1.286 . . . . 0.0 111.134 178.046 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 68.2 m-80 -139.5 39.82 2.05 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.438 1.095 . . . . 0.0 109.761 -170.453 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 52.1 mm-40 -55.41 -32.61 62.82 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.75 0.82 . . . . 0.0 111.092 176.37 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 33.4 mm-40 -65.99 -47.67 73.78 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 118.373 0.533 . . . . 0.0 110.324 178.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.49 -39.83 85.2 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 118.581 0.628 . . . . 0.0 109.993 -178.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.49 -49.39 77.96 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 121.621 -0.674 . . . . 0.0 110.453 173.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -61.75 -28.67 70.4 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 123.764 0.697 . . . . 0.0 112.131 178.367 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 17.2 ttmt -54.97 -29.47 56.9 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 125.772 1.629 . . . . 0.0 112.009 178.346 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -123.65 10.5 9.05 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.794 0.837 . . . . 0.0 111.831 178.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 65.25 28.27 73.37 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 123.825 0.726 . . . . 0.0 112.94 -177.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 56.7 t -62.35 127.49 22.45 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 172.084 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 42.3 ttp -137.29 0.79 2.36 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.532 1.133 . . . . 0.0 110.966 -176.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 24.4 m -144.95 162.74 36.15 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 126.535 1.934 . . . . 0.0 107.634 179.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 41.0 pt -143.29 156.55 60.92 Favored Pre-proline 0 CA--C 1.545 0.754 0 C-N-CA 124.897 1.279 . . . . 0.0 108.583 176.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -66.89 139.6 46.36 Favored 'Cis proline' 0 C--N 1.349 0.575 0 CA-C-N 120.522 1.222 . . . . 0.0 110.207 -5.097 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 31.9 m -132.11 138.59 48.16 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 176.198 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 88.5 mt -116.09 128.5 55.73 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 -171.367 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -119.23 125.54 49.41 Favored 'General case' 0 CA--C 1.509 -0.626 0 N-CA-C 102.551 -3.129 . . . . 0.0 102.551 177.459 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 1.7 t -105.64 122.6 59.31 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 N-CA-C 103.609 -2.737 . . . . 0.0 103.609 -179.387 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.8 mp -120.23 153.52 36.2 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 -176.57 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -136.63 124.97 23.28 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 171.501 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.5 t70 48.62 36.04 7.04 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.016 1.327 . . . . 0.0 112.284 174.026 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 99.8 2.34 56.23 Favored Glycine 0 CA--C 1.532 1.113 0 CA-C-O 117.92 -1.489 . . . . 0.0 114.98 170.055 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -122.36 146.75 47.04 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 120.273 2.037 . . . . 0.0 109.571 176.122 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 62.0 t -66.82 130.01 31.83 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 N-CA-C 107.405 -1.332 . . . . 0.0 107.405 170.216 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 30.7 m -118.29 -17.19 7.36 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 C-N-CA 124.641 1.177 . . . . 0.0 111.338 176.21 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -156.4 167.55 30.09 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 120.547 1.521 . . . . 0.0 110.61 172.477 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 19.1 m -146.42 142.62 28.35 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.589 1.156 . . . . 0.0 108.706 174.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 49.5 m -144.58 156.71 44.27 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.025 1.33 . . . . 0.0 108.734 176.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 39.8 t -134.23 146.38 31.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 -174.657 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 76.32 -175.95 52.36 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 123.532 0.587 . . . . 0.0 112.436 177.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -63.29 148.78 47.31 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.989 0.915 . . . . 0.0 111.286 -179.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -148.84 142.13 15.85 Favored Pre-proline 0 CA--C 1.534 0.335 0 C-N-CA 125.626 1.57 . . . . 0.0 107.24 167.816 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -72.26 160.8 46.23 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 122.871 2.381 . . . . 0.0 110.787 175.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 40.5 pttt -59.31 -30.12 68.12 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 -176.275 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -65.22 -49.72 68.62 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 118.355 0.525 . . . . 0.0 109.639 174.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.74 -37.86 88.93 Favored 'General case' 0 CA--C 1.528 0.118 0 O-C-N 122.063 -0.398 . . . . 0.0 110.853 179.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 84.5 mt -63.77 -44.62 92.88 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 122.722 0.409 . . . . 0.0 111.289 175.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -60.7 -41.95 96.23 Favored 'General case' 0 C--O 1.223 -0.291 0 CA-C-O 118.903 -0.57 . . . . 0.0 109.838 176.07 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -64.24 -40.93 97.05 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 118.383 0.538 . . . . 0.0 110.777 -179.535 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 56.3 tp -61.0 -44.89 96.75 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 124.965 1.306 . . . . 0.0 110.715 176.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 75.4 t -62.15 -43.83 98.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 123.602 0.761 . . . . 0.0 109.621 173.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -62.6 -24.05 67.37 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 125.186 1.395 . . . . 0.0 112.203 -173.296 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -54.85 -26.1 33.08 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 118.611 -0.709 . . . . 0.0 112.222 171.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 86.1 m-70 -123.8 -11.62 7.67 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 113.423 0.897 . . . . 0.0 113.423 -168.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 70.4 mt . . . . . 0 C--O 1.249 1.045 0 CA-C-N 119.16 0.891 . . . . 0.0 109.292 171.678 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 7.6 mt . . . . . 0 N--CA 1.446 -0.656 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 10.4 t -135.71 158.8 39.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 106.441 -1.688 . . . . 0.0 106.441 -172.292 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 14.1 mtpt -119.99 125.14 47.66 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 105.793 -1.928 . . . . 0.0 105.793 -177.443 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -136.65 166.46 23.49 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.485 0.66 . . . . 0.0 111.422 -173.297 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 22.9 p -132.38 176.23 8.6 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 126.013 1.725 . . . . 0.0 107.819 172.55 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -53.58 -29.49 37.67 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.859 0.863 . . . . 0.0 112.465 177.734 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 54.2 mt-30 -66.53 -29.35 69.41 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.048 1.339 . . . . 0.0 112.915 179.068 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 23.5 p -123.3 -15.65 7.13 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.565 1.146 . . . . 0.0 113.416 -169.213 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -52.88 -48.15 67.34 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 124.53 1.132 . . . . 0.0 112.048 -172.379 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.9 m -63.92 -39.38 94.03 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.013 0.525 . . . . 0.0 111.779 -177.532 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.84 -43.78 87.48 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 178.752 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -66.08 -43.3 87.76 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 122.425 0.29 . . . . 0.0 110.747 -179.465 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 37.6 p -77.51 -5.32 49.61 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 -175.659 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 73.1 m -73.27 -21.88 60.5 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 177.11 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -87.98 72.18 9.29 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 118.75 0.705 . . . . 0.0 111.527 -169.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 85.09 -151.73 26.2 Favored Glycine 0 C--N 1.336 0.573 0 N-CA-C 110.479 -1.049 . . . . 0.0 110.479 172.1 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 97.6 t -72.18 132.95 32.69 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 168.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 49.6 t -138.2 143.96 31.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 N-CA-C 105.756 -1.942 . . . . 0.0 105.756 179.265 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 5.6 tt -122.85 101.6 7.53 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 106.303 -1.74 . . . . 0.0 106.303 -178.218 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -81.78 147.06 29.6 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.659 -179.405 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -125.43 93.8 3.96 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 126.588 1.955 . . . . 0.0 107.194 -175.238 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -75.8 112.79 12.55 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 175.328 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -149.94 -176.04 5.28 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.432 1.093 . . . . 0.0 108.644 -172.013 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -152.79 147.69 19.52 Favored Pre-proline 0 CA--C 1.531 0.236 0 N-CA-C 106.085 -1.821 . . . . 0.0 106.085 167.141 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -59.11 -18.29 43.06 Favored 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 121.848 1.699 . . . . 0.0 114.595 177.096 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 2.0 m95 -75.19 -14.22 60.52 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 118.818 0.735 . . . . 0.0 111.865 176.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 25.0 t -64.32 153.33 38.68 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.499 1.519 . . . . 0.0 111.063 -177.059 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -103.26 -65.14 0.71 Allowed Glycine 0 CA--C 1.53 0.982 0 CA-C-O 118.424 -1.209 . . . . 0.0 110.514 171.657 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_exo -53.22 -31.7 56.93 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 123.525 2.816 . . . . 0.0 114.608 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 34.3 m -58.63 -32.59 69.17 Favored 'General case' 0 CA--C 1.537 0.451 0 O-C-N 121.509 -0.744 . . . . 0.0 111.857 176.875 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.3 mmtp -68.36 -23.83 64.73 Favored 'General case' 0 CA--C 1.531 0.244 0 O-C-N 121.273 -0.892 . . . . 0.0 110.888 179.213 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 28.9 mtm -71.57 -40.93 69.61 Favored 'General case' 0 C--N 1.339 0.148 0 CA-C-N 118.79 0.723 . . . . 0.0 110.636 176.639 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 19.2 tt -83.14 -21.37 8.98 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-O 118.918 -0.563 . . . . 0.0 111.529 -176.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -49.79 -50.62 66.46 Favored Pre-proline 0 CA--C 1.55 0.952 0 CA-C-N 120.14 1.336 . . . . 0.0 114.003 177.206 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -66.46 -26.39 47.59 Favored 'Trans proline' 0 C--N 1.351 0.701 0 CA-C-N 121.688 1.639 . . . . 0.0 112.451 175.826 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 6.0 t -67.63 -40.08 83.43 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-N 118.907 0.776 . . . . 0.0 109.136 173.551 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 91.3 mt -64.3 -34.21 77.6 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 119.462 1.028 . . . . 0.0 111.224 172.341 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -66.32 -38.14 86.99 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 119.606 1.094 . . . . 0.0 111.385 171.537 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -63.78 -36.09 82.76 Favored 'General case' 0 C--N 1.33 -0.248 0 O-C-N 120.299 -1.501 . . . . 0.0 110.115 172.22 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 18.7 mt -66.58 -37.25 84.52 Favored 'General case' 0 C--N 1.334 -0.097 0 CA-C-O 117.892 -1.051 . . . . 0.0 112.087 173.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -54.1 -47.05 72.18 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 120.569 1.532 . . . . 0.0 109.65 168.359 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 44.1 mt-30 -74.49 -13.67 60.72 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 113.283 0.846 . . . . 0.0 113.283 -174.572 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 61.7 mt-10 -120.93 -24.27 5.67 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 124.417 1.087 . . . . 0.0 113.01 -170.264 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 17.5 mtp -131.99 -5.2 3.53 Favored 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 -175.747 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -58.43 -12.17 12.16 Favored Glycine 0 CA--C 1.538 1.472 0 CA-C-N 120.488 1.494 . . . . 0.0 115.393 -172.688 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -74.83 -25.99 59.39 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.326 1.45 . . . . 0.0 112.226 174.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.479 ' HA ' ' HE3' ' A' ' 49' ' ' LYS . 0.0 OUTLIER -123.67 -18.16 6.19 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 125.575 1.55 . . . . 0.0 112.144 -177.504 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 55.7 tp -118.13 150.71 38.91 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 124.167 0.987 . . . . 0.0 110.552 -169.577 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -124.02 145.0 49.5 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 104.821 -2.289 . . . . 0.0 104.821 167.785 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 90.0 mt -120.59 129.32 75.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 104.395 -2.446 . . . . 0.0 104.395 -177.614 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 98.7 t -126.23 98.45 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 CA-C-N 119.217 0.917 . . . . 0.0 109.403 -170.383 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -73.47 137.62 44.62 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 176.332 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 15.1 tt -141.34 125.43 16.79 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 C-N-CA 123.769 0.827 . . . . 0.0 108.79 176.683 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 60.6 t0 -83.47 104.2 13.42 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 124.62 1.168 . . . . 0.0 108.953 -172.713 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 30.3 m -58.81 -27.05 33.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 118.713 -0.66 . . . . 0.0 111.959 -174.587 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -65.57 -17.75 64.81 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 119.346 0.975 . . . . 0.0 112.171 -176.623 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -120.57 3.44 10.7 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.869 1.268 . . . . 0.0 111.222 178.011 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 69.0 m-80 -139.11 40.02 2.12 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.43 1.092 . . . . 0.0 109.814 -169.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 51.8 mm-40 -55.46 -32.09 62.49 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.122 0.969 . . . . 0.0 111.257 176.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 36.8 mm-40 -66.25 -48.45 70.47 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 118.493 0.588 . . . . 0.0 110.357 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.15 -39.46 82.63 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 118.408 0.549 . . . . 0.0 109.556 -178.652 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -58.95 -48.69 80.6 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 121.31 -0.869 . . . . 0.0 110.327 173.441 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -61.19 -28.66 69.45 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 123.985 0.802 . . . . 0.0 112.202 177.657 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 44.9 tttp -55.97 -29.24 59.94 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.965 1.306 . . . . 0.0 111.686 179.181 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -122.88 10.43 9.54 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.705 0.802 . . . . 0.0 111.739 179.467 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 64.95 28.37 73.41 Favored Glycine 0 CA--C 1.533 1.186 0 CA-C-O 119.39 -0.672 . . . . 0.0 112.892 -177.368 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 61.4 t -62.27 125.56 18.87 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 171.78 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 12.0 tpt -136.53 1.28 2.59 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.608 1.163 . . . . 0.0 111.085 -175.884 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 24.6 m -144.82 163.11 35.07 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 126.626 1.97 . . . . 0.0 107.481 179.394 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 38.5 pt -142.88 156.26 62.4 Favored Pre-proline 0 CA--C 1.545 0.765 0 C-N-CA 124.574 1.15 . . . . 0.0 108.847 175.835 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -66.65 138.9 42.11 Favored 'Cis proline' 0 N--CA 1.458 -0.582 0 CA-C-N 120.361 1.164 . . . . 0.0 110.179 -5.618 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 32.3 m -129.77 142.71 50.65 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 174.657 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 88.4 mt -123.39 126.52 46.95 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 -168.502 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -118.41 119.39 34.46 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 103.969 -2.604 . . . . 0.0 103.969 179.526 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 5.1 t -90.23 123.15 42.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 103.565 -2.754 . . . . 0.0 103.565 171.871 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.2 mp -111.61 153.64 26.03 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 173.071 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -136.15 124.32 23.07 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 105.916 -1.883 . . . . 0.0 105.916 174.246 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 31.9 t70 50.96 34.13 10.06 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.573 1.149 . . . . 0.0 112.251 177.143 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 98.55 0.86 57.84 Favored Glycine 0 CA--C 1.531 1.038 0 CA-C-O 118.227 -1.318 . . . . 0.0 114.956 169.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -128.38 150.32 50.16 Favored 'General case' 0 C--N 1.34 0.153 0 CA-C-N 119.999 1.9 . . . . 0.0 109.916 178.205 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 47.9 t -62.26 133.24 28.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 176.743 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.6 p -117.92 -24.73 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 C-N-CA 125.087 1.355 . . . . 0.0 109.58 177.09 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -158.79 164.98 35.31 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 120.035 1.289 . . . . 0.0 110.506 175.041 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 10.6 m -136.26 150.88 49.14 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.709 1.204 . . . . 0.0 108.891 177.652 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 62.3 m -150.52 159.3 44.58 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.622 1.569 . . . . 0.0 108.768 169.736 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 40.7 t -133.77 147.73 30.66 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 -176.495 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 76.93 -178.03 51.51 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 123.637 0.637 . . . . 0.0 112.423 176.519 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -64.73 150.29 47.59 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.886 0.874 . . . . 0.0 110.826 178.648 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -149.02 145.53 19.7 Favored Pre-proline 0 C--O 1.235 0.321 0 C-N-CA 125.677 1.591 . . . . 0.0 106.93 167.529 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -70.84 161.19 46.94 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 122.649 2.233 . . . . 0.0 110.462 174.401 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 63.5 pttt -58.71 -31.74 68.54 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -175.602 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -68.02 -45.49 73.85 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 118.244 0.475 . . . . 0.0 109.859 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.7 -40.43 95.36 Favored 'General case' 0 C--O 1.232 0.159 0 O-C-N 122.039 -0.413 . . . . 0.0 110.339 177.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 97.4 mt -64.57 -40.6 95.84 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 122.307 0.243 . . . . 0.0 111.313 176.077 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 18.9 mt-30 -59.83 -39.3 84.61 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 118.759 -0.638 . . . . 0.0 110.108 175.608 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -68.14 -40.35 82.45 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 118.941 0.791 . . . . 0.0 110.808 178.122 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 43.9 tp -60.34 -37.89 82.08 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.312 1.445 . . . . 0.0 111.313 176.441 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 99.4 t -68.74 -49.75 61.41 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 C-N-CA 123.756 0.823 . . . . 0.0 109.578 170.327 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -58.09 -39.25 78.11 Favored 'General case' 0 CA--C 1.519 -0.218 0 C-N-CA 125.453 1.501 . . . . 0.0 112.119 -168.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 13.3 ptmm? -65.44 -5.92 9.02 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 113.364 0.876 . . . . 0.0 113.364 -178.761 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -127.04 -3.48 6.38 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.548 1.139 . . . . 0.0 113.595 175.431 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 46.9 mt . . . . . 0 C--O 1.248 0.988 0 CA-C-N 119.413 1.006 . . . . 0.0 109.164 170.289 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 7.5 mt . . . . . 0 CA--C 1.536 0.419 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 37.3 t -137.68 164.77 27.91 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 C-N-CA 127.106 2.162 . . . . 0.0 106.2 -179.133 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 8.1 ttmt -120.14 146.34 46.07 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 107.1 -1.445 . . . . 0.0 107.1 173.84 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -143.64 169.97 16.73 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.717 0.77 . . . . 0.0 111.029 -178.242 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 18.6 p -133.77 173.43 11.54 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 127.699 2.4 . . . . 0.0 107.863 176.428 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -54.93 -31.41 60.32 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 121.578 -0.701 . . . . 0.0 112.547 177.851 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 59.4 mt-30 -70.77 -27.62 64.06 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.113 1.365 . . . . 0.0 112.959 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 25.5 p -118.89 -18.95 8.74 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.425 1.09 . . . . 0.0 113.524 -168.666 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -52.99 -46.47 68.32 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 125.014 1.326 . . . . 0.0 111.942 -172.436 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.0 m -63.79 -38.39 90.92 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 122.79 0.436 . . . . 0.0 111.795 -176.274 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -68.54 -44.6 74.2 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 177.388 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 67.6 mm-40 -63.95 -34.46 78.02 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-O 119.545 -0.264 . . . . 0.0 111.223 -178.134 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 33.3 p -85.79 1.63 48.9 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.012 0.925 . . . . 0.0 113.427 -176.533 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 70.9 m -101.79 31.52 3.81 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.14 0.976 . . . . 0.0 111.601 -177.504 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -133.72 65.05 1.59 Allowed 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.44 1.096 . . . . 0.0 110.104 -177.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 89.84 -154.32 23.79 Favored Glycine 0 C--N 1.338 0.661 0 N-CA-C 110.294 -1.123 . . . . 0.0 110.294 175.536 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 48.5 t -71.71 135.7 27.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 N-CA-C 106.214 -1.772 . . . . 0.0 106.214 168.401 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 49.2 t -137.62 141.98 37.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 178.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 60.4 tp -122.96 98.79 6.06 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 -177.487 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -79.39 148.72 31.89 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 178.432 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -127.98 93.98 3.82 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 126.543 1.937 . . . . 0.0 107.443 -178.046 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -73.4 112.6 9.62 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 105.735 -1.95 . . . . 0.0 105.735 175.034 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -148.64 -177.2 5.65 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 124.847 1.259 . . . . 0.0 108.173 -172.718 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -156.01 149.35 18.69 Favored Pre-proline 0 N--CA 1.453 -0.29 0 N-CA-C 106.154 -1.795 . . . . 0.0 106.154 167.824 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -68.93 -13.18 36.19 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 CA-C-N 120.866 1.345 . . . . 0.0 113.96 -177.368 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 46.4 p-90 -69.74 -20.39 63.51 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 120.147 1.34 . . . . 0.0 111.975 169.628 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 29.1 t -59.17 148.33 31.94 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.06 1.344 . . . . 0.0 111.05 -171.68 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -97.09 -60.59 0.96 Allowed Glycine 0 CA--C 1.532 1.113 0 CA-C-O 118.722 -1.043 . . . . 0.0 111.335 169.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -66.37 -25.99 48.6 Favored 'Trans proline' 0 C--N 1.349 0.574 0 CA-C-N 120.387 2.093 . . . . 0.0 112.983 -173.111 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 24.5 m -58.26 -33.98 69.99 Favored 'General case' 0 CA--C 1.534 0.346 0 O-C-N 121.627 -0.671 . . . . 0.0 111.218 174.346 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.1 mmtp -68.24 -22.87 64.75 Favored 'General case' 0 CA--C 1.531 0.242 0 O-C-N 121.591 -0.693 . . . . 0.0 111.078 -179.565 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 35.3 mtm -71.34 -44.21 65.51 Favored 'General case' 0 C--N 1.34 0.184 0 CA-C-N 118.863 0.756 . . . . 0.0 110.323 175.811 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 17.2 tt -83.04 -22.73 8.61 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-O 118.628 -0.701 . . . . 0.0 111.555 -176.423 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -49.05 -52.04 50.81 Favored Pre-proline 0 CA--C 1.548 0.888 0 CA-C-N 120.28 1.4 . . . . 0.0 114.223 178.839 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -66.41 -29.9 44.94 Favored 'Trans proline' 0 C--N 1.351 0.667 0 CA-C-N 121.574 1.598 . . . . 0.0 111.985 176.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.0 t -66.49 -40.26 86.04 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-O 118.722 -0.656 . . . . 0.0 109.403 175.016 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 45.7 mt -64.54 -37.05 86.21 Favored 'General case' 0 C--O 1.224 -0.258 0 CA-C-N 119.507 1.049 . . . . 0.0 110.613 174.769 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -63.03 -44.47 95.85 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 119.104 0.866 . . . . 0.0 111.083 173.187 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -63.94 -39.79 94.97 Favored 'General case' 0 CA--C 1.534 0.334 0 O-C-N 121.166 -0.959 . . . . 0.0 110.451 177.566 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -63.68 -43.28 97.11 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 125.175 1.39 . . . . 0.0 109.641 177.285 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -58.74 -43.12 90.15 Favored 'General case' 0 CA--C 1.521 -0.143 0 C-N-CA 123.767 0.827 . . . . 0.0 110.917 176.519 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -70.5 -10.19 58.55 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -106.31 -27.58 10.92 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 125.735 1.614 . . . . 0.0 111.518 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 22.2 mtp -126.14 -2.47 7.01 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 113.51 0.929 . . . . 0.0 113.51 -169.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.82 -7.3 6.17 Favored Glycine 0 CA--C 1.533 1.215 0 CA-C-N 119.591 1.087 . . . . 0.0 115.538 -176.1 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -75.71 -27.64 58.29 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 118.597 1.198 . . . . 0.0 111.638 171.575 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 45.0 mmtm -121.03 -20.51 6.81 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 125.514 1.526 . . . . 0.0 112.347 -175.765 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 48.8 tp -119.83 151.91 38.11 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.131 0.972 . . . . 0.0 111.546 -168.276 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -120.41 143.84 48.25 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 105.011 -2.218 . . . . 0.0 105.011 166.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 58.6 mt -112.56 140.2 33.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 105.497 -2.038 . . . . 0.0 105.497 173.036 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 95.1 t -132.75 98.96 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 -172.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 47.6 mtpt -73.9 140.43 45.65 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 175.363 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 13.0 tt -141.01 126.16 18.57 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 175.569 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -83.79 101.86 11.9 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 124.728 1.211 . . . . 0.0 108.786 -173.082 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 24.9 m -59.95 -25.63 33.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 118.667 -0.683 . . . . 0.0 111.961 -174.498 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -65.05 -18.45 65.31 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 119.464 1.029 . . . . 0.0 112.143 -177.09 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -120.22 4.02 10.84 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.809 1.244 . . . . 0.0 111.072 177.541 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -139.2 40.56 2.1 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.607 1.163 . . . . 0.0 109.592 -170.652 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 48.0 mm-40 -55.84 -32.55 63.7 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.184 0.993 . . . . 0.0 111.257 177.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -65.74 -46.27 79.51 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 118.385 0.539 . . . . 0.0 110.425 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.13 -39.19 79.03 Favored 'General case' 0 C--O 1.223 -0.317 0 CA-C-N 118.457 0.571 . . . . 0.0 109.618 -179.246 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.06 -48.36 81.89 Favored 'General case' 0 CA--C 1.533 0.326 0 O-C-N 121.256 -0.902 . . . . 0.0 110.25 173.177 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -60.68 -28.75 68.49 Favored Glycine 0 CA--C 1.529 0.938 0 C-N-CA 124.079 0.847 . . . . 0.0 112.36 177.251 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 47.3 tttp -55.94 -29.32 59.96 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 124.861 1.265 . . . . 0.0 111.709 179.345 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -123.2 10.63 9.35 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.621 0.768 . . . . 0.0 111.767 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 63.6 31.57 81.21 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 123.641 0.639 . . . . 0.0 112.636 -176.833 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 55.1 t -65.83 121.87 15.73 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 171.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 98.5 mmm -131.59 2.64 4.14 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.898 1.279 . . . . 0.0 111.382 -178.425 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 24.5 m -144.83 161.17 39.94 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 126.652 1.981 . . . . 0.0 107.565 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 38.7 pt -142.69 154.36 62.69 Favored Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 124.726 1.211 . . . . 0.0 108.41 176.333 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -68.26 140.14 53.89 Favored 'Cis proline' 0 C--N 1.349 0.601 0 CA-C-N 120.495 1.212 . . . . 0.0 110.541 -3.133 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 33.9 m -131.86 142.83 49.81 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 175.067 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 83.0 mt -121.24 127.4 51.39 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 -170.006 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -120.64 124.63 45.7 Favored 'General case' 0 CA--C 1.508 -0.637 0 N-CA-C 102.851 -3.018 . . . . 0.0 102.851 178.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 1.3 t -106.04 125.87 61.58 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 N-CA-C 103.872 -2.64 . . . . 0.0 103.872 -178.735 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.7 mp -122.08 152.9 39.34 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 -175.502 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -135.71 116.71 14.27 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 106.522 -1.659 . . . . 0.0 106.522 178.096 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.1 t70 49.58 38.42 14.79 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.915 1.286 . . . . 0.0 112.571 176.533 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 104.14 -2.87 43.99 Favored Glycine 0 CA--C 1.529 0.92 0 CA-C-O 118.056 -1.414 . . . . 0.0 115.418 168.85 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -126.57 147.17 49.91 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 120.129 1.964 . . . . 0.0 109.995 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 61.0 t -62.58 131.43 27.94 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 174.144 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 9.9 p -119.3 -20.67 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.732 0 C-N-CA 125.006 1.322 . . . . 0.0 110.093 178.102 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -159.96 166.75 29.46 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 120.58 1.536 . . . . 0.0 110.272 172.533 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 17.4 m -136.75 151.34 49.1 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.647 1.579 . . . . 0.0 108.798 176.276 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 46.3 m -148.35 157.4 43.46 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.871 1.669 . . . . 0.0 108.595 169.633 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 39.4 t -133.8 146.24 32.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 -178.296 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 79.58 -175.87 54.88 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 123.646 0.641 . . . . 0.0 112.296 176.022 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -62.46 145.28 54.56 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.577 0.751 . . . . 0.0 110.563 178.763 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 68.9 mttt -143.72 134.31 12.23 Favored Pre-proline 0 CA--C 1.532 0.258 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 168.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -69.5 160.76 48.56 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.306 2.004 . . . . 0.0 109.907 174.25 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 49.7 pttt -59.24 -28.3 66.57 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 -176.829 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -65.54 -47.89 74.35 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 118.444 0.565 . . . . 0.0 109.975 174.116 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.53 -37.65 88.28 Favored 'General case' 0 CA--C 1.529 0.173 0 O-C-N 121.859 -0.526 . . . . 0.0 110.619 177.527 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 83.0 mt -65.19 -42.12 93.89 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-O 119.285 -0.388 . . . . 0.0 111.383 176.541 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 15.8 mt-30 -59.3 -42.87 92.35 Favored 'General case' 0 C--O 1.225 -0.214 0 CA-C-N 118.697 0.681 . . . . 0.0 109.643 175.056 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -65.99 -38.6 88.91 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 118.017 0.371 . . . . 0.0 110.683 -179.127 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 65.9 tp -61.15 -47.25 87.06 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 125.025 1.33 . . . . 0.0 110.328 176.424 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 97.3 t -61.55 -43.26 96.64 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 123.902 0.881 . . . . 0.0 110.045 174.041 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -61.51 -26.05 67.67 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 125.18 1.392 . . . . 0.0 112.136 -172.088 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 82.3 mttt -55.15 -24.88 28.62 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 118.774 -0.632 . . . . 0.0 112.617 172.436 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 43.3 m-70 -121.74 -10.67 8.71 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 -167.707 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 78.7 mt . . . . . 0 C--O 1.249 1.077 0 CA-C-N 118.565 0.62 . . . . 0.0 109.457 172.586 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.9 mt . . . . . 0 CA--C 1.537 0.471 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 29.0 t -136.47 163.97 32.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 C-N-CA 126.724 2.01 . . . . 0.0 106.273 -178.465 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.52 133.78 49.81 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 104.923 -2.251 . . . . 0.0 104.923 176.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -135.22 175.11 9.89 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 123.875 0.87 . . . . 0.0 111.37 -171.438 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 31.3 p -137.87 178.56 7.02 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 125.244 1.418 . . . . 0.0 107.779 169.671 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -49.3 -30.34 7.27 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.895 0.878 . . . . 0.0 112.4 169.424 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -64.81 -27.47 68.91 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.003 1.321 . . . . 0.0 112.776 -179.689 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 14.1 p -130.83 -17.55 3.16 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 114.298 1.222 . . . . 0.0 114.298 -167.63 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 56.8 t80 -52.2 -47.28 65.67 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 124.463 1.105 . . . . 0.0 112.259 -170.327 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.2 m -64.56 -37.9 89.15 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 122.62 0.368 . . . . 0.0 111.849 -176.349 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -69.09 -44.56 72.24 Favored 'General case' 0 N--CA 1.452 -0.343 0 O-C-N 122.017 -0.427 . . . . 0.0 109.96 176.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 68.9 mm-40 -63.22 -35.82 81.59 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 122.529 0.331 . . . . 0.0 110.921 -178.188 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.407 ' HA ' HG21 ' A' ' 20' ' ' VAL . 29.3 p -82.85 0.62 43.22 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 -176.89 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 70.7 m -102.04 29.21 5.2 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.972 0.909 . . . . 0.0 112.068 -175.583 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -135.2 55.24 1.89 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.831 0.853 . . . . 0.0 111.387 -173.58 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 107.39 -152.06 16.91 Favored Glycine 0 C--N 1.337 0.614 0 N-CA-C 109.954 -1.258 . . . . 0.0 109.954 173.323 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.2 t -74.83 135.75 26.65 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 N-CA-C 104.88 -2.267 . . . . 0.0 104.88 166.754 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.407 HG21 ' HA ' ' A' ' 15' ' ' THR . 34.3 t -136.15 139.47 45.61 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 N-CA-C 106.441 -1.688 . . . . 0.0 106.441 178.765 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.8 tt -124.17 100.11 6.56 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 106.131 -1.803 . . . . 0.0 106.131 -177.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -81.33 145.67 30.75 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.236 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -124.52 94.02 4.08 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 125.899 1.68 . . . . 0.0 107.619 -176.784 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -74.22 112.51 10.45 Favored 'General case' 0 C--O 1.24 0.58 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 175.388 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -148.96 -176.51 5.37 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.966 1.306 . . . . 0.0 108.548 -172.581 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -156.44 146.74 15.9 Favored Pre-proline 0 CA--C 1.533 0.296 0 N-CA-C 106.16 -1.793 . . . . 0.0 106.16 168.073 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -60.76 -17.95 53.04 Favored 'Trans proline' 0 CA--C 1.534 0.495 0 C-N-CA 121.662 1.575 . . . . 0.0 115.799 -178.373 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 50.5 p-90 -69.23 -20.56 63.95 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 119.99 1.268 . . . . 0.0 112.011 173.411 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 34.1 t -58.9 146.9 35.99 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 125.055 1.342 . . . . 0.0 111.231 -172.443 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -95.4 -62.43 0.99 Allowed Glycine 0 CA--C 1.531 1.082 0 CA-C-O 118.647 -1.085 . . . . 0.0 111.163 170.56 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -64.43 -26.53 62.9 Favored 'Trans proline' 0 C--N 1.35 0.634 0 CA-C-N 120.257 2.029 . . . . 0.0 113.387 -173.1 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 30.2 m -57.29 -34.7 68.95 Favored 'General case' 0 CA--C 1.537 0.456 0 O-C-N 121.63 -0.669 . . . . 0.0 111.479 174.385 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.9 mmtp -67.91 -24.49 65.21 Favored 'General case' 0 CA--C 1.531 0.25 0 O-C-N 121.645 -0.659 . . . . 0.0 111.057 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 32.3 mtm -71.25 -44.04 66.07 Favored 'General case' 0 C--N 1.34 0.18 0 CA-C-N 118.654 0.661 . . . . 0.0 110.411 177.212 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 14.5 tt -82.21 -23.69 9.33 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-O 118.745 -0.645 . . . . 0.0 111.523 -176.048 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -48.59 -51.46 52.33 Favored Pre-proline 0 CA--C 1.548 0.888 0 CA-C-N 120.062 1.301 . . . . 0.0 114.262 179.443 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -66.93 -28.08 42.53 Favored 'Trans proline' 0 C--N 1.35 0.649 0 CA-C-N 121.807 1.681 . . . . 0.0 112.407 176.766 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.6 t -67.8 -37.92 79.32 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 O-C-N 121.584 -0.698 . . . . 0.0 109.313 174.595 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 95.0 mt -67.16 -35.4 79.6 Favored 'General case' 0 C--N 1.34 0.166 0 CA-C-N 119.516 1.053 . . . . 0.0 111.328 172.677 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -61.96 -43.07 99.6 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 119.548 1.067 . . . . 0.0 110.755 171.664 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -63.38 -41.35 98.79 Favored 'General case' 0 CA--C 1.53 0.179 0 O-C-N 121.279 -0.888 . . . . 0.0 110.421 175.072 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 35.3 tp -60.82 -42.21 97.23 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 123.494 0.718 . . . . 0.0 110.24 177.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -60.54 -43.82 96.79 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 123.347 0.659 . . . . 0.0 110.728 177.119 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 -71.4 -10.72 60.21 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.29 0.636 . . . . 0.0 112.629 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -105.59 -28.09 10.97 Favored 'General case' 0 C--O 1.232 0.172 0 C-N-CA 125.46 1.504 . . . . 0.0 111.42 -178.335 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 22.8 mtp -131.44 0.27 4.04 Favored 'General case' 0 N--CA 1.461 0.105 0 N-CA-C 113.658 0.985 . . . . 0.0 113.658 -169.002 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -55.82 -10.31 3.35 Favored Glycine 0 CA--C 1.535 1.343 0 C-N-CA 124.747 1.165 . . . . 0.0 115.926 -176.456 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -72.86 -29.14 62.97 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.597 1.159 . . . . 0.0 112.049 172.812 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 42.3 mmtm -126.37 -14.9 5.79 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 125.732 1.613 . . . . 0.0 112.842 -175.593 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 58.9 tp -120.3 142.59 48.95 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 124.144 0.978 . . . . 0.0 109.925 -170.722 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -117.73 145.48 44.43 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 104.899 -2.26 . . . . 0.0 104.899 167.862 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 73.7 mt -116.19 138.19 47.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 105.399 -2.075 . . . . 0.0 105.399 176.371 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 93.1 t -132.59 96.47 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -169.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 54.4 mtpt -74.24 139.05 44.07 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 177.328 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 17.3 tt -141.41 125.62 16.89 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 176.787 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 39.4 t0 -82.35 104.89 12.99 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 124.737 1.215 . . . . 0.0 108.428 -175.241 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 30.5 m -60.47 -25.8 35.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 C-N-CA 123.464 0.705 . . . . 0.0 112.194 -173.329 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -64.83 -26.54 68.38 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 119.188 0.904 . . . . 0.0 111.468 -177.674 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -108.97 6.38 25.14 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.098 1.359 . . . . 0.0 110.791 -179.205 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 68.3 m-80 -146.69 39.66 1.06 Allowed 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.536 1.135 . . . . 0.0 110.137 -168.369 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -57.84 -29.6 65.1 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.448 1.099 . . . . 0.0 110.541 179.366 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 48.1 mp0 -65.4 -51.35 60.93 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 124.7 1.2 . . . . 0.0 109.923 177.85 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.12 -38.55 85.79 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.536 0.734 . . . . 0.0 109.748 -178.654 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.1 -48.62 80.95 Favored 'General case' 0 CA--C 1.534 0.34 0 O-C-N 121.105 -0.997 . . . . 0.0 110.255 172.185 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -60.59 -28.92 68.52 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 123.887 0.756 . . . . 0.0 112.397 177.519 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 73.7 tttt -55.82 -29.28 59.52 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 125.047 1.339 . . . . 0.0 111.674 179.329 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -123.64 10.17 9.03 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.647 0.779 . . . . 0.0 111.87 179.288 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 64.37 28.75 73.5 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 123.736 0.684 . . . . 0.0 112.839 -176.692 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 51.0 t -62.08 125.65 18.81 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 172.054 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 12.0 tpt -137.6 0.71 2.28 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.567 1.147 . . . . 0.0 111.15 -176.312 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 28.0 m -144.87 162.67 36.24 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 126.594 1.957 . . . . 0.0 107.439 179.031 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 40.2 pt -142.97 154.44 61.89 Favored Pre-proline 0 CA--C 1.546 0.809 0 C-N-CA 124.502 1.121 . . . . 0.0 108.916 177.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -68.03 138.49 44.33 Favored 'Cis proline' 0 C--N 1.35 0.628 0 CA-C-N 120.427 1.188 . . . . 0.0 110.376 -3.58 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 26.0 m -129.42 141.55 51.01 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 173.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 86.7 mt -122.82 127.17 48.71 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 -169.488 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -115.99 123.63 48.5 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 103.683 -2.71 . . . . 0.0 103.683 177.419 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 6.2 t -99.24 125.13 52.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 103.993 -2.595 . . . . 0.0 103.993 177.545 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.7 mp -122.5 153.67 38.86 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 4.5 tmtp? -135.19 120.24 18.72 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 106.306 -1.739 . . . . 0.0 106.306 175.264 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.5 t70 50.69 36.88 15.15 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.901 1.28 . . . . 0.0 112.559 175.362 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 106.24 -4.26 38.04 Favored Glycine 0 CA--C 1.526 0.779 0 CA-C-O 118.104 -1.387 . . . . 0.0 115.326 168.601 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -130.87 147.72 52.55 Favored 'General case' 0 C--N 1.339 0.132 0 CA-C-N 120.085 1.942 . . . . 0.0 110.205 -177.453 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 53.0 t -63.26 132.86 29.24 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 178.604 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 5.2 p -119.21 -20.39 4.99 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 C-N-CA 124.823 1.249 . . . . 0.0 110.795 174.502 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -158.23 168.73 26.23 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 120.544 1.52 . . . . 0.0 110.903 173.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 10.3 m -138.26 150.94 47.16 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.399 1.48 . . . . 0.0 108.497 175.449 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 2.7 m -146.54 157.16 43.69 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 125.761 1.624 . . . . 0.0 108.653 169.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 39.5 t -133.67 147.14 30.92 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 176.883 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 78.47 -176.94 54.07 Favored Glycine 0 CA--C 1.53 0.973 0 CA-C-O 121.638 0.577 . . . . 0.0 112.406 177.101 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 60.0 t80 -65.91 145.03 56.4 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.921 0.888 . . . . 0.0 110.896 -179.344 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -141.93 140.57 19.96 Favored Pre-proline 0 CA--C 1.535 0.37 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 167.766 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -72.11 162.5 41.55 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 122.68 2.254 . . . . 0.0 110.781 175.757 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 31.9 pttt -58.91 -30.99 68.23 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 -177.881 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -66.94 -49.76 64.5 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 118.336 0.516 . . . . 0.0 109.969 176.194 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.24 -39.4 94.5 Favored 'General case' 0 CA--C 1.529 0.146 0 O-C-N 121.923 -0.486 . . . . 0.0 110.512 179.307 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 59.3 mt -62.48 -45.22 94.01 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 123.345 0.658 . . . . 0.0 111.013 176.315 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 19.2 mt-30 -58.79 -42.15 88.39 Favored 'General case' 0 C--O 1.225 -0.214 0 CA-C-N 118.311 0.505 . . . . 0.0 110.262 176.229 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -66.89 -38.62 86.62 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 118.488 0.586 . . . . 0.0 110.817 -179.079 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 64.8 tp -63.67 -38.32 90.68 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.869 1.267 . . . . 0.0 110.956 176.257 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 96.4 t -68.54 -46.38 80.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-N 119.083 0.856 . . . . 0.0 109.787 172.241 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -56.79 -41.96 78.61 Favored 'General case' 0 CA--C 1.519 -0.219 0 C-N-CA 125.449 1.499 . . . . 0.0 111.802 -168.374 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -68.39 -5.62 20.05 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -175.755 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 83.5 m-70 -123.72 2.56 8.86 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.311 1.044 . . . . 0.0 112.8 178.566 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 53.9 mt . . . . . 0 C--O 1.249 1.058 0 CA-C-N 119.306 0.957 . . . . 0.0 109.545 174.449 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.9 mt . . . . . 0 CA--C 1.538 0.497 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 29.5 t -139.53 163.72 25.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 C-N-CA 126.426 1.89 . . . . 0.0 107.138 -174.326 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -113.74 146.03 40.47 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 174.284 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -145.25 168.02 21.43 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 123.086 0.554 . . . . 0.0 110.077 175.884 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 31.7 p -132.42 178.57 6.72 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 168.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -53.29 -28.14 26.51 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.385 0.674 . . . . 0.0 112.292 174.781 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 -66.05 -29.01 69.28 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.294 1.838 . . . . 0.0 112.832 179.26 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 16.6 p -129.62 -14.61 4.1 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 -167.38 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -52.61 -47.03 67.22 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 124.453 1.101 . . . . 0.0 111.987 -172.499 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.8 m -63.84 -38.88 92.73 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 122.855 0.462 . . . . 0.0 111.787 -177.23 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -67.56 -44.79 77.4 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 177.857 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -64.02 -35.76 81.78 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 122.392 0.277 . . . . 0.0 111.062 -178.299 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 29.0 p -84.12 0.18 49.49 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.868 0.867 . . . . 0.0 113.251 -176.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 70.1 m -99.41 30.0 3.74 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.127 0.971 . . . . 0.0 111.758 -177.807 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -132.95 56.75 1.83 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.255 1.022 . . . . 0.0 110.543 -176.52 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 97.14 -155.36 20.66 Favored Glycine 0 C--N 1.336 0.572 0 N-CA-C 110.043 -1.223 . . . . 0.0 110.043 175.314 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 65.5 t -71.42 133.09 32.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 168.392 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 46.9 t -137.25 141.59 39.57 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 N-CA-C 105.907 -1.886 . . . . 0.0 105.907 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 3.8 tt -122.81 100.21 6.79 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 106.208 -1.775 . . . . 0.0 106.208 -175.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -82.09 146.22 29.75 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.402 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -125.63 94.2 4.06 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 126.101 1.761 . . . . 0.0 107.323 -178.118 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -73.54 113.46 10.68 Favored 'General case' 0 C--O 1.24 0.563 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 174.489 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -149.01 -177.33 5.75 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.842 1.257 . . . . 0.0 108.595 -172.891 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -156.21 148.3 17.46 Favored Pre-proline 0 CA--C 1.532 0.268 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 167.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -60.61 -18.63 55.97 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 121.796 1.664 . . . . 0.0 115.68 -179.288 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 50.6 p-90 -69.69 -20.14 63.56 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 119.987 1.267 . . . . 0.0 112.01 173.801 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 33.7 t -59.56 148.37 33.61 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 124.975 1.31 . . . . 0.0 111.185 -172.626 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -97.78 -63.36 0.89 Allowed Glycine 0 CA--C 1.529 0.962 0 CA-C-O 118.503 -1.165 . . . . 0.0 110.92 171.569 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -62.34 -26.57 77.1 Favored 'Trans proline' 0 C--N 1.351 0.704 0 CA-C-N 120.367 2.084 . . . . 0.0 113.73 -174.652 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 34.3 m -57.08 -35.59 69.57 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 121.653 -0.654 . . . . 0.0 111.513 174.388 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.0 mmtp -67.32 -25.54 66.07 Favored 'General case' 0 CA--C 1.53 0.208 0 O-C-N 121.63 -0.669 . . . . 0.0 110.977 -179.27 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 31.4 mtm -70.86 -44.24 66.81 Favored 'General case' 0 C--N 1.341 0.222 0 CA-C-N 118.619 0.645 . . . . 0.0 110.313 177.195 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 15.4 tt -83.32 -23.65 8.24 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 CA-C-O 118.685 -0.674 . . . . 0.0 111.831 -174.816 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -48.78 -51.45 53.84 Favored Pre-proline 0 CA--C 1.547 0.843 0 CA-C-N 119.941 1.246 . . . . 0.0 114.072 179.027 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -66.78 -29.22 42.65 Favored 'Trans proline' 0 C--N 1.35 0.642 0 CA-C-N 121.737 1.656 . . . . 0.0 112.24 176.839 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.2 t -67.91 -36.83 77.07 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 O-C-N 121.545 -0.722 . . . . 0.0 109.579 175.255 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 55.2 mt -68.15 -35.25 77.76 Favored 'General case' 0 C--O 1.226 -0.178 0 CA-C-N 119.43 1.014 . . . . 0.0 111.07 173.369 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -61.96 -42.83 99.56 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 119.196 0.907 . . . . 0.0 110.803 170.491 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -64.76 -38.71 91.9 Favored 'General case' 0 CA--C 1.532 0.277 0 O-C-N 121.092 -1.005 . . . . 0.0 110.686 176.109 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 43.5 tp -61.82 -42.92 99.63 Favored 'General case' 0 C--N 1.335 -0.032 0 C-N-CA 123.625 0.77 . . . . 0.0 109.95 175.289 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -60.23 -42.2 94.7 Favored 'General case' 0 CA--C 1.522 -0.119 0 C-N-CA 123.041 0.536 . . . . 0.0 110.728 178.116 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 -72.34 -10.92 60.4 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 112.573 0.582 . . . . 0.0 112.573 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -105.36 -32.86 8.38 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 125.353 1.461 . . . . 0.0 111.545 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 82.1 mmm -126.16 -5.7 6.67 Favored 'General case' 0 C--O 1.227 -0.127 0 CA-C-O 118.226 -0.892 . . . . 0.0 113.097 -167.587 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -57.82 -13.95 14.65 Favored Glycine 0 CA--C 1.532 1.155 0 CA-C-N 120.027 1.285 . . . . 0.0 114.873 -174.823 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -66.73 -27.32 67.52 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.508 1.123 . . . . 0.0 112.011 172.513 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.471 ' HA ' ' HE3' ' A' ' 49' ' ' LYS . 0.0 OUTLIER -120.93 -21.61 6.48 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 126.094 1.757 . . . . 0.0 111.84 179.787 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 35.9 tp -109.49 157.67 18.74 Favored 'General case' 0 C--O 1.232 0.169 0 C-N-CA 123.994 0.918 . . . . 0.0 111.428 -169.081 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -131.27 143.19 50.36 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 103.846 -2.65 . . . . 0.0 103.846 166.52 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 73.6 mt -116.01 140.38 38.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 105.517 -2.031 . . . . 0.0 105.517 176.886 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 81.3 t -132.53 98.36 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 -172.017 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -74.3 140.34 44.83 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 174.781 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 14.9 tt -142.63 126.91 15.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 N-CA-C 108.679 -0.859 . . . . 0.0 108.679 176.513 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 62.2 t0 -84.4 105.36 15.18 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 124.609 1.163 . . . . 0.0 109.057 -173.11 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 31.4 m -59.61 -26.14 33.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 118.664 -0.684 . . . . 0.0 112.023 -175.113 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -65.18 -18.6 65.44 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 119.407 1.003 . . . . 0.0 112.143 -176.489 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -119.87 3.71 11.03 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.916 1.287 . . . . 0.0 111.173 178.584 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -139.39 40.29 2.07 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 124.528 1.131 . . . . 0.0 109.82 -169.836 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 51.4 mm-40 -56.04 -33.05 64.58 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.997 0.919 . . . . 0.0 111.227 178.015 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -66.08 -46.53 77.37 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 118.509 0.595 . . . . 0.0 110.549 179.414 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.19 -39.03 78.93 Favored 'General case' 0 C--O 1.223 -0.32 0 O-C-N 121.816 -0.553 . . . . 0.0 109.721 -179.296 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -58.79 -47.95 82.96 Favored 'General case' 0 CA--C 1.534 0.346 0 O-C-N 121.062 -1.024 . . . . 0.0 110.244 172.502 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -60.38 -28.47 67.26 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 124.171 0.891 . . . . 0.0 112.421 177.046 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 48.2 tptt -56.2 -29.07 60.42 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.546 1.139 . . . . 0.0 111.491 179.322 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -123.99 10.26 8.82 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.511 0.724 . . . . 0.0 111.661 -179.45 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 63.36 30.51 77.77 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 123.693 0.663 . . . . 0.0 112.572 -176.253 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 61.5 t -61.37 122.34 11.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 173.053 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 25.8 ptp -129.9 -12.4 4.22 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 124.923 1.289 . . . . 0.0 112.748 -171.817 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 23.0 m -139.9 165.23 27.87 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 127.396 2.278 . . . . 0.0 108.124 178.014 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 36.7 pt -142.13 154.79 65.05 Favored Pre-proline 0 CA--C 1.545 0.772 0 C-N-CA 124.845 1.258 . . . . 0.0 108.567 177.757 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -67.94 139.87 51.34 Favored 'Cis proline' 0 C--N 1.351 0.664 0 CA-C-N 120.481 1.208 . . . . 0.0 110.414 -2.817 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 22.7 m -130.99 139.12 49.96 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 174.705 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 85.5 mt -119.46 126.1 50.51 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 106.819 -1.548 . . . . 0.0 106.819 -169.609 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -117.01 119.28 34.82 Favored 'General case' 0 CA--C 1.511 -0.535 0 N-CA-C 103.755 -2.683 . . . . 0.0 103.755 177.59 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.4 t -92.34 124.29 44.75 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 N-CA-C 103.582 -2.747 . . . . 0.0 103.582 173.43 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.3 mp -115.03 155.12 27.58 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 174.098 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -136.73 123.75 21.53 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 171.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 27.9 t70 49.45 38.03 13.37 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.008 1.323 . . . . 0.0 112.456 177.195 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 101.64 -2.72 53.05 Favored Glycine 0 CA--C 1.528 0.865 0 CA-C-O 118.108 -1.384 . . . . 0.0 115.395 168.795 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -131.47 151.74 51.3 Favored 'General case' 0 CA--C 1.528 0.109 0 CA-C-N 120.063 1.931 . . . . 0.0 110.185 -178.706 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 38.8 t -62.85 133.32 28.7 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.9 p -120.61 -20.28 4.57 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 C-N-CA 125.324 1.45 . . . . 0.0 109.872 177.735 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -161.02 168.73 23.91 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 120.315 1.416 . . . . 0.0 110.47 171.672 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 10.5 m -140.46 151.03 44.54 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.078 1.351 . . . . 0.0 108.741 175.837 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 58.7 m -150.45 157.21 42.77 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.283 1.433 . . . . 0.0 108.835 169.429 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 43.7 t -133.89 144.56 35.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 -178.855 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 79.24 -175.07 55.21 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 123.434 0.54 . . . . 0.0 112.153 178.481 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -63.58 148.77 47.97 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.742 0.817 . . . . 0.0 111.031 -179.258 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 45.6 mttm -144.14 135.54 12.68 Favored Pre-proline 0 C--O 1.233 0.234 0 N-CA-C 106.406 -1.702 . . . . 0.0 106.406 168.617 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -70.0 162.37 42.46 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 122.154 1.903 . . . . 0.0 110.266 173.155 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 18.2 ptmt -55.98 -31.02 62.63 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.424 1.09 . . . . 0.0 113.533 -179.599 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -67.43 -49.69 62.62 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 118.528 0.604 . . . . 0.0 109.767 176.176 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.04 -39.38 94.56 Favored 'General case' 0 C--N 1.34 0.173 0 C-N-CA 122.896 0.478 . . . . 0.0 110.72 179.338 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 86.2 mt -62.95 -45.39 92.69 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.111 0.564 . . . . 0.0 111.166 176.399 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -61.07 -41.14 96.08 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-O 118.944 -0.551 . . . . 0.0 110.353 176.777 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -63.72 -41.62 98.04 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 118.427 0.558 . . . . 0.0 110.275 179.174 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 67.8 tp -61.73 -41.49 97.71 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 124.729 1.212 . . . . 0.0 110.98 177.707 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 75.1 t -62.39 -47.72 91.7 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 CA-C-N 118.757 0.708 . . . . 0.0 109.365 171.77 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 -61.76 -26.53 68.14 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 125.504 1.522 . . . . 0.0 112.291 -171.818 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -53.83 -26.87 26.42 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 123.604 0.761 . . . . 0.0 112.416 172.604 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 72.8 m-70 -123.49 -6.09 8.16 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 113.852 1.056 . . . . 0.0 113.852 -167.805 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 79.9 mt . . . . . 0 C--O 1.249 1.062 0 CA-C-N 118.814 0.733 . . . . 0.0 109.286 171.851 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.2 mt . . . . . 0 CA--C 1.534 0.359 0 N-CA-C 106.225 -1.769 . . . . 0.0 106.225 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 43.4 t -134.2 163.07 38.01 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 C-N-CA 126.89 2.076 . . . . 0.0 106.0 -178.013 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 1.4 tmtt? -129.01 131.54 47.41 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 104.247 -2.501 . . . . 0.0 104.247 179.555 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -142.6 173.46 11.51 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 123.732 0.813 . . . . 0.0 110.973 -169.247 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 23.6 p -136.91 174.01 11.08 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 125.066 1.347 . . . . 0.0 107.573 169.82 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -51.13 -27.97 9.79 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.726 1.21 . . . . 0.0 112.976 176.442 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -57.99 -30.59 66.18 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.103 1.761 . . . . 0.0 112.767 178.409 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.0 m -139.55 -7.4 1.3 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.837 0.855 . . . . 0.0 113.277 -169.494 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 69.2 t80 -51.45 -44.0 62.25 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.409 1.084 . . . . 0.0 111.925 -177.19 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.7 m -63.58 -38.39 90.96 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 122.991 0.516 . . . . 0.0 111.804 -178.379 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -68.32 -44.82 74.54 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 176.462 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 67.7 mm-40 -62.43 -36.83 83.62 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 122.67 0.388 . . . . 0.0 111.124 -178.24 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.7 p -83.13 0.7 43.98 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.072 0.949 . . . . 0.0 113.46 -177.842 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 68.0 m -105.15 33.33 3.71 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.206 1.002 . . . . 0.0 111.125 -176.61 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -132.8 60.25 1.71 Allowed 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.253 1.021 . . . . 0.0 109.966 -178.243 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 92.11 -153.71 22.0 Favored Glycine 0 C--N 1.337 0.633 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 177.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 82.9 t -74.06 137.01 24.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 168.702 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 48.1 t -139.21 145.96 26.54 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 N-CA-C 105.952 -1.87 . . . . 0.0 105.952 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.3 tt -125.01 99.09 5.97 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 106.448 -1.686 . . . . 0.0 106.448 -176.09 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -79.51 144.63 33.78 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 123.572 0.749 . . . . 0.0 109.17 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -126.92 94.35 4.01 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 126.045 1.738 . . . . 0.0 107.643 -176.316 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -74.49 113.46 11.76 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 173.452 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -147.22 -171.47 3.79 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.128 1.371 . . . . 0.0 108.225 -175.449 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -161.32 148.0 11.52 Favored Pre-proline 0 CA--C 1.533 0.306 0 N-CA-C 105.996 -1.853 . . . . 0.0 105.996 166.671 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -60.58 -18.07 52.47 Favored 'Trans proline' 0 CA--C 1.534 0.477 0 C-N-CA 121.776 1.651 . . . . 0.0 115.745 -178.673 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 50.7 p-90 -69.76 -20.57 63.49 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 120.029 1.286 . . . . 0.0 111.998 173.673 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 26.9 t -59.89 148.74 33.8 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 124.902 1.281 . . . . 0.0 111.096 -172.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -100.6 -63.97 0.79 Allowed Glycine 0 CA--C 1.529 0.938 0 CA-C-O 118.501 -1.166 . . . . 0.0 110.492 172.561 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_exo -53.77 -32.4 65.9 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 123.244 2.629 . . . . 0.0 114.495 -179.346 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 35.9 m -57.55 -34.82 69.57 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.326 0.651 . . . . 0.0 111.635 176.781 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.5 mmtp -67.93 -25.49 65.5 Favored 'General case' 0 CA--C 1.531 0.248 0 O-C-N 121.589 -0.694 . . . . 0.0 110.836 -179.575 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 30.0 mtm -71.25 -42.46 68.79 Favored 'General case' 0 C--N 1.341 0.213 0 CA-C-N 118.67 0.668 . . . . 0.0 110.444 176.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 17.1 tt -84.07 -22.48 8.11 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-O 118.807 -0.616 . . . . 0.0 111.53 -175.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -48.99 -51.21 57.58 Favored Pre-proline 0 CA--C 1.547 0.862 0 CA-C-N 120.028 1.285 . . . . 0.0 113.971 178.221 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -67.07 -28.37 41.33 Favored 'Trans proline' 0 C--N 1.35 0.614 0 CA-C-N 121.724 1.652 . . . . 0.0 112.303 176.641 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 13.0 t -66.45 -39.3 83.69 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 174.269 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 87.4 mt -67.06 -34.7 78.25 Favored 'General case' 0 C--N 1.34 0.165 0 CA-C-N 119.22 0.918 . . . . 0.0 111.323 173.652 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -62.5 -44.36 96.56 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 119.571 1.078 . . . . 0.0 110.746 171.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -64.42 -38.31 90.6 Favored 'General case' 0 CA--C 1.532 0.271 0 O-C-N 121.233 -0.917 . . . . 0.0 110.7 176.69 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 61.5 tp -63.22 -44.26 95.79 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.619 0.768 . . . . 0.0 110.015 176.766 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -59.31 -41.73 89.73 Favored 'General case' 0 CA--C 1.521 -0.153 0 C-N-CA 123.41 0.684 . . . . 0.0 111.009 177.378 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -72.06 -10.38 59.7 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.075 0.55 . . . . 0.0 112.464 -179.422 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 -104.77 -33.43 8.44 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 125.208 1.403 . . . . 0.0 111.662 179.176 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 74.8 mmm -121.29 -4.44 9.43 Favored 'General case' 0 C--O 1.224 -0.242 0 CA-C-O 118.18 -0.914 . . . . 0.0 112.658 -168.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -58.22 -14.09 17.58 Favored Glycine 0 CA--C 1.531 1.075 0 CA-C-N 120.07 1.305 . . . . 0.0 115.23 -173.237 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -70.14 -25.14 63.33 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 118.533 1.167 . . . . 0.0 111.775 172.626 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.428 ' HA ' ' HE2' ' A' ' 49' ' ' LYS . 9.7 mmpt? -123.67 -17.43 6.41 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 126.519 1.928 . . . . 0.0 111.628 -175.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 28.0 tp -118.94 159.39 23.9 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 124.718 1.207 . . . . 0.0 111.021 -169.451 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 37.2 ttmt -134.82 145.2 48.12 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 104.108 -2.552 . . . . 0.0 104.108 167.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 62.3 mt -115.81 141.11 34.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 175.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 69.1 t -132.83 96.81 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 -172.257 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -75.96 131.91 39.88 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 177.498 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 15.9 tt -140.34 135.49 36.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -97.78 115.57 28.28 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 123.875 0.87 . . . . 0.0 111.049 -168.045 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 35.7 m -60.96 -19.62 20.15 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 O-C-N 121.582 -0.699 . . . . 0.0 112.321 -178.019 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -63.39 -21.75 66.47 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.757 1.223 . . . . 0.0 113.004 179.092 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -131.79 1.76 4.01 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.655 0.782 . . . . 0.0 112.625 178.467 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 63.4 m-80 -129.88 39.41 3.7 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.683 0.793 . . . . 0.0 110.896 -170.333 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.2 mp0 -54.97 -31.88 61.11 Favored 'General case' 0 C--N 1.34 0.178 0 C-N-CA 123.707 0.803 . . . . 0.0 111.896 176.854 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 27.4 tp10 -67.31 -47.08 71.63 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 123.979 0.912 . . . . 0.0 110.556 -178.299 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.72 -39.46 76.84 Favored 'General case' 0 CA--C 1.535 0.395 0 O-C-N 121.728 -0.607 . . . . 0.0 109.561 179.316 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.29 -47.45 85.34 Favored 'General case' 0 CA--C 1.533 0.312 0 O-C-N 121.423 -0.798 . . . . 0.0 110.56 174.02 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -62.66 -27.11 69.3 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 124.055 0.836 . . . . 0.0 111.876 178.448 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 5.8 tppt? -55.67 -28.44 55.54 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.568 1.147 . . . . 0.0 111.877 177.641 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -124.22 11.39 8.78 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.81 0.844 . . . . 0.0 111.572 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 63.77 30.48 77.79 Favored Glycine 0 CA--C 1.532 1.094 0 C-N-CA 123.72 0.676 . . . . 0.0 112.761 -177.458 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 60.9 t -65.86 125.66 23.45 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 172.28 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 66.8 mtt -136.75 3.98 2.77 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.821 1.249 . . . . 0.0 111.448 -179.275 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 23.4 m -144.05 162.62 35.75 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 126.676 1.991 . . . . 0.0 107.768 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 44.2 pt -141.72 155.48 66.44 Favored Pre-proline 0 CA--C 1.545 0.78 0 C-N-CA 124.445 1.098 . . . . 0.0 108.796 175.819 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -67.38 139.62 48.1 Favored 'Cis proline' 0 C--N 1.35 0.607 0 CA-C-N 120.209 1.11 . . . . 0.0 110.209 -5.796 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 50.9 m -132.65 140.69 48.29 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 174.721 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 87.8 mt -123.62 129.18 50.76 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 -169.564 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -120.94 122.9 41.18 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 103.431 -2.803 . . . . 0.0 103.431 177.471 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 1.8 t -100.22 120.17 49.3 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 N-CA-C 103.899 -2.63 . . . . 0.0 103.899 176.218 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.3 mp -112.03 155.16 24.24 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 -178.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 57.8 tttp -134.59 115.59 14.04 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 105.785 -1.932 . . . . 0.0 105.785 177.412 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.0 t70 49.87 39.17 17.72 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.893 1.277 . . . . 0.0 112.374 176.784 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 104.79 -5.62 43.39 Favored Glycine 0 CA--C 1.529 0.955 0 CA-C-O 118.139 -1.367 . . . . 0.0 115.295 169.041 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -131.29 149.27 52.63 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 120.054 1.927 . . . . 0.0 110.527 -177.697 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 39.2 t -63.59 134.49 28.57 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 -179.326 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 8.7 p -118.94 -26.41 2.51 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 C-N-CA 125.065 1.346 . . . . 0.0 110.504 172.488 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -149.9 165.28 33.06 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 120.689 1.586 . . . . 0.0 110.046 173.829 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 17.2 m -140.86 151.18 44.1 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.442 1.497 . . . . 0.0 108.025 178.116 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 37.3 m -151.25 157.06 42.1 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.415 1.486 . . . . 0.0 109.265 169.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 30.6 t -135.62 145.65 31.14 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 -176.456 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 75.81 -176.75 50.65 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 123.896 0.76 . . . . 0.0 111.893 178.754 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 47.4 t80 -62.06 137.58 58.27 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 173.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 64.6 tttt -149.94 137.68 11.76 Favored Pre-proline 0 C--O 1.235 0.316 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 -178.602 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -70.7 153.73 64.45 Favored 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 121.628 1.552 . . . . 0.0 111.959 -172.635 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 29.2 ttpp -52.18 -45.39 65.11 Favored 'General case' 0 CA--C 1.518 -0.256 0 C-N-CA 125.805 1.642 . . . . 0.0 112.313 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -62.92 -43.31 99.14 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 -176.098 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.98 -43.1 96.73 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 122.421 0.288 . . . . 0.0 110.499 179.297 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 76.8 mt -62.32 -44.08 97.32 Favored 'General case' 0 C--O 1.231 0.095 0 CA-C-N 117.535 0.152 . . . . 0.0 110.911 178.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -74.24 -29.27 61.62 Favored 'General case' 0 N--CA 1.451 -0.42 0 O-C-N 122.178 -0.326 . . . . 0.0 110.892 -175.544 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 31.9 tp10 -70.23 -37.72 75.07 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 124.566 1.146 . . . . 0.0 110.543 173.651 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 53.6 mt -60.86 -50.32 73.89 Favored 'General case' 0 C--O 1.224 -0.246 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 172.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 33.0 t -52.22 -46.33 44.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 122.853 0.461 . . . . 0.0 109.949 173.329 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -62.77 -38.43 90.56 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 123.974 0.909 . . . . 0.0 112.258 -171.564 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 16.9 ptmt -67.13 -18.25 65.22 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 118.125 -0.94 . . . . 0.0 112.644 -175.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 5.1 p-80 -127.13 -8.41 5.93 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 115.002 1.482 . . . . 0.0 115.002 -174.249 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 10.2 mt . . . . . 0 C--O 1.248 0.997 0 CA-C-O 118.029 -0.986 . . . . 0.0 109.368 167.433 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.8 mt . . . . . 0 CA--C 1.537 0.459 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 14.7 t -138.53 162.12 29.91 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 126.395 1.878 . . . . 0.0 106.805 -175.608 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -116.5 144.05 44.82 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 106.03 -1.841 . . . . 0.0 106.03 172.735 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -144.36 157.66 44.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.385 0.612 . . . . 0.0 111.566 -176.279 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 16.1 p -105.3 171.07 7.52 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 126.292 1.837 . . . . 0.0 107.646 168.309 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -47.26 -43.85 22.44 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 124.72 1.208 . . . . 0.0 113.112 176.181 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 66.9 mm-40 -79.93 -35.04 38.35 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 122.654 0.382 . . . . 0.0 111.533 -175.771 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.2 m -71.81 -32.38 67.53 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 122.772 0.429 . . . . 0.0 111.315 176.883 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -52.72 -46.74 67.53 Favored 'General case' 0 N--CA 1.457 -0.116 0 C-N-CA 125.128 1.371 . . . . 0.0 112.245 -169.737 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 9.5 m -63.75 -38.4 90.98 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 118.105 0.412 . . . . 0.0 111.86 -176.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -68.81 -44.31 73.81 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 176.856 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 69.0 mm-40 -63.94 -37.21 86.56 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 122.451 0.3 . . . . 0.0 110.925 -178.015 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.423 ' HA ' HG21 ' A' ' 20' ' ' VAL . 28.8 p -80.52 0.1 35.2 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.992 0.917 . . . . 0.0 113.332 -177.552 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 70.8 m -98.13 28.76 3.84 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.097 0.959 . . . . 0.0 112.16 -177.685 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -136.73 81.06 1.85 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.209 1.004 . . . . 0.0 110.023 -178.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 82.64 -156.66 35.17 Favored Glycine 0 C--N 1.338 0.65 0 N-CA-C 110.722 -0.951 . . . . 0.0 110.722 173.477 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 44.9 t -74.17 135.4 27.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 N-CA-C 106.034 -1.839 . . . . 0.0 106.034 168.338 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.423 HG21 ' HA ' ' A' ' 15' ' ' THR . 40.2 t -135.57 136.85 50.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 179.158 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.2 tt -120.01 111.36 17.8 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 106.198 -1.778 . . . . 0.0 106.198 -179.586 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -94.31 144.92 25.12 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 123.854 0.862 . . . . 0.0 109.104 -175.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -124.16 93.73 4.0 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 125.56 1.544 . . . . 0.0 107.469 -176.115 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -73.77 113.44 10.91 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 105.815 -1.92 . . . . 0.0 105.815 174.095 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -150.41 -176.57 5.53 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.727 1.211 . . . . 0.0 108.227 -171.156 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -152.13 149.15 22.58 Favored Pre-proline 0 C--N 1.331 -0.215 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 167.069 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -67.95 -12.65 35.95 Favored 'Trans proline' 0 N--CA 1.459 -0.543 0 CA-C-N 121.179 1.457 . . . . 0.0 113.071 -179.653 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 1.5 m95 -76.27 -12.84 60.15 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.665 0.786 . . . . 0.0 111.876 172.601 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 29.7 t -64.07 153.62 36.92 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.317 1.447 . . . . 0.0 111.089 -176.65 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.403 ' H ' ' HD2' ' A' ' 31' ' ' PRO . . . -101.51 -62.98 0.76 Allowed Glycine 0 CA--C 1.532 1.137 0 C-N-CA 124.723 1.154 . . . . 0.0 111.268 170.319 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.403 ' HD2' ' H ' ' A' ' 30' ' ' GLY . 25.3 Cg_endo -64.88 -25.96 59.72 Favored 'Trans proline' 0 C--N 1.35 0.611 0 CA-C-N 120.472 2.136 . . . . 0.0 113.266 -173.72 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 25.7 m -57.59 -34.43 69.23 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 121.537 -0.727 . . . . 0.0 111.433 174.05 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.4 mmtp -67.7 -22.79 65.25 Favored 'General case' 0 CA--C 1.531 0.22 0 O-C-N 121.663 -0.648 . . . . 0.0 111.199 -179.575 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 34.0 mtm -71.15 -43.64 67.12 Favored 'General case' 0 C--N 1.34 0.179 0 CA-C-N 118.723 0.692 . . . . 0.0 110.359 176.387 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 13.4 tt -84.21 -23.32 7.78 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-O 118.817 -0.611 . . . . 0.0 111.691 -175.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -48.4 -51.17 53.19 Favored Pre-proline 0 CA--C 1.548 0.889 0 CA-C-N 119.959 1.254 . . . . 0.0 114.27 178.6 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -66.59 -29.36 44.08 Favored 'Trans proline' 0 C--N 1.351 0.685 0 CA-C-N 121.628 1.617 . . . . 0.0 112.108 176.696 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 5.1 t -68.06 -36.59 76.01 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 O-C-N 121.585 -0.697 . . . . 0.0 109.751 175.274 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 74.1 mt -67.21 -36.05 80.9 Favored 'General case' 0 C--N 1.34 0.166 0 CA-C-N 119.518 1.053 . . . . 0.0 111.153 172.525 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -62.1 -42.66 99.45 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 119.227 0.921 . . . . 0.0 110.808 171.07 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -63.91 -39.44 94.19 Favored 'General case' 0 CA--C 1.533 0.298 0 O-C-N 121.078 -1.014 . . . . 0.0 110.381 175.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 36.9 tp -62.81 -42.36 99.68 Favored 'General case' 0 CA--C 1.527 0.088 0 C-N-CA 123.754 0.822 . . . . 0.0 110.237 176.651 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -59.09 -43.15 91.83 Favored 'General case' 0 CA--C 1.522 -0.13 0 C-N-CA 123.363 0.665 . . . . 0.0 110.657 176.454 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -71.44 -10.67 60.14 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.327 0.651 . . . . 0.0 112.645 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 23.9 mm-40 -106.63 -28.41 10.24 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 125.419 1.487 . . . . 0.0 111.759 -178.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 23.1 mtp -131.73 -1.7 3.79 Favored 'General case' 0 N--CA 1.461 0.118 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 -169.126 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -54.69 -15.6 6.39 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 124.777 1.179 . . . . 0.0 115.616 -174.18 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -69.7 -28.91 66.24 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.842 1.257 . . . . 0.0 112.016 175.044 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 41.7 mmtm -123.88 -16.06 6.73 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 125.757 1.623 . . . . 0.0 112.39 -177.125 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 58.5 tp -119.28 139.04 52.56 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 123.982 0.913 . . . . 0.0 110.289 -170.889 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -111.69 145.67 38.87 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 105.009 -2.219 . . . . 0.0 105.009 168.074 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 90.4 mt -116.99 138.93 46.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 105.747 -1.946 . . . . 0.0 105.747 174.763 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 98.3 t -132.75 98.87 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 -171.709 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 54.2 mtpt -74.28 140.25 44.82 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 174.518 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 14.3 tt -142.71 128.05 16.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 177.305 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 64.6 t0 -87.57 107.22 18.49 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 124.4 1.08 . . . . 0.0 109.323 -169.787 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 29.0 m -61.69 -20.81 24.15 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 CA-C-O 118.737 -0.649 . . . . 0.0 112.143 -177.447 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -69.04 -14.06 62.81 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 119.691 1.132 . . . . 0.0 112.112 178.365 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -127.06 0.52 6.52 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.1 0.96 . . . . 0.0 111.997 178.501 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 67.8 m-80 -138.39 41.92 2.21 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.735 0.814 . . . . 0.0 111.104 -169.247 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 5.4 mp0 -54.62 -31.66 57.57 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.376 0.67 . . . . 0.0 112.104 176.118 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 -64.72 -46.69 81.23 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 118.471 0.578 . . . . 0.0 110.411 -178.578 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.6 -38.49 73.99 Favored 'General case' 0 C--O 1.223 -0.303 0 C-N-CA 123.162 0.585 . . . . 0.0 109.503 -178.915 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -58.09 -47.9 81.8 Favored 'General case' 0 CA--C 1.535 0.376 0 O-C-N 121.28 -0.888 . . . . 0.0 110.236 172.681 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -61.34 -29.02 70.33 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 124.117 0.865 . . . . 0.0 112.265 177.717 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 74.3 tttt -55.7 -28.73 57.26 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.774 1.23 . . . . 0.0 111.873 178.432 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -123.2 9.94 9.28 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.69 0.796 . . . . 0.0 111.956 178.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 63.57 31.71 81.71 Favored Glycine 0 CA--C 1.533 1.218 0 CA-C-O 119.459 -0.634 . . . . 0.0 112.578 -176.764 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 61.3 t -64.19 124.59 19.26 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 172.725 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 78.2 mtm -137.06 3.53 2.66 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.924 1.29 . . . . 0.0 111.522 -178.902 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 39.1 m -141.48 163.87 31.76 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 126.767 2.027 . . . . 0.0 107.532 175.616 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 41.1 pt -142.99 155.12 62.49 Favored Pre-proline 0 CA--C 1.546 0.806 0 C-N-CA 124.596 1.158 . . . . 0.0 108.626 174.723 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -67.62 137.68 39.15 Favored 'Cis proline' 0 C--N 1.349 0.587 0 CA-C-N 120.5 1.214 . . . . 0.0 110.204 -4.415 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 35.9 m -129.96 134.17 47.28 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 106.97 -1.493 . . . . 0.0 106.97 175.647 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 10.9 mp -114.47 126.54 55.07 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 -169.238 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -114.73 147.72 39.3 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 104.583 -2.377 . . . . 0.0 104.583 175.493 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.4 t -126.79 128.79 71.24 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.624 0 N-CA-C 104.706 -2.331 . . . . 0.0 104.706 -177.681 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.4 mp -130.22 147.89 52.0 Favored 'General case' 0 N--CA 1.445 -0.725 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 -172.518 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 21.4 tptm -133.74 118.32 17.95 Favored 'General case' 0 CA--C 1.514 -0.439 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 29.2 t70 51.15 33.89 10.17 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.486 1.515 . . . . 0.0 112.55 174.068 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 110.72 -3.48 29.07 Favored Glycine 0 CA--C 1.527 0.806 0 CA-C-O 118.062 -1.41 . . . . 0.0 114.869 169.063 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -130.2 144.78 51.56 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 120.027 1.914 . . . . 0.0 110.164 -177.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 13.6 p -65.55 133.23 30.94 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 176.339 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 8.0 p -126.28 -19.02 2.78 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-O 117.653 -1.165 . . . . 0.0 111.239 -179.416 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -156.48 169.96 23.42 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 121.116 1.78 . . . . 0.0 111.529 177.538 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 15.6 m -147.11 151.73 37.31 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.454 1.501 . . . . 0.0 108.907 178.211 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 65.1 m -152.25 157.39 41.35 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 126.18 1.792 . . . . 0.0 108.321 171.903 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 28.7 t -134.06 142.76 40.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 -176.44 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.56 -176.81 53.56 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 123.58 0.61 . . . . 0.0 112.44 177.445 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 66.1 t80 -63.17 150.4 42.98 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.39 1.076 . . . . 0.0 110.939 178.3 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -146.97 146.14 24.91 Favored Pre-proline 0 N--CA 1.467 0.384 0 C-N-CA 125.355 1.462 . . . . 0.0 107.4 168.034 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -71.24 157.66 56.62 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 122.444 2.096 . . . . 0.0 110.219 170.567 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 48.5 pttt -58.48 -30.29 66.87 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -178.373 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -67.18 -45.12 77.92 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 118.508 0.594 . . . . 0.0 109.946 178.092 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.47 -38.12 89.93 Favored 'General case' 0 CA--C 1.529 0.165 0 O-C-N 121.845 -0.534 . . . . 0.0 110.57 176.33 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 95.0 mt -64.34 -42.74 96.12 Favored 'General case' 0 C--O 1.226 -0.146 0 CA-C-O 119.26 -0.4 . . . . 0.0 111.327 176.562 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 15.8 mt-30 -58.11 -42.16 85.13 Favored 'General case' 0 C--O 1.226 -0.139 0 CA-C-N 118.584 0.629 . . . . 0.0 109.971 174.343 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -65.08 -40.09 94.15 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 118.115 0.416 . . . . 0.0 110.579 -179.414 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 68.9 tp -61.97 -43.74 98.21 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.44 1.096 . . . . 0.0 110.712 176.478 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 93.3 t -62.56 -43.44 98.43 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 123.585 0.754 . . . . 0.0 109.743 174.347 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -60.28 -27.67 67.47 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 125.101 1.36 . . . . 0.0 112.055 -172.646 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -56.07 -24.07 37.65 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.549 0.74 . . . . 0.0 112.668 174.488 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 47.4 m-70 -125.37 -3.42 7.39 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 -168.202 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 84.2 mt . . . . . 0 C--O 1.25 1.083 0 CA-C-N 118.785 0.721 . . . . 0.0 109.184 172.65 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.5 mt . . . . . 0 CA--C 1.537 0.457 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 18.2 t -138.36 161.97 30.62 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 C-N-CA 126.157 1.783 . . . . 0.0 106.887 -175.524 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 3.7 tppp? -116.33 142.04 47.37 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 106.001 -1.852 . . . . 0.0 106.001 172.92 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -146.36 166.33 26.66 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.399 0.619 . . . . 0.0 111.053 -177.55 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.442 HG22 HD21 ' A' ' 60' ' ' ASN . 28.5 p -135.47 174.36 10.7 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 126.444 1.897 . . . . 0.0 107.578 170.821 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -48.53 -29.78 4.57 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.851 1.26 . . . . 0.0 113.149 173.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -59.35 -29.84 67.95 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.071 1.348 . . . . 0.0 113.052 178.856 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 14.4 m -141.22 -7.1 1.04 Allowed 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 -169.355 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 77.8 t80 -53.75 -43.64 69.31 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 124.009 0.923 . . . . 0.0 111.772 -174.569 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.7 m -63.35 -38.91 92.98 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.086 0.554 . . . . 0.0 111.762 -179.24 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -68.13 -44.26 76.48 Favored 'General case' 0 N--CA 1.453 -0.313 0 O-C-N 122.05 -0.406 . . . . 0.0 109.954 177.514 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 67.3 mm-40 -63.11 -36.47 83.7 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 122.367 0.267 . . . . 0.0 110.985 -178.677 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 25.6 p -82.93 1.21 40.75 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.049 0.939 . . . . 0.0 113.367 -177.561 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 67.4 m -101.63 31.01 3.98 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.204 1.002 . . . . 0.0 111.746 -176.677 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -132.66 62.09 1.66 Allowed 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.198 0.999 . . . . 0.0 110.206 -178.234 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 91.54 -156.24 23.86 Favored Glycine 0 C--N 1.339 0.715 0 N-CA-C 109.899 -1.281 . . . . 0.0 109.899 176.279 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 94.4 t -70.81 135.32 28.32 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 168.377 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 55.7 t -137.51 142.95 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 N-CA-C 105.742 -1.947 . . . . 0.0 105.742 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.2 tt -122.94 100.87 7.11 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 -176.683 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -83.29 146.03 28.76 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.376 -179.162 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -124.46 94.08 4.1 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 125.906 1.682 . . . . 0.0 107.356 -177.359 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -73.91 112.79 10.37 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 105.891 -1.892 . . . . 0.0 105.891 175.157 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -148.56 -178.91 6.59 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.95 1.3 . . . . 0.0 108.475 -172.704 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -158.34 147.76 14.91 Favored Pre-proline 0 CA--C 1.531 0.245 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 167.886 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -62.87 -12.0 27.06 Favored 'Trans proline' 0 CA--C 1.535 0.573 0 CA-C-N 121.53 1.582 . . . . 0.0 116.086 -178.762 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 54.2 p-90 -70.72 -19.33 62.76 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 120.731 1.605 . . . . 0.0 111.784 171.036 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 15.3 t -61.2 162.58 7.3 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.41 1.484 . . . . 0.0 111.187 -177.836 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -119.94 -59.19 0.25 Allowed Glycine 0 CA--C 1.531 1.049 0 CA-C-O 118.513 -1.159 . . . . 0.0 110.694 171.773 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -54.13 -31.46 65.41 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 123.832 3.021 . . . . 0.0 114.118 179.126 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 79.8 m -52.37 -37.0 55.14 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.694 1.198 . . . . 0.0 111.915 174.168 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 75.2 mttt -83.06 -14.69 53.32 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.381 0.672 . . . . 0.0 110.861 -175.107 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 26.8 mtm -73.1 -43.71 61.39 Favored 'General case' 0 C--N 1.341 0.197 0 CA-C-N 118.886 0.767 . . . . 0.0 109.541 169.438 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 16.3 tt -80.37 -23.95 11.4 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-O 118.609 -0.71 . . . . 0.0 111.431 -178.33 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -48.39 -51.16 53.11 Favored Pre-proline 0 CA--C 1.548 0.881 0 CA-C-N 120.359 1.436 . . . . 0.0 114.315 179.028 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -66.9 -25.76 44.81 Favored 'Trans proline' 0 C--N 1.349 0.59 0 CA-C-N 121.958 1.735 . . . . 0.0 112.597 176.263 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.5 t -71.4 -35.77 58.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 O-C-N 121.454 -0.779 . . . . 0.0 109.589 174.304 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 95.7 mt -66.78 -35.26 79.67 Favored 'General case' 0 C--N 1.341 0.202 0 CA-C-N 119.515 1.052 . . . . 0.0 111.233 170.388 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -63.09 -42.13 99.55 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 119.566 1.075 . . . . 0.0 110.83 171.808 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -60.73 -44.86 96.11 Favored 'General case' 0 CA--C 1.53 0.174 0 O-C-N 121.505 -0.747 . . . . 0.0 110.021 173.78 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 34.0 tp -60.7 -41.85 96.02 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.668 0.787 . . . . 0.0 110.355 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -60.97 -43.5 98.7 Favored 'General case' 0 CA--C 1.521 -0.172 0 C-N-CA 123.264 0.626 . . . . 0.0 110.82 177.092 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -72.41 -10.71 60.13 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.276 0.63 . . . . 0.0 112.502 179.747 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -104.44 -28.57 11.25 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 125.31 1.444 . . . . 0.0 111.367 -178.655 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 25.4 mtp -133.69 -2.66 2.98 Favored 'General case' 0 C--N 1.339 0.146 0 N-CA-C 113.966 1.099 . . . . 0.0 113.966 -169.117 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -55.05 -17.2 9.44 Favored Glycine 0 CA--C 1.534 1.259 0 CA-C-N 120.148 1.34 . . . . 0.0 115.234 -173.046 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -67.14 -30.7 70.75 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.727 1.211 . . . . 0.0 111.934 174.093 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 40.3 mmtm -117.21 -17.41 10.22 Favored 'General case' 0 N--CA 1.462 0.149 0 C-N-CA 125.989 1.716 . . . . 0.0 111.938 -178.607 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 46.8 tp -116.75 154.66 30.27 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.2 1.0 . . . . 0.0 110.599 -169.803 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -130.12 144.56 51.42 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 104.11 -2.552 . . . . 0.0 104.11 167.196 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 75.8 mt -117.7 138.27 48.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 105.266 -2.124 . . . . 0.0 105.266 177.831 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 96.9 t -133.09 98.2 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 -169.699 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 52.6 mtpt -74.11 139.57 44.67 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 175.875 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 13.5 tt -141.76 127.16 18.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 176.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -85.27 103.73 14.48 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.615 1.166 . . . . 0.0 108.901 -171.832 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 29.7 m -59.85 -25.63 33.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 118.614 -0.708 . . . . 0.0 112.003 -174.504 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -65.41 -17.82 64.83 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 119.494 1.043 . . . . 0.0 112.055 -178.087 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -120.65 5.31 10.56 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.103 1.361 . . . . 0.0 111.037 178.384 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.442 HD21 HG22 ' A' ' 7' ' ' THR . 66.5 m-80 -141.39 40.28 1.74 Allowed 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.588 1.155 . . . . 0.0 109.665 -171.016 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 51.2 mm-40 -55.2 -31.29 61.31 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.854 0.861 . . . . 0.0 110.893 175.832 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -65.91 -50.42 64.5 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 124.056 0.943 . . . . 0.0 109.941 179.676 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.9 -38.8 83.42 Favored 'General case' 0 C--O 1.223 -0.299 0 C-N-CA 123.37 0.668 . . . . 0.0 109.643 -178.78 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -58.99 -48.03 83.05 Favored 'General case' 0 CA--C 1.533 0.299 0 O-C-N 121.061 -1.024 . . . . 0.0 110.305 172.489 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -60.95 -28.77 69.2 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 123.901 0.762 . . . . 0.0 112.331 177.499 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 47.8 tptt -56.33 -29.2 60.99 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.723 1.209 . . . . 0.0 111.471 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -124.16 10.91 8.77 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.507 0.723 . . . . 0.0 111.679 -179.385 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 63.75 31.16 79.85 Favored Glycine 0 CA--C 1.532 1.14 0 C-N-CA 123.643 0.639 . . . . 0.0 112.584 -176.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 49.3 t -65.7 123.78 19.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 171.771 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 67.1 mtt -136.07 3.64 2.92 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.693 1.197 . . . . 0.0 111.463 -178.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 25.6 m -143.93 161.53 38.46 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 126.849 2.06 . . . . 0.0 107.302 178.128 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 39.0 pt -143.25 156.11 61.23 Favored Pre-proline 0 CA--C 1.545 0.761 0 C-N-CA 124.636 1.175 . . . . 0.0 108.76 177.389 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -67.15 139.1 44.69 Favored 'Cis proline' 0 C--N 1.35 0.629 0 CA-C-N 120.347 1.16 . . . . 0.0 110.168 -4.745 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 26.6 m -130.14 140.76 50.74 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 174.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 89.8 mt -120.08 125.0 47.2 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 106.546 -1.65 . . . . 0.0 106.546 -169.458 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -114.86 119.83 37.93 Favored 'General case' 0 CA--C 1.512 -0.509 0 N-CA-C 103.663 -2.717 . . . . 0.0 103.663 177.064 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.8 t -90.58 123.18 42.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 103.217 -2.883 . . . . 0.0 103.217 172.249 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.1 mp -114.66 155.84 25.85 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 173.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -137.91 122.75 18.84 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 173.478 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.0 t70 49.55 37.33 12.15 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.034 1.334 . . . . 0.0 112.471 176.399 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 103.91 -4.27 45.66 Favored Glycine 0 CA--C 1.529 0.918 0 CA-C-O 118.217 -1.324 . . . . 0.0 115.202 168.831 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -131.85 152.81 50.76 Favored 'General case' 0 C--N 1.339 0.137 0 CA-C-N 120.054 1.927 . . . . 0.0 110.209 -177.813 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 40.8 t -63.14 134.15 28.5 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.5 p -119.02 -20.81 4.8 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 C-N-CA 125.377 1.471 . . . . 0.0 110.006 176.039 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -161.04 169.15 23.06 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 120.23 1.377 . . . . 0.0 110.685 169.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 8.9 m -136.14 150.83 49.24 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.369 1.468 . . . . 0.0 108.288 173.482 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 63.7 m -151.07 159.11 44.71 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.483 1.513 . . . . 0.0 108.559 169.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 40.4 t -133.84 148.54 30.38 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 N-CA-C 107.929 -1.138 . . . . 0.0 107.929 -177.502 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 76.86 -174.88 54.08 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 123.45 0.548 . . . . 0.0 112.404 175.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -64.78 148.62 50.85 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.001 0.92 . . . . 0.0 110.935 -179.69 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.75 142.18 16.41 Favored Pre-proline 0 CA--C 1.533 0.322 0 C-N-CA 125.455 1.502 . . . . 0.0 107.093 167.604 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -72.45 161.44 44.23 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 122.747 2.298 . . . . 0.0 110.635 175.554 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 41.5 pttt -59.25 -29.99 67.95 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 -178.248 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -66.38 -49.7 65.95 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 118.418 0.554 . . . . 0.0 109.908 176.147 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.57 -39.96 95.73 Favored 'General case' 0 CA--C 1.528 0.132 0 O-C-N 122.026 -0.421 . . . . 0.0 110.599 179.039 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 78.4 mt -62.94 -43.55 98.47 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.021 0.528 . . . . 0.0 111.188 177.066 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -59.16 -41.78 89.19 Favored 'General case' 0 C--O 1.225 -0.189 0 CA-C-N 118.342 0.519 . . . . 0.0 109.981 176.057 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -66.78 -38.98 87.6 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 118.624 0.647 . . . . 0.0 110.876 -179.665 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 67.4 tp -62.47 -36.64 83.12 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.842 1.257 . . . . 0.0 110.972 176.44 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 94.2 t -70.48 -49.32 53.84 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 CA-C-N 119.178 0.899 . . . . 0.0 109.501 171.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -56.46 -40.55 75.03 Favored 'General case' 0 CA--C 1.52 -0.204 0 C-N-CA 125.901 1.68 . . . . 0.0 111.854 -168.253 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -67.37 -6.21 17.92 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 -176.3 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 90.4 m-70 -120.89 -7.54 9.49 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.346 1.058 . . . . 0.0 112.686 177.596 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 60.6 mt . . . . . 0 C--O 1.248 0.99 0 CA-C-N 119.239 0.927 . . . . 0.0 109.15 173.811 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.2 mt . . . . . 0 CA--C 1.536 0.421 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 31.9 t -136.33 163.48 33.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 126.192 1.797 . . . . 0.0 106.877 -175.839 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -118.05 142.84 46.96 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 105.919 -1.882 . . . . 0.0 105.919 174.334 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -144.52 166.4 25.26 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.407 0.622 . . . . 0.0 111.027 -177.261 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 18.3 p -134.09 171.21 14.54 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 126.448 1.899 . . . . 0.0 107.731 171.423 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -52.73 -29.42 26.88 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.611 1.164 . . . . 0.0 113.046 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 56.7 mt-30 -62.87 -28.98 70.4 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.216 1.406 . . . . 0.0 113.004 179.554 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.4 m -136.27 -6.63 2.04 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 113.517 0.932 . . . . 0.0 113.517 -169.115 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -52.19 -43.97 64.44 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.431 1.092 . . . . 0.0 111.677 -178.058 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.5 m -63.21 -38.95 93.19 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.063 0.545 . . . . 0.0 111.857 -179.04 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -67.98 -44.35 76.87 Favored 'General case' 0 N--CA 1.452 -0.344 0 O-C-N 122.02 -0.425 . . . . 0.0 110.066 177.585 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 66.7 mm-40 -63.22 -35.87 81.75 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 122.416 0.286 . . . . 0.0 110.946 -178.746 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 27.5 p -83.51 1.37 42.22 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.044 0.938 . . . . 0.0 113.377 -177.322 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 68.1 m -102.02 30.97 4.13 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.18 0.992 . . . . 0.0 111.802 -176.55 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -132.68 57.79 1.78 Allowed 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.1 0.96 . . . . 0.0 110.526 -177.617 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 98.65 -153.43 19.88 Favored Glycine 0 C--N 1.337 0.636 0 N-CA-C 110.084 -1.206 . . . . 0.0 110.084 174.547 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 55.0 t -72.05 135.06 28.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 N-CA-C 105.744 -1.947 . . . . 0.0 105.744 167.786 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 46.6 t -137.5 142.96 35.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 105.908 -1.886 . . . . 0.0 105.908 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.6 tt -125.27 101.42 6.97 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 106.03 -1.841 . . . . 0.0 106.03 -177.596 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -82.55 144.64 30.23 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.275 -179.532 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -121.18 93.79 4.13 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 125.955 1.702 . . . . 0.0 107.166 -178.553 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -72.7 111.6 7.99 Favored 'General case' 0 C--O 1.239 0.545 0 N-CA-C 105.689 -1.967 . . . . 0.0 105.689 174.298 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -146.86 -177.46 5.67 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 125.241 1.417 . . . . 0.0 108.168 -171.643 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -155.73 149.59 19.25 Favored Pre-proline 0 C--N 1.33 -0.265 0 N-CA-C 106.405 -1.702 . . . . 0.0 106.405 168.078 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -68.53 -12.58 35.17 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 121.378 1.386 . . . . 0.0 114.231 -176.371 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 52.0 p-90 -71.02 -19.69 62.48 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 120.233 1.378 . . . . 0.0 112.192 169.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 27.8 t -60.36 153.25 23.23 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.964 1.306 . . . . 0.0 111.419 -172.004 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.405 ' H ' ' HD2' ' A' ' 31' ' ' PRO . . . -102.46 -61.2 0.73 Allowed Glycine 0 CA--C 1.533 1.195 0 C-N-CA 124.585 1.088 . . . . 0.0 111.626 171.49 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.405 ' HD2' ' H ' ' A' ' 30' ' ' GLY . 28.5 Cg_endo -66.95 -25.57 44.63 Favored 'Trans proline' 0 C--N 1.348 0.517 0 CA-C-N 120.46 2.13 . . . . 0.0 112.702 -174.582 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 24.6 m -56.41 -35.51 67.87 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 121.235 -0.916 . . . . 0.0 111.023 172.387 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.6 mmtp -69.31 -26.21 64.61 Favored 'General case' 0 CA--C 1.529 0.155 0 O-C-N 121.564 -0.71 . . . . 0.0 111.296 -178.815 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 5.1 ptt? -85.7 -31.55 22.41 Favored 'General case' 0 C--N 1.34 0.188 0 CA-C-N 118.961 0.8 . . . . 0.0 111.414 -176.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 18.2 tt -77.57 -25.26 14.78 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-O 118.591 -0.718 . . . . 0.0 111.537 170.098 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -49.71 -49.57 72.23 Favored Pre-proline 0 CA--C 1.547 0.839 0 CA-C-N 120.379 1.445 . . . . 0.0 114.367 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -66.35 -28.88 46.55 Favored 'Trans proline' 0 C--N 1.349 0.601 0 CA-C-N 122.038 1.763 . . . . 0.0 112.122 176.365 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.1 t -67.82 -37.26 78.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 O-C-N 121.666 -0.646 . . . . 0.0 109.553 174.554 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 96.1 mt -66.74 -34.82 78.69 Favored 'General case' 0 C--N 1.34 0.175 0 CA-C-N 119.46 1.027 . . . . 0.0 111.422 171.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -63.05 -42.33 99.7 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 119.556 1.071 . . . . 0.0 110.716 171.476 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -63.94 -39.49 94.27 Favored 'General case' 0 CA--C 1.531 0.24 0 O-C-N 121.243 -0.911 . . . . 0.0 110.421 175.791 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 42.8 tp -62.4 -43.04 99.77 Favored 'General case' 0 CA--C 1.527 0.077 0 C-N-CA 123.643 0.777 . . . . 0.0 110.205 175.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -60.06 -42.36 94.34 Favored 'General case' 0 CA--C 1.521 -0.137 0 C-N-CA 123.453 0.701 . . . . 0.0 110.805 178.373 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 -71.98 -10.8 60.28 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.263 0.625 . . . . 0.0 112.481 -179.417 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -105.54 -32.53 8.46 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 125.265 1.426 . . . . 0.0 111.415 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 71.5 mmm -125.77 -3.14 7.18 Favored 'General case' 0 C--O 1.226 -0.138 0 CA-C-O 118.414 -0.803 . . . . 0.0 113.152 -167.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -57.63 -13.59 12.48 Favored Glycine 0 CA--C 1.533 1.185 0 CA-C-N 119.769 1.168 . . . . 0.0 115.847 -172.168 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -77.1 -24.98 51.73 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 118.462 1.131 . . . . 0.0 111.721 174.847 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 51.1 mmtt -117.38 -21.08 8.85 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 125.648 1.579 . . . . 0.0 111.445 -177.052 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 52.2 tp -122.26 148.45 44.98 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 125.16 1.384 . . . . 0.0 110.223 -169.289 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -120.64 145.42 47.42 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 105.116 -2.179 . . . . 0.0 105.116 167.564 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 77.3 mt -115.01 138.01 46.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 105.637 -1.986 . . . . 0.0 105.637 176.693 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 93.5 t -133.56 98.6 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-N 118.879 0.763 . . . . 0.0 109.236 -170.193 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 52.9 mtpt -73.89 140.37 45.63 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 176.144 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 13.9 tt -142.72 127.87 16.39 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 176.053 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 50.6 t0 -84.02 103.43 13.25 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 124.732 1.213 . . . . 0.0 109.004 -172.344 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 28.3 m -59.36 -28.36 39.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 118.819 -0.61 . . . . 0.0 111.888 -174.401 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -66.64 -19.3 65.73 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 119.258 0.935 . . . . 0.0 111.846 -177.419 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -114.62 1.41 14.23 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.547 1.539 . . . . 0.0 110.828 178.851 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 68.3 m-80 -141.67 42.42 1.72 Allowed 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 124.4 1.08 . . . . 0.0 109.54 -169.492 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 45.0 mm-40 -55.81 -32.57 63.67 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.041 0.936 . . . . 0.0 111.269 178.239 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 -66.08 -47.58 73.8 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 118.384 0.538 . . . . 0.0 110.47 179.473 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.94 -39.41 79.59 Favored 'General case' 0 C--O 1.223 -0.327 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 -178.734 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -58.99 -47.81 83.83 Favored 'General case' 0 CA--C 1.533 0.325 0 O-C-N 121.207 -0.933 . . . . 0.0 110.264 173.097 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -60.85 -28.72 68.87 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 124.062 0.839 . . . . 0.0 112.405 177.178 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 24.4 tptp -56.18 -29.21 60.53 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.68 1.192 . . . . 0.0 111.47 179.482 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -124.27 10.73 8.69 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.557 0.743 . . . . 0.0 111.61 -179.1 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 63.71 31.36 80.51 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 123.728 0.68 . . . . 0.0 112.588 -177.238 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 53.7 t -65.55 123.67 18.94 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 172.376 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 99.0 mtp -135.99 3.49 2.93 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.757 1.223 . . . . 0.0 111.486 -179.121 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 24.5 m -143.89 160.96 39.88 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 126.656 1.983 . . . . 0.0 107.409 178.751 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 41.9 pt -143.14 154.9 61.89 Favored Pre-proline 0 CA--C 1.545 0.781 0 C-N-CA 124.468 1.107 . . . . 0.0 108.93 177.261 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -67.1 139.69 47.54 Favored 'Cis proline' 0 C--N 1.35 0.626 0 CA-C-N 120.373 1.169 . . . . 0.0 110.42 -4.603 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 24.6 m -130.36 140.8 50.59 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 174.197 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 86.2 mt -121.28 123.57 42.52 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 -169.03 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -114.06 122.45 46.93 Favored 'General case' 0 CA--C 1.512 -0.513 0 N-CA-C 103.627 -2.731 . . . . 0.0 103.627 178.737 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.2 t -96.02 127.18 48.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 N-CA-C 104.002 -2.592 . . . . 0.0 104.002 174.297 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.0 mp -119.66 155.05 33.09 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 177.328 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -137.05 119.47 15.82 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 106.376 -1.713 . . . . 0.0 106.376 176.309 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.0 t70 49.52 38.2 14.04 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.97 1.308 . . . . 0.0 112.482 177.136 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 104.67 -5.1 43.31 Favored Glycine 0 CA--C 1.529 0.944 0 CA-C-O 118.148 -1.362 . . . . 0.0 115.46 168.675 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -130.81 150.57 51.92 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 120.006 1.903 . . . . 0.0 110.276 -177.675 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 42.9 t -62.73 133.29 28.6 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.4 p -119.25 -21.03 4.61 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 125.19 1.396 . . . . 0.0 110.36 176.052 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -158.51 168.59 26.51 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 120.582 1.537 . . . . 0.0 110.317 173.715 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 18.1 m -146.37 143.31 28.99 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.385 1.074 . . . . 0.0 109.063 175.23 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 49.5 m -144.62 156.23 44.02 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.561 1.544 . . . . 0.0 108.66 176.213 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 41.2 t -133.76 146.44 31.77 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 -175.419 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 75.21 -174.25 52.12 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 123.292 0.473 . . . . 0.0 112.271 178.185 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 67.4 t80 -65.3 148.66 51.31 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.674 0.79 . . . . 0.0 111.347 -178.175 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.29 140.18 14.64 Favored Pre-proline 0 CA--C 1.534 0.349 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 167.383 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -72.05 161.66 44.07 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 122.718 2.279 . . . . 0.0 110.497 175.505 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 49.3 pttt -58.51 -29.34 66.19 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 113.571 0.952 . . . . 0.0 113.571 -178.717 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -65.91 -50.34 64.8 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 118.595 0.634 . . . . 0.0 109.559 176.049 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.53 -39.07 93.46 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 122.721 0.409 . . . . 0.0 110.821 178.855 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 87.8 mt -63.49 -44.06 95.47 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 122.985 0.514 . . . . 0.0 111.156 176.849 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 -61.17 -41.95 97.68 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-N 118.426 0.557 . . . . 0.0 110.153 176.025 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -63.31 -41.18 98.91 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 118.15 0.432 . . . . 0.0 110.238 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 61.3 tp -61.71 -46.01 91.5 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.705 1.202 . . . . 0.0 110.674 176.801 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 72.8 t -58.32 -44.86 89.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 CA-C-N 118.75 0.705 . . . . 0.0 109.462 173.58 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -62.59 -25.29 68.0 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.905 1.282 . . . . 0.0 112.153 -174.017 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -57.61 -22.14 43.42 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 118.506 -0.759 . . . . 0.0 112.452 172.613 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 70.8 m-70 -124.09 -8.26 7.69 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 -168.555 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 77.3 mt . . . . . 0 C--O 1.246 0.886 0 CA-C-O 118.363 -0.827 . . . . 0.0 109.416 171.54 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 12.0 mt . . . . . 0 N--CA 1.449 -0.517 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 5.4 t -137.45 160.85 34.87 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 C-N-CA 126.702 2.001 . . . . 0.0 106.472 -174.654 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.34 133.07 50.12 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 105.358 -2.09 . . . . 0.0 105.358 176.506 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -142.8 174.96 10.19 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 123.611 0.764 . . . . 0.0 111.421 -170.057 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.3 p -138.14 171.74 13.94 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 126.732 2.013 . . . . 0.0 106.661 168.765 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -50.45 -27.95 7.42 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 175.386 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -55.06 -31.33 61.05 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.732 1.613 . . . . 0.0 112.756 177.286 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.1 m -139.67 -10.1 1.21 Allowed 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 124.035 0.934 . . . . 0.0 113.059 -170.615 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -53.57 -42.08 67.2 Favored 'General case' 0 C--O 1.231 0.117 0 C-N-CA 124.472 1.109 . . . . 0.0 111.316 -177.287 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.4 m -63.38 -36.9 85.27 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.16 0.584 . . . . 0.0 112.027 179.766 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -69.7 -44.25 70.79 Favored 'General case' 0 N--CA 1.453 -0.313 0 O-C-N 121.998 -0.439 . . . . 0.0 110.005 177.013 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -62.8 -40.88 98.74 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 122.827 0.451 . . . . 0.0 110.463 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.434 ' HA ' HG21 ' A' ' 20' ' ' VAL . 26.0 p -77.3 1.84 17.53 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.867 0.867 . . . . 0.0 113.252 -179.484 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 63.5 m -105.18 32.76 4.02 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.531 1.132 . . . . 0.0 111.206 179.758 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -130.97 51.48 2.13 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.2 1.0 . . . . 0.0 110.51 -178.125 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 97.27 -156.7 20.85 Favored Glycine 0 C--N 1.337 0.588 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 179.24 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 74.4 t -70.94 136.59 25.59 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 168.406 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.434 HG21 ' HA ' ' A' ' 15' ' ' THR . 54.6 t -137.84 135.55 45.66 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 N-CA-C 106.039 -1.838 . . . . 0.0 106.039 -179.084 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.0 tt -113.25 99.95 8.2 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 105.754 -1.943 . . . . 0.0 105.754 -176.817 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -83.07 146.62 28.6 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 179.499 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -127.21 94.17 3.93 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 126.236 1.814 . . . . 0.0 107.66 -176.364 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -74.5 114.07 12.47 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 106.109 -1.811 . . . . 0.0 106.109 175.862 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -149.99 -177.04 5.68 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.918 1.287 . . . . 0.0 108.778 -171.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -152.86 147.16 18.77 Favored Pre-proline 0 CA--C 1.531 0.245 0 N-CA-C 105.936 -1.875 . . . . 0.0 105.936 167.266 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -58.81 -18.39 41.4 Favored 'Trans proline' 0 CA--C 1.531 0.36 0 C-N-CA 121.933 1.755 . . . . 0.0 114.844 178.572 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 1.9 m95 -74.28 -14.65 60.94 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 118.91 0.777 . . . . 0.0 111.908 176.754 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 34.9 t -63.95 152.54 39.69 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.41 1.484 . . . . 0.0 111.14 -175.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -100.5 -64.4 0.8 Allowed Glycine 0 CA--C 1.53 1.002 0 CA-C-O 118.446 -1.197 . . . . 0.0 110.997 171.375 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -62.3 -26.28 77.08 Favored 'Trans proline' 0 C--N 1.35 0.646 0 CA-C-N 120.44 2.12 . . . . 0.0 113.675 -174.706 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 33.7 m -57.01 -34.41 68.15 Favored 'General case' 0 CA--C 1.537 0.446 0 O-C-N 121.577 -0.702 . . . . 0.0 111.627 174.243 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.2 mmtp -67.53 -24.36 65.55 Favored 'General case' 0 CA--C 1.531 0.226 0 O-C-N 121.529 -0.732 . . . . 0.0 111.118 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 30.8 mtm -72.45 -42.7 64.72 Favored 'General case' 0 C--N 1.34 0.159 0 CA-C-N 118.581 0.628 . . . . 0.0 110.439 177.396 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 17.1 tt -83.48 -22.12 8.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-O 118.726 -0.654 . . . . 0.0 111.7 -175.117 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -50.24 -52.18 56.3 Favored Pre-proline 0 CA--C 1.549 0.915 0 CA-C-N 120.059 1.3 . . . . 0.0 113.674 177.563 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -66.84 -27.62 43.71 Favored 'Trans proline' 0 C--N 1.351 0.675 0 CA-C-N 121.606 1.609 . . . . 0.0 112.305 176.546 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 22.0 t -68.1 -39.19 80.97 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 O-C-N 121.541 -0.724 . . . . 0.0 109.5 175.381 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 53.2 mt -65.31 -36.3 83.62 Favored 'General case' 0 C--N 1.34 0.16 0 CA-C-N 119.265 0.939 . . . . 0.0 111.085 172.406 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -63.62 -38.5 91.36 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 118.803 0.729 . . . . 0.0 111.178 172.353 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -66.63 -35.42 80.15 Favored 'General case' 0 CA--C 1.531 0.244 0 O-C-N 120.35 -1.469 . . . . 0.0 110.691 173.875 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.58 -44.84 92.88 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.594 0.758 . . . . 0.0 109.733 177.014 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 53.2 t0 -53.66 -48.22 69.64 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 124.972 1.309 . . . . 0.0 110.397 172.562 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -68.43 -8.11 37.67 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -178.316 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 77.7 mt-10 -109.6 -36.64 5.9 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.996 1.319 . . . . 0.0 112.265 -176.762 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 6.2 ptp -145.12 22.96 1.53 Allowed 'General case' 0 C--N 1.341 0.212 0 N-CA-C 114.865 1.432 . . . . 0.0 114.865 178.644 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -60.84 -5.68 5.69 Favored Glycine 0 CA--C 1.537 1.46 0 CA-C-N 119.996 1.271 . . . . 0.0 115.221 177.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -78.6 -33.17 47.68 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.586 1.154 . . . . 0.0 111.296 170.035 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -95.45 -35.23 11.79 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 124.844 1.258 . . . . 0.0 110.659 178.425 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 60.8 tp -105.14 153.06 22.03 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.452 1.101 . . . . 0.0 111.745 -169.791 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 14.4 ttmm -121.85 144.46 48.82 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 104.426 -2.435 . . . . 0.0 104.426 166.046 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 79.3 mt -120.66 135.62 60.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 104.872 -2.269 . . . . 0.0 104.872 179.311 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 99.3 t -130.0 98.61 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 -172.288 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 52.4 mtmt -71.47 138.88 49.36 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 172.831 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 17.1 tt -142.28 123.59 12.24 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 177.835 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 59.3 t0 -83.32 106.98 15.53 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 124.282 1.033 . . . . 0.0 108.566 -173.395 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 31.7 m -60.07 -24.68 30.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 118.551 -0.737 . . . . 0.0 112.043 -175.178 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -64.75 -19.73 65.95 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 119.659 1.118 . . . . 0.0 112.002 -179.178 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -116.44 4.44 13.34 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.069 1.347 . . . . 0.0 110.85 178.102 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 68.4 m-80 -141.35 39.16 1.73 Allowed 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 124.537 1.135 . . . . 0.0 110.169 -169.141 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 53.4 mm-40 -56.48 -34.8 67.26 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.358 0.663 . . . . 0.0 110.851 176.132 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -65.34 -46.18 81.26 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 122.78 0.432 . . . . 0.0 110.305 177.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.29 -40.62 86.12 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.482 0.713 . . . . 0.0 110.043 -178.79 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -58.26 -49.49 76.91 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.389 0.675 . . . . 0.0 110.109 172.715 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -59.67 -29.57 67.31 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 123.958 0.789 . . . . 0.0 112.432 177.14 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 22.6 ttmt -55.39 -28.91 57.11 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.497 1.519 . . . . 0.0 112.042 178.609 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -123.61 9.49 8.98 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 123.868 0.867 . . . . 0.0 111.948 178.053 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 65.14 28.77 73.94 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 123.819 0.723 . . . . 0.0 112.935 -176.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 54.5 t -61.67 128.99 24.07 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 172.394 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 22.4 ttt -137.93 0.37 2.17 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.573 1.149 . . . . 0.0 111.145 -177.448 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 25.2 m -145.08 163.95 32.72 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 126.558 1.943 . . . . 0.0 107.612 179.513 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 39.5 pt -143.41 155.82 60.77 Favored Pre-proline 0 CA--C 1.547 0.832 0 C-N-CA 124.603 1.161 . . . . 0.0 108.85 176.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -67.24 138.66 42.8 Favored 'Cis proline' 0 C--N 1.351 0.671 0 CA-C-N 120.453 1.197 . . . . 0.0 110.288 -4.464 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 32.8 m -130.22 141.1 50.66 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 175.26 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 83.0 mt -122.62 128.47 50.71 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 -167.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -122.54 118.36 28.06 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 104.013 -2.588 . . . . 0.0 104.013 -178.302 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 14.7 t -92.92 119.28 40.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 104.108 -2.553 . . . . 0.0 104.108 173.641 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.8 mp -109.74 153.91 23.65 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 172.398 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -134.34 125.06 26.84 Favored 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 170.524 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.0 t70 48.48 35.02 5.31 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.234 1.414 . . . . 0.0 112.181 173.255 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 101.69 0.67 52.7 Favored Glycine 0 CA--C 1.532 1.146 0 CA-C-O 117.876 -1.513 . . . . 0.0 115.289 170.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -123.29 146.42 47.9 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 120.491 2.145 . . . . 0.0 109.5 176.866 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 11.4 p -68.67 132.48 32.89 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 170.568 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 33.7 m -119.91 -21.0 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 124.439 1.096 . . . . 0.0 110.996 178.07 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -155.75 162.86 40.45 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 120.44 1.473 . . . . 0.0 110.851 174.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 9.0 m -139.13 151.06 46.36 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.673 1.189 . . . . 0.0 108.708 177.846 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 48.6 m -151.55 159.32 44.17 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.408 1.483 . . . . 0.0 108.874 169.526 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 42.7 t -133.93 144.67 34.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 -176.667 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 77.87 177.97 48.06 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 123.639 0.638 . . . . 0.0 112.494 176.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 55.2 t80 -61.35 145.14 52.53 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 123.866 0.866 . . . . 0.0 111.089 -179.299 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.37 141.27 14.91 Favored Pre-proline 0 CA--C 1.535 0.403 0 C-N-CA 126.206 1.802 . . . . 0.0 106.843 177.8 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -72.35 156.79 54.38 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 122.409 2.073 . . . . 0.0 110.722 176.784 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 42.2 pttt -57.5 -32.54 67.13 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 -175.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -68.77 -43.04 76.59 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 118.5 0.591 . . . . 0.0 109.504 178.79 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.47 -42.05 98.6 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 118.354 0.525 . . . . 0.0 110.517 176.621 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 97.1 mt -60.86 -48.84 79.99 Favored 'General case' 0 N--CA 1.461 0.095 0 CA-C-O 121.08 0.467 . . . . 0.0 110.686 178.286 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -71.57 -28.29 63.74 Favored 'General case' 0 N--CA 1.451 -0.381 0 O-C-N 122.037 -0.414 . . . . 0.0 110.866 -175.038 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -70.03 -37.25 75.55 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 118.404 0.547 . . . . 0.0 111.355 170.393 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 8.7 tp -62.79 -34.5 77.4 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.5 1.12 . . . . 0.0 110.274 174.764 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 48.9 t -69.99 -45.97 74.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 123.836 0.854 . . . . 0.0 110.066 169.304 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -59.91 -36.58 77.3 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 124.73 1.212 . . . . 0.0 111.937 -172.175 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 11.0 ptmm? -67.06 -6.25 16.5 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 178.587 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -123.35 -18.07 6.36 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.136 0.974 . . . . 0.0 113.363 175.498 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 31.7 mt . . . . . 0 C--O 1.249 1.034 0 CA-C-N 119.913 1.233 . . . . 0.0 109.459 171.784 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.1 mt . . . . . 0 C--O 1.237 0.4 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 44.6 t -138.79 164.03 26.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 126.494 1.917 . . . . 0.0 106.733 -174.379 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 4.7 mtpt -117.01 142.84 46.45 Favored 'General case' 0 CA--C 1.517 -0.31 0 C-N-CA 125.345 1.458 . . . . 0.0 107.373 173.508 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -142.81 165.62 26.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.422 0.63 . . . . 0.0 110.525 178.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 17.5 p -132.55 172.25 12.75 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 126.254 1.822 . . . . 0.0 107.664 170.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -52.39 -29.53 24.59 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.238 1.015 . . . . 0.0 113.111 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 56.1 mt-30 -63.47 -28.96 70.32 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.12 1.368 . . . . 0.0 113.174 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.2 m -136.88 -5.49 1.92 Allowed 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 113.842 1.053 . . . . 0.0 113.842 -168.744 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -52.39 -44.07 65.12 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.166 0.987 . . . . 0.0 111.65 -177.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.5 m -63.23 -38.57 91.68 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.129 0.572 . . . . 0.0 111.849 -179.1 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -68.1 -44.34 76.45 Favored 'General case' 0 N--CA 1.452 -0.337 0 O-C-N 121.994 -0.442 . . . . 0.0 110.023 177.87 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 66.1 mm-40 -63.61 -35.76 81.56 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 122.391 0.276 . . . . 0.0 110.979 -178.805 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 26.4 p -83.91 1.44 43.36 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.029 0.931 . . . . 0.0 113.329 -177.312 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 69.1 m -100.17 30.27 3.89 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.23 1.012 . . . . 0.0 111.742 -177.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -133.26 61.95 1.67 Allowed 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.297 1.039 . . . . 0.0 110.195 -177.081 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 92.24 -156.53 23.52 Favored Glycine 0 C--N 1.338 0.694 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 175.821 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 59.1 t -71.31 134.23 30.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 N-CA-C 106.506 -1.665 . . . . 0.0 106.506 168.548 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 47.1 t -136.99 141.11 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 105.915 -1.883 . . . . 0.0 105.915 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 3.7 tt -122.19 100.3 6.89 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 106.255 -1.757 . . . . 0.0 106.255 -176.411 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -83.25 145.42 29.14 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.293 -179.646 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -123.95 94.12 4.13 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 126.083 1.753 . . . . 0.0 107.196 -177.457 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -74.13 112.26 10.09 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 105.884 -1.895 . . . . 0.0 105.884 174.836 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -148.3 -177.12 5.59 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.704 1.201 . . . . 0.0 108.608 -172.749 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -155.87 146.98 16.55 Favored Pre-proline 0 CA--C 1.531 0.232 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 168.153 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -60.75 -17.27 48.98 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 121.818 1.679 . . . . 0.0 116.01 -177.781 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 54.0 p-90 -70.04 -20.12 63.26 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 120.03 1.286 . . . . 0.0 111.914 173.638 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 29.0 t -59.58 150.97 25.66 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.991 1.316 . . . . 0.0 110.971 -174.537 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -104.99 -58.61 0.67 Allowed Glycine 0 CA--C 1.531 1.062 0 CA-C-O 118.704 -1.053 . . . . 0.0 110.97 172.024 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -56.54 -33.08 91.88 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 123.217 2.611 . . . . 0.0 113.712 -179.288 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 29.7 m -57.82 -34.57 69.81 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.441 0.696 . . . . 0.0 111.403 176.539 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.4 mmtp -68.38 -24.54 64.79 Favored 'General case' 0 CA--C 1.531 0.22 0 O-C-N 121.5 -0.75 . . . . 0.0 111.063 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 31.1 mtm -70.8 -42.27 70.52 Favored 'General case' 0 C--N 1.34 0.186 0 CA-C-N 118.742 0.701 . . . . 0.0 110.405 176.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 19.1 tt -85.0 -23.76 7.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 CA-C-O 118.53 -0.748 . . . . 0.0 111.782 -175.306 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -49.38 -50.52 64.55 Favored Pre-proline 0 CA--C 1.548 0.867 0 CA-C-N 120.088 1.313 . . . . 0.0 114.191 178.271 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -66.93 -27.76 42.83 Favored 'Trans proline' 0 C--N 1.351 0.674 0 CA-C-N 121.779 1.671 . . . . 0.0 112.069 176.474 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.8 t -68.94 -37.12 76.87 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 O-C-N 121.589 -0.694 . . . . 0.0 109.769 173.807 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 95.6 mt -65.5 -34.69 78.87 Favored 'General case' 0 C--N 1.339 0.135 0 CA-C-N 119.743 1.156 . . . . 0.0 111.025 172.447 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -61.97 -43.79 98.1 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 119.376 0.989 . . . . 0.0 110.944 170.465 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -63.67 -40.18 96.18 Favored 'General case' 0 CA--C 1.531 0.218 0 O-C-N 121.172 -0.955 . . . . 0.0 110.711 175.868 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 39.8 tp -61.98 -41.96 98.61 Favored 'General case' 0 C--N 1.334 -0.105 0 C-N-CA 124.372 1.069 . . . . 0.0 109.919 178.125 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -60.82 -42.96 98.73 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 122.949 0.499 . . . . 0.0 110.696 175.86 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -71.97 -10.4 59.72 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 112.6 0.592 . . . . 0.0 112.6 179.299 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -105.36 -28.38 10.91 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 125.437 1.495 . . . . 0.0 111.377 -178.65 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 26.8 mtp -134.3 -1.56 2.88 Favored 'General case' 0 N--CA 1.462 0.146 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 -168.702 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -56.91 -13.91 9.26 Favored Glycine 0 CA--C 1.532 1.126 0 CA-C-N 119.913 1.233 . . . . 0.0 115.434 -173.777 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -69.73 -29.93 67.42 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 118.674 1.237 . . . . 0.0 111.73 173.121 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 45.6 mmtm -115.7 -20.27 10.17 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 125.512 1.525 . . . . 0.0 111.889 -178.848 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 36.6 tp -112.57 157.17 21.51 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 123.984 0.914 . . . . 0.0 111.41 -168.553 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -132.34 144.51 50.6 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 103.806 -2.665 . . . . 0.0 103.806 166.572 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 83.0 mt -118.02 139.43 45.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 105.274 -2.121 . . . . 0.0 105.274 177.818 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 81.9 t -132.26 98.78 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 -170.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 52.4 mtmt -74.2 136.69 42.79 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 175.153 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 15.3 tt -139.98 124.82 19.88 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 176.366 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -82.79 105.08 13.51 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 124.717 1.207 . . . . 0.0 108.784 -174.733 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 27.7 m -60.37 -27.06 38.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 118.684 -0.674 . . . . 0.0 111.898 -174.349 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -66.1 -19.83 65.97 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 119.423 1.011 . . . . 0.0 111.773 -177.371 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -113.83 1.59 14.84 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.534 1.534 . . . . 0.0 110.891 178.646 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 68.7 m-80 -141.68 41.77 1.72 Allowed 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.27 1.028 . . . . 0.0 109.889 -169.392 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 46.7 mm-40 -56.03 -32.37 63.96 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.806 0.842 . . . . 0.0 111.262 177.847 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 35.0 mm-40 -65.72 -47.21 76.1 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 118.407 0.549 . . . . 0.0 110.5 179.199 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.2 -39.04 78.86 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 121.801 -0.562 . . . . 0.0 109.634 -178.734 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -58.79 -48.28 81.82 Favored 'General case' 0 CA--C 1.534 0.343 0 O-C-N 121.142 -0.974 . . . . 0.0 110.171 172.695 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -60.45 -28.67 67.74 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 124.078 0.847 . . . . 0.0 112.438 177.189 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 47.7 tptt -56.23 -29.28 60.79 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.629 1.171 . . . . 0.0 111.425 179.498 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -124.0 10.7 8.85 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.671 0.788 . . . . 0.0 111.598 -179.442 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 64.41 28.52 73.21 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 123.819 0.723 . . . . 0.0 112.802 -177.141 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 49.1 t -62.86 125.94 20.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 172.689 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 40.3 ttp -138.49 1.86 2.19 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.487 1.115 . . . . 0.0 111.036 -177.092 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 24.8 m -144.31 161.98 37.58 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 126.789 2.036 . . . . 0.0 107.374 178.715 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 40.7 pt -143.13 155.91 61.7 Favored Pre-proline 0 CA--C 1.544 0.721 0 C-N-CA 124.631 1.173 . . . . 0.0 108.768 177.816 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -67.05 139.54 46.66 Favored 'Cis proline' 0 C--N 1.349 0.588 0 CA-C-N 120.459 1.2 . . . . 0.0 110.26 -4.714 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 28.1 m -130.81 139.95 50.24 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 174.792 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 88.0 mt -120.33 124.49 45.69 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 -169.472 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -115.18 119.7 37.27 Favored 'General case' 0 CA--C 1.512 -0.509 0 N-CA-C 103.578 -2.749 . . . . 0.0 103.578 177.782 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.2 t -93.1 123.31 45.14 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 N-CA-C 103.432 -2.803 . . . . 0.0 103.432 173.414 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.1 mp -114.86 155.25 27.16 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 174.823 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -137.94 123.38 19.55 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 172.81 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.2 t70 49.36 36.87 10.46 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.084 1.354 . . . . 0.0 112.537 176.009 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 103.4 -2.83 46.59 Favored Glycine 0 CA--C 1.529 0.92 0 CA-C-O 118.122 -1.377 . . . . 0.0 115.285 168.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -128.62 149.98 50.41 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 120.074 1.937 . . . . 0.0 110.077 -179.434 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 44.3 t -62.0 131.53 27.25 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 175.162 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.1 p -117.44 -22.94 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 C-N-CA 125.102 1.361 . . . . 0.0 109.406 179.009 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -162.3 168.04 22.9 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 120.463 1.483 . . . . 0.0 110.097 169.87 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 14.0 m -136.56 151.07 48.98 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.363 1.465 . . . . 0.0 108.796 177.563 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 58.3 m -148.38 157.28 43.38 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.631 1.573 . . . . 0.0 108.649 169.574 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 42.6 t -133.6 145.33 33.77 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 -178.578 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 78.27 -176.29 54.24 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 123.553 0.597 . . . . 0.0 111.877 179.113 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -63.72 148.91 47.91 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.484 0.714 . . . . 0.0 110.41 178.003 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 42.9 mttt -142.4 138.24 16.28 Favored Pre-proline 0 C--O 1.235 0.311 0 N-CA-C 106.352 -1.722 . . . . 0.0 106.352 168.774 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -66.57 160.03 47.97 Favored 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 121.88 1.72 . . . . 0.0 110.925 178.321 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 33.7 tttm -48.85 -46.72 42.68 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 126.071 1.748 . . . . 0.0 112.987 -178.86 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 27.4 mm-40 -72.98 -35.94 66.99 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.207 -176.282 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.64 -36.6 84.78 Favored 'General case' 0 C--N 1.341 0.233 0 CA-C-N 118.979 0.808 . . . . 0.0 111.054 173.304 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 87.1 mt -64.53 -45.78 85.72 Favored 'General case' 0 N--CA 1.456 -0.137 0 CA-C-O 119.197 -0.43 . . . . 0.0 110.665 176.105 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 8.9 mt-30 -57.99 -42.44 85.16 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-N 118.501 0.591 . . . . 0.0 110.787 173.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -64.61 -39.58 93.98 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 118.016 0.371 . . . . 0.0 110.508 -178.815 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 57.8 tp -61.86 -44.0 97.72 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 124.636 1.174 . . . . 0.0 110.568 176.399 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 86.6 t -61.22 -44.13 97.78 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-N 118.821 0.737 . . . . 0.0 109.39 173.023 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -60.58 -28.34 68.4 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 125.019 1.328 . . . . 0.0 112.15 -173.574 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -56.4 -24.12 42.71 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 123.402 0.681 . . . . 0.0 112.498 174.245 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 72.2 m-70 -123.18 -9.18 8.16 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 -168.369 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 74.5 mt . . . . . 0 C--O 1.249 1.045 0 CA-C-N 118.948 0.794 . . . . 0.0 109.333 171.298 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.8 mt . . . . . 0 CA--C 1.537 0.472 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 21.5 t -134.88 160.87 41.01 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 C-N-CA 126.68 1.992 . . . . 0.0 106.521 -176.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.23 139.1 50.7 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 105.368 -2.086 . . . . 0.0 105.368 169.284 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -140.68 168.94 18.6 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 121.296 0.569 . . . . 0.0 110.886 -178.674 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 17.4 p -133.19 169.67 16.54 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 126.334 1.854 . . . . 0.0 107.987 175.37 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -53.42 -29.31 34.53 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.443 1.097 . . . . 0.0 113.039 -178.517 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 57.0 mt-30 -61.28 -29.26 69.75 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.164 1.386 . . . . 0.0 112.944 178.684 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.6 m -136.86 -7.19 1.87 Allowed 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 -169.45 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -53.25 -43.65 67.52 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.349 1.06 . . . . 0.0 111.516 -177.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.8 m -62.86 -39.87 95.74 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.058 0.543 . . . . 0.0 111.76 179.518 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.66 -43.38 84.73 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 122.71 0.404 . . . . 0.0 110.074 177.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 68.5 mm-40 -64.09 -42.82 96.8 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 122.265 0.226 . . . . 0.0 110.551 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.423 ' HA ' HG21 ' A' ' 20' ' ' VAL . 35.5 p -77.89 -5.86 52.4 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 124.262 1.025 . . . . 0.0 113.568 -176.979 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 72.7 m -74.72 -20.26 59.91 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 177.924 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -87.41 69.23 9.87 Favored 'General case' 0 CA--C 1.537 0.451 0 O-C-N 121.483 -0.761 . . . . 0.0 111.581 -170.012 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 85.28 -151.51 25.75 Favored Glycine 0 C--N 1.337 0.612 0 N-CA-C 109.993 -1.243 . . . . 0.0 109.993 173.799 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 58.0 t -71.17 137.11 24.43 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 168.63 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.423 HG21 ' HA ' ' A' ' 15' ' ' THR . 57.7 t -140.37 146.99 23.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 105.777 -1.935 . . . . 0.0 105.777 179.08 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.5 tt -124.96 99.35 6.09 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 -176.359 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -81.43 147.86 29.56 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.732 -179.689 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -126.48 95.21 4.29 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 126.145 1.778 . . . . 0.0 107.27 -178.787 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -73.81 115.36 13.16 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 174.455 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -149.16 -178.06 6.17 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.351 1.46 . . . . 0.0 108.553 -173.739 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -156.12 149.65 18.97 Favored Pre-proline 0 CA--C 1.531 0.238 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 167.934 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_exo -59.62 -19.16 51.51 Favored 'Trans proline' 0 CA--C 1.534 0.504 0 C-N-CA 122.323 2.015 . . . . 0.0 115.775 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 52.4 p-90 -70.85 -20.11 62.57 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 119.933 1.242 . . . . 0.0 112.035 174.585 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 23.9 t -61.45 152.35 30.13 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 125.025 1.33 . . . . 0.0 111.344 -172.786 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -101.63 -66.59 0.78 Allowed Glycine 0 CA--C 1.529 0.963 0 CA-C-O 118.424 -1.209 . . . . 0.0 110.528 173.03 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -54.75 -30.42 67.06 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 123.12 2.547 . . . . 0.0 114.275 -179.548 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 39.4 m -56.26 -34.87 66.82 Favored 'General case' 0 CA--C 1.538 0.495 0 O-C-N 121.467 -0.77 . . . . 0.0 111.551 175.685 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.4 mmtp -68.94 -29.61 67.89 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 123.427 0.691 . . . . 0.0 110.944 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 5.0 ptt? -85.55 -30.03 23.7 Favored 'General case' 0 C--N 1.34 0.153 0 CA-C-N 118.809 0.731 . . . . 0.0 111.539 -177.002 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 19.5 tt -77.87 -20.77 13.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-O 118.626 -0.702 . . . . 0.0 111.56 169.795 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -51.7 -49.61 82.14 Favored Pre-proline 0 CA--C 1.548 0.887 0 CA-C-N 120.83 1.65 . . . . 0.0 113.852 178.232 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -66.18 -28.3 48.31 Favored 'Trans proline' 0 C--N 1.35 0.631 0 CA-C-N 121.922 1.722 . . . . 0.0 112.285 175.352 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 23.9 t -66.93 -39.23 83.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 174.429 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 95.1 mt -64.6 -37.0 86.08 Favored 'General case' 0 C--N 1.341 0.239 0 CA-C-N 119.531 1.06 . . . . 0.0 111.155 171.786 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -64.66 -40.79 96.04 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 119.385 0.993 . . . . 0.0 110.857 174.507 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -63.02 -40.02 96.49 Favored 'General case' 0 CA--C 1.531 0.232 0 O-C-N 121.067 -1.021 . . . . 0.0 110.187 174.158 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.35 -47.28 84.31 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.885 0.874 . . . . 0.0 109.746 175.499 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -59.01 -40.57 85.36 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 123.62 0.768 . . . . 0.0 111.03 179.262 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 -73.92 -10.71 59.93 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.303 0.641 . . . . 0.0 112.377 -179.395 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -103.44 -33.88 8.91 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 124.954 1.302 . . . . 0.0 111.791 178.292 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 86.6 mmm -125.08 -3.77 7.53 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 113.237 0.829 . . . . 0.0 113.237 -168.913 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -62.63 -3.57 5.82 Favored Glycine 0 CA--C 1.532 1.147 0 CA-C-N 119.853 1.206 . . . . 0.0 115.342 -175.415 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -73.96 -27.68 61.12 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 118.519 1.16 . . . . 0.0 111.201 169.756 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.3 -23.07 3.3 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 125.289 1.435 . . . . 0.0 111.59 -171.313 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 45.0 tp -111.24 151.61 28.1 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 124.878 1.271 . . . . 0.0 110.169 -169.771 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -118.82 144.8 46.12 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 105.541 -2.022 . . . . 0.0 105.541 168.322 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 73.1 mt -116.53 136.96 51.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 105.384 -2.08 . . . . 0.0 105.384 175.658 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 97.3 t -133.06 97.08 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 -169.91 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -73.97 139.48 44.86 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 107.648 -1.242 . . . . 0.0 107.648 175.633 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 11.5 tt -141.05 129.27 23.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.395 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 178.265 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 61.7 t0 -87.83 105.44 17.41 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 124.809 1.243 . . . . 0.0 110.06 -169.399 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 27.0 m -62.58 -18.46 20.69 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 CA-C-O 118.539 -0.743 . . . . 0.0 112.449 -177.347 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -67.54 -15.5 63.69 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 119.863 1.211 . . . . 0.0 112.023 176.591 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -127.18 1.03 6.45 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.236 1.014 . . . . 0.0 111.89 178.323 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 67.0 m-80 -137.55 41.0 2.4 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.737 0.815 . . . . 0.0 111.209 -169.35 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 5.3 mp0 -54.11 -32.08 53.94 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.203 0.601 . . . . 0.0 111.76 174.754 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -66.3 -47.44 73.59 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 118.423 0.556 . . . . 0.0 110.498 -177.707 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.07 -39.26 79.2 Favored 'General case' 0 CA--C 1.534 0.345 0 O-C-N 121.836 -0.54 . . . . 0.0 109.591 -179.416 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -58.53 -48.45 80.81 Favored 'General case' 0 CA--C 1.534 0.338 0 O-C-N 121.244 -0.91 . . . . 0.0 110.463 173.496 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -61.92 -28.15 69.83 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 124.179 0.895 . . . . 0.0 112.166 178.015 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 71.7 tttt -55.66 -28.76 57.23 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.853 1.261 . . . . 0.0 111.683 178.057 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -123.17 10.58 9.37 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.775 0.83 . . . . 0.0 111.803 179.252 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 65.38 27.46 72.5 Favored Glycine 0 CA--C 1.534 1.239 0 C-N-CA 123.85 0.738 . . . . 0.0 113.024 -177.944 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 60.4 t -62.72 127.63 23.17 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 171.786 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 22.6 ttt -137.16 0.49 2.35 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.612 1.165 . . . . 0.0 111.05 -176.837 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 25.2 m -144.92 162.51 36.67 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 126.514 1.926 . . . . 0.0 107.719 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 41.1 pt -142.8 156.79 62.47 Favored Pre-proline 0 CA--C 1.544 0.747 0 C-N-CA 124.858 1.263 . . . . 0.0 108.615 177.832 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -66.74 140.7 51.32 Favored 'Cis proline' 0 C--N 1.349 0.594 0 CA-C-N 120.464 1.201 . . . . 0.0 110.416 -5.714 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 32.2 m -135.2 135.96 41.41 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 176.625 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -115.4 132.11 56.72 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 -172.494 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -120.22 121.87 39.67 Favored 'General case' 0 CA--C 1.513 -0.443 0 N-CA-C 103.545 -2.761 . . . . 0.0 103.545 177.343 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 8.3 t -92.67 123.36 44.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 103.331 -2.84 . . . . 0.0 103.331 172.227 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.2 mp -113.09 155.7 24.44 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 175.918 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 60.8 tttp -135.65 124.62 24.2 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 105.854 -1.906 . . . . 0.0 105.854 173.479 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 30.8 t70 50.64 34.73 10.23 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.693 1.197 . . . . 0.0 112.119 176.199 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 100.38 -1.13 55.86 Favored Glycine 0 CA--C 1.529 0.951 0 CA-C-O 118.27 -1.294 . . . . 0.0 114.92 169.883 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -132.28 152.37 51.39 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 120.072 1.936 . . . . 0.0 110.24 -179.487 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 29.0 t -62.31 135.14 27.17 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 -178.602 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.9 p -120.59 -25.84 2.44 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 125.16 1.384 . . . . 0.0 110.237 175.135 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -155.95 170.24 22.59 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 120.22 1.373 . . . . 0.0 109.792 177.404 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 30.0 m -152.43 153.73 34.13 Favored 'General case' 0 CA--C 1.541 0.612 0 O-C-N 120.747 -1.221 . . . . 0.0 110.271 -176.197 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 41.7 m -150.22 154.45 37.98 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.561 1.544 . . . . 0.0 108.981 168.813 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 43.4 t -132.9 141.0 46.06 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 N-CA-C 107.03 -1.471 . . . . 0.0 107.03 -177.113 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 76.67 179.19 47.34 Favored Glycine 0 CA--C 1.53 0.992 0 N-CA-C 111.436 -0.665 . . . . 0.0 111.436 -177.131 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 36.1 t80 -63.18 132.62 52.36 Favored 'General case' 0 C--O 1.231 0.129 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 175.85 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 13.1 mptt -135.47 147.4 61.65 Favored Pre-proline 0 CA--C 1.536 0.419 0 C-N-CA 126.676 1.99 . . . . 0.0 106.176 174.262 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -71.53 158.07 54.67 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 122.513 2.142 . . . . 0.0 110.521 178.758 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 20.7 pttp -58.25 -29.25 65.63 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -62.4 -42.84 99.74 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.215 0.606 . . . . 0.0 110.433 176.368 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.62 -47.38 78.78 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 118.544 0.611 . . . . 0.0 110.09 -178.934 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 10.1 mp -56.09 -47.44 78.03 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.577 0.751 . . . . 0.0 109.912 176.167 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 14.7 mt-30 -61.73 -39.9 93.18 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-O 118.729 -0.653 . . . . 0.0 112.058 178.928 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -64.69 -42.83 95.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 119.073 0.852 . . . . 0.0 110.029 178.528 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 31.0 mt -66.92 -35.3 79.68 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 118.586 0.63 . . . . 0.0 111.562 179.034 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 44.0 t -60.99 -50.99 78.29 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 170.024 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -61.26 -33.65 73.88 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 125.383 1.473 . . . . 0.0 111.862 -173.424 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 59.1 mtpt -56.36 -27.93 57.54 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 118.332 -0.842 . . . . 0.0 112.212 174.652 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -128.92 -5.47 5.06 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 114.688 1.366 . . . . 0.0 114.688 -167.803 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 17.5 mt . . . . . 0 C--O 1.25 1.082 0 CA-C-N 119.655 1.116 . . . . 0.0 108.725 168.569 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.3 mt . . . . . 0 CA--C 1.538 0.502 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 20.7 t -135.77 161.37 38.54 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 126.696 1.998 . . . . 0.0 106.103 -176.526 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.62 138.89 50.62 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 105.652 -1.981 . . . . 0.0 105.652 169.149 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -139.2 171.39 14.36 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 123.453 0.701 . . . . 0.0 110.852 -178.652 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.0 p -136.18 171.66 14.15 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 125.768 1.627 . . . . 0.0 108.454 175.29 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -38.82 -39.93 0.57 Allowed 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 126.415 1.886 . . . . 0.0 113.525 170.862 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 43.5 mm-40 -68.62 -26.03 65.14 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.095 0.958 . . . . 0.0 113.088 -173.414 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.1 m -134.18 -8.95 2.62 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 113.585 0.958 . . . . 0.0 113.585 -169.873 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 67.4 t80 -54.03 -45.17 71.49 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 124.363 1.065 . . . . 0.0 111.44 -176.486 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 9.3 m -63.25 -37.42 87.18 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.041 0.536 . . . . 0.0 111.729 -178.556 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -68.41 -44.77 74.32 Favored 'General case' 0 N--CA 1.454 -0.272 0 O-C-N 122.036 -0.415 . . . . 0.0 110.055 177.143 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 67.0 mm-40 -63.21 -35.78 81.46 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 122.414 0.286 . . . . 0.0 110.955 -178.6 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.9 p -83.98 1.36 44.04 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.2 1.0 . . . . 0.0 113.496 -177.471 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 66.5 m -102.15 32.58 3.43 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.099 0.959 . . . . 0.0 111.403 -177.105 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -132.78 58.18 1.77 Allowed 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.354 1.062 . . . . 0.0 110.155 -178.757 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 93.97 -154.08 21.42 Favored Glycine 0 C--N 1.339 0.728 0 N-CA-C 110.084 -1.206 . . . . 0.0 110.084 176.269 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 84.7 t -71.19 134.84 29.24 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 168.142 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 58.8 t -139.07 142.07 34.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 105.639 -1.985 . . . . 0.0 105.639 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 3.4 tt -120.51 99.37 6.52 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 -174.663 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -81.33 146.83 30.16 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 179.432 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -126.09 94.14 4.01 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 125.983 1.713 . . . . 0.0 106.961 -177.557 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -73.95 113.97 11.73 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 106.179 -1.786 . . . . 0.0 106.179 174.871 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -149.75 -175.85 5.19 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 125.107 1.363 . . . . 0.0 107.883 -172.23 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -155.84 148.36 17.8 Favored Pre-proline 0 N--CA 1.451 -0.376 0 N-CA-C 106.106 -1.813 . . . . 0.0 106.106 167.46 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -68.35 -12.92 36.34 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 CA-C-N 120.871 1.347 . . . . 0.0 113.923 -178.45 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 42.6 p-90 -69.88 -20.94 63.37 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 120.221 1.373 . . . . 0.0 111.978 169.526 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 26.8 t -59.3 149.19 29.51 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.117 1.367 . . . . 0.0 111.123 -171.165 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -97.02 -60.39 0.97 Allowed Glycine 0 CA--C 1.533 1.19 0 CA-C-O 118.715 -1.047 . . . . 0.0 111.418 170.016 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -66.77 -25.9 45.7 Favored 'Trans proline' 0 C--N 1.349 0.576 0 CA-C-N 120.444 2.122 . . . . 0.0 112.813 -173.412 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 22.5 m -58.73 -32.23 69.02 Favored 'General case' 0 CA--C 1.536 0.41 0 O-C-N 121.524 -0.735 . . . . 0.0 111.401 174.392 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.7 mmtp -69.03 -23.01 64.02 Favored 'General case' 0 CA--C 1.532 0.257 0 O-C-N 121.373 -0.829 . . . . 0.0 111.109 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 34.0 mtm -71.52 -42.65 67.71 Favored 'General case' 0 C--N 1.34 0.194 0 CA-C-N 118.763 0.711 . . . . 0.0 110.404 175.729 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 16.5 tt -84.0 -22.12 8.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-O 118.741 -0.647 . . . . 0.0 111.599 -176.459 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -49.39 -51.16 60.38 Favored Pre-proline 0 CA--C 1.547 0.845 0 CA-C-N 120.009 1.277 . . . . 0.0 113.894 177.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -67.59 -25.98 40.29 Favored 'Trans proline' 0 C--N 1.351 0.66 0 CA-C-N 121.828 1.689 . . . . 0.0 112.528 176.334 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 15.2 t -70.05 -37.01 71.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 O-C-N 121.555 -0.715 . . . . 0.0 109.49 174.604 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 93.6 mt -67.41 -36.72 81.83 Favored 'General case' 0 C--O 1.226 -0.152 0 CA-C-N 119.576 1.08 . . . . 0.0 111.267 171.816 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -62.43 -41.59 98.82 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 119.385 0.993 . . . . 0.0 110.686 172.27 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 30.9 mm-40 -60.08 -45.91 91.33 Favored 'General case' 0 N--CA 1.455 -0.18 0 O-C-N 121.401 -0.812 . . . . 0.0 110.139 173.286 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.13 -44.09 92.03 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.886 0.874 . . . . 0.0 109.576 179.513 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -60.46 -42.78 96.88 Favored 'General case' 0 CA--C 1.522 -0.117 0 C-N-CA 123.559 0.743 . . . . 0.0 111.245 178.51 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -72.6 -10.22 59.53 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.366 0.666 . . . . 0.0 112.459 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -103.13 -33.75 9.11 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 125.315 1.446 . . . . 0.0 110.723 -179.203 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 88.4 mmm -130.12 -4.05 4.46 Favored 'General case' 0 C--N 1.341 0.203 0 N-CA-C 113.869 1.063 . . . . 0.0 113.869 -167.885 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.61 -11.41 15.51 Favored Glycine 0 CA--C 1.532 1.095 0 CA-C-N 119.954 1.252 . . . . 0.0 114.993 -173.575 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -67.05 -28.23 68.04 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 118.434 1.117 . . . . 0.0 111.595 172.012 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -120.8 -25.16 5.5 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 125.56 1.544 . . . . 0.0 111.686 -178.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 35.3 tp -102.58 159.6 15.31 Favored 'General case' 0 C--O 1.232 0.149 0 C-N-CA 124.202 1.001 . . . . 0.0 110.504 -170.216 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -132.68 143.54 49.71 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 104.326 -2.472 . . . . 0.0 104.326 167.403 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 67.5 mt -117.09 138.76 46.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 105.28 -2.118 . . . . 0.0 105.28 177.548 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 97.7 t -132.9 94.22 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 -169.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 27.9 mtpp -73.43 141.07 46.92 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 176.738 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 11.8 tt -142.73 126.86 15.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 178.582 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 57.4 t0 -86.25 104.61 15.95 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 124.783 1.233 . . . . 0.0 109.253 -170.948 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 26.1 m -61.79 -20.74 24.19 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-O 118.625 -0.702 . . . . 0.0 112.271 -176.817 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -67.6 -13.83 62.41 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 119.723 1.147 . . . . 0.0 111.958 177.345 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -124.23 3.28 8.54 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.666 1.187 . . . . 0.0 111.506 175.854 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 65.0 m-80 -141.65 41.25 1.72 Allowed 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 124.13 0.972 . . . . 0.0 111.29 -169.673 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 3.7 mp0 -52.89 -31.55 40.31 Favored 'General case' 0 CA--C 1.531 0.25 0 O-C-N 121.972 -0.455 . . . . 0.0 111.716 172.806 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -65.05 -50.76 64.92 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 123.905 0.882 . . . . 0.0 109.77 -178.857 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.34 -36.95 77.42 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.33 0.652 . . . . 0.0 109.839 -178.471 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.41 -45.99 89.96 Favored 'General case' 0 CA--C 1.534 0.365 0 O-C-N 120.834 -1.167 . . . . 0.0 110.669 171.295 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -63.5 -28.12 71.92 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 123.906 0.765 . . . . 0.0 112.189 177.654 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 74.0 tttt -56.15 -29.17 60.4 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.964 1.306 . . . . 0.0 111.613 179.202 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -123.82 6.17 8.74 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.291 0.636 . . . . 0.0 112.273 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 62.44 41.63 99.76 Favored Glycine 0 CA--C 1.53 0.99 0 N-CA-C 111.698 -0.561 . . . . 0.0 111.698 -175.546 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 95.2 t -63.38 94.3 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 124.852 1.261 . . . . 0.0 107.963 173.852 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 1.6 pmm? -73.77 -30.72 62.93 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 125.235 1.414 . . . . 0.0 112.452 -175.325 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 52.0 m -147.42 175.0 11.16 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 126.067 1.747 . . . . 0.0 109.653 -172.221 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 42.8 pt -137.2 154.87 76.02 Favored Pre-proline 0 CA--C 1.546 0.813 0 C-N-CA 125.045 1.338 . . . . 0.0 108.631 175.211 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -67.93 141.54 60.19 Favored 'Cis proline' 0 N--CA 1.458 -0.612 0 CA-C-N 120.467 1.203 . . . . 0.0 110.493 -4.215 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 18.4 m -135.88 137.51 41.51 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 175.016 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -114.79 133.39 55.96 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 -173.802 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -120.78 116.49 25.34 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 103.18 -2.896 . . . . 0.0 103.18 176.848 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.4 t -91.79 121.36 42.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 103.723 -2.695 . . . . 0.0 103.723 173.431 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.4 mp -110.51 155.28 22.48 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 175.896 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 26.4 ttpp -133.7 115.05 14.13 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 105.677 -1.971 . . . . 0.0 105.677 176.387 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 27.6 t0 50.09 39.98 20.55 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.675 1.19 . . . . 0.0 112.461 176.303 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 103.59 -4.22 46.82 Favored Glycine 0 CA--C 1.529 0.958 0 CA-C-O 118.184 -1.342 . . . . 0.0 115.345 168.729 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -132.27 150.2 52.21 Favored 'General case' 0 C--N 1.34 0.155 0 CA-C-N 120.056 1.928 . . . . 0.0 110.32 -178.75 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 22.1 t -62.99 134.66 28.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 -179.352 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.3 p -117.97 -27.67 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 C-N-CA 125.016 1.326 . . . . 0.0 110.169 174.393 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 40.8 mm-40 -150.22 163.14 39.01 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 120.201 1.364 . . . . 0.0 110.177 172.281 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 17.9 m -141.04 145.08 35.4 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.057 1.343 . . . . 0.0 108.44 176.735 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 20.0 m -144.74 151.99 39.7 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.389 1.476 . . . . 0.0 108.845 175.622 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 59.2 t -132.44 142.96 41.24 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 -177.059 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 79.14 179.5 52.02 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 123.876 0.751 . . . . 0.0 111.815 -178.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -57.96 144.76 38.29 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 123.391 0.676 . . . . 0.0 110.511 178.219 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -149.64 134.93 9.7 Favored Pre-proline 0 N--CA 1.453 -0.303 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 -175.944 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -74.39 156.81 45.7 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 122.12 1.88 . . . . 0.0 110.787 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 17.7 ptmt -56.9 -31.77 65.22 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 124.019 0.927 . . . . 0.0 112.266 177.627 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -66.09 -48.54 70.6 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 118.731 0.696 . . . . 0.0 110.011 179.447 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.94 -44.36 96.29 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 118.009 0.368 . . . . 0.0 110.335 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 83.3 mt -61.73 -42.68 99.27 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-O 119.465 -0.303 . . . . 0.0 110.505 178.391 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -61.62 -39.85 92.75 Favored 'General case' 0 C--O 1.222 -0.343 0 CA-C-O 118.132 -0.937 . . . . 0.0 111.268 175.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -64.11 -41.9 97.09 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 119.822 1.192 . . . . 0.0 110.421 178.385 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 88.8 mt -63.54 -38.63 91.87 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 122.904 0.482 . . . . 0.0 111.165 178.129 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 49.7 t -63.33 -51.26 73.26 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 C-N-CA 123.676 0.79 . . . . 0.0 109.542 171.51 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -59.63 -40.76 88.69 Favored 'General case' 0 C--N 1.332 -0.153 0 C-N-CA 125.907 1.683 . . . . 0.0 111.503 -169.407 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 13.7 ptmm? -69.5 -6.63 31.89 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 118.155 -0.926 . . . . 0.0 113.16 -177.83 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 93.6 m-70 -124.96 -15.4 6.4 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 177.105 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 19.7 mt . . . . . 0 C--O 1.249 1.076 0 CA-C-N 119.563 1.074 . . . . 0.0 109.371 169.404 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.6 mt . . . . . 0 C--O 1.236 0.39 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 21.4 t -133.95 159.56 42.31 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 C-N-CA 126.221 1.808 . . . . 0.0 106.498 -176.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -115.2 128.44 56.17 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 105.428 -2.064 . . . . 0.0 105.428 178.837 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -138.5 166.76 23.48 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 121.576 0.703 . . . . 0.0 112.313 -173.884 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.448 HG22 HD21 ' A' ' 60' ' ' ASN . 36.4 p -137.09 179.24 6.5 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 125.648 1.579 . . . . 0.0 107.715 171.105 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -49.14 -29.8 5.85 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.25 1.02 . . . . 0.0 112.706 170.18 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -63.04 -27.54 69.47 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.007 1.323 . . . . 0.0 112.805 179.341 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 13.6 p -132.08 -20.22 2.48 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 -167.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 56.4 t80 -51.98 -47.52 64.81 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 124.767 1.227 . . . . 0.0 112.534 -169.782 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.3 m -64.6 -38.57 91.47 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 122.666 0.386 . . . . 0.0 111.665 -175.894 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -68.04 -45.01 75.12 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 176.567 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 -62.9 -36.5 83.58 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 119.301 -0.38 . . . . 0.0 111.082 -177.572 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.8 p -83.75 -0.04 49.24 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 113.526 0.936 . . . . 0.0 113.526 -177.059 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 70.3 m -102.6 31.34 4.14 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.986 0.914 . . . . 0.0 111.494 -175.878 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -132.35 53.04 2.03 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.181 0.992 . . . . 0.0 110.781 -175.883 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 99.62 -156.21 19.79 Favored Glycine 0 C--N 1.338 0.655 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 176.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 90.0 t -70.18 136.43 26.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 167.576 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 60.6 t -139.59 147.13 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 N-CA-C 105.576 -2.009 . . . . 0.0 105.576 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.1 tt -125.17 99.0 5.89 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 -175.557 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -80.26 147.44 31.19 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 123.258 0.623 . . . . 0.0 109.548 -179.162 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -129.44 93.94 3.66 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 126.126 1.77 . . . . 0.0 108.163 -174.673 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -75.17 112.58 11.58 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 106.321 -1.733 . . . . 0.0 106.321 174.903 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -149.46 -176.57 5.44 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.775 1.23 . . . . 0.0 108.218 -173.931 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -156.67 149.1 17.86 Favored Pre-proline 0 CA--C 1.531 0.239 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 167.713 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -60.85 -19.13 60.57 Favored 'Trans proline' 0 N--CA 1.46 -0.47 0 C-N-CA 121.568 1.512 . . . . 0.0 115.43 179.134 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 48.5 p-90 -69.72 -20.06 63.54 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 119.926 1.239 . . . . 0.0 111.927 173.766 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 25.4 t -59.62 147.83 35.88 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.932 1.293 . . . . 0.0 111.072 -172.217 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -96.91 -63.62 0.92 Allowed Glycine 0 CA--C 1.529 0.94 0 CA-C-O 118.479 -1.178 . . . . 0.0 110.862 171.376 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -62.68 -26.2 75.38 Favored 'Trans proline' 0 C--N 1.349 0.605 0 CA-C-N 120.314 2.057 . . . . 0.0 113.543 -174.716 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 35.1 m -57.65 -34.34 69.26 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 118.653 0.66 . . . . 0.0 111.471 174.676 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.9 mmtp -67.88 -25.28 65.44 Favored 'General case' 0 CA--C 1.531 0.236 0 O-C-N 121.553 -0.717 . . . . 0.0 110.921 -179.437 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 31.0 mtm -71.91 -42.81 66.28 Favored 'General case' 0 C--N 1.34 0.16 0 CA-C-N 118.696 0.68 . . . . 0.0 110.444 176.874 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 13.5 tt -84.05 -21.73 8.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-O 118.826 -0.607 . . . . 0.0 111.56 -175.761 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -48.82 -51.8 51.25 Favored Pre-proline 0 CA--C 1.546 0.819 0 CA-C-N 119.994 1.27 . . . . 0.0 113.643 177.769 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -67.27 -29.0 39.4 Favored 'Trans proline' 0 C--N 1.351 0.682 0 CA-C-N 121.756 1.663 . . . . 0.0 112.555 176.605 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 31.4 t -65.48 -40.24 87.61 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 174.81 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 76.9 mt -67.78 -35.54 78.86 Favored 'General case' 0 C--O 1.224 -0.238 0 CA-C-N 119.299 0.954 . . . . 0.0 111.482 173.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -62.38 -42.27 99.28 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 119.549 1.068 . . . . 0.0 110.736 172.794 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -65.03 -39.38 93.3 Favored 'General case' 0 CA--C 1.532 0.265 0 O-C-N 121.28 -0.887 . . . . 0.0 110.505 175.713 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.24 -46.37 90.02 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.638 0.775 . . . . 0.0 109.348 175.486 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -58.88 -42.94 90.69 Favored 'General case' 0 CA--C 1.521 -0.144 0 C-N-CA 123.833 0.853 . . . . 0.0 111.279 179.386 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -70.79 -10.47 59.58 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.428 0.691 . . . . 0.0 112.607 179.338 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 58.2 mt-10 -106.16 -30.62 9.12 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 125.601 1.56 . . . . 0.0 111.46 -177.511 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 91.6 mmm -127.62 -5.38 5.83 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 -171.511 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.81 -10.69 14.21 Favored Glycine 0 CA--C 1.531 1.036 0 CA-C-N 119.828 1.194 . . . . 0.0 114.854 -174.106 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -65.41 -28.48 69.28 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 118.509 1.154 . . . . 0.0 111.51 171.502 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -123.31 -25.84 4.38 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 125.427 1.491 . . . . 0.0 111.639 -179.0 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 31.6 tp -100.07 161.61 13.5 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 124.306 1.042 . . . . 0.0 110.385 -170.244 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -135.95 144.6 45.53 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 104.447 -2.427 . . . . 0.0 104.447 168.066 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 59.9 mt -116.65 139.32 43.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 105.489 -2.041 . . . . 0.0 105.489 176.518 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 93.2 t -132.98 96.31 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 -169.717 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -74.39 138.02 43.1 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 178.175 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 13.4 tt -141.4 128.73 21.32 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 177.964 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 64.6 t0 -87.94 106.68 18.27 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.603 1.161 . . . . 0.0 109.797 -169.529 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 31.3 m -62.08 -19.02 20.92 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 CA-C-O 118.693 -0.67 . . . . 0.0 112.473 -176.821 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -67.2 -15.72 63.87 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 119.685 1.129 . . . . 0.0 112.105 176.955 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -127.21 1.86 6.42 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.306 1.042 . . . . 0.0 111.863 179.155 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.448 HD21 HG22 ' A' ' 7' ' ' THR . 63.8 m-80 -137.63 40.52 2.39 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.732 0.813 . . . . 0.0 111.447 -169.235 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 5.5 mp0 -54.41 -32.58 57.59 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.056 0.542 . . . . 0.0 111.781 174.873 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 32.9 mm-40 -65.73 -48.96 70.17 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 118.514 0.597 . . . . 0.0 110.136 -179.07 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.39 -37.82 80.76 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.036 0.534 . . . . 0.0 109.927 -178.925 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.4 -48.59 81.08 Favored 'General case' 0 CA--C 1.535 0.372 0 O-C-N 121.064 -1.022 . . . . 0.0 110.363 172.32 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -60.62 -27.67 66.58 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 124.225 0.916 . . . . 0.0 112.334 177.535 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 47.3 tttp -55.52 -29.11 58.29 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.84 1.256 . . . . 0.0 111.726 178.415 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -123.54 10.8 9.15 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.554 0.742 . . . . 0.0 111.732 179.242 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 64.12 30.44 77.78 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 123.649 0.642 . . . . 0.0 112.629 -176.434 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 61.5 t -65.44 125.8 23.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 171.038 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 67.0 mtt -136.36 3.84 2.86 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.811 1.244 . . . . 0.0 111.465 -179.209 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 24.2 m -144.05 161.79 37.88 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 126.591 1.957 . . . . 0.0 107.697 179.672 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 42.5 pt -141.56 154.51 66.59 Favored Pre-proline 0 CA--C 1.545 0.774 0 C-N-CA 124.424 1.09 . . . . 0.0 108.811 176.141 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -67.42 140.02 50.34 Favored 'Cis proline' 0 C--N 1.349 0.586 0 CA-C-N 120.356 1.163 . . . . 0.0 110.385 -4.278 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 42.4 m -132.71 142.24 48.96 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 173.672 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 91.6 mt -125.21 129.46 50.15 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 107.37 -1.345 . . . . 0.0 107.37 -169.259 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -119.84 118.49 30.92 Favored 'General case' 0 CA--C 1.513 -0.476 0 N-CA-C 103.27 -2.863 . . . . 0.0 103.27 178.772 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 4.5 t -88.6 122.83 40.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 103.007 -2.96 . . . . 0.0 103.007 172.297 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.2 mp -112.05 157.42 20.78 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 174.401 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 89.1 tttt -136.42 124.51 22.96 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 106.304 -1.739 . . . . 0.0 106.304 169.922 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.0 t70 49.22 38.02 12.48 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.909 1.284 . . . . 0.0 112.389 175.677 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 100.87 -2.4 55.55 Favored Glycine 0 CA--C 1.53 0.979 0 CA-C-O 118.15 -1.361 . . . . 0.0 115.167 169.214 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -131.96 152.54 51.04 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 120.174 1.987 . . . . 0.0 110.284 -179.15 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 22.0 t -62.92 134.52 28.12 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 -179.252 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.5 p -120.14 -24.23 3.03 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 C-N-CA 125.471 1.508 . . . . 0.0 109.958 176.89 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -158.79 172.2 18.68 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 120.262 1.392 . . . . 0.0 109.601 173.656 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 26.5 m -148.87 153.15 37.65 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 120.555 -1.34 . . . . 0.0 109.543 -179.243 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 48.4 m -150.22 154.44 37.95 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.218 1.407 . . . . 0.0 109.051 169.699 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 40.9 t -133.59 142.17 42.32 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 -177.673 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 75.69 -177.9 48.92 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 123.43 0.538 . . . . 0.0 111.838 -178.668 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 59.2 t80 -59.52 143.97 48.62 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 123.238 0.615 . . . . 0.0 110.683 179.212 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -150.27 137.12 11.23 Favored Pre-proline 0 C--O 1.234 0.267 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 -176.502 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -73.12 153.83 51.97 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 122.009 1.806 . . . . 0.0 110.486 176.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 57.6 pttt -60.79 -31.61 70.97 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 118.897 -0.573 . . . . 0.0 111.818 -178.404 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -66.45 -42.5 87.53 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.279 0.632 . . . . 0.0 110.438 -179.179 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.18 -44.48 88.32 Favored 'General case' 0 C--O 1.232 0.16 0 O-C-N 121.961 -0.462 . . . . 0.0 109.898 179.148 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 92.0 mt -62.61 -40.22 96.25 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.582 177.899 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -60.4 -41.19 93.34 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-O 118.577 -0.725 . . . . 0.0 111.498 174.638 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -63.39 -42.71 98.83 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 118.924 0.784 . . . . 0.0 110.007 176.914 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 40.7 mt -63.65 -41.62 98.19 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 118.739 0.699 . . . . 0.0 111.382 177.758 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 43.1 t -57.51 -49.34 80.68 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 C-N-CA 123.546 0.738 . . . . 0.0 109.239 171.921 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -63.05 -31.44 72.58 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.403 1.481 . . . . 0.0 111.964 -173.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -58.67 -24.73 61.83 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 118.236 -0.888 . . . . 0.0 112.213 174.397 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 82.3 m-70 -125.69 -14.56 6.23 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 113.863 1.06 . . . . 0.0 113.863 -168.8 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 23.8 mt . . . . . 0 C--O 1.247 0.964 0 CA-C-N 119.692 1.133 . . . . 0.0 109.125 168.975 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 7.6 mt . . . . . 0 CA--C 1.536 0.405 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 38.7 t -135.0 164.1 34.68 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 C-N-CA 127.065 2.146 . . . . 0.0 106.082 -179.291 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 6.2 ttmt -120.85 146.22 46.79 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 175.016 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -146.48 167.78 22.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.335 0.588 . . . . 0.0 111.104 -176.779 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 16.0 p -132.57 170.62 14.91 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 126.394 1.878 . . . . 0.0 107.896 171.358 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -52.97 -29.76 30.95 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.034 0.933 . . . . 0.0 113.125 -179.096 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 56.6 mt-30 -62.47 -28.98 70.19 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.124 1.37 . . . . 0.0 112.933 179.537 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.6 m -136.33 -5.89 2.04 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 113.517 0.932 . . . . 0.0 113.517 -169.191 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 81.9 t80 -53.43 -44.01 68.46 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.174 0.99 . . . . 0.0 111.281 -178.614 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.2 m -62.89 -39.06 93.33 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.252 0.621 . . . . 0.0 111.935 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.77 -43.89 82.82 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 122.697 0.399 . . . . 0.0 109.993 178.299 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -64.53 -41.54 96.31 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 122.235 0.214 . . . . 0.0 110.709 -179.769 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.409 ' HA ' HG21 ' A' ' 20' ' ' VAL . 36.3 p -79.47 -3.65 47.59 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 124.308 1.043 . . . . 0.0 113.544 -176.567 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 74.7 m -75.07 -21.4 59.01 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 176.855 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -88.02 71.74 9.32 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 121.55 -0.719 . . . . 0.0 111.586 -169.848 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 84.13 -152.75 28.58 Favored Glycine 0 C--N 1.336 0.566 0 N-CA-C 110.304 -1.118 . . . . 0.0 110.304 173.303 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 63.2 t -70.7 134.36 30.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 169.114 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.409 HG21 ' HA ' ' A' ' 15' ' ' THR . 61.6 t -139.09 138.81 41.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 105.786 -1.931 . . . . 0.0 105.786 179.34 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.9 tt -117.37 104.31 11.0 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 -177.558 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -89.45 147.1 24.2 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 -177.308 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -127.42 94.13 3.9 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 125.551 1.54 . . . . 0.0 107.333 -175.672 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -74.46 112.77 10.96 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 105.68 -1.971 . . . . 0.0 105.68 174.878 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -149.41 -174.94 4.81 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 124.911 1.284 . . . . 0.0 108.095 -172.056 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -152.77 148.78 20.95 Favored Pre-proline 0 N--CA 1.453 -0.285 0 N-CA-C 105.83 -1.915 . . . . 0.0 105.83 167.174 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -68.21 -11.89 33.39 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 CA-C-N 121.101 1.429 . . . . 0.0 112.855 178.149 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 1.3 m95 -77.22 -12.34 59.94 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.775 0.83 . . . . 0.0 111.814 172.329 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 17.4 t -64.65 160.95 18.69 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.353 1.461 . . . . 0.0 110.834 -178.78 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -115.52 -58.02 0.34 Allowed Glycine 0 CA--C 1.531 1.046 0 CA-C-O 118.631 -1.094 . . . . 0.0 111.069 171.436 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -56.22 -33.63 91.29 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 123.506 2.804 . . . . 0.0 113.395 178.368 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 23.0 m -58.4 -33.71 69.94 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 121.705 -0.622 . . . . 0.0 111.555 176.34 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.5 mmtp -68.5 -22.24 64.55 Favored 'General case' 0 CA--C 1.531 0.238 0 O-C-N 121.499 -0.75 . . . . 0.0 111.086 -179.686 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 35.3 mtm -70.15 -43.27 71.23 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-N 118.731 0.696 . . . . 0.0 110.298 175.346 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 18.2 tt -85.2 -23.7 7.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-O 118.379 -0.82 . . . . 0.0 111.701 -176.603 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -49.04 -50.19 64.47 Favored Pre-proline 0 CA--C 1.549 0.914 0 CA-C-N 120.407 1.458 . . . . 0.0 114.516 179.038 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -66.13 -30.64 46.6 Favored 'Trans proline' 0 C--N 1.351 0.666 0 CA-C-N 121.636 1.62 . . . . 0.0 111.682 176.449 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.6 t -66.03 -39.81 85.55 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-O 118.305 -0.855 . . . . 0.0 109.449 174.125 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 94.7 mt -62.53 -37.66 86.95 Favored 'General case' 0 C--N 1.34 0.185 0 CA-C-N 119.916 1.235 . . . . 0.0 110.874 173.786 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -63.02 -45.4 92.5 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 119.411 1.005 . . . . 0.0 110.978 173.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 50.8 mm-40 -65.26 -37.33 86.87 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 120.923 -1.111 . . . . 0.0 110.83 178.44 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -63.94 -42.99 97.19 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 125.154 1.382 . . . . 0.0 109.392 176.156 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -58.5 -43.59 89.14 Favored 'General case' 0 CA--C 1.521 -0.137 0 C-N-CA 123.941 0.896 . . . . 0.0 111.203 176.014 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -70.26 -12.8 61.84 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -179.013 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -102.25 -33.38 9.64 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 125.228 1.411 . . . . 0.0 111.088 -179.483 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 79.5 mmm -119.49 -5.61 10.29 Favored 'General case' 0 N--CA 1.461 0.117 0 CA-C-O 118.584 -0.722 . . . . 0.0 112.837 -168.654 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -61.4 -8.01 11.86 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 124.583 1.087 . . . . 0.0 115.574 -173.705 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -75.53 -26.41 58.04 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 118.736 1.268 . . . . 0.0 111.365 171.497 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 50.8 mmtt -118.15 -24.29 7.04 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 125.503 1.521 . . . . 0.0 111.684 -176.524 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 47.4 tp -116.4 152.99 32.85 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 124.379 1.072 . . . . 0.0 112.056 -167.74 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -119.41 142.15 48.47 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 104.986 -2.227 . . . . 0.0 104.986 166.551 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 75.8 mt -110.94 140.28 30.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 105.667 -1.975 . . . . 0.0 105.667 172.567 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 97.3 t -131.79 98.35 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -175.095 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -75.09 140.48 43.48 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 174.435 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 13.7 tt -142.88 124.77 12.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 178.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -82.68 105.31 13.61 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 124.594 1.158 . . . . 0.0 108.832 -173.935 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 31.0 m -60.12 -25.58 33.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 118.536 -0.745 . . . . 0.0 111.959 -175.618 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -65.71 -18.01 65.02 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 119.597 1.089 . . . . 0.0 112.047 -177.252 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -118.69 3.51 11.68 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.893 1.277 . . . . 0.0 111.132 177.392 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -139.81 40.46 2.0 Allowed 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 124.563 1.145 . . . . 0.0 109.758 -170.179 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 50.5 mm-40 -55.54 -32.42 62.93 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.907 0.883 . . . . 0.0 111.024 176.388 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 33.1 mm-40 -65.33 -48.27 73.61 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 118.411 0.551 . . . . 0.0 110.255 178.702 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.43 -40.27 85.48 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.235 0.614 . . . . 0.0 109.927 -178.561 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.98 -47.33 86.27 Favored 'General case' 0 CA--C 1.533 0.293 0 O-C-N 121.541 -0.725 . . . . 0.0 110.76 173.583 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -62.9 -29.01 72.87 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 123.554 0.597 . . . . 0.0 111.944 177.796 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 17.9 ttmt -55.6 -29.87 59.9 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 125.837 1.655 . . . . 0.0 111.999 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -123.67 7.9 8.85 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 123.491 0.717 . . . . 0.0 112.197 -179.766 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 63.09 41.41 99.78 Favored Glycine 0 CA--C 1.53 0.996 0 CA-C-N 118.329 0.513 . . . . 0.0 111.857 -176.431 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 88.3 t -66.07 91.52 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 C-N-CA 124.71 1.204 . . . . 0.0 107.774 174.52 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 25.1 ptt? -73.57 -28.12 61.68 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 124.707 1.203 . . . . 0.0 112.94 -176.138 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 34.4 m -146.72 174.85 11.08 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 125.973 1.709 . . . . 0.0 109.491 -170.733 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 41.6 pt -139.49 156.56 71.42 Favored Pre-proline 0 CA--C 1.545 0.752 0 C-N-CA 125.169 1.388 . . . . 0.0 108.669 174.785 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -67.46 138.97 44.99 Favored 'Cis proline' 0 C--N 1.349 0.561 0 CA-C-N 120.577 1.242 . . . . 0.0 110.13 -5.08 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 23.4 m -132.91 135.23 45.43 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 176.194 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 10.8 mp -114.81 125.68 53.96 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 -169.526 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -115.41 122.63 46.4 Favored 'General case' 0 CA--C 1.515 -0.393 0 N-CA-C 103.708 -2.701 . . . . 0.0 103.708 177.523 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 4.3 t -92.87 125.7 45.41 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.481 0 N-CA-C 103.655 -2.72 . . . . 0.0 103.655 169.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.2 mp -114.08 152.17 31.44 Favored 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 172.808 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -137.96 126.16 23.03 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 174.414 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 32.2 t70 50.86 33.17 8.21 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.976 1.31 . . . . 0.0 112.264 178.139 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 100.65 0.06 55.41 Favored Glycine 0 CA--C 1.531 1.059 0 CA-C-O 118.207 -1.33 . . . . 0.0 114.965 169.69 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -128.51 150.46 50.16 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 120.002 1.901 . . . . 0.0 109.929 179.218 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 47.1 t -62.09 132.62 27.87 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 175.471 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.6 p -119.53 -21.75 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 C-N-CA 125.129 1.372 . . . . 0.0 109.79 178.446 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -159.65 165.01 33.57 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 120.184 1.356 . . . . 0.0 110.751 171.814 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 10.7 m -136.32 150.82 49.05 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.255 1.422 . . . . 0.0 108.916 176.487 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 73.3 m -150.67 156.83 42.12 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.885 1.674 . . . . 0.0 108.696 170.594 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 47.5 t -133.49 145.3 33.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 -176.926 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 79.43 178.32 51.06 Favored Glycine 0 CA--C 1.53 1.025 0 C-N-CA 123.928 0.775 . . . . 0.0 112.706 175.253 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -60.06 148.35 36.05 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 123.798 0.839 . . . . 0.0 111.017 179.241 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -149.29 136.7 11.15 Favored Pre-proline 0 CA--C 1.534 0.334 0 C-N-CA 125.492 1.517 . . . . 0.0 107.084 -178.846 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -69.3 158.98 55.52 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 122.019 1.813 . . . . 0.0 111.04 177.348 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -55.06 -43.19 73.64 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 124.799 1.24 . . . . 0.0 112.739 -178.031 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -61.49 -44.08 97.72 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.009 0.524 . . . . 0.0 110.257 178.446 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.49 -36.51 82.92 Favored 'General case' 0 CA--C 1.528 0.129 0 O-C-N 121.865 -0.522 . . . . 0.0 111.017 178.719 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 92.4 mt -62.98 -42.11 99.74 Favored 'General case' 0 N--CA 1.456 -0.14 0 O-C-N 122.134 -0.353 . . . . 0.0 110.91 173.949 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -60.55 -39.8 89.27 Favored 'General case' 0 C--O 1.224 -0.284 0 CA-C-O 118.712 -0.661 . . . . 0.0 110.178 175.18 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -65.75 -40.9 92.56 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 119.02 0.827 . . . . 0.0 110.601 178.694 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 60.4 tp -60.44 -37.51 81.18 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 125.406 1.482 . . . . 0.0 110.958 177.22 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 92.9 t -69.38 -51.63 40.64 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 123.509 0.724 . . . . 0.0 109.698 171.321 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -58.27 -38.14 76.37 Favored 'General case' 0 C--N 1.334 -0.101 0 C-N-CA 125.939 1.695 . . . . 0.0 112.099 -168.135 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -65.42 -8.49 19.11 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 113.342 0.867 . . . . 0.0 113.342 -178.848 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -120.91 -10.46 9.1 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 124.293 1.037 . . . . 0.0 113.062 178.641 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 55.8 mt . . . . . 0 C--O 1.248 0.996 0 CA-C-N 119.204 0.911 . . . . 0.0 109.314 173.562 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.9 mt . . . . . 0 CA--C 1.538 0.5 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 40.8 t -138.07 163.88 28.71 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 126.284 1.834 . . . . 0.0 107.345 -174.624 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -115.29 146.07 41.86 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 174.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -147.94 167.57 24.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.31 0.576 . . . . 0.0 111.253 -179.594 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 18.0 p -136.25 172.26 13.27 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 126.253 1.821 . . . . 0.0 106.98 168.866 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -49.88 -28.53 6.68 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.824 0.85 . . . . 0.0 113.073 174.699 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -56.86 -31.98 65.36 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.619 1.568 . . . . 0.0 112.933 178.447 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 14.8 m -142.26 -4.78 1.0 Allowed 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -169.223 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -54.35 -41.67 69.39 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.98 0.912 . . . . 0.0 111.724 -176.156 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.2 p -59.96 -45.73 91.72 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 124.01 0.924 . . . . 0.0 111.747 177.587 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.2 -43.72 94.17 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 122.719 0.408 . . . . 0.0 110.284 178.069 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -63.4 -35.85 81.77 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 119.475 -0.298 . . . . 0.0 111.076 -179.255 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 29.1 p -85.5 3.58 39.72 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.094 0.957 . . . . 0.0 113.253 -176.698 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 60.5 m -106.43 30.78 5.69 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.165 0.986 . . . . 0.0 111.684 -176.344 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -132.5 37.91 3.48 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.573 0.749 . . . . 0.0 112.313 -174.149 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 121.04 -153.52 16.6 Favored Glycine 0 C--N 1.335 0.52 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 175.421 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 53.5 t -74.45 133.95 30.5 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 N-CA-C 105.011 -2.218 . . . . 0.0 105.011 166.628 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 43.2 t -137.03 133.81 47.76 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 N-CA-C 105.896 -1.89 . . . . 0.0 105.896 -178.484 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 5.1 tt -116.89 101.18 8.31 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 106.138 -1.801 . . . . 0.0 106.138 -177.437 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -81.82 145.8 30.22 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.342 179.595 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -126.15 94.17 4.02 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 125.918 1.687 . . . . 0.0 107.444 -177.451 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -73.1 112.85 9.52 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 105.936 -1.875 . . . . 0.0 105.936 174.649 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -149.38 -176.68 5.48 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.88 1.272 . . . . 0.0 108.403 -172.207 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -151.95 147.92 20.7 Favored Pre-proline 0 C--O 1.233 0.213 0 N-CA-C 105.545 -2.02 . . . . 0.0 105.545 167.228 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -68.03 -11.64 32.67 Favored 'Trans proline' 0 CA--C 1.534 0.498 0 CA-C-N 121.1 1.429 . . . . 0.0 113.276 -178.615 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 1.6 m95 -75.77 -13.7 60.3 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.637 0.775 . . . . 0.0 111.803 172.35 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 23.0 t -63.4 158.21 21.21 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.438 1.495 . . . . 0.0 110.971 -178.646 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -113.22 -57.82 0.41 Allowed Glycine 0 CA--C 1.531 1.065 0 CA-C-O 118.581 -1.121 . . . . 0.0 111.05 171.804 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -55.96 -33.76 90.06 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 123.366 2.711 . . . . 0.0 113.575 178.86 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 23.4 m -58.04 -34.15 69.76 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.271 0.628 . . . . 0.0 111.537 176.372 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.4 mmtp -68.5 -22.6 64.53 Favored 'General case' 0 CA--C 1.531 0.242 0 O-C-N 121.471 -0.768 . . . . 0.0 111.094 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 33.4 mtm -71.07 -42.85 68.84 Favored 'General case' 0 C--N 1.34 0.172 0 CA-C-N 118.841 0.746 . . . . 0.0 110.33 176.339 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 16.6 tt -85.29 -24.64 6.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-O 118.557 -0.735 . . . . 0.0 111.701 -175.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -48.85 -50.27 62.47 Favored Pre-proline 0 CA--C 1.549 0.912 0 CA-C-N 120.062 1.301 . . . . 0.0 114.219 178.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -67.08 -28.94 40.68 Favored 'Trans proline' 0 C--N 1.35 0.626 0 CA-C-N 121.774 1.669 . . . . 0.0 111.977 176.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.1 t -66.43 -40.89 87.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 CA-C-O 118.614 -0.708 . . . . 0.0 109.27 173.776 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 94.6 mt -63.23 -37.27 86.59 Favored 'General case' 0 C--N 1.34 0.188 0 CA-C-N 119.504 1.047 . . . . 0.0 110.855 174.58 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -62.37 -43.78 98.01 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 119.356 0.98 . . . . 0.0 111.107 173.02 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -62.74 -39.04 92.86 Favored 'General case' 0 CA--C 1.535 0.374 0 O-C-N 121.185 -0.947 . . . . 0.0 110.286 175.748 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.96 -43.65 98.22 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 124.556 1.142 . . . . 0.0 110.069 177.864 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -59.43 -42.71 92.51 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 123.679 0.792 . . . . 0.0 110.842 176.586 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -71.49 -10.61 60.04 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -179.644 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -106.6 -28.35 10.3 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 125.517 1.527 . . . . 0.0 111.651 -178.95 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 23.0 mtp -130.48 1.76 4.55 Favored 'General case' 0 N--CA 1.462 0.156 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -169.944 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -56.93 -11.63 6.09 Favored Glycine 0 CA--C 1.533 1.19 0 N-CA-C 115.993 1.157 . . . . 0.0 115.993 -175.399 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -78.58 -25.99 45.43 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 118.893 1.347 . . . . 0.0 111.778 173.777 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 52.1 mmtt -117.13 -19.8 9.54 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 125.468 1.507 . . . . 0.0 111.734 -176.031 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 57.1 tp -124.97 144.85 50.15 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 124.68 1.192 . . . . 0.0 110.668 -168.802 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -116.75 145.87 43.2 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 105.183 -2.154 . . . . 0.0 105.183 167.704 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 68.1 mt -115.83 140.24 38.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 105.768 -1.938 . . . . 0.0 105.768 175.179 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 80.8 t -132.84 98.23 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 -171.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -74.17 140.33 45.08 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 174.806 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 13.6 tt -143.49 124.97 11.09 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 178.783 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 61.0 t0 -83.89 106.63 15.71 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 124.401 1.08 . . . . 0.0 108.883 -172.331 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 33.0 m -59.81 -25.11 31.28 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 CA-C-O 118.444 -0.788 . . . . 0.0 112.072 -175.71 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -65.29 -18.6 65.44 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 119.646 1.112 . . . . 0.0 112.026 -178.556 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -118.7 4.53 11.6 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.041 1.337 . . . . 0.0 110.948 177.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 68.6 m-80 -140.5 38.72 1.87 Allowed 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 124.383 1.073 . . . . 0.0 110.151 -169.785 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 55.1 mm-40 -56.05 -33.27 64.83 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.295 0.638 . . . . 0.0 110.849 174.904 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -66.52 -47.93 71.36 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 118.3 0.5 . . . . 0.0 110.284 178.127 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.96 -40.86 91.68 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 118.65 0.659 . . . . 0.0 110.0 -179.236 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.35 -50.35 74.29 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.361 0.664 . . . . 0.0 110.1 174.08 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -60.37 -28.39 67.11 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 123.879 0.752 . . . . 0.0 112.334 177.928 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 21.9 ttmt -55.05 -29.48 57.56 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 125.565 1.546 . . . . 0.0 111.898 178.16 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -124.12 11.07 8.82 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.846 0.858 . . . . 0.0 111.71 178.775 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 67.38 24.42 73.63 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 123.914 0.768 . . . . 0.0 113.214 -177.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 48.9 t -63.65 129.62 27.53 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 171.649 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 35.0 ttm -142.64 4.37 1.52 Allowed 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.269 1.028 . . . . 0.0 111.278 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 22.8 m -142.6 161.58 37.7 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 126.697 1.999 . . . . 0.0 107.539 178.828 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 43.0 pt -143.0 156.45 61.95 Favored Pre-proline 0 CA--C 1.545 0.76 0 C-N-CA 124.588 1.155 . . . . 0.0 108.921 178.935 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -66.9 139.18 44.28 Favored 'Cis proline' 0 C--N 1.348 0.547 0 CA-C-N 120.423 1.187 . . . . 0.0 110.18 -5.68 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 33.1 m -131.37 139.1 49.42 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 174.832 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 83.7 mt -119.82 128.55 53.8 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 -169.59 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -117.86 124.32 48.04 Favored 'General case' 0 CA--C 1.516 -0.354 0 N-CA-C 103.973 -2.603 . . . . 0.0 103.973 177.515 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 15.9 t -96.38 122.68 48.12 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 N-CA-C 104.118 -2.549 . . . . 0.0 104.118 173.704 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.9 mp -116.16 152.45 33.67 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 175.317 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 57.8 tttp -135.02 121.83 20.97 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 173.123 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.4 t70 48.66 37.13 8.83 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.889 1.275 . . . . 0.0 112.264 175.469 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 99.07 2.1 57.02 Favored Glycine 0 CA--C 1.53 0.971 0 CA-C-O 117.954 -1.47 . . . . 0.0 115.283 169.539 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -122.1 145.55 48.06 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 120.292 2.046 . . . . 0.0 109.323 175.616 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 58.5 t -65.79 130.85 31.47 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 170.218 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 35.4 m -119.45 -19.27 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 CA-C-O 117.717 -1.135 . . . . 0.0 111.314 175.216 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -155.21 167.93 28.75 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 120.444 1.475 . . . . 0.0 111.191 173.345 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 14.3 m -141.84 151.11 42.45 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.767 1.627 . . . . 0.0 108.698 177.778 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 58.8 m -150.16 156.27 41.31 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.514 1.525 . . . . 0.0 108.57 169.146 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 42.3 t -133.62 144.91 34.54 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 -178.237 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 78.22 -175.86 54.43 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 123.695 0.664 . . . . 0.0 111.817 179.102 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -62.56 147.17 49.9 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.371 0.669 . . . . 0.0 110.415 177.963 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 58.6 mttt -142.22 138.0 16.25 Favored Pre-proline 0 C--O 1.234 0.281 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 168.615 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -68.6 165.09 30.54 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 122.134 1.889 . . . . 0.0 111.029 177.532 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -53.77 -44.04 69.72 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 125.531 1.532 . . . . 0.0 112.698 -178.773 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -63.78 -43.71 95.53 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.097 177.912 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.77 -38.49 86.66 Favored 'General case' 0 C--N 1.339 0.12 0 O-C-N 121.776 -0.577 . . . . 0.0 110.58 -179.792 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 51.9 mt -62.22 -45.87 91.42 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 123.511 0.724 . . . . 0.0 110.746 175.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 11.3 mt-30 -58.92 -41.0 86.26 Favored 'General case' 0 C--O 1.225 -0.19 0 CA-C-N 118.383 0.538 . . . . 0.0 110.769 175.214 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -65.9 -39.92 91.03 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 118.875 0.761 . . . . 0.0 110.81 179.747 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 67.8 tp -62.54 -36.38 82.42 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.339 1.456 . . . . 0.0 111.181 177.096 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 84.2 t -69.11 -47.88 72.36 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-N 118.572 0.623 . . . . 0.0 109.857 169.95 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -57.18 -40.6 77.66 Favored 'General case' 0 CA--C 1.521 -0.155 0 C-N-CA 125.498 1.519 . . . . 0.0 111.893 -168.535 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -65.52 -6.44 10.75 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 -178.54 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -126.59 0.4 6.84 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 124.526 1.13 . . . . 0.0 113.426 176.732 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 54.7 mt . . . . . 0 C--O 1.247 0.955 0 CA-C-N 119.462 1.028 . . . . 0.0 109.004 171.35 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.6 mt . . . . . 0 CA--C 1.539 0.547 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 47.3 t -140.34 164.3 22.36 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 C-N-CA 127.049 2.14 . . . . 0.0 106.99 -173.804 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 3.7 tppp? -113.87 147.37 38.57 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 175.741 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -146.85 168.91 20.25 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 123.109 0.564 . . . . 0.0 110.535 175.901 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 33.2 p -136.03 177.73 7.61 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 125.929 1.691 . . . . 0.0 107.961 170.923 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -42.75 -37.85 1.9 Allowed 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.3 1.44 . . . . 0.0 112.836 169.666 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 50.8 mm-40 -73.88 -26.24 60.45 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.805 0.842 . . . . 0.0 113.03 -174.835 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 14.3 p -121.74 -19.77 6.68 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 -169.413 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -53.82 -45.85 70.97 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 124.54 1.136 . . . . 0.0 111.925 -171.826 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.6 m -65.7 -23.96 66.88 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 112.937 0.717 . . . . 0.0 112.937 -177.14 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -90.66 -28.68 18.21 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 124.086 0.954 . . . . 0.0 111.443 176.878 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 68.9 mm-40 -70.81 -32.63 69.77 Favored 'General case' 0 N--CA 1.453 -0.325 0 O-C-N 121.797 -0.564 . . . . 0.0 110.829 173.266 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 22.9 p -88.71 4.56 46.9 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 113.847 1.055 . . . . 0.0 113.847 -170.277 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 30.4 p -108.67 29.16 7.68 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.336 1.054 . . . . 0.0 112.339 -174.83 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -129.32 50.73 2.12 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.218 1.007 . . . . 0.0 110.954 -174.357 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 103.68 -155.37 17.82 Favored Glycine 0 C--N 1.337 0.625 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 178.26 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 45.1 t -71.53 138.22 22.12 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 N-CA-C 105.694 -1.965 . . . . 0.0 105.694 167.552 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 47.3 t -138.22 139.25 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 N-CA-C 105.739 -1.949 . . . . 0.0 105.739 179.316 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 61.1 tp -122.6 101.72 7.64 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 106.703 -1.592 . . . . 0.0 106.703 -176.912 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -83.27 151.28 25.68 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 179.767 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -130.4 94.21 3.62 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 126.482 1.913 . . . . 0.0 107.242 -178.51 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -74.2 114.46 12.57 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 105.704 -1.962 . . . . 0.0 105.704 174.895 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -149.46 -177.63 5.96 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.094 1.357 . . . . 0.0 108.521 -172.856 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -155.63 147.94 17.59 Favored Pre-proline 0 CA--C 1.532 0.255 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 168.062 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -61.2 -18.06 56.21 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 121.649 1.566 . . . . 0.0 115.72 -178.749 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 49.7 p-90 -69.02 -20.68 64.14 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 119.963 1.256 . . . . 0.0 111.878 173.549 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 30.6 t -59.22 146.33 39.56 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 125.146 1.379 . . . . 0.0 111.054 -172.787 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -95.22 -60.26 1.07 Allowed Glycine 0 CA--C 1.531 1.064 0 CA-C-O 118.795 -1.003 . . . . 0.0 111.36 169.795 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -66.04 -26.25 50.88 Favored 'Trans proline' 0 C--N 1.35 0.656 0 CA-C-N 120.293 2.047 . . . . 0.0 113.101 -172.693 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 30.8 m -57.53 -35.14 69.89 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 121.699 -0.625 . . . . 0.0 111.295 174.605 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.0 mmtp -67.3 -26.09 66.36 Favored 'General case' 0 CA--C 1.53 0.207 0 O-C-N 121.673 -0.642 . . . . 0.0 110.928 -179.757 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 29.8 mtm -71.85 -44.17 64.28 Favored 'General case' 0 C--N 1.34 0.173 0 CA-C-N 118.585 0.63 . . . . 0.0 110.426 177.615 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 15.5 tt -79.86 -22.16 11.95 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-O 118.574 -0.727 . . . . 0.0 111.351 -177.201 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -48.93 -52.32 47.71 Favored Pre-proline 0 CA--C 1.549 0.942 0 CA-C-N 120.424 1.466 . . . . 0.0 114.241 179.125 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -66.71 -26.92 45.29 Favored 'Trans proline' 0 C--N 1.35 0.607 0 CA-C-N 121.748 1.66 . . . . 0.0 112.454 176.512 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 6.1 t -69.82 -37.86 74.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 O-C-N 121.688 -0.633 . . . . 0.0 109.454 174.907 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 43.2 mt -65.66 -36.72 84.49 Favored 'General case' 0 C--O 1.224 -0.267 0 CA-C-N 119.286 0.948 . . . . 0.0 110.517 172.848 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -63.34 -43.73 96.89 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 119.198 0.908 . . . . 0.0 111.079 173.013 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -60.61 -44.98 95.68 Favored 'General case' 0 CA--C 1.531 0.241 0 O-C-N 121.243 -0.911 . . . . 0.0 110.186 175.889 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -62.16 -41.88 98.73 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 124.846 1.258 . . . . 0.0 109.942 179.397 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -60.24 -42.85 96.14 Favored 'General case' 0 CA--C 1.521 -0.168 0 C-N-CA 123.879 0.872 . . . . 0.0 110.905 176.846 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -71.54 -10.46 59.8 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 122.976 0.51 . . . . 0.0 112.337 -179.202 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -103.59 -34.0 8.8 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 125.205 1.402 . . . . 0.0 111.234 178.946 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 74.6 mmm -121.86 -5.63 9.08 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 113.364 0.876 . . . . 0.0 113.364 -168.512 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -57.83 -15.11 18.37 Favored Glycine 0 CA--C 1.532 1.133 0 CA-C-N 119.718 1.145 . . . . 0.0 115.135 -173.203 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -69.71 -30.48 68.12 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 118.441 1.12 . . . . 0.0 111.728 173.574 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 45.9 mmtm -112.82 -19.69 11.89 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 125.456 1.502 . . . . 0.0 111.676 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 30.1 tp -117.55 157.15 26.83 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.412 1.085 . . . . 0.0 111.214 -169.232 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 37.4 ttmt -128.3 141.32 51.48 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 103.893 -2.632 . . . . 0.0 103.893 166.453 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 62.2 mt -108.15 141.53 23.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 105.925 -1.88 . . . . 0.0 105.925 175.04 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 84.7 t -132.69 98.44 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 -173.494 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt -74.31 140.49 44.93 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 174.397 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 15.0 tt -142.35 126.81 16.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 176.671 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 49.2 t0 -83.42 103.49 12.83 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.795 1.238 . . . . 0.0 109.067 -173.076 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 28.2 m -60.1 -27.15 38.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 118.766 -0.635 . . . . 0.0 112.028 -174.686 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -66.31 -19.54 65.84 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 119.321 0.964 . . . . 0.0 111.73 -177.617 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -114.13 1.78 14.69 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.558 1.543 . . . . 0.0 110.893 178.493 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 69.0 m-80 -141.98 42.52 1.68 Allowed 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.387 1.075 . . . . 0.0 109.79 -169.515 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 45.2 mm-40 -56.22 -33.07 65.01 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.794 0.838 . . . . 0.0 111.236 178.746 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 36.0 mm-40 -65.78 -46.72 77.68 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 118.379 0.536 . . . . 0.0 110.389 179.074 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.45 -38.51 77.81 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 121.798 -0.564 . . . . 0.0 109.778 -178.914 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -58.78 -47.54 84.36 Favored 'General case' 0 CA--C 1.535 0.376 0 O-C-N 120.978 -1.076 . . . . 0.0 110.241 171.916 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -59.97 -28.93 66.9 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 124.087 0.851 . . . . 0.0 112.506 176.594 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 50.1 tptt -56.27 -29.05 60.61 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.602 1.161 . . . . 0.0 111.551 179.73 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -123.34 10.39 9.24 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.568 0.747 . . . . 0.0 111.664 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 62.31 33.31 85.72 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 123.558 0.599 . . . . 0.0 112.427 -176.176 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 57.5 t -64.94 121.06 13.29 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 173.001 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 26.1 mmt -132.45 2.64 3.85 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.96 1.304 . . . . 0.0 111.465 -179.009 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 30.0 m -144.82 161.48 39.17 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 126.953 2.101 . . . . 0.0 107.062 178.242 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 34.5 pt -144.21 155.18 58.18 Favored Pre-proline 0 CA--C 1.545 0.788 0 C-N-CA 124.772 1.229 . . . . 0.0 108.451 177.406 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -68.54 139.54 51.47 Favored 'Cis proline' 0 C--N 1.35 0.624 0 CA-C-N 120.651 1.268 . . . . 0.0 110.53 -2.474 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 32.0 m -132.89 132.57 42.21 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 177.391 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 6.9 mp -110.52 131.17 55.28 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 -171.735 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -122.38 128.35 50.86 Favored 'General case' 0 CA--C 1.508 -0.638 0 N-CA-C 103.388 -2.819 . . . . 0.0 103.388 179.132 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 1.5 t -110.61 127.13 67.86 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.751 0 N-CA-C 104.337 -2.468 . . . . 0.0 104.337 -176.255 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.3 mp -126.08 152.05 46.37 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 -174.813 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -138.04 125.47 21.94 Favored 'General case' 0 CA--C 1.513 -0.479 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 175.221 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 29.2 t70 49.84 33.12 6.02 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.959 1.303 . . . . 0.0 112.348 173.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 99.41 4.59 56.14 Favored Glycine 0 CA--C 1.53 1.018 0 CA-C-O 118.018 -1.434 . . . . 0.0 114.551 170.641 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -122.0 144.89 48.62 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 120.101 1.951 . . . . 0.0 109.043 174.617 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 14.3 p -68.74 129.71 33.43 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 169.996 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 27.7 m -115.62 -20.87 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 CA-C-O 117.577 -1.201 . . . . 0.0 111.052 179.586 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -159.42 166.36 31.19 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 120.734 1.606 . . . . 0.0 111.402 176.343 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 13.3 m -136.34 151.18 49.31 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.991 1.716 . . . . 0.0 108.519 175.418 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 74.1 m -150.26 158.11 43.81 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.882 1.673 . . . . 0.0 108.671 171.206 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 39.2 t -133.97 148.21 30.32 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 -177.01 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.68 177.24 51.86 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 123.973 0.797 . . . . 0.0 112.705 171.797 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 47.6 t80 -62.55 135.46 57.42 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.352 0.661 . . . . 0.0 109.59 175.598 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 13.0 mptt -136.05 136.2 22.58 Favored Pre-proline 0 CA--C 1.533 0.324 0 C-N-CA 126.429 1.892 . . . . 0.0 105.995 175.389 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -70.61 160.19 50.28 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 122.493 2.128 . . . . 0.0 110.591 176.18 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 41.5 pttt -59.34 -28.9 67.25 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -177.108 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -65.86 -48.86 70.15 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 122.839 0.456 . . . . 0.0 110.037 173.92 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.6 -37.9 89.06 Favored 'General case' 0 CA--C 1.529 0.162 0 O-C-N 121.898 -0.501 . . . . 0.0 110.711 178.296 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 79.3 mt -64.97 -41.56 95.34 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 119.355 -0.355 . . . . 0.0 111.255 176.267 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 15.6 mt-30 -59.32 -41.05 88.17 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 118.824 0.738 . . . . 0.0 110.086 174.588 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -64.77 -40.82 95.9 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 118.199 0.454 . . . . 0.0 110.365 178.724 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 63.3 tp -61.03 -43.77 98.4 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.733 1.213 . . . . 0.0 110.755 177.681 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 78.5 t -61.42 -46.43 96.61 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 123.651 0.78 . . . . 0.0 109.37 173.125 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -61.91 -25.73 67.75 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 125.017 1.327 . . . . 0.0 112.239 -173.086 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 49.2 mtpt -55.86 -24.58 37.73 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 118.658 -0.687 . . . . 0.0 112.576 172.327 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 80.9 m-70 -123.34 -8.2 8.13 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 -168.912 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 82.1 mt . . . . . 0 C--O 1.248 0.975 0 CA-C-N 119.155 0.889 . . . . 0.0 109.327 171.512 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.3 mt . . . . . 0 CA--C 1.534 0.351 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 41.3 t -135.32 163.72 35.05 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 C-N-CA 126.353 1.861 . . . . 0.0 106.251 -177.127 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 6.2 ttmt -118.99 144.83 46.28 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 174.69 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -145.12 166.49 25.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.393 0.615 . . . . 0.0 110.976 -177.027 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.9 p -133.09 169.92 16.15 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 126.254 1.822 . . . . 0.0 107.779 171.29 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -52.63 -29.71 27.61 Favored 'General case' 0 CA--C 1.535 0.365 0 C-N-CA 124.499 1.12 . . . . 0.0 113.23 -178.67 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 82.6 mm-40 -63.54 -29.0 70.33 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.788 1.235 . . . . 0.0 113.103 179.748 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.6 m -135.17 -6.85 2.31 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 -169.295 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -52.14 -42.98 63.8 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.439 1.096 . . . . 0.0 111.722 -178.77 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.6 m -62.74 -39.15 93.19 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.111 0.564 . . . . 0.0 111.83 -179.02 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -68.54 -43.89 75.7 Favored 'General case' 0 N--CA 1.452 -0.329 0 O-C-N 122.011 -0.431 . . . . 0.0 110.079 177.68 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 67.1 mm-40 -63.05 -34.52 77.76 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-O 119.618 -0.229 . . . . 0.0 111.085 -179.068 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 27.4 p -85.65 3.66 39.94 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 113.524 0.935 . . . . 0.0 113.524 -176.507 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 69.6 m -105.4 30.05 5.99 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.053 0.941 . . . . 0.0 112.07 -175.515 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -132.83 37.46 3.45 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.455 0.702 . . . . 0.0 112.702 -173.248 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 123.11 -152.47 16.93 Favored Glycine 0 N--CA 1.465 0.593 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 174.022 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 67.4 t -73.09 133.72 31.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 104.528 -2.397 . . . . 0.0 104.528 165.848 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 40.7 t -136.26 130.19 47.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.8 tt -110.9 99.49 8.39 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 105.865 -1.902 . . . . 0.0 105.865 -178.106 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -80.07 143.16 34.23 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 178.325 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -123.91 94.05 4.11 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 125.806 1.642 . . . . 0.0 107.159 -176.911 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -73.88 113.15 10.72 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 105.791 -1.929 . . . . 0.0 105.791 174.758 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -148.86 -177.05 5.58 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.785 1.234 . . . . 0.0 108.354 -173.125 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -156.07 149.06 18.27 Favored Pre-proline 0 CA--C 1.531 0.224 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 167.726 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -61.44 -18.17 57.83 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 121.707 1.605 . . . . 0.0 115.61 179.657 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 52.6 p-90 -70.56 -19.44 62.88 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 120.002 1.274 . . . . 0.0 111.901 173.789 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 19.5 t -60.03 151.99 25.08 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 124.944 1.298 . . . . 0.0 110.844 -174.951 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -105.88 -58.0 0.64 Allowed Glycine 0 CA--C 1.531 1.058 0 CA-C-O 118.842 -0.976 . . . . 0.0 111.017 171.397 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -56.91 -33.16 94.53 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 123.28 2.653 . . . . 0.0 113.518 -179.615 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 31.4 m -58.11 -34.05 69.77 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.202 0.601 . . . . 0.0 111.423 176.829 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.2 mmtp -68.42 -24.85 64.79 Favored 'General case' 0 CA--C 1.53 0.184 0 O-C-N 121.534 -0.729 . . . . 0.0 110.927 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 31.0 mtm -70.65 -43.21 69.65 Favored 'General case' 0 C--N 1.34 0.153 0 CA-C-N 118.735 0.698 . . . . 0.0 110.357 176.625 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 17.5 tt -83.08 -22.74 8.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-O 118.61 -0.709 . . . . 0.0 111.616 -176.355 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -49.28 -51.08 60.4 Favored Pre-proline 0 CA--C 1.547 0.853 0 CA-C-N 120.234 1.379 . . . . 0.0 114.261 178.766 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -66.49 -28.97 45.33 Favored 'Trans proline' 0 C--N 1.351 0.675 0 CA-C-N 121.675 1.634 . . . . 0.0 112.028 176.378 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.2 t -68.27 -36.67 76.0 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 O-C-N 121.645 -0.659 . . . . 0.0 109.703 175.08 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 87.9 mt -66.39 -36.06 81.89 Favored 'General case' 0 C--N 1.341 0.212 0 CA-C-N 119.654 1.115 . . . . 0.0 111.144 171.761 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -62.45 -42.94 99.83 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 119.376 0.989 . . . . 0.0 110.799 171.82 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -63.92 -39.98 95.41 Favored 'General case' 0 CA--C 1.532 0.272 0 O-C-N 121.199 -0.938 . . . . 0.0 110.466 176.273 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 44.8 tp -62.05 -42.96 99.74 Favored 'General case' 0 CA--C 1.528 0.098 0 C-N-CA 123.867 0.867 . . . . 0.0 109.992 176.295 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -60.39 -42.45 95.9 Favored 'General case' 0 CA--C 1.52 -0.185 0 C-N-CA 123.275 0.63 . . . . 0.0 110.845 178.412 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -71.69 -10.8 60.31 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.319 0.648 . . . . 0.0 112.511 -179.763 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -105.52 -31.98 8.72 Favored 'General case' 0 C--O 1.232 0.15 0 C-N-CA 125.486 1.514 . . . . 0.0 111.458 -179.582 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 80.0 mmm -125.47 -3.32 7.34 Favored 'General case' 0 N--CA 1.46 0.06 0 CA-C-O 118.407 -0.806 . . . . 0.0 113.113 -167.662 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -57.85 -10.91 7.18 Favored Glycine 0 CA--C 1.534 1.226 0 C-N-CA 124.826 1.203 . . . . 0.0 115.919 -173.735 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -75.22 -24.57 57.75 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 118.502 1.151 . . . . 0.0 111.881 173.458 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 50.6 mtmt -128.26 -16.01 4.54 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 125.757 1.623 . . . . 0.0 111.887 -173.014 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 58.9 tp -123.0 144.23 49.4 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 124.816 1.246 . . . . 0.0 110.283 -172.227 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -116.25 145.39 43.18 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 105.256 -2.127 . . . . 0.0 105.256 167.305 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 82.6 mt -115.12 137.9 47.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 105.298 -2.112 . . . . 0.0 105.298 175.477 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 95.2 t -132.06 96.9 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 -171.917 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -74.96 137.03 41.34 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 176.954 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 13.3 tt -140.43 126.73 21.47 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 178.92 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -83.63 106.53 15.42 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 124.462 1.105 . . . . 0.0 109.098 -172.355 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 34.6 m -58.97 -27.7 36.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 118.643 -0.694 . . . . 0.0 111.99 -176.03 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -65.69 -17.23 64.46 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 119.347 0.976 . . . . 0.0 112.204 -176.593 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -121.96 4.16 9.92 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.927 1.291 . . . . 0.0 111.225 179.484 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 68.7 m-80 -141.28 40.47 1.76 Allowed 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.197 0.999 . . . . 0.0 109.785 -170.607 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 53.7 mm-40 -54.42 -30.84 53.69 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.097 0.959 . . . . 0.0 111.09 175.375 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -66.16 -50.18 64.83 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 123.99 0.916 . . . . 0.0 110.167 -179.273 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.77 -38.96 80.4 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 -178.428 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -58.62 -48.29 81.5 Favored 'General case' 0 CA--C 1.534 0.342 0 O-C-N 121.298 -0.876 . . . . 0.0 110.357 172.737 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -61.23 -28.76 69.71 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 123.905 0.764 . . . . 0.0 112.213 177.767 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 19.9 tptm -56.19 -29.3 60.69 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.697 1.199 . . . . 0.0 111.509 179.621 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -123.73 10.82 9.03 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.552 0.741 . . . . 0.0 111.627 -179.394 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 64.35 30.81 78.88 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 123.616 0.627 . . . . 0.0 112.582 -177.226 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 61.0 t -65.96 122.44 16.92 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 171.06 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 26.1 mmt -132.65 3.5 3.84 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.784 1.233 . . . . 0.0 111.381 -178.312 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 23.7 m -144.66 162.23 37.19 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 126.652 1.981 . . . . 0.0 107.621 179.781 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 17.7 pt -142.42 155.14 64.31 Favored Pre-proline 0 CA--C 1.544 0.731 0 C-N-CA 124.663 1.185 . . . . 0.0 108.689 175.195 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -67.99 138.32 43.39 Favored 'Cis proline' 0 C--N 1.35 0.63 0 CA-C-N 120.469 1.203 . . . . 0.0 110.399 -3.975 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 44.9 m -131.33 140.61 49.77 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 174.981 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 83.4 mt -122.32 127.73 50.18 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 -169.376 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -117.84 125.4 50.46 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 103.984 -2.599 . . . . 0.0 103.984 178.379 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 10.0 t -97.05 123.58 49.45 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 N-CA-C 104.145 -2.539 . . . . 0.0 104.145 172.953 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.9 mp -115.19 151.69 33.96 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 175.408 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 21.0 tptm -133.55 119.37 19.41 Favored 'General case' 0 CA--C 1.516 -0.363 0 N-CA-C 106.229 -1.767 . . . . 0.0 106.229 174.402 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.2 t70 50.83 37.59 17.52 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.626 1.17 . . . . 0.0 112.483 175.964 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 103.73 -2.35 45.42 Favored Glycine 0 CA--C 1.527 0.826 0 CA-C-O 118.087 -1.396 . . . . 0.0 115.582 168.61 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -128.41 145.25 51.14 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 120.033 1.917 . . . . 0.0 109.773 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 61.4 t -61.63 132.52 27.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 173.763 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.4 p -119.49 -21.85 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.77 0 C-N-CA 124.413 1.085 . . . . 0.0 110.372 174.887 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -157.62 165.56 35.17 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 120.552 1.524 . . . . 0.0 111.053 175.269 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 11.7 m -137.57 151.21 48.12 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.219 1.408 . . . . 0.0 109.004 179.577 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 58.4 m -148.47 157.23 43.34 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 126.022 1.729 . . . . 0.0 108.561 169.399 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 36.6 t -133.71 146.71 31.38 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 -179.354 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 79.41 -175.97 54.86 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 123.504 0.573 . . . . 0.0 112.19 177.135 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -63.17 146.55 53.1 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.579 0.752 . . . . 0.0 110.618 178.511 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 66.7 mttt -143.9 136.17 13.29 Favored Pre-proline 0 CA--C 1.532 0.284 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 168.832 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -70.42 160.42 49.59 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 122.408 2.072 . . . . 0.0 110.086 174.981 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 49.0 pttt -58.4 -28.59 65.34 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 113.569 0.952 . . . . 0.0 113.569 -177.369 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -65.25 -50.34 66.17 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 118.61 0.641 . . . . 0.0 109.741 174.874 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.81 -39.84 95.53 Favored 'General case' 0 C--N 1.34 0.165 0 C-N-CA 122.89 0.476 . . . . 0.0 110.627 178.473 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 92.3 mt -64.08 -42.54 96.92 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 122.74 0.416 . . . . 0.0 111.344 177.276 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -61.8 -40.07 93.94 Favored 'General case' 0 C--O 1.223 -0.29 0 CA-C-N 118.592 0.633 . . . . 0.0 110.197 176.469 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -65.5 -41.92 92.7 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 118.729 0.695 . . . . 0.0 110.302 178.84 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 58.3 tp -60.55 -38.29 84.03 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.744 1.618 . . . . 0.0 111.22 177.115 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 71.5 t -68.01 -49.92 63.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 C-N-CA 123.822 0.849 . . . . 0.0 109.545 171.939 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 -58.63 -40.68 84.02 Favored 'General case' 0 C--N 1.333 -0.122 0 C-N-CA 125.344 1.458 . . . . 0.0 111.821 -168.403 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.421 ' HG3' ' CD2' ' A' ' 103' ' ' HIS . 22.0 ptmt -65.75 -8.31 20.45 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 -177.542 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' HIS . . . . . 0.421 ' CD2' ' HG3' ' A' ' 102' ' ' LYS . 94.7 m-70 -124.14 1.9 8.56 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 124.413 1.085 . . . . 0.0 113.695 179.605 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 55.8 mt . . . . . 0 C--O 1.248 1.025 0 CA-C-N 119.386 0.994 . . . . 0.0 109.227 172.519 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.8 mt . . . . . 0 CA--C 1.536 0.428 0 N-CA-C 106.97 -1.493 . . . . 0.0 106.97 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 20.2 t -138.59 163.95 27.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 126.621 1.968 . . . . 0.0 106.856 -176.664 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.48 ' HE2' ' H ' ' A' ' 6' ' ' ALA . 0.0 OUTLIER -125.25 136.49 53.59 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 105.618 -1.993 . . . . 0.0 105.618 177.011 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.48 ' H ' ' HE2' ' A' ' 5' ' ' LYS . . . -141.3 176.2 9.04 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 123.631 0.772 . . . . 0.0 112.473 -169.542 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.4 p -130.08 173.12 11.04 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 127.646 2.378 . . . . 0.0 107.924 175.094 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -45.95 -39.9 9.52 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 124.643 1.177 . . . . 0.0 113.521 177.774 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 80.8 mm-40 -90.43 -38.02 13.56 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 122.921 0.489 . . . . 0.0 111.727 -174.681 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 11.4 m -67.83 -33.63 75.15 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 118.143 0.429 . . . . 0.0 110.927 177.34 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 33.4 t80 -50.77 -45.96 59.24 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 126.143 1.777 . . . . 0.0 111.217 -176.958 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 9.7 m -64.86 -37.8 88.85 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 118.601 0.637 . . . . 0.0 111.876 -175.864 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -68.53 -45.68 71.56 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 175.593 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -64.21 -36.75 85.09 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 122.486 0.314 . . . . 0.0 111.252 -176.432 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.409 ' HA ' HG21 ' A' ' 20' ' ' VAL . 36.8 p -81.17 -4.1 54.3 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 124.071 0.948 . . . . 0.0 113.031 -176.688 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 70.0 m -94.66 28.64 2.57 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.937 0.895 . . . . 0.0 111.754 -177.989 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -134.01 66.84 1.53 Allowed 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.541 1.137 . . . . 0.0 110.229 -177.708 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 88.13 -156.56 27.37 Favored Glycine 0 C--N 1.337 0.59 0 N-CA-C 110.373 -1.091 . . . . 0.0 110.373 174.205 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 97.9 t -71.41 132.85 32.82 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 N-CA-C 106.889 -1.522 . . . . 0.0 106.889 168.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.409 HG21 ' HA ' ' A' ' 15' ' ' THR . 47.2 t -136.46 146.34 29.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 179.74 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 5.0 tt -128.06 100.56 5.93 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 -176.812 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -81.97 146.27 29.83 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.256 -179.615 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -124.56 94.42 4.19 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 126.113 1.765 . . . . 0.0 107.458 -176.394 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -74.44 112.42 10.6 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 106.05 -1.833 . . . . 0.0 106.05 175.505 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -149.24 -177.22 5.71 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.668 1.187 . . . . 0.0 108.575 -174.087 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -155.65 146.96 16.71 Favored Pre-proline 0 CA--C 1.532 0.277 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 167.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_exo -60.29 -18.21 51.2 Favored 'Trans proline' 0 N--CA 1.461 -0.439 0 C-N-CA 121.821 1.68 . . . . 0.0 115.86 -178.359 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 51.3 p-90 -69.35 -20.43 63.85 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 119.949 1.25 . . . . 0.0 111.937 173.674 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 34.2 t -59.31 148.21 33.05 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 125.065 1.346 . . . . 0.0 111.199 -172.577 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -97.61 -63.28 0.89 Allowed Glycine 0 CA--C 1.53 0.971 0 CA-C-O 118.403 -1.22 . . . . 0.0 110.974 171.64 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -62.24 -26.52 77.53 Favored 'Trans proline' 0 C--N 1.35 0.613 0 CA-C-N 120.424 2.112 . . . . 0.0 113.679 -174.827 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 33.8 m -57.39 -34.98 69.43 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 121.582 -0.698 . . . . 0.0 111.515 174.464 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.8 mmtp -67.53 -24.94 65.6 Favored 'General case' 0 CA--C 1.53 0.182 0 O-C-N 121.602 -0.686 . . . . 0.0 111.021 -179.613 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 31.3 mtm -71.22 -43.41 67.4 Favored 'General case' 0 C--N 1.34 0.182 0 CA-C-N 118.68 0.673 . . . . 0.0 110.421 176.966 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 14.1 tt -84.18 -23.48 7.76 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-O 118.705 -0.664 . . . . 0.0 111.727 -174.646 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -48.88 -51.47 54.44 Favored Pre-proline 0 CA--C 1.548 0.877 0 CA-C-N 119.911 1.232 . . . . 0.0 114.076 178.486 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -66.57 -29.67 43.8 Favored 'Trans proline' 0 C--N 1.35 0.65 0 CA-C-N 121.611 1.611 . . . . 0.0 112.194 176.883 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 5.4 t -66.46 -39.92 85.24 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 175.218 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 67.9 mt -64.99 -38.23 90.26 Favored 'General case' 0 C--N 1.34 0.169 0 CA-C-N 119.317 0.962 . . . . 0.0 110.858 174.513 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -61.6 -43.9 97.99 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 119.011 0.823 . . . . 0.0 111.122 172.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -62.34 -38.5 89.75 Favored 'General case' 0 CA--C 1.533 0.327 0 O-C-N 121.393 -0.817 . . . . 0.0 110.223 175.609 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.77 -44.48 96.08 Favored 'General case' 0 C--N 1.333 -0.114 0 C-N-CA 124.074 0.95 . . . . 0.0 110.391 177.097 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -60.24 -41.89 94.1 Favored 'General case' 0 CA--C 1.521 -0.165 0 C-N-CA 123.24 0.616 . . . . 0.0 110.92 177.9 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 -72.01 -11.03 60.58 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 -179.075 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -106.45 -32.69 7.99 Favored 'General case' 0 C--O 1.232 0.133 0 C-N-CA 125.226 1.411 . . . . 0.0 111.639 -179.642 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 87.4 mmm -125.75 -4.18 7.08 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-O 118.357 -0.83 . . . . 0.0 113.022 -168.284 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -58.39 -11.77 10.8 Favored Glycine 0 CA--C 1.533 1.188 0 CA-C-N 119.835 1.198 . . . . 0.0 114.811 -175.921 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -65.98 -27.95 68.53 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 118.418 1.109 . . . . 0.0 111.83 171.378 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.464 ' HA ' ' HE3' ' A' ' 49' ' ' LYS . 0.0 OUTLIER -121.28 -24.87 5.36 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 125.954 1.701 . . . . 0.0 111.81 179.333 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 45.9 tp -103.0 157.76 16.76 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 124.144 0.977 . . . . 0.0 111.036 -169.674 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -133.88 144.41 48.88 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 103.957 -2.608 . . . . 0.0 103.957 166.65 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 66.2 mt -118.56 140.54 41.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 105.61 -1.996 . . . . 0.0 105.61 178.305 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 74.0 t -133.0 97.21 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 -170.205 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 51.3 mtmt -74.35 134.46 42.5 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 177.294 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 20.2 tt -137.92 126.8 33.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 178.167 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 62.9 t0 -87.84 103.97 16.15 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 114.727 -1.124 . . . . 0.0 108.419 -171.599 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 23.0 m -61.7 -23.2 30.29 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 CA-C-O 118.766 -0.635 . . . . 0.0 112.208 -174.339 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -65.34 -22.67 66.84 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 119.25 0.932 . . . . 0.0 111.562 -179.742 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -117.28 1.71 12.47 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.926 1.29 . . . . 0.0 111.323 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 66.6 m-80 -139.36 43.34 2.02 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 125.167 1.387 . . . . 0.0 108.798 -171.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.411 ' CD ' ' H ' ' A' ' 61' ' ' GLN . 3.4 mp0 -60.64 -35.44 76.21 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.034 0.934 . . . . 0.0 109.825 -175.451 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 -62.64 -44.49 96.15 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 123.674 0.79 . . . . 0.0 110.218 179.174 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -66.7 -40.86 88.65 Favored 'General case' 0 C--O 1.225 -0.188 0 C-N-CA 123.467 0.707 . . . . 0.0 110.082 -178.061 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.38 -50.06 75.41 Favored 'General case' 0 CA--C 1.532 0.283 0 O-C-N 121.742 -0.598 . . . . 0.0 110.058 173.185 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -58.43 -29.77 63.96 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 123.558 0.599 . . . . 0.0 112.55 176.347 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 9.8 ttpt -58.05 -26.61 62.7 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 125.758 1.623 . . . . 0.0 111.994 -178.35 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -123.61 11.04 9.13 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.886 0.874 . . . . 0.0 111.944 176.75 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 65.89 29.05 74.24 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 123.567 0.603 . . . . 0.0 112.765 -177.173 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 61.8 t -65.65 125.26 22.37 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 170.14 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 98.7 mtp -135.25 3.41 3.11 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.747 1.219 . . . . 0.0 111.515 -179.131 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 24.0 m -144.1 162.05 37.26 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 126.588 1.955 . . . . 0.0 107.743 179.228 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 38.6 pt -142.11 154.39 64.64 Favored Pre-proline 0 CA--C 1.545 0.767 0 C-N-CA 124.534 1.134 . . . . 0.0 108.685 176.332 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -67.71 140.07 51.63 Favored 'Cis proline' 0 C--N 1.351 0.692 0 CA-C-N 120.437 1.192 . . . . 0.0 110.429 -3.149 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 35.8 m -131.74 143.52 50.3 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 173.801 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 88.3 mt -123.9 126.84 47.08 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 -169.441 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -115.87 121.71 43.18 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 103.17 -2.9 . . . . 0.0 103.17 177.563 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 4.6 t -94.21 129.14 44.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 103.641 -2.726 . . . . 0.0 103.641 174.43 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.7 mp -122.89 154.81 37.83 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 178.841 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -138.33 123.32 19.0 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 174.12 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.0 t70 49.86 37.41 13.45 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.07 1.348 . . . . 0.0 112.647 176.299 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 105.1 -4.23 41.29 Favored Glycine 0 CA--C 1.529 0.916 0 CA-C-O 118.184 -1.342 . . . . 0.0 115.271 168.58 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -131.92 150.68 52.08 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 120.056 1.928 . . . . 0.0 110.374 -177.221 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 44.6 t -62.2 132.14 27.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 178.57 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.8 p -120.44 -21.75 3.94 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 C-N-CA 125.436 1.494 . . . . 0.0 109.926 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -159.84 172.21 18.05 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 120.121 1.328 . . . . 0.0 109.873 174.034 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 25.9 m -146.53 151.41 37.29 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.708 1.203 . . . . 0.0 109.246 177.925 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 4.2 m -147.13 156.87 43.35 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 125.507 1.523 . . . . 0.0 109.14 170.174 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 35.5 t -134.85 143.32 37.82 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 -177.962 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 76.17 -173.89 53.65 Favored Glycine 0 CA--C 1.531 1.052 0 CA-C-O 121.509 0.505 . . . . 0.0 111.862 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 65.4 t80 -63.56 149.2 46.86 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.483 0.713 . . . . 0.0 110.871 179.453 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 27.4 mttp -144.71 136.92 13.2 Favored Pre-proline 0 CA--C 1.534 0.342 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 168.247 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -70.44 161.3 46.52 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 122.32 2.013 . . . . 0.0 110.228 174.558 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 46.5 pttt -59.15 -29.53 67.49 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 -177.429 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -64.86 -50.13 67.81 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 118.951 0.796 . . . . 0.0 109.737 175.096 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.62 -39.47 94.44 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 122.73 0.412 . . . . 0.0 110.821 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 77.1 mt -63.68 -44.46 93.66 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 122.949 0.5 . . . . 0.0 111.249 176.385 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 12.4 mt-30 -61.4 -39.44 90.73 Favored 'General case' 0 C--O 1.224 -0.243 0 CA-C-O 118.704 -0.665 . . . . 0.0 110.371 176.358 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -65.6 -40.46 92.69 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 118.915 0.78 . . . . 0.0 110.439 178.643 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 68.9 tp -62.93 -35.73 81.07 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.634 1.574 . . . . 0.0 111.451 177.491 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 76.9 t -69.04 -50.96 48.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 C-N-CA 123.638 0.775 . . . . 0.0 109.584 169.615 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -58.27 -38.5 77.08 Favored 'General case' 0 CA--C 1.522 -0.117 0 C-N-CA 126.013 1.725 . . . . 0.0 112.196 -168.561 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -64.68 -6.96 8.92 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 -179.096 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -123.25 -5.9 8.31 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 124.395 1.078 . . . . 0.0 113.276 176.849 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 57.6 mt . . . . . 0 C--O 1.246 0.911 0 CA-C-N 119.319 0.963 . . . . 0.0 109.223 172.678 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.1 mp . . . . . 0 N--CA 1.448 -0.557 0 N-CA-C 105.134 -2.172 . . . . 0.0 105.134 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 46.8 t -132.91 164.4 35.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 C-N-CA 127.165 2.186 . . . . 0.0 105.904 -175.251 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 6.3 ttmt -121.67 147.2 46.19 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 177.007 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -147.35 168.32 22.11 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 123.279 0.632 . . . . 0.0 110.449 179.546 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.407 HG22 HD21 ' A' ' 60' ' ' ASN . 33.8 p -134.68 179.78 6.08 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 125.595 1.558 . . . . 0.0 107.371 169.314 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -49.17 -29.74 5.9 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.842 0.857 . . . . 0.0 112.685 170.167 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -65.18 -27.15 68.5 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.265 1.426 . . . . 0.0 113.138 179.27 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.9 p -134.43 -16.9 2.06 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 114.66 1.356 . . . . 0.0 114.66 -167.097 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -55.11 -45.13 75.48 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 124.442 1.097 . . . . 0.0 111.85 -170.091 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.7 m -63.26 -39.0 93.35 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 122.747 0.419 . . . . 0.0 111.613 -178.014 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -68.43 -44.49 74.87 Favored 'General case' 0 N--CA 1.452 -0.361 0 O-C-N 122.119 -0.363 . . . . 0.0 110.076 177.398 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -63.34 -34.6 78.06 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-O 119.33 -0.367 . . . . 0.0 111.108 -178.442 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 35.0 p -86.83 3.48 45.12 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.192 0.997 . . . . 0.0 113.268 -176.635 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 69.5 m -105.36 32.29 4.36 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.252 1.021 . . . . 0.0 111.562 -177.035 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -132.3 53.74 1.98 Allowed 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.197 0.999 . . . . 0.0 110.798 -176.836 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 97.55 -157.17 20.79 Favored Glycine 0 C--N 1.339 0.703 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 177.952 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 91.1 t -70.17 137.11 24.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 167.915 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 61.9 t -138.16 144.94 29.42 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 N-CA-C 105.479 -2.045 . . . . 0.0 105.479 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 41.8 tp -122.97 99.42 6.37 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 106.611 -1.625 . . . . 0.0 106.611 -177.321 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -78.52 149.95 33.0 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 109.319 -0.622 . . . . 0.0 109.319 177.763 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -129.15 94.38 3.8 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 126.761 2.024 . . . . 0.0 106.821 -179.341 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -73.25 114.51 11.52 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 105.882 -1.896 . . . . 0.0 105.882 174.253 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -147.38 -177.85 5.92 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 125.507 1.523 . . . . 0.0 108.301 -171.154 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -155.72 148.69 18.19 Favored Pre-proline 0 C--O 1.235 0.303 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 168.058 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -67.56 -13.25 38.4 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 121.656 1.571 . . . . 0.0 114.469 -175.206 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 53.4 p-90 -71.1 -20.26 62.36 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 120.194 1.361 . . . . 0.0 112.283 170.494 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 34.7 t -61.0 153.66 24.63 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.078 1.351 . . . . 0.0 111.523 -172.117 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -103.26 -65.53 0.72 Allowed Glycine 0 CA--C 1.53 0.983 0 CA-C-O 118.385 -1.23 . . . . 0.0 110.91 174.479 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_exo -55.77 -30.03 74.38 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.965 2.444 . . . . 0.0 114.118 179.661 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 33.2 m -58.18 -30.34 66.33 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 121.321 -0.862 . . . . 0.0 111.977 175.222 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.5 mmtp -72.68 -38.26 67.64 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 123.314 0.646 . . . . 0.0 110.014 178.046 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 5.8 ptt? -72.76 -31.52 64.97 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 118.817 0.735 . . . . 0.0 111.639 -176.327 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 15.9 tt -78.26 -19.1 13.53 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-O 118.925 -0.56 . . . . 0.0 111.969 174.608 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -54.94 -49.33 92.59 Favored Pre-proline 0 CA--C 1.545 0.77 0 CA-C-N 120.272 1.397 . . . . 0.0 113.655 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -66.53 -26.58 46.94 Favored 'Trans proline' 0 C--N 1.351 0.696 0 CA-C-N 121.95 1.732 . . . . 0.0 112.344 175.722 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 11.7 t -67.19 -39.7 83.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 174.11 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 96.3 mt -67.02 -34.34 77.51 Favored 'General case' 0 C--N 1.339 0.122 0 CA-C-N 119.013 0.824 . . . . 0.0 111.579 173.431 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -64.68 -42.26 95.47 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 119.338 0.972 . . . . 0.0 110.859 172.318 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -62.64 -37.77 87.66 Favored 'General case' 0 CA--C 1.531 0.235 0 O-C-N 120.884 -1.135 . . . . 0.0 110.457 173.969 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 42.9 tp -63.99 -42.42 97.19 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 123.114 0.566 . . . . 0.0 110.314 177.361 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -57.8 -44.47 86.34 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 118.983 0.81 . . . . 0.0 110.881 173.418 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -68.99 -8.87 48.91 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -177.898 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -112.2 -30.05 7.35 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 125.787 1.635 . . . . 0.0 111.973 -179.096 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 87.1 mmm -129.1 -7.66 4.86 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -169.539 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -58.48 -15.93 26.74 Favored Glycine 0 CA--C 1.529 0.949 0 CA-C-N 119.906 1.23 . . . . 0.0 114.674 -171.618 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -65.75 -26.2 67.62 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.297 1.039 . . . . 0.0 111.653 174.221 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.458 ' HA ' ' HE3' ' A' ' 49' ' ' LYS . 0.0 OUTLIER -122.91 -19.91 5.99 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.932 1.693 . . . . 0.0 111.884 179.761 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 36.0 tp -110.37 154.5 23.46 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 124.113 0.965 . . . . 0.0 111.144 -169.848 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 36.1 ttmt -130.96 144.28 51.36 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 104.6 -2.37 . . . . 0.0 104.6 167.867 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 94.1 mt -115.75 136.54 52.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 105.305 -2.109 . . . . 0.0 105.305 179.393 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 95.8 t -132.35 98.77 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-N 119.11 0.868 . . . . 0.0 109.23 -169.252 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 29.6 mtpp -74.57 139.99 44.1 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 175.618 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 13.0 tt -141.61 128.08 19.76 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 176.632 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 60.4 t0 -85.21 104.6 15.23 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 124.554 1.142 . . . . 0.0 109.196 -171.232 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 31.1 m -58.91 -26.46 32.55 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-O 118.593 -0.718 . . . . 0.0 112.017 -175.569 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -65.29 -18.57 65.42 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 119.454 1.024 . . . . 0.0 112.18 -177.341 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -119.8 4.39 11.02 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.921 1.289 . . . . 0.0 111.071 177.937 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.407 HD21 HG22 ' A' ' 7' ' ' THR . 68.0 m-80 -139.24 39.92 2.09 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 124.456 1.102 . . . . 0.0 109.642 -170.533 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 49.9 mm-40 -55.67 -33.32 64.01 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.929 0.892 . . . . 0.0 111.112 177.523 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 -66.29 -49.04 68.43 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 118.353 0.524 . . . . 0.0 110.189 179.093 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.52 -39.66 88.75 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.351 0.661 . . . . 0.0 109.846 -179.006 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.64 -49.05 79.28 Favored 'General case' 0 CA--C 1.533 0.292 0 O-C-N 121.149 -0.97 . . . . 0.0 110.322 173.344 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -60.46 -28.49 67.5 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 123.916 0.77 . . . . 0.0 112.262 177.257 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 72.2 tttt -56.13 -29.03 60.14 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 125.068 1.347 . . . . 0.0 111.698 179.662 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -123.47 10.64 9.18 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.63 0.772 . . . . 0.0 111.703 179.426 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 64.1 31.15 79.87 Favored Glycine 0 CA--C 1.532 1.14 0 C-N-CA 123.708 0.67 . . . . 0.0 112.617 -176.747 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 61.8 t -65.94 121.6 15.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 171.336 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 26.1 mmt -132.47 2.17 3.8 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.797 1.239 . . . . 0.0 111.514 -178.583 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 31.5 m -145.65 161.74 39.16 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 126.789 2.036 . . . . 0.0 107.401 179.372 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 41.6 pt -142.62 156.79 63.03 Favored Pre-proline 0 CA--C 1.545 0.773 0 C-N-CA 124.734 1.214 . . . . 0.0 108.739 177.663 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -65.48 142.69 55.56 Favored 'Cis proline' 0 C--N 1.35 0.627 0 CA-C-N 120.413 1.183 . . . . 0.0 110.231 -5.751 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 18.6 m -135.62 132.86 37.61 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 175.87 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -110.02 134.59 51.97 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 -174.954 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -121.98 125.75 47.02 Favored 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 102.593 -3.114 . . . . 0.0 102.593 177.022 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 1.9 t -103.67 122.3 56.17 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 N-CA-C 103.605 -2.739 . . . . 0.0 103.605 -179.771 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.7 mp -119.45 155.8 31.37 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 -175.891 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -136.81 126.2 24.99 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 170.214 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.2 t70 48.36 36.02 6.5 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.93 1.292 . . . . 0.0 112.294 172.366 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 98.31 2.53 57.84 Favored Glycine 0 CA--C 1.533 1.189 0 CA-C-O 117.925 -1.486 . . . . 0.0 115.108 171.47 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -121.42 145.88 47.47 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 120.364 2.082 . . . . 0.0 109.569 175.844 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 67.6 t -66.32 130.03 31.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 169.617 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 35.5 m -114.42 -21.92 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 CA-C-O 117.666 -1.159 . . . . 0.0 110.985 174.751 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -156.36 168.23 27.98 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 120.605 1.548 . . . . 0.0 111.023 173.609 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 14.1 m -143.72 151.0 39.49 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.597 1.559 . . . . 0.0 109.186 -177.458 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 13.0 m -152.61 153.95 34.39 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.375 1.47 . . . . 0.0 109.221 168.777 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 61.0 t -132.69 142.33 42.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 -172.94 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 75.84 -172.32 54.12 Favored Glycine 0 CA--C 1.529 0.913 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 -173.747 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -60.08 148.86 34.3 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.566 0.698 . . . . 0.0 110.303 174.615 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 39.5 tptt -149.14 122.44 4.53 Favored Pre-proline 0 N--CA 1.45 -0.431 0 N-CA-C 105.717 -1.956 . . . . 0.0 105.717 -173.915 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -68.5 155.67 68.23 Favored 'Trans proline' 0 N--CA 1.454 -0.807 0 C-N-CA 121.369 1.379 . . . . 0.0 111.101 -174.878 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -52.26 -46.88 65.97 Favored 'General case' 0 N--CA 1.461 0.121 0 C-N-CA 125.205 1.402 . . . . 0.0 112.021 -179.357 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -62.26 -40.39 96.04 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 122.95 0.5 . . . . 0.0 110.672 -179.104 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -69.45 -37.51 77.38 Favored 'General case' 0 N--CA 1.456 -0.162 0 O-C-N 121.796 -0.565 . . . . 0.0 110.798 179.475 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 98.5 mt -60.43 -43.4 96.82 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-O 119.285 -0.388 . . . . 0.0 110.18 173.389 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -62.11 -37.05 83.64 Favored 'General case' 0 N--CA 1.461 0.103 0 CA-C-N 118.431 0.56 . . . . 0.0 111.732 176.017 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -61.79 -48.74 79.26 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 118.429 0.559 . . . . 0.0 109.781 175.219 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 34.9 mt -62.47 -36.69 83.27 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 118.381 0.537 . . . . 0.0 111.431 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 56.1 t -61.48 -51.81 68.46 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 172.794 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -69.2 -22.04 63.92 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 -172.903 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 65.2 mttm -57.65 -26.36 61.51 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 118.213 -0.899 . . . . 0.0 111.548 170.115 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -126.13 -18.05 5.1 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 113.645 0.98 . . . . 0.0 113.645 -169.666 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 33.4 mt . . . . . 0 C--O 1.247 0.926 0 CA-C-N 119.935 1.243 . . . . 0.0 109.156 169.097 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.3 mt . . . . . 0 CA--C 1.537 0.48 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 23.4 t -136.55 162.99 34.41 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 C-N-CA 126.271 1.829 . . . . 0.0 106.94 -174.922 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.21 132.77 55.49 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 105.128 -2.175 . . . . 0.0 105.128 173.965 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -136.25 169.7 17.22 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 123.309 0.644 . . . . 0.0 110.976 -177.218 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.9 p -135.91 171.98 13.68 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 125.597 1.559 . . . . 0.0 107.505 169.679 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -51.79 -27.8 13.47 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.502 1.121 . . . . 0.0 112.946 178.061 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -57.97 -32.37 67.78 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 126.256 1.823 . . . . 0.0 112.809 178.849 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.0 m -141.22 -3.73 1.19 Allowed 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 113.383 0.883 . . . . 0.0 113.383 -169.166 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 78.3 t80 -53.51 -41.6 66.48 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.172 0.989 . . . . 0.0 111.633 -178.069 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.1 p -60.67 -45.5 93.89 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 124.045 0.938 . . . . 0.0 111.774 177.807 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.03 -43.62 95.02 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 122.737 0.415 . . . . 0.0 110.284 178.175 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 65.4 mm-40 -63.4 -37.24 86.53 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-O 119.414 -0.326 . . . . 0.0 110.962 -179.39 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.4 ' HA ' HG21 ' A' ' 20' ' ' VAL . 31.6 p -83.98 3.26 35.04 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.221 1.008 . . . . 0.0 113.277 -177.26 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 63.4 m -104.13 31.47 4.55 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.296 1.038 . . . . 0.0 111.459 -177.758 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -134.51 64.02 1.61 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.297 1.039 . . . . 0.0 110.229 -177.486 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 88.89 -158.33 28.13 Favored Glycine 0 C--N 1.337 0.603 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 177.483 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 59.1 t -69.94 135.5 28.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 168.905 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.4 HG21 ' HA ' ' A' ' 15' ' ' THR . 46.8 t -137.35 140.17 42.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 N-CA-C 105.763 -1.94 . . . . 0.0 105.763 179.26 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 52.3 tp -118.98 99.58 6.82 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 106.622 -1.622 . . . . 0.0 106.622 -178.774 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -79.67 149.35 31.27 Favored 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 178.025 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -130.43 93.99 3.57 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 126.532 1.933 . . . . 0.0 107.596 -177.02 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -74.44 113.82 12.11 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 105.821 -1.918 . . . . 0.0 105.821 175.275 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -149.9 -175.82 5.19 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 124.667 1.187 . . . . 0.0 108.455 -172.28 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -151.82 147.74 20.53 Favored Pre-proline 0 C--O 1.233 0.199 0 N-CA-C 105.64 -1.985 . . . . 0.0 105.64 167.19 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -67.1 -13.05 38.39 Favored 'Trans proline' 0 CA--C 1.535 0.533 0 CA-C-N 121.093 1.426 . . . . 0.0 113.104 -179.073 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 1.3 m95 -76.4 -13.51 60.12 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.841 0.856 . . . . 0.0 111.907 173.074 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 31.4 t -63.87 154.37 33.9 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 125.387 1.475 . . . . 0.0 111.076 -176.908 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -104.74 -65.4 0.68 Allowed Glycine 0 CA--C 1.53 0.997 0 CA-C-O 118.324 -1.265 . . . . 0.0 110.589 172.213 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -53.26 -32.02 58.78 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 123.4 2.733 . . . . 0.0 114.633 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 33.2 m -57.91 -34.37 69.77 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 121.574 -0.704 . . . . 0.0 111.721 176.548 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.0 mmtp -67.76 -23.17 65.2 Favored 'General case' 0 CA--C 1.53 0.188 0 O-C-N 121.492 -0.755 . . . . 0.0 111.074 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 32.2 mtm -70.83 -43.52 68.39 Favored 'General case' 0 C--N 1.339 0.143 0 CA-C-N 118.784 0.72 . . . . 0.0 110.357 176.018 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 17.3 tt -83.61 -22.61 8.33 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-O 118.75 -0.643 . . . . 0.0 111.698 -176.387 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -48.94 -51.43 55.29 Favored Pre-proline 0 CA--C 1.547 0.861 0 CA-C-N 120.032 1.287 . . . . 0.0 114.035 178.431 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -67.56 -25.16 41.16 Favored 'Trans proline' 0 C--N 1.351 0.688 0 CA-C-N 121.78 1.672 . . . . 0.0 112.367 176.674 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.4 t -72.07 -35.1 52.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 O-C-N 121.506 -0.746 . . . . 0.0 109.613 175.249 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 69.6 mt -67.97 -35.98 79.28 Favored 'General case' 0 C--N 1.338 0.095 0 CA-C-N 119.329 0.968 . . . . 0.0 111.036 170.989 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -62.4 -41.61 98.8 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 119.058 0.845 . . . . 0.0 110.818 170.862 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -61.99 -42.38 99.08 Favored 'General case' 0 C--N 1.331 -0.23 0 O-C-N 121.182 -0.948 . . . . 0.0 110.27 174.185 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 46.3 tp -61.62 -40.65 95.61 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.993 0.917 . . . . 0.0 110.642 178.586 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -60.98 -41.47 96.47 Favored 'General case' 0 C--N 1.334 -0.099 0 C-N-CA 123.108 0.563 . . . . 0.0 110.821 174.574 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -75.55 -11.08 59.95 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.023 0.529 . . . . 0.0 112.362 178.778 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -91.44 -50.45 5.79 Favored 'General case' 0 C--O 1.232 0.15 0 C-N-CA 124.928 1.291 . . . . 0.0 109.636 178.117 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 24.9 mtm -140.49 21.3 2.37 Favored 'General case' 0 N--CA 1.465 0.275 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -170.812 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -56.34 -11.7 5.28 Favored Glycine 0 CA--C 1.538 1.473 0 CA-C-N 120.197 1.362 . . . . 0.0 114.591 174.16 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -72.77 -28.7 62.76 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 118.694 1.247 . . . . 0.0 111.723 171.454 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -107.9 -24.92 11.45 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 125.922 1.689 . . . . 0.0 111.302 -179.558 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 48.8 tp -114.42 157.54 22.75 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 124.498 1.119 . . . . 0.0 111.307 -168.664 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -128.7 143.42 50.93 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 104.214 -2.513 . . . . 0.0 104.214 166.94 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 82.3 mt -117.44 138.5 47.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 105.367 -2.086 . . . . 0.0 105.367 178.199 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 98.8 t -132.59 98.74 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 -170.977 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 52.6 mtmt -70.93 141.6 51.11 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 107.848 -1.168 . . . . 0.0 107.848 173.323 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 16.5 tt -144.05 125.2 9.73 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 174.221 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 54.1 t0 -83.82 105.65 14.89 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.362 1.065 . . . . 0.0 108.629 -173.489 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 30.9 m -59.31 -26.25 33.25 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-O 118.538 -0.744 . . . . 0.0 111.939 -174.988 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -65.11 -18.27 65.16 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 119.453 1.024 . . . . 0.0 112.179 -177.401 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -119.69 3.82 11.11 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.915 1.286 . . . . 0.0 111.134 178.046 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 68.2 m-80 -139.5 39.82 2.05 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.438 1.095 . . . . 0.0 109.761 -170.453 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 52.1 mm-40 -55.41 -32.61 62.82 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.75 0.82 . . . . 0.0 111.092 176.37 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 33.4 mm-40 -65.99 -47.67 73.78 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 118.373 0.533 . . . . 0.0 110.324 178.938 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.49 -39.83 85.2 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 118.581 0.628 . . . . 0.0 109.993 -178.982 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.49 -49.39 77.96 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 121.621 -0.674 . . . . 0.0 110.453 173.499 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -61.75 -28.67 70.4 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 123.764 0.697 . . . . 0.0 112.131 178.367 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 17.2 ttmt -54.97 -29.47 56.9 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 125.772 1.629 . . . . 0.0 112.009 178.346 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -123.65 10.5 9.05 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.794 0.837 . . . . 0.0 111.831 178.865 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 65.25 28.27 73.37 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 123.825 0.726 . . . . 0.0 112.94 -177.756 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 56.7 t -62.35 127.49 22.45 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 172.084 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 42.3 ttp -137.29 0.79 2.36 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.532 1.133 . . . . 0.0 110.966 -176.814 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 24.4 m -144.95 162.74 36.15 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 126.535 1.934 . . . . 0.0 107.634 179.557 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 41.0 pt -143.29 156.55 60.92 Favored Pre-proline 0 CA--C 1.545 0.754 0 C-N-CA 124.897 1.279 . . . . 0.0 108.583 176.694 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -66.89 139.6 46.36 Favored 'Cis proline' 0 C--N 1.349 0.575 0 CA-C-N 120.522 1.222 . . . . 0.0 110.207 -5.097 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 31.9 m -132.11 138.59 48.16 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 176.198 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 88.5 mt -116.09 128.5 55.73 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 -171.367 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -119.23 125.54 49.41 Favored 'General case' 0 CA--C 1.509 -0.626 0 N-CA-C 102.551 -3.129 . . . . 0.0 102.551 177.459 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 1.7 t -105.64 122.6 59.31 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 N-CA-C 103.609 -2.737 . . . . 0.0 103.609 -179.387 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.8 mp -120.23 153.52 36.2 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 -176.57 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -136.63 124.97 23.28 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 171.501 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.5 t70 48.62 36.04 7.04 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.016 1.327 . . . . 0.0 112.284 174.026 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 99.8 2.34 56.23 Favored Glycine 0 CA--C 1.532 1.113 0 CA-C-O 117.92 -1.489 . . . . 0.0 114.98 170.055 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -122.36 146.75 47.04 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 120.273 2.037 . . . . 0.0 109.571 176.122 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 62.0 t -66.82 130.01 31.83 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 N-CA-C 107.405 -1.332 . . . . 0.0 107.405 170.216 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 30.7 m -118.29 -17.19 7.36 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 C-N-CA 124.641 1.177 . . . . 0.0 111.338 176.21 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -156.4 167.55 30.09 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 120.547 1.521 . . . . 0.0 110.61 172.477 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 19.1 m -146.42 142.62 28.35 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.589 1.156 . . . . 0.0 108.706 174.423 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 49.5 m -144.58 156.71 44.27 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.025 1.33 . . . . 0.0 108.734 176.672 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 39.8 t -134.23 146.38 31.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 -174.657 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 76.32 -175.95 52.36 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 123.532 0.587 . . . . 0.0 112.436 177.558 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -63.29 148.78 47.31 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.989 0.915 . . . . 0.0 111.286 -179.825 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -148.84 142.13 15.85 Favored Pre-proline 0 CA--C 1.534 0.335 0 C-N-CA 125.626 1.57 . . . . 0.0 107.24 167.816 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -72.26 160.8 46.23 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 122.871 2.381 . . . . 0.0 110.787 175.636 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 40.5 pttt -59.31 -30.12 68.12 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 -176.275 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -65.22 -49.72 68.62 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 118.355 0.525 . . . . 0.0 109.639 174.91 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.74 -37.86 88.93 Favored 'General case' 0 CA--C 1.528 0.118 0 O-C-N 122.063 -0.398 . . . . 0.0 110.853 179.22 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 84.5 mt -63.77 -44.62 92.88 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 122.722 0.409 . . . . 0.0 111.289 175.989 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -60.7 -41.95 96.23 Favored 'General case' 0 C--O 1.223 -0.291 0 CA-C-O 118.903 -0.57 . . . . 0.0 109.838 176.07 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -64.24 -40.93 97.05 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 118.383 0.538 . . . . 0.0 110.777 -179.535 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 56.3 tp -61.0 -44.89 96.75 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 124.965 1.306 . . . . 0.0 110.715 176.639 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 75.4 t -62.15 -43.83 98.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 123.602 0.761 . . . . 0.0 109.621 173.77 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -62.6 -24.05 67.37 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 125.186 1.395 . . . . 0.0 112.203 -173.296 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -54.85 -26.1 33.08 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 118.611 -0.709 . . . . 0.0 112.222 171.848 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 86.1 m-70 -123.8 -11.62 7.67 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 113.423 0.897 . . . . 0.0 113.423 -168.814 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 70.4 mt . . . . . 0 C--O 1.249 1.045 0 CA-C-N 119.16 0.891 . . . . 0.0 109.292 171.678 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.1 ttm . . . . . 0 N--CA 1.484 1.247 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -68.64 -20.89 64.49 Favored 'General case' 0 CA--C 1.509 -0.611 0 N-CA-C 115.699 1.74 . . . . 0.0 115.699 -175.65 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 7.6 mt -87.55 133.63 29.83 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 -172.702 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 10.4 t -135.71 158.8 39.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 106.441 -1.688 . . . . 0.0 106.441 -172.292 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 14.1 mtpt -119.99 125.14 47.66 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 105.793 -1.928 . . . . 0.0 105.793 -177.443 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -136.65 166.46 23.49 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.485 0.66 . . . . 0.0 111.422 -173.297 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 22.9 p -132.38 176.23 8.6 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 126.013 1.725 . . . . 0.0 107.819 172.55 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -53.58 -29.49 37.67 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.859 0.863 . . . . 0.0 112.465 177.734 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 54.2 mt-30 -66.53 -29.35 69.41 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.048 1.339 . . . . 0.0 112.915 179.068 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 23.5 p -123.3 -15.65 7.13 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.565 1.146 . . . . 0.0 113.416 -169.213 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -52.88 -48.15 67.34 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 124.53 1.132 . . . . 0.0 112.048 -172.379 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.9 m -63.92 -39.38 94.03 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.013 0.525 . . . . 0.0 111.779 -177.532 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.84 -43.78 87.48 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 178.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -66.08 -43.3 87.76 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 122.425 0.29 . . . . 0.0 110.747 -179.465 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 37.6 p -77.51 -5.32 49.61 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 -175.659 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 73.1 m -73.27 -21.88 60.5 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 177.11 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -87.98 72.18 9.29 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 118.75 0.705 . . . . 0.0 111.527 -169.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 85.09 -151.73 26.2 Favored Glycine 0 C--N 1.336 0.573 0 N-CA-C 110.479 -1.049 . . . . 0.0 110.479 172.1 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 97.6 t -72.18 132.95 32.69 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 168.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 49.6 t -138.2 143.96 31.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 N-CA-C 105.756 -1.942 . . . . 0.0 105.756 179.265 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 5.6 tt -122.85 101.6 7.53 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 106.303 -1.74 . . . . 0.0 106.303 -178.218 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -81.78 147.06 29.6 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.659 -179.405 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -125.43 93.8 3.96 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 126.588 1.955 . . . . 0.0 107.194 -175.238 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -75.8 112.79 12.55 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 175.328 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -149.94 -176.04 5.28 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.432 1.093 . . . . 0.0 108.644 -172.013 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -152.79 147.69 19.52 Favored Pre-proline 0 CA--C 1.531 0.236 0 N-CA-C 106.085 -1.821 . . . . 0.0 106.085 167.141 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -59.11 -18.29 43.06 Favored 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 121.848 1.699 . . . . 0.0 114.595 177.096 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 2.0 m95 -75.19 -14.22 60.52 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 118.818 0.735 . . . . 0.0 111.865 176.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 25.0 t -64.32 153.33 38.68 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.499 1.519 . . . . 0.0 111.063 -177.059 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -103.26 -65.14 0.71 Allowed Glycine 0 CA--C 1.53 0.982 0 CA-C-O 118.424 -1.209 . . . . 0.0 110.514 171.657 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_exo -53.22 -31.7 56.93 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 123.525 2.816 . . . . 0.0 114.608 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 34.3 m -58.63 -32.59 69.17 Favored 'General case' 0 CA--C 1.537 0.451 0 O-C-N 121.509 -0.744 . . . . 0.0 111.857 176.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.3 mmtp -68.36 -23.83 64.73 Favored 'General case' 0 CA--C 1.531 0.244 0 O-C-N 121.273 -0.892 . . . . 0.0 110.888 179.213 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 28.9 mtm -71.57 -40.93 69.61 Favored 'General case' 0 C--N 1.339 0.148 0 CA-C-N 118.79 0.723 . . . . 0.0 110.636 176.639 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 19.2 tt -83.14 -21.37 8.98 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-O 118.918 -0.563 . . . . 0.0 111.529 -176.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -49.79 -50.62 66.46 Favored Pre-proline 0 CA--C 1.55 0.952 0 CA-C-N 120.14 1.336 . . . . 0.0 114.003 177.206 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -66.46 -26.39 47.59 Favored 'Trans proline' 0 C--N 1.351 0.701 0 CA-C-N 121.688 1.639 . . . . 0.0 112.451 175.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 6.0 t -67.63 -40.08 83.43 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-N 118.907 0.776 . . . . 0.0 109.136 173.551 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 91.3 mt -64.3 -34.21 77.6 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 119.462 1.028 . . . . 0.0 111.224 172.341 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -66.32 -38.14 86.99 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 119.606 1.094 . . . . 0.0 111.385 171.537 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -63.78 -36.09 82.76 Favored 'General case' 0 C--N 1.33 -0.248 0 O-C-N 120.299 -1.501 . . . . 0.0 110.115 172.22 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 18.7 mt -66.58 -37.25 84.52 Favored 'General case' 0 C--N 1.334 -0.097 0 CA-C-O 117.892 -1.051 . . . . 0.0 112.087 173.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -54.1 -47.05 72.18 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 120.569 1.532 . . . . 0.0 109.65 168.359 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 44.1 mt-30 -74.49 -13.67 60.72 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 113.283 0.846 . . . . 0.0 113.283 -174.572 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 61.7 mt-10 -120.93 -24.27 5.67 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 124.417 1.087 . . . . 0.0 113.01 -170.264 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 17.5 mtp -131.99 -5.2 3.53 Favored 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 -175.747 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -58.43 -12.17 12.16 Favored Glycine 0 CA--C 1.538 1.472 0 CA-C-N 120.488 1.494 . . . . 0.0 115.393 -172.688 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -74.83 -25.99 59.39 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.326 1.45 . . . . 0.0 112.226 174.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.479 ' HA ' ' HE3' ' A' ' 49' ' ' LYS . 0.0 OUTLIER -123.67 -18.16 6.19 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 125.575 1.55 . . . . 0.0 112.144 -177.504 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 55.7 tp -118.13 150.71 38.91 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 124.167 0.987 . . . . 0.0 110.552 -169.577 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -124.02 145.0 49.5 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 104.821 -2.289 . . . . 0.0 104.821 167.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 90.0 mt -120.59 129.32 75.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 104.395 -2.446 . . . . 0.0 104.395 -177.614 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 98.7 t -126.23 98.45 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 CA-C-N 119.217 0.917 . . . . 0.0 109.403 -170.383 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -73.47 137.62 44.62 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 176.332 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 15.1 tt -141.34 125.43 16.79 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 C-N-CA 123.769 0.827 . . . . 0.0 108.79 176.683 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 60.6 t0 -83.47 104.2 13.42 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 124.62 1.168 . . . . 0.0 108.953 -172.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 30.3 m -58.81 -27.05 33.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 118.713 -0.66 . . . . 0.0 111.959 -174.587 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -65.57 -17.75 64.81 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 119.346 0.975 . . . . 0.0 112.171 -176.623 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -120.57 3.44 10.7 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.869 1.268 . . . . 0.0 111.222 178.011 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 69.0 m-80 -139.11 40.02 2.12 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.43 1.092 . . . . 0.0 109.814 -169.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 51.8 mm-40 -55.46 -32.09 62.49 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.122 0.969 . . . . 0.0 111.257 176.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 36.8 mm-40 -66.25 -48.45 70.47 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 118.493 0.588 . . . . 0.0 110.357 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.15 -39.46 82.63 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 118.408 0.549 . . . . 0.0 109.556 -178.652 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -58.95 -48.69 80.6 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 121.31 -0.869 . . . . 0.0 110.327 173.441 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -61.19 -28.66 69.45 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 123.985 0.802 . . . . 0.0 112.202 177.657 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 44.9 tttp -55.97 -29.24 59.94 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.965 1.306 . . . . 0.0 111.686 179.181 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -122.88 10.43 9.54 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.705 0.802 . . . . 0.0 111.739 179.467 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 64.95 28.37 73.41 Favored Glycine 0 CA--C 1.533 1.186 0 CA-C-O 119.39 -0.672 . . . . 0.0 112.892 -177.368 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 61.4 t -62.27 125.56 18.87 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 171.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 12.0 tpt -136.53 1.28 2.59 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.608 1.163 . . . . 0.0 111.085 -175.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 24.6 m -144.82 163.11 35.07 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 126.626 1.97 . . . . 0.0 107.481 179.394 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 38.5 pt -142.88 156.26 62.4 Favored Pre-proline 0 CA--C 1.545 0.765 0 C-N-CA 124.574 1.15 . . . . 0.0 108.847 175.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -66.65 138.9 42.11 Favored 'Cis proline' 0 N--CA 1.458 -0.582 0 CA-C-N 120.361 1.164 . . . . 0.0 110.179 -5.618 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 32.3 m -129.77 142.71 50.65 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 174.657 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 88.4 mt -123.39 126.52 46.95 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 -168.502 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -118.41 119.39 34.46 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 103.969 -2.604 . . . . 0.0 103.969 179.526 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 5.1 t -90.23 123.15 42.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 103.565 -2.754 . . . . 0.0 103.565 171.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.2 mp -111.61 153.64 26.03 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 173.071 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -136.15 124.32 23.07 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 105.916 -1.883 . . . . 0.0 105.916 174.246 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 31.9 t70 50.96 34.13 10.06 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.573 1.149 . . . . 0.0 112.251 177.143 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 98.55 0.86 57.84 Favored Glycine 0 CA--C 1.531 1.038 0 CA-C-O 118.227 -1.318 . . . . 0.0 114.956 169.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -128.38 150.32 50.16 Favored 'General case' 0 C--N 1.34 0.153 0 CA-C-N 119.999 1.9 . . . . 0.0 109.916 178.205 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 47.9 t -62.26 133.24 28.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 176.743 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.6 p -117.92 -24.73 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 C-N-CA 125.087 1.355 . . . . 0.0 109.58 177.09 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -158.79 164.98 35.31 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 120.035 1.289 . . . . 0.0 110.506 175.041 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 10.6 m -136.26 150.88 49.14 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.709 1.204 . . . . 0.0 108.891 177.652 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 62.3 m -150.52 159.3 44.58 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.622 1.569 . . . . 0.0 108.768 169.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 40.7 t -133.77 147.73 30.66 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 -176.495 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 76.93 -178.03 51.51 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 123.637 0.637 . . . . 0.0 112.423 176.519 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -64.73 150.29 47.59 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.886 0.874 . . . . 0.0 110.826 178.648 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -149.02 145.53 19.7 Favored Pre-proline 0 C--O 1.235 0.321 0 C-N-CA 125.677 1.591 . . . . 0.0 106.93 167.529 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -70.84 161.19 46.94 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 122.649 2.233 . . . . 0.0 110.462 174.401 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 63.5 pttt -58.71 -31.74 68.54 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -175.602 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -68.02 -45.49 73.85 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 118.244 0.475 . . . . 0.0 109.859 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.7 -40.43 95.36 Favored 'General case' 0 C--O 1.232 0.159 0 O-C-N 122.039 -0.413 . . . . 0.0 110.339 177.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 97.4 mt -64.57 -40.6 95.84 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 122.307 0.243 . . . . 0.0 111.313 176.077 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 18.9 mt-30 -59.83 -39.3 84.61 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 118.759 -0.638 . . . . 0.0 110.108 175.608 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -68.14 -40.35 82.45 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 118.941 0.791 . . . . 0.0 110.808 178.122 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 43.9 tp -60.34 -37.89 82.08 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.312 1.445 . . . . 0.0 111.313 176.441 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 99.4 t -68.74 -49.75 61.41 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 C-N-CA 123.756 0.823 . . . . 0.0 109.578 170.327 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -58.09 -39.25 78.11 Favored 'General case' 0 CA--C 1.519 -0.218 0 C-N-CA 125.453 1.501 . . . . 0.0 112.119 -168.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 13.3 ptmm? -65.44 -5.92 9.02 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 113.364 0.876 . . . . 0.0 113.364 -178.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -127.04 -3.48 6.38 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.548 1.139 . . . . 0.0 113.595 175.431 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 46.9 mt . . . . . 0 C--O 1.248 0.988 0 CA-C-N 119.413 1.006 . . . . 0.0 109.164 170.289 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 43.5 tpp . . . . . 0 N--CA 1.483 1.196 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -144.73 -174.09 4.24 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.535 1.134 . . . . 0.0 110.476 -170.244 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 7.5 mt -70.05 147.27 11.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 168.643 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 37.3 t -137.68 164.77 27.91 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 C-N-CA 127.106 2.162 . . . . 0.0 106.2 -179.133 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 8.1 ttmt -120.14 146.34 46.07 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 107.1 -1.445 . . . . 0.0 107.1 173.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -143.64 169.97 16.73 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.717 0.77 . . . . 0.0 111.029 -178.242 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 18.6 p -133.77 173.43 11.54 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 127.699 2.4 . . . . 0.0 107.863 176.428 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -54.93 -31.41 60.32 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 121.578 -0.701 . . . . 0.0 112.547 177.851 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 59.4 mt-30 -70.77 -27.62 64.06 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.113 1.365 . . . . 0.0 112.959 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 25.5 p -118.89 -18.95 8.74 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.425 1.09 . . . . 0.0 113.524 -168.666 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -52.99 -46.47 68.32 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 125.014 1.326 . . . . 0.0 111.942 -172.436 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.0 m -63.79 -38.39 90.92 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 122.79 0.436 . . . . 0.0 111.795 -176.274 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -68.54 -44.6 74.2 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 177.388 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 67.6 mm-40 -63.95 -34.46 78.02 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-O 119.545 -0.264 . . . . 0.0 111.223 -178.134 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 33.3 p -85.79 1.63 48.9 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.012 0.925 . . . . 0.0 113.427 -176.533 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 70.9 m -101.79 31.52 3.81 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.14 0.976 . . . . 0.0 111.601 -177.504 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -133.72 65.05 1.59 Allowed 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.44 1.096 . . . . 0.0 110.104 -177.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 89.84 -154.32 23.79 Favored Glycine 0 C--N 1.338 0.661 0 N-CA-C 110.294 -1.123 . . . . 0.0 110.294 175.536 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 48.5 t -71.71 135.7 27.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 N-CA-C 106.214 -1.772 . . . . 0.0 106.214 168.401 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 49.2 t -137.62 141.98 37.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 178.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 60.4 tp -122.96 98.79 6.06 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 -177.487 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -79.39 148.72 31.89 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 178.432 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -127.98 93.98 3.82 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 126.543 1.937 . . . . 0.0 107.443 -178.046 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -73.4 112.6 9.62 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 105.735 -1.95 . . . . 0.0 105.735 175.034 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -148.64 -177.2 5.65 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 124.847 1.259 . . . . 0.0 108.173 -172.718 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -156.01 149.35 18.69 Favored Pre-proline 0 N--CA 1.453 -0.29 0 N-CA-C 106.154 -1.795 . . . . 0.0 106.154 167.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -68.93 -13.18 36.19 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 CA-C-N 120.866 1.345 . . . . 0.0 113.96 -177.368 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 46.4 p-90 -69.74 -20.39 63.51 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 120.147 1.34 . . . . 0.0 111.975 169.628 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 29.1 t -59.17 148.33 31.94 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.06 1.344 . . . . 0.0 111.05 -171.68 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -97.09 -60.59 0.96 Allowed Glycine 0 CA--C 1.532 1.113 0 CA-C-O 118.722 -1.043 . . . . 0.0 111.335 169.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -66.37 -25.99 48.6 Favored 'Trans proline' 0 C--N 1.349 0.574 0 CA-C-N 120.387 2.093 . . . . 0.0 112.983 -173.111 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 24.5 m -58.26 -33.98 69.99 Favored 'General case' 0 CA--C 1.534 0.346 0 O-C-N 121.627 -0.671 . . . . 0.0 111.218 174.346 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.1 mmtp -68.24 -22.87 64.75 Favored 'General case' 0 CA--C 1.531 0.242 0 O-C-N 121.591 -0.693 . . . . 0.0 111.078 -179.565 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 35.3 mtm -71.34 -44.21 65.51 Favored 'General case' 0 C--N 1.34 0.184 0 CA-C-N 118.863 0.756 . . . . 0.0 110.323 175.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 17.2 tt -83.04 -22.73 8.61 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-O 118.628 -0.701 . . . . 0.0 111.555 -176.423 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -49.05 -52.04 50.81 Favored Pre-proline 0 CA--C 1.548 0.888 0 CA-C-N 120.28 1.4 . . . . 0.0 114.223 178.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -66.41 -29.9 44.94 Favored 'Trans proline' 0 C--N 1.351 0.667 0 CA-C-N 121.574 1.598 . . . . 0.0 111.985 176.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.0 t -66.49 -40.26 86.04 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-O 118.722 -0.656 . . . . 0.0 109.403 175.016 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 45.7 mt -64.54 -37.05 86.21 Favored 'General case' 0 C--O 1.224 -0.258 0 CA-C-N 119.507 1.049 . . . . 0.0 110.613 174.769 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -63.03 -44.47 95.85 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 119.104 0.866 . . . . 0.0 111.083 173.187 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -63.94 -39.79 94.97 Favored 'General case' 0 CA--C 1.534 0.334 0 O-C-N 121.166 -0.959 . . . . 0.0 110.451 177.566 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -63.68 -43.28 97.11 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 125.175 1.39 . . . . 0.0 109.641 177.285 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -58.74 -43.12 90.15 Favored 'General case' 0 CA--C 1.521 -0.143 0 C-N-CA 123.767 0.827 . . . . 0.0 110.917 176.519 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -70.5 -10.19 58.55 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -106.31 -27.58 10.92 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 125.735 1.614 . . . . 0.0 111.518 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 22.2 mtp -126.14 -2.47 7.01 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 113.51 0.929 . . . . 0.0 113.51 -169.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.82 -7.3 6.17 Favored Glycine 0 CA--C 1.533 1.215 0 CA-C-N 119.591 1.087 . . . . 0.0 115.538 -176.1 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -75.71 -27.64 58.29 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 118.597 1.198 . . . . 0.0 111.638 171.575 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 45.0 mmtm -121.03 -20.51 6.81 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 125.514 1.526 . . . . 0.0 112.347 -175.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 48.8 tp -119.83 151.91 38.11 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.131 0.972 . . . . 0.0 111.546 -168.276 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -120.41 143.84 48.25 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 105.011 -2.218 . . . . 0.0 105.011 166.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 58.6 mt -112.56 140.2 33.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 105.497 -2.038 . . . . 0.0 105.497 173.036 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 95.1 t -132.75 98.96 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 -172.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 47.6 mtpt -73.9 140.43 45.65 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 175.363 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 13.0 tt -141.01 126.16 18.57 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 175.569 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -83.79 101.86 11.9 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 124.728 1.211 . . . . 0.0 108.786 -173.082 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 24.9 m -59.95 -25.63 33.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 118.667 -0.683 . . . . 0.0 111.961 -174.498 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -65.05 -18.45 65.31 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 119.464 1.029 . . . . 0.0 112.143 -177.09 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -120.22 4.02 10.84 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.809 1.244 . . . . 0.0 111.072 177.541 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -139.2 40.56 2.1 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.607 1.163 . . . . 0.0 109.592 -170.652 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 48.0 mm-40 -55.84 -32.55 63.7 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.184 0.993 . . . . 0.0 111.257 177.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -65.74 -46.27 79.51 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 118.385 0.539 . . . . 0.0 110.425 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.13 -39.19 79.03 Favored 'General case' 0 C--O 1.223 -0.317 0 CA-C-N 118.457 0.571 . . . . 0.0 109.618 -179.246 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.06 -48.36 81.89 Favored 'General case' 0 CA--C 1.533 0.326 0 O-C-N 121.256 -0.902 . . . . 0.0 110.25 173.177 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -60.68 -28.75 68.49 Favored Glycine 0 CA--C 1.529 0.938 0 C-N-CA 124.079 0.847 . . . . 0.0 112.36 177.251 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 47.3 tttp -55.94 -29.32 59.96 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 124.861 1.265 . . . . 0.0 111.709 179.345 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -123.2 10.63 9.35 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.621 0.768 . . . . 0.0 111.767 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 63.6 31.57 81.21 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 123.641 0.639 . . . . 0.0 112.636 -176.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 55.1 t -65.83 121.87 15.73 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 171.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 98.5 mmm -131.59 2.64 4.14 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.898 1.279 . . . . 0.0 111.382 -178.425 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 24.5 m -144.83 161.17 39.94 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 126.652 1.981 . . . . 0.0 107.565 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 38.7 pt -142.69 154.36 62.69 Favored Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 124.726 1.211 . . . . 0.0 108.41 176.333 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -68.26 140.14 53.89 Favored 'Cis proline' 0 C--N 1.349 0.601 0 CA-C-N 120.495 1.212 . . . . 0.0 110.541 -3.133 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 33.9 m -131.86 142.83 49.81 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 175.067 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 83.0 mt -121.24 127.4 51.39 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 -170.006 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -120.64 124.63 45.7 Favored 'General case' 0 CA--C 1.508 -0.637 0 N-CA-C 102.851 -3.018 . . . . 0.0 102.851 178.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 1.3 t -106.04 125.87 61.58 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 N-CA-C 103.872 -2.64 . . . . 0.0 103.872 -178.735 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.7 mp -122.08 152.9 39.34 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 -175.502 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -135.71 116.71 14.27 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 106.522 -1.659 . . . . 0.0 106.522 178.096 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.1 t70 49.58 38.42 14.79 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.915 1.286 . . . . 0.0 112.571 176.533 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 104.14 -2.87 43.99 Favored Glycine 0 CA--C 1.529 0.92 0 CA-C-O 118.056 -1.414 . . . . 0.0 115.418 168.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -126.57 147.17 49.91 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 120.129 1.964 . . . . 0.0 109.995 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 61.0 t -62.58 131.43 27.94 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 174.144 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 9.9 p -119.3 -20.67 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.732 0 C-N-CA 125.006 1.322 . . . . 0.0 110.093 178.102 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -159.96 166.75 29.46 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 120.58 1.536 . . . . 0.0 110.272 172.533 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 17.4 m -136.75 151.34 49.1 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.647 1.579 . . . . 0.0 108.798 176.276 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 46.3 m -148.35 157.4 43.46 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.871 1.669 . . . . 0.0 108.595 169.633 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 39.4 t -133.8 146.24 32.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 -178.296 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 79.58 -175.87 54.88 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 123.646 0.641 . . . . 0.0 112.296 176.022 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -62.46 145.28 54.56 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.577 0.751 . . . . 0.0 110.563 178.763 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 68.9 mttt -143.72 134.31 12.23 Favored Pre-proline 0 CA--C 1.532 0.258 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 168.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -69.5 160.76 48.56 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.306 2.004 . . . . 0.0 109.907 174.25 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 49.7 pttt -59.24 -28.3 66.57 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 -176.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -65.54 -47.89 74.35 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 118.444 0.565 . . . . 0.0 109.975 174.116 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.53 -37.65 88.28 Favored 'General case' 0 CA--C 1.529 0.173 0 O-C-N 121.859 -0.526 . . . . 0.0 110.619 177.527 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 83.0 mt -65.19 -42.12 93.89 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-O 119.285 -0.388 . . . . 0.0 111.383 176.541 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 15.8 mt-30 -59.3 -42.87 92.35 Favored 'General case' 0 C--O 1.225 -0.214 0 CA-C-N 118.697 0.681 . . . . 0.0 109.643 175.056 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -65.99 -38.6 88.91 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 118.017 0.371 . . . . 0.0 110.683 -179.127 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 65.9 tp -61.15 -47.25 87.06 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 125.025 1.33 . . . . 0.0 110.328 176.424 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 97.3 t -61.55 -43.26 96.64 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 123.902 0.881 . . . . 0.0 110.045 174.041 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -61.51 -26.05 67.67 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 125.18 1.392 . . . . 0.0 112.136 -172.088 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 82.3 mttt -55.15 -24.88 28.62 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 118.774 -0.632 . . . . 0.0 112.617 172.436 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 43.3 m-70 -121.74 -10.67 8.71 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 -167.707 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 78.7 mt . . . . . 0 C--O 1.249 1.077 0 CA-C-N 118.565 0.62 . . . . 0.0 109.457 172.586 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.0 mmt . . . . . 0 N--CA 1.485 1.281 0 CA-C-O 120.766 0.317 . . . . 0.0 110.148 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -150.44 -176.98 5.7 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.135 1.374 . . . . 0.0 109.201 -175.255 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.9 mt -73.79 144.93 12.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 167.3 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 29.0 t -136.47 163.97 32.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 C-N-CA 126.724 2.01 . . . . 0.0 106.273 -178.465 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.52 133.78 49.81 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 104.923 -2.251 . . . . 0.0 104.923 176.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -135.22 175.11 9.89 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 123.875 0.87 . . . . 0.0 111.37 -171.438 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 31.3 p -137.87 178.56 7.02 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 125.244 1.418 . . . . 0.0 107.779 169.671 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -49.3 -30.34 7.27 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.895 0.878 . . . . 0.0 112.4 169.424 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -64.81 -27.47 68.91 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.003 1.321 . . . . 0.0 112.776 -179.689 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 14.1 p -130.83 -17.55 3.16 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 114.298 1.222 . . . . 0.0 114.298 -167.63 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 56.8 t80 -52.2 -47.28 65.67 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 124.463 1.105 . . . . 0.0 112.259 -170.327 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.2 m -64.56 -37.9 89.15 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 122.62 0.368 . . . . 0.0 111.849 -176.349 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -69.09 -44.56 72.24 Favored 'General case' 0 N--CA 1.452 -0.343 0 O-C-N 122.017 -0.427 . . . . 0.0 109.96 176.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 68.9 mm-40 -63.22 -35.82 81.59 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 122.529 0.331 . . . . 0.0 110.921 -178.188 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.407 ' HA ' HG21 ' A' ' 20' ' ' VAL . 29.3 p -82.85 0.62 43.22 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 -176.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 70.7 m -102.04 29.21 5.2 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.972 0.909 . . . . 0.0 112.068 -175.583 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -135.2 55.24 1.89 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.831 0.853 . . . . 0.0 111.387 -173.58 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 107.39 -152.06 16.91 Favored Glycine 0 C--N 1.337 0.614 0 N-CA-C 109.954 -1.258 . . . . 0.0 109.954 173.323 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.2 t -74.83 135.75 26.65 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 N-CA-C 104.88 -2.267 . . . . 0.0 104.88 166.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.407 HG21 ' HA ' ' A' ' 15' ' ' THR . 34.3 t -136.15 139.47 45.61 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 N-CA-C 106.441 -1.688 . . . . 0.0 106.441 178.765 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.8 tt -124.17 100.11 6.56 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 106.131 -1.803 . . . . 0.0 106.131 -177.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -81.33 145.67 30.75 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.236 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -124.52 94.02 4.08 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 125.899 1.68 . . . . 0.0 107.619 -176.784 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -74.22 112.51 10.45 Favored 'General case' 0 C--O 1.24 0.58 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 175.388 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -148.96 -176.51 5.37 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.966 1.306 . . . . 0.0 108.548 -172.581 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -156.44 146.74 15.9 Favored Pre-proline 0 CA--C 1.533 0.296 0 N-CA-C 106.16 -1.793 . . . . 0.0 106.16 168.073 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -60.76 -17.95 53.04 Favored 'Trans proline' 0 CA--C 1.534 0.495 0 C-N-CA 121.662 1.575 . . . . 0.0 115.799 -178.373 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 50.5 p-90 -69.23 -20.56 63.95 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 119.99 1.268 . . . . 0.0 112.011 173.411 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 34.1 t -58.9 146.9 35.99 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 125.055 1.342 . . . . 0.0 111.231 -172.443 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -95.4 -62.43 0.99 Allowed Glycine 0 CA--C 1.531 1.082 0 CA-C-O 118.647 -1.085 . . . . 0.0 111.163 170.56 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -64.43 -26.53 62.9 Favored 'Trans proline' 0 C--N 1.35 0.634 0 CA-C-N 120.257 2.029 . . . . 0.0 113.387 -173.1 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 30.2 m -57.29 -34.7 68.95 Favored 'General case' 0 CA--C 1.537 0.456 0 O-C-N 121.63 -0.669 . . . . 0.0 111.479 174.385 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.9 mmtp -67.91 -24.49 65.21 Favored 'General case' 0 CA--C 1.531 0.25 0 O-C-N 121.645 -0.659 . . . . 0.0 111.057 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 32.3 mtm -71.25 -44.04 66.07 Favored 'General case' 0 C--N 1.34 0.18 0 CA-C-N 118.654 0.661 . . . . 0.0 110.411 177.212 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 14.5 tt -82.21 -23.69 9.33 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-O 118.745 -0.645 . . . . 0.0 111.523 -176.048 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -48.59 -51.46 52.33 Favored Pre-proline 0 CA--C 1.548 0.888 0 CA-C-N 120.062 1.301 . . . . 0.0 114.262 179.443 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -66.93 -28.08 42.53 Favored 'Trans proline' 0 C--N 1.35 0.649 0 CA-C-N 121.807 1.681 . . . . 0.0 112.407 176.766 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.6 t -67.8 -37.92 79.32 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 O-C-N 121.584 -0.698 . . . . 0.0 109.313 174.595 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 95.0 mt -67.16 -35.4 79.6 Favored 'General case' 0 C--N 1.34 0.166 0 CA-C-N 119.516 1.053 . . . . 0.0 111.328 172.677 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -61.96 -43.07 99.6 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 119.548 1.067 . . . . 0.0 110.755 171.664 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -63.38 -41.35 98.79 Favored 'General case' 0 CA--C 1.53 0.179 0 O-C-N 121.279 -0.888 . . . . 0.0 110.421 175.072 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 35.3 tp -60.82 -42.21 97.23 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 123.494 0.718 . . . . 0.0 110.24 177.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -60.54 -43.82 96.79 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 123.347 0.659 . . . . 0.0 110.728 177.119 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 -71.4 -10.72 60.21 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.29 0.636 . . . . 0.0 112.629 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -105.59 -28.09 10.97 Favored 'General case' 0 C--O 1.232 0.172 0 C-N-CA 125.46 1.504 . . . . 0.0 111.42 -178.335 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 22.8 mtp -131.44 0.27 4.04 Favored 'General case' 0 N--CA 1.461 0.105 0 N-CA-C 113.658 0.985 . . . . 0.0 113.658 -169.002 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -55.82 -10.31 3.35 Favored Glycine 0 CA--C 1.535 1.343 0 C-N-CA 124.747 1.165 . . . . 0.0 115.926 -176.456 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -72.86 -29.14 62.97 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.597 1.159 . . . . 0.0 112.049 172.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 42.3 mmtm -126.37 -14.9 5.79 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 125.732 1.613 . . . . 0.0 112.842 -175.593 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 58.9 tp -120.3 142.59 48.95 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 124.144 0.978 . . . . 0.0 109.925 -170.722 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -117.73 145.48 44.43 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 104.899 -2.26 . . . . 0.0 104.899 167.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 73.7 mt -116.19 138.19 47.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 105.399 -2.075 . . . . 0.0 105.399 176.371 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 93.1 t -132.59 96.47 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -169.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 54.4 mtpt -74.24 139.05 44.07 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 177.328 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 17.3 tt -141.41 125.62 16.89 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 176.787 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 39.4 t0 -82.35 104.89 12.99 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 124.737 1.215 . . . . 0.0 108.428 -175.241 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 30.5 m -60.47 -25.8 35.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 C-N-CA 123.464 0.705 . . . . 0.0 112.194 -173.329 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -64.83 -26.54 68.38 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 119.188 0.904 . . . . 0.0 111.468 -177.674 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -108.97 6.38 25.14 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.098 1.359 . . . . 0.0 110.791 -179.205 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 68.3 m-80 -146.69 39.66 1.06 Allowed 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.536 1.135 . . . . 0.0 110.137 -168.369 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -57.84 -29.6 65.1 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.448 1.099 . . . . 0.0 110.541 179.366 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 48.1 mp0 -65.4 -51.35 60.93 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 124.7 1.2 . . . . 0.0 109.923 177.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.12 -38.55 85.79 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.536 0.734 . . . . 0.0 109.748 -178.654 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.1 -48.62 80.95 Favored 'General case' 0 CA--C 1.534 0.34 0 O-C-N 121.105 -0.997 . . . . 0.0 110.255 172.185 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -60.59 -28.92 68.52 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 123.887 0.756 . . . . 0.0 112.397 177.519 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 73.7 tttt -55.82 -29.28 59.52 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 125.047 1.339 . . . . 0.0 111.674 179.329 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -123.64 10.17 9.03 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.647 0.779 . . . . 0.0 111.87 179.288 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 64.37 28.75 73.5 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 123.736 0.684 . . . . 0.0 112.839 -176.692 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 51.0 t -62.08 125.65 18.81 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 172.054 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 12.0 tpt -137.6 0.71 2.28 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.567 1.147 . . . . 0.0 111.15 -176.312 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 28.0 m -144.87 162.67 36.24 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 126.594 1.957 . . . . 0.0 107.439 179.031 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 40.2 pt -142.97 154.44 61.89 Favored Pre-proline 0 CA--C 1.546 0.809 0 C-N-CA 124.502 1.121 . . . . 0.0 108.916 177.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -68.03 138.49 44.33 Favored 'Cis proline' 0 C--N 1.35 0.628 0 CA-C-N 120.427 1.188 . . . . 0.0 110.376 -3.58 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 26.0 m -129.42 141.55 51.01 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 173.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 86.7 mt -122.82 127.17 48.71 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 -169.488 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -115.99 123.63 48.5 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 103.683 -2.71 . . . . 0.0 103.683 177.419 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 6.2 t -99.24 125.13 52.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 103.993 -2.595 . . . . 0.0 103.993 177.545 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.7 mp -122.5 153.67 38.86 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 4.5 tmtp? -135.19 120.24 18.72 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 106.306 -1.739 . . . . 0.0 106.306 175.264 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.5 t70 50.69 36.88 15.15 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.901 1.28 . . . . 0.0 112.559 175.362 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 106.24 -4.26 38.04 Favored Glycine 0 CA--C 1.526 0.779 0 CA-C-O 118.104 -1.387 . . . . 0.0 115.326 168.601 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -130.87 147.72 52.55 Favored 'General case' 0 C--N 1.339 0.132 0 CA-C-N 120.085 1.942 . . . . 0.0 110.205 -177.453 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 53.0 t -63.26 132.86 29.24 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 178.604 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 5.2 p -119.21 -20.39 4.99 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 C-N-CA 124.823 1.249 . . . . 0.0 110.795 174.502 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -158.23 168.73 26.23 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 120.544 1.52 . . . . 0.0 110.903 173.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 10.3 m -138.26 150.94 47.16 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.399 1.48 . . . . 0.0 108.497 175.449 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 2.7 m -146.54 157.16 43.69 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 125.761 1.624 . . . . 0.0 108.653 169.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 39.5 t -133.67 147.14 30.92 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 176.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 78.47 -176.94 54.07 Favored Glycine 0 CA--C 1.53 0.973 0 CA-C-O 121.638 0.577 . . . . 0.0 112.406 177.101 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 60.0 t80 -65.91 145.03 56.4 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.921 0.888 . . . . 0.0 110.896 -179.344 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -141.93 140.57 19.96 Favored Pre-proline 0 CA--C 1.535 0.37 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 167.766 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -72.11 162.5 41.55 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 122.68 2.254 . . . . 0.0 110.781 175.757 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 31.9 pttt -58.91 -30.99 68.23 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 -177.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -66.94 -49.76 64.5 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 118.336 0.516 . . . . 0.0 109.969 176.194 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.24 -39.4 94.5 Favored 'General case' 0 CA--C 1.529 0.146 0 O-C-N 121.923 -0.486 . . . . 0.0 110.512 179.307 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 59.3 mt -62.48 -45.22 94.01 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 123.345 0.658 . . . . 0.0 111.013 176.315 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 19.2 mt-30 -58.79 -42.15 88.39 Favored 'General case' 0 C--O 1.225 -0.214 0 CA-C-N 118.311 0.505 . . . . 0.0 110.262 176.229 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -66.89 -38.62 86.62 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 118.488 0.586 . . . . 0.0 110.817 -179.079 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 64.8 tp -63.67 -38.32 90.68 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.869 1.267 . . . . 0.0 110.956 176.257 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 96.4 t -68.54 -46.38 80.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-N 119.083 0.856 . . . . 0.0 109.787 172.241 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -56.79 -41.96 78.61 Favored 'General case' 0 CA--C 1.519 -0.219 0 C-N-CA 125.449 1.499 . . . . 0.0 111.802 -168.374 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -68.39 -5.62 20.05 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -175.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 83.5 m-70 -123.72 2.56 8.86 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.311 1.044 . . . . 0.0 112.8 178.566 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 53.9 mt . . . . . 0 C--O 1.249 1.058 0 CA-C-N 119.306 0.957 . . . . 0.0 109.545 174.449 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.472 ' HG3' ' H ' ' A' ' 2' ' ' ALA 0.252 20.8 ptm . . . . . 0 N--CA 1.48 1.067 0 CA-C-O 118.778 -0.63 . . . . 0.0 112.033 . . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.472 ' H ' ' HG3' ' A' ' 1' ' ' MET . . . -158.33 -176.31 5.83 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 125.264 1.426 . . . . 0.0 109.034 -170.12 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.9 mt -75.56 145.63 10.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 167.035 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 29.5 t -139.53 163.72 25.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 C-N-CA 126.426 1.89 . . . . 0.0 107.138 -174.326 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -113.74 146.03 40.47 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 174.284 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -145.25 168.02 21.43 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 123.086 0.554 . . . . 0.0 110.077 175.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 31.7 p -132.42 178.57 6.72 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 168.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -53.29 -28.14 26.51 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.385 0.674 . . . . 0.0 112.292 174.781 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 -66.05 -29.01 69.28 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.294 1.838 . . . . 0.0 112.832 179.26 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 16.6 p -129.62 -14.61 4.1 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 -167.38 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -52.61 -47.03 67.22 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 124.453 1.101 . . . . 0.0 111.987 -172.499 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.8 m -63.84 -38.88 92.73 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 122.855 0.462 . . . . 0.0 111.787 -177.23 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -67.56 -44.79 77.4 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 177.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -64.02 -35.76 81.78 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 122.392 0.277 . . . . 0.0 111.062 -178.299 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 29.0 p -84.12 0.18 49.49 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.868 0.867 . . . . 0.0 113.251 -176.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 70.1 m -99.41 30.0 3.74 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.127 0.971 . . . . 0.0 111.758 -177.807 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -132.95 56.75 1.83 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.255 1.022 . . . . 0.0 110.543 -176.52 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 97.14 -155.36 20.66 Favored Glycine 0 C--N 1.336 0.572 0 N-CA-C 110.043 -1.223 . . . . 0.0 110.043 175.314 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 65.5 t -71.42 133.09 32.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 168.392 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 46.9 t -137.25 141.59 39.57 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 N-CA-C 105.907 -1.886 . . . . 0.0 105.907 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 3.8 tt -122.81 100.21 6.79 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 106.208 -1.775 . . . . 0.0 106.208 -175.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -82.09 146.22 29.75 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.402 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -125.63 94.2 4.06 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 126.101 1.761 . . . . 0.0 107.323 -178.118 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -73.54 113.46 10.68 Favored 'General case' 0 C--O 1.24 0.563 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 174.489 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -149.01 -177.33 5.75 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.842 1.257 . . . . 0.0 108.595 -172.891 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -156.21 148.3 17.46 Favored Pre-proline 0 CA--C 1.532 0.268 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 167.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -60.61 -18.63 55.97 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 121.796 1.664 . . . . 0.0 115.68 -179.288 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 50.6 p-90 -69.69 -20.14 63.56 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 119.987 1.267 . . . . 0.0 112.01 173.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 33.7 t -59.56 148.37 33.61 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 124.975 1.31 . . . . 0.0 111.185 -172.626 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -97.78 -63.36 0.89 Allowed Glycine 0 CA--C 1.529 0.962 0 CA-C-O 118.503 -1.165 . . . . 0.0 110.92 171.569 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -62.34 -26.57 77.1 Favored 'Trans proline' 0 C--N 1.351 0.704 0 CA-C-N 120.367 2.084 . . . . 0.0 113.73 -174.652 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 34.3 m -57.08 -35.59 69.57 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 121.653 -0.654 . . . . 0.0 111.513 174.388 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.0 mmtp -67.32 -25.54 66.07 Favored 'General case' 0 CA--C 1.53 0.208 0 O-C-N 121.63 -0.669 . . . . 0.0 110.977 -179.27 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 31.4 mtm -70.86 -44.24 66.81 Favored 'General case' 0 C--N 1.341 0.222 0 CA-C-N 118.619 0.645 . . . . 0.0 110.313 177.195 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 15.4 tt -83.32 -23.65 8.24 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 CA-C-O 118.685 -0.674 . . . . 0.0 111.831 -174.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -48.78 -51.45 53.84 Favored Pre-proline 0 CA--C 1.547 0.843 0 CA-C-N 119.941 1.246 . . . . 0.0 114.072 179.027 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -66.78 -29.22 42.65 Favored 'Trans proline' 0 C--N 1.35 0.642 0 CA-C-N 121.737 1.656 . . . . 0.0 112.24 176.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.2 t -67.91 -36.83 77.07 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 O-C-N 121.545 -0.722 . . . . 0.0 109.579 175.255 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 55.2 mt -68.15 -35.25 77.76 Favored 'General case' 0 C--O 1.226 -0.178 0 CA-C-N 119.43 1.014 . . . . 0.0 111.07 173.369 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -61.96 -42.83 99.56 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 119.196 0.907 . . . . 0.0 110.803 170.491 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -64.76 -38.71 91.9 Favored 'General case' 0 CA--C 1.532 0.277 0 O-C-N 121.092 -1.005 . . . . 0.0 110.686 176.109 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 43.5 tp -61.82 -42.92 99.63 Favored 'General case' 0 C--N 1.335 -0.032 0 C-N-CA 123.625 0.77 . . . . 0.0 109.95 175.289 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -60.23 -42.2 94.7 Favored 'General case' 0 CA--C 1.522 -0.119 0 C-N-CA 123.041 0.536 . . . . 0.0 110.728 178.116 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 -72.34 -10.92 60.4 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 112.573 0.582 . . . . 0.0 112.573 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -105.36 -32.86 8.38 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 125.353 1.461 . . . . 0.0 111.545 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 82.1 mmm -126.16 -5.7 6.67 Favored 'General case' 0 C--O 1.227 -0.127 0 CA-C-O 118.226 -0.892 . . . . 0.0 113.097 -167.587 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -57.82 -13.95 14.65 Favored Glycine 0 CA--C 1.532 1.155 0 CA-C-N 120.027 1.285 . . . . 0.0 114.873 -174.823 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -66.73 -27.32 67.52 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.508 1.123 . . . . 0.0 112.011 172.513 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.471 ' HA ' ' HE3' ' A' ' 49' ' ' LYS . 0.0 OUTLIER -120.93 -21.61 6.48 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 126.094 1.757 . . . . 0.0 111.84 179.787 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 35.9 tp -109.49 157.67 18.74 Favored 'General case' 0 C--O 1.232 0.169 0 C-N-CA 123.994 0.918 . . . . 0.0 111.428 -169.081 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -131.27 143.19 50.36 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 103.846 -2.65 . . . . 0.0 103.846 166.52 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 73.6 mt -116.01 140.38 38.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 105.517 -2.031 . . . . 0.0 105.517 176.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 81.3 t -132.53 98.36 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 -172.017 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -74.3 140.34 44.83 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 174.781 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 14.9 tt -142.63 126.91 15.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 N-CA-C 108.679 -0.859 . . . . 0.0 108.679 176.513 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 62.2 t0 -84.4 105.36 15.18 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 124.609 1.163 . . . . 0.0 109.057 -173.11 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 31.4 m -59.61 -26.14 33.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 118.664 -0.684 . . . . 0.0 112.023 -175.113 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -65.18 -18.6 65.44 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 119.407 1.003 . . . . 0.0 112.143 -176.489 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -119.87 3.71 11.03 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.916 1.287 . . . . 0.0 111.173 178.584 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -139.39 40.29 2.07 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 124.528 1.131 . . . . 0.0 109.82 -169.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 51.4 mm-40 -56.04 -33.05 64.58 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.997 0.919 . . . . 0.0 111.227 178.015 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -66.08 -46.53 77.37 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 118.509 0.595 . . . . 0.0 110.549 179.414 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.19 -39.03 78.93 Favored 'General case' 0 C--O 1.223 -0.32 0 O-C-N 121.816 -0.553 . . . . 0.0 109.721 -179.296 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -58.79 -47.95 82.96 Favored 'General case' 0 CA--C 1.534 0.346 0 O-C-N 121.062 -1.024 . . . . 0.0 110.244 172.502 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -60.38 -28.47 67.26 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 124.171 0.891 . . . . 0.0 112.421 177.046 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 48.2 tptt -56.2 -29.07 60.42 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.546 1.139 . . . . 0.0 111.491 179.322 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -123.99 10.26 8.82 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.511 0.724 . . . . 0.0 111.661 -179.45 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 63.36 30.51 77.77 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 123.693 0.663 . . . . 0.0 112.572 -176.253 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 61.5 t -61.37 122.34 11.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 173.053 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 25.8 ptp -129.9 -12.4 4.22 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 124.923 1.289 . . . . 0.0 112.748 -171.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 23.0 m -139.9 165.23 27.87 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 127.396 2.278 . . . . 0.0 108.124 178.014 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 36.7 pt -142.13 154.79 65.05 Favored Pre-proline 0 CA--C 1.545 0.772 0 C-N-CA 124.845 1.258 . . . . 0.0 108.567 177.757 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -67.94 139.87 51.34 Favored 'Cis proline' 0 C--N 1.351 0.664 0 CA-C-N 120.481 1.208 . . . . 0.0 110.414 -2.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 22.7 m -130.99 139.12 49.96 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 174.705 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 85.5 mt -119.46 126.1 50.51 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 106.819 -1.548 . . . . 0.0 106.819 -169.609 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -117.01 119.28 34.82 Favored 'General case' 0 CA--C 1.511 -0.535 0 N-CA-C 103.755 -2.683 . . . . 0.0 103.755 177.59 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.4 t -92.34 124.29 44.75 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 N-CA-C 103.582 -2.747 . . . . 0.0 103.582 173.43 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.3 mp -115.03 155.12 27.58 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 174.098 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -136.73 123.75 21.53 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 171.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 27.9 t70 49.45 38.03 13.37 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.008 1.323 . . . . 0.0 112.456 177.195 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 101.64 -2.72 53.05 Favored Glycine 0 CA--C 1.528 0.865 0 CA-C-O 118.108 -1.384 . . . . 0.0 115.395 168.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -131.47 151.74 51.3 Favored 'General case' 0 CA--C 1.528 0.109 0 CA-C-N 120.063 1.931 . . . . 0.0 110.185 -178.706 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 38.8 t -62.85 133.32 28.7 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.9 p -120.61 -20.28 4.57 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 C-N-CA 125.324 1.45 . . . . 0.0 109.872 177.735 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -161.02 168.73 23.91 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 120.315 1.416 . . . . 0.0 110.47 171.672 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 10.5 m -140.46 151.03 44.54 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.078 1.351 . . . . 0.0 108.741 175.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 58.7 m -150.45 157.21 42.77 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.283 1.433 . . . . 0.0 108.835 169.429 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 43.7 t -133.89 144.56 35.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 -178.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 79.24 -175.07 55.21 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 123.434 0.54 . . . . 0.0 112.153 178.481 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -63.58 148.77 47.97 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.742 0.817 . . . . 0.0 111.031 -179.258 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 45.6 mttm -144.14 135.54 12.68 Favored Pre-proline 0 C--O 1.233 0.234 0 N-CA-C 106.406 -1.702 . . . . 0.0 106.406 168.617 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -70.0 162.37 42.46 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 122.154 1.903 . . . . 0.0 110.266 173.155 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 18.2 ptmt -55.98 -31.02 62.63 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.424 1.09 . . . . 0.0 113.533 -179.599 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -67.43 -49.69 62.62 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 118.528 0.604 . . . . 0.0 109.767 176.176 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.04 -39.38 94.56 Favored 'General case' 0 C--N 1.34 0.173 0 C-N-CA 122.896 0.478 . . . . 0.0 110.72 179.338 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 86.2 mt -62.95 -45.39 92.69 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.111 0.564 . . . . 0.0 111.166 176.399 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -61.07 -41.14 96.08 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-O 118.944 -0.551 . . . . 0.0 110.353 176.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -63.72 -41.62 98.04 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 118.427 0.558 . . . . 0.0 110.275 179.174 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 67.8 tp -61.73 -41.49 97.71 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 124.729 1.212 . . . . 0.0 110.98 177.707 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 75.1 t -62.39 -47.72 91.7 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 CA-C-N 118.757 0.708 . . . . 0.0 109.365 171.77 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 -61.76 -26.53 68.14 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 125.504 1.522 . . . . 0.0 112.291 -171.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -53.83 -26.87 26.42 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 123.604 0.761 . . . . 0.0 112.416 172.604 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 72.8 m-70 -123.49 -6.09 8.16 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 113.852 1.056 . . . . 0.0 113.852 -167.805 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 79.9 mt . . . . . 0 C--O 1.249 1.062 0 CA-C-N 118.814 0.733 . . . . 0.0 109.286 171.851 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.7 tpt . . . . . 0 N--CA 1.479 1.007 0 CA-C-O 118.949 -0.548 . . . . 0.0 110.248 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -163.87 -174.46 3.64 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.541 1.537 . . . . 0.0 108.205 -172.581 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.2 mt -75.3 142.62 14.31 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 N-CA-C 106.225 -1.769 . . . . 0.0 106.225 166.302 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 43.4 t -134.2 163.07 38.01 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 C-N-CA 126.89 2.076 . . . . 0.0 106.0 -178.013 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 1.4 tmtt? -129.01 131.54 47.41 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 104.247 -2.501 . . . . 0.0 104.247 179.555 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -142.6 173.46 11.51 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 123.732 0.813 . . . . 0.0 110.973 -169.247 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 23.6 p -136.91 174.01 11.08 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 125.066 1.347 . . . . 0.0 107.573 169.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -51.13 -27.97 9.79 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.726 1.21 . . . . 0.0 112.976 176.442 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -57.99 -30.59 66.18 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.103 1.761 . . . . 0.0 112.767 178.409 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.0 m -139.55 -7.4 1.3 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.837 0.855 . . . . 0.0 113.277 -169.494 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 69.2 t80 -51.45 -44.0 62.25 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.409 1.084 . . . . 0.0 111.925 -177.19 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.7 m -63.58 -38.39 90.96 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 122.991 0.516 . . . . 0.0 111.804 -178.379 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -68.32 -44.82 74.54 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 176.462 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 67.7 mm-40 -62.43 -36.83 83.62 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 122.67 0.388 . . . . 0.0 111.124 -178.24 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.7 p -83.13 0.7 43.98 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.072 0.949 . . . . 0.0 113.46 -177.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 68.0 m -105.15 33.33 3.71 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.206 1.002 . . . . 0.0 111.125 -176.61 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -132.8 60.25 1.71 Allowed 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.253 1.021 . . . . 0.0 109.966 -178.243 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 92.11 -153.71 22.0 Favored Glycine 0 C--N 1.337 0.633 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 177.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 82.9 t -74.06 137.01 24.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 168.702 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 48.1 t -139.21 145.96 26.54 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 N-CA-C 105.952 -1.87 . . . . 0.0 105.952 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.3 tt -125.01 99.09 5.97 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 106.448 -1.686 . . . . 0.0 106.448 -176.09 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -79.51 144.63 33.78 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 123.572 0.749 . . . . 0.0 109.17 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -126.92 94.35 4.01 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 126.045 1.738 . . . . 0.0 107.643 -176.316 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -74.49 113.46 11.76 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 173.452 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -147.22 -171.47 3.79 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.128 1.371 . . . . 0.0 108.225 -175.449 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -161.32 148.0 11.52 Favored Pre-proline 0 CA--C 1.533 0.306 0 N-CA-C 105.996 -1.853 . . . . 0.0 105.996 166.671 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -60.58 -18.07 52.47 Favored 'Trans proline' 0 CA--C 1.534 0.477 0 C-N-CA 121.776 1.651 . . . . 0.0 115.745 -178.673 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 50.7 p-90 -69.76 -20.57 63.49 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 120.029 1.286 . . . . 0.0 111.998 173.673 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 26.9 t -59.89 148.74 33.8 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 124.902 1.281 . . . . 0.0 111.096 -172.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -100.6 -63.97 0.79 Allowed Glycine 0 CA--C 1.529 0.938 0 CA-C-O 118.501 -1.166 . . . . 0.0 110.492 172.561 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_exo -53.77 -32.4 65.9 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 123.244 2.629 . . . . 0.0 114.495 -179.346 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 35.9 m -57.55 -34.82 69.57 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.326 0.651 . . . . 0.0 111.635 176.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.5 mmtp -67.93 -25.49 65.5 Favored 'General case' 0 CA--C 1.531 0.248 0 O-C-N 121.589 -0.694 . . . . 0.0 110.836 -179.575 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 30.0 mtm -71.25 -42.46 68.79 Favored 'General case' 0 C--N 1.341 0.213 0 CA-C-N 118.67 0.668 . . . . 0.0 110.444 176.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 17.1 tt -84.07 -22.48 8.11 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-O 118.807 -0.616 . . . . 0.0 111.53 -175.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -48.99 -51.21 57.58 Favored Pre-proline 0 CA--C 1.547 0.862 0 CA-C-N 120.028 1.285 . . . . 0.0 113.971 178.221 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -67.07 -28.37 41.33 Favored 'Trans proline' 0 C--N 1.35 0.614 0 CA-C-N 121.724 1.652 . . . . 0.0 112.303 176.641 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 13.0 t -66.45 -39.3 83.69 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 174.269 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 87.4 mt -67.06 -34.7 78.25 Favored 'General case' 0 C--N 1.34 0.165 0 CA-C-N 119.22 0.918 . . . . 0.0 111.323 173.652 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -62.5 -44.36 96.56 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 119.571 1.078 . . . . 0.0 110.746 171.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -64.42 -38.31 90.6 Favored 'General case' 0 CA--C 1.532 0.271 0 O-C-N 121.233 -0.917 . . . . 0.0 110.7 176.69 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 61.5 tp -63.22 -44.26 95.79 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.619 0.768 . . . . 0.0 110.015 176.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -59.31 -41.73 89.73 Favored 'General case' 0 CA--C 1.521 -0.153 0 C-N-CA 123.41 0.684 . . . . 0.0 111.009 177.378 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -72.06 -10.38 59.7 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.075 0.55 . . . . 0.0 112.464 -179.422 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 -104.77 -33.43 8.44 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 125.208 1.403 . . . . 0.0 111.662 179.176 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 74.8 mmm -121.29 -4.44 9.43 Favored 'General case' 0 C--O 1.224 -0.242 0 CA-C-O 118.18 -0.914 . . . . 0.0 112.658 -168.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -58.22 -14.09 17.58 Favored Glycine 0 CA--C 1.531 1.075 0 CA-C-N 120.07 1.305 . . . . 0.0 115.23 -173.237 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -70.14 -25.14 63.33 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 118.533 1.167 . . . . 0.0 111.775 172.626 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.428 ' HA ' ' HE2' ' A' ' 49' ' ' LYS . 9.7 mmpt? -123.67 -17.43 6.41 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 126.519 1.928 . . . . 0.0 111.628 -175.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 28.0 tp -118.94 159.39 23.9 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 124.718 1.207 . . . . 0.0 111.021 -169.451 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 37.2 ttmt -134.82 145.2 48.12 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 104.108 -2.552 . . . . 0.0 104.108 167.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 62.3 mt -115.81 141.11 34.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 175.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 69.1 t -132.83 96.81 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 -172.257 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -75.96 131.91 39.88 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 177.498 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 15.9 tt -140.34 135.49 36.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -97.78 115.57 28.28 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 123.875 0.87 . . . . 0.0 111.049 -168.045 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 35.7 m -60.96 -19.62 20.15 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 O-C-N 121.582 -0.699 . . . . 0.0 112.321 -178.019 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -63.39 -21.75 66.47 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.757 1.223 . . . . 0.0 113.004 179.092 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -131.79 1.76 4.01 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.655 0.782 . . . . 0.0 112.625 178.467 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 63.4 m-80 -129.88 39.41 3.7 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.683 0.793 . . . . 0.0 110.896 -170.333 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.2 mp0 -54.97 -31.88 61.11 Favored 'General case' 0 C--N 1.34 0.178 0 C-N-CA 123.707 0.803 . . . . 0.0 111.896 176.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 27.4 tp10 -67.31 -47.08 71.63 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 123.979 0.912 . . . . 0.0 110.556 -178.299 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.72 -39.46 76.84 Favored 'General case' 0 CA--C 1.535 0.395 0 O-C-N 121.728 -0.607 . . . . 0.0 109.561 179.316 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.29 -47.45 85.34 Favored 'General case' 0 CA--C 1.533 0.312 0 O-C-N 121.423 -0.798 . . . . 0.0 110.56 174.02 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -62.66 -27.11 69.3 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 124.055 0.836 . . . . 0.0 111.876 178.448 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 5.8 tppt? -55.67 -28.44 55.54 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.568 1.147 . . . . 0.0 111.877 177.641 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -124.22 11.39 8.78 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.81 0.844 . . . . 0.0 111.572 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 63.77 30.48 77.79 Favored Glycine 0 CA--C 1.532 1.094 0 C-N-CA 123.72 0.676 . . . . 0.0 112.761 -177.458 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 60.9 t -65.86 125.66 23.45 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 172.28 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 66.8 mtt -136.75 3.98 2.77 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.821 1.249 . . . . 0.0 111.448 -179.275 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 23.4 m -144.05 162.62 35.75 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 126.676 1.991 . . . . 0.0 107.768 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 44.2 pt -141.72 155.48 66.44 Favored Pre-proline 0 CA--C 1.545 0.78 0 C-N-CA 124.445 1.098 . . . . 0.0 108.796 175.819 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -67.38 139.62 48.1 Favored 'Cis proline' 0 C--N 1.35 0.607 0 CA-C-N 120.209 1.11 . . . . 0.0 110.209 -5.796 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 50.9 m -132.65 140.69 48.29 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 174.721 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 87.8 mt -123.62 129.18 50.76 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 -169.564 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -120.94 122.9 41.18 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 103.431 -2.803 . . . . 0.0 103.431 177.471 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 1.8 t -100.22 120.17 49.3 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 N-CA-C 103.899 -2.63 . . . . 0.0 103.899 176.218 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.3 mp -112.03 155.16 24.24 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 -178.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 57.8 tttp -134.59 115.59 14.04 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 105.785 -1.932 . . . . 0.0 105.785 177.412 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.0 t70 49.87 39.17 17.72 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.893 1.277 . . . . 0.0 112.374 176.784 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 104.79 -5.62 43.39 Favored Glycine 0 CA--C 1.529 0.955 0 CA-C-O 118.139 -1.367 . . . . 0.0 115.295 169.041 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -131.29 149.27 52.63 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 120.054 1.927 . . . . 0.0 110.527 -177.697 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 39.2 t -63.59 134.49 28.57 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 -179.326 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 8.7 p -118.94 -26.41 2.51 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 C-N-CA 125.065 1.346 . . . . 0.0 110.504 172.488 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -149.9 165.28 33.06 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 120.689 1.586 . . . . 0.0 110.046 173.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 17.2 m -140.86 151.18 44.1 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.442 1.497 . . . . 0.0 108.025 178.116 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 37.3 m -151.25 157.06 42.1 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.415 1.486 . . . . 0.0 109.265 169.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 30.6 t -135.62 145.65 31.14 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 -176.456 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 75.81 -176.75 50.65 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 123.896 0.76 . . . . 0.0 111.893 178.754 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 47.4 t80 -62.06 137.58 58.27 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 173.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 64.6 tttt -149.94 137.68 11.76 Favored Pre-proline 0 C--O 1.235 0.316 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 -178.602 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -70.7 153.73 64.45 Favored 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 121.628 1.552 . . . . 0.0 111.959 -172.635 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 29.2 ttpp -52.18 -45.39 65.11 Favored 'General case' 0 CA--C 1.518 -0.256 0 C-N-CA 125.805 1.642 . . . . 0.0 112.313 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -62.92 -43.31 99.14 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 -176.098 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.98 -43.1 96.73 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 122.421 0.288 . . . . 0.0 110.499 179.297 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 76.8 mt -62.32 -44.08 97.32 Favored 'General case' 0 C--O 1.231 0.095 0 CA-C-N 117.535 0.152 . . . . 0.0 110.911 178.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -74.24 -29.27 61.62 Favored 'General case' 0 N--CA 1.451 -0.42 0 O-C-N 122.178 -0.326 . . . . 0.0 110.892 -175.544 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 31.9 tp10 -70.23 -37.72 75.07 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 124.566 1.146 . . . . 0.0 110.543 173.651 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 53.6 mt -60.86 -50.32 73.89 Favored 'General case' 0 C--O 1.224 -0.246 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 172.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 33.0 t -52.22 -46.33 44.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 122.853 0.461 . . . . 0.0 109.949 173.329 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -62.77 -38.43 90.56 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 123.974 0.909 . . . . 0.0 112.258 -171.564 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 16.9 ptmt -67.13 -18.25 65.22 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 118.125 -0.94 . . . . 0.0 112.644 -175.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 5.1 p-80 -127.13 -8.41 5.93 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 115.002 1.482 . . . . 0.0 115.002 -174.249 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 10.2 mt . . . . . 0 C--O 1.248 0.997 0 CA-C-O 118.029 -0.986 . . . . 0.0 109.368 167.433 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.6 ttm . . . . . 0 N--CA 1.483 1.212 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -157.23 -163.62 1.42 Allowed 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.311 1.444 . . . . 0.0 108.828 -172.321 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.8 mt -72.82 145.58 11.75 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 166.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 14.7 t -138.53 162.12 29.91 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 126.395 1.878 . . . . 0.0 106.805 -175.608 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -116.5 144.05 44.82 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 106.03 -1.841 . . . . 0.0 106.03 172.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -144.36 157.66 44.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.385 0.612 . . . . 0.0 111.566 -176.279 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 16.1 p -105.3 171.07 7.52 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 126.292 1.837 . . . . 0.0 107.646 168.309 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -47.26 -43.85 22.44 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 124.72 1.208 . . . . 0.0 113.112 176.181 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 66.9 mm-40 -79.93 -35.04 38.35 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 122.654 0.382 . . . . 0.0 111.533 -175.771 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.2 m -71.81 -32.38 67.53 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 122.772 0.429 . . . . 0.0 111.315 176.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -52.72 -46.74 67.53 Favored 'General case' 0 N--CA 1.457 -0.116 0 C-N-CA 125.128 1.371 . . . . 0.0 112.245 -169.737 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 9.5 m -63.75 -38.4 90.98 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 118.105 0.412 . . . . 0.0 111.86 -176.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -68.81 -44.31 73.81 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 176.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 69.0 mm-40 -63.94 -37.21 86.56 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 122.451 0.3 . . . . 0.0 110.925 -178.015 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.423 ' HA ' HG21 ' A' ' 20' ' ' VAL . 28.8 p -80.52 0.1 35.2 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.992 0.917 . . . . 0.0 113.332 -177.552 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 70.8 m -98.13 28.76 3.84 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.097 0.959 . . . . 0.0 112.16 -177.685 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -136.73 81.06 1.85 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.209 1.004 . . . . 0.0 110.023 -178.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 82.64 -156.66 35.17 Favored Glycine 0 C--N 1.338 0.65 0 N-CA-C 110.722 -0.951 . . . . 0.0 110.722 173.477 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 44.9 t -74.17 135.4 27.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 N-CA-C 106.034 -1.839 . . . . 0.0 106.034 168.338 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.423 HG21 ' HA ' ' A' ' 15' ' ' THR . 40.2 t -135.57 136.85 50.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 179.158 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.2 tt -120.01 111.36 17.8 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 106.198 -1.778 . . . . 0.0 106.198 -179.586 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -94.31 144.92 25.12 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 123.854 0.862 . . . . 0.0 109.104 -175.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -124.16 93.73 4.0 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 125.56 1.544 . . . . 0.0 107.469 -176.115 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -73.77 113.44 10.91 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 105.815 -1.92 . . . . 0.0 105.815 174.095 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -150.41 -176.57 5.53 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.727 1.211 . . . . 0.0 108.227 -171.156 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -152.13 149.15 22.58 Favored Pre-proline 0 C--N 1.331 -0.215 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 167.069 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -67.95 -12.65 35.95 Favored 'Trans proline' 0 N--CA 1.459 -0.543 0 CA-C-N 121.179 1.457 . . . . 0.0 113.071 -179.653 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 1.5 m95 -76.27 -12.84 60.15 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.665 0.786 . . . . 0.0 111.876 172.601 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 29.7 t -64.07 153.62 36.92 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.317 1.447 . . . . 0.0 111.089 -176.65 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.403 ' H ' ' HD2' ' A' ' 31' ' ' PRO . . . -101.51 -62.98 0.76 Allowed Glycine 0 CA--C 1.532 1.137 0 C-N-CA 124.723 1.154 . . . . 0.0 111.268 170.319 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.403 ' HD2' ' H ' ' A' ' 30' ' ' GLY . 25.3 Cg_endo -64.88 -25.96 59.72 Favored 'Trans proline' 0 C--N 1.35 0.611 0 CA-C-N 120.472 2.136 . . . . 0.0 113.266 -173.72 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 25.7 m -57.59 -34.43 69.23 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 121.537 -0.727 . . . . 0.0 111.433 174.05 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.4 mmtp -67.7 -22.79 65.25 Favored 'General case' 0 CA--C 1.531 0.22 0 O-C-N 121.663 -0.648 . . . . 0.0 111.199 -179.575 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 34.0 mtm -71.15 -43.64 67.12 Favored 'General case' 0 C--N 1.34 0.179 0 CA-C-N 118.723 0.692 . . . . 0.0 110.359 176.387 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 13.4 tt -84.21 -23.32 7.78 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-O 118.817 -0.611 . . . . 0.0 111.691 -175.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -48.4 -51.17 53.19 Favored Pre-proline 0 CA--C 1.548 0.889 0 CA-C-N 119.959 1.254 . . . . 0.0 114.27 178.6 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -66.59 -29.36 44.08 Favored 'Trans proline' 0 C--N 1.351 0.685 0 CA-C-N 121.628 1.617 . . . . 0.0 112.108 176.696 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 5.1 t -68.06 -36.59 76.01 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 O-C-N 121.585 -0.697 . . . . 0.0 109.751 175.274 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 74.1 mt -67.21 -36.05 80.9 Favored 'General case' 0 C--N 1.34 0.166 0 CA-C-N 119.518 1.053 . . . . 0.0 111.153 172.525 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -62.1 -42.66 99.45 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 119.227 0.921 . . . . 0.0 110.808 171.07 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -63.91 -39.44 94.19 Favored 'General case' 0 CA--C 1.533 0.298 0 O-C-N 121.078 -1.014 . . . . 0.0 110.381 175.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 36.9 tp -62.81 -42.36 99.68 Favored 'General case' 0 CA--C 1.527 0.088 0 C-N-CA 123.754 0.822 . . . . 0.0 110.237 176.651 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -59.09 -43.15 91.83 Favored 'General case' 0 CA--C 1.522 -0.13 0 C-N-CA 123.363 0.665 . . . . 0.0 110.657 176.454 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -71.44 -10.67 60.14 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.327 0.651 . . . . 0.0 112.645 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 23.9 mm-40 -106.63 -28.41 10.24 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 125.419 1.487 . . . . 0.0 111.759 -178.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 23.1 mtp -131.73 -1.7 3.79 Favored 'General case' 0 N--CA 1.461 0.118 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 -169.126 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -54.69 -15.6 6.39 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 124.777 1.179 . . . . 0.0 115.616 -174.18 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -69.7 -28.91 66.24 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.842 1.257 . . . . 0.0 112.016 175.044 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 41.7 mmtm -123.88 -16.06 6.73 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 125.757 1.623 . . . . 0.0 112.39 -177.125 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 58.5 tp -119.28 139.04 52.56 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 123.982 0.913 . . . . 0.0 110.289 -170.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -111.69 145.67 38.87 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 105.009 -2.219 . . . . 0.0 105.009 168.074 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 90.4 mt -116.99 138.93 46.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 105.747 -1.946 . . . . 0.0 105.747 174.763 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 98.3 t -132.75 98.87 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 -171.709 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 54.2 mtpt -74.28 140.25 44.82 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 174.518 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 14.3 tt -142.71 128.05 16.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 177.305 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 64.6 t0 -87.57 107.22 18.49 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 124.4 1.08 . . . . 0.0 109.323 -169.787 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 29.0 m -61.69 -20.81 24.15 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 CA-C-O 118.737 -0.649 . . . . 0.0 112.143 -177.447 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -69.04 -14.06 62.81 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 119.691 1.132 . . . . 0.0 112.112 178.365 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -127.06 0.52 6.52 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.1 0.96 . . . . 0.0 111.997 178.501 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 67.8 m-80 -138.39 41.92 2.21 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.735 0.814 . . . . 0.0 111.104 -169.247 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 5.4 mp0 -54.62 -31.66 57.57 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.376 0.67 . . . . 0.0 112.104 176.118 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 -64.72 -46.69 81.23 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 118.471 0.578 . . . . 0.0 110.411 -178.578 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.6 -38.49 73.99 Favored 'General case' 0 C--O 1.223 -0.303 0 C-N-CA 123.162 0.585 . . . . 0.0 109.503 -178.915 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -58.09 -47.9 81.8 Favored 'General case' 0 CA--C 1.535 0.376 0 O-C-N 121.28 -0.888 . . . . 0.0 110.236 172.681 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -61.34 -29.02 70.33 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 124.117 0.865 . . . . 0.0 112.265 177.717 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 74.3 tttt -55.7 -28.73 57.26 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.774 1.23 . . . . 0.0 111.873 178.432 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -123.2 9.94 9.28 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.69 0.796 . . . . 0.0 111.956 178.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 63.57 31.71 81.71 Favored Glycine 0 CA--C 1.533 1.218 0 CA-C-O 119.459 -0.634 . . . . 0.0 112.578 -176.764 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 61.3 t -64.19 124.59 19.26 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 172.725 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 78.2 mtm -137.06 3.53 2.66 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.924 1.29 . . . . 0.0 111.522 -178.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 39.1 m -141.48 163.87 31.76 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 126.767 2.027 . . . . 0.0 107.532 175.616 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 41.1 pt -142.99 155.12 62.49 Favored Pre-proline 0 CA--C 1.546 0.806 0 C-N-CA 124.596 1.158 . . . . 0.0 108.626 174.723 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -67.62 137.68 39.15 Favored 'Cis proline' 0 C--N 1.349 0.587 0 CA-C-N 120.5 1.214 . . . . 0.0 110.204 -4.415 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 35.9 m -129.96 134.17 47.28 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 106.97 -1.493 . . . . 0.0 106.97 175.647 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 10.9 mp -114.47 126.54 55.07 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 -169.238 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -114.73 147.72 39.3 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 104.583 -2.377 . . . . 0.0 104.583 175.493 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.4 t -126.79 128.79 71.24 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.624 0 N-CA-C 104.706 -2.331 . . . . 0.0 104.706 -177.681 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.4 mp -130.22 147.89 52.0 Favored 'General case' 0 N--CA 1.445 -0.725 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 -172.518 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 21.4 tptm -133.74 118.32 17.95 Favored 'General case' 0 CA--C 1.514 -0.439 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 29.2 t70 51.15 33.89 10.17 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.486 1.515 . . . . 0.0 112.55 174.068 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 110.72 -3.48 29.07 Favored Glycine 0 CA--C 1.527 0.806 0 CA-C-O 118.062 -1.41 . . . . 0.0 114.869 169.063 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -130.2 144.78 51.56 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 120.027 1.914 . . . . 0.0 110.164 -177.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 13.6 p -65.55 133.23 30.94 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 176.339 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 8.0 p -126.28 -19.02 2.78 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-O 117.653 -1.165 . . . . 0.0 111.239 -179.416 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -156.48 169.96 23.42 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 121.116 1.78 . . . . 0.0 111.529 177.538 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 15.6 m -147.11 151.73 37.31 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.454 1.501 . . . . 0.0 108.907 178.211 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 65.1 m -152.25 157.39 41.35 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 126.18 1.792 . . . . 0.0 108.321 171.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 28.7 t -134.06 142.76 40.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 -176.44 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.56 -176.81 53.56 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 123.58 0.61 . . . . 0.0 112.44 177.445 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 66.1 t80 -63.17 150.4 42.98 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.39 1.076 . . . . 0.0 110.939 178.3 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -146.97 146.14 24.91 Favored Pre-proline 0 N--CA 1.467 0.384 0 C-N-CA 125.355 1.462 . . . . 0.0 107.4 168.034 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -71.24 157.66 56.62 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 122.444 2.096 . . . . 0.0 110.219 170.567 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 48.5 pttt -58.48 -30.29 66.87 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -178.373 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -67.18 -45.12 77.92 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 118.508 0.594 . . . . 0.0 109.946 178.092 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.47 -38.12 89.93 Favored 'General case' 0 CA--C 1.529 0.165 0 O-C-N 121.845 -0.534 . . . . 0.0 110.57 176.33 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 95.0 mt -64.34 -42.74 96.12 Favored 'General case' 0 C--O 1.226 -0.146 0 CA-C-O 119.26 -0.4 . . . . 0.0 111.327 176.562 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 15.8 mt-30 -58.11 -42.16 85.13 Favored 'General case' 0 C--O 1.226 -0.139 0 CA-C-N 118.584 0.629 . . . . 0.0 109.971 174.343 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -65.08 -40.09 94.15 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 118.115 0.416 . . . . 0.0 110.579 -179.414 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 68.9 tp -61.97 -43.74 98.21 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.44 1.096 . . . . 0.0 110.712 176.478 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 93.3 t -62.56 -43.44 98.43 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 123.585 0.754 . . . . 0.0 109.743 174.347 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -60.28 -27.67 67.47 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 125.101 1.36 . . . . 0.0 112.055 -172.646 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -56.07 -24.07 37.65 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.549 0.74 . . . . 0.0 112.668 174.488 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 47.4 m-70 -125.37 -3.42 7.39 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 -168.202 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 84.2 mt . . . . . 0 C--O 1.25 1.083 0 CA-C-N 118.785 0.721 . . . . 0.0 109.184 172.65 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.199 0 CA-C-O 118.391 -0.814 . . . . 0.0 113.017 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -152.07 177.98 9.94 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 119.888 1.222 . . . . 0.0 109.952 -172.287 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.5 mt -75.64 147.46 8.09 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 167.278 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 18.2 t -138.36 161.97 30.62 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 C-N-CA 126.157 1.783 . . . . 0.0 106.887 -175.524 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 3.7 tppp? -116.33 142.04 47.37 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 106.001 -1.852 . . . . 0.0 106.001 172.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -146.36 166.33 26.66 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.399 0.619 . . . . 0.0 111.053 -177.55 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.442 HG22 HD21 ' A' ' 60' ' ' ASN . 28.5 p -135.47 174.36 10.7 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 126.444 1.897 . . . . 0.0 107.578 170.821 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -48.53 -29.78 4.57 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.851 1.26 . . . . 0.0 113.149 173.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -59.35 -29.84 67.95 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.071 1.348 . . . . 0.0 113.052 178.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 14.4 m -141.22 -7.1 1.04 Allowed 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 -169.355 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 77.8 t80 -53.75 -43.64 69.31 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 124.009 0.923 . . . . 0.0 111.772 -174.569 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.7 m -63.35 -38.91 92.98 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.086 0.554 . . . . 0.0 111.762 -179.24 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -68.13 -44.26 76.48 Favored 'General case' 0 N--CA 1.453 -0.313 0 O-C-N 122.05 -0.406 . . . . 0.0 109.954 177.514 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 67.3 mm-40 -63.11 -36.47 83.7 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 122.367 0.267 . . . . 0.0 110.985 -178.677 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 25.6 p -82.93 1.21 40.75 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.049 0.939 . . . . 0.0 113.367 -177.561 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 67.4 m -101.63 31.01 3.98 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.204 1.002 . . . . 0.0 111.746 -176.677 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -132.66 62.09 1.66 Allowed 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.198 0.999 . . . . 0.0 110.206 -178.234 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 91.54 -156.24 23.86 Favored Glycine 0 C--N 1.339 0.715 0 N-CA-C 109.899 -1.281 . . . . 0.0 109.899 176.279 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 94.4 t -70.81 135.32 28.32 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 168.377 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 55.7 t -137.51 142.95 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 N-CA-C 105.742 -1.947 . . . . 0.0 105.742 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.2 tt -122.94 100.87 7.11 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 -176.683 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -83.29 146.03 28.76 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.376 -179.162 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -124.46 94.08 4.1 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 125.906 1.682 . . . . 0.0 107.356 -177.359 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -73.91 112.79 10.37 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 105.891 -1.892 . . . . 0.0 105.891 175.157 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -148.56 -178.91 6.59 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.95 1.3 . . . . 0.0 108.475 -172.704 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -158.34 147.76 14.91 Favored Pre-proline 0 CA--C 1.531 0.245 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 167.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -62.87 -12.0 27.06 Favored 'Trans proline' 0 CA--C 1.535 0.573 0 CA-C-N 121.53 1.582 . . . . 0.0 116.086 -178.762 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 54.2 p-90 -70.72 -19.33 62.76 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 120.731 1.605 . . . . 0.0 111.784 171.036 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 15.3 t -61.2 162.58 7.3 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.41 1.484 . . . . 0.0 111.187 -177.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -119.94 -59.19 0.25 Allowed Glycine 0 CA--C 1.531 1.049 0 CA-C-O 118.513 -1.159 . . . . 0.0 110.694 171.773 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -54.13 -31.46 65.41 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 123.832 3.021 . . . . 0.0 114.118 179.126 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 79.8 m -52.37 -37.0 55.14 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.694 1.198 . . . . 0.0 111.915 174.168 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 75.2 mttt -83.06 -14.69 53.32 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.381 0.672 . . . . 0.0 110.861 -175.107 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 26.8 mtm -73.1 -43.71 61.39 Favored 'General case' 0 C--N 1.341 0.197 0 CA-C-N 118.886 0.767 . . . . 0.0 109.541 169.438 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 16.3 tt -80.37 -23.95 11.4 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-O 118.609 -0.71 . . . . 0.0 111.431 -178.33 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -48.39 -51.16 53.11 Favored Pre-proline 0 CA--C 1.548 0.881 0 CA-C-N 120.359 1.436 . . . . 0.0 114.315 179.028 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -66.9 -25.76 44.81 Favored 'Trans proline' 0 C--N 1.349 0.59 0 CA-C-N 121.958 1.735 . . . . 0.0 112.597 176.263 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.5 t -71.4 -35.77 58.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 O-C-N 121.454 -0.779 . . . . 0.0 109.589 174.304 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 95.7 mt -66.78 -35.26 79.67 Favored 'General case' 0 C--N 1.341 0.202 0 CA-C-N 119.515 1.052 . . . . 0.0 111.233 170.388 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -63.09 -42.13 99.55 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 119.566 1.075 . . . . 0.0 110.83 171.808 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -60.73 -44.86 96.11 Favored 'General case' 0 CA--C 1.53 0.174 0 O-C-N 121.505 -0.747 . . . . 0.0 110.021 173.78 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 34.0 tp -60.7 -41.85 96.02 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.668 0.787 . . . . 0.0 110.355 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -60.97 -43.5 98.7 Favored 'General case' 0 CA--C 1.521 -0.172 0 C-N-CA 123.264 0.626 . . . . 0.0 110.82 177.092 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -72.41 -10.71 60.13 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.276 0.63 . . . . 0.0 112.502 179.747 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -104.44 -28.57 11.25 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 125.31 1.444 . . . . 0.0 111.367 -178.655 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 25.4 mtp -133.69 -2.66 2.98 Favored 'General case' 0 C--N 1.339 0.146 0 N-CA-C 113.966 1.099 . . . . 0.0 113.966 -169.117 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -55.05 -17.2 9.44 Favored Glycine 0 CA--C 1.534 1.259 0 CA-C-N 120.148 1.34 . . . . 0.0 115.234 -173.046 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -67.14 -30.7 70.75 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.727 1.211 . . . . 0.0 111.934 174.093 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 40.3 mmtm -117.21 -17.41 10.22 Favored 'General case' 0 N--CA 1.462 0.149 0 C-N-CA 125.989 1.716 . . . . 0.0 111.938 -178.607 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 46.8 tp -116.75 154.66 30.27 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.2 1.0 . . . . 0.0 110.599 -169.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -130.12 144.56 51.42 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 104.11 -2.552 . . . . 0.0 104.11 167.196 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 75.8 mt -117.7 138.27 48.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 105.266 -2.124 . . . . 0.0 105.266 177.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 96.9 t -133.09 98.2 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 -169.699 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 52.6 mtpt -74.11 139.57 44.67 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 175.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 13.5 tt -141.76 127.16 18.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 176.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -85.27 103.73 14.48 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.615 1.166 . . . . 0.0 108.901 -171.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 29.7 m -59.85 -25.63 33.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 118.614 -0.708 . . . . 0.0 112.003 -174.504 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -65.41 -17.82 64.83 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 119.494 1.043 . . . . 0.0 112.055 -178.087 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -120.65 5.31 10.56 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.103 1.361 . . . . 0.0 111.037 178.384 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.442 HD21 HG22 ' A' ' 7' ' ' THR . 66.5 m-80 -141.39 40.28 1.74 Allowed 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.588 1.155 . . . . 0.0 109.665 -171.016 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 51.2 mm-40 -55.2 -31.29 61.31 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.854 0.861 . . . . 0.0 110.893 175.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -65.91 -50.42 64.5 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 124.056 0.943 . . . . 0.0 109.941 179.676 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.9 -38.8 83.42 Favored 'General case' 0 C--O 1.223 -0.299 0 C-N-CA 123.37 0.668 . . . . 0.0 109.643 -178.78 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -58.99 -48.03 83.05 Favored 'General case' 0 CA--C 1.533 0.299 0 O-C-N 121.061 -1.024 . . . . 0.0 110.305 172.489 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -60.95 -28.77 69.2 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 123.901 0.762 . . . . 0.0 112.331 177.499 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 47.8 tptt -56.33 -29.2 60.99 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.723 1.209 . . . . 0.0 111.471 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -124.16 10.91 8.77 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.507 0.723 . . . . 0.0 111.679 -179.385 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 63.75 31.16 79.85 Favored Glycine 0 CA--C 1.532 1.14 0 C-N-CA 123.643 0.639 . . . . 0.0 112.584 -176.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 49.3 t -65.7 123.78 19.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 171.771 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 67.1 mtt -136.07 3.64 2.92 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.693 1.197 . . . . 0.0 111.463 -178.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 25.6 m -143.93 161.53 38.46 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 126.849 2.06 . . . . 0.0 107.302 178.128 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 39.0 pt -143.25 156.11 61.23 Favored Pre-proline 0 CA--C 1.545 0.761 0 C-N-CA 124.636 1.175 . . . . 0.0 108.76 177.389 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -67.15 139.1 44.69 Favored 'Cis proline' 0 C--N 1.35 0.629 0 CA-C-N 120.347 1.16 . . . . 0.0 110.168 -4.745 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 26.6 m -130.14 140.76 50.74 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 174.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 89.8 mt -120.08 125.0 47.2 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 106.546 -1.65 . . . . 0.0 106.546 -169.458 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -114.86 119.83 37.93 Favored 'General case' 0 CA--C 1.512 -0.509 0 N-CA-C 103.663 -2.717 . . . . 0.0 103.663 177.064 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.8 t -90.58 123.18 42.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 103.217 -2.883 . . . . 0.0 103.217 172.249 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.1 mp -114.66 155.84 25.85 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 173.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -137.91 122.75 18.84 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 173.478 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.0 t70 49.55 37.33 12.15 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.034 1.334 . . . . 0.0 112.471 176.399 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 103.91 -4.27 45.66 Favored Glycine 0 CA--C 1.529 0.918 0 CA-C-O 118.217 -1.324 . . . . 0.0 115.202 168.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -131.85 152.81 50.76 Favored 'General case' 0 C--N 1.339 0.137 0 CA-C-N 120.054 1.927 . . . . 0.0 110.209 -177.813 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 40.8 t -63.14 134.15 28.5 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.5 p -119.02 -20.81 4.8 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 C-N-CA 125.377 1.471 . . . . 0.0 110.006 176.039 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -161.04 169.15 23.06 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 120.23 1.377 . . . . 0.0 110.685 169.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 8.9 m -136.14 150.83 49.24 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.369 1.468 . . . . 0.0 108.288 173.482 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 63.7 m -151.07 159.11 44.71 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.483 1.513 . . . . 0.0 108.559 169.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 40.4 t -133.84 148.54 30.38 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 N-CA-C 107.929 -1.138 . . . . 0.0 107.929 -177.502 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 76.86 -174.88 54.08 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 123.45 0.548 . . . . 0.0 112.404 175.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -64.78 148.62 50.85 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.001 0.92 . . . . 0.0 110.935 -179.69 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.75 142.18 16.41 Favored Pre-proline 0 CA--C 1.533 0.322 0 C-N-CA 125.455 1.502 . . . . 0.0 107.093 167.604 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -72.45 161.44 44.23 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 122.747 2.298 . . . . 0.0 110.635 175.554 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 41.5 pttt -59.25 -29.99 67.95 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 -178.248 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -66.38 -49.7 65.95 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 118.418 0.554 . . . . 0.0 109.908 176.147 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.57 -39.96 95.73 Favored 'General case' 0 CA--C 1.528 0.132 0 O-C-N 122.026 -0.421 . . . . 0.0 110.599 179.039 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 78.4 mt -62.94 -43.55 98.47 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.021 0.528 . . . . 0.0 111.188 177.066 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -59.16 -41.78 89.19 Favored 'General case' 0 C--O 1.225 -0.189 0 CA-C-N 118.342 0.519 . . . . 0.0 109.981 176.057 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -66.78 -38.98 87.6 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 118.624 0.647 . . . . 0.0 110.876 -179.665 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 67.4 tp -62.47 -36.64 83.12 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.842 1.257 . . . . 0.0 110.972 176.44 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 94.2 t -70.48 -49.32 53.84 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 CA-C-N 119.178 0.899 . . . . 0.0 109.501 171.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -56.46 -40.55 75.03 Favored 'General case' 0 CA--C 1.52 -0.204 0 C-N-CA 125.901 1.68 . . . . 0.0 111.854 -168.253 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -67.37 -6.21 17.92 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 -176.3 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 90.4 m-70 -120.89 -7.54 9.49 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.346 1.058 . . . . 0.0 112.686 177.596 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 60.6 mt . . . . . 0 C--O 1.248 0.99 0 CA-C-N 119.239 0.927 . . . . 0.0 109.15 173.811 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.8 mpp? . . . . . 0 N--CA 1.482 1.151 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -149.93 -173.38 4.41 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.518 1.527 . . . . 0.0 108.805 -177.549 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.2 mt -75.25 145.09 11.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 167.346 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 31.9 t -136.33 163.48 33.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 126.192 1.797 . . . . 0.0 106.877 -175.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -118.05 142.84 46.96 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 105.919 -1.882 . . . . 0.0 105.919 174.334 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -144.52 166.4 25.26 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.407 0.622 . . . . 0.0 111.027 -177.261 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 18.3 p -134.09 171.21 14.54 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 126.448 1.899 . . . . 0.0 107.731 171.423 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -52.73 -29.42 26.88 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.611 1.164 . . . . 0.0 113.046 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 56.7 mt-30 -62.87 -28.98 70.4 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.216 1.406 . . . . 0.0 113.004 179.554 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.4 m -136.27 -6.63 2.04 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 113.517 0.932 . . . . 0.0 113.517 -169.115 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -52.19 -43.97 64.44 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.431 1.092 . . . . 0.0 111.677 -178.058 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.5 m -63.21 -38.95 93.19 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.063 0.545 . . . . 0.0 111.857 -179.04 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -67.98 -44.35 76.87 Favored 'General case' 0 N--CA 1.452 -0.344 0 O-C-N 122.02 -0.425 . . . . 0.0 110.066 177.585 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 66.7 mm-40 -63.22 -35.87 81.75 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 122.416 0.286 . . . . 0.0 110.946 -178.746 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 27.5 p -83.51 1.37 42.22 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.044 0.938 . . . . 0.0 113.377 -177.322 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 68.1 m -102.02 30.97 4.13 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.18 0.992 . . . . 0.0 111.802 -176.55 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -132.68 57.79 1.78 Allowed 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.1 0.96 . . . . 0.0 110.526 -177.617 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 98.65 -153.43 19.88 Favored Glycine 0 C--N 1.337 0.636 0 N-CA-C 110.084 -1.206 . . . . 0.0 110.084 174.547 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 55.0 t -72.05 135.06 28.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 N-CA-C 105.744 -1.947 . . . . 0.0 105.744 167.786 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 46.6 t -137.5 142.96 35.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 105.908 -1.886 . . . . 0.0 105.908 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.6 tt -125.27 101.42 6.97 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 106.03 -1.841 . . . . 0.0 106.03 -177.596 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -82.55 144.64 30.23 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.275 -179.532 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -121.18 93.79 4.13 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 125.955 1.702 . . . . 0.0 107.166 -178.553 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -72.7 111.6 7.99 Favored 'General case' 0 C--O 1.239 0.545 0 N-CA-C 105.689 -1.967 . . . . 0.0 105.689 174.298 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -146.86 -177.46 5.67 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 125.241 1.417 . . . . 0.0 108.168 -171.643 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -155.73 149.59 19.25 Favored Pre-proline 0 C--N 1.33 -0.265 0 N-CA-C 106.405 -1.702 . . . . 0.0 106.405 168.078 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -68.53 -12.58 35.17 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 121.378 1.386 . . . . 0.0 114.231 -176.371 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 52.0 p-90 -71.02 -19.69 62.48 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 120.233 1.378 . . . . 0.0 112.192 169.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 27.8 t -60.36 153.25 23.23 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.964 1.306 . . . . 0.0 111.419 -172.004 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.405 ' H ' ' HD2' ' A' ' 31' ' ' PRO . . . -102.46 -61.2 0.73 Allowed Glycine 0 CA--C 1.533 1.195 0 C-N-CA 124.585 1.088 . . . . 0.0 111.626 171.49 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.405 ' HD2' ' H ' ' A' ' 30' ' ' GLY . 28.5 Cg_endo -66.95 -25.57 44.63 Favored 'Trans proline' 0 C--N 1.348 0.517 0 CA-C-N 120.46 2.13 . . . . 0.0 112.702 -174.582 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 24.6 m -56.41 -35.51 67.87 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 121.235 -0.916 . . . . 0.0 111.023 172.387 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.6 mmtp -69.31 -26.21 64.61 Favored 'General case' 0 CA--C 1.529 0.155 0 O-C-N 121.564 -0.71 . . . . 0.0 111.296 -178.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 5.1 ptt? -85.7 -31.55 22.41 Favored 'General case' 0 C--N 1.34 0.188 0 CA-C-N 118.961 0.8 . . . . 0.0 111.414 -176.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 18.2 tt -77.57 -25.26 14.78 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-O 118.591 -0.718 . . . . 0.0 111.537 170.098 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -49.71 -49.57 72.23 Favored Pre-proline 0 CA--C 1.547 0.839 0 CA-C-N 120.379 1.445 . . . . 0.0 114.367 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -66.35 -28.88 46.55 Favored 'Trans proline' 0 C--N 1.349 0.601 0 CA-C-N 122.038 1.763 . . . . 0.0 112.122 176.365 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.1 t -67.82 -37.26 78.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 O-C-N 121.666 -0.646 . . . . 0.0 109.553 174.554 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 96.1 mt -66.74 -34.82 78.69 Favored 'General case' 0 C--N 1.34 0.175 0 CA-C-N 119.46 1.027 . . . . 0.0 111.422 171.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -63.05 -42.33 99.7 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 119.556 1.071 . . . . 0.0 110.716 171.476 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -63.94 -39.49 94.27 Favored 'General case' 0 CA--C 1.531 0.24 0 O-C-N 121.243 -0.911 . . . . 0.0 110.421 175.791 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 42.8 tp -62.4 -43.04 99.77 Favored 'General case' 0 CA--C 1.527 0.077 0 C-N-CA 123.643 0.777 . . . . 0.0 110.205 175.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -60.06 -42.36 94.34 Favored 'General case' 0 CA--C 1.521 -0.137 0 C-N-CA 123.453 0.701 . . . . 0.0 110.805 178.373 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 -71.98 -10.8 60.28 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.263 0.625 . . . . 0.0 112.481 -179.417 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -105.54 -32.53 8.46 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 125.265 1.426 . . . . 0.0 111.415 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 71.5 mmm -125.77 -3.14 7.18 Favored 'General case' 0 C--O 1.226 -0.138 0 CA-C-O 118.414 -0.803 . . . . 0.0 113.152 -167.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -57.63 -13.59 12.48 Favored Glycine 0 CA--C 1.533 1.185 0 CA-C-N 119.769 1.168 . . . . 0.0 115.847 -172.168 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -77.1 -24.98 51.73 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 118.462 1.131 . . . . 0.0 111.721 174.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 51.1 mmtt -117.38 -21.08 8.85 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 125.648 1.579 . . . . 0.0 111.445 -177.052 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 52.2 tp -122.26 148.45 44.98 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 125.16 1.384 . . . . 0.0 110.223 -169.289 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -120.64 145.42 47.42 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 105.116 -2.179 . . . . 0.0 105.116 167.564 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 77.3 mt -115.01 138.01 46.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 105.637 -1.986 . . . . 0.0 105.637 176.693 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 93.5 t -133.56 98.6 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-N 118.879 0.763 . . . . 0.0 109.236 -170.193 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 52.9 mtpt -73.89 140.37 45.63 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 176.144 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 13.9 tt -142.72 127.87 16.39 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 176.053 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 50.6 t0 -84.02 103.43 13.25 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 124.732 1.213 . . . . 0.0 109.004 -172.344 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 28.3 m -59.36 -28.36 39.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 118.819 -0.61 . . . . 0.0 111.888 -174.401 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -66.64 -19.3 65.73 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 119.258 0.935 . . . . 0.0 111.846 -177.419 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -114.62 1.41 14.23 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.547 1.539 . . . . 0.0 110.828 178.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 68.3 m-80 -141.67 42.42 1.72 Allowed 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 124.4 1.08 . . . . 0.0 109.54 -169.492 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 45.0 mm-40 -55.81 -32.57 63.67 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.041 0.936 . . . . 0.0 111.269 178.239 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 -66.08 -47.58 73.8 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 118.384 0.538 . . . . 0.0 110.47 179.473 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.94 -39.41 79.59 Favored 'General case' 0 C--O 1.223 -0.327 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 -178.734 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -58.99 -47.81 83.83 Favored 'General case' 0 CA--C 1.533 0.325 0 O-C-N 121.207 -0.933 . . . . 0.0 110.264 173.097 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -60.85 -28.72 68.87 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 124.062 0.839 . . . . 0.0 112.405 177.178 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 24.4 tptp -56.18 -29.21 60.53 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.68 1.192 . . . . 0.0 111.47 179.482 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -124.27 10.73 8.69 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.557 0.743 . . . . 0.0 111.61 -179.1 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 63.71 31.36 80.51 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 123.728 0.68 . . . . 0.0 112.588 -177.238 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 53.7 t -65.55 123.67 18.94 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 172.376 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 99.0 mtp -135.99 3.49 2.93 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.757 1.223 . . . . 0.0 111.486 -179.121 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 24.5 m -143.89 160.96 39.88 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 126.656 1.983 . . . . 0.0 107.409 178.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 41.9 pt -143.14 154.9 61.89 Favored Pre-proline 0 CA--C 1.545 0.781 0 C-N-CA 124.468 1.107 . . . . 0.0 108.93 177.261 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -67.1 139.69 47.54 Favored 'Cis proline' 0 C--N 1.35 0.626 0 CA-C-N 120.373 1.169 . . . . 0.0 110.42 -4.603 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 24.6 m -130.36 140.8 50.59 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 174.197 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 86.2 mt -121.28 123.57 42.52 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 -169.03 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -114.06 122.45 46.93 Favored 'General case' 0 CA--C 1.512 -0.513 0 N-CA-C 103.627 -2.731 . . . . 0.0 103.627 178.737 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.2 t -96.02 127.18 48.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 N-CA-C 104.002 -2.592 . . . . 0.0 104.002 174.297 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.0 mp -119.66 155.05 33.09 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 177.328 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -137.05 119.47 15.82 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 106.376 -1.713 . . . . 0.0 106.376 176.309 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.0 t70 49.52 38.2 14.04 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.97 1.308 . . . . 0.0 112.482 177.136 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 104.67 -5.1 43.31 Favored Glycine 0 CA--C 1.529 0.944 0 CA-C-O 118.148 -1.362 . . . . 0.0 115.46 168.675 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -130.81 150.57 51.92 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 120.006 1.903 . . . . 0.0 110.276 -177.675 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 42.9 t -62.73 133.29 28.6 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.4 p -119.25 -21.03 4.61 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 125.19 1.396 . . . . 0.0 110.36 176.052 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -158.51 168.59 26.51 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 120.582 1.537 . . . . 0.0 110.317 173.715 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 18.1 m -146.37 143.31 28.99 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.385 1.074 . . . . 0.0 109.063 175.23 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 49.5 m -144.62 156.23 44.02 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.561 1.544 . . . . 0.0 108.66 176.213 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 41.2 t -133.76 146.44 31.77 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 -175.419 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 75.21 -174.25 52.12 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 123.292 0.473 . . . . 0.0 112.271 178.185 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 67.4 t80 -65.3 148.66 51.31 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.674 0.79 . . . . 0.0 111.347 -178.175 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.29 140.18 14.64 Favored Pre-proline 0 CA--C 1.534 0.349 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 167.383 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -72.05 161.66 44.07 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 122.718 2.279 . . . . 0.0 110.497 175.505 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 49.3 pttt -58.51 -29.34 66.19 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 113.571 0.952 . . . . 0.0 113.571 -178.717 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -65.91 -50.34 64.8 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 118.595 0.634 . . . . 0.0 109.559 176.049 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.53 -39.07 93.46 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 122.721 0.409 . . . . 0.0 110.821 178.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 87.8 mt -63.49 -44.06 95.47 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 122.985 0.514 . . . . 0.0 111.156 176.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 -61.17 -41.95 97.68 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-N 118.426 0.557 . . . . 0.0 110.153 176.025 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -63.31 -41.18 98.91 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 118.15 0.432 . . . . 0.0 110.238 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 61.3 tp -61.71 -46.01 91.5 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.705 1.202 . . . . 0.0 110.674 176.801 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 72.8 t -58.32 -44.86 89.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 CA-C-N 118.75 0.705 . . . . 0.0 109.462 173.58 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -62.59 -25.29 68.0 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.905 1.282 . . . . 0.0 112.153 -174.017 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -57.61 -22.14 43.42 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 118.506 -0.759 . . . . 0.0 112.452 172.613 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 70.8 m-70 -124.09 -8.26 7.69 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 -168.555 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 77.3 mt . . . . . 0 C--O 1.246 0.886 0 CA-C-O 118.363 -0.827 . . . . 0.0 109.416 171.54 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.3 mtt . . . . . 0 N--CA 1.483 1.19 0 CA-C-O 118.985 -0.531 . . . . 0.0 111.154 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -67.2 -20.62 65.73 Favored 'General case' 0 CA--C 1.51 -0.581 0 N-CA-C 116.844 2.164 . . . . 0.0 116.844 -169.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 12.0 mt -82.12 137.61 20.84 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.192 0 CA-C-N 114.312 -1.313 . . . . 0.0 108.901 -168.666 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 5.4 t -137.45 160.85 34.87 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 C-N-CA 126.702 2.001 . . . . 0.0 106.472 -174.654 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.34 133.07 50.12 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 105.358 -2.09 . . . . 0.0 105.358 176.506 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -142.8 174.96 10.19 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 123.611 0.764 . . . . 0.0 111.421 -170.057 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.3 p -138.14 171.74 13.94 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 126.732 2.013 . . . . 0.0 106.661 168.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -50.45 -27.95 7.42 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 175.386 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -55.06 -31.33 61.05 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.732 1.613 . . . . 0.0 112.756 177.286 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.1 m -139.67 -10.1 1.21 Allowed 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 124.035 0.934 . . . . 0.0 113.059 -170.615 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -53.57 -42.08 67.2 Favored 'General case' 0 C--O 1.231 0.117 0 C-N-CA 124.472 1.109 . . . . 0.0 111.316 -177.287 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.4 m -63.38 -36.9 85.27 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.16 0.584 . . . . 0.0 112.027 179.766 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -69.7 -44.25 70.79 Favored 'General case' 0 N--CA 1.453 -0.313 0 O-C-N 121.998 -0.439 . . . . 0.0 110.005 177.013 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -62.8 -40.88 98.74 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 122.827 0.451 . . . . 0.0 110.463 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.434 ' HA ' HG21 ' A' ' 20' ' ' VAL . 26.0 p -77.3 1.84 17.53 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.867 0.867 . . . . 0.0 113.252 -179.484 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 63.5 m -105.18 32.76 4.02 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.531 1.132 . . . . 0.0 111.206 179.758 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -130.97 51.48 2.13 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.2 1.0 . . . . 0.0 110.51 -178.125 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 97.27 -156.7 20.85 Favored Glycine 0 C--N 1.337 0.588 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 179.24 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 74.4 t -70.94 136.59 25.59 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 168.406 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.434 HG21 ' HA ' ' A' ' 15' ' ' THR . 54.6 t -137.84 135.55 45.66 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 N-CA-C 106.039 -1.838 . . . . 0.0 106.039 -179.084 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.0 tt -113.25 99.95 8.2 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 105.754 -1.943 . . . . 0.0 105.754 -176.817 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -83.07 146.62 28.6 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 179.499 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -127.21 94.17 3.93 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 126.236 1.814 . . . . 0.0 107.66 -176.364 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -74.5 114.07 12.47 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 106.109 -1.811 . . . . 0.0 106.109 175.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -149.99 -177.04 5.68 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.918 1.287 . . . . 0.0 108.778 -171.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -152.86 147.16 18.77 Favored Pre-proline 0 CA--C 1.531 0.245 0 N-CA-C 105.936 -1.875 . . . . 0.0 105.936 167.266 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -58.81 -18.39 41.4 Favored 'Trans proline' 0 CA--C 1.531 0.36 0 C-N-CA 121.933 1.755 . . . . 0.0 114.844 178.572 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 1.9 m95 -74.28 -14.65 60.94 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 118.91 0.777 . . . . 0.0 111.908 176.754 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 34.9 t -63.95 152.54 39.69 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.41 1.484 . . . . 0.0 111.14 -175.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -100.5 -64.4 0.8 Allowed Glycine 0 CA--C 1.53 1.002 0 CA-C-O 118.446 -1.197 . . . . 0.0 110.997 171.375 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -62.3 -26.28 77.08 Favored 'Trans proline' 0 C--N 1.35 0.646 0 CA-C-N 120.44 2.12 . . . . 0.0 113.675 -174.706 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 33.7 m -57.01 -34.41 68.15 Favored 'General case' 0 CA--C 1.537 0.446 0 O-C-N 121.577 -0.702 . . . . 0.0 111.627 174.243 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.2 mmtp -67.53 -24.36 65.55 Favored 'General case' 0 CA--C 1.531 0.226 0 O-C-N 121.529 -0.732 . . . . 0.0 111.118 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 30.8 mtm -72.45 -42.7 64.72 Favored 'General case' 0 C--N 1.34 0.159 0 CA-C-N 118.581 0.628 . . . . 0.0 110.439 177.396 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 17.1 tt -83.48 -22.12 8.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-O 118.726 -0.654 . . . . 0.0 111.7 -175.117 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -50.24 -52.18 56.3 Favored Pre-proline 0 CA--C 1.549 0.915 0 CA-C-N 120.059 1.3 . . . . 0.0 113.674 177.563 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -66.84 -27.62 43.71 Favored 'Trans proline' 0 C--N 1.351 0.675 0 CA-C-N 121.606 1.609 . . . . 0.0 112.305 176.546 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 22.0 t -68.1 -39.19 80.97 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 O-C-N 121.541 -0.724 . . . . 0.0 109.5 175.381 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 53.2 mt -65.31 -36.3 83.62 Favored 'General case' 0 C--N 1.34 0.16 0 CA-C-N 119.265 0.939 . . . . 0.0 111.085 172.406 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -63.62 -38.5 91.36 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 118.803 0.729 . . . . 0.0 111.178 172.353 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -66.63 -35.42 80.15 Favored 'General case' 0 CA--C 1.531 0.244 0 O-C-N 120.35 -1.469 . . . . 0.0 110.691 173.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.58 -44.84 92.88 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.594 0.758 . . . . 0.0 109.733 177.014 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 53.2 t0 -53.66 -48.22 69.64 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 124.972 1.309 . . . . 0.0 110.397 172.562 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -68.43 -8.11 37.67 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -178.316 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 77.7 mt-10 -109.6 -36.64 5.9 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.996 1.319 . . . . 0.0 112.265 -176.762 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 6.2 ptp -145.12 22.96 1.53 Allowed 'General case' 0 C--N 1.341 0.212 0 N-CA-C 114.865 1.432 . . . . 0.0 114.865 178.644 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -60.84 -5.68 5.69 Favored Glycine 0 CA--C 1.537 1.46 0 CA-C-N 119.996 1.271 . . . . 0.0 115.221 177.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -78.6 -33.17 47.68 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.586 1.154 . . . . 0.0 111.296 170.035 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -95.45 -35.23 11.79 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 124.844 1.258 . . . . 0.0 110.659 178.425 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 60.8 tp -105.14 153.06 22.03 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.452 1.101 . . . . 0.0 111.745 -169.791 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 14.4 ttmm -121.85 144.46 48.82 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 104.426 -2.435 . . . . 0.0 104.426 166.046 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 79.3 mt -120.66 135.62 60.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 104.872 -2.269 . . . . 0.0 104.872 179.311 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 99.3 t -130.0 98.61 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 -172.288 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 52.4 mtmt -71.47 138.88 49.36 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 172.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 17.1 tt -142.28 123.59 12.24 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 177.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 59.3 t0 -83.32 106.98 15.53 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 124.282 1.033 . . . . 0.0 108.566 -173.395 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 31.7 m -60.07 -24.68 30.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 118.551 -0.737 . . . . 0.0 112.043 -175.178 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -64.75 -19.73 65.95 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 119.659 1.118 . . . . 0.0 112.002 -179.178 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -116.44 4.44 13.34 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.069 1.347 . . . . 0.0 110.85 178.102 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 68.4 m-80 -141.35 39.16 1.73 Allowed 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 124.537 1.135 . . . . 0.0 110.169 -169.141 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 53.4 mm-40 -56.48 -34.8 67.26 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.358 0.663 . . . . 0.0 110.851 176.132 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -65.34 -46.18 81.26 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 122.78 0.432 . . . . 0.0 110.305 177.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.29 -40.62 86.12 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.482 0.713 . . . . 0.0 110.043 -178.79 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -58.26 -49.49 76.91 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.389 0.675 . . . . 0.0 110.109 172.715 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -59.67 -29.57 67.31 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 123.958 0.789 . . . . 0.0 112.432 177.14 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 22.6 ttmt -55.39 -28.91 57.11 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.497 1.519 . . . . 0.0 112.042 178.609 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -123.61 9.49 8.98 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 123.868 0.867 . . . . 0.0 111.948 178.053 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 65.14 28.77 73.94 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 123.819 0.723 . . . . 0.0 112.935 -176.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 54.5 t -61.67 128.99 24.07 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 172.394 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 22.4 ttt -137.93 0.37 2.17 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.573 1.149 . . . . 0.0 111.145 -177.448 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 25.2 m -145.08 163.95 32.72 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 126.558 1.943 . . . . 0.0 107.612 179.513 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 39.5 pt -143.41 155.82 60.77 Favored Pre-proline 0 CA--C 1.547 0.832 0 C-N-CA 124.603 1.161 . . . . 0.0 108.85 176.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -67.24 138.66 42.8 Favored 'Cis proline' 0 C--N 1.351 0.671 0 CA-C-N 120.453 1.197 . . . . 0.0 110.288 -4.464 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 32.8 m -130.22 141.1 50.66 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 175.26 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 83.0 mt -122.62 128.47 50.71 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 -167.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -122.54 118.36 28.06 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 104.013 -2.588 . . . . 0.0 104.013 -178.302 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 14.7 t -92.92 119.28 40.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 104.108 -2.553 . . . . 0.0 104.108 173.641 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.8 mp -109.74 153.91 23.65 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 172.398 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -134.34 125.06 26.84 Favored 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 170.524 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.0 t70 48.48 35.02 5.31 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.234 1.414 . . . . 0.0 112.181 173.255 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 101.69 0.67 52.7 Favored Glycine 0 CA--C 1.532 1.146 0 CA-C-O 117.876 -1.513 . . . . 0.0 115.289 170.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -123.29 146.42 47.9 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 120.491 2.145 . . . . 0.0 109.5 176.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 11.4 p -68.67 132.48 32.89 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 170.568 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 33.7 m -119.91 -21.0 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 124.439 1.096 . . . . 0.0 110.996 178.07 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -155.75 162.86 40.45 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 120.44 1.473 . . . . 0.0 110.851 174.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 9.0 m -139.13 151.06 46.36 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.673 1.189 . . . . 0.0 108.708 177.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 48.6 m -151.55 159.32 44.17 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.408 1.483 . . . . 0.0 108.874 169.526 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 42.7 t -133.93 144.67 34.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 -176.667 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 77.87 177.97 48.06 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 123.639 0.638 . . . . 0.0 112.494 176.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 55.2 t80 -61.35 145.14 52.53 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 123.866 0.866 . . . . 0.0 111.089 -179.299 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.37 141.27 14.91 Favored Pre-proline 0 CA--C 1.535 0.403 0 C-N-CA 126.206 1.802 . . . . 0.0 106.843 177.8 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -72.35 156.79 54.38 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 122.409 2.073 . . . . 0.0 110.722 176.784 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 42.2 pttt -57.5 -32.54 67.13 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 -175.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -68.77 -43.04 76.59 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 118.5 0.591 . . . . 0.0 109.504 178.79 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.47 -42.05 98.6 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 118.354 0.525 . . . . 0.0 110.517 176.621 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 97.1 mt -60.86 -48.84 79.99 Favored 'General case' 0 N--CA 1.461 0.095 0 CA-C-O 121.08 0.467 . . . . 0.0 110.686 178.286 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -71.57 -28.29 63.74 Favored 'General case' 0 N--CA 1.451 -0.381 0 O-C-N 122.037 -0.414 . . . . 0.0 110.866 -175.038 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -70.03 -37.25 75.55 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 118.404 0.547 . . . . 0.0 111.355 170.393 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 8.7 tp -62.79 -34.5 77.4 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.5 1.12 . . . . 0.0 110.274 174.764 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 48.9 t -69.99 -45.97 74.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 123.836 0.854 . . . . 0.0 110.066 169.304 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -59.91 -36.58 77.3 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 124.73 1.212 . . . . 0.0 111.937 -172.175 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 11.0 ptmm? -67.06 -6.25 16.5 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 178.587 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -123.35 -18.07 6.36 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.136 0.974 . . . . 0.0 113.363 175.498 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 31.7 mt . . . . . 0 C--O 1.249 1.034 0 CA-C-N 119.913 1.233 . . . . 0.0 109.459 171.784 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.5 ttt . . . . . 0 N--CA 1.479 0.993 0 CA-C-O 119.082 -0.485 . . . . 0.0 110.076 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -165.23 -175.62 3.72 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 126.096 1.759 . . . . 0.0 107.876 -171.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.1 mt -76.15 142.67 14.09 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 165.586 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 44.6 t -138.79 164.03 26.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 126.494 1.917 . . . . 0.0 106.733 -174.379 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 4.7 mtpt -117.01 142.84 46.45 Favored 'General case' 0 CA--C 1.517 -0.31 0 C-N-CA 125.345 1.458 . . . . 0.0 107.373 173.508 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -142.81 165.62 26.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.422 0.63 . . . . 0.0 110.525 178.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 17.5 p -132.55 172.25 12.75 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 126.254 1.822 . . . . 0.0 107.664 170.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -52.39 -29.53 24.59 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.238 1.015 . . . . 0.0 113.111 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 56.1 mt-30 -63.47 -28.96 70.32 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.12 1.368 . . . . 0.0 113.174 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.2 m -136.88 -5.49 1.92 Allowed 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 113.842 1.053 . . . . 0.0 113.842 -168.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -52.39 -44.07 65.12 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.166 0.987 . . . . 0.0 111.65 -177.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.5 m -63.23 -38.57 91.68 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.129 0.572 . . . . 0.0 111.849 -179.1 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -68.1 -44.34 76.45 Favored 'General case' 0 N--CA 1.452 -0.337 0 O-C-N 121.994 -0.442 . . . . 0.0 110.023 177.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 66.1 mm-40 -63.61 -35.76 81.56 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 122.391 0.276 . . . . 0.0 110.979 -178.805 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 26.4 p -83.91 1.44 43.36 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.029 0.931 . . . . 0.0 113.329 -177.312 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 69.1 m -100.17 30.27 3.89 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.23 1.012 . . . . 0.0 111.742 -177.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -133.26 61.95 1.67 Allowed 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.297 1.039 . . . . 0.0 110.195 -177.081 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 92.24 -156.53 23.52 Favored Glycine 0 C--N 1.338 0.694 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 175.821 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 59.1 t -71.31 134.23 30.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 N-CA-C 106.506 -1.665 . . . . 0.0 106.506 168.548 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 47.1 t -136.99 141.11 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 105.915 -1.883 . . . . 0.0 105.915 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 3.7 tt -122.19 100.3 6.89 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 106.255 -1.757 . . . . 0.0 106.255 -176.411 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -83.25 145.42 29.14 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.293 -179.646 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -123.95 94.12 4.13 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 126.083 1.753 . . . . 0.0 107.196 -177.457 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -74.13 112.26 10.09 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 105.884 -1.895 . . . . 0.0 105.884 174.836 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -148.3 -177.12 5.59 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.704 1.201 . . . . 0.0 108.608 -172.749 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -155.87 146.98 16.55 Favored Pre-proline 0 CA--C 1.531 0.232 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 168.153 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -60.75 -17.27 48.98 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 121.818 1.679 . . . . 0.0 116.01 -177.781 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 54.0 p-90 -70.04 -20.12 63.26 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 120.03 1.286 . . . . 0.0 111.914 173.638 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 29.0 t -59.58 150.97 25.66 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.991 1.316 . . . . 0.0 110.971 -174.537 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -104.99 -58.61 0.67 Allowed Glycine 0 CA--C 1.531 1.062 0 CA-C-O 118.704 -1.053 . . . . 0.0 110.97 172.024 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -56.54 -33.08 91.88 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 123.217 2.611 . . . . 0.0 113.712 -179.288 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 29.7 m -57.82 -34.57 69.81 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.441 0.696 . . . . 0.0 111.403 176.539 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.4 mmtp -68.38 -24.54 64.79 Favored 'General case' 0 CA--C 1.531 0.22 0 O-C-N 121.5 -0.75 . . . . 0.0 111.063 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 31.1 mtm -70.8 -42.27 70.52 Favored 'General case' 0 C--N 1.34 0.186 0 CA-C-N 118.742 0.701 . . . . 0.0 110.405 176.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 19.1 tt -85.0 -23.76 7.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 CA-C-O 118.53 -0.748 . . . . 0.0 111.782 -175.306 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -49.38 -50.52 64.55 Favored Pre-proline 0 CA--C 1.548 0.867 0 CA-C-N 120.088 1.313 . . . . 0.0 114.191 178.271 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -66.93 -27.76 42.83 Favored 'Trans proline' 0 C--N 1.351 0.674 0 CA-C-N 121.779 1.671 . . . . 0.0 112.069 176.474 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.8 t -68.94 -37.12 76.87 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 O-C-N 121.589 -0.694 . . . . 0.0 109.769 173.807 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 95.6 mt -65.5 -34.69 78.87 Favored 'General case' 0 C--N 1.339 0.135 0 CA-C-N 119.743 1.156 . . . . 0.0 111.025 172.447 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -61.97 -43.79 98.1 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 119.376 0.989 . . . . 0.0 110.944 170.465 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -63.67 -40.18 96.18 Favored 'General case' 0 CA--C 1.531 0.218 0 O-C-N 121.172 -0.955 . . . . 0.0 110.711 175.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 39.8 tp -61.98 -41.96 98.61 Favored 'General case' 0 C--N 1.334 -0.105 0 C-N-CA 124.372 1.069 . . . . 0.0 109.919 178.125 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -60.82 -42.96 98.73 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 122.949 0.499 . . . . 0.0 110.696 175.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -71.97 -10.4 59.72 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 112.6 0.592 . . . . 0.0 112.6 179.299 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -105.36 -28.38 10.91 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 125.437 1.495 . . . . 0.0 111.377 -178.65 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 26.8 mtp -134.3 -1.56 2.88 Favored 'General case' 0 N--CA 1.462 0.146 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 -168.702 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -56.91 -13.91 9.26 Favored Glycine 0 CA--C 1.532 1.126 0 CA-C-N 119.913 1.233 . . . . 0.0 115.434 -173.777 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -69.73 -29.93 67.42 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 118.674 1.237 . . . . 0.0 111.73 173.121 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 45.6 mmtm -115.7 -20.27 10.17 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 125.512 1.525 . . . . 0.0 111.889 -178.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 36.6 tp -112.57 157.17 21.51 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 123.984 0.914 . . . . 0.0 111.41 -168.553 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -132.34 144.51 50.6 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 103.806 -2.665 . . . . 0.0 103.806 166.572 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 83.0 mt -118.02 139.43 45.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 105.274 -2.121 . . . . 0.0 105.274 177.818 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 81.9 t -132.26 98.78 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 -170.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 52.4 mtmt -74.2 136.69 42.79 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 175.153 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 15.3 tt -139.98 124.82 19.88 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 176.366 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -82.79 105.08 13.51 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 124.717 1.207 . . . . 0.0 108.784 -174.733 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 27.7 m -60.37 -27.06 38.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 118.684 -0.674 . . . . 0.0 111.898 -174.349 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -66.1 -19.83 65.97 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 119.423 1.011 . . . . 0.0 111.773 -177.371 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -113.83 1.59 14.84 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.534 1.534 . . . . 0.0 110.891 178.646 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 68.7 m-80 -141.68 41.77 1.72 Allowed 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.27 1.028 . . . . 0.0 109.889 -169.392 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 46.7 mm-40 -56.03 -32.37 63.96 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.806 0.842 . . . . 0.0 111.262 177.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 35.0 mm-40 -65.72 -47.21 76.1 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 118.407 0.549 . . . . 0.0 110.5 179.199 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.2 -39.04 78.86 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 121.801 -0.562 . . . . 0.0 109.634 -178.734 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -58.79 -48.28 81.82 Favored 'General case' 0 CA--C 1.534 0.343 0 O-C-N 121.142 -0.974 . . . . 0.0 110.171 172.695 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -60.45 -28.67 67.74 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 124.078 0.847 . . . . 0.0 112.438 177.189 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 47.7 tptt -56.23 -29.28 60.79 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.629 1.171 . . . . 0.0 111.425 179.498 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -124.0 10.7 8.85 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.671 0.788 . . . . 0.0 111.598 -179.442 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 64.41 28.52 73.21 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 123.819 0.723 . . . . 0.0 112.802 -177.141 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 49.1 t -62.86 125.94 20.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 172.689 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 40.3 ttp -138.49 1.86 2.19 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.487 1.115 . . . . 0.0 111.036 -177.092 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 24.8 m -144.31 161.98 37.58 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 126.789 2.036 . . . . 0.0 107.374 178.715 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 40.7 pt -143.13 155.91 61.7 Favored Pre-proline 0 CA--C 1.544 0.721 0 C-N-CA 124.631 1.173 . . . . 0.0 108.768 177.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -67.05 139.54 46.66 Favored 'Cis proline' 0 C--N 1.349 0.588 0 CA-C-N 120.459 1.2 . . . . 0.0 110.26 -4.714 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 28.1 m -130.81 139.95 50.24 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 174.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 88.0 mt -120.33 124.49 45.69 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 -169.472 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -115.18 119.7 37.27 Favored 'General case' 0 CA--C 1.512 -0.509 0 N-CA-C 103.578 -2.749 . . . . 0.0 103.578 177.782 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.2 t -93.1 123.31 45.14 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 N-CA-C 103.432 -2.803 . . . . 0.0 103.432 173.414 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.1 mp -114.86 155.25 27.16 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 174.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -137.94 123.38 19.55 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 172.81 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.2 t70 49.36 36.87 10.46 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.084 1.354 . . . . 0.0 112.537 176.009 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 103.4 -2.83 46.59 Favored Glycine 0 CA--C 1.529 0.92 0 CA-C-O 118.122 -1.377 . . . . 0.0 115.285 168.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -128.62 149.98 50.41 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 120.074 1.937 . . . . 0.0 110.077 -179.434 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 44.3 t -62.0 131.53 27.25 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 175.162 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.1 p -117.44 -22.94 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 C-N-CA 125.102 1.361 . . . . 0.0 109.406 179.009 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -162.3 168.04 22.9 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 120.463 1.483 . . . . 0.0 110.097 169.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 14.0 m -136.56 151.07 48.98 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.363 1.465 . . . . 0.0 108.796 177.563 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 58.3 m -148.38 157.28 43.38 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.631 1.573 . . . . 0.0 108.649 169.574 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 42.6 t -133.6 145.33 33.77 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 -178.578 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 78.27 -176.29 54.24 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 123.553 0.597 . . . . 0.0 111.877 179.113 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -63.72 148.91 47.91 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.484 0.714 . . . . 0.0 110.41 178.003 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 42.9 mttt -142.4 138.24 16.28 Favored Pre-proline 0 C--O 1.235 0.311 0 N-CA-C 106.352 -1.722 . . . . 0.0 106.352 168.774 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -66.57 160.03 47.97 Favored 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 121.88 1.72 . . . . 0.0 110.925 178.321 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 33.7 tttm -48.85 -46.72 42.68 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 126.071 1.748 . . . . 0.0 112.987 -178.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 27.4 mm-40 -72.98 -35.94 66.99 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.207 -176.282 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.64 -36.6 84.78 Favored 'General case' 0 C--N 1.341 0.233 0 CA-C-N 118.979 0.808 . . . . 0.0 111.054 173.304 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 87.1 mt -64.53 -45.78 85.72 Favored 'General case' 0 N--CA 1.456 -0.137 0 CA-C-O 119.197 -0.43 . . . . 0.0 110.665 176.105 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 8.9 mt-30 -57.99 -42.44 85.16 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-N 118.501 0.591 . . . . 0.0 110.787 173.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -64.61 -39.58 93.98 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 118.016 0.371 . . . . 0.0 110.508 -178.815 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 57.8 tp -61.86 -44.0 97.72 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 124.636 1.174 . . . . 0.0 110.568 176.399 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 86.6 t -61.22 -44.13 97.78 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-N 118.821 0.737 . . . . 0.0 109.39 173.023 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -60.58 -28.34 68.4 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 125.019 1.328 . . . . 0.0 112.15 -173.574 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -56.4 -24.12 42.71 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 123.402 0.681 . . . . 0.0 112.498 174.245 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 72.2 m-70 -123.18 -9.18 8.16 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 -168.369 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 74.5 mt . . . . . 0 C--O 1.249 1.045 0 CA-C-N 118.948 0.794 . . . . 0.0 109.333 171.298 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 46.4 tpp . . . . . 0 N--CA 1.484 1.235 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -143.58 -179.26 6.33 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.728 1.211 . . . . 0.0 110.353 -172.465 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.8 mt -72.26 148.8 9.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 168.787 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 21.5 t -134.88 160.87 41.01 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 C-N-CA 126.68 1.992 . . . . 0.0 106.521 -176.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.23 139.1 50.7 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 105.368 -2.086 . . . . 0.0 105.368 169.284 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -140.68 168.94 18.6 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 121.296 0.569 . . . . 0.0 110.886 -178.674 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 17.4 p -133.19 169.67 16.54 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 126.334 1.854 . . . . 0.0 107.987 175.37 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -53.42 -29.31 34.53 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.443 1.097 . . . . 0.0 113.039 -178.517 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 57.0 mt-30 -61.28 -29.26 69.75 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.164 1.386 . . . . 0.0 112.944 178.684 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.6 m -136.86 -7.19 1.87 Allowed 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 -169.45 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -53.25 -43.65 67.52 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.349 1.06 . . . . 0.0 111.516 -177.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.8 m -62.86 -39.87 95.74 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.058 0.543 . . . . 0.0 111.76 179.518 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.66 -43.38 84.73 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 122.71 0.404 . . . . 0.0 110.074 177.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 68.5 mm-40 -64.09 -42.82 96.8 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 122.265 0.226 . . . . 0.0 110.551 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.423 ' HA ' HG21 ' A' ' 20' ' ' VAL . 35.5 p -77.89 -5.86 52.4 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 124.262 1.025 . . . . 0.0 113.568 -176.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 72.7 m -74.72 -20.26 59.91 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 177.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -87.41 69.23 9.87 Favored 'General case' 0 CA--C 1.537 0.451 0 O-C-N 121.483 -0.761 . . . . 0.0 111.581 -170.012 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 85.28 -151.51 25.75 Favored Glycine 0 C--N 1.337 0.612 0 N-CA-C 109.993 -1.243 . . . . 0.0 109.993 173.799 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 58.0 t -71.17 137.11 24.43 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 168.63 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.423 HG21 ' HA ' ' A' ' 15' ' ' THR . 57.7 t -140.37 146.99 23.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 105.777 -1.935 . . . . 0.0 105.777 179.08 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.5 tt -124.96 99.35 6.09 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 -176.359 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -81.43 147.86 29.56 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.732 -179.689 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -126.48 95.21 4.29 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 126.145 1.778 . . . . 0.0 107.27 -178.787 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -73.81 115.36 13.16 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 174.455 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -149.16 -178.06 6.17 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.351 1.46 . . . . 0.0 108.553 -173.739 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -156.12 149.65 18.97 Favored Pre-proline 0 CA--C 1.531 0.238 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 167.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_exo -59.62 -19.16 51.51 Favored 'Trans proline' 0 CA--C 1.534 0.504 0 C-N-CA 122.323 2.015 . . . . 0.0 115.775 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 52.4 p-90 -70.85 -20.11 62.57 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 119.933 1.242 . . . . 0.0 112.035 174.585 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 23.9 t -61.45 152.35 30.13 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 125.025 1.33 . . . . 0.0 111.344 -172.786 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -101.63 -66.59 0.78 Allowed Glycine 0 CA--C 1.529 0.963 0 CA-C-O 118.424 -1.209 . . . . 0.0 110.528 173.03 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -54.75 -30.42 67.06 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 123.12 2.547 . . . . 0.0 114.275 -179.548 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 39.4 m -56.26 -34.87 66.82 Favored 'General case' 0 CA--C 1.538 0.495 0 O-C-N 121.467 -0.77 . . . . 0.0 111.551 175.685 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.4 mmtp -68.94 -29.61 67.89 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 123.427 0.691 . . . . 0.0 110.944 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 5.0 ptt? -85.55 -30.03 23.7 Favored 'General case' 0 C--N 1.34 0.153 0 CA-C-N 118.809 0.731 . . . . 0.0 111.539 -177.002 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 19.5 tt -77.87 -20.77 13.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-O 118.626 -0.702 . . . . 0.0 111.56 169.795 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -51.7 -49.61 82.14 Favored Pre-proline 0 CA--C 1.548 0.887 0 CA-C-N 120.83 1.65 . . . . 0.0 113.852 178.232 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -66.18 -28.3 48.31 Favored 'Trans proline' 0 C--N 1.35 0.631 0 CA-C-N 121.922 1.722 . . . . 0.0 112.285 175.352 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 23.9 t -66.93 -39.23 83.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 174.429 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 95.1 mt -64.6 -37.0 86.08 Favored 'General case' 0 C--N 1.341 0.239 0 CA-C-N 119.531 1.06 . . . . 0.0 111.155 171.786 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -64.66 -40.79 96.04 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 119.385 0.993 . . . . 0.0 110.857 174.507 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -63.02 -40.02 96.49 Favored 'General case' 0 CA--C 1.531 0.232 0 O-C-N 121.067 -1.021 . . . . 0.0 110.187 174.158 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.35 -47.28 84.31 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.885 0.874 . . . . 0.0 109.746 175.499 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -59.01 -40.57 85.36 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 123.62 0.768 . . . . 0.0 111.03 179.262 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 -73.92 -10.71 59.93 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.303 0.641 . . . . 0.0 112.377 -179.395 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -103.44 -33.88 8.91 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 124.954 1.302 . . . . 0.0 111.791 178.292 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 86.6 mmm -125.08 -3.77 7.53 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 113.237 0.829 . . . . 0.0 113.237 -168.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -62.63 -3.57 5.82 Favored Glycine 0 CA--C 1.532 1.147 0 CA-C-N 119.853 1.206 . . . . 0.0 115.342 -175.415 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -73.96 -27.68 61.12 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 118.519 1.16 . . . . 0.0 111.201 169.756 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.3 -23.07 3.3 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 125.289 1.435 . . . . 0.0 111.59 -171.313 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 45.0 tp -111.24 151.61 28.1 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 124.878 1.271 . . . . 0.0 110.169 -169.771 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -118.82 144.8 46.12 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 105.541 -2.022 . . . . 0.0 105.541 168.322 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 73.1 mt -116.53 136.96 51.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 105.384 -2.08 . . . . 0.0 105.384 175.658 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 97.3 t -133.06 97.08 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 -169.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -73.97 139.48 44.86 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 107.648 -1.242 . . . . 0.0 107.648 175.633 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 11.5 tt -141.05 129.27 23.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.395 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 178.265 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 61.7 t0 -87.83 105.44 17.41 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 124.809 1.243 . . . . 0.0 110.06 -169.399 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 27.0 m -62.58 -18.46 20.69 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 CA-C-O 118.539 -0.743 . . . . 0.0 112.449 -177.347 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -67.54 -15.5 63.69 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 119.863 1.211 . . . . 0.0 112.023 176.591 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -127.18 1.03 6.45 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.236 1.014 . . . . 0.0 111.89 178.323 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 67.0 m-80 -137.55 41.0 2.4 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.737 0.815 . . . . 0.0 111.209 -169.35 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 5.3 mp0 -54.11 -32.08 53.94 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.203 0.601 . . . . 0.0 111.76 174.754 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -66.3 -47.44 73.59 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 118.423 0.556 . . . . 0.0 110.498 -177.707 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.07 -39.26 79.2 Favored 'General case' 0 CA--C 1.534 0.345 0 O-C-N 121.836 -0.54 . . . . 0.0 109.591 -179.416 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -58.53 -48.45 80.81 Favored 'General case' 0 CA--C 1.534 0.338 0 O-C-N 121.244 -0.91 . . . . 0.0 110.463 173.496 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -61.92 -28.15 69.83 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 124.179 0.895 . . . . 0.0 112.166 178.015 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 71.7 tttt -55.66 -28.76 57.23 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.853 1.261 . . . . 0.0 111.683 178.057 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -123.17 10.58 9.37 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.775 0.83 . . . . 0.0 111.803 179.252 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 65.38 27.46 72.5 Favored Glycine 0 CA--C 1.534 1.239 0 C-N-CA 123.85 0.738 . . . . 0.0 113.024 -177.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 60.4 t -62.72 127.63 23.17 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 171.786 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 22.6 ttt -137.16 0.49 2.35 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.612 1.165 . . . . 0.0 111.05 -176.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 25.2 m -144.92 162.51 36.67 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 126.514 1.926 . . . . 0.0 107.719 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 41.1 pt -142.8 156.79 62.47 Favored Pre-proline 0 CA--C 1.544 0.747 0 C-N-CA 124.858 1.263 . . . . 0.0 108.615 177.832 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -66.74 140.7 51.32 Favored 'Cis proline' 0 C--N 1.349 0.594 0 CA-C-N 120.464 1.201 . . . . 0.0 110.416 -5.714 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 32.2 m -135.2 135.96 41.41 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 176.625 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -115.4 132.11 56.72 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 -172.494 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -120.22 121.87 39.67 Favored 'General case' 0 CA--C 1.513 -0.443 0 N-CA-C 103.545 -2.761 . . . . 0.0 103.545 177.343 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 8.3 t -92.67 123.36 44.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 103.331 -2.84 . . . . 0.0 103.331 172.227 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.2 mp -113.09 155.7 24.44 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 175.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 60.8 tttp -135.65 124.62 24.2 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 105.854 -1.906 . . . . 0.0 105.854 173.479 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 30.8 t70 50.64 34.73 10.23 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.693 1.197 . . . . 0.0 112.119 176.199 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 100.38 -1.13 55.86 Favored Glycine 0 CA--C 1.529 0.951 0 CA-C-O 118.27 -1.294 . . . . 0.0 114.92 169.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -132.28 152.37 51.39 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 120.072 1.936 . . . . 0.0 110.24 -179.487 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 29.0 t -62.31 135.14 27.17 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 -178.602 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.9 p -120.59 -25.84 2.44 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 125.16 1.384 . . . . 0.0 110.237 175.135 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -155.95 170.24 22.59 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 120.22 1.373 . . . . 0.0 109.792 177.404 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 30.0 m -152.43 153.73 34.13 Favored 'General case' 0 CA--C 1.541 0.612 0 O-C-N 120.747 -1.221 . . . . 0.0 110.271 -176.197 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 41.7 m -150.22 154.45 37.98 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.561 1.544 . . . . 0.0 108.981 168.813 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 43.4 t -132.9 141.0 46.06 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 N-CA-C 107.03 -1.471 . . . . 0.0 107.03 -177.113 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 76.67 179.19 47.34 Favored Glycine 0 CA--C 1.53 0.992 0 N-CA-C 111.436 -0.665 . . . . 0.0 111.436 -177.131 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 36.1 t80 -63.18 132.62 52.36 Favored 'General case' 0 C--O 1.231 0.129 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 175.85 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 13.1 mptt -135.47 147.4 61.65 Favored Pre-proline 0 CA--C 1.536 0.419 0 C-N-CA 126.676 1.99 . . . . 0.0 106.176 174.262 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -71.53 158.07 54.67 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 122.513 2.142 . . . . 0.0 110.521 178.758 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 20.7 pttp -58.25 -29.25 65.63 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -62.4 -42.84 99.74 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.215 0.606 . . . . 0.0 110.433 176.368 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.62 -47.38 78.78 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 118.544 0.611 . . . . 0.0 110.09 -178.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 10.1 mp -56.09 -47.44 78.03 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.577 0.751 . . . . 0.0 109.912 176.167 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 14.7 mt-30 -61.73 -39.9 93.18 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-O 118.729 -0.653 . . . . 0.0 112.058 178.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -64.69 -42.83 95.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 119.073 0.852 . . . . 0.0 110.029 178.528 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 31.0 mt -66.92 -35.3 79.68 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 118.586 0.63 . . . . 0.0 111.562 179.034 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 44.0 t -60.99 -50.99 78.29 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 170.024 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -61.26 -33.65 73.88 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 125.383 1.473 . . . . 0.0 111.862 -173.424 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 59.1 mtpt -56.36 -27.93 57.54 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 118.332 -0.842 . . . . 0.0 112.212 174.652 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -128.92 -5.47 5.06 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 114.688 1.366 . . . . 0.0 114.688 -167.803 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 17.5 mt . . . . . 0 C--O 1.25 1.082 0 CA-C-N 119.655 1.116 . . . . 0.0 108.725 168.569 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.8 tpp . . . . . 0 N--CA 1.478 0.973 0 CA-C-O 118.912 -0.566 . . . . 0.0 110.251 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -164.56 -175.57 3.92 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 125.588 1.555 . . . . 0.0 108.366 -173.423 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.3 mt -75.92 143.78 12.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 166.288 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 20.7 t -135.77 161.37 38.54 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 126.696 1.998 . . . . 0.0 106.103 -176.526 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.62 138.89 50.62 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 105.652 -1.981 . . . . 0.0 105.652 169.149 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -139.2 171.39 14.36 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 123.453 0.701 . . . . 0.0 110.852 -178.652 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.0 p -136.18 171.66 14.15 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 125.768 1.627 . . . . 0.0 108.454 175.29 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -38.82 -39.93 0.57 Allowed 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 126.415 1.886 . . . . 0.0 113.525 170.862 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 43.5 mm-40 -68.62 -26.03 65.14 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.095 0.958 . . . . 0.0 113.088 -173.414 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.1 m -134.18 -8.95 2.62 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 113.585 0.958 . . . . 0.0 113.585 -169.873 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 67.4 t80 -54.03 -45.17 71.49 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 124.363 1.065 . . . . 0.0 111.44 -176.486 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 9.3 m -63.25 -37.42 87.18 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.041 0.536 . . . . 0.0 111.729 -178.556 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -68.41 -44.77 74.32 Favored 'General case' 0 N--CA 1.454 -0.272 0 O-C-N 122.036 -0.415 . . . . 0.0 110.055 177.143 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 67.0 mm-40 -63.21 -35.78 81.46 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 122.414 0.286 . . . . 0.0 110.955 -178.6 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.9 p -83.98 1.36 44.04 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.2 1.0 . . . . 0.0 113.496 -177.471 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 66.5 m -102.15 32.58 3.43 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.099 0.959 . . . . 0.0 111.403 -177.105 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -132.78 58.18 1.77 Allowed 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.354 1.062 . . . . 0.0 110.155 -178.757 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 93.97 -154.08 21.42 Favored Glycine 0 C--N 1.339 0.728 0 N-CA-C 110.084 -1.206 . . . . 0.0 110.084 176.269 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 84.7 t -71.19 134.84 29.24 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 168.142 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 58.8 t -139.07 142.07 34.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 105.639 -1.985 . . . . 0.0 105.639 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 3.4 tt -120.51 99.37 6.52 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 -174.663 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -81.33 146.83 30.16 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 179.432 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -126.09 94.14 4.01 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 125.983 1.713 . . . . 0.0 106.961 -177.557 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -73.95 113.97 11.73 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 106.179 -1.786 . . . . 0.0 106.179 174.871 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -149.75 -175.85 5.19 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 125.107 1.363 . . . . 0.0 107.883 -172.23 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -155.84 148.36 17.8 Favored Pre-proline 0 N--CA 1.451 -0.376 0 N-CA-C 106.106 -1.813 . . . . 0.0 106.106 167.46 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -68.35 -12.92 36.34 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 CA-C-N 120.871 1.347 . . . . 0.0 113.923 -178.45 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 42.6 p-90 -69.88 -20.94 63.37 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 120.221 1.373 . . . . 0.0 111.978 169.526 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 26.8 t -59.3 149.19 29.51 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.117 1.367 . . . . 0.0 111.123 -171.165 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -97.02 -60.39 0.97 Allowed Glycine 0 CA--C 1.533 1.19 0 CA-C-O 118.715 -1.047 . . . . 0.0 111.418 170.016 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -66.77 -25.9 45.7 Favored 'Trans proline' 0 C--N 1.349 0.576 0 CA-C-N 120.444 2.122 . . . . 0.0 112.813 -173.412 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 22.5 m -58.73 -32.23 69.02 Favored 'General case' 0 CA--C 1.536 0.41 0 O-C-N 121.524 -0.735 . . . . 0.0 111.401 174.392 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.7 mmtp -69.03 -23.01 64.02 Favored 'General case' 0 CA--C 1.532 0.257 0 O-C-N 121.373 -0.829 . . . . 0.0 111.109 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 34.0 mtm -71.52 -42.65 67.71 Favored 'General case' 0 C--N 1.34 0.194 0 CA-C-N 118.763 0.711 . . . . 0.0 110.404 175.729 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 16.5 tt -84.0 -22.12 8.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-O 118.741 -0.647 . . . . 0.0 111.599 -176.459 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -49.39 -51.16 60.38 Favored Pre-proline 0 CA--C 1.547 0.845 0 CA-C-N 120.009 1.277 . . . . 0.0 113.894 177.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -67.59 -25.98 40.29 Favored 'Trans proline' 0 C--N 1.351 0.66 0 CA-C-N 121.828 1.689 . . . . 0.0 112.528 176.334 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 15.2 t -70.05 -37.01 71.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 O-C-N 121.555 -0.715 . . . . 0.0 109.49 174.604 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 93.6 mt -67.41 -36.72 81.83 Favored 'General case' 0 C--O 1.226 -0.152 0 CA-C-N 119.576 1.08 . . . . 0.0 111.267 171.816 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -62.43 -41.59 98.82 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 119.385 0.993 . . . . 0.0 110.686 172.27 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 30.9 mm-40 -60.08 -45.91 91.33 Favored 'General case' 0 N--CA 1.455 -0.18 0 O-C-N 121.401 -0.812 . . . . 0.0 110.139 173.286 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.13 -44.09 92.03 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.886 0.874 . . . . 0.0 109.576 179.513 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -60.46 -42.78 96.88 Favored 'General case' 0 CA--C 1.522 -0.117 0 C-N-CA 123.559 0.743 . . . . 0.0 111.245 178.51 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -72.6 -10.22 59.53 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.366 0.666 . . . . 0.0 112.459 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -103.13 -33.75 9.11 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 125.315 1.446 . . . . 0.0 110.723 -179.203 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 88.4 mmm -130.12 -4.05 4.46 Favored 'General case' 0 C--N 1.341 0.203 0 N-CA-C 113.869 1.063 . . . . 0.0 113.869 -167.885 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.61 -11.41 15.51 Favored Glycine 0 CA--C 1.532 1.095 0 CA-C-N 119.954 1.252 . . . . 0.0 114.993 -173.575 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -67.05 -28.23 68.04 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 118.434 1.117 . . . . 0.0 111.595 172.012 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -120.8 -25.16 5.5 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 125.56 1.544 . . . . 0.0 111.686 -178.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 35.3 tp -102.58 159.6 15.31 Favored 'General case' 0 C--O 1.232 0.149 0 C-N-CA 124.202 1.001 . . . . 0.0 110.504 -170.216 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -132.68 143.54 49.71 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 104.326 -2.472 . . . . 0.0 104.326 167.403 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 67.5 mt -117.09 138.76 46.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 105.28 -2.118 . . . . 0.0 105.28 177.548 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 97.7 t -132.9 94.22 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 -169.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 27.9 mtpp -73.43 141.07 46.92 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 176.738 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 11.8 tt -142.73 126.86 15.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 178.582 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 57.4 t0 -86.25 104.61 15.95 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 124.783 1.233 . . . . 0.0 109.253 -170.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 26.1 m -61.79 -20.74 24.19 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-O 118.625 -0.702 . . . . 0.0 112.271 -176.817 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -67.6 -13.83 62.41 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 119.723 1.147 . . . . 0.0 111.958 177.345 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -124.23 3.28 8.54 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.666 1.187 . . . . 0.0 111.506 175.854 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 65.0 m-80 -141.65 41.25 1.72 Allowed 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 124.13 0.972 . . . . 0.0 111.29 -169.673 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 3.7 mp0 -52.89 -31.55 40.31 Favored 'General case' 0 CA--C 1.531 0.25 0 O-C-N 121.972 -0.455 . . . . 0.0 111.716 172.806 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -65.05 -50.76 64.92 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 123.905 0.882 . . . . 0.0 109.77 -178.857 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.34 -36.95 77.42 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.33 0.652 . . . . 0.0 109.839 -178.471 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.41 -45.99 89.96 Favored 'General case' 0 CA--C 1.534 0.365 0 O-C-N 120.834 -1.167 . . . . 0.0 110.669 171.295 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -63.5 -28.12 71.92 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 123.906 0.765 . . . . 0.0 112.189 177.654 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 74.0 tttt -56.15 -29.17 60.4 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.964 1.306 . . . . 0.0 111.613 179.202 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -123.82 6.17 8.74 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.291 0.636 . . . . 0.0 112.273 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 62.44 41.63 99.76 Favored Glycine 0 CA--C 1.53 0.99 0 N-CA-C 111.698 -0.561 . . . . 0.0 111.698 -175.546 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 95.2 t -63.38 94.3 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 124.852 1.261 . . . . 0.0 107.963 173.852 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 1.6 pmm? -73.77 -30.72 62.93 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 125.235 1.414 . . . . 0.0 112.452 -175.325 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 52.0 m -147.42 175.0 11.16 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 126.067 1.747 . . . . 0.0 109.653 -172.221 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 42.8 pt -137.2 154.87 76.02 Favored Pre-proline 0 CA--C 1.546 0.813 0 C-N-CA 125.045 1.338 . . . . 0.0 108.631 175.211 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -67.93 141.54 60.19 Favored 'Cis proline' 0 N--CA 1.458 -0.612 0 CA-C-N 120.467 1.203 . . . . 0.0 110.493 -4.215 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 18.4 m -135.88 137.51 41.51 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 175.016 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -114.79 133.39 55.96 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 -173.802 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -120.78 116.49 25.34 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 103.18 -2.896 . . . . 0.0 103.18 176.848 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.4 t -91.79 121.36 42.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 103.723 -2.695 . . . . 0.0 103.723 173.431 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.4 mp -110.51 155.28 22.48 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 175.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 26.4 ttpp -133.7 115.05 14.13 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 105.677 -1.971 . . . . 0.0 105.677 176.387 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 27.6 t0 50.09 39.98 20.55 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.675 1.19 . . . . 0.0 112.461 176.303 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 103.59 -4.22 46.82 Favored Glycine 0 CA--C 1.529 0.958 0 CA-C-O 118.184 -1.342 . . . . 0.0 115.345 168.729 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -132.27 150.2 52.21 Favored 'General case' 0 C--N 1.34 0.155 0 CA-C-N 120.056 1.928 . . . . 0.0 110.32 -178.75 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 22.1 t -62.99 134.66 28.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 -179.352 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.3 p -117.97 -27.67 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 C-N-CA 125.016 1.326 . . . . 0.0 110.169 174.393 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 40.8 mm-40 -150.22 163.14 39.01 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 120.201 1.364 . . . . 0.0 110.177 172.281 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 17.9 m -141.04 145.08 35.4 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.057 1.343 . . . . 0.0 108.44 176.735 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 20.0 m -144.74 151.99 39.7 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.389 1.476 . . . . 0.0 108.845 175.622 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 59.2 t -132.44 142.96 41.24 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 -177.059 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 79.14 179.5 52.02 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 123.876 0.751 . . . . 0.0 111.815 -178.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -57.96 144.76 38.29 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 123.391 0.676 . . . . 0.0 110.511 178.219 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -149.64 134.93 9.7 Favored Pre-proline 0 N--CA 1.453 -0.303 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 -175.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -74.39 156.81 45.7 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 122.12 1.88 . . . . 0.0 110.787 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 17.7 ptmt -56.9 -31.77 65.22 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 124.019 0.927 . . . . 0.0 112.266 177.627 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -66.09 -48.54 70.6 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 118.731 0.696 . . . . 0.0 110.011 179.447 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.94 -44.36 96.29 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 118.009 0.368 . . . . 0.0 110.335 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 83.3 mt -61.73 -42.68 99.27 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-O 119.465 -0.303 . . . . 0.0 110.505 178.391 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -61.62 -39.85 92.75 Favored 'General case' 0 C--O 1.222 -0.343 0 CA-C-O 118.132 -0.937 . . . . 0.0 111.268 175.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -64.11 -41.9 97.09 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 119.822 1.192 . . . . 0.0 110.421 178.385 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 88.8 mt -63.54 -38.63 91.87 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 122.904 0.482 . . . . 0.0 111.165 178.129 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 49.7 t -63.33 -51.26 73.26 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 C-N-CA 123.676 0.79 . . . . 0.0 109.542 171.51 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -59.63 -40.76 88.69 Favored 'General case' 0 C--N 1.332 -0.153 0 C-N-CA 125.907 1.683 . . . . 0.0 111.503 -169.407 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 13.7 ptmm? -69.5 -6.63 31.89 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 118.155 -0.926 . . . . 0.0 113.16 -177.83 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 93.6 m-70 -124.96 -15.4 6.4 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 177.105 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 19.7 mt . . . . . 0 C--O 1.249 1.076 0 CA-C-N 119.563 1.074 . . . . 0.0 109.371 169.404 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.0 mtt . . . . . 0 N--CA 1.479 1.004 0 CA-C-O 118.981 -0.533 . . . . 0.0 109.907 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -161.17 -172.43 3.42 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.607 1.563 . . . . 0.0 108.436 -174.717 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.6 mt -74.95 143.54 13.23 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 166.45 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 21.4 t -133.95 159.56 42.31 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 C-N-CA 126.221 1.808 . . . . 0.0 106.498 -176.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -115.2 128.44 56.17 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 105.428 -2.064 . . . . 0.0 105.428 178.837 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -138.5 166.76 23.48 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 121.576 0.703 . . . . 0.0 112.313 -173.884 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.448 HG22 HD21 ' A' ' 60' ' ' ASN . 36.4 p -137.09 179.24 6.5 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 125.648 1.579 . . . . 0.0 107.715 171.105 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -49.14 -29.8 5.85 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.25 1.02 . . . . 0.0 112.706 170.18 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -63.04 -27.54 69.47 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.007 1.323 . . . . 0.0 112.805 179.341 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 13.6 p -132.08 -20.22 2.48 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 -167.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 56.4 t80 -51.98 -47.52 64.81 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 124.767 1.227 . . . . 0.0 112.534 -169.782 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.3 m -64.6 -38.57 91.47 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 122.666 0.386 . . . . 0.0 111.665 -175.894 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -68.04 -45.01 75.12 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 176.567 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 -62.9 -36.5 83.58 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 119.301 -0.38 . . . . 0.0 111.082 -177.572 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.8 p -83.75 -0.04 49.24 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 113.526 0.936 . . . . 0.0 113.526 -177.059 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 70.3 m -102.6 31.34 4.14 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.986 0.914 . . . . 0.0 111.494 -175.878 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -132.35 53.04 2.03 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.181 0.992 . . . . 0.0 110.781 -175.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 99.62 -156.21 19.79 Favored Glycine 0 C--N 1.338 0.655 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 176.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 90.0 t -70.18 136.43 26.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 167.576 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 60.6 t -139.59 147.13 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 N-CA-C 105.576 -2.009 . . . . 0.0 105.576 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.1 tt -125.17 99.0 5.89 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 -175.557 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -80.26 147.44 31.19 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 123.258 0.623 . . . . 0.0 109.548 -179.162 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -129.44 93.94 3.66 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 126.126 1.77 . . . . 0.0 108.163 -174.673 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -75.17 112.58 11.58 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 106.321 -1.733 . . . . 0.0 106.321 174.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -149.46 -176.57 5.44 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.775 1.23 . . . . 0.0 108.218 -173.931 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -156.67 149.1 17.86 Favored Pre-proline 0 CA--C 1.531 0.239 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 167.713 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -60.85 -19.13 60.57 Favored 'Trans proline' 0 N--CA 1.46 -0.47 0 C-N-CA 121.568 1.512 . . . . 0.0 115.43 179.134 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 48.5 p-90 -69.72 -20.06 63.54 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 119.926 1.239 . . . . 0.0 111.927 173.766 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 25.4 t -59.62 147.83 35.88 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.932 1.293 . . . . 0.0 111.072 -172.217 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -96.91 -63.62 0.92 Allowed Glycine 0 CA--C 1.529 0.94 0 CA-C-O 118.479 -1.178 . . . . 0.0 110.862 171.376 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -62.68 -26.2 75.38 Favored 'Trans proline' 0 C--N 1.349 0.605 0 CA-C-N 120.314 2.057 . . . . 0.0 113.543 -174.716 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 35.1 m -57.65 -34.34 69.26 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 118.653 0.66 . . . . 0.0 111.471 174.676 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.9 mmtp -67.88 -25.28 65.44 Favored 'General case' 0 CA--C 1.531 0.236 0 O-C-N 121.553 -0.717 . . . . 0.0 110.921 -179.437 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 31.0 mtm -71.91 -42.81 66.28 Favored 'General case' 0 C--N 1.34 0.16 0 CA-C-N 118.696 0.68 . . . . 0.0 110.444 176.874 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 13.5 tt -84.05 -21.73 8.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-O 118.826 -0.607 . . . . 0.0 111.56 -175.761 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -48.82 -51.8 51.25 Favored Pre-proline 0 CA--C 1.546 0.819 0 CA-C-N 119.994 1.27 . . . . 0.0 113.643 177.769 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -67.27 -29.0 39.4 Favored 'Trans proline' 0 C--N 1.351 0.682 0 CA-C-N 121.756 1.663 . . . . 0.0 112.555 176.605 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 31.4 t -65.48 -40.24 87.61 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 174.81 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 76.9 mt -67.78 -35.54 78.86 Favored 'General case' 0 C--O 1.224 -0.238 0 CA-C-N 119.299 0.954 . . . . 0.0 111.482 173.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -62.38 -42.27 99.28 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 119.549 1.068 . . . . 0.0 110.736 172.794 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -65.03 -39.38 93.3 Favored 'General case' 0 CA--C 1.532 0.265 0 O-C-N 121.28 -0.887 . . . . 0.0 110.505 175.713 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.24 -46.37 90.02 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.638 0.775 . . . . 0.0 109.348 175.486 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -58.88 -42.94 90.69 Favored 'General case' 0 CA--C 1.521 -0.144 0 C-N-CA 123.833 0.853 . . . . 0.0 111.279 179.386 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -70.79 -10.47 59.58 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.428 0.691 . . . . 0.0 112.607 179.338 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 58.2 mt-10 -106.16 -30.62 9.12 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 125.601 1.56 . . . . 0.0 111.46 -177.511 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 91.6 mmm -127.62 -5.38 5.83 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 -171.511 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.81 -10.69 14.21 Favored Glycine 0 CA--C 1.531 1.036 0 CA-C-N 119.828 1.194 . . . . 0.0 114.854 -174.106 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -65.41 -28.48 69.28 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 118.509 1.154 . . . . 0.0 111.51 171.502 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -123.31 -25.84 4.38 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 125.427 1.491 . . . . 0.0 111.639 -179.0 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 31.6 tp -100.07 161.61 13.5 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 124.306 1.042 . . . . 0.0 110.385 -170.244 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -135.95 144.6 45.53 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 104.447 -2.427 . . . . 0.0 104.447 168.066 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 59.9 mt -116.65 139.32 43.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 105.489 -2.041 . . . . 0.0 105.489 176.518 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 93.2 t -132.98 96.31 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 -169.717 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -74.39 138.02 43.1 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 178.175 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 13.4 tt -141.4 128.73 21.32 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 177.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 64.6 t0 -87.94 106.68 18.27 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.603 1.161 . . . . 0.0 109.797 -169.529 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 31.3 m -62.08 -19.02 20.92 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 CA-C-O 118.693 -0.67 . . . . 0.0 112.473 -176.821 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -67.2 -15.72 63.87 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 119.685 1.129 . . . . 0.0 112.105 176.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -127.21 1.86 6.42 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.306 1.042 . . . . 0.0 111.863 179.155 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.448 HD21 HG22 ' A' ' 7' ' ' THR . 63.8 m-80 -137.63 40.52 2.39 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.732 0.813 . . . . 0.0 111.447 -169.235 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 5.5 mp0 -54.41 -32.58 57.59 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.056 0.542 . . . . 0.0 111.781 174.873 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 32.9 mm-40 -65.73 -48.96 70.17 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 118.514 0.597 . . . . 0.0 110.136 -179.07 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.39 -37.82 80.76 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.036 0.534 . . . . 0.0 109.927 -178.925 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.4 -48.59 81.08 Favored 'General case' 0 CA--C 1.535 0.372 0 O-C-N 121.064 -1.022 . . . . 0.0 110.363 172.32 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -60.62 -27.67 66.58 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 124.225 0.916 . . . . 0.0 112.334 177.535 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 47.3 tttp -55.52 -29.11 58.29 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.84 1.256 . . . . 0.0 111.726 178.415 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -123.54 10.8 9.15 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.554 0.742 . . . . 0.0 111.732 179.242 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 64.12 30.44 77.78 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 123.649 0.642 . . . . 0.0 112.629 -176.434 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 61.5 t -65.44 125.8 23.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 171.038 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 67.0 mtt -136.36 3.84 2.86 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.811 1.244 . . . . 0.0 111.465 -179.209 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 24.2 m -144.05 161.79 37.88 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 126.591 1.957 . . . . 0.0 107.697 179.672 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 42.5 pt -141.56 154.51 66.59 Favored Pre-proline 0 CA--C 1.545 0.774 0 C-N-CA 124.424 1.09 . . . . 0.0 108.811 176.141 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -67.42 140.02 50.34 Favored 'Cis proline' 0 C--N 1.349 0.586 0 CA-C-N 120.356 1.163 . . . . 0.0 110.385 -4.278 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 42.4 m -132.71 142.24 48.96 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 173.672 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 91.6 mt -125.21 129.46 50.15 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 107.37 -1.345 . . . . 0.0 107.37 -169.259 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -119.84 118.49 30.92 Favored 'General case' 0 CA--C 1.513 -0.476 0 N-CA-C 103.27 -2.863 . . . . 0.0 103.27 178.772 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 4.5 t -88.6 122.83 40.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 103.007 -2.96 . . . . 0.0 103.007 172.297 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.2 mp -112.05 157.42 20.78 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 174.401 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 89.1 tttt -136.42 124.51 22.96 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 106.304 -1.739 . . . . 0.0 106.304 169.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.0 t70 49.22 38.02 12.48 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.909 1.284 . . . . 0.0 112.389 175.677 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 100.87 -2.4 55.55 Favored Glycine 0 CA--C 1.53 0.979 0 CA-C-O 118.15 -1.361 . . . . 0.0 115.167 169.214 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -131.96 152.54 51.04 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 120.174 1.987 . . . . 0.0 110.284 -179.15 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 22.0 t -62.92 134.52 28.12 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 -179.252 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.5 p -120.14 -24.23 3.03 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 C-N-CA 125.471 1.508 . . . . 0.0 109.958 176.89 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -158.79 172.2 18.68 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 120.262 1.392 . . . . 0.0 109.601 173.656 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 26.5 m -148.87 153.15 37.65 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 120.555 -1.34 . . . . 0.0 109.543 -179.243 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 48.4 m -150.22 154.44 37.95 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.218 1.407 . . . . 0.0 109.051 169.699 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 40.9 t -133.59 142.17 42.32 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 -177.673 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 75.69 -177.9 48.92 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 123.43 0.538 . . . . 0.0 111.838 -178.668 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 59.2 t80 -59.52 143.97 48.62 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 123.238 0.615 . . . . 0.0 110.683 179.212 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -150.27 137.12 11.23 Favored Pre-proline 0 C--O 1.234 0.267 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 -176.502 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -73.12 153.83 51.97 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 122.009 1.806 . . . . 0.0 110.486 176.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 57.6 pttt -60.79 -31.61 70.97 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 118.897 -0.573 . . . . 0.0 111.818 -178.404 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -66.45 -42.5 87.53 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.279 0.632 . . . . 0.0 110.438 -179.179 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.18 -44.48 88.32 Favored 'General case' 0 C--O 1.232 0.16 0 O-C-N 121.961 -0.462 . . . . 0.0 109.898 179.148 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 92.0 mt -62.61 -40.22 96.25 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.582 177.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -60.4 -41.19 93.34 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-O 118.577 -0.725 . . . . 0.0 111.498 174.638 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -63.39 -42.71 98.83 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 118.924 0.784 . . . . 0.0 110.007 176.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 40.7 mt -63.65 -41.62 98.19 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 118.739 0.699 . . . . 0.0 111.382 177.758 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 43.1 t -57.51 -49.34 80.68 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 C-N-CA 123.546 0.738 . . . . 0.0 109.239 171.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -63.05 -31.44 72.58 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.403 1.481 . . . . 0.0 111.964 -173.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -58.67 -24.73 61.83 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 118.236 -0.888 . . . . 0.0 112.213 174.397 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 82.3 m-70 -125.69 -14.56 6.23 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 113.863 1.06 . . . . 0.0 113.863 -168.8 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 23.8 mt . . . . . 0 C--O 1.247 0.964 0 CA-C-N 119.692 1.133 . . . . 0.0 109.125 168.975 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 44.7 tpp . . . . . 0 N--CA 1.483 1.185 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -143.82 -173.73 4.06 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.536 1.134 . . . . 0.0 110.527 -170.001 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 7.6 mt -69.95 145.6 12.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 168.34 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 38.7 t -135.0 164.1 34.68 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 C-N-CA 127.065 2.146 . . . . 0.0 106.082 -179.291 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 6.2 ttmt -120.85 146.22 46.79 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 175.016 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -146.48 167.78 22.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.335 0.588 . . . . 0.0 111.104 -176.779 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 16.0 p -132.57 170.62 14.91 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 126.394 1.878 . . . . 0.0 107.896 171.358 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -52.97 -29.76 30.95 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.034 0.933 . . . . 0.0 113.125 -179.096 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 56.6 mt-30 -62.47 -28.98 70.19 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.124 1.37 . . . . 0.0 112.933 179.537 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.6 m -136.33 -5.89 2.04 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 113.517 0.932 . . . . 0.0 113.517 -169.191 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 81.9 t80 -53.43 -44.01 68.46 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.174 0.99 . . . . 0.0 111.281 -178.614 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.2 m -62.89 -39.06 93.33 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.252 0.621 . . . . 0.0 111.935 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.77 -43.89 82.82 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 122.697 0.399 . . . . 0.0 109.993 178.299 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -64.53 -41.54 96.31 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 122.235 0.214 . . . . 0.0 110.709 -179.769 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.409 ' HA ' HG21 ' A' ' 20' ' ' VAL . 36.3 p -79.47 -3.65 47.59 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 124.308 1.043 . . . . 0.0 113.544 -176.567 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 74.7 m -75.07 -21.4 59.01 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 176.855 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -88.02 71.74 9.32 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 121.55 -0.719 . . . . 0.0 111.586 -169.848 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 84.13 -152.75 28.58 Favored Glycine 0 C--N 1.336 0.566 0 N-CA-C 110.304 -1.118 . . . . 0.0 110.304 173.303 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 63.2 t -70.7 134.36 30.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 169.114 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.409 HG21 ' HA ' ' A' ' 15' ' ' THR . 61.6 t -139.09 138.81 41.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 105.786 -1.931 . . . . 0.0 105.786 179.34 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.9 tt -117.37 104.31 11.0 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 -177.558 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -89.45 147.1 24.2 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 -177.308 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -127.42 94.13 3.9 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 125.551 1.54 . . . . 0.0 107.333 -175.672 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -74.46 112.77 10.96 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 105.68 -1.971 . . . . 0.0 105.68 174.878 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -149.41 -174.94 4.81 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 124.911 1.284 . . . . 0.0 108.095 -172.056 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -152.77 148.78 20.95 Favored Pre-proline 0 N--CA 1.453 -0.285 0 N-CA-C 105.83 -1.915 . . . . 0.0 105.83 167.174 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -68.21 -11.89 33.39 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 CA-C-N 121.101 1.429 . . . . 0.0 112.855 178.149 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 1.3 m95 -77.22 -12.34 59.94 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.775 0.83 . . . . 0.0 111.814 172.329 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 17.4 t -64.65 160.95 18.69 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.353 1.461 . . . . 0.0 110.834 -178.78 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -115.52 -58.02 0.34 Allowed Glycine 0 CA--C 1.531 1.046 0 CA-C-O 118.631 -1.094 . . . . 0.0 111.069 171.436 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -56.22 -33.63 91.29 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 123.506 2.804 . . . . 0.0 113.395 178.368 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 23.0 m -58.4 -33.71 69.94 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 121.705 -0.622 . . . . 0.0 111.555 176.34 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.5 mmtp -68.5 -22.24 64.55 Favored 'General case' 0 CA--C 1.531 0.238 0 O-C-N 121.499 -0.75 . . . . 0.0 111.086 -179.686 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 35.3 mtm -70.15 -43.27 71.23 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-N 118.731 0.696 . . . . 0.0 110.298 175.346 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 18.2 tt -85.2 -23.7 7.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-O 118.379 -0.82 . . . . 0.0 111.701 -176.603 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -49.04 -50.19 64.47 Favored Pre-proline 0 CA--C 1.549 0.914 0 CA-C-N 120.407 1.458 . . . . 0.0 114.516 179.038 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -66.13 -30.64 46.6 Favored 'Trans proline' 0 C--N 1.351 0.666 0 CA-C-N 121.636 1.62 . . . . 0.0 111.682 176.449 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.6 t -66.03 -39.81 85.55 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-O 118.305 -0.855 . . . . 0.0 109.449 174.125 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 94.7 mt -62.53 -37.66 86.95 Favored 'General case' 0 C--N 1.34 0.185 0 CA-C-N 119.916 1.235 . . . . 0.0 110.874 173.786 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -63.02 -45.4 92.5 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 119.411 1.005 . . . . 0.0 110.978 173.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 50.8 mm-40 -65.26 -37.33 86.87 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 120.923 -1.111 . . . . 0.0 110.83 178.44 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -63.94 -42.99 97.19 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 125.154 1.382 . . . . 0.0 109.392 176.156 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -58.5 -43.59 89.14 Favored 'General case' 0 CA--C 1.521 -0.137 0 C-N-CA 123.941 0.896 . . . . 0.0 111.203 176.014 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -70.26 -12.8 61.84 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -179.013 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -102.25 -33.38 9.64 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 125.228 1.411 . . . . 0.0 111.088 -179.483 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 79.5 mmm -119.49 -5.61 10.29 Favored 'General case' 0 N--CA 1.461 0.117 0 CA-C-O 118.584 -0.722 . . . . 0.0 112.837 -168.654 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -61.4 -8.01 11.86 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 124.583 1.087 . . . . 0.0 115.574 -173.705 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -75.53 -26.41 58.04 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 118.736 1.268 . . . . 0.0 111.365 171.497 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 50.8 mmtt -118.15 -24.29 7.04 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 125.503 1.521 . . . . 0.0 111.684 -176.524 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 47.4 tp -116.4 152.99 32.85 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 124.379 1.072 . . . . 0.0 112.056 -167.74 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -119.41 142.15 48.47 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 104.986 -2.227 . . . . 0.0 104.986 166.551 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 75.8 mt -110.94 140.28 30.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 105.667 -1.975 . . . . 0.0 105.667 172.567 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 97.3 t -131.79 98.35 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -175.095 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -75.09 140.48 43.48 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 174.435 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 13.7 tt -142.88 124.77 12.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 178.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -82.68 105.31 13.61 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 124.594 1.158 . . . . 0.0 108.832 -173.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 31.0 m -60.12 -25.58 33.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 118.536 -0.745 . . . . 0.0 111.959 -175.618 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -65.71 -18.01 65.02 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 119.597 1.089 . . . . 0.0 112.047 -177.252 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -118.69 3.51 11.68 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.893 1.277 . . . . 0.0 111.132 177.392 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -139.81 40.46 2.0 Allowed 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 124.563 1.145 . . . . 0.0 109.758 -170.179 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 50.5 mm-40 -55.54 -32.42 62.93 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.907 0.883 . . . . 0.0 111.024 176.388 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 33.1 mm-40 -65.33 -48.27 73.61 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 118.411 0.551 . . . . 0.0 110.255 178.702 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.43 -40.27 85.48 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.235 0.614 . . . . 0.0 109.927 -178.561 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.98 -47.33 86.27 Favored 'General case' 0 CA--C 1.533 0.293 0 O-C-N 121.541 -0.725 . . . . 0.0 110.76 173.583 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -62.9 -29.01 72.87 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 123.554 0.597 . . . . 0.0 111.944 177.796 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 17.9 ttmt -55.6 -29.87 59.9 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 125.837 1.655 . . . . 0.0 111.999 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -123.67 7.9 8.85 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 123.491 0.717 . . . . 0.0 112.197 -179.766 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 63.09 41.41 99.78 Favored Glycine 0 CA--C 1.53 0.996 0 CA-C-N 118.329 0.513 . . . . 0.0 111.857 -176.431 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 88.3 t -66.07 91.52 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 C-N-CA 124.71 1.204 . . . . 0.0 107.774 174.52 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 25.1 ptt? -73.57 -28.12 61.68 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 124.707 1.203 . . . . 0.0 112.94 -176.138 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 34.4 m -146.72 174.85 11.08 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 125.973 1.709 . . . . 0.0 109.491 -170.733 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 41.6 pt -139.49 156.56 71.42 Favored Pre-proline 0 CA--C 1.545 0.752 0 C-N-CA 125.169 1.388 . . . . 0.0 108.669 174.785 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -67.46 138.97 44.99 Favored 'Cis proline' 0 C--N 1.349 0.561 0 CA-C-N 120.577 1.242 . . . . 0.0 110.13 -5.08 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 23.4 m -132.91 135.23 45.43 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 176.194 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 10.8 mp -114.81 125.68 53.96 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 -169.526 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -115.41 122.63 46.4 Favored 'General case' 0 CA--C 1.515 -0.393 0 N-CA-C 103.708 -2.701 . . . . 0.0 103.708 177.523 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 4.3 t -92.87 125.7 45.41 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.481 0 N-CA-C 103.655 -2.72 . . . . 0.0 103.655 169.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.2 mp -114.08 152.17 31.44 Favored 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 172.808 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -137.96 126.16 23.03 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 174.414 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 32.2 t70 50.86 33.17 8.21 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.976 1.31 . . . . 0.0 112.264 178.139 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 100.65 0.06 55.41 Favored Glycine 0 CA--C 1.531 1.059 0 CA-C-O 118.207 -1.33 . . . . 0.0 114.965 169.69 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -128.51 150.46 50.16 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 120.002 1.901 . . . . 0.0 109.929 179.218 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 47.1 t -62.09 132.62 27.87 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 175.471 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.6 p -119.53 -21.75 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 C-N-CA 125.129 1.372 . . . . 0.0 109.79 178.446 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -159.65 165.01 33.57 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 120.184 1.356 . . . . 0.0 110.751 171.814 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 10.7 m -136.32 150.82 49.05 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.255 1.422 . . . . 0.0 108.916 176.487 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 73.3 m -150.67 156.83 42.12 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.885 1.674 . . . . 0.0 108.696 170.594 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 47.5 t -133.49 145.3 33.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 -176.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 79.43 178.32 51.06 Favored Glycine 0 CA--C 1.53 1.025 0 C-N-CA 123.928 0.775 . . . . 0.0 112.706 175.253 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -60.06 148.35 36.05 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 123.798 0.839 . . . . 0.0 111.017 179.241 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -149.29 136.7 11.15 Favored Pre-proline 0 CA--C 1.534 0.334 0 C-N-CA 125.492 1.517 . . . . 0.0 107.084 -178.846 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -69.3 158.98 55.52 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 122.019 1.813 . . . . 0.0 111.04 177.348 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -55.06 -43.19 73.64 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 124.799 1.24 . . . . 0.0 112.739 -178.031 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -61.49 -44.08 97.72 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.009 0.524 . . . . 0.0 110.257 178.446 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.49 -36.51 82.92 Favored 'General case' 0 CA--C 1.528 0.129 0 O-C-N 121.865 -0.522 . . . . 0.0 111.017 178.719 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 92.4 mt -62.98 -42.11 99.74 Favored 'General case' 0 N--CA 1.456 -0.14 0 O-C-N 122.134 -0.353 . . . . 0.0 110.91 173.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -60.55 -39.8 89.27 Favored 'General case' 0 C--O 1.224 -0.284 0 CA-C-O 118.712 -0.661 . . . . 0.0 110.178 175.18 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -65.75 -40.9 92.56 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 119.02 0.827 . . . . 0.0 110.601 178.694 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 60.4 tp -60.44 -37.51 81.18 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 125.406 1.482 . . . . 0.0 110.958 177.22 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 92.9 t -69.38 -51.63 40.64 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 123.509 0.724 . . . . 0.0 109.698 171.321 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -58.27 -38.14 76.37 Favored 'General case' 0 C--N 1.334 -0.101 0 C-N-CA 125.939 1.695 . . . . 0.0 112.099 -168.135 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -65.42 -8.49 19.11 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 113.342 0.867 . . . . 0.0 113.342 -178.848 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -120.91 -10.46 9.1 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 124.293 1.037 . . . . 0.0 113.062 178.641 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 55.8 mt . . . . . 0 C--O 1.248 0.996 0 CA-C-N 119.204 0.911 . . . . 0.0 109.314 173.562 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.1 mmt . . . . . 0 N--CA 1.484 1.233 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -151.97 -174.59 4.91 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.041 1.336 . . . . 0.0 109.211 -174.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.9 mt -75.67 143.79 12.77 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 167.146 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 40.8 t -138.07 163.88 28.71 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 126.284 1.834 . . . . 0.0 107.345 -174.624 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -115.29 146.07 41.86 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 174.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -147.94 167.57 24.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.31 0.576 . . . . 0.0 111.253 -179.594 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 18.0 p -136.25 172.26 13.27 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 126.253 1.821 . . . . 0.0 106.98 168.866 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -49.88 -28.53 6.68 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.824 0.85 . . . . 0.0 113.073 174.699 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -56.86 -31.98 65.36 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.619 1.568 . . . . 0.0 112.933 178.447 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 14.8 m -142.26 -4.78 1.0 Allowed 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -169.223 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -54.35 -41.67 69.39 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.98 0.912 . . . . 0.0 111.724 -176.156 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.2 p -59.96 -45.73 91.72 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 124.01 0.924 . . . . 0.0 111.747 177.587 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.2 -43.72 94.17 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 122.719 0.408 . . . . 0.0 110.284 178.069 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -63.4 -35.85 81.77 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 119.475 -0.298 . . . . 0.0 111.076 -179.255 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 29.1 p -85.5 3.58 39.72 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.094 0.957 . . . . 0.0 113.253 -176.698 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 60.5 m -106.43 30.78 5.69 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.165 0.986 . . . . 0.0 111.684 -176.344 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -132.5 37.91 3.48 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.573 0.749 . . . . 0.0 112.313 -174.149 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 121.04 -153.52 16.6 Favored Glycine 0 C--N 1.335 0.52 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 175.421 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 53.5 t -74.45 133.95 30.5 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 N-CA-C 105.011 -2.218 . . . . 0.0 105.011 166.628 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 43.2 t -137.03 133.81 47.76 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 N-CA-C 105.896 -1.89 . . . . 0.0 105.896 -178.484 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 5.1 tt -116.89 101.18 8.31 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 106.138 -1.801 . . . . 0.0 106.138 -177.437 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -81.82 145.8 30.22 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.342 179.595 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -126.15 94.17 4.02 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 125.918 1.687 . . . . 0.0 107.444 -177.451 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -73.1 112.85 9.52 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 105.936 -1.875 . . . . 0.0 105.936 174.649 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -149.38 -176.68 5.48 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.88 1.272 . . . . 0.0 108.403 -172.207 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -151.95 147.92 20.7 Favored Pre-proline 0 C--O 1.233 0.213 0 N-CA-C 105.545 -2.02 . . . . 0.0 105.545 167.228 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -68.03 -11.64 32.67 Favored 'Trans proline' 0 CA--C 1.534 0.498 0 CA-C-N 121.1 1.429 . . . . 0.0 113.276 -178.615 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 1.6 m95 -75.77 -13.7 60.3 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.637 0.775 . . . . 0.0 111.803 172.35 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 23.0 t -63.4 158.21 21.21 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.438 1.495 . . . . 0.0 110.971 -178.646 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -113.22 -57.82 0.41 Allowed Glycine 0 CA--C 1.531 1.065 0 CA-C-O 118.581 -1.121 . . . . 0.0 111.05 171.804 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -55.96 -33.76 90.06 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 123.366 2.711 . . . . 0.0 113.575 178.86 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 23.4 m -58.04 -34.15 69.76 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.271 0.628 . . . . 0.0 111.537 176.372 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.4 mmtp -68.5 -22.6 64.53 Favored 'General case' 0 CA--C 1.531 0.242 0 O-C-N 121.471 -0.768 . . . . 0.0 111.094 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 33.4 mtm -71.07 -42.85 68.84 Favored 'General case' 0 C--N 1.34 0.172 0 CA-C-N 118.841 0.746 . . . . 0.0 110.33 176.339 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 16.6 tt -85.29 -24.64 6.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-O 118.557 -0.735 . . . . 0.0 111.701 -175.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -48.85 -50.27 62.47 Favored Pre-proline 0 CA--C 1.549 0.912 0 CA-C-N 120.062 1.301 . . . . 0.0 114.219 178.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -67.08 -28.94 40.68 Favored 'Trans proline' 0 C--N 1.35 0.626 0 CA-C-N 121.774 1.669 . . . . 0.0 111.977 176.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.1 t -66.43 -40.89 87.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 CA-C-O 118.614 -0.708 . . . . 0.0 109.27 173.776 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 94.6 mt -63.23 -37.27 86.59 Favored 'General case' 0 C--N 1.34 0.188 0 CA-C-N 119.504 1.047 . . . . 0.0 110.855 174.58 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -62.37 -43.78 98.01 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 119.356 0.98 . . . . 0.0 111.107 173.02 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -62.74 -39.04 92.86 Favored 'General case' 0 CA--C 1.535 0.374 0 O-C-N 121.185 -0.947 . . . . 0.0 110.286 175.748 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.96 -43.65 98.22 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 124.556 1.142 . . . . 0.0 110.069 177.864 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -59.43 -42.71 92.51 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 123.679 0.792 . . . . 0.0 110.842 176.586 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -71.49 -10.61 60.04 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -179.644 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -106.6 -28.35 10.3 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 125.517 1.527 . . . . 0.0 111.651 -178.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 23.0 mtp -130.48 1.76 4.55 Favored 'General case' 0 N--CA 1.462 0.156 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -169.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -56.93 -11.63 6.09 Favored Glycine 0 CA--C 1.533 1.19 0 N-CA-C 115.993 1.157 . . . . 0.0 115.993 -175.399 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -78.58 -25.99 45.43 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 118.893 1.347 . . . . 0.0 111.778 173.777 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 52.1 mmtt -117.13 -19.8 9.54 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 125.468 1.507 . . . . 0.0 111.734 -176.031 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 57.1 tp -124.97 144.85 50.15 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 124.68 1.192 . . . . 0.0 110.668 -168.802 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -116.75 145.87 43.2 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 105.183 -2.154 . . . . 0.0 105.183 167.704 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 68.1 mt -115.83 140.24 38.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 105.768 -1.938 . . . . 0.0 105.768 175.179 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 80.8 t -132.84 98.23 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 -171.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -74.17 140.33 45.08 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 174.806 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 13.6 tt -143.49 124.97 11.09 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 178.783 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 61.0 t0 -83.89 106.63 15.71 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 124.401 1.08 . . . . 0.0 108.883 -172.331 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 33.0 m -59.81 -25.11 31.28 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 CA-C-O 118.444 -0.788 . . . . 0.0 112.072 -175.71 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -65.29 -18.6 65.44 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 119.646 1.112 . . . . 0.0 112.026 -178.556 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -118.7 4.53 11.6 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.041 1.337 . . . . 0.0 110.948 177.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 68.6 m-80 -140.5 38.72 1.87 Allowed 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 124.383 1.073 . . . . 0.0 110.151 -169.785 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 55.1 mm-40 -56.05 -33.27 64.83 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.295 0.638 . . . . 0.0 110.849 174.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -66.52 -47.93 71.36 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 118.3 0.5 . . . . 0.0 110.284 178.127 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.96 -40.86 91.68 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 118.65 0.659 . . . . 0.0 110.0 -179.236 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.35 -50.35 74.29 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.361 0.664 . . . . 0.0 110.1 174.08 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -60.37 -28.39 67.11 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 123.879 0.752 . . . . 0.0 112.334 177.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 21.9 ttmt -55.05 -29.48 57.56 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 125.565 1.546 . . . . 0.0 111.898 178.16 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -124.12 11.07 8.82 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.846 0.858 . . . . 0.0 111.71 178.775 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 67.38 24.42 73.63 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 123.914 0.768 . . . . 0.0 113.214 -177.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 48.9 t -63.65 129.62 27.53 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 171.649 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 35.0 ttm -142.64 4.37 1.52 Allowed 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.269 1.028 . . . . 0.0 111.278 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 22.8 m -142.6 161.58 37.7 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 126.697 1.999 . . . . 0.0 107.539 178.828 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 43.0 pt -143.0 156.45 61.95 Favored Pre-proline 0 CA--C 1.545 0.76 0 C-N-CA 124.588 1.155 . . . . 0.0 108.921 178.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -66.9 139.18 44.28 Favored 'Cis proline' 0 C--N 1.348 0.547 0 CA-C-N 120.423 1.187 . . . . 0.0 110.18 -5.68 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 33.1 m -131.37 139.1 49.42 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 174.832 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 83.7 mt -119.82 128.55 53.8 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 -169.59 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -117.86 124.32 48.04 Favored 'General case' 0 CA--C 1.516 -0.354 0 N-CA-C 103.973 -2.603 . . . . 0.0 103.973 177.515 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 15.9 t -96.38 122.68 48.12 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 N-CA-C 104.118 -2.549 . . . . 0.0 104.118 173.704 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.9 mp -116.16 152.45 33.67 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 175.317 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 57.8 tttp -135.02 121.83 20.97 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 173.123 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.4 t70 48.66 37.13 8.83 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.889 1.275 . . . . 0.0 112.264 175.469 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 99.07 2.1 57.02 Favored Glycine 0 CA--C 1.53 0.971 0 CA-C-O 117.954 -1.47 . . . . 0.0 115.283 169.539 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -122.1 145.55 48.06 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 120.292 2.046 . . . . 0.0 109.323 175.616 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 58.5 t -65.79 130.85 31.47 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 170.218 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 35.4 m -119.45 -19.27 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 CA-C-O 117.717 -1.135 . . . . 0.0 111.314 175.216 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -155.21 167.93 28.75 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 120.444 1.475 . . . . 0.0 111.191 173.345 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 14.3 m -141.84 151.11 42.45 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.767 1.627 . . . . 0.0 108.698 177.778 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 58.8 m -150.16 156.27 41.31 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.514 1.525 . . . . 0.0 108.57 169.146 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 42.3 t -133.62 144.91 34.54 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 -178.237 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 78.22 -175.86 54.43 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 123.695 0.664 . . . . 0.0 111.817 179.102 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -62.56 147.17 49.9 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.371 0.669 . . . . 0.0 110.415 177.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 58.6 mttt -142.22 138.0 16.25 Favored Pre-proline 0 C--O 1.234 0.281 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 168.615 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -68.6 165.09 30.54 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 122.134 1.889 . . . . 0.0 111.029 177.532 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -53.77 -44.04 69.72 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 125.531 1.532 . . . . 0.0 112.698 -178.773 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -63.78 -43.71 95.53 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.097 177.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.77 -38.49 86.66 Favored 'General case' 0 C--N 1.339 0.12 0 O-C-N 121.776 -0.577 . . . . 0.0 110.58 -179.792 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 51.9 mt -62.22 -45.87 91.42 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 123.511 0.724 . . . . 0.0 110.746 175.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 11.3 mt-30 -58.92 -41.0 86.26 Favored 'General case' 0 C--O 1.225 -0.19 0 CA-C-N 118.383 0.538 . . . . 0.0 110.769 175.214 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -65.9 -39.92 91.03 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 118.875 0.761 . . . . 0.0 110.81 179.747 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 67.8 tp -62.54 -36.38 82.42 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.339 1.456 . . . . 0.0 111.181 177.096 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 84.2 t -69.11 -47.88 72.36 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-N 118.572 0.623 . . . . 0.0 109.857 169.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -57.18 -40.6 77.66 Favored 'General case' 0 CA--C 1.521 -0.155 0 C-N-CA 125.498 1.519 . . . . 0.0 111.893 -168.535 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -65.52 -6.44 10.75 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 -178.54 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -126.59 0.4 6.84 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 124.526 1.13 . . . . 0.0 113.426 176.732 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 54.7 mt . . . . . 0 C--O 1.247 0.955 0 CA-C-N 119.462 1.028 . . . . 0.0 109.004 171.35 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.4 ptt? . . . . . 0 N--CA 1.481 1.104 0 CA-C-O 118.563 -0.732 . . . . 0.0 112.762 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -158.04 -175.64 5.47 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 119.799 1.181 . . . . 0.0 109.413 -169.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.6 mt -75.89 144.34 12.05 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 167.781 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 47.3 t -140.34 164.3 22.36 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 C-N-CA 127.049 2.14 . . . . 0.0 106.99 -173.804 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 3.7 tppp? -113.87 147.37 38.57 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 175.741 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -146.85 168.91 20.25 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 123.109 0.564 . . . . 0.0 110.535 175.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 33.2 p -136.03 177.73 7.61 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 125.929 1.691 . . . . 0.0 107.961 170.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -42.75 -37.85 1.9 Allowed 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.3 1.44 . . . . 0.0 112.836 169.666 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 50.8 mm-40 -73.88 -26.24 60.45 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.805 0.842 . . . . 0.0 113.03 -174.835 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 14.3 p -121.74 -19.77 6.68 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 -169.413 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -53.82 -45.85 70.97 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 124.54 1.136 . . . . 0.0 111.925 -171.826 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.6 m -65.7 -23.96 66.88 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 112.937 0.717 . . . . 0.0 112.937 -177.14 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -90.66 -28.68 18.21 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 124.086 0.954 . . . . 0.0 111.443 176.878 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 68.9 mm-40 -70.81 -32.63 69.77 Favored 'General case' 0 N--CA 1.453 -0.325 0 O-C-N 121.797 -0.564 . . . . 0.0 110.829 173.266 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 22.9 p -88.71 4.56 46.9 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 113.847 1.055 . . . . 0.0 113.847 -170.277 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 30.4 p -108.67 29.16 7.68 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.336 1.054 . . . . 0.0 112.339 -174.83 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -129.32 50.73 2.12 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.218 1.007 . . . . 0.0 110.954 -174.357 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 103.68 -155.37 17.82 Favored Glycine 0 C--N 1.337 0.625 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 178.26 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 45.1 t -71.53 138.22 22.12 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 N-CA-C 105.694 -1.965 . . . . 0.0 105.694 167.552 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 47.3 t -138.22 139.25 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 N-CA-C 105.739 -1.949 . . . . 0.0 105.739 179.316 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 61.1 tp -122.6 101.72 7.64 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 106.703 -1.592 . . . . 0.0 106.703 -176.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -83.27 151.28 25.68 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 179.767 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -130.4 94.21 3.62 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 126.482 1.913 . . . . 0.0 107.242 -178.51 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -74.2 114.46 12.57 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 105.704 -1.962 . . . . 0.0 105.704 174.895 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -149.46 -177.63 5.96 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.094 1.357 . . . . 0.0 108.521 -172.856 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -155.63 147.94 17.59 Favored Pre-proline 0 CA--C 1.532 0.255 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 168.062 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -61.2 -18.06 56.21 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 121.649 1.566 . . . . 0.0 115.72 -178.749 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 49.7 p-90 -69.02 -20.68 64.14 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 119.963 1.256 . . . . 0.0 111.878 173.549 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 30.6 t -59.22 146.33 39.56 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 125.146 1.379 . . . . 0.0 111.054 -172.787 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -95.22 -60.26 1.07 Allowed Glycine 0 CA--C 1.531 1.064 0 CA-C-O 118.795 -1.003 . . . . 0.0 111.36 169.795 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -66.04 -26.25 50.88 Favored 'Trans proline' 0 C--N 1.35 0.656 0 CA-C-N 120.293 2.047 . . . . 0.0 113.101 -172.693 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 30.8 m -57.53 -35.14 69.89 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 121.699 -0.625 . . . . 0.0 111.295 174.605 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.0 mmtp -67.3 -26.09 66.36 Favored 'General case' 0 CA--C 1.53 0.207 0 O-C-N 121.673 -0.642 . . . . 0.0 110.928 -179.757 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 29.8 mtm -71.85 -44.17 64.28 Favored 'General case' 0 C--N 1.34 0.173 0 CA-C-N 118.585 0.63 . . . . 0.0 110.426 177.615 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 15.5 tt -79.86 -22.16 11.95 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-O 118.574 -0.727 . . . . 0.0 111.351 -177.201 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -48.93 -52.32 47.71 Favored Pre-proline 0 CA--C 1.549 0.942 0 CA-C-N 120.424 1.466 . . . . 0.0 114.241 179.125 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -66.71 -26.92 45.29 Favored 'Trans proline' 0 C--N 1.35 0.607 0 CA-C-N 121.748 1.66 . . . . 0.0 112.454 176.512 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 6.1 t -69.82 -37.86 74.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 O-C-N 121.688 -0.633 . . . . 0.0 109.454 174.907 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 43.2 mt -65.66 -36.72 84.49 Favored 'General case' 0 C--O 1.224 -0.267 0 CA-C-N 119.286 0.948 . . . . 0.0 110.517 172.848 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -63.34 -43.73 96.89 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 119.198 0.908 . . . . 0.0 111.079 173.013 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -60.61 -44.98 95.68 Favored 'General case' 0 CA--C 1.531 0.241 0 O-C-N 121.243 -0.911 . . . . 0.0 110.186 175.889 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -62.16 -41.88 98.73 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 124.846 1.258 . . . . 0.0 109.942 179.397 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -60.24 -42.85 96.14 Favored 'General case' 0 CA--C 1.521 -0.168 0 C-N-CA 123.879 0.872 . . . . 0.0 110.905 176.846 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -71.54 -10.46 59.8 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 122.976 0.51 . . . . 0.0 112.337 -179.202 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -103.59 -34.0 8.8 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 125.205 1.402 . . . . 0.0 111.234 178.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 74.6 mmm -121.86 -5.63 9.08 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 113.364 0.876 . . . . 0.0 113.364 -168.512 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -57.83 -15.11 18.37 Favored Glycine 0 CA--C 1.532 1.133 0 CA-C-N 119.718 1.145 . . . . 0.0 115.135 -173.203 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -69.71 -30.48 68.12 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 118.441 1.12 . . . . 0.0 111.728 173.574 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 45.9 mmtm -112.82 -19.69 11.89 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 125.456 1.502 . . . . 0.0 111.676 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 30.1 tp -117.55 157.15 26.83 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.412 1.085 . . . . 0.0 111.214 -169.232 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 37.4 ttmt -128.3 141.32 51.48 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 103.893 -2.632 . . . . 0.0 103.893 166.453 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 62.2 mt -108.15 141.53 23.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 105.925 -1.88 . . . . 0.0 105.925 175.04 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 84.7 t -132.69 98.44 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 -173.494 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt -74.31 140.49 44.93 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 174.397 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 15.0 tt -142.35 126.81 16.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 176.671 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 49.2 t0 -83.42 103.49 12.83 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.795 1.238 . . . . 0.0 109.067 -173.076 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 28.2 m -60.1 -27.15 38.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 118.766 -0.635 . . . . 0.0 112.028 -174.686 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -66.31 -19.54 65.84 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 119.321 0.964 . . . . 0.0 111.73 -177.617 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -114.13 1.78 14.69 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.558 1.543 . . . . 0.0 110.893 178.493 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 69.0 m-80 -141.98 42.52 1.68 Allowed 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.387 1.075 . . . . 0.0 109.79 -169.515 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 45.2 mm-40 -56.22 -33.07 65.01 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.794 0.838 . . . . 0.0 111.236 178.746 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 36.0 mm-40 -65.78 -46.72 77.68 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 118.379 0.536 . . . . 0.0 110.389 179.074 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.45 -38.51 77.81 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 121.798 -0.564 . . . . 0.0 109.778 -178.914 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -58.78 -47.54 84.36 Favored 'General case' 0 CA--C 1.535 0.376 0 O-C-N 120.978 -1.076 . . . . 0.0 110.241 171.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -59.97 -28.93 66.9 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 124.087 0.851 . . . . 0.0 112.506 176.594 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 50.1 tptt -56.27 -29.05 60.61 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.602 1.161 . . . . 0.0 111.551 179.73 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -123.34 10.39 9.24 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.568 0.747 . . . . 0.0 111.664 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 62.31 33.31 85.72 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 123.558 0.599 . . . . 0.0 112.427 -176.176 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 57.5 t -64.94 121.06 13.29 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 173.001 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 26.1 mmt -132.45 2.64 3.85 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.96 1.304 . . . . 0.0 111.465 -179.009 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 30.0 m -144.82 161.48 39.17 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 126.953 2.101 . . . . 0.0 107.062 178.242 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 34.5 pt -144.21 155.18 58.18 Favored Pre-proline 0 CA--C 1.545 0.788 0 C-N-CA 124.772 1.229 . . . . 0.0 108.451 177.406 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -68.54 139.54 51.47 Favored 'Cis proline' 0 C--N 1.35 0.624 0 CA-C-N 120.651 1.268 . . . . 0.0 110.53 -2.474 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 32.0 m -132.89 132.57 42.21 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 177.391 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 6.9 mp -110.52 131.17 55.28 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 -171.735 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -122.38 128.35 50.86 Favored 'General case' 0 CA--C 1.508 -0.638 0 N-CA-C 103.388 -2.819 . . . . 0.0 103.388 179.132 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 1.5 t -110.61 127.13 67.86 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.751 0 N-CA-C 104.337 -2.468 . . . . 0.0 104.337 -176.255 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.3 mp -126.08 152.05 46.37 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 -174.813 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -138.04 125.47 21.94 Favored 'General case' 0 CA--C 1.513 -0.479 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 175.221 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 29.2 t70 49.84 33.12 6.02 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.959 1.303 . . . . 0.0 112.348 173.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 99.41 4.59 56.14 Favored Glycine 0 CA--C 1.53 1.018 0 CA-C-O 118.018 -1.434 . . . . 0.0 114.551 170.641 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -122.0 144.89 48.62 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 120.101 1.951 . . . . 0.0 109.043 174.617 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 14.3 p -68.74 129.71 33.43 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 169.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 27.7 m -115.62 -20.87 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 CA-C-O 117.577 -1.201 . . . . 0.0 111.052 179.586 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -159.42 166.36 31.19 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 120.734 1.606 . . . . 0.0 111.402 176.343 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 13.3 m -136.34 151.18 49.31 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.991 1.716 . . . . 0.0 108.519 175.418 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 74.1 m -150.26 158.11 43.81 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.882 1.673 . . . . 0.0 108.671 171.206 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 39.2 t -133.97 148.21 30.32 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 -177.01 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.68 177.24 51.86 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 123.973 0.797 . . . . 0.0 112.705 171.797 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 47.6 t80 -62.55 135.46 57.42 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.352 0.661 . . . . 0.0 109.59 175.598 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 13.0 mptt -136.05 136.2 22.58 Favored Pre-proline 0 CA--C 1.533 0.324 0 C-N-CA 126.429 1.892 . . . . 0.0 105.995 175.389 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -70.61 160.19 50.28 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 122.493 2.128 . . . . 0.0 110.591 176.18 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 41.5 pttt -59.34 -28.9 67.25 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -177.108 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -65.86 -48.86 70.15 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 122.839 0.456 . . . . 0.0 110.037 173.92 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.6 -37.9 89.06 Favored 'General case' 0 CA--C 1.529 0.162 0 O-C-N 121.898 -0.501 . . . . 0.0 110.711 178.296 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 79.3 mt -64.97 -41.56 95.34 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 119.355 -0.355 . . . . 0.0 111.255 176.267 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 15.6 mt-30 -59.32 -41.05 88.17 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 118.824 0.738 . . . . 0.0 110.086 174.588 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -64.77 -40.82 95.9 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 118.199 0.454 . . . . 0.0 110.365 178.724 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 63.3 tp -61.03 -43.77 98.4 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.733 1.213 . . . . 0.0 110.755 177.681 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 78.5 t -61.42 -46.43 96.61 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 123.651 0.78 . . . . 0.0 109.37 173.125 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -61.91 -25.73 67.75 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 125.017 1.327 . . . . 0.0 112.239 -173.086 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 49.2 mtpt -55.86 -24.58 37.73 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 118.658 -0.687 . . . . 0.0 112.576 172.327 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 80.9 m-70 -123.34 -8.2 8.13 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 -168.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 82.1 mt . . . . . 0 C--O 1.248 0.975 0 CA-C-N 119.155 0.889 . . . . 0.0 109.327 171.512 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.8 mmt . . . . . 0 N--CA 1.483 1.224 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -151.74 -175.47 5.22 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 125.006 1.322 . . . . 0.0 109.373 -174.548 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.3 mt -75.34 142.12 14.96 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 166.737 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 41.3 t -135.32 163.72 35.05 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 C-N-CA 126.353 1.861 . . . . 0.0 106.251 -177.127 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 6.2 ttmt -118.99 144.83 46.28 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 174.69 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -145.12 166.49 25.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.393 0.615 . . . . 0.0 110.976 -177.027 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.9 p -133.09 169.92 16.15 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 126.254 1.822 . . . . 0.0 107.779 171.29 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -52.63 -29.71 27.61 Favored 'General case' 0 CA--C 1.535 0.365 0 C-N-CA 124.499 1.12 . . . . 0.0 113.23 -178.67 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 82.6 mm-40 -63.54 -29.0 70.33 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.788 1.235 . . . . 0.0 113.103 179.748 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.6 m -135.17 -6.85 2.31 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 -169.295 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -52.14 -42.98 63.8 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.439 1.096 . . . . 0.0 111.722 -178.77 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.6 m -62.74 -39.15 93.19 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.111 0.564 . . . . 0.0 111.83 -179.02 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -68.54 -43.89 75.7 Favored 'General case' 0 N--CA 1.452 -0.329 0 O-C-N 122.011 -0.431 . . . . 0.0 110.079 177.68 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 67.1 mm-40 -63.05 -34.52 77.76 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-O 119.618 -0.229 . . . . 0.0 111.085 -179.068 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 27.4 p -85.65 3.66 39.94 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 113.524 0.935 . . . . 0.0 113.524 -176.507 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 69.6 m -105.4 30.05 5.99 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.053 0.941 . . . . 0.0 112.07 -175.515 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -132.83 37.46 3.45 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.455 0.702 . . . . 0.0 112.702 -173.248 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 123.11 -152.47 16.93 Favored Glycine 0 N--CA 1.465 0.593 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 174.022 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 67.4 t -73.09 133.72 31.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 104.528 -2.397 . . . . 0.0 104.528 165.848 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 40.7 t -136.26 130.19 47.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.8 tt -110.9 99.49 8.39 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 105.865 -1.902 . . . . 0.0 105.865 -178.106 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -80.07 143.16 34.23 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 178.325 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -123.91 94.05 4.11 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 125.806 1.642 . . . . 0.0 107.159 -176.911 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -73.88 113.15 10.72 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 105.791 -1.929 . . . . 0.0 105.791 174.758 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -148.86 -177.05 5.58 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.785 1.234 . . . . 0.0 108.354 -173.125 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -156.07 149.06 18.27 Favored Pre-proline 0 CA--C 1.531 0.224 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 167.726 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -61.44 -18.17 57.83 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 121.707 1.605 . . . . 0.0 115.61 179.657 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 52.6 p-90 -70.56 -19.44 62.88 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 120.002 1.274 . . . . 0.0 111.901 173.789 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 19.5 t -60.03 151.99 25.08 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 124.944 1.298 . . . . 0.0 110.844 -174.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -105.88 -58.0 0.64 Allowed Glycine 0 CA--C 1.531 1.058 0 CA-C-O 118.842 -0.976 . . . . 0.0 111.017 171.397 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -56.91 -33.16 94.53 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 123.28 2.653 . . . . 0.0 113.518 -179.615 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 31.4 m -58.11 -34.05 69.77 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.202 0.601 . . . . 0.0 111.423 176.829 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.2 mmtp -68.42 -24.85 64.79 Favored 'General case' 0 CA--C 1.53 0.184 0 O-C-N 121.534 -0.729 . . . . 0.0 110.927 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 31.0 mtm -70.65 -43.21 69.65 Favored 'General case' 0 C--N 1.34 0.153 0 CA-C-N 118.735 0.698 . . . . 0.0 110.357 176.625 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 17.5 tt -83.08 -22.74 8.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-O 118.61 -0.709 . . . . 0.0 111.616 -176.355 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -49.28 -51.08 60.4 Favored Pre-proline 0 CA--C 1.547 0.853 0 CA-C-N 120.234 1.379 . . . . 0.0 114.261 178.766 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -66.49 -28.97 45.33 Favored 'Trans proline' 0 C--N 1.351 0.675 0 CA-C-N 121.675 1.634 . . . . 0.0 112.028 176.378 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.2 t -68.27 -36.67 76.0 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 O-C-N 121.645 -0.659 . . . . 0.0 109.703 175.08 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 87.9 mt -66.39 -36.06 81.89 Favored 'General case' 0 C--N 1.341 0.212 0 CA-C-N 119.654 1.115 . . . . 0.0 111.144 171.761 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -62.45 -42.94 99.83 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 119.376 0.989 . . . . 0.0 110.799 171.82 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -63.92 -39.98 95.41 Favored 'General case' 0 CA--C 1.532 0.272 0 O-C-N 121.199 -0.938 . . . . 0.0 110.466 176.273 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 44.8 tp -62.05 -42.96 99.74 Favored 'General case' 0 CA--C 1.528 0.098 0 C-N-CA 123.867 0.867 . . . . 0.0 109.992 176.295 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -60.39 -42.45 95.9 Favored 'General case' 0 CA--C 1.52 -0.185 0 C-N-CA 123.275 0.63 . . . . 0.0 110.845 178.412 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -71.69 -10.8 60.31 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.319 0.648 . . . . 0.0 112.511 -179.763 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -105.52 -31.98 8.72 Favored 'General case' 0 C--O 1.232 0.15 0 C-N-CA 125.486 1.514 . . . . 0.0 111.458 -179.582 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 80.0 mmm -125.47 -3.32 7.34 Favored 'General case' 0 N--CA 1.46 0.06 0 CA-C-O 118.407 -0.806 . . . . 0.0 113.113 -167.662 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -57.85 -10.91 7.18 Favored Glycine 0 CA--C 1.534 1.226 0 C-N-CA 124.826 1.203 . . . . 0.0 115.919 -173.735 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -75.22 -24.57 57.75 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 118.502 1.151 . . . . 0.0 111.881 173.458 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 50.6 mtmt -128.26 -16.01 4.54 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 125.757 1.623 . . . . 0.0 111.887 -173.014 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 58.9 tp -123.0 144.23 49.4 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 124.816 1.246 . . . . 0.0 110.283 -172.227 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -116.25 145.39 43.18 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 105.256 -2.127 . . . . 0.0 105.256 167.305 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 82.6 mt -115.12 137.9 47.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 105.298 -2.112 . . . . 0.0 105.298 175.477 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 95.2 t -132.06 96.9 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 -171.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -74.96 137.03 41.34 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 176.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 13.3 tt -140.43 126.73 21.47 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 178.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -83.63 106.53 15.42 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 124.462 1.105 . . . . 0.0 109.098 -172.355 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 34.6 m -58.97 -27.7 36.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 118.643 -0.694 . . . . 0.0 111.99 -176.03 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -65.69 -17.23 64.46 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 119.347 0.976 . . . . 0.0 112.204 -176.593 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -121.96 4.16 9.92 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.927 1.291 . . . . 0.0 111.225 179.484 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 68.7 m-80 -141.28 40.47 1.76 Allowed 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.197 0.999 . . . . 0.0 109.785 -170.607 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 53.7 mm-40 -54.42 -30.84 53.69 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.097 0.959 . . . . 0.0 111.09 175.375 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -66.16 -50.18 64.83 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 123.99 0.916 . . . . 0.0 110.167 -179.273 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.77 -38.96 80.4 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 -178.428 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -58.62 -48.29 81.5 Favored 'General case' 0 CA--C 1.534 0.342 0 O-C-N 121.298 -0.876 . . . . 0.0 110.357 172.737 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -61.23 -28.76 69.71 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 123.905 0.764 . . . . 0.0 112.213 177.767 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 19.9 tptm -56.19 -29.3 60.69 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.697 1.199 . . . . 0.0 111.509 179.621 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -123.73 10.82 9.03 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.552 0.741 . . . . 0.0 111.627 -179.394 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 64.35 30.81 78.88 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 123.616 0.627 . . . . 0.0 112.582 -177.226 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 61.0 t -65.96 122.44 16.92 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 171.06 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 26.1 mmt -132.65 3.5 3.84 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.784 1.233 . . . . 0.0 111.381 -178.312 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 23.7 m -144.66 162.23 37.19 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 126.652 1.981 . . . . 0.0 107.621 179.781 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 17.7 pt -142.42 155.14 64.31 Favored Pre-proline 0 CA--C 1.544 0.731 0 C-N-CA 124.663 1.185 . . . . 0.0 108.689 175.195 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -67.99 138.32 43.39 Favored 'Cis proline' 0 C--N 1.35 0.63 0 CA-C-N 120.469 1.203 . . . . 0.0 110.399 -3.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 44.9 m -131.33 140.61 49.77 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 174.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 83.4 mt -122.32 127.73 50.18 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 -169.376 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -117.84 125.4 50.46 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 103.984 -2.599 . . . . 0.0 103.984 178.379 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 10.0 t -97.05 123.58 49.45 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 N-CA-C 104.145 -2.539 . . . . 0.0 104.145 172.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.9 mp -115.19 151.69 33.96 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 175.408 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 21.0 tptm -133.55 119.37 19.41 Favored 'General case' 0 CA--C 1.516 -0.363 0 N-CA-C 106.229 -1.767 . . . . 0.0 106.229 174.402 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.2 t70 50.83 37.59 17.52 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.626 1.17 . . . . 0.0 112.483 175.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 103.73 -2.35 45.42 Favored Glycine 0 CA--C 1.527 0.826 0 CA-C-O 118.087 -1.396 . . . . 0.0 115.582 168.61 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -128.41 145.25 51.14 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 120.033 1.917 . . . . 0.0 109.773 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 61.4 t -61.63 132.52 27.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 173.763 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.4 p -119.49 -21.85 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.77 0 C-N-CA 124.413 1.085 . . . . 0.0 110.372 174.887 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -157.62 165.56 35.17 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 120.552 1.524 . . . . 0.0 111.053 175.269 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 11.7 m -137.57 151.21 48.12 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.219 1.408 . . . . 0.0 109.004 179.577 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 58.4 m -148.47 157.23 43.34 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 126.022 1.729 . . . . 0.0 108.561 169.399 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 36.6 t -133.71 146.71 31.38 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 -179.354 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 79.41 -175.97 54.86 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 123.504 0.573 . . . . 0.0 112.19 177.135 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -63.17 146.55 53.1 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.579 0.752 . . . . 0.0 110.618 178.511 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 66.7 mttt -143.9 136.17 13.29 Favored Pre-proline 0 CA--C 1.532 0.284 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 168.832 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -70.42 160.42 49.59 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 122.408 2.072 . . . . 0.0 110.086 174.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 49.0 pttt -58.4 -28.59 65.34 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 113.569 0.952 . . . . 0.0 113.569 -177.369 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -65.25 -50.34 66.17 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 118.61 0.641 . . . . 0.0 109.741 174.874 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.81 -39.84 95.53 Favored 'General case' 0 C--N 1.34 0.165 0 C-N-CA 122.89 0.476 . . . . 0.0 110.627 178.473 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 92.3 mt -64.08 -42.54 96.92 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 122.74 0.416 . . . . 0.0 111.344 177.276 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -61.8 -40.07 93.94 Favored 'General case' 0 C--O 1.223 -0.29 0 CA-C-N 118.592 0.633 . . . . 0.0 110.197 176.469 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -65.5 -41.92 92.7 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 118.729 0.695 . . . . 0.0 110.302 178.84 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 58.3 tp -60.55 -38.29 84.03 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.744 1.618 . . . . 0.0 111.22 177.115 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 71.5 t -68.01 -49.92 63.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 C-N-CA 123.822 0.849 . . . . 0.0 109.545 171.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 -58.63 -40.68 84.02 Favored 'General case' 0 C--N 1.333 -0.122 0 C-N-CA 125.344 1.458 . . . . 0.0 111.821 -168.403 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.421 ' HG3' ' CD2' ' A' ' 103' ' ' HIS . 22.0 ptmt -65.75 -8.31 20.45 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 -177.542 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' HIS . . . . . 0.421 ' CD2' ' HG3' ' A' ' 102' ' ' LYS . 94.7 m-70 -124.14 1.9 8.56 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 124.413 1.085 . . . . 0.0 113.695 179.605 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 55.8 mt . . . . . 0 C--O 1.248 1.025 0 CA-C-N 119.386 0.994 . . . . 0.0 109.227 172.519 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.2 tmm? . . . . . 0 N--CA 1.48 1.031 0 CA-C-O 118.628 -0.701 . . . . 0.0 109.877 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -163.62 -173.58 3.35 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.622 1.569 . . . . 0.0 108.386 -178.429 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.8 mt -75.2 146.32 9.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 N-CA-C 106.97 -1.493 . . . . 0.0 106.97 166.853 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 20.2 t -138.59 163.95 27.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 126.621 1.968 . . . . 0.0 106.856 -176.664 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.48 ' HE2' ' H ' ' A' ' 6' ' ' ALA . 0.0 OUTLIER -125.25 136.49 53.59 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 105.618 -1.993 . . . . 0.0 105.618 177.011 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.48 ' H ' ' HE2' ' A' ' 5' ' ' LYS . . . -141.3 176.2 9.04 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 123.631 0.772 . . . . 0.0 112.473 -169.542 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.4 p -130.08 173.12 11.04 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 127.646 2.378 . . . . 0.0 107.924 175.094 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -45.95 -39.9 9.52 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 124.643 1.177 . . . . 0.0 113.521 177.774 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 80.8 mm-40 -90.43 -38.02 13.56 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 122.921 0.489 . . . . 0.0 111.727 -174.681 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 11.4 m -67.83 -33.63 75.15 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 118.143 0.429 . . . . 0.0 110.927 177.34 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 33.4 t80 -50.77 -45.96 59.24 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 126.143 1.777 . . . . 0.0 111.217 -176.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 9.7 m -64.86 -37.8 88.85 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 118.601 0.637 . . . . 0.0 111.876 -175.864 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -68.53 -45.68 71.56 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 175.593 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -64.21 -36.75 85.09 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 122.486 0.314 . . . . 0.0 111.252 -176.432 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.409 ' HA ' HG21 ' A' ' 20' ' ' VAL . 36.8 p -81.17 -4.1 54.3 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 124.071 0.948 . . . . 0.0 113.031 -176.688 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 70.0 m -94.66 28.64 2.57 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.937 0.895 . . . . 0.0 111.754 -177.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -134.01 66.84 1.53 Allowed 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.541 1.137 . . . . 0.0 110.229 -177.708 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 88.13 -156.56 27.37 Favored Glycine 0 C--N 1.337 0.59 0 N-CA-C 110.373 -1.091 . . . . 0.0 110.373 174.205 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 97.9 t -71.41 132.85 32.82 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 N-CA-C 106.889 -1.522 . . . . 0.0 106.889 168.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.409 HG21 ' HA ' ' A' ' 15' ' ' THR . 47.2 t -136.46 146.34 29.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 179.74 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 5.0 tt -128.06 100.56 5.93 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 -176.812 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -81.97 146.27 29.83 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.256 -179.615 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -124.56 94.42 4.19 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 126.113 1.765 . . . . 0.0 107.458 -176.394 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -74.44 112.42 10.6 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 106.05 -1.833 . . . . 0.0 106.05 175.505 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -149.24 -177.22 5.71 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.668 1.187 . . . . 0.0 108.575 -174.087 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -155.65 146.96 16.71 Favored Pre-proline 0 CA--C 1.532 0.277 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 167.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_exo -60.29 -18.21 51.2 Favored 'Trans proline' 0 N--CA 1.461 -0.439 0 C-N-CA 121.821 1.68 . . . . 0.0 115.86 -178.359 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 51.3 p-90 -69.35 -20.43 63.85 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 119.949 1.25 . . . . 0.0 111.937 173.674 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 34.2 t -59.31 148.21 33.05 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 125.065 1.346 . . . . 0.0 111.199 -172.577 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -97.61 -63.28 0.89 Allowed Glycine 0 CA--C 1.53 0.971 0 CA-C-O 118.403 -1.22 . . . . 0.0 110.974 171.64 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -62.24 -26.52 77.53 Favored 'Trans proline' 0 C--N 1.35 0.613 0 CA-C-N 120.424 2.112 . . . . 0.0 113.679 -174.827 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 33.8 m -57.39 -34.98 69.43 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 121.582 -0.698 . . . . 0.0 111.515 174.464 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.8 mmtp -67.53 -24.94 65.6 Favored 'General case' 0 CA--C 1.53 0.182 0 O-C-N 121.602 -0.686 . . . . 0.0 111.021 -179.613 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 31.3 mtm -71.22 -43.41 67.4 Favored 'General case' 0 C--N 1.34 0.182 0 CA-C-N 118.68 0.673 . . . . 0.0 110.421 176.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 14.1 tt -84.18 -23.48 7.76 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-O 118.705 -0.664 . . . . 0.0 111.727 -174.646 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -48.88 -51.47 54.44 Favored Pre-proline 0 CA--C 1.548 0.877 0 CA-C-N 119.911 1.232 . . . . 0.0 114.076 178.486 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -66.57 -29.67 43.8 Favored 'Trans proline' 0 C--N 1.35 0.65 0 CA-C-N 121.611 1.611 . . . . 0.0 112.194 176.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 5.4 t -66.46 -39.92 85.24 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 175.218 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 67.9 mt -64.99 -38.23 90.26 Favored 'General case' 0 C--N 1.34 0.169 0 CA-C-N 119.317 0.962 . . . . 0.0 110.858 174.513 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -61.6 -43.9 97.99 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 119.011 0.823 . . . . 0.0 111.122 172.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -62.34 -38.5 89.75 Favored 'General case' 0 CA--C 1.533 0.327 0 O-C-N 121.393 -0.817 . . . . 0.0 110.223 175.609 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.77 -44.48 96.08 Favored 'General case' 0 C--N 1.333 -0.114 0 C-N-CA 124.074 0.95 . . . . 0.0 110.391 177.097 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -60.24 -41.89 94.1 Favored 'General case' 0 CA--C 1.521 -0.165 0 C-N-CA 123.24 0.616 . . . . 0.0 110.92 177.9 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 -72.01 -11.03 60.58 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 -179.075 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -106.45 -32.69 7.99 Favored 'General case' 0 C--O 1.232 0.133 0 C-N-CA 125.226 1.411 . . . . 0.0 111.639 -179.642 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 87.4 mmm -125.75 -4.18 7.08 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-O 118.357 -0.83 . . . . 0.0 113.022 -168.284 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -58.39 -11.77 10.8 Favored Glycine 0 CA--C 1.533 1.188 0 CA-C-N 119.835 1.198 . . . . 0.0 114.811 -175.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -65.98 -27.95 68.53 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 118.418 1.109 . . . . 0.0 111.83 171.378 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.464 ' HA ' ' HE3' ' A' ' 49' ' ' LYS . 0.0 OUTLIER -121.28 -24.87 5.36 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 125.954 1.701 . . . . 0.0 111.81 179.333 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 45.9 tp -103.0 157.76 16.76 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 124.144 0.977 . . . . 0.0 111.036 -169.674 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -133.88 144.41 48.88 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 103.957 -2.608 . . . . 0.0 103.957 166.65 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 66.2 mt -118.56 140.54 41.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 105.61 -1.996 . . . . 0.0 105.61 178.305 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 74.0 t -133.0 97.21 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 -170.205 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 51.3 mtmt -74.35 134.46 42.5 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 177.294 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 20.2 tt -137.92 126.8 33.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 178.167 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 62.9 t0 -87.84 103.97 16.15 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 114.727 -1.124 . . . . 0.0 108.419 -171.599 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 23.0 m -61.7 -23.2 30.29 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 CA-C-O 118.766 -0.635 . . . . 0.0 112.208 -174.339 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -65.34 -22.67 66.84 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 119.25 0.932 . . . . 0.0 111.562 -179.742 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -117.28 1.71 12.47 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.926 1.29 . . . . 0.0 111.323 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 66.6 m-80 -139.36 43.34 2.02 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 125.167 1.387 . . . . 0.0 108.798 -171.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.411 ' CD ' ' H ' ' A' ' 61' ' ' GLN . 3.4 mp0 -60.64 -35.44 76.21 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.034 0.934 . . . . 0.0 109.825 -175.451 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 -62.64 -44.49 96.15 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 123.674 0.79 . . . . 0.0 110.218 179.174 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -66.7 -40.86 88.65 Favored 'General case' 0 C--O 1.225 -0.188 0 C-N-CA 123.467 0.707 . . . . 0.0 110.082 -178.061 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.38 -50.06 75.41 Favored 'General case' 0 CA--C 1.532 0.283 0 O-C-N 121.742 -0.598 . . . . 0.0 110.058 173.185 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -58.43 -29.77 63.96 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 123.558 0.599 . . . . 0.0 112.55 176.347 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 9.8 ttpt -58.05 -26.61 62.7 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 125.758 1.623 . . . . 0.0 111.994 -178.35 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -123.61 11.04 9.13 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.886 0.874 . . . . 0.0 111.944 176.75 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 65.89 29.05 74.24 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 123.567 0.603 . . . . 0.0 112.765 -177.173 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 61.8 t -65.65 125.26 22.37 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 170.14 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 98.7 mtp -135.25 3.41 3.11 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.747 1.219 . . . . 0.0 111.515 -179.131 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 24.0 m -144.1 162.05 37.26 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 126.588 1.955 . . . . 0.0 107.743 179.228 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 38.6 pt -142.11 154.39 64.64 Favored Pre-proline 0 CA--C 1.545 0.767 0 C-N-CA 124.534 1.134 . . . . 0.0 108.685 176.332 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -67.71 140.07 51.63 Favored 'Cis proline' 0 C--N 1.351 0.692 0 CA-C-N 120.437 1.192 . . . . 0.0 110.429 -3.149 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 35.8 m -131.74 143.52 50.3 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 173.801 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 88.3 mt -123.9 126.84 47.08 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 -169.441 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -115.87 121.71 43.18 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 103.17 -2.9 . . . . 0.0 103.17 177.563 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 4.6 t -94.21 129.14 44.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 103.641 -2.726 . . . . 0.0 103.641 174.43 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.7 mp -122.89 154.81 37.83 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 178.841 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -138.33 123.32 19.0 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 174.12 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.0 t70 49.86 37.41 13.45 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.07 1.348 . . . . 0.0 112.647 176.299 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 105.1 -4.23 41.29 Favored Glycine 0 CA--C 1.529 0.916 0 CA-C-O 118.184 -1.342 . . . . 0.0 115.271 168.58 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -131.92 150.68 52.08 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 120.056 1.928 . . . . 0.0 110.374 -177.221 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 44.6 t -62.2 132.14 27.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 178.57 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.8 p -120.44 -21.75 3.94 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 C-N-CA 125.436 1.494 . . . . 0.0 109.926 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -159.84 172.21 18.05 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 120.121 1.328 . . . . 0.0 109.873 174.034 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 25.9 m -146.53 151.41 37.29 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.708 1.203 . . . . 0.0 109.246 177.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 4.2 m -147.13 156.87 43.35 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 125.507 1.523 . . . . 0.0 109.14 170.174 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 35.5 t -134.85 143.32 37.82 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 -177.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 76.17 -173.89 53.65 Favored Glycine 0 CA--C 1.531 1.052 0 CA-C-O 121.509 0.505 . . . . 0.0 111.862 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 65.4 t80 -63.56 149.2 46.86 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.483 0.713 . . . . 0.0 110.871 179.453 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 27.4 mttp -144.71 136.92 13.2 Favored Pre-proline 0 CA--C 1.534 0.342 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 168.247 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -70.44 161.3 46.52 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 122.32 2.013 . . . . 0.0 110.228 174.558 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 46.5 pttt -59.15 -29.53 67.49 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 -177.429 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -64.86 -50.13 67.81 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 118.951 0.796 . . . . 0.0 109.737 175.096 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.62 -39.47 94.44 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 122.73 0.412 . . . . 0.0 110.821 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 77.1 mt -63.68 -44.46 93.66 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 122.949 0.5 . . . . 0.0 111.249 176.385 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 12.4 mt-30 -61.4 -39.44 90.73 Favored 'General case' 0 C--O 1.224 -0.243 0 CA-C-O 118.704 -0.665 . . . . 0.0 110.371 176.358 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -65.6 -40.46 92.69 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 118.915 0.78 . . . . 0.0 110.439 178.643 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 68.9 tp -62.93 -35.73 81.07 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.634 1.574 . . . . 0.0 111.451 177.491 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 76.9 t -69.04 -50.96 48.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 C-N-CA 123.638 0.775 . . . . 0.0 109.584 169.615 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -58.27 -38.5 77.08 Favored 'General case' 0 CA--C 1.522 -0.117 0 C-N-CA 126.013 1.725 . . . . 0.0 112.196 -168.561 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -64.68 -6.96 8.92 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 -179.096 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -123.25 -5.9 8.31 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 124.395 1.078 . . . . 0.0 113.276 176.849 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 57.6 mt . . . . . 0 C--O 1.246 0.911 0 CA-C-N 119.319 0.963 . . . . 0.0 109.223 172.678 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 78.5 mtm . . . . . 0 N--CA 1.481 1.12 0 CA-C-O 120.399 0.143 . . . . 0.0 110.884 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 68.87 167.14 0.27 Allowed 'General case' 0 C--O 1.237 0.42 0 C-N-CA 128.776 2.831 . . . . 0.0 114.756 169.596 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.1 mp -87.01 141.88 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 N-CA-C 105.134 -2.172 . . . . 0.0 105.134 169.301 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 46.8 t -132.91 164.4 35.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 C-N-CA 127.165 2.186 . . . . 0.0 105.904 -175.251 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 6.3 ttmt -121.67 147.2 46.19 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 177.007 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -147.35 168.32 22.11 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 123.279 0.632 . . . . 0.0 110.449 179.546 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.407 HG22 HD21 ' A' ' 60' ' ' ASN . 33.8 p -134.68 179.78 6.08 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 125.595 1.558 . . . . 0.0 107.371 169.314 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -49.17 -29.74 5.9 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.842 0.857 . . . . 0.0 112.685 170.167 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -65.18 -27.15 68.5 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.265 1.426 . . . . 0.0 113.138 179.27 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.9 p -134.43 -16.9 2.06 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 114.66 1.356 . . . . 0.0 114.66 -167.097 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -55.11 -45.13 75.48 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 124.442 1.097 . . . . 0.0 111.85 -170.091 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.7 m -63.26 -39.0 93.35 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 122.747 0.419 . . . . 0.0 111.613 -178.014 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -68.43 -44.49 74.87 Favored 'General case' 0 N--CA 1.452 -0.361 0 O-C-N 122.119 -0.363 . . . . 0.0 110.076 177.398 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -63.34 -34.6 78.06 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-O 119.33 -0.367 . . . . 0.0 111.108 -178.442 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 35.0 p -86.83 3.48 45.12 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.192 0.997 . . . . 0.0 113.268 -176.635 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 69.5 m -105.36 32.29 4.36 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.252 1.021 . . . . 0.0 111.562 -177.035 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -132.3 53.74 1.98 Allowed 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.197 0.999 . . . . 0.0 110.798 -176.836 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 97.55 -157.17 20.79 Favored Glycine 0 C--N 1.339 0.703 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 177.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 91.1 t -70.17 137.11 24.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 167.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 61.9 t -138.16 144.94 29.42 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 N-CA-C 105.479 -2.045 . . . . 0.0 105.479 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 41.8 tp -122.97 99.42 6.37 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 106.611 -1.625 . . . . 0.0 106.611 -177.321 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -78.52 149.95 33.0 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 109.319 -0.622 . . . . 0.0 109.319 177.763 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -129.15 94.38 3.8 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 126.761 2.024 . . . . 0.0 106.821 -179.341 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -73.25 114.51 11.52 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 105.882 -1.896 . . . . 0.0 105.882 174.253 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -147.38 -177.85 5.92 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 125.507 1.523 . . . . 0.0 108.301 -171.154 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -155.72 148.69 18.19 Favored Pre-proline 0 C--O 1.235 0.303 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 168.058 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -67.56 -13.25 38.4 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 121.656 1.571 . . . . 0.0 114.469 -175.206 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 53.4 p-90 -71.1 -20.26 62.36 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 120.194 1.361 . . . . 0.0 112.283 170.494 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 34.7 t -61.0 153.66 24.63 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.078 1.351 . . . . 0.0 111.523 -172.117 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -103.26 -65.53 0.72 Allowed Glycine 0 CA--C 1.53 0.983 0 CA-C-O 118.385 -1.23 . . . . 0.0 110.91 174.479 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_exo -55.77 -30.03 74.38 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.965 2.444 . . . . 0.0 114.118 179.661 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 33.2 m -58.18 -30.34 66.33 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 121.321 -0.862 . . . . 0.0 111.977 175.222 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.5 mmtp -72.68 -38.26 67.64 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 123.314 0.646 . . . . 0.0 110.014 178.046 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 5.8 ptt? -72.76 -31.52 64.97 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 118.817 0.735 . . . . 0.0 111.639 -176.327 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 15.9 tt -78.26 -19.1 13.53 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-O 118.925 -0.56 . . . . 0.0 111.969 174.608 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -54.94 -49.33 92.59 Favored Pre-proline 0 CA--C 1.545 0.77 0 CA-C-N 120.272 1.397 . . . . 0.0 113.655 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -66.53 -26.58 46.94 Favored 'Trans proline' 0 C--N 1.351 0.696 0 CA-C-N 121.95 1.732 . . . . 0.0 112.344 175.722 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 11.7 t -67.19 -39.7 83.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 174.11 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 96.3 mt -67.02 -34.34 77.51 Favored 'General case' 0 C--N 1.339 0.122 0 CA-C-N 119.013 0.824 . . . . 0.0 111.579 173.431 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -64.68 -42.26 95.47 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 119.338 0.972 . . . . 0.0 110.859 172.318 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -62.64 -37.77 87.66 Favored 'General case' 0 CA--C 1.531 0.235 0 O-C-N 120.884 -1.135 . . . . 0.0 110.457 173.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 42.9 tp -63.99 -42.42 97.19 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 123.114 0.566 . . . . 0.0 110.314 177.361 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -57.8 -44.47 86.34 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 118.983 0.81 . . . . 0.0 110.881 173.418 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -68.99 -8.87 48.91 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -177.898 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -112.2 -30.05 7.35 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 125.787 1.635 . . . . 0.0 111.973 -179.096 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 87.1 mmm -129.1 -7.66 4.86 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -169.539 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -58.48 -15.93 26.74 Favored Glycine 0 CA--C 1.529 0.949 0 CA-C-N 119.906 1.23 . . . . 0.0 114.674 -171.618 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -65.75 -26.2 67.62 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.297 1.039 . . . . 0.0 111.653 174.221 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.458 ' HA ' ' HE3' ' A' ' 49' ' ' LYS . 0.0 OUTLIER -122.91 -19.91 5.99 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.932 1.693 . . . . 0.0 111.884 179.761 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 36.0 tp -110.37 154.5 23.46 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 124.113 0.965 . . . . 0.0 111.144 -169.848 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 36.1 ttmt -130.96 144.28 51.36 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 104.6 -2.37 . . . . 0.0 104.6 167.867 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 94.1 mt -115.75 136.54 52.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 105.305 -2.109 . . . . 0.0 105.305 179.393 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 95.8 t -132.35 98.77 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-N 119.11 0.868 . . . . 0.0 109.23 -169.252 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 29.6 mtpp -74.57 139.99 44.1 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 175.618 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 13.0 tt -141.61 128.08 19.76 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 176.632 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 60.4 t0 -85.21 104.6 15.23 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 124.554 1.142 . . . . 0.0 109.196 -171.232 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 31.1 m -58.91 -26.46 32.55 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-O 118.593 -0.718 . . . . 0.0 112.017 -175.569 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -65.29 -18.57 65.42 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 119.454 1.024 . . . . 0.0 112.18 -177.341 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -119.8 4.39 11.02 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.921 1.289 . . . . 0.0 111.071 177.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.407 HD21 HG22 ' A' ' 7' ' ' THR . 68.0 m-80 -139.24 39.92 2.09 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 124.456 1.102 . . . . 0.0 109.642 -170.533 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 49.9 mm-40 -55.67 -33.32 64.01 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.929 0.892 . . . . 0.0 111.112 177.523 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 -66.29 -49.04 68.43 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 118.353 0.524 . . . . 0.0 110.189 179.093 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.52 -39.66 88.75 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.351 0.661 . . . . 0.0 109.846 -179.006 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.64 -49.05 79.28 Favored 'General case' 0 CA--C 1.533 0.292 0 O-C-N 121.149 -0.97 . . . . 0.0 110.322 173.344 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -60.46 -28.49 67.5 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 123.916 0.77 . . . . 0.0 112.262 177.257 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 72.2 tttt -56.13 -29.03 60.14 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 125.068 1.347 . . . . 0.0 111.698 179.662 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -123.47 10.64 9.18 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.63 0.772 . . . . 0.0 111.703 179.426 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 64.1 31.15 79.87 Favored Glycine 0 CA--C 1.532 1.14 0 C-N-CA 123.708 0.67 . . . . 0.0 112.617 -176.747 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 61.8 t -65.94 121.6 15.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 171.336 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 26.1 mmt -132.47 2.17 3.8 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.797 1.239 . . . . 0.0 111.514 -178.583 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 31.5 m -145.65 161.74 39.16 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 126.789 2.036 . . . . 0.0 107.401 179.372 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 41.6 pt -142.62 156.79 63.03 Favored Pre-proline 0 CA--C 1.545 0.773 0 C-N-CA 124.734 1.214 . . . . 0.0 108.739 177.663 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -65.48 142.69 55.56 Favored 'Cis proline' 0 C--N 1.35 0.627 0 CA-C-N 120.413 1.183 . . . . 0.0 110.231 -5.751 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 18.6 m -135.62 132.86 37.61 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 175.87 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -110.02 134.59 51.97 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 -174.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -121.98 125.75 47.02 Favored 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 102.593 -3.114 . . . . 0.0 102.593 177.022 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 1.9 t -103.67 122.3 56.17 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 N-CA-C 103.605 -2.739 . . . . 0.0 103.605 -179.771 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.7 mp -119.45 155.8 31.37 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 -175.891 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -136.81 126.2 24.99 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 170.214 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.2 t70 48.36 36.02 6.5 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.93 1.292 . . . . 0.0 112.294 172.366 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 98.31 2.53 57.84 Favored Glycine 0 CA--C 1.533 1.189 0 CA-C-O 117.925 -1.486 . . . . 0.0 115.108 171.47 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -121.42 145.88 47.47 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 120.364 2.082 . . . . 0.0 109.569 175.844 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 67.6 t -66.32 130.03 31.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 169.617 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 35.5 m -114.42 -21.92 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 CA-C-O 117.666 -1.159 . . . . 0.0 110.985 174.751 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -156.36 168.23 27.98 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 120.605 1.548 . . . . 0.0 111.023 173.609 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 14.1 m -143.72 151.0 39.49 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.597 1.559 . . . . 0.0 109.186 -177.458 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 13.0 m -152.61 153.95 34.39 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.375 1.47 . . . . 0.0 109.221 168.777 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 61.0 t -132.69 142.33 42.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 -172.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 75.84 -172.32 54.12 Favored Glycine 0 CA--C 1.529 0.913 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 -173.747 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -60.08 148.86 34.3 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.566 0.698 . . . . 0.0 110.303 174.615 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 39.5 tptt -149.14 122.44 4.53 Favored Pre-proline 0 N--CA 1.45 -0.431 0 N-CA-C 105.717 -1.956 . . . . 0.0 105.717 -173.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -68.5 155.67 68.23 Favored 'Trans proline' 0 N--CA 1.454 -0.807 0 C-N-CA 121.369 1.379 . . . . 0.0 111.101 -174.878 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -52.26 -46.88 65.97 Favored 'General case' 0 N--CA 1.461 0.121 0 C-N-CA 125.205 1.402 . . . . 0.0 112.021 -179.357 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -62.26 -40.39 96.04 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 122.95 0.5 . . . . 0.0 110.672 -179.104 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -69.45 -37.51 77.38 Favored 'General case' 0 N--CA 1.456 -0.162 0 O-C-N 121.796 -0.565 . . . . 0.0 110.798 179.475 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 98.5 mt -60.43 -43.4 96.82 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-O 119.285 -0.388 . . . . 0.0 110.18 173.389 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -62.11 -37.05 83.64 Favored 'General case' 0 N--CA 1.461 0.103 0 CA-C-N 118.431 0.56 . . . . 0.0 111.732 176.017 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -61.79 -48.74 79.26 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 118.429 0.559 . . . . 0.0 109.781 175.219 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 34.9 mt -62.47 -36.69 83.27 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 118.381 0.537 . . . . 0.0 111.431 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 56.1 t -61.48 -51.81 68.46 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 172.794 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -69.2 -22.04 63.92 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 -172.903 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 65.2 mttm -57.65 -26.36 61.51 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 118.213 -0.899 . . . . 0.0 111.548 170.115 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -126.13 -18.05 5.1 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 113.645 0.98 . . . . 0.0 113.645 -169.666 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 33.4 mt . . . . . 0 C--O 1.247 0.926 0 CA-C-N 119.935 1.243 . . . . 0.0 109.156 169.097 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.3 mpt? . . . . . 0 N--CA 1.478 0.962 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -162.47 -175.3 4.43 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 126.137 1.775 . . . . 0.0 107.805 -177.736 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.3 mt -76.02 144.37 11.97 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 166.058 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 23.4 t -136.55 162.99 34.41 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 C-N-CA 126.271 1.829 . . . . 0.0 106.94 -174.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.21 132.77 55.49 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 105.128 -2.175 . . . . 0.0 105.128 173.965 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -136.25 169.7 17.22 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 123.309 0.644 . . . . 0.0 110.976 -177.218 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.9 p -135.91 171.98 13.68 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 125.597 1.559 . . . . 0.0 107.505 169.679 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -51.79 -27.8 13.47 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.502 1.121 . . . . 0.0 112.946 178.061 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -57.97 -32.37 67.78 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 126.256 1.823 . . . . 0.0 112.809 178.849 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.0 m -141.22 -3.73 1.19 Allowed 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 113.383 0.883 . . . . 0.0 113.383 -169.166 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 78.3 t80 -53.51 -41.6 66.48 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.172 0.989 . . . . 0.0 111.633 -178.069 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.1 p -60.67 -45.5 93.89 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 124.045 0.938 . . . . 0.0 111.774 177.807 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.03 -43.62 95.02 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 122.737 0.415 . . . . 0.0 110.284 178.175 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 65.4 mm-40 -63.4 -37.24 86.53 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-O 119.414 -0.326 . . . . 0.0 110.962 -179.39 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.4 ' HA ' HG21 ' A' ' 20' ' ' VAL . 31.6 p -83.98 3.26 35.04 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.221 1.008 . . . . 0.0 113.277 -177.26 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 63.4 m -104.13 31.47 4.55 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.296 1.038 . . . . 0.0 111.459 -177.758 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -134.51 64.02 1.61 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.297 1.039 . . . . 0.0 110.229 -177.486 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 88.89 -158.33 28.13 Favored Glycine 0 C--N 1.337 0.603 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 177.483 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 59.1 t -69.94 135.5 28.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 168.905 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.4 HG21 ' HA ' ' A' ' 15' ' ' THR . 46.8 t -137.35 140.17 42.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 N-CA-C 105.763 -1.94 . . . . 0.0 105.763 179.26 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 52.3 tp -118.98 99.58 6.82 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 106.622 -1.622 . . . . 0.0 106.622 -178.774 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -79.67 149.35 31.27 Favored 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 178.025 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -130.43 93.99 3.57 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 126.532 1.933 . . . . 0.0 107.596 -177.02 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -74.44 113.82 12.11 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 105.821 -1.918 . . . . 0.0 105.821 175.275 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -149.9 -175.82 5.19 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 124.667 1.187 . . . . 0.0 108.455 -172.28 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -151.82 147.74 20.53 Favored Pre-proline 0 C--O 1.233 0.199 0 N-CA-C 105.64 -1.985 . . . . 0.0 105.64 167.19 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -67.1 -13.05 38.39 Favored 'Trans proline' 0 CA--C 1.535 0.533 0 CA-C-N 121.093 1.426 . . . . 0.0 113.104 -179.073 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 1.3 m95 -76.4 -13.51 60.12 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.841 0.856 . . . . 0.0 111.907 173.074 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 31.4 t -63.87 154.37 33.9 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 125.387 1.475 . . . . 0.0 111.076 -176.908 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -104.74 -65.4 0.68 Allowed Glycine 0 CA--C 1.53 0.997 0 CA-C-O 118.324 -1.265 . . . . 0.0 110.589 172.213 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -53.26 -32.02 58.78 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 123.4 2.733 . . . . 0.0 114.633 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 33.2 m -57.91 -34.37 69.77 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 121.574 -0.704 . . . . 0.0 111.721 176.548 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.0 mmtp -67.76 -23.17 65.2 Favored 'General case' 0 CA--C 1.53 0.188 0 O-C-N 121.492 -0.755 . . . . 0.0 111.074 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 32.2 mtm -70.83 -43.52 68.39 Favored 'General case' 0 C--N 1.339 0.143 0 CA-C-N 118.784 0.72 . . . . 0.0 110.357 176.018 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 17.3 tt -83.61 -22.61 8.33 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-O 118.75 -0.643 . . . . 0.0 111.698 -176.387 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -48.94 -51.43 55.29 Favored Pre-proline 0 CA--C 1.547 0.861 0 CA-C-N 120.032 1.287 . . . . 0.0 114.035 178.431 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -67.56 -25.16 41.16 Favored 'Trans proline' 0 C--N 1.351 0.688 0 CA-C-N 121.78 1.672 . . . . 0.0 112.367 176.674 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.4 t -72.07 -35.1 52.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 O-C-N 121.506 -0.746 . . . . 0.0 109.613 175.249 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 69.6 mt -67.97 -35.98 79.28 Favored 'General case' 0 C--N 1.338 0.095 0 CA-C-N 119.329 0.968 . . . . 0.0 111.036 170.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -62.4 -41.61 98.8 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 119.058 0.845 . . . . 0.0 110.818 170.862 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -61.99 -42.38 99.08 Favored 'General case' 0 C--N 1.331 -0.23 0 O-C-N 121.182 -0.948 . . . . 0.0 110.27 174.185 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 46.3 tp -61.62 -40.65 95.61 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.993 0.917 . . . . 0.0 110.642 178.586 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -60.98 -41.47 96.47 Favored 'General case' 0 C--N 1.334 -0.099 0 C-N-CA 123.108 0.563 . . . . 0.0 110.821 174.574 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -75.55 -11.08 59.95 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.023 0.529 . . . . 0.0 112.362 178.778 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -91.44 -50.45 5.79 Favored 'General case' 0 C--O 1.232 0.15 0 C-N-CA 124.928 1.291 . . . . 0.0 109.636 178.117 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 24.9 mtm -140.49 21.3 2.37 Favored 'General case' 0 N--CA 1.465 0.275 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -170.812 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -56.34 -11.7 5.28 Favored Glycine 0 CA--C 1.538 1.473 0 CA-C-N 120.197 1.362 . . . . 0.0 114.591 174.16 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -72.77 -28.7 62.76 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 118.694 1.247 . . . . 0.0 111.723 171.454 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -107.9 -24.92 11.45 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 125.922 1.689 . . . . 0.0 111.302 -179.558 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 48.8 tp -114.42 157.54 22.75 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 124.498 1.119 . . . . 0.0 111.307 -168.664 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -128.7 143.42 50.93 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 104.214 -2.513 . . . . 0.0 104.214 166.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 82.3 mt -117.44 138.5 47.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 105.367 -2.086 . . . . 0.0 105.367 178.199 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 98.8 t -132.59 98.74 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 -170.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 52.6 mtmt -70.93 141.6 51.11 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 107.848 -1.168 . . . . 0.0 107.848 173.323 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 16.5 tt -144.05 125.2 9.73 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 174.221 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 54.1 t0 -83.82 105.65 14.89 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.362 1.065 . . . . 0.0 108.629 -173.489 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 30.9 m -59.31 -26.25 33.25 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-O 118.538 -0.744 . . . . 0.0 111.939 -174.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -65.11 -18.27 65.16 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 119.453 1.024 . . . . 0.0 112.179 -177.401 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -119.69 3.82 11.11 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.915 1.286 . . . . 0.0 111.134 178.046 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 68.2 m-80 -139.5 39.82 2.05 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.438 1.095 . . . . 0.0 109.761 -170.453 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 52.1 mm-40 -55.41 -32.61 62.82 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.75 0.82 . . . . 0.0 111.092 176.37 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 33.4 mm-40 -65.99 -47.67 73.78 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 118.373 0.533 . . . . 0.0 110.324 178.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.49 -39.83 85.2 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 118.581 0.628 . . . . 0.0 109.993 -178.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.49 -49.39 77.96 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 121.621 -0.674 . . . . 0.0 110.453 173.499 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -61.75 -28.67 70.4 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 123.764 0.697 . . . . 0.0 112.131 178.367 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 17.2 ttmt -54.97 -29.47 56.9 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 125.772 1.629 . . . . 0.0 112.009 178.346 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -123.65 10.5 9.05 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.794 0.837 . . . . 0.0 111.831 178.865 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 65.25 28.27 73.37 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 123.825 0.726 . . . . 0.0 112.94 -177.756 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 56.7 t -62.35 127.49 22.45 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 172.084 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 42.3 ttp -137.29 0.79 2.36 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.532 1.133 . . . . 0.0 110.966 -176.814 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 24.4 m -144.95 162.74 36.15 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 126.535 1.934 . . . . 0.0 107.634 179.557 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 41.0 pt -143.29 156.55 60.92 Favored Pre-proline 0 CA--C 1.545 0.754 0 C-N-CA 124.897 1.279 . . . . 0.0 108.583 176.694 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -66.89 139.6 46.36 Favored 'Cis proline' 0 C--N 1.349 0.575 0 CA-C-N 120.522 1.222 . . . . 0.0 110.207 -5.097 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 31.9 m -132.11 138.59 48.16 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 176.198 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 88.5 mt -116.09 128.5 55.73 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 -171.367 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -119.23 125.54 49.41 Favored 'General case' 0 CA--C 1.509 -0.626 0 N-CA-C 102.551 -3.129 . . . . 0.0 102.551 177.459 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 1.7 t -105.64 122.6 59.31 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 N-CA-C 103.609 -2.737 . . . . 0.0 103.609 -179.387 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.8 mp -120.23 153.52 36.2 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 -176.57 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -136.63 124.97 23.28 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 171.501 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.5 t70 48.62 36.04 7.04 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.016 1.327 . . . . 0.0 112.284 174.026 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 99.8 2.34 56.23 Favored Glycine 0 CA--C 1.532 1.113 0 CA-C-O 117.92 -1.489 . . . . 0.0 114.98 170.055 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -122.36 146.75 47.04 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 120.273 2.037 . . . . 0.0 109.571 176.122 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 62.0 t -66.82 130.01 31.83 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 N-CA-C 107.405 -1.332 . . . . 0.0 107.405 170.216 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 30.7 m -118.29 -17.19 7.36 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 C-N-CA 124.641 1.177 . . . . 0.0 111.338 176.21 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -156.4 167.55 30.09 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 120.547 1.521 . . . . 0.0 110.61 172.477 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 19.1 m -146.42 142.62 28.35 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.589 1.156 . . . . 0.0 108.706 174.423 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 49.5 m -144.58 156.71 44.27 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.025 1.33 . . . . 0.0 108.734 176.672 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 39.8 t -134.23 146.38 31.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 -174.657 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 76.32 -175.95 52.36 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 123.532 0.587 . . . . 0.0 112.436 177.558 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -63.29 148.78 47.31 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.989 0.915 . . . . 0.0 111.286 -179.825 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -148.84 142.13 15.85 Favored Pre-proline 0 CA--C 1.534 0.335 0 C-N-CA 125.626 1.57 . . . . 0.0 107.24 167.816 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -72.26 160.8 46.23 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 122.871 2.381 . . . . 0.0 110.787 175.636 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 40.5 pttt -59.31 -30.12 68.12 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 -176.275 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -65.22 -49.72 68.62 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 118.355 0.525 . . . . 0.0 109.639 174.91 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.74 -37.86 88.93 Favored 'General case' 0 CA--C 1.528 0.118 0 O-C-N 122.063 -0.398 . . . . 0.0 110.853 179.22 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 84.5 mt -63.77 -44.62 92.88 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 122.722 0.409 . . . . 0.0 111.289 175.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -60.7 -41.95 96.23 Favored 'General case' 0 C--O 1.223 -0.291 0 CA-C-O 118.903 -0.57 . . . . 0.0 109.838 176.07 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -64.24 -40.93 97.05 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 118.383 0.538 . . . . 0.0 110.777 -179.535 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 56.3 tp -61.0 -44.89 96.75 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 124.965 1.306 . . . . 0.0 110.715 176.639 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 75.4 t -62.15 -43.83 98.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 123.602 0.761 . . . . 0.0 109.621 173.77 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -62.6 -24.05 67.37 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 125.186 1.395 . . . . 0.0 112.203 -173.296 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -54.85 -26.1 33.08 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 118.611 -0.709 . . . . 0.0 112.222 171.848 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 86.1 m-70 -123.8 -11.62 7.67 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 113.423 0.897 . . . . 0.0 113.423 -168.814 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 70.4 mt . . . . . 0 C--O 1.249 1.045 0 CA-C-N 119.16 0.891 . . . . 0.0 109.292 171.678 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 7.6 mt . . . . . 0 N--CA 1.446 -0.656 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 10.4 t -135.71 158.8 39.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 106.441 -1.688 . . . . 0.0 106.441 -172.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 14.1 mtpt -119.99 125.14 47.66 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 105.793 -1.928 . . . . 0.0 105.793 -177.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -136.65 166.46 23.49 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.485 0.66 . . . . 0.0 111.422 -173.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 22.9 p -132.38 176.23 8.6 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 126.013 1.725 . . . . 0.0 107.819 172.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -53.58 -29.49 37.67 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.859 0.863 . . . . 0.0 112.465 177.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 54.2 mt-30 -66.53 -29.35 69.41 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.048 1.339 . . . . 0.0 112.915 179.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 23.5 p -123.3 -15.65 7.13 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.565 1.146 . . . . 0.0 113.416 -169.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -52.88 -48.15 67.34 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 124.53 1.132 . . . . 0.0 112.048 -172.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.9 m -63.92 -39.38 94.03 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.013 0.525 . . . . 0.0 111.779 -177.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.84 -43.78 87.48 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 178.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -66.08 -43.3 87.76 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 122.425 0.29 . . . . 0.0 110.747 -179.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 37.6 p -77.51 -5.32 49.61 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 -175.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 73.1 m -73.27 -21.88 60.5 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 177.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -87.98 72.18 9.29 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 118.75 0.705 . . . . 0.0 111.527 -169.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 85.09 -151.73 26.2 Favored Glycine 0 C--N 1.336 0.573 0 N-CA-C 110.479 -1.049 . . . . 0.0 110.479 172.1 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 97.6 t -72.18 132.95 32.69 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 168.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 49.6 t -138.2 143.96 31.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 N-CA-C 105.756 -1.942 . . . . 0.0 105.756 179.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 5.6 tt -122.85 101.6 7.53 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 106.303 -1.74 . . . . 0.0 106.303 -178.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -81.78 147.06 29.6 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.659 -179.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -125.43 93.8 3.96 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 126.588 1.955 . . . . 0.0 107.194 -175.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -75.8 112.79 12.55 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 175.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -149.94 -176.04 5.28 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.432 1.093 . . . . 0.0 108.644 -172.013 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -152.79 147.69 19.52 Favored Pre-proline 0 CA--C 1.531 0.236 0 N-CA-C 106.085 -1.821 . . . . 0.0 106.085 167.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -59.11 -18.29 43.06 Favored 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 121.848 1.699 . . . . 0.0 114.595 177.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 2.0 m95 -75.19 -14.22 60.52 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 118.818 0.735 . . . . 0.0 111.865 176.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 25.0 t -64.32 153.33 38.68 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.499 1.519 . . . . 0.0 111.063 -177.059 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -103.26 -65.14 0.71 Allowed Glycine 0 CA--C 1.53 0.982 0 CA-C-O 118.424 -1.209 . . . . 0.0 110.514 171.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_exo -53.22 -31.7 56.93 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 123.525 2.816 . . . . 0.0 114.608 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 34.3 m -58.63 -32.59 69.17 Favored 'General case' 0 CA--C 1.537 0.451 0 O-C-N 121.509 -0.744 . . . . 0.0 111.857 176.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.3 mmtp -68.36 -23.83 64.73 Favored 'General case' 0 CA--C 1.531 0.244 0 O-C-N 121.273 -0.892 . . . . 0.0 110.888 179.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 28.9 mtm -71.57 -40.93 69.61 Favored 'General case' 0 C--N 1.339 0.148 0 CA-C-N 118.79 0.723 . . . . 0.0 110.636 176.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 19.2 tt -83.14 -21.37 8.98 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-O 118.918 -0.563 . . . . 0.0 111.529 -176.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -49.79 -50.62 66.46 Favored Pre-proline 0 CA--C 1.55 0.952 0 CA-C-N 120.14 1.336 . . . . 0.0 114.003 177.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -66.46 -26.39 47.59 Favored 'Trans proline' 0 C--N 1.351 0.701 0 CA-C-N 121.688 1.639 . . . . 0.0 112.451 175.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 6.0 t -67.63 -40.08 83.43 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-N 118.907 0.776 . . . . 0.0 109.136 173.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 91.3 mt -64.3 -34.21 77.6 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 119.462 1.028 . . . . 0.0 111.224 172.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -66.32 -38.14 86.99 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 119.606 1.094 . . . . 0.0 111.385 171.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -63.78 -36.09 82.76 Favored 'General case' 0 C--N 1.33 -0.248 0 O-C-N 120.299 -1.501 . . . . 0.0 110.115 172.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 18.7 mt -66.58 -37.25 84.52 Favored 'General case' 0 C--N 1.334 -0.097 0 CA-C-O 117.892 -1.051 . . . . 0.0 112.087 173.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -54.1 -47.05 72.18 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 120.569 1.532 . . . . 0.0 109.65 168.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 44.1 mt-30 -74.49 -13.67 60.72 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 113.283 0.846 . . . . 0.0 113.283 -174.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 61.7 mt-10 -120.93 -24.27 5.67 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 124.417 1.087 . . . . 0.0 113.01 -170.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 17.5 mtp -131.99 -5.2 3.53 Favored 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 -175.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -58.43 -12.17 12.16 Favored Glycine 0 CA--C 1.538 1.472 0 CA-C-N 120.488 1.494 . . . . 0.0 115.393 -172.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -74.83 -25.99 59.39 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.326 1.45 . . . . 0.0 112.226 174.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.479 ' HA ' ' HE3' ' A' ' 49' ' ' LYS . 0.0 OUTLIER -123.67 -18.16 6.19 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 125.575 1.55 . . . . 0.0 112.144 -177.504 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 55.7 tp -118.13 150.71 38.91 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 124.167 0.987 . . . . 0.0 110.552 -169.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -124.02 145.0 49.5 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 104.821 -2.289 . . . . 0.0 104.821 167.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 90.0 mt -120.59 129.32 75.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 104.395 -2.446 . . . . 0.0 104.395 -177.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 98.7 t -126.23 98.45 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 CA-C-N 119.217 0.917 . . . . 0.0 109.403 -170.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -73.47 137.62 44.62 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 176.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 15.1 tt -141.34 125.43 16.79 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 C-N-CA 123.769 0.827 . . . . 0.0 108.79 176.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 60.6 t0 -83.47 104.2 13.42 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 124.62 1.168 . . . . 0.0 108.953 -172.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 30.3 m -58.81 -27.05 33.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 118.713 -0.66 . . . . 0.0 111.959 -174.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -65.57 -17.75 64.81 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 119.346 0.975 . . . . 0.0 112.171 -176.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -120.57 3.44 10.7 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.869 1.268 . . . . 0.0 111.222 178.011 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 69.0 m-80 -139.11 40.02 2.12 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.43 1.092 . . . . 0.0 109.814 -169.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 51.8 mm-40 -55.46 -32.09 62.49 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.122 0.969 . . . . 0.0 111.257 176.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 36.8 mm-40 -66.25 -48.45 70.47 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 118.493 0.588 . . . . 0.0 110.357 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.15 -39.46 82.63 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 118.408 0.549 . . . . 0.0 109.556 -178.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -58.95 -48.69 80.6 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 121.31 -0.869 . . . . 0.0 110.327 173.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -61.19 -28.66 69.45 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 123.985 0.802 . . . . 0.0 112.202 177.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 44.9 tttp -55.97 -29.24 59.94 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.965 1.306 . . . . 0.0 111.686 179.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -122.88 10.43 9.54 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.705 0.802 . . . . 0.0 111.739 179.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 64.95 28.37 73.41 Favored Glycine 0 CA--C 1.533 1.186 0 CA-C-O 119.39 -0.672 . . . . 0.0 112.892 -177.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 61.4 t -62.27 125.56 18.87 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 171.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 12.0 tpt -136.53 1.28 2.59 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.608 1.163 . . . . 0.0 111.085 -175.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 24.6 m -144.82 163.11 35.07 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 126.626 1.97 . . . . 0.0 107.481 179.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 38.5 pt -142.88 156.26 62.4 Favored Pre-proline 0 CA--C 1.545 0.765 0 C-N-CA 124.574 1.15 . . . . 0.0 108.847 175.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -66.65 138.9 42.11 Favored 'Cis proline' 0 N--CA 1.458 -0.582 0 CA-C-N 120.361 1.164 . . . . 0.0 110.179 -5.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 32.3 m -129.77 142.71 50.65 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 174.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 88.4 mt -123.39 126.52 46.95 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 -168.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -118.41 119.39 34.46 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 103.969 -2.604 . . . . 0.0 103.969 179.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 5.1 t -90.23 123.15 42.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 103.565 -2.754 . . . . 0.0 103.565 171.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.2 mp -111.61 153.64 26.03 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 173.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -136.15 124.32 23.07 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 105.916 -1.883 . . . . 0.0 105.916 174.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 31.9 t70 50.96 34.13 10.06 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.573 1.149 . . . . 0.0 112.251 177.143 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 98.55 0.86 57.84 Favored Glycine 0 CA--C 1.531 1.038 0 CA-C-O 118.227 -1.318 . . . . 0.0 114.956 169.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -128.38 150.32 50.16 Favored 'General case' 0 C--N 1.34 0.153 0 CA-C-N 119.999 1.9 . . . . 0.0 109.916 178.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 47.9 t -62.26 133.24 28.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 176.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.6 p -117.92 -24.73 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 C-N-CA 125.087 1.355 . . . . 0.0 109.58 177.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -158.79 164.98 35.31 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 120.035 1.289 . . . . 0.0 110.506 175.041 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 10.6 m -136.26 150.88 49.14 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.709 1.204 . . . . 0.0 108.891 177.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 62.3 m -150.52 159.3 44.58 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.622 1.569 . . . . 0.0 108.768 169.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 40.7 t -133.77 147.73 30.66 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 -176.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 76.93 -178.03 51.51 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 123.637 0.637 . . . . 0.0 112.423 176.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -64.73 150.29 47.59 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.886 0.874 . . . . 0.0 110.826 178.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -149.02 145.53 19.7 Favored Pre-proline 0 C--O 1.235 0.321 0 C-N-CA 125.677 1.591 . . . . 0.0 106.93 167.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -70.84 161.19 46.94 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 122.649 2.233 . . . . 0.0 110.462 174.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 63.5 pttt -58.71 -31.74 68.54 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -175.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -68.02 -45.49 73.85 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 118.244 0.475 . . . . 0.0 109.859 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.7 -40.43 95.36 Favored 'General case' 0 C--O 1.232 0.159 0 O-C-N 122.039 -0.413 . . . . 0.0 110.339 177.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 97.4 mt -64.57 -40.6 95.84 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 122.307 0.243 . . . . 0.0 111.313 176.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 18.9 mt-30 -59.83 -39.3 84.61 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 118.759 -0.638 . . . . 0.0 110.108 175.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -68.14 -40.35 82.45 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 118.941 0.791 . . . . 0.0 110.808 178.122 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 43.9 tp -60.34 -37.89 82.08 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.312 1.445 . . . . 0.0 111.313 176.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 99.4 t -68.74 -49.75 61.41 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 C-N-CA 123.756 0.823 . . . . 0.0 109.578 170.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -58.09 -39.25 78.11 Favored 'General case' 0 CA--C 1.519 -0.218 0 C-N-CA 125.453 1.501 . . . . 0.0 112.119 -168.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 13.3 ptmm? -65.44 -5.92 9.02 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 113.364 0.876 . . . . 0.0 113.364 -178.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -127.04 -3.48 6.38 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.548 1.139 . . . . 0.0 113.595 175.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 46.9 mt . . . . . 0 C--O 1.248 0.988 0 CA-C-N 119.413 1.006 . . . . 0.0 109.164 170.289 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 7.5 mt . . . . . 0 CA--C 1.536 0.419 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 37.3 t -137.68 164.77 27.91 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 C-N-CA 127.106 2.162 . . . . 0.0 106.2 -179.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 8.1 ttmt -120.14 146.34 46.07 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 107.1 -1.445 . . . . 0.0 107.1 173.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -143.64 169.97 16.73 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.717 0.77 . . . . 0.0 111.029 -178.242 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 18.6 p -133.77 173.43 11.54 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 127.699 2.4 . . . . 0.0 107.863 176.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -54.93 -31.41 60.32 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 121.578 -0.701 . . . . 0.0 112.547 177.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 59.4 mt-30 -70.77 -27.62 64.06 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.113 1.365 . . . . 0.0 112.959 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 25.5 p -118.89 -18.95 8.74 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.425 1.09 . . . . 0.0 113.524 -168.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -52.99 -46.47 68.32 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 125.014 1.326 . . . . 0.0 111.942 -172.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.0 m -63.79 -38.39 90.92 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 122.79 0.436 . . . . 0.0 111.795 -176.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -68.54 -44.6 74.2 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 177.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 67.6 mm-40 -63.95 -34.46 78.02 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-O 119.545 -0.264 . . . . 0.0 111.223 -178.134 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 33.3 p -85.79 1.63 48.9 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.012 0.925 . . . . 0.0 113.427 -176.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 70.9 m -101.79 31.52 3.81 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.14 0.976 . . . . 0.0 111.601 -177.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -133.72 65.05 1.59 Allowed 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.44 1.096 . . . . 0.0 110.104 -177.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 89.84 -154.32 23.79 Favored Glycine 0 C--N 1.338 0.661 0 N-CA-C 110.294 -1.123 . . . . 0.0 110.294 175.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 48.5 t -71.71 135.7 27.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 N-CA-C 106.214 -1.772 . . . . 0.0 106.214 168.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 49.2 t -137.62 141.98 37.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 178.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 60.4 tp -122.96 98.79 6.06 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 -177.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -79.39 148.72 31.89 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 178.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -127.98 93.98 3.82 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 126.543 1.937 . . . . 0.0 107.443 -178.046 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -73.4 112.6 9.62 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 105.735 -1.95 . . . . 0.0 105.735 175.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -148.64 -177.2 5.65 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 124.847 1.259 . . . . 0.0 108.173 -172.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -156.01 149.35 18.69 Favored Pre-proline 0 N--CA 1.453 -0.29 0 N-CA-C 106.154 -1.795 . . . . 0.0 106.154 167.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -68.93 -13.18 36.19 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 CA-C-N 120.866 1.345 . . . . 0.0 113.96 -177.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 46.4 p-90 -69.74 -20.39 63.51 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 120.147 1.34 . . . . 0.0 111.975 169.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 29.1 t -59.17 148.33 31.94 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.06 1.344 . . . . 0.0 111.05 -171.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -97.09 -60.59 0.96 Allowed Glycine 0 CA--C 1.532 1.113 0 CA-C-O 118.722 -1.043 . . . . 0.0 111.335 169.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -66.37 -25.99 48.6 Favored 'Trans proline' 0 C--N 1.349 0.574 0 CA-C-N 120.387 2.093 . . . . 0.0 112.983 -173.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 24.5 m -58.26 -33.98 69.99 Favored 'General case' 0 CA--C 1.534 0.346 0 O-C-N 121.627 -0.671 . . . . 0.0 111.218 174.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.1 mmtp -68.24 -22.87 64.75 Favored 'General case' 0 CA--C 1.531 0.242 0 O-C-N 121.591 -0.693 . . . . 0.0 111.078 -179.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 35.3 mtm -71.34 -44.21 65.51 Favored 'General case' 0 C--N 1.34 0.184 0 CA-C-N 118.863 0.756 . . . . 0.0 110.323 175.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 17.2 tt -83.04 -22.73 8.61 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-O 118.628 -0.701 . . . . 0.0 111.555 -176.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -49.05 -52.04 50.81 Favored Pre-proline 0 CA--C 1.548 0.888 0 CA-C-N 120.28 1.4 . . . . 0.0 114.223 178.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -66.41 -29.9 44.94 Favored 'Trans proline' 0 C--N 1.351 0.667 0 CA-C-N 121.574 1.598 . . . . 0.0 111.985 176.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.0 t -66.49 -40.26 86.04 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-O 118.722 -0.656 . . . . 0.0 109.403 175.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 45.7 mt -64.54 -37.05 86.21 Favored 'General case' 0 C--O 1.224 -0.258 0 CA-C-N 119.507 1.049 . . . . 0.0 110.613 174.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -63.03 -44.47 95.85 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 119.104 0.866 . . . . 0.0 111.083 173.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -63.94 -39.79 94.97 Favored 'General case' 0 CA--C 1.534 0.334 0 O-C-N 121.166 -0.959 . . . . 0.0 110.451 177.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -63.68 -43.28 97.11 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 125.175 1.39 . . . . 0.0 109.641 177.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -58.74 -43.12 90.15 Favored 'General case' 0 CA--C 1.521 -0.143 0 C-N-CA 123.767 0.827 . . . . 0.0 110.917 176.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -70.5 -10.19 58.55 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -106.31 -27.58 10.92 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 125.735 1.614 . . . . 0.0 111.518 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 22.2 mtp -126.14 -2.47 7.01 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 113.51 0.929 . . . . 0.0 113.51 -169.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.82 -7.3 6.17 Favored Glycine 0 CA--C 1.533 1.215 0 CA-C-N 119.591 1.087 . . . . 0.0 115.538 -176.1 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -75.71 -27.64 58.29 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 118.597 1.198 . . . . 0.0 111.638 171.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 45.0 mmtm -121.03 -20.51 6.81 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 125.514 1.526 . . . . 0.0 112.347 -175.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 48.8 tp -119.83 151.91 38.11 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.131 0.972 . . . . 0.0 111.546 -168.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -120.41 143.84 48.25 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 105.011 -2.218 . . . . 0.0 105.011 166.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 58.6 mt -112.56 140.2 33.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 105.497 -2.038 . . . . 0.0 105.497 173.036 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 95.1 t -132.75 98.96 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 -172.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 47.6 mtpt -73.9 140.43 45.65 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 175.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 13.0 tt -141.01 126.16 18.57 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 175.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -83.79 101.86 11.9 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 124.728 1.211 . . . . 0.0 108.786 -173.082 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 24.9 m -59.95 -25.63 33.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 118.667 -0.683 . . . . 0.0 111.961 -174.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -65.05 -18.45 65.31 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 119.464 1.029 . . . . 0.0 112.143 -177.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -120.22 4.02 10.84 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.809 1.244 . . . . 0.0 111.072 177.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -139.2 40.56 2.1 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.607 1.163 . . . . 0.0 109.592 -170.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 48.0 mm-40 -55.84 -32.55 63.7 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.184 0.993 . . . . 0.0 111.257 177.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -65.74 -46.27 79.51 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 118.385 0.539 . . . . 0.0 110.425 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.13 -39.19 79.03 Favored 'General case' 0 C--O 1.223 -0.317 0 CA-C-N 118.457 0.571 . . . . 0.0 109.618 -179.246 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.06 -48.36 81.89 Favored 'General case' 0 CA--C 1.533 0.326 0 O-C-N 121.256 -0.902 . . . . 0.0 110.25 173.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -60.68 -28.75 68.49 Favored Glycine 0 CA--C 1.529 0.938 0 C-N-CA 124.079 0.847 . . . . 0.0 112.36 177.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 47.3 tttp -55.94 -29.32 59.96 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 124.861 1.265 . . . . 0.0 111.709 179.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -123.2 10.63 9.35 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.621 0.768 . . . . 0.0 111.767 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 63.6 31.57 81.21 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 123.641 0.639 . . . . 0.0 112.636 -176.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 55.1 t -65.83 121.87 15.73 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 171.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 98.5 mmm -131.59 2.64 4.14 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.898 1.279 . . . . 0.0 111.382 -178.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 24.5 m -144.83 161.17 39.94 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 126.652 1.981 . . . . 0.0 107.565 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 38.7 pt -142.69 154.36 62.69 Favored Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 124.726 1.211 . . . . 0.0 108.41 176.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -68.26 140.14 53.89 Favored 'Cis proline' 0 C--N 1.349 0.601 0 CA-C-N 120.495 1.212 . . . . 0.0 110.541 -3.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 33.9 m -131.86 142.83 49.81 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 175.067 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 83.0 mt -121.24 127.4 51.39 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 -170.006 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -120.64 124.63 45.7 Favored 'General case' 0 CA--C 1.508 -0.637 0 N-CA-C 102.851 -3.018 . . . . 0.0 102.851 178.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 1.3 t -106.04 125.87 61.58 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 N-CA-C 103.872 -2.64 . . . . 0.0 103.872 -178.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.7 mp -122.08 152.9 39.34 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 -175.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -135.71 116.71 14.27 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 106.522 -1.659 . . . . 0.0 106.522 178.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.1 t70 49.58 38.42 14.79 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.915 1.286 . . . . 0.0 112.571 176.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 104.14 -2.87 43.99 Favored Glycine 0 CA--C 1.529 0.92 0 CA-C-O 118.056 -1.414 . . . . 0.0 115.418 168.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -126.57 147.17 49.91 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 120.129 1.964 . . . . 0.0 109.995 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 61.0 t -62.58 131.43 27.94 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 174.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 9.9 p -119.3 -20.67 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.732 0 C-N-CA 125.006 1.322 . . . . 0.0 110.093 178.102 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -159.96 166.75 29.46 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 120.58 1.536 . . . . 0.0 110.272 172.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 17.4 m -136.75 151.34 49.1 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.647 1.579 . . . . 0.0 108.798 176.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 46.3 m -148.35 157.4 43.46 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.871 1.669 . . . . 0.0 108.595 169.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 39.4 t -133.8 146.24 32.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 -178.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 79.58 -175.87 54.88 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 123.646 0.641 . . . . 0.0 112.296 176.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -62.46 145.28 54.56 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.577 0.751 . . . . 0.0 110.563 178.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 68.9 mttt -143.72 134.31 12.23 Favored Pre-proline 0 CA--C 1.532 0.258 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 168.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -69.5 160.76 48.56 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.306 2.004 . . . . 0.0 109.907 174.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 49.7 pttt -59.24 -28.3 66.57 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 -176.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -65.54 -47.89 74.35 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 118.444 0.565 . . . . 0.0 109.975 174.116 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.53 -37.65 88.28 Favored 'General case' 0 CA--C 1.529 0.173 0 O-C-N 121.859 -0.526 . . . . 0.0 110.619 177.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 83.0 mt -65.19 -42.12 93.89 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-O 119.285 -0.388 . . . . 0.0 111.383 176.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 15.8 mt-30 -59.3 -42.87 92.35 Favored 'General case' 0 C--O 1.225 -0.214 0 CA-C-N 118.697 0.681 . . . . 0.0 109.643 175.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -65.99 -38.6 88.91 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 118.017 0.371 . . . . 0.0 110.683 -179.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 65.9 tp -61.15 -47.25 87.06 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 125.025 1.33 . . . . 0.0 110.328 176.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 97.3 t -61.55 -43.26 96.64 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 123.902 0.881 . . . . 0.0 110.045 174.041 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -61.51 -26.05 67.67 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 125.18 1.392 . . . . 0.0 112.136 -172.088 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 82.3 mttt -55.15 -24.88 28.62 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 118.774 -0.632 . . . . 0.0 112.617 172.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 43.3 m-70 -121.74 -10.67 8.71 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 -167.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 78.7 mt . . . . . 0 C--O 1.249 1.077 0 CA-C-N 118.565 0.62 . . . . 0.0 109.457 172.586 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.9 mt . . . . . 0 CA--C 1.537 0.471 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 29.0 t -136.47 163.97 32.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 C-N-CA 126.724 2.01 . . . . 0.0 106.273 -178.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.52 133.78 49.81 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 104.923 -2.251 . . . . 0.0 104.923 176.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -135.22 175.11 9.89 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 123.875 0.87 . . . . 0.0 111.37 -171.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 31.3 p -137.87 178.56 7.02 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 125.244 1.418 . . . . 0.0 107.779 169.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -49.3 -30.34 7.27 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.895 0.878 . . . . 0.0 112.4 169.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -64.81 -27.47 68.91 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.003 1.321 . . . . 0.0 112.776 -179.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 14.1 p -130.83 -17.55 3.16 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 114.298 1.222 . . . . 0.0 114.298 -167.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 56.8 t80 -52.2 -47.28 65.67 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 124.463 1.105 . . . . 0.0 112.259 -170.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.2 m -64.56 -37.9 89.15 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 122.62 0.368 . . . . 0.0 111.849 -176.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -69.09 -44.56 72.24 Favored 'General case' 0 N--CA 1.452 -0.343 0 O-C-N 122.017 -0.427 . . . . 0.0 109.96 176.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 68.9 mm-40 -63.22 -35.82 81.59 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 122.529 0.331 . . . . 0.0 110.921 -178.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.407 ' HA ' HG21 ' A' ' 20' ' ' VAL . 29.3 p -82.85 0.62 43.22 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 -176.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 70.7 m -102.04 29.21 5.2 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.972 0.909 . . . . 0.0 112.068 -175.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -135.2 55.24 1.89 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.831 0.853 . . . . 0.0 111.387 -173.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 107.39 -152.06 16.91 Favored Glycine 0 C--N 1.337 0.614 0 N-CA-C 109.954 -1.258 . . . . 0.0 109.954 173.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.2 t -74.83 135.75 26.65 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 N-CA-C 104.88 -2.267 . . . . 0.0 104.88 166.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.407 HG21 ' HA ' ' A' ' 15' ' ' THR . 34.3 t -136.15 139.47 45.61 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 N-CA-C 106.441 -1.688 . . . . 0.0 106.441 178.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.8 tt -124.17 100.11 6.56 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 106.131 -1.803 . . . . 0.0 106.131 -177.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -81.33 145.67 30.75 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.236 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -124.52 94.02 4.08 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 125.899 1.68 . . . . 0.0 107.619 -176.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -74.22 112.51 10.45 Favored 'General case' 0 C--O 1.24 0.58 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 175.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -148.96 -176.51 5.37 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.966 1.306 . . . . 0.0 108.548 -172.581 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -156.44 146.74 15.9 Favored Pre-proline 0 CA--C 1.533 0.296 0 N-CA-C 106.16 -1.793 . . . . 0.0 106.16 168.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -60.76 -17.95 53.04 Favored 'Trans proline' 0 CA--C 1.534 0.495 0 C-N-CA 121.662 1.575 . . . . 0.0 115.799 -178.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 50.5 p-90 -69.23 -20.56 63.95 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 119.99 1.268 . . . . 0.0 112.011 173.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 34.1 t -58.9 146.9 35.99 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 125.055 1.342 . . . . 0.0 111.231 -172.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -95.4 -62.43 0.99 Allowed Glycine 0 CA--C 1.531 1.082 0 CA-C-O 118.647 -1.085 . . . . 0.0 111.163 170.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -64.43 -26.53 62.9 Favored 'Trans proline' 0 C--N 1.35 0.634 0 CA-C-N 120.257 2.029 . . . . 0.0 113.387 -173.1 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 30.2 m -57.29 -34.7 68.95 Favored 'General case' 0 CA--C 1.537 0.456 0 O-C-N 121.63 -0.669 . . . . 0.0 111.479 174.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.9 mmtp -67.91 -24.49 65.21 Favored 'General case' 0 CA--C 1.531 0.25 0 O-C-N 121.645 -0.659 . . . . 0.0 111.057 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 32.3 mtm -71.25 -44.04 66.07 Favored 'General case' 0 C--N 1.34 0.18 0 CA-C-N 118.654 0.661 . . . . 0.0 110.411 177.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 14.5 tt -82.21 -23.69 9.33 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-O 118.745 -0.645 . . . . 0.0 111.523 -176.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -48.59 -51.46 52.33 Favored Pre-proline 0 CA--C 1.548 0.888 0 CA-C-N 120.062 1.301 . . . . 0.0 114.262 179.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -66.93 -28.08 42.53 Favored 'Trans proline' 0 C--N 1.35 0.649 0 CA-C-N 121.807 1.681 . . . . 0.0 112.407 176.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.6 t -67.8 -37.92 79.32 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 O-C-N 121.584 -0.698 . . . . 0.0 109.313 174.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 95.0 mt -67.16 -35.4 79.6 Favored 'General case' 0 C--N 1.34 0.166 0 CA-C-N 119.516 1.053 . . . . 0.0 111.328 172.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -61.96 -43.07 99.6 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 119.548 1.067 . . . . 0.0 110.755 171.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -63.38 -41.35 98.79 Favored 'General case' 0 CA--C 1.53 0.179 0 O-C-N 121.279 -0.888 . . . . 0.0 110.421 175.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 35.3 tp -60.82 -42.21 97.23 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 123.494 0.718 . . . . 0.0 110.24 177.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -60.54 -43.82 96.79 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 123.347 0.659 . . . . 0.0 110.728 177.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 -71.4 -10.72 60.21 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.29 0.636 . . . . 0.0 112.629 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -105.59 -28.09 10.97 Favored 'General case' 0 C--O 1.232 0.172 0 C-N-CA 125.46 1.504 . . . . 0.0 111.42 -178.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 22.8 mtp -131.44 0.27 4.04 Favored 'General case' 0 N--CA 1.461 0.105 0 N-CA-C 113.658 0.985 . . . . 0.0 113.658 -169.002 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -55.82 -10.31 3.35 Favored Glycine 0 CA--C 1.535 1.343 0 C-N-CA 124.747 1.165 . . . . 0.0 115.926 -176.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -72.86 -29.14 62.97 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.597 1.159 . . . . 0.0 112.049 172.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 42.3 mmtm -126.37 -14.9 5.79 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 125.732 1.613 . . . . 0.0 112.842 -175.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 58.9 tp -120.3 142.59 48.95 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 124.144 0.978 . . . . 0.0 109.925 -170.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -117.73 145.48 44.43 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 104.899 -2.26 . . . . 0.0 104.899 167.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 73.7 mt -116.19 138.19 47.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 105.399 -2.075 . . . . 0.0 105.399 176.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 93.1 t -132.59 96.47 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -169.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 54.4 mtpt -74.24 139.05 44.07 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 177.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 17.3 tt -141.41 125.62 16.89 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 176.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 39.4 t0 -82.35 104.89 12.99 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 124.737 1.215 . . . . 0.0 108.428 -175.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 30.5 m -60.47 -25.8 35.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 C-N-CA 123.464 0.705 . . . . 0.0 112.194 -173.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -64.83 -26.54 68.38 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 119.188 0.904 . . . . 0.0 111.468 -177.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -108.97 6.38 25.14 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.098 1.359 . . . . 0.0 110.791 -179.205 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 68.3 m-80 -146.69 39.66 1.06 Allowed 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.536 1.135 . . . . 0.0 110.137 -168.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -57.84 -29.6 65.1 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.448 1.099 . . . . 0.0 110.541 179.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 48.1 mp0 -65.4 -51.35 60.93 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 124.7 1.2 . . . . 0.0 109.923 177.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.12 -38.55 85.79 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.536 0.734 . . . . 0.0 109.748 -178.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.1 -48.62 80.95 Favored 'General case' 0 CA--C 1.534 0.34 0 O-C-N 121.105 -0.997 . . . . 0.0 110.255 172.185 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -60.59 -28.92 68.52 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 123.887 0.756 . . . . 0.0 112.397 177.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 73.7 tttt -55.82 -29.28 59.52 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 125.047 1.339 . . . . 0.0 111.674 179.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -123.64 10.17 9.03 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.647 0.779 . . . . 0.0 111.87 179.288 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 64.37 28.75 73.5 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 123.736 0.684 . . . . 0.0 112.839 -176.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 51.0 t -62.08 125.65 18.81 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 172.054 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 12.0 tpt -137.6 0.71 2.28 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.567 1.147 . . . . 0.0 111.15 -176.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 28.0 m -144.87 162.67 36.24 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 126.594 1.957 . . . . 0.0 107.439 179.031 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 40.2 pt -142.97 154.44 61.89 Favored Pre-proline 0 CA--C 1.546 0.809 0 C-N-CA 124.502 1.121 . . . . 0.0 108.916 177.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -68.03 138.49 44.33 Favored 'Cis proline' 0 C--N 1.35 0.628 0 CA-C-N 120.427 1.188 . . . . 0.0 110.376 -3.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 26.0 m -129.42 141.55 51.01 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 173.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 86.7 mt -122.82 127.17 48.71 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 -169.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -115.99 123.63 48.5 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 103.683 -2.71 . . . . 0.0 103.683 177.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 6.2 t -99.24 125.13 52.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 103.993 -2.595 . . . . 0.0 103.993 177.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.7 mp -122.5 153.67 38.86 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 4.5 tmtp? -135.19 120.24 18.72 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 106.306 -1.739 . . . . 0.0 106.306 175.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.5 t70 50.69 36.88 15.15 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.901 1.28 . . . . 0.0 112.559 175.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 106.24 -4.26 38.04 Favored Glycine 0 CA--C 1.526 0.779 0 CA-C-O 118.104 -1.387 . . . . 0.0 115.326 168.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -130.87 147.72 52.55 Favored 'General case' 0 C--N 1.339 0.132 0 CA-C-N 120.085 1.942 . . . . 0.0 110.205 -177.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 53.0 t -63.26 132.86 29.24 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 178.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 5.2 p -119.21 -20.39 4.99 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 C-N-CA 124.823 1.249 . . . . 0.0 110.795 174.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -158.23 168.73 26.23 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 120.544 1.52 . . . . 0.0 110.903 173.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 10.3 m -138.26 150.94 47.16 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.399 1.48 . . . . 0.0 108.497 175.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 2.7 m -146.54 157.16 43.69 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 125.761 1.624 . . . . 0.0 108.653 169.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 39.5 t -133.67 147.14 30.92 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 176.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 78.47 -176.94 54.07 Favored Glycine 0 CA--C 1.53 0.973 0 CA-C-O 121.638 0.577 . . . . 0.0 112.406 177.101 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 60.0 t80 -65.91 145.03 56.4 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.921 0.888 . . . . 0.0 110.896 -179.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -141.93 140.57 19.96 Favored Pre-proline 0 CA--C 1.535 0.37 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 167.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -72.11 162.5 41.55 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 122.68 2.254 . . . . 0.0 110.781 175.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 31.9 pttt -58.91 -30.99 68.23 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 -177.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -66.94 -49.76 64.5 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 118.336 0.516 . . . . 0.0 109.969 176.194 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.24 -39.4 94.5 Favored 'General case' 0 CA--C 1.529 0.146 0 O-C-N 121.923 -0.486 . . . . 0.0 110.512 179.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 59.3 mt -62.48 -45.22 94.01 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 123.345 0.658 . . . . 0.0 111.013 176.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 19.2 mt-30 -58.79 -42.15 88.39 Favored 'General case' 0 C--O 1.225 -0.214 0 CA-C-N 118.311 0.505 . . . . 0.0 110.262 176.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -66.89 -38.62 86.62 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 118.488 0.586 . . . . 0.0 110.817 -179.079 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 64.8 tp -63.67 -38.32 90.68 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.869 1.267 . . . . 0.0 110.956 176.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 96.4 t -68.54 -46.38 80.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-N 119.083 0.856 . . . . 0.0 109.787 172.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -56.79 -41.96 78.61 Favored 'General case' 0 CA--C 1.519 -0.219 0 C-N-CA 125.449 1.499 . . . . 0.0 111.802 -168.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -68.39 -5.62 20.05 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -175.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 83.5 m-70 -123.72 2.56 8.86 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.311 1.044 . . . . 0.0 112.8 178.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 53.9 mt . . . . . 0 C--O 1.249 1.058 0 CA-C-N 119.306 0.957 . . . . 0.0 109.545 174.449 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.9 mt . . . . . 0 CA--C 1.538 0.497 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 29.5 t -139.53 163.72 25.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 C-N-CA 126.426 1.89 . . . . 0.0 107.138 -174.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -113.74 146.03 40.47 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 174.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -145.25 168.02 21.43 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 123.086 0.554 . . . . 0.0 110.077 175.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 31.7 p -132.42 178.57 6.72 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 168.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -53.29 -28.14 26.51 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.385 0.674 . . . . 0.0 112.292 174.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 -66.05 -29.01 69.28 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.294 1.838 . . . . 0.0 112.832 179.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 16.6 p -129.62 -14.61 4.1 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 -167.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -52.61 -47.03 67.22 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 124.453 1.101 . . . . 0.0 111.987 -172.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.8 m -63.84 -38.88 92.73 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 122.855 0.462 . . . . 0.0 111.787 -177.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -67.56 -44.79 77.4 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 177.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -64.02 -35.76 81.78 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 122.392 0.277 . . . . 0.0 111.062 -178.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 29.0 p -84.12 0.18 49.49 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.868 0.867 . . . . 0.0 113.251 -176.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 70.1 m -99.41 30.0 3.74 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.127 0.971 . . . . 0.0 111.758 -177.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -132.95 56.75 1.83 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.255 1.022 . . . . 0.0 110.543 -176.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 97.14 -155.36 20.66 Favored Glycine 0 C--N 1.336 0.572 0 N-CA-C 110.043 -1.223 . . . . 0.0 110.043 175.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 65.5 t -71.42 133.09 32.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 168.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 46.9 t -137.25 141.59 39.57 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 N-CA-C 105.907 -1.886 . . . . 0.0 105.907 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 3.8 tt -122.81 100.21 6.79 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 106.208 -1.775 . . . . 0.0 106.208 -175.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -82.09 146.22 29.75 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.402 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -125.63 94.2 4.06 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 126.101 1.761 . . . . 0.0 107.323 -178.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -73.54 113.46 10.68 Favored 'General case' 0 C--O 1.24 0.563 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 174.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -149.01 -177.33 5.75 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.842 1.257 . . . . 0.0 108.595 -172.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -156.21 148.3 17.46 Favored Pre-proline 0 CA--C 1.532 0.268 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 167.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -60.61 -18.63 55.97 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 121.796 1.664 . . . . 0.0 115.68 -179.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 50.6 p-90 -69.69 -20.14 63.56 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 119.987 1.267 . . . . 0.0 112.01 173.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 33.7 t -59.56 148.37 33.61 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 124.975 1.31 . . . . 0.0 111.185 -172.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -97.78 -63.36 0.89 Allowed Glycine 0 CA--C 1.529 0.962 0 CA-C-O 118.503 -1.165 . . . . 0.0 110.92 171.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -62.34 -26.57 77.1 Favored 'Trans proline' 0 C--N 1.351 0.704 0 CA-C-N 120.367 2.084 . . . . 0.0 113.73 -174.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 34.3 m -57.08 -35.59 69.57 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 121.653 -0.654 . . . . 0.0 111.513 174.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.0 mmtp -67.32 -25.54 66.07 Favored 'General case' 0 CA--C 1.53 0.208 0 O-C-N 121.63 -0.669 . . . . 0.0 110.977 -179.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 31.4 mtm -70.86 -44.24 66.81 Favored 'General case' 0 C--N 1.341 0.222 0 CA-C-N 118.619 0.645 . . . . 0.0 110.313 177.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 15.4 tt -83.32 -23.65 8.24 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 CA-C-O 118.685 -0.674 . . . . 0.0 111.831 -174.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -48.78 -51.45 53.84 Favored Pre-proline 0 CA--C 1.547 0.843 0 CA-C-N 119.941 1.246 . . . . 0.0 114.072 179.027 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -66.78 -29.22 42.65 Favored 'Trans proline' 0 C--N 1.35 0.642 0 CA-C-N 121.737 1.656 . . . . 0.0 112.24 176.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.2 t -67.91 -36.83 77.07 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 O-C-N 121.545 -0.722 . . . . 0.0 109.579 175.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 55.2 mt -68.15 -35.25 77.76 Favored 'General case' 0 C--O 1.226 -0.178 0 CA-C-N 119.43 1.014 . . . . 0.0 111.07 173.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -61.96 -42.83 99.56 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 119.196 0.907 . . . . 0.0 110.803 170.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -64.76 -38.71 91.9 Favored 'General case' 0 CA--C 1.532 0.277 0 O-C-N 121.092 -1.005 . . . . 0.0 110.686 176.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 43.5 tp -61.82 -42.92 99.63 Favored 'General case' 0 C--N 1.335 -0.032 0 C-N-CA 123.625 0.77 . . . . 0.0 109.95 175.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -60.23 -42.2 94.7 Favored 'General case' 0 CA--C 1.522 -0.119 0 C-N-CA 123.041 0.536 . . . . 0.0 110.728 178.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 -72.34 -10.92 60.4 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 112.573 0.582 . . . . 0.0 112.573 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -105.36 -32.86 8.38 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 125.353 1.461 . . . . 0.0 111.545 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 82.1 mmm -126.16 -5.7 6.67 Favored 'General case' 0 C--O 1.227 -0.127 0 CA-C-O 118.226 -0.892 . . . . 0.0 113.097 -167.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -57.82 -13.95 14.65 Favored Glycine 0 CA--C 1.532 1.155 0 CA-C-N 120.027 1.285 . . . . 0.0 114.873 -174.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -66.73 -27.32 67.52 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.508 1.123 . . . . 0.0 112.011 172.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.471 ' HA ' ' HE3' ' A' ' 49' ' ' LYS . 0.0 OUTLIER -120.93 -21.61 6.48 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 126.094 1.757 . . . . 0.0 111.84 179.787 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 35.9 tp -109.49 157.67 18.74 Favored 'General case' 0 C--O 1.232 0.169 0 C-N-CA 123.994 0.918 . . . . 0.0 111.428 -169.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -131.27 143.19 50.36 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 103.846 -2.65 . . . . 0.0 103.846 166.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 73.6 mt -116.01 140.38 38.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 105.517 -2.031 . . . . 0.0 105.517 176.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 81.3 t -132.53 98.36 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 -172.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -74.3 140.34 44.83 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 174.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 14.9 tt -142.63 126.91 15.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 N-CA-C 108.679 -0.859 . . . . 0.0 108.679 176.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 62.2 t0 -84.4 105.36 15.18 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 124.609 1.163 . . . . 0.0 109.057 -173.11 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 31.4 m -59.61 -26.14 33.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 118.664 -0.684 . . . . 0.0 112.023 -175.113 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -65.18 -18.6 65.44 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 119.407 1.003 . . . . 0.0 112.143 -176.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -119.87 3.71 11.03 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.916 1.287 . . . . 0.0 111.173 178.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -139.39 40.29 2.07 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 124.528 1.131 . . . . 0.0 109.82 -169.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 51.4 mm-40 -56.04 -33.05 64.58 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.997 0.919 . . . . 0.0 111.227 178.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -66.08 -46.53 77.37 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 118.509 0.595 . . . . 0.0 110.549 179.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.19 -39.03 78.93 Favored 'General case' 0 C--O 1.223 -0.32 0 O-C-N 121.816 -0.553 . . . . 0.0 109.721 -179.296 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -58.79 -47.95 82.96 Favored 'General case' 0 CA--C 1.534 0.346 0 O-C-N 121.062 -1.024 . . . . 0.0 110.244 172.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -60.38 -28.47 67.26 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 124.171 0.891 . . . . 0.0 112.421 177.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 48.2 tptt -56.2 -29.07 60.42 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.546 1.139 . . . . 0.0 111.491 179.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -123.99 10.26 8.82 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.511 0.724 . . . . 0.0 111.661 -179.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 63.36 30.51 77.77 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 123.693 0.663 . . . . 0.0 112.572 -176.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 61.5 t -61.37 122.34 11.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 173.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 25.8 ptp -129.9 -12.4 4.22 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 124.923 1.289 . . . . 0.0 112.748 -171.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 23.0 m -139.9 165.23 27.87 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 127.396 2.278 . . . . 0.0 108.124 178.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 36.7 pt -142.13 154.79 65.05 Favored Pre-proline 0 CA--C 1.545 0.772 0 C-N-CA 124.845 1.258 . . . . 0.0 108.567 177.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -67.94 139.87 51.34 Favored 'Cis proline' 0 C--N 1.351 0.664 0 CA-C-N 120.481 1.208 . . . . 0.0 110.414 -2.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 22.7 m -130.99 139.12 49.96 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 174.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 85.5 mt -119.46 126.1 50.51 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 106.819 -1.548 . . . . 0.0 106.819 -169.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -117.01 119.28 34.82 Favored 'General case' 0 CA--C 1.511 -0.535 0 N-CA-C 103.755 -2.683 . . . . 0.0 103.755 177.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.4 t -92.34 124.29 44.75 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 N-CA-C 103.582 -2.747 . . . . 0.0 103.582 173.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.3 mp -115.03 155.12 27.58 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 174.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -136.73 123.75 21.53 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 171.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 27.9 t70 49.45 38.03 13.37 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.008 1.323 . . . . 0.0 112.456 177.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 101.64 -2.72 53.05 Favored Glycine 0 CA--C 1.528 0.865 0 CA-C-O 118.108 -1.384 . . . . 0.0 115.395 168.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -131.47 151.74 51.3 Favored 'General case' 0 CA--C 1.528 0.109 0 CA-C-N 120.063 1.931 . . . . 0.0 110.185 -178.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 38.8 t -62.85 133.32 28.7 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.9 p -120.61 -20.28 4.57 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 C-N-CA 125.324 1.45 . . . . 0.0 109.872 177.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -161.02 168.73 23.91 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 120.315 1.416 . . . . 0.0 110.47 171.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 10.5 m -140.46 151.03 44.54 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.078 1.351 . . . . 0.0 108.741 175.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 58.7 m -150.45 157.21 42.77 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.283 1.433 . . . . 0.0 108.835 169.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 43.7 t -133.89 144.56 35.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 -178.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 79.24 -175.07 55.21 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 123.434 0.54 . . . . 0.0 112.153 178.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -63.58 148.77 47.97 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.742 0.817 . . . . 0.0 111.031 -179.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 45.6 mttm -144.14 135.54 12.68 Favored Pre-proline 0 C--O 1.233 0.234 0 N-CA-C 106.406 -1.702 . . . . 0.0 106.406 168.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -70.0 162.37 42.46 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 122.154 1.903 . . . . 0.0 110.266 173.155 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 18.2 ptmt -55.98 -31.02 62.63 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.424 1.09 . . . . 0.0 113.533 -179.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -67.43 -49.69 62.62 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 118.528 0.604 . . . . 0.0 109.767 176.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.04 -39.38 94.56 Favored 'General case' 0 C--N 1.34 0.173 0 C-N-CA 122.896 0.478 . . . . 0.0 110.72 179.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 86.2 mt -62.95 -45.39 92.69 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.111 0.564 . . . . 0.0 111.166 176.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -61.07 -41.14 96.08 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-O 118.944 -0.551 . . . . 0.0 110.353 176.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -63.72 -41.62 98.04 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 118.427 0.558 . . . . 0.0 110.275 179.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 67.8 tp -61.73 -41.49 97.71 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 124.729 1.212 . . . . 0.0 110.98 177.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 75.1 t -62.39 -47.72 91.7 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 CA-C-N 118.757 0.708 . . . . 0.0 109.365 171.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 -61.76 -26.53 68.14 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 125.504 1.522 . . . . 0.0 112.291 -171.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -53.83 -26.87 26.42 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 123.604 0.761 . . . . 0.0 112.416 172.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 72.8 m-70 -123.49 -6.09 8.16 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 113.852 1.056 . . . . 0.0 113.852 -167.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 79.9 mt . . . . . 0 C--O 1.249 1.062 0 CA-C-N 118.814 0.733 . . . . 0.0 109.286 171.851 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.2 mt . . . . . 0 CA--C 1.534 0.359 0 N-CA-C 106.225 -1.769 . . . . 0.0 106.225 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 43.4 t -134.2 163.07 38.01 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 C-N-CA 126.89 2.076 . . . . 0.0 106.0 -178.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 1.4 tmtt? -129.01 131.54 47.41 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 104.247 -2.501 . . . . 0.0 104.247 179.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -142.6 173.46 11.51 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 123.732 0.813 . . . . 0.0 110.973 -169.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 23.6 p -136.91 174.01 11.08 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 125.066 1.347 . . . . 0.0 107.573 169.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -51.13 -27.97 9.79 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.726 1.21 . . . . 0.0 112.976 176.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -57.99 -30.59 66.18 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.103 1.761 . . . . 0.0 112.767 178.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.0 m -139.55 -7.4 1.3 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.837 0.855 . . . . 0.0 113.277 -169.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 69.2 t80 -51.45 -44.0 62.25 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.409 1.084 . . . . 0.0 111.925 -177.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.7 m -63.58 -38.39 90.96 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 122.991 0.516 . . . . 0.0 111.804 -178.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -68.32 -44.82 74.54 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 176.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 67.7 mm-40 -62.43 -36.83 83.62 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 122.67 0.388 . . . . 0.0 111.124 -178.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.7 p -83.13 0.7 43.98 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.072 0.949 . . . . 0.0 113.46 -177.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 68.0 m -105.15 33.33 3.71 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.206 1.002 . . . . 0.0 111.125 -176.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -132.8 60.25 1.71 Allowed 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.253 1.021 . . . . 0.0 109.966 -178.243 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 92.11 -153.71 22.0 Favored Glycine 0 C--N 1.337 0.633 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 177.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 82.9 t -74.06 137.01 24.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 168.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 48.1 t -139.21 145.96 26.54 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 N-CA-C 105.952 -1.87 . . . . 0.0 105.952 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.3 tt -125.01 99.09 5.97 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 106.448 -1.686 . . . . 0.0 106.448 -176.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -79.51 144.63 33.78 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 123.572 0.749 . . . . 0.0 109.17 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -126.92 94.35 4.01 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 126.045 1.738 . . . . 0.0 107.643 -176.316 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -74.49 113.46 11.76 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 173.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -147.22 -171.47 3.79 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.128 1.371 . . . . 0.0 108.225 -175.449 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -161.32 148.0 11.52 Favored Pre-proline 0 CA--C 1.533 0.306 0 N-CA-C 105.996 -1.853 . . . . 0.0 105.996 166.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -60.58 -18.07 52.47 Favored 'Trans proline' 0 CA--C 1.534 0.477 0 C-N-CA 121.776 1.651 . . . . 0.0 115.745 -178.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 50.7 p-90 -69.76 -20.57 63.49 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 120.029 1.286 . . . . 0.0 111.998 173.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 26.9 t -59.89 148.74 33.8 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 124.902 1.281 . . . . 0.0 111.096 -172.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -100.6 -63.97 0.79 Allowed Glycine 0 CA--C 1.529 0.938 0 CA-C-O 118.501 -1.166 . . . . 0.0 110.492 172.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_exo -53.77 -32.4 65.9 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 123.244 2.629 . . . . 0.0 114.495 -179.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 35.9 m -57.55 -34.82 69.57 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.326 0.651 . . . . 0.0 111.635 176.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.5 mmtp -67.93 -25.49 65.5 Favored 'General case' 0 CA--C 1.531 0.248 0 O-C-N 121.589 -0.694 . . . . 0.0 110.836 -179.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 30.0 mtm -71.25 -42.46 68.79 Favored 'General case' 0 C--N 1.341 0.213 0 CA-C-N 118.67 0.668 . . . . 0.0 110.444 176.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 17.1 tt -84.07 -22.48 8.11 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-O 118.807 -0.616 . . . . 0.0 111.53 -175.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -48.99 -51.21 57.58 Favored Pre-proline 0 CA--C 1.547 0.862 0 CA-C-N 120.028 1.285 . . . . 0.0 113.971 178.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -67.07 -28.37 41.33 Favored 'Trans proline' 0 C--N 1.35 0.614 0 CA-C-N 121.724 1.652 . . . . 0.0 112.303 176.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 13.0 t -66.45 -39.3 83.69 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 174.269 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 87.4 mt -67.06 -34.7 78.25 Favored 'General case' 0 C--N 1.34 0.165 0 CA-C-N 119.22 0.918 . . . . 0.0 111.323 173.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -62.5 -44.36 96.56 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 119.571 1.078 . . . . 0.0 110.746 171.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -64.42 -38.31 90.6 Favored 'General case' 0 CA--C 1.532 0.271 0 O-C-N 121.233 -0.917 . . . . 0.0 110.7 176.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 61.5 tp -63.22 -44.26 95.79 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.619 0.768 . . . . 0.0 110.015 176.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -59.31 -41.73 89.73 Favored 'General case' 0 CA--C 1.521 -0.153 0 C-N-CA 123.41 0.684 . . . . 0.0 111.009 177.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -72.06 -10.38 59.7 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.075 0.55 . . . . 0.0 112.464 -179.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 -104.77 -33.43 8.44 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 125.208 1.403 . . . . 0.0 111.662 179.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 74.8 mmm -121.29 -4.44 9.43 Favored 'General case' 0 C--O 1.224 -0.242 0 CA-C-O 118.18 -0.914 . . . . 0.0 112.658 -168.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -58.22 -14.09 17.58 Favored Glycine 0 CA--C 1.531 1.075 0 CA-C-N 120.07 1.305 . . . . 0.0 115.23 -173.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -70.14 -25.14 63.33 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 118.533 1.167 . . . . 0.0 111.775 172.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.428 ' HA ' ' HE2' ' A' ' 49' ' ' LYS . 9.7 mmpt? -123.67 -17.43 6.41 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 126.519 1.928 . . . . 0.0 111.628 -175.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 28.0 tp -118.94 159.39 23.9 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 124.718 1.207 . . . . 0.0 111.021 -169.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 37.2 ttmt -134.82 145.2 48.12 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 104.108 -2.552 . . . . 0.0 104.108 167.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 62.3 mt -115.81 141.11 34.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 175.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 69.1 t -132.83 96.81 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 -172.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -75.96 131.91 39.88 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 177.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 15.9 tt -140.34 135.49 36.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -97.78 115.57 28.28 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 123.875 0.87 . . . . 0.0 111.049 -168.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 35.7 m -60.96 -19.62 20.15 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 O-C-N 121.582 -0.699 . . . . 0.0 112.321 -178.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -63.39 -21.75 66.47 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.757 1.223 . . . . 0.0 113.004 179.092 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -131.79 1.76 4.01 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.655 0.782 . . . . 0.0 112.625 178.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 63.4 m-80 -129.88 39.41 3.7 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.683 0.793 . . . . 0.0 110.896 -170.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.2 mp0 -54.97 -31.88 61.11 Favored 'General case' 0 C--N 1.34 0.178 0 C-N-CA 123.707 0.803 . . . . 0.0 111.896 176.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 27.4 tp10 -67.31 -47.08 71.63 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 123.979 0.912 . . . . 0.0 110.556 -178.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.72 -39.46 76.84 Favored 'General case' 0 CA--C 1.535 0.395 0 O-C-N 121.728 -0.607 . . . . 0.0 109.561 179.316 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.29 -47.45 85.34 Favored 'General case' 0 CA--C 1.533 0.312 0 O-C-N 121.423 -0.798 . . . . 0.0 110.56 174.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -62.66 -27.11 69.3 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 124.055 0.836 . . . . 0.0 111.876 178.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 5.8 tppt? -55.67 -28.44 55.54 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.568 1.147 . . . . 0.0 111.877 177.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -124.22 11.39 8.78 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.81 0.844 . . . . 0.0 111.572 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 63.77 30.48 77.79 Favored Glycine 0 CA--C 1.532 1.094 0 C-N-CA 123.72 0.676 . . . . 0.0 112.761 -177.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 60.9 t -65.86 125.66 23.45 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 172.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 66.8 mtt -136.75 3.98 2.77 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.821 1.249 . . . . 0.0 111.448 -179.275 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 23.4 m -144.05 162.62 35.75 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 126.676 1.991 . . . . 0.0 107.768 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 44.2 pt -141.72 155.48 66.44 Favored Pre-proline 0 CA--C 1.545 0.78 0 C-N-CA 124.445 1.098 . . . . 0.0 108.796 175.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -67.38 139.62 48.1 Favored 'Cis proline' 0 C--N 1.35 0.607 0 CA-C-N 120.209 1.11 . . . . 0.0 110.209 -5.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 50.9 m -132.65 140.69 48.29 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 174.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 87.8 mt -123.62 129.18 50.76 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 -169.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -120.94 122.9 41.18 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 103.431 -2.803 . . . . 0.0 103.431 177.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 1.8 t -100.22 120.17 49.3 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 N-CA-C 103.899 -2.63 . . . . 0.0 103.899 176.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.3 mp -112.03 155.16 24.24 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 -178.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 57.8 tttp -134.59 115.59 14.04 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 105.785 -1.932 . . . . 0.0 105.785 177.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.0 t70 49.87 39.17 17.72 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.893 1.277 . . . . 0.0 112.374 176.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 104.79 -5.62 43.39 Favored Glycine 0 CA--C 1.529 0.955 0 CA-C-O 118.139 -1.367 . . . . 0.0 115.295 169.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -131.29 149.27 52.63 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 120.054 1.927 . . . . 0.0 110.527 -177.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 39.2 t -63.59 134.49 28.57 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 -179.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 8.7 p -118.94 -26.41 2.51 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 C-N-CA 125.065 1.346 . . . . 0.0 110.504 172.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -149.9 165.28 33.06 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 120.689 1.586 . . . . 0.0 110.046 173.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 17.2 m -140.86 151.18 44.1 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.442 1.497 . . . . 0.0 108.025 178.116 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 37.3 m -151.25 157.06 42.1 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.415 1.486 . . . . 0.0 109.265 169.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 30.6 t -135.62 145.65 31.14 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 -176.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 75.81 -176.75 50.65 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 123.896 0.76 . . . . 0.0 111.893 178.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 47.4 t80 -62.06 137.58 58.27 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 173.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 64.6 tttt -149.94 137.68 11.76 Favored Pre-proline 0 C--O 1.235 0.316 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 -178.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -70.7 153.73 64.45 Favored 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 121.628 1.552 . . . . 0.0 111.959 -172.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 29.2 ttpp -52.18 -45.39 65.11 Favored 'General case' 0 CA--C 1.518 -0.256 0 C-N-CA 125.805 1.642 . . . . 0.0 112.313 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -62.92 -43.31 99.14 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 -176.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.98 -43.1 96.73 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 122.421 0.288 . . . . 0.0 110.499 179.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 76.8 mt -62.32 -44.08 97.32 Favored 'General case' 0 C--O 1.231 0.095 0 CA-C-N 117.535 0.152 . . . . 0.0 110.911 178.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -74.24 -29.27 61.62 Favored 'General case' 0 N--CA 1.451 -0.42 0 O-C-N 122.178 -0.326 . . . . 0.0 110.892 -175.544 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 31.9 tp10 -70.23 -37.72 75.07 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 124.566 1.146 . . . . 0.0 110.543 173.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 53.6 mt -60.86 -50.32 73.89 Favored 'General case' 0 C--O 1.224 -0.246 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 172.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 33.0 t -52.22 -46.33 44.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 122.853 0.461 . . . . 0.0 109.949 173.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -62.77 -38.43 90.56 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 123.974 0.909 . . . . 0.0 112.258 -171.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 16.9 ptmt -67.13 -18.25 65.22 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 118.125 -0.94 . . . . 0.0 112.644 -175.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 25.2 p80 -127.13 -8.41 5.93 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 115.002 1.482 . . . . 0.0 115.002 -174.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 10.2 mt . . . . . 0 C--O 1.248 0.997 0 CA-C-O 118.029 -0.986 . . . . 0.0 109.368 167.433 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.8 mt . . . . . 0 CA--C 1.537 0.459 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 14.7 t -138.53 162.12 29.91 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 126.395 1.878 . . . . 0.0 106.805 -175.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -116.5 144.05 44.82 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 106.03 -1.841 . . . . 0.0 106.03 172.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -144.36 157.66 44.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.385 0.612 . . . . 0.0 111.566 -176.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 16.1 p -105.3 171.07 7.52 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 126.292 1.837 . . . . 0.0 107.646 168.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -47.26 -43.85 22.44 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 124.72 1.208 . . . . 0.0 113.112 176.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 66.9 mm-40 -79.93 -35.04 38.35 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 122.654 0.382 . . . . 0.0 111.533 -175.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.2 m -71.81 -32.38 67.53 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 122.772 0.429 . . . . 0.0 111.315 176.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -52.72 -46.74 67.53 Favored 'General case' 0 N--CA 1.457 -0.116 0 C-N-CA 125.128 1.371 . . . . 0.0 112.245 -169.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 9.5 m -63.75 -38.4 90.98 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 118.105 0.412 . . . . 0.0 111.86 -176.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -68.81 -44.31 73.81 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 176.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 69.0 mm-40 -63.94 -37.21 86.56 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 122.451 0.3 . . . . 0.0 110.925 -178.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.423 ' HA ' HG21 ' A' ' 20' ' ' VAL . 28.8 p -80.52 0.1 35.2 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.992 0.917 . . . . 0.0 113.332 -177.552 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 70.8 m -98.13 28.76 3.84 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.097 0.959 . . . . 0.0 112.16 -177.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -136.73 81.06 1.85 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.209 1.004 . . . . 0.0 110.023 -178.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 82.64 -156.66 35.17 Favored Glycine 0 C--N 1.338 0.65 0 N-CA-C 110.722 -0.951 . . . . 0.0 110.722 173.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 44.9 t -74.17 135.4 27.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 N-CA-C 106.034 -1.839 . . . . 0.0 106.034 168.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.423 HG21 ' HA ' ' A' ' 15' ' ' THR . 40.2 t -135.57 136.85 50.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 179.158 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.2 tt -120.01 111.36 17.8 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 106.198 -1.778 . . . . 0.0 106.198 -179.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -94.31 144.92 25.12 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 123.854 0.862 . . . . 0.0 109.104 -175.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -124.16 93.73 4.0 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 125.56 1.544 . . . . 0.0 107.469 -176.115 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -73.77 113.44 10.91 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 105.815 -1.92 . . . . 0.0 105.815 174.095 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -150.41 -176.57 5.53 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.727 1.211 . . . . 0.0 108.227 -171.156 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -152.13 149.15 22.58 Favored Pre-proline 0 C--N 1.331 -0.215 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 167.069 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -67.95 -12.65 35.95 Favored 'Trans proline' 0 N--CA 1.459 -0.543 0 CA-C-N 121.179 1.457 . . . . 0.0 113.071 -179.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 1.5 m95 -76.27 -12.84 60.15 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.665 0.786 . . . . 0.0 111.876 172.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 29.7 t -64.07 153.62 36.92 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.317 1.447 . . . . 0.0 111.089 -176.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.403 ' H ' ' HD2' ' A' ' 31' ' ' PRO . . . -101.51 -62.98 0.76 Allowed Glycine 0 CA--C 1.532 1.137 0 C-N-CA 124.723 1.154 . . . . 0.0 111.268 170.319 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.403 ' HD2' ' H ' ' A' ' 30' ' ' GLY . 25.3 Cg_endo -64.88 -25.96 59.72 Favored 'Trans proline' 0 C--N 1.35 0.611 0 CA-C-N 120.472 2.136 . . . . 0.0 113.266 -173.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 25.7 m -57.59 -34.43 69.23 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 121.537 -0.727 . . . . 0.0 111.433 174.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.4 mmtp -67.7 -22.79 65.25 Favored 'General case' 0 CA--C 1.531 0.22 0 O-C-N 121.663 -0.648 . . . . 0.0 111.199 -179.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 34.0 mtm -71.15 -43.64 67.12 Favored 'General case' 0 C--N 1.34 0.179 0 CA-C-N 118.723 0.692 . . . . 0.0 110.359 176.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 13.4 tt -84.21 -23.32 7.78 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-O 118.817 -0.611 . . . . 0.0 111.691 -175.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -48.4 -51.17 53.19 Favored Pre-proline 0 CA--C 1.548 0.889 0 CA-C-N 119.959 1.254 . . . . 0.0 114.27 178.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -66.59 -29.36 44.08 Favored 'Trans proline' 0 C--N 1.351 0.685 0 CA-C-N 121.628 1.617 . . . . 0.0 112.108 176.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 5.1 t -68.06 -36.59 76.01 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 O-C-N 121.585 -0.697 . . . . 0.0 109.751 175.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 74.1 mt -67.21 -36.05 80.9 Favored 'General case' 0 C--N 1.34 0.166 0 CA-C-N 119.518 1.053 . . . . 0.0 111.153 172.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -62.1 -42.66 99.45 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 119.227 0.921 . . . . 0.0 110.808 171.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -63.91 -39.44 94.19 Favored 'General case' 0 CA--C 1.533 0.298 0 O-C-N 121.078 -1.014 . . . . 0.0 110.381 175.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 36.9 tp -62.81 -42.36 99.68 Favored 'General case' 0 CA--C 1.527 0.088 0 C-N-CA 123.754 0.822 . . . . 0.0 110.237 176.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -59.09 -43.15 91.83 Favored 'General case' 0 CA--C 1.522 -0.13 0 C-N-CA 123.363 0.665 . . . . 0.0 110.657 176.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -71.44 -10.67 60.14 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.327 0.651 . . . . 0.0 112.645 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 23.9 mm-40 -106.63 -28.41 10.24 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 125.419 1.487 . . . . 0.0 111.759 -178.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 23.1 mtp -131.73 -1.7 3.79 Favored 'General case' 0 N--CA 1.461 0.118 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 -169.126 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -54.69 -15.6 6.39 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 124.777 1.179 . . . . 0.0 115.616 -174.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -69.7 -28.91 66.24 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.842 1.257 . . . . 0.0 112.016 175.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 41.7 mmtm -123.88 -16.06 6.73 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 125.757 1.623 . . . . 0.0 112.39 -177.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 58.5 tp -119.28 139.04 52.56 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 123.982 0.913 . . . . 0.0 110.289 -170.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -111.69 145.67 38.87 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 105.009 -2.219 . . . . 0.0 105.009 168.074 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 90.4 mt -116.99 138.93 46.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 105.747 -1.946 . . . . 0.0 105.747 174.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 98.3 t -132.75 98.87 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 -171.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 54.2 mtpt -74.28 140.25 44.82 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 174.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 14.3 tt -142.71 128.05 16.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 177.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 64.6 t0 -87.57 107.22 18.49 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 124.4 1.08 . . . . 0.0 109.323 -169.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 29.0 m -61.69 -20.81 24.15 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 CA-C-O 118.737 -0.649 . . . . 0.0 112.143 -177.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -69.04 -14.06 62.81 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 119.691 1.132 . . . . 0.0 112.112 178.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -127.06 0.52 6.52 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.1 0.96 . . . . 0.0 111.997 178.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 67.8 m-80 -138.39 41.92 2.21 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.735 0.814 . . . . 0.0 111.104 -169.247 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 5.4 mp0 -54.62 -31.66 57.57 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.376 0.67 . . . . 0.0 112.104 176.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 -64.72 -46.69 81.23 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 118.471 0.578 . . . . 0.0 110.411 -178.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.6 -38.49 73.99 Favored 'General case' 0 C--O 1.223 -0.303 0 C-N-CA 123.162 0.585 . . . . 0.0 109.503 -178.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -58.09 -47.9 81.8 Favored 'General case' 0 CA--C 1.535 0.376 0 O-C-N 121.28 -0.888 . . . . 0.0 110.236 172.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -61.34 -29.02 70.33 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 124.117 0.865 . . . . 0.0 112.265 177.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 74.3 tttt -55.7 -28.73 57.26 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.774 1.23 . . . . 0.0 111.873 178.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -123.2 9.94 9.28 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.69 0.796 . . . . 0.0 111.956 178.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 63.57 31.71 81.71 Favored Glycine 0 CA--C 1.533 1.218 0 CA-C-O 119.459 -0.634 . . . . 0.0 112.578 -176.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 61.3 t -64.19 124.59 19.26 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 172.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 78.2 mtm -137.06 3.53 2.66 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.924 1.29 . . . . 0.0 111.522 -178.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 39.1 m -141.48 163.87 31.76 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 126.767 2.027 . . . . 0.0 107.532 175.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 41.1 pt -142.99 155.12 62.49 Favored Pre-proline 0 CA--C 1.546 0.806 0 C-N-CA 124.596 1.158 . . . . 0.0 108.626 174.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -67.62 137.68 39.15 Favored 'Cis proline' 0 C--N 1.349 0.587 0 CA-C-N 120.5 1.214 . . . . 0.0 110.204 -4.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 35.9 m -129.96 134.17 47.28 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 106.97 -1.493 . . . . 0.0 106.97 175.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 10.9 mp -114.47 126.54 55.07 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 -169.238 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -114.73 147.72 39.3 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 104.583 -2.377 . . . . 0.0 104.583 175.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.4 t -126.79 128.79 71.24 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.624 0 N-CA-C 104.706 -2.331 . . . . 0.0 104.706 -177.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.4 mp -130.22 147.89 52.0 Favored 'General case' 0 N--CA 1.445 -0.725 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 -172.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 21.4 tptm -133.74 118.32 17.95 Favored 'General case' 0 CA--C 1.514 -0.439 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 29.2 t70 51.15 33.89 10.17 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.486 1.515 . . . . 0.0 112.55 174.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 110.72 -3.48 29.07 Favored Glycine 0 CA--C 1.527 0.806 0 CA-C-O 118.062 -1.41 . . . . 0.0 114.869 169.063 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -130.2 144.78 51.56 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 120.027 1.914 . . . . 0.0 110.164 -177.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 13.6 p -65.55 133.23 30.94 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 176.339 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 8.0 p -126.28 -19.02 2.78 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-O 117.653 -1.165 . . . . 0.0 111.239 -179.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -156.48 169.96 23.42 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 121.116 1.78 . . . . 0.0 111.529 177.538 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 15.6 m -147.11 151.73 37.31 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.454 1.501 . . . . 0.0 108.907 178.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 65.1 m -152.25 157.39 41.35 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 126.18 1.792 . . . . 0.0 108.321 171.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 28.7 t -134.06 142.76 40.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 -176.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.56 -176.81 53.56 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 123.58 0.61 . . . . 0.0 112.44 177.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 66.1 t80 -63.17 150.4 42.98 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.39 1.076 . . . . 0.0 110.939 178.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -146.97 146.14 24.91 Favored Pre-proline 0 N--CA 1.467 0.384 0 C-N-CA 125.355 1.462 . . . . 0.0 107.4 168.034 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -71.24 157.66 56.62 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 122.444 2.096 . . . . 0.0 110.219 170.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 48.5 pttt -58.48 -30.29 66.87 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -178.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -67.18 -45.12 77.92 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 118.508 0.594 . . . . 0.0 109.946 178.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.47 -38.12 89.93 Favored 'General case' 0 CA--C 1.529 0.165 0 O-C-N 121.845 -0.534 . . . . 0.0 110.57 176.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 95.0 mt -64.34 -42.74 96.12 Favored 'General case' 0 C--O 1.226 -0.146 0 CA-C-O 119.26 -0.4 . . . . 0.0 111.327 176.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 15.8 mt-30 -58.11 -42.16 85.13 Favored 'General case' 0 C--O 1.226 -0.139 0 CA-C-N 118.584 0.629 . . . . 0.0 109.971 174.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -65.08 -40.09 94.15 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 118.115 0.416 . . . . 0.0 110.579 -179.414 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 68.9 tp -61.97 -43.74 98.21 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.44 1.096 . . . . 0.0 110.712 176.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 93.3 t -62.56 -43.44 98.43 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 123.585 0.754 . . . . 0.0 109.743 174.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -60.28 -27.67 67.47 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 125.101 1.36 . . . . 0.0 112.055 -172.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -56.07 -24.07 37.65 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.549 0.74 . . . . 0.0 112.668 174.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 47.4 m-70 -125.37 -3.42 7.39 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 -168.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 84.2 mt . . . . . 0 C--O 1.25 1.083 0 CA-C-N 118.785 0.721 . . . . 0.0 109.184 172.65 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.5 mt . . . . . 0 CA--C 1.537 0.457 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 18.2 t -138.36 161.97 30.62 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 C-N-CA 126.157 1.783 . . . . 0.0 106.887 -175.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 3.7 tppp? -116.33 142.04 47.37 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 106.001 -1.852 . . . . 0.0 106.001 172.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -146.36 166.33 26.66 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.399 0.619 . . . . 0.0 111.053 -177.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.442 HG22 HD21 ' A' ' 60' ' ' ASN . 28.5 p -135.47 174.36 10.7 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 126.444 1.897 . . . . 0.0 107.578 170.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -48.53 -29.78 4.57 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.851 1.26 . . . . 0.0 113.149 173.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -59.35 -29.84 67.95 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.071 1.348 . . . . 0.0 113.052 178.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 14.4 m -141.22 -7.1 1.04 Allowed 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 -169.355 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 77.8 t80 -53.75 -43.64 69.31 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 124.009 0.923 . . . . 0.0 111.772 -174.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.7 m -63.35 -38.91 92.98 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.086 0.554 . . . . 0.0 111.762 -179.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -68.13 -44.26 76.48 Favored 'General case' 0 N--CA 1.453 -0.313 0 O-C-N 122.05 -0.406 . . . . 0.0 109.954 177.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 67.3 mm-40 -63.11 -36.47 83.7 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 122.367 0.267 . . . . 0.0 110.985 -178.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 25.6 p -82.93 1.21 40.75 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.049 0.939 . . . . 0.0 113.367 -177.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 67.4 m -101.63 31.01 3.98 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.204 1.002 . . . . 0.0 111.746 -176.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -132.66 62.09 1.66 Allowed 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.198 0.999 . . . . 0.0 110.206 -178.234 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 91.54 -156.24 23.86 Favored Glycine 0 C--N 1.339 0.715 0 N-CA-C 109.899 -1.281 . . . . 0.0 109.899 176.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 94.4 t -70.81 135.32 28.32 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 168.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 55.7 t -137.51 142.95 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 N-CA-C 105.742 -1.947 . . . . 0.0 105.742 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.2 tt -122.94 100.87 7.11 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 -176.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -83.29 146.03 28.76 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.376 -179.162 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -124.46 94.08 4.1 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 125.906 1.682 . . . . 0.0 107.356 -177.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -73.91 112.79 10.37 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 105.891 -1.892 . . . . 0.0 105.891 175.157 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -148.56 -178.91 6.59 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.95 1.3 . . . . 0.0 108.475 -172.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -158.34 147.76 14.91 Favored Pre-proline 0 CA--C 1.531 0.245 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 167.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -62.87 -12.0 27.06 Favored 'Trans proline' 0 CA--C 1.535 0.573 0 CA-C-N 121.53 1.582 . . . . 0.0 116.086 -178.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 54.2 p-90 -70.72 -19.33 62.76 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 120.731 1.605 . . . . 0.0 111.784 171.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 15.3 t -61.2 162.58 7.3 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.41 1.484 . . . . 0.0 111.187 -177.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -119.94 -59.19 0.25 Allowed Glycine 0 CA--C 1.531 1.049 0 CA-C-O 118.513 -1.159 . . . . 0.0 110.694 171.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -54.13 -31.46 65.41 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 123.832 3.021 . . . . 0.0 114.118 179.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 79.8 m -52.37 -37.0 55.14 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.694 1.198 . . . . 0.0 111.915 174.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 75.2 mttt -83.06 -14.69 53.32 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.381 0.672 . . . . 0.0 110.861 -175.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 26.8 mtm -73.1 -43.71 61.39 Favored 'General case' 0 C--N 1.341 0.197 0 CA-C-N 118.886 0.767 . . . . 0.0 109.541 169.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 16.3 tt -80.37 -23.95 11.4 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-O 118.609 -0.71 . . . . 0.0 111.431 -178.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -48.39 -51.16 53.11 Favored Pre-proline 0 CA--C 1.548 0.881 0 CA-C-N 120.359 1.436 . . . . 0.0 114.315 179.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -66.9 -25.76 44.81 Favored 'Trans proline' 0 C--N 1.349 0.59 0 CA-C-N 121.958 1.735 . . . . 0.0 112.597 176.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.5 t -71.4 -35.77 58.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 O-C-N 121.454 -0.779 . . . . 0.0 109.589 174.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 95.7 mt -66.78 -35.26 79.67 Favored 'General case' 0 C--N 1.341 0.202 0 CA-C-N 119.515 1.052 . . . . 0.0 111.233 170.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -63.09 -42.13 99.55 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 119.566 1.075 . . . . 0.0 110.83 171.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -60.73 -44.86 96.11 Favored 'General case' 0 CA--C 1.53 0.174 0 O-C-N 121.505 -0.747 . . . . 0.0 110.021 173.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 34.0 tp -60.7 -41.85 96.02 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.668 0.787 . . . . 0.0 110.355 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -60.97 -43.5 98.7 Favored 'General case' 0 CA--C 1.521 -0.172 0 C-N-CA 123.264 0.626 . . . . 0.0 110.82 177.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -72.41 -10.71 60.13 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.276 0.63 . . . . 0.0 112.502 179.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -104.44 -28.57 11.25 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 125.31 1.444 . . . . 0.0 111.367 -178.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 25.4 mtp -133.69 -2.66 2.98 Favored 'General case' 0 C--N 1.339 0.146 0 N-CA-C 113.966 1.099 . . . . 0.0 113.966 -169.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -55.05 -17.2 9.44 Favored Glycine 0 CA--C 1.534 1.259 0 CA-C-N 120.148 1.34 . . . . 0.0 115.234 -173.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -67.14 -30.7 70.75 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.727 1.211 . . . . 0.0 111.934 174.093 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 40.3 mmtm -117.21 -17.41 10.22 Favored 'General case' 0 N--CA 1.462 0.149 0 C-N-CA 125.989 1.716 . . . . 0.0 111.938 -178.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 46.8 tp -116.75 154.66 30.27 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.2 1.0 . . . . 0.0 110.599 -169.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -130.12 144.56 51.42 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 104.11 -2.552 . . . . 0.0 104.11 167.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 75.8 mt -117.7 138.27 48.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 105.266 -2.124 . . . . 0.0 105.266 177.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 96.9 t -133.09 98.2 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 -169.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 52.6 mtpt -74.11 139.57 44.67 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 175.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 13.5 tt -141.76 127.16 18.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 176.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -85.27 103.73 14.48 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.615 1.166 . . . . 0.0 108.901 -171.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 29.7 m -59.85 -25.63 33.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 118.614 -0.708 . . . . 0.0 112.003 -174.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -65.41 -17.82 64.83 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 119.494 1.043 . . . . 0.0 112.055 -178.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -120.65 5.31 10.56 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.103 1.361 . . . . 0.0 111.037 178.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.442 HD21 HG22 ' A' ' 7' ' ' THR . 66.5 m-80 -141.39 40.28 1.74 Allowed 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.588 1.155 . . . . 0.0 109.665 -171.016 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 51.2 mm-40 -55.2 -31.29 61.31 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.854 0.861 . . . . 0.0 110.893 175.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -65.91 -50.42 64.5 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 124.056 0.943 . . . . 0.0 109.941 179.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.9 -38.8 83.42 Favored 'General case' 0 C--O 1.223 -0.299 0 C-N-CA 123.37 0.668 . . . . 0.0 109.643 -178.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -58.99 -48.03 83.05 Favored 'General case' 0 CA--C 1.533 0.299 0 O-C-N 121.061 -1.024 . . . . 0.0 110.305 172.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -60.95 -28.77 69.2 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 123.901 0.762 . . . . 0.0 112.331 177.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 47.8 tptt -56.33 -29.2 60.99 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.723 1.209 . . . . 0.0 111.471 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -124.16 10.91 8.77 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.507 0.723 . . . . 0.0 111.679 -179.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 63.75 31.16 79.85 Favored Glycine 0 CA--C 1.532 1.14 0 C-N-CA 123.643 0.639 . . . . 0.0 112.584 -176.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 49.3 t -65.7 123.78 19.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 171.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 67.1 mtt -136.07 3.64 2.92 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.693 1.197 . . . . 0.0 111.463 -178.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 25.6 m -143.93 161.53 38.46 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 126.849 2.06 . . . . 0.0 107.302 178.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 39.0 pt -143.25 156.11 61.23 Favored Pre-proline 0 CA--C 1.545 0.761 0 C-N-CA 124.636 1.175 . . . . 0.0 108.76 177.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -67.15 139.1 44.69 Favored 'Cis proline' 0 C--N 1.35 0.629 0 CA-C-N 120.347 1.16 . . . . 0.0 110.168 -4.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 26.6 m -130.14 140.76 50.74 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 174.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 89.8 mt -120.08 125.0 47.2 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 106.546 -1.65 . . . . 0.0 106.546 -169.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -114.86 119.83 37.93 Favored 'General case' 0 CA--C 1.512 -0.509 0 N-CA-C 103.663 -2.717 . . . . 0.0 103.663 177.064 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.8 t -90.58 123.18 42.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 103.217 -2.883 . . . . 0.0 103.217 172.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.1 mp -114.66 155.84 25.85 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 173.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -137.91 122.75 18.84 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 173.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.0 t70 49.55 37.33 12.15 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.034 1.334 . . . . 0.0 112.471 176.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 103.91 -4.27 45.66 Favored Glycine 0 CA--C 1.529 0.918 0 CA-C-O 118.217 -1.324 . . . . 0.0 115.202 168.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -131.85 152.81 50.76 Favored 'General case' 0 C--N 1.339 0.137 0 CA-C-N 120.054 1.927 . . . . 0.0 110.209 -177.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 40.8 t -63.14 134.15 28.5 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.5 p -119.02 -20.81 4.8 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 C-N-CA 125.377 1.471 . . . . 0.0 110.006 176.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -161.04 169.15 23.06 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 120.23 1.377 . . . . 0.0 110.685 169.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 8.9 m -136.14 150.83 49.24 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.369 1.468 . . . . 0.0 108.288 173.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 63.7 m -151.07 159.11 44.71 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.483 1.513 . . . . 0.0 108.559 169.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 40.4 t -133.84 148.54 30.38 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 N-CA-C 107.929 -1.138 . . . . 0.0 107.929 -177.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 76.86 -174.88 54.08 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 123.45 0.548 . . . . 0.0 112.404 175.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -64.78 148.62 50.85 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.001 0.92 . . . . 0.0 110.935 -179.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.75 142.18 16.41 Favored Pre-proline 0 CA--C 1.533 0.322 0 C-N-CA 125.455 1.502 . . . . 0.0 107.093 167.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -72.45 161.44 44.23 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 122.747 2.298 . . . . 0.0 110.635 175.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 41.5 pttt -59.25 -29.99 67.95 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 -178.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -66.38 -49.7 65.95 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 118.418 0.554 . . . . 0.0 109.908 176.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.57 -39.96 95.73 Favored 'General case' 0 CA--C 1.528 0.132 0 O-C-N 122.026 -0.421 . . . . 0.0 110.599 179.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 78.4 mt -62.94 -43.55 98.47 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.021 0.528 . . . . 0.0 111.188 177.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -59.16 -41.78 89.19 Favored 'General case' 0 C--O 1.225 -0.189 0 CA-C-N 118.342 0.519 . . . . 0.0 109.981 176.057 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -66.78 -38.98 87.6 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 118.624 0.647 . . . . 0.0 110.876 -179.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 67.4 tp -62.47 -36.64 83.12 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.842 1.257 . . . . 0.0 110.972 176.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 94.2 t -70.48 -49.32 53.84 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 CA-C-N 119.178 0.899 . . . . 0.0 109.501 171.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -56.46 -40.55 75.03 Favored 'General case' 0 CA--C 1.52 -0.204 0 C-N-CA 125.901 1.68 . . . . 0.0 111.854 -168.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -67.37 -6.21 17.92 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 -176.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 90.4 m-70 -120.89 -7.54 9.49 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.346 1.058 . . . . 0.0 112.686 177.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 60.6 mt . . . . . 0 C--O 1.248 0.99 0 CA-C-N 119.239 0.927 . . . . 0.0 109.15 173.811 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.2 mt . . . . . 0 CA--C 1.536 0.421 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 31.9 t -136.33 163.48 33.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 126.192 1.797 . . . . 0.0 106.877 -175.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -118.05 142.84 46.96 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 105.919 -1.882 . . . . 0.0 105.919 174.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -144.52 166.4 25.26 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.407 0.622 . . . . 0.0 111.027 -177.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 18.3 p -134.09 171.21 14.54 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 126.448 1.899 . . . . 0.0 107.731 171.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -52.73 -29.42 26.88 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.611 1.164 . . . . 0.0 113.046 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 56.7 mt-30 -62.87 -28.98 70.4 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.216 1.406 . . . . 0.0 113.004 179.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.4 m -136.27 -6.63 2.04 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 113.517 0.932 . . . . 0.0 113.517 -169.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -52.19 -43.97 64.44 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.431 1.092 . . . . 0.0 111.677 -178.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.5 m -63.21 -38.95 93.19 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.063 0.545 . . . . 0.0 111.857 -179.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -67.98 -44.35 76.87 Favored 'General case' 0 N--CA 1.452 -0.344 0 O-C-N 122.02 -0.425 . . . . 0.0 110.066 177.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 66.7 mm-40 -63.22 -35.87 81.75 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 122.416 0.286 . . . . 0.0 110.946 -178.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 27.5 p -83.51 1.37 42.22 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.044 0.938 . . . . 0.0 113.377 -177.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 68.1 m -102.02 30.97 4.13 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.18 0.992 . . . . 0.0 111.802 -176.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -132.68 57.79 1.78 Allowed 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.1 0.96 . . . . 0.0 110.526 -177.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 98.65 -153.43 19.88 Favored Glycine 0 C--N 1.337 0.636 0 N-CA-C 110.084 -1.206 . . . . 0.0 110.084 174.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 55.0 t -72.05 135.06 28.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 N-CA-C 105.744 -1.947 . . . . 0.0 105.744 167.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 46.6 t -137.5 142.96 35.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 105.908 -1.886 . . . . 0.0 105.908 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.6 tt -125.27 101.42 6.97 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 106.03 -1.841 . . . . 0.0 106.03 -177.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -82.55 144.64 30.23 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.275 -179.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -121.18 93.79 4.13 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 125.955 1.702 . . . . 0.0 107.166 -178.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -72.7 111.6 7.99 Favored 'General case' 0 C--O 1.239 0.545 0 N-CA-C 105.689 -1.967 . . . . 0.0 105.689 174.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -146.86 -177.46 5.67 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 125.241 1.417 . . . . 0.0 108.168 -171.643 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -155.73 149.59 19.25 Favored Pre-proline 0 C--N 1.33 -0.265 0 N-CA-C 106.405 -1.702 . . . . 0.0 106.405 168.078 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -68.53 -12.58 35.17 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 121.378 1.386 . . . . 0.0 114.231 -176.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 52.0 p-90 -71.02 -19.69 62.48 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 120.233 1.378 . . . . 0.0 112.192 169.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 27.8 t -60.36 153.25 23.23 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.964 1.306 . . . . 0.0 111.419 -172.004 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.405 ' H ' ' HD2' ' A' ' 31' ' ' PRO . . . -102.46 -61.2 0.73 Allowed Glycine 0 CA--C 1.533 1.195 0 C-N-CA 124.585 1.088 . . . . 0.0 111.626 171.49 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.405 ' HD2' ' H ' ' A' ' 30' ' ' GLY . 28.5 Cg_endo -66.95 -25.57 44.63 Favored 'Trans proline' 0 C--N 1.348 0.517 0 CA-C-N 120.46 2.13 . . . . 0.0 112.702 -174.582 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 24.6 m -56.41 -35.51 67.87 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 121.235 -0.916 . . . . 0.0 111.023 172.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.6 mmtp -69.31 -26.21 64.61 Favored 'General case' 0 CA--C 1.529 0.155 0 O-C-N 121.564 -0.71 . . . . 0.0 111.296 -178.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 5.1 ptt? -85.7 -31.55 22.41 Favored 'General case' 0 C--N 1.34 0.188 0 CA-C-N 118.961 0.8 . . . . 0.0 111.414 -176.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 18.2 tt -77.57 -25.26 14.78 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-O 118.591 -0.718 . . . . 0.0 111.537 170.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -49.71 -49.57 72.23 Favored Pre-proline 0 CA--C 1.547 0.839 0 CA-C-N 120.379 1.445 . . . . 0.0 114.367 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -66.35 -28.88 46.55 Favored 'Trans proline' 0 C--N 1.349 0.601 0 CA-C-N 122.038 1.763 . . . . 0.0 112.122 176.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.1 t -67.82 -37.26 78.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 O-C-N 121.666 -0.646 . . . . 0.0 109.553 174.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 96.1 mt -66.74 -34.82 78.69 Favored 'General case' 0 C--N 1.34 0.175 0 CA-C-N 119.46 1.027 . . . . 0.0 111.422 171.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -63.05 -42.33 99.7 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 119.556 1.071 . . . . 0.0 110.716 171.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -63.94 -39.49 94.27 Favored 'General case' 0 CA--C 1.531 0.24 0 O-C-N 121.243 -0.911 . . . . 0.0 110.421 175.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 42.8 tp -62.4 -43.04 99.77 Favored 'General case' 0 CA--C 1.527 0.077 0 C-N-CA 123.643 0.777 . . . . 0.0 110.205 175.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -60.06 -42.36 94.34 Favored 'General case' 0 CA--C 1.521 -0.137 0 C-N-CA 123.453 0.701 . . . . 0.0 110.805 178.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 -71.98 -10.8 60.28 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.263 0.625 . . . . 0.0 112.481 -179.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -105.54 -32.53 8.46 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 125.265 1.426 . . . . 0.0 111.415 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 71.5 mmm -125.77 -3.14 7.18 Favored 'General case' 0 C--O 1.226 -0.138 0 CA-C-O 118.414 -0.803 . . . . 0.0 113.152 -167.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -57.63 -13.59 12.48 Favored Glycine 0 CA--C 1.533 1.185 0 CA-C-N 119.769 1.168 . . . . 0.0 115.847 -172.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -77.1 -24.98 51.73 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 118.462 1.131 . . . . 0.0 111.721 174.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 51.1 mmtt -117.38 -21.08 8.85 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 125.648 1.579 . . . . 0.0 111.445 -177.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 52.2 tp -122.26 148.45 44.98 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 125.16 1.384 . . . . 0.0 110.223 -169.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -120.64 145.42 47.42 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 105.116 -2.179 . . . . 0.0 105.116 167.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 77.3 mt -115.01 138.01 46.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 105.637 -1.986 . . . . 0.0 105.637 176.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 93.5 t -133.56 98.6 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-N 118.879 0.763 . . . . 0.0 109.236 -170.193 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 52.9 mtpt -73.89 140.37 45.63 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 176.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 13.9 tt -142.72 127.87 16.39 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 176.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 50.6 t0 -84.02 103.43 13.25 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 124.732 1.213 . . . . 0.0 109.004 -172.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 28.3 m -59.36 -28.36 39.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 118.819 -0.61 . . . . 0.0 111.888 -174.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -66.64 -19.3 65.73 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 119.258 0.935 . . . . 0.0 111.846 -177.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -114.62 1.41 14.23 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.547 1.539 . . . . 0.0 110.828 178.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 68.3 m-80 -141.67 42.42 1.72 Allowed 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 124.4 1.08 . . . . 0.0 109.54 -169.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 45.0 mm-40 -55.81 -32.57 63.67 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.041 0.936 . . . . 0.0 111.269 178.239 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 -66.08 -47.58 73.8 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 118.384 0.538 . . . . 0.0 110.47 179.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.94 -39.41 79.59 Favored 'General case' 0 C--O 1.223 -0.327 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 -178.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -58.99 -47.81 83.83 Favored 'General case' 0 CA--C 1.533 0.325 0 O-C-N 121.207 -0.933 . . . . 0.0 110.264 173.097 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -60.85 -28.72 68.87 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 124.062 0.839 . . . . 0.0 112.405 177.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 24.4 tptp -56.18 -29.21 60.53 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.68 1.192 . . . . 0.0 111.47 179.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -124.27 10.73 8.69 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.557 0.743 . . . . 0.0 111.61 -179.1 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 63.71 31.36 80.51 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 123.728 0.68 . . . . 0.0 112.588 -177.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 53.7 t -65.55 123.67 18.94 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 172.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 99.0 mtp -135.99 3.49 2.93 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.757 1.223 . . . . 0.0 111.486 -179.121 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 24.5 m -143.89 160.96 39.88 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 126.656 1.983 . . . . 0.0 107.409 178.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 41.9 pt -143.14 154.9 61.89 Favored Pre-proline 0 CA--C 1.545 0.781 0 C-N-CA 124.468 1.107 . . . . 0.0 108.93 177.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -67.1 139.69 47.54 Favored 'Cis proline' 0 C--N 1.35 0.626 0 CA-C-N 120.373 1.169 . . . . 0.0 110.42 -4.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 24.6 m -130.36 140.8 50.59 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 174.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 86.2 mt -121.28 123.57 42.52 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 -169.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -114.06 122.45 46.93 Favored 'General case' 0 CA--C 1.512 -0.513 0 N-CA-C 103.627 -2.731 . . . . 0.0 103.627 178.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.2 t -96.02 127.18 48.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 N-CA-C 104.002 -2.592 . . . . 0.0 104.002 174.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.0 mp -119.66 155.05 33.09 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 177.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -137.05 119.47 15.82 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 106.376 -1.713 . . . . 0.0 106.376 176.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.0 t70 49.52 38.2 14.04 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.97 1.308 . . . . 0.0 112.482 177.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 104.67 -5.1 43.31 Favored Glycine 0 CA--C 1.529 0.944 0 CA-C-O 118.148 -1.362 . . . . 0.0 115.46 168.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -130.81 150.57 51.92 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 120.006 1.903 . . . . 0.0 110.276 -177.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 42.9 t -62.73 133.29 28.6 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.4 p -119.25 -21.03 4.61 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 125.19 1.396 . . . . 0.0 110.36 176.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -158.51 168.59 26.51 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 120.582 1.537 . . . . 0.0 110.317 173.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 18.1 m -146.37 143.31 28.99 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.385 1.074 . . . . 0.0 109.063 175.23 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 49.5 m -144.62 156.23 44.02 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.561 1.544 . . . . 0.0 108.66 176.213 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 41.2 t -133.76 146.44 31.77 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 -175.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 75.21 -174.25 52.12 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 123.292 0.473 . . . . 0.0 112.271 178.185 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 67.4 t80 -65.3 148.66 51.31 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.674 0.79 . . . . 0.0 111.347 -178.175 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.29 140.18 14.64 Favored Pre-proline 0 CA--C 1.534 0.349 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 167.383 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -72.05 161.66 44.07 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 122.718 2.279 . . . . 0.0 110.497 175.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 49.3 pttt -58.51 -29.34 66.19 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 113.571 0.952 . . . . 0.0 113.571 -178.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -65.91 -50.34 64.8 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 118.595 0.634 . . . . 0.0 109.559 176.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.53 -39.07 93.46 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 122.721 0.409 . . . . 0.0 110.821 178.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 87.8 mt -63.49 -44.06 95.47 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 122.985 0.514 . . . . 0.0 111.156 176.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 -61.17 -41.95 97.68 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-N 118.426 0.557 . . . . 0.0 110.153 176.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -63.31 -41.18 98.91 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 118.15 0.432 . . . . 0.0 110.238 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 61.3 tp -61.71 -46.01 91.5 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.705 1.202 . . . . 0.0 110.674 176.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 72.8 t -58.32 -44.86 89.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 CA-C-N 118.75 0.705 . . . . 0.0 109.462 173.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -62.59 -25.29 68.0 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.905 1.282 . . . . 0.0 112.153 -174.017 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -57.61 -22.14 43.42 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 118.506 -0.759 . . . . 0.0 112.452 172.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 70.8 m-70 -124.09 -8.26 7.69 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 -168.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 77.3 mt . . . . . 0 C--O 1.246 0.886 0 CA-C-O 118.363 -0.827 . . . . 0.0 109.416 171.54 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 12.0 mt . . . . . 0 N--CA 1.449 -0.517 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 5.4 t -137.45 160.85 34.87 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 C-N-CA 126.702 2.001 . . . . 0.0 106.472 -174.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.34 133.07 50.12 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 105.358 -2.09 . . . . 0.0 105.358 176.506 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -142.8 174.96 10.19 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 123.611 0.764 . . . . 0.0 111.421 -170.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.3 p -138.14 171.74 13.94 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 126.732 2.013 . . . . 0.0 106.661 168.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -50.45 -27.95 7.42 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 175.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -55.06 -31.33 61.05 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.732 1.613 . . . . 0.0 112.756 177.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.1 m -139.67 -10.1 1.21 Allowed 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 124.035 0.934 . . . . 0.0 113.059 -170.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -53.57 -42.08 67.2 Favored 'General case' 0 C--O 1.231 0.117 0 C-N-CA 124.472 1.109 . . . . 0.0 111.316 -177.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.4 m -63.38 -36.9 85.27 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.16 0.584 . . . . 0.0 112.027 179.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -69.7 -44.25 70.79 Favored 'General case' 0 N--CA 1.453 -0.313 0 O-C-N 121.998 -0.439 . . . . 0.0 110.005 177.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -62.8 -40.88 98.74 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 122.827 0.451 . . . . 0.0 110.463 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.434 ' HA ' HG21 ' A' ' 20' ' ' VAL . 26.0 p -77.3 1.84 17.53 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.867 0.867 . . . . 0.0 113.252 -179.484 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 63.5 m -105.18 32.76 4.02 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.531 1.132 . . . . 0.0 111.206 179.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -130.97 51.48 2.13 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.2 1.0 . . . . 0.0 110.51 -178.125 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 97.27 -156.7 20.85 Favored Glycine 0 C--N 1.337 0.588 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 179.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 74.4 t -70.94 136.59 25.59 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 168.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.434 HG21 ' HA ' ' A' ' 15' ' ' THR . 54.6 t -137.84 135.55 45.66 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 N-CA-C 106.039 -1.838 . . . . 0.0 106.039 -179.084 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.0 tt -113.25 99.95 8.2 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 105.754 -1.943 . . . . 0.0 105.754 -176.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -83.07 146.62 28.6 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 179.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -127.21 94.17 3.93 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 126.236 1.814 . . . . 0.0 107.66 -176.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -74.5 114.07 12.47 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 106.109 -1.811 . . . . 0.0 106.109 175.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -149.99 -177.04 5.68 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.918 1.287 . . . . 0.0 108.778 -171.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -152.86 147.16 18.77 Favored Pre-proline 0 CA--C 1.531 0.245 0 N-CA-C 105.936 -1.875 . . . . 0.0 105.936 167.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -58.81 -18.39 41.4 Favored 'Trans proline' 0 CA--C 1.531 0.36 0 C-N-CA 121.933 1.755 . . . . 0.0 114.844 178.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 1.9 m95 -74.28 -14.65 60.94 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 118.91 0.777 . . . . 0.0 111.908 176.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 34.9 t -63.95 152.54 39.69 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.41 1.484 . . . . 0.0 111.14 -175.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -100.5 -64.4 0.8 Allowed Glycine 0 CA--C 1.53 1.002 0 CA-C-O 118.446 -1.197 . . . . 0.0 110.997 171.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -62.3 -26.28 77.08 Favored 'Trans proline' 0 C--N 1.35 0.646 0 CA-C-N 120.44 2.12 . . . . 0.0 113.675 -174.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 33.7 m -57.01 -34.41 68.15 Favored 'General case' 0 CA--C 1.537 0.446 0 O-C-N 121.577 -0.702 . . . . 0.0 111.627 174.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.2 mmtp -67.53 -24.36 65.55 Favored 'General case' 0 CA--C 1.531 0.226 0 O-C-N 121.529 -0.732 . . . . 0.0 111.118 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 30.8 mtm -72.45 -42.7 64.72 Favored 'General case' 0 C--N 1.34 0.159 0 CA-C-N 118.581 0.628 . . . . 0.0 110.439 177.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 17.1 tt -83.48 -22.12 8.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-O 118.726 -0.654 . . . . 0.0 111.7 -175.117 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -50.24 -52.18 56.3 Favored Pre-proline 0 CA--C 1.549 0.915 0 CA-C-N 120.059 1.3 . . . . 0.0 113.674 177.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -66.84 -27.62 43.71 Favored 'Trans proline' 0 C--N 1.351 0.675 0 CA-C-N 121.606 1.609 . . . . 0.0 112.305 176.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 22.0 t -68.1 -39.19 80.97 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 O-C-N 121.541 -0.724 . . . . 0.0 109.5 175.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 53.2 mt -65.31 -36.3 83.62 Favored 'General case' 0 C--N 1.34 0.16 0 CA-C-N 119.265 0.939 . . . . 0.0 111.085 172.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -63.62 -38.5 91.36 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 118.803 0.729 . . . . 0.0 111.178 172.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -66.63 -35.42 80.15 Favored 'General case' 0 CA--C 1.531 0.244 0 O-C-N 120.35 -1.469 . . . . 0.0 110.691 173.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.58 -44.84 92.88 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.594 0.758 . . . . 0.0 109.733 177.014 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 53.2 t0 -53.66 -48.22 69.64 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 124.972 1.309 . . . . 0.0 110.397 172.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -68.43 -8.11 37.67 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -178.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 77.7 mt-10 -109.6 -36.64 5.9 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.996 1.319 . . . . 0.0 112.265 -176.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 6.2 ptp -145.12 22.96 1.53 Allowed 'General case' 0 C--N 1.341 0.212 0 N-CA-C 114.865 1.432 . . . . 0.0 114.865 178.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -60.84 -5.68 5.69 Favored Glycine 0 CA--C 1.537 1.46 0 CA-C-N 119.996 1.271 . . . . 0.0 115.221 177.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -78.6 -33.17 47.68 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.586 1.154 . . . . 0.0 111.296 170.035 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -95.45 -35.23 11.79 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 124.844 1.258 . . . . 0.0 110.659 178.425 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 60.8 tp -105.14 153.06 22.03 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.452 1.101 . . . . 0.0 111.745 -169.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 14.4 ttmm -121.85 144.46 48.82 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 104.426 -2.435 . . . . 0.0 104.426 166.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 79.3 mt -120.66 135.62 60.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 104.872 -2.269 . . . . 0.0 104.872 179.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 99.3 t -130.0 98.61 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 -172.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 52.4 mtmt -71.47 138.88 49.36 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 172.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 17.1 tt -142.28 123.59 12.24 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 177.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 59.3 t0 -83.32 106.98 15.53 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 124.282 1.033 . . . . 0.0 108.566 -173.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 31.7 m -60.07 -24.68 30.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 118.551 -0.737 . . . . 0.0 112.043 -175.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -64.75 -19.73 65.95 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 119.659 1.118 . . . . 0.0 112.002 -179.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -116.44 4.44 13.34 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.069 1.347 . . . . 0.0 110.85 178.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 68.4 m-80 -141.35 39.16 1.73 Allowed 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 124.537 1.135 . . . . 0.0 110.169 -169.141 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 53.4 mm-40 -56.48 -34.8 67.26 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.358 0.663 . . . . 0.0 110.851 176.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -65.34 -46.18 81.26 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 122.78 0.432 . . . . 0.0 110.305 177.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.29 -40.62 86.12 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.482 0.713 . . . . 0.0 110.043 -178.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -58.26 -49.49 76.91 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.389 0.675 . . . . 0.0 110.109 172.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -59.67 -29.57 67.31 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 123.958 0.789 . . . . 0.0 112.432 177.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 22.6 ttmt -55.39 -28.91 57.11 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.497 1.519 . . . . 0.0 112.042 178.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -123.61 9.49 8.98 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 123.868 0.867 . . . . 0.0 111.948 178.053 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 65.14 28.77 73.94 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 123.819 0.723 . . . . 0.0 112.935 -176.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 54.5 t -61.67 128.99 24.07 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 172.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 22.4 ttt -137.93 0.37 2.17 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.573 1.149 . . . . 0.0 111.145 -177.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 25.2 m -145.08 163.95 32.72 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 126.558 1.943 . . . . 0.0 107.612 179.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 39.5 pt -143.41 155.82 60.77 Favored Pre-proline 0 CA--C 1.547 0.832 0 C-N-CA 124.603 1.161 . . . . 0.0 108.85 176.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -67.24 138.66 42.8 Favored 'Cis proline' 0 C--N 1.351 0.671 0 CA-C-N 120.453 1.197 . . . . 0.0 110.288 -4.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 32.8 m -130.22 141.1 50.66 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 175.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 83.0 mt -122.62 128.47 50.71 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 -167.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -122.54 118.36 28.06 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 104.013 -2.588 . . . . 0.0 104.013 -178.302 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 14.7 t -92.92 119.28 40.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 104.108 -2.553 . . . . 0.0 104.108 173.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.8 mp -109.74 153.91 23.65 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 172.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -134.34 125.06 26.84 Favored 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 170.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.0 t70 48.48 35.02 5.31 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.234 1.414 . . . . 0.0 112.181 173.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 101.69 0.67 52.7 Favored Glycine 0 CA--C 1.532 1.146 0 CA-C-O 117.876 -1.513 . . . . 0.0 115.289 170.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -123.29 146.42 47.9 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 120.491 2.145 . . . . 0.0 109.5 176.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 11.4 p -68.67 132.48 32.89 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 170.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 33.7 m -119.91 -21.0 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 124.439 1.096 . . . . 0.0 110.996 178.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -155.75 162.86 40.45 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 120.44 1.473 . . . . 0.0 110.851 174.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 9.0 m -139.13 151.06 46.36 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.673 1.189 . . . . 0.0 108.708 177.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 48.6 m -151.55 159.32 44.17 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.408 1.483 . . . . 0.0 108.874 169.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 42.7 t -133.93 144.67 34.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 -176.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 77.87 177.97 48.06 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 123.639 0.638 . . . . 0.0 112.494 176.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 55.2 t80 -61.35 145.14 52.53 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 123.866 0.866 . . . . 0.0 111.089 -179.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.37 141.27 14.91 Favored Pre-proline 0 CA--C 1.535 0.403 0 C-N-CA 126.206 1.802 . . . . 0.0 106.843 177.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -72.35 156.79 54.38 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 122.409 2.073 . . . . 0.0 110.722 176.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 42.2 pttt -57.5 -32.54 67.13 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 -175.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -68.77 -43.04 76.59 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 118.5 0.591 . . . . 0.0 109.504 178.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.47 -42.05 98.6 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 118.354 0.525 . . . . 0.0 110.517 176.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 97.1 mt -60.86 -48.84 79.99 Favored 'General case' 0 N--CA 1.461 0.095 0 CA-C-O 121.08 0.467 . . . . 0.0 110.686 178.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -71.57 -28.29 63.74 Favored 'General case' 0 N--CA 1.451 -0.381 0 O-C-N 122.037 -0.414 . . . . 0.0 110.866 -175.038 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -70.03 -37.25 75.55 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 118.404 0.547 . . . . 0.0 111.355 170.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 8.7 tp -62.79 -34.5 77.4 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.5 1.12 . . . . 0.0 110.274 174.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 48.9 t -69.99 -45.97 74.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 123.836 0.854 . . . . 0.0 110.066 169.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -59.91 -36.58 77.3 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 124.73 1.212 . . . . 0.0 111.937 -172.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 11.0 ptmm? -67.06 -6.25 16.5 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 178.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -123.35 -18.07 6.36 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.136 0.974 . . . . 0.0 113.363 175.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 31.7 mt . . . . . 0 C--O 1.249 1.034 0 CA-C-N 119.913 1.233 . . . . 0.0 109.459 171.784 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.1 mt . . . . . 0 C--O 1.237 0.4 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 44.6 t -138.79 164.03 26.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 126.494 1.917 . . . . 0.0 106.733 -174.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 4.7 mtpt -117.01 142.84 46.45 Favored 'General case' 0 CA--C 1.517 -0.31 0 C-N-CA 125.345 1.458 . . . . 0.0 107.373 173.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -142.81 165.62 26.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.422 0.63 . . . . 0.0 110.525 178.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 17.5 p -132.55 172.25 12.75 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 126.254 1.822 . . . . 0.0 107.664 170.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -52.39 -29.53 24.59 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.238 1.015 . . . . 0.0 113.111 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 56.1 mt-30 -63.47 -28.96 70.32 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.12 1.368 . . . . 0.0 113.174 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.2 m -136.88 -5.49 1.92 Allowed 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 113.842 1.053 . . . . 0.0 113.842 -168.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -52.39 -44.07 65.12 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.166 0.987 . . . . 0.0 111.65 -177.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.5 m -63.23 -38.57 91.68 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.129 0.572 . . . . 0.0 111.849 -179.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -68.1 -44.34 76.45 Favored 'General case' 0 N--CA 1.452 -0.337 0 O-C-N 121.994 -0.442 . . . . 0.0 110.023 177.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 66.1 mm-40 -63.61 -35.76 81.56 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 122.391 0.276 . . . . 0.0 110.979 -178.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 26.4 p -83.91 1.44 43.36 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.029 0.931 . . . . 0.0 113.329 -177.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 69.1 m -100.17 30.27 3.89 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.23 1.012 . . . . 0.0 111.742 -177.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -133.26 61.95 1.67 Allowed 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.297 1.039 . . . . 0.0 110.195 -177.081 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 92.24 -156.53 23.52 Favored Glycine 0 C--N 1.338 0.694 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 175.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 59.1 t -71.31 134.23 30.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 N-CA-C 106.506 -1.665 . . . . 0.0 106.506 168.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 47.1 t -136.99 141.11 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 105.915 -1.883 . . . . 0.0 105.915 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 3.7 tt -122.19 100.3 6.89 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 106.255 -1.757 . . . . 0.0 106.255 -176.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -83.25 145.42 29.14 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.293 -179.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -123.95 94.12 4.13 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 126.083 1.753 . . . . 0.0 107.196 -177.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -74.13 112.26 10.09 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 105.884 -1.895 . . . . 0.0 105.884 174.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -148.3 -177.12 5.59 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.704 1.201 . . . . 0.0 108.608 -172.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -155.87 146.98 16.55 Favored Pre-proline 0 CA--C 1.531 0.232 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 168.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -60.75 -17.27 48.98 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 121.818 1.679 . . . . 0.0 116.01 -177.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 54.0 p-90 -70.04 -20.12 63.26 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 120.03 1.286 . . . . 0.0 111.914 173.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 29.0 t -59.58 150.97 25.66 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.991 1.316 . . . . 0.0 110.971 -174.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -104.99 -58.61 0.67 Allowed Glycine 0 CA--C 1.531 1.062 0 CA-C-O 118.704 -1.053 . . . . 0.0 110.97 172.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -56.54 -33.08 91.88 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 123.217 2.611 . . . . 0.0 113.712 -179.288 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 29.7 m -57.82 -34.57 69.81 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.441 0.696 . . . . 0.0 111.403 176.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.4 mmtp -68.38 -24.54 64.79 Favored 'General case' 0 CA--C 1.531 0.22 0 O-C-N 121.5 -0.75 . . . . 0.0 111.063 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 31.1 mtm -70.8 -42.27 70.52 Favored 'General case' 0 C--N 1.34 0.186 0 CA-C-N 118.742 0.701 . . . . 0.0 110.405 176.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 19.1 tt -85.0 -23.76 7.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 CA-C-O 118.53 -0.748 . . . . 0.0 111.782 -175.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -49.38 -50.52 64.55 Favored Pre-proline 0 CA--C 1.548 0.867 0 CA-C-N 120.088 1.313 . . . . 0.0 114.191 178.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -66.93 -27.76 42.83 Favored 'Trans proline' 0 C--N 1.351 0.674 0 CA-C-N 121.779 1.671 . . . . 0.0 112.069 176.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.8 t -68.94 -37.12 76.87 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 O-C-N 121.589 -0.694 . . . . 0.0 109.769 173.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 95.6 mt -65.5 -34.69 78.87 Favored 'General case' 0 C--N 1.339 0.135 0 CA-C-N 119.743 1.156 . . . . 0.0 111.025 172.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -61.97 -43.79 98.1 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 119.376 0.989 . . . . 0.0 110.944 170.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -63.67 -40.18 96.18 Favored 'General case' 0 CA--C 1.531 0.218 0 O-C-N 121.172 -0.955 . . . . 0.0 110.711 175.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 39.8 tp -61.98 -41.96 98.61 Favored 'General case' 0 C--N 1.334 -0.105 0 C-N-CA 124.372 1.069 . . . . 0.0 109.919 178.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -60.82 -42.96 98.73 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 122.949 0.499 . . . . 0.0 110.696 175.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -71.97 -10.4 59.72 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 112.6 0.592 . . . . 0.0 112.6 179.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -105.36 -28.38 10.91 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 125.437 1.495 . . . . 0.0 111.377 -178.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 26.8 mtp -134.3 -1.56 2.88 Favored 'General case' 0 N--CA 1.462 0.146 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 -168.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -56.91 -13.91 9.26 Favored Glycine 0 CA--C 1.532 1.126 0 CA-C-N 119.913 1.233 . . . . 0.0 115.434 -173.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -69.73 -29.93 67.42 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 118.674 1.237 . . . . 0.0 111.73 173.121 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 45.6 mmtm -115.7 -20.27 10.17 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 125.512 1.525 . . . . 0.0 111.889 -178.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 36.6 tp -112.57 157.17 21.51 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 123.984 0.914 . . . . 0.0 111.41 -168.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -132.34 144.51 50.6 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 103.806 -2.665 . . . . 0.0 103.806 166.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 83.0 mt -118.02 139.43 45.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 105.274 -2.121 . . . . 0.0 105.274 177.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 81.9 t -132.26 98.78 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 -170.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 52.4 mtmt -74.2 136.69 42.79 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 175.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 15.3 tt -139.98 124.82 19.88 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 176.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -82.79 105.08 13.51 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 124.717 1.207 . . . . 0.0 108.784 -174.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 27.7 m -60.37 -27.06 38.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 118.684 -0.674 . . . . 0.0 111.898 -174.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -66.1 -19.83 65.97 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 119.423 1.011 . . . . 0.0 111.773 -177.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -113.83 1.59 14.84 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.534 1.534 . . . . 0.0 110.891 178.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 68.7 m-80 -141.68 41.77 1.72 Allowed 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.27 1.028 . . . . 0.0 109.889 -169.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 46.7 mm-40 -56.03 -32.37 63.96 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.806 0.842 . . . . 0.0 111.262 177.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 35.0 mm-40 -65.72 -47.21 76.1 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 118.407 0.549 . . . . 0.0 110.5 179.199 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.2 -39.04 78.86 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 121.801 -0.562 . . . . 0.0 109.634 -178.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -58.79 -48.28 81.82 Favored 'General case' 0 CA--C 1.534 0.343 0 O-C-N 121.142 -0.974 . . . . 0.0 110.171 172.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -60.45 -28.67 67.74 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 124.078 0.847 . . . . 0.0 112.438 177.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 47.7 tptt -56.23 -29.28 60.79 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.629 1.171 . . . . 0.0 111.425 179.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -124.0 10.7 8.85 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.671 0.788 . . . . 0.0 111.598 -179.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 64.41 28.52 73.21 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 123.819 0.723 . . . . 0.0 112.802 -177.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 49.1 t -62.86 125.94 20.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 172.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 40.3 ttp -138.49 1.86 2.19 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.487 1.115 . . . . 0.0 111.036 -177.092 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 24.8 m -144.31 161.98 37.58 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 126.789 2.036 . . . . 0.0 107.374 178.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 40.7 pt -143.13 155.91 61.7 Favored Pre-proline 0 CA--C 1.544 0.721 0 C-N-CA 124.631 1.173 . . . . 0.0 108.768 177.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -67.05 139.54 46.66 Favored 'Cis proline' 0 C--N 1.349 0.588 0 CA-C-N 120.459 1.2 . . . . 0.0 110.26 -4.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 28.1 m -130.81 139.95 50.24 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 174.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 88.0 mt -120.33 124.49 45.69 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 -169.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -115.18 119.7 37.27 Favored 'General case' 0 CA--C 1.512 -0.509 0 N-CA-C 103.578 -2.749 . . . . 0.0 103.578 177.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.2 t -93.1 123.31 45.14 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 N-CA-C 103.432 -2.803 . . . . 0.0 103.432 173.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.1 mp -114.86 155.25 27.16 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 174.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -137.94 123.38 19.55 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 172.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.2 t70 49.36 36.87 10.46 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.084 1.354 . . . . 0.0 112.537 176.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 103.4 -2.83 46.59 Favored Glycine 0 CA--C 1.529 0.92 0 CA-C-O 118.122 -1.377 . . . . 0.0 115.285 168.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -128.62 149.98 50.41 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 120.074 1.937 . . . . 0.0 110.077 -179.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 44.3 t -62.0 131.53 27.25 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 175.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.1 p -117.44 -22.94 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 C-N-CA 125.102 1.361 . . . . 0.0 109.406 179.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -162.3 168.04 22.9 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 120.463 1.483 . . . . 0.0 110.097 169.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 14.0 m -136.56 151.07 48.98 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.363 1.465 . . . . 0.0 108.796 177.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 58.3 m -148.38 157.28 43.38 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.631 1.573 . . . . 0.0 108.649 169.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 42.6 t -133.6 145.33 33.77 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 -178.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 78.27 -176.29 54.24 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 123.553 0.597 . . . . 0.0 111.877 179.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -63.72 148.91 47.91 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.484 0.714 . . . . 0.0 110.41 178.003 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 42.9 mttt -142.4 138.24 16.28 Favored Pre-proline 0 C--O 1.235 0.311 0 N-CA-C 106.352 -1.722 . . . . 0.0 106.352 168.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -66.57 160.03 47.97 Favored 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 121.88 1.72 . . . . 0.0 110.925 178.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 33.7 tttm -48.85 -46.72 42.68 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 126.071 1.748 . . . . 0.0 112.987 -178.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 27.4 mm-40 -72.98 -35.94 66.99 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.207 -176.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.64 -36.6 84.78 Favored 'General case' 0 C--N 1.341 0.233 0 CA-C-N 118.979 0.808 . . . . 0.0 111.054 173.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 87.1 mt -64.53 -45.78 85.72 Favored 'General case' 0 N--CA 1.456 -0.137 0 CA-C-O 119.197 -0.43 . . . . 0.0 110.665 176.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 8.9 mt-30 -57.99 -42.44 85.16 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-N 118.501 0.591 . . . . 0.0 110.787 173.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -64.61 -39.58 93.98 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 118.016 0.371 . . . . 0.0 110.508 -178.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 57.8 tp -61.86 -44.0 97.72 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 124.636 1.174 . . . . 0.0 110.568 176.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 86.6 t -61.22 -44.13 97.78 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-N 118.821 0.737 . . . . 0.0 109.39 173.023 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -60.58 -28.34 68.4 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 125.019 1.328 . . . . 0.0 112.15 -173.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -56.4 -24.12 42.71 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 123.402 0.681 . . . . 0.0 112.498 174.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 72.2 m-70 -123.18 -9.18 8.16 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 -168.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 74.5 mt . . . . . 0 C--O 1.249 1.045 0 CA-C-N 118.948 0.794 . . . . 0.0 109.333 171.298 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.8 mt . . . . . 0 CA--C 1.537 0.472 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 21.5 t -134.88 160.87 41.01 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 C-N-CA 126.68 1.992 . . . . 0.0 106.521 -176.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.23 139.1 50.7 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 105.368 -2.086 . . . . 0.0 105.368 169.284 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -140.68 168.94 18.6 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 121.296 0.569 . . . . 0.0 110.886 -178.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 17.4 p -133.19 169.67 16.54 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 126.334 1.854 . . . . 0.0 107.987 175.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -53.42 -29.31 34.53 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.443 1.097 . . . . 0.0 113.039 -178.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 57.0 mt-30 -61.28 -29.26 69.75 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.164 1.386 . . . . 0.0 112.944 178.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.6 m -136.86 -7.19 1.87 Allowed 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 -169.45 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -53.25 -43.65 67.52 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.349 1.06 . . . . 0.0 111.516 -177.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.8 m -62.86 -39.87 95.74 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.058 0.543 . . . . 0.0 111.76 179.518 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.66 -43.38 84.73 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 122.71 0.404 . . . . 0.0 110.074 177.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 68.5 mm-40 -64.09 -42.82 96.8 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 122.265 0.226 . . . . 0.0 110.551 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.423 ' HA ' HG21 ' A' ' 20' ' ' VAL . 35.5 p -77.89 -5.86 52.4 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 124.262 1.025 . . . . 0.0 113.568 -176.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 72.7 m -74.72 -20.26 59.91 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 177.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -87.41 69.23 9.87 Favored 'General case' 0 CA--C 1.537 0.451 0 O-C-N 121.483 -0.761 . . . . 0.0 111.581 -170.012 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 85.28 -151.51 25.75 Favored Glycine 0 C--N 1.337 0.612 0 N-CA-C 109.993 -1.243 . . . . 0.0 109.993 173.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 58.0 t -71.17 137.11 24.43 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 168.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.423 HG21 ' HA ' ' A' ' 15' ' ' THR . 57.7 t -140.37 146.99 23.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 105.777 -1.935 . . . . 0.0 105.777 179.08 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.5 tt -124.96 99.35 6.09 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 -176.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -81.43 147.86 29.56 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.732 -179.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -126.48 95.21 4.29 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 126.145 1.778 . . . . 0.0 107.27 -178.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -73.81 115.36 13.16 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 174.455 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -149.16 -178.06 6.17 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.351 1.46 . . . . 0.0 108.553 -173.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -156.12 149.65 18.97 Favored Pre-proline 0 CA--C 1.531 0.238 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 167.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_exo -59.62 -19.16 51.51 Favored 'Trans proline' 0 CA--C 1.534 0.504 0 C-N-CA 122.323 2.015 . . . . 0.0 115.775 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 52.4 p-90 -70.85 -20.11 62.57 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 119.933 1.242 . . . . 0.0 112.035 174.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 23.9 t -61.45 152.35 30.13 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 125.025 1.33 . . . . 0.0 111.344 -172.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -101.63 -66.59 0.78 Allowed Glycine 0 CA--C 1.529 0.963 0 CA-C-O 118.424 -1.209 . . . . 0.0 110.528 173.03 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -54.75 -30.42 67.06 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 123.12 2.547 . . . . 0.0 114.275 -179.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 39.4 m -56.26 -34.87 66.82 Favored 'General case' 0 CA--C 1.538 0.495 0 O-C-N 121.467 -0.77 . . . . 0.0 111.551 175.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.4 mmtp -68.94 -29.61 67.89 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 123.427 0.691 . . . . 0.0 110.944 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 5.0 ptt? -85.55 -30.03 23.7 Favored 'General case' 0 C--N 1.34 0.153 0 CA-C-N 118.809 0.731 . . . . 0.0 111.539 -177.002 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 19.5 tt -77.87 -20.77 13.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-O 118.626 -0.702 . . . . 0.0 111.56 169.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -51.7 -49.61 82.14 Favored Pre-proline 0 CA--C 1.548 0.887 0 CA-C-N 120.83 1.65 . . . . 0.0 113.852 178.232 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -66.18 -28.3 48.31 Favored 'Trans proline' 0 C--N 1.35 0.631 0 CA-C-N 121.922 1.722 . . . . 0.0 112.285 175.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 23.9 t -66.93 -39.23 83.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 174.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 95.1 mt -64.6 -37.0 86.08 Favored 'General case' 0 C--N 1.341 0.239 0 CA-C-N 119.531 1.06 . . . . 0.0 111.155 171.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -64.66 -40.79 96.04 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 119.385 0.993 . . . . 0.0 110.857 174.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -63.02 -40.02 96.49 Favored 'General case' 0 CA--C 1.531 0.232 0 O-C-N 121.067 -1.021 . . . . 0.0 110.187 174.158 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.35 -47.28 84.31 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.885 0.874 . . . . 0.0 109.746 175.499 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -59.01 -40.57 85.36 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 123.62 0.768 . . . . 0.0 111.03 179.262 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 -73.92 -10.71 59.93 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.303 0.641 . . . . 0.0 112.377 -179.395 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -103.44 -33.88 8.91 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 124.954 1.302 . . . . 0.0 111.791 178.292 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 86.6 mmm -125.08 -3.77 7.53 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 113.237 0.829 . . . . 0.0 113.237 -168.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -62.63 -3.57 5.82 Favored Glycine 0 CA--C 1.532 1.147 0 CA-C-N 119.853 1.206 . . . . 0.0 115.342 -175.415 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -73.96 -27.68 61.12 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 118.519 1.16 . . . . 0.0 111.201 169.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.3 -23.07 3.3 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 125.289 1.435 . . . . 0.0 111.59 -171.313 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 45.0 tp -111.24 151.61 28.1 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 124.878 1.271 . . . . 0.0 110.169 -169.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -118.82 144.8 46.12 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 105.541 -2.022 . . . . 0.0 105.541 168.322 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 73.1 mt -116.53 136.96 51.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 105.384 -2.08 . . . . 0.0 105.384 175.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 97.3 t -133.06 97.08 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 -169.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -73.97 139.48 44.86 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 107.648 -1.242 . . . . 0.0 107.648 175.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 11.5 tt -141.05 129.27 23.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.395 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 178.265 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 61.7 t0 -87.83 105.44 17.41 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 124.809 1.243 . . . . 0.0 110.06 -169.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 27.0 m -62.58 -18.46 20.69 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 CA-C-O 118.539 -0.743 . . . . 0.0 112.449 -177.347 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -67.54 -15.5 63.69 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 119.863 1.211 . . . . 0.0 112.023 176.591 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -127.18 1.03 6.45 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.236 1.014 . . . . 0.0 111.89 178.323 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 67.0 m-80 -137.55 41.0 2.4 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.737 0.815 . . . . 0.0 111.209 -169.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 5.3 mp0 -54.11 -32.08 53.94 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.203 0.601 . . . . 0.0 111.76 174.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -66.3 -47.44 73.59 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 118.423 0.556 . . . . 0.0 110.498 -177.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.07 -39.26 79.2 Favored 'General case' 0 CA--C 1.534 0.345 0 O-C-N 121.836 -0.54 . . . . 0.0 109.591 -179.416 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -58.53 -48.45 80.81 Favored 'General case' 0 CA--C 1.534 0.338 0 O-C-N 121.244 -0.91 . . . . 0.0 110.463 173.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -61.92 -28.15 69.83 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 124.179 0.895 . . . . 0.0 112.166 178.015 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 71.7 tttt -55.66 -28.76 57.23 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.853 1.261 . . . . 0.0 111.683 178.057 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -123.17 10.58 9.37 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.775 0.83 . . . . 0.0 111.803 179.252 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 65.38 27.46 72.5 Favored Glycine 0 CA--C 1.534 1.239 0 C-N-CA 123.85 0.738 . . . . 0.0 113.024 -177.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 60.4 t -62.72 127.63 23.17 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 171.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 22.6 ttt -137.16 0.49 2.35 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.612 1.165 . . . . 0.0 111.05 -176.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 25.2 m -144.92 162.51 36.67 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 126.514 1.926 . . . . 0.0 107.719 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 41.1 pt -142.8 156.79 62.47 Favored Pre-proline 0 CA--C 1.544 0.747 0 C-N-CA 124.858 1.263 . . . . 0.0 108.615 177.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -66.74 140.7 51.32 Favored 'Cis proline' 0 C--N 1.349 0.594 0 CA-C-N 120.464 1.201 . . . . 0.0 110.416 -5.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 32.2 m -135.2 135.96 41.41 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 176.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -115.4 132.11 56.72 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 -172.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -120.22 121.87 39.67 Favored 'General case' 0 CA--C 1.513 -0.443 0 N-CA-C 103.545 -2.761 . . . . 0.0 103.545 177.343 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 8.3 t -92.67 123.36 44.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 103.331 -2.84 . . . . 0.0 103.331 172.227 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.2 mp -113.09 155.7 24.44 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 175.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 60.8 tttp -135.65 124.62 24.2 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 105.854 -1.906 . . . . 0.0 105.854 173.479 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 30.8 t70 50.64 34.73 10.23 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.693 1.197 . . . . 0.0 112.119 176.199 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 100.38 -1.13 55.86 Favored Glycine 0 CA--C 1.529 0.951 0 CA-C-O 118.27 -1.294 . . . . 0.0 114.92 169.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -132.28 152.37 51.39 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 120.072 1.936 . . . . 0.0 110.24 -179.487 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 29.0 t -62.31 135.14 27.17 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 -178.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.9 p -120.59 -25.84 2.44 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 125.16 1.384 . . . . 0.0 110.237 175.135 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -155.95 170.24 22.59 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 120.22 1.373 . . . . 0.0 109.792 177.404 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 30.0 m -152.43 153.73 34.13 Favored 'General case' 0 CA--C 1.541 0.612 0 O-C-N 120.747 -1.221 . . . . 0.0 110.271 -176.197 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 41.7 m -150.22 154.45 37.98 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.561 1.544 . . . . 0.0 108.981 168.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 43.4 t -132.9 141.0 46.06 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 N-CA-C 107.03 -1.471 . . . . 0.0 107.03 -177.113 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 76.67 179.19 47.34 Favored Glycine 0 CA--C 1.53 0.992 0 N-CA-C 111.436 -0.665 . . . . 0.0 111.436 -177.131 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 36.1 t80 -63.18 132.62 52.36 Favored 'General case' 0 C--O 1.231 0.129 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 175.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 13.1 mptt -135.47 147.4 61.65 Favored Pre-proline 0 CA--C 1.536 0.419 0 C-N-CA 126.676 1.99 . . . . 0.0 106.176 174.262 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -71.53 158.07 54.67 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 122.513 2.142 . . . . 0.0 110.521 178.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 20.7 pttp -58.25 -29.25 65.63 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -62.4 -42.84 99.74 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.215 0.606 . . . . 0.0 110.433 176.368 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.62 -47.38 78.78 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 118.544 0.611 . . . . 0.0 110.09 -178.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 10.1 mp -56.09 -47.44 78.03 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.577 0.751 . . . . 0.0 109.912 176.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 14.7 mt-30 -61.73 -39.9 93.18 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-O 118.729 -0.653 . . . . 0.0 112.058 178.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -64.69 -42.83 95.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 119.073 0.852 . . . . 0.0 110.029 178.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 31.0 mt -66.92 -35.3 79.68 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 118.586 0.63 . . . . 0.0 111.562 179.034 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 44.0 t -60.99 -50.99 78.29 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 170.024 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -61.26 -33.65 73.88 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 125.383 1.473 . . . . 0.0 111.862 -173.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 59.1 mtpt -56.36 -27.93 57.54 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 118.332 -0.842 . . . . 0.0 112.212 174.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -128.92 -5.47 5.06 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 114.688 1.366 . . . . 0.0 114.688 -167.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 17.5 mt . . . . . 0 C--O 1.25 1.082 0 CA-C-N 119.655 1.116 . . . . 0.0 108.725 168.569 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.3 mt . . . . . 0 CA--C 1.538 0.502 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 20.7 t -135.77 161.37 38.54 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 126.696 1.998 . . . . 0.0 106.103 -176.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.62 138.89 50.62 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 105.652 -1.981 . . . . 0.0 105.652 169.149 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -139.2 171.39 14.36 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 123.453 0.701 . . . . 0.0 110.852 -178.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.0 p -136.18 171.66 14.15 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 125.768 1.627 . . . . 0.0 108.454 175.29 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -38.82 -39.93 0.57 Allowed 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 126.415 1.886 . . . . 0.0 113.525 170.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 43.5 mm-40 -68.62 -26.03 65.14 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.095 0.958 . . . . 0.0 113.088 -173.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.1 m -134.18 -8.95 2.62 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 113.585 0.958 . . . . 0.0 113.585 -169.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 67.4 t80 -54.03 -45.17 71.49 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 124.363 1.065 . . . . 0.0 111.44 -176.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 9.3 m -63.25 -37.42 87.18 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.041 0.536 . . . . 0.0 111.729 -178.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -68.41 -44.77 74.32 Favored 'General case' 0 N--CA 1.454 -0.272 0 O-C-N 122.036 -0.415 . . . . 0.0 110.055 177.143 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 67.0 mm-40 -63.21 -35.78 81.46 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 122.414 0.286 . . . . 0.0 110.955 -178.6 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.9 p -83.98 1.36 44.04 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.2 1.0 . . . . 0.0 113.496 -177.471 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 66.5 m -102.15 32.58 3.43 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.099 0.959 . . . . 0.0 111.403 -177.105 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -132.78 58.18 1.77 Allowed 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.354 1.062 . . . . 0.0 110.155 -178.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 93.97 -154.08 21.42 Favored Glycine 0 C--N 1.339 0.728 0 N-CA-C 110.084 -1.206 . . . . 0.0 110.084 176.269 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 84.7 t -71.19 134.84 29.24 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 168.142 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 58.8 t -139.07 142.07 34.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 105.639 -1.985 . . . . 0.0 105.639 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 3.4 tt -120.51 99.37 6.52 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 -174.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -81.33 146.83 30.16 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 179.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -126.09 94.14 4.01 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 125.983 1.713 . . . . 0.0 106.961 -177.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -73.95 113.97 11.73 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 106.179 -1.786 . . . . 0.0 106.179 174.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -149.75 -175.85 5.19 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 125.107 1.363 . . . . 0.0 107.883 -172.23 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -155.84 148.36 17.8 Favored Pre-proline 0 N--CA 1.451 -0.376 0 N-CA-C 106.106 -1.813 . . . . 0.0 106.106 167.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -68.35 -12.92 36.34 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 CA-C-N 120.871 1.347 . . . . 0.0 113.923 -178.45 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 42.6 p-90 -69.88 -20.94 63.37 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 120.221 1.373 . . . . 0.0 111.978 169.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 26.8 t -59.3 149.19 29.51 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.117 1.367 . . . . 0.0 111.123 -171.165 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -97.02 -60.39 0.97 Allowed Glycine 0 CA--C 1.533 1.19 0 CA-C-O 118.715 -1.047 . . . . 0.0 111.418 170.016 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -66.77 -25.9 45.7 Favored 'Trans proline' 0 C--N 1.349 0.576 0 CA-C-N 120.444 2.122 . . . . 0.0 112.813 -173.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 22.5 m -58.73 -32.23 69.02 Favored 'General case' 0 CA--C 1.536 0.41 0 O-C-N 121.524 -0.735 . . . . 0.0 111.401 174.392 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.7 mmtp -69.03 -23.01 64.02 Favored 'General case' 0 CA--C 1.532 0.257 0 O-C-N 121.373 -0.829 . . . . 0.0 111.109 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 34.0 mtm -71.52 -42.65 67.71 Favored 'General case' 0 C--N 1.34 0.194 0 CA-C-N 118.763 0.711 . . . . 0.0 110.404 175.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 16.5 tt -84.0 -22.12 8.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-O 118.741 -0.647 . . . . 0.0 111.599 -176.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -49.39 -51.16 60.38 Favored Pre-proline 0 CA--C 1.547 0.845 0 CA-C-N 120.009 1.277 . . . . 0.0 113.894 177.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -67.59 -25.98 40.29 Favored 'Trans proline' 0 C--N 1.351 0.66 0 CA-C-N 121.828 1.689 . . . . 0.0 112.528 176.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 15.2 t -70.05 -37.01 71.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 O-C-N 121.555 -0.715 . . . . 0.0 109.49 174.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 93.6 mt -67.41 -36.72 81.83 Favored 'General case' 0 C--O 1.226 -0.152 0 CA-C-N 119.576 1.08 . . . . 0.0 111.267 171.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -62.43 -41.59 98.82 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 119.385 0.993 . . . . 0.0 110.686 172.27 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 30.9 mm-40 -60.08 -45.91 91.33 Favored 'General case' 0 N--CA 1.455 -0.18 0 O-C-N 121.401 -0.812 . . . . 0.0 110.139 173.286 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.13 -44.09 92.03 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.886 0.874 . . . . 0.0 109.576 179.513 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -60.46 -42.78 96.88 Favored 'General case' 0 CA--C 1.522 -0.117 0 C-N-CA 123.559 0.743 . . . . 0.0 111.245 178.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -72.6 -10.22 59.53 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.366 0.666 . . . . 0.0 112.459 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -103.13 -33.75 9.11 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 125.315 1.446 . . . . 0.0 110.723 -179.203 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 88.4 mmm -130.12 -4.05 4.46 Favored 'General case' 0 C--N 1.341 0.203 0 N-CA-C 113.869 1.063 . . . . 0.0 113.869 -167.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.61 -11.41 15.51 Favored Glycine 0 CA--C 1.532 1.095 0 CA-C-N 119.954 1.252 . . . . 0.0 114.993 -173.575 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -67.05 -28.23 68.04 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 118.434 1.117 . . . . 0.0 111.595 172.012 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -120.8 -25.16 5.5 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 125.56 1.544 . . . . 0.0 111.686 -178.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 35.3 tp -102.58 159.6 15.31 Favored 'General case' 0 C--O 1.232 0.149 0 C-N-CA 124.202 1.001 . . . . 0.0 110.504 -170.216 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -132.68 143.54 49.71 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 104.326 -2.472 . . . . 0.0 104.326 167.403 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 67.5 mt -117.09 138.76 46.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 105.28 -2.118 . . . . 0.0 105.28 177.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 97.7 t -132.9 94.22 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 -169.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 27.9 mtpp -73.43 141.07 46.92 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 176.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 11.8 tt -142.73 126.86 15.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 178.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 57.4 t0 -86.25 104.61 15.95 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 124.783 1.233 . . . . 0.0 109.253 -170.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 26.1 m -61.79 -20.74 24.19 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-O 118.625 -0.702 . . . . 0.0 112.271 -176.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -67.6 -13.83 62.41 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 119.723 1.147 . . . . 0.0 111.958 177.345 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -124.23 3.28 8.54 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.666 1.187 . . . . 0.0 111.506 175.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 65.0 m-80 -141.65 41.25 1.72 Allowed 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 124.13 0.972 . . . . 0.0 111.29 -169.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 3.7 mp0 -52.89 -31.55 40.31 Favored 'General case' 0 CA--C 1.531 0.25 0 O-C-N 121.972 -0.455 . . . . 0.0 111.716 172.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -65.05 -50.76 64.92 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 123.905 0.882 . . . . 0.0 109.77 -178.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.34 -36.95 77.42 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.33 0.652 . . . . 0.0 109.839 -178.471 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.41 -45.99 89.96 Favored 'General case' 0 CA--C 1.534 0.365 0 O-C-N 120.834 -1.167 . . . . 0.0 110.669 171.295 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -63.5 -28.12 71.92 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 123.906 0.765 . . . . 0.0 112.189 177.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 74.0 tttt -56.15 -29.17 60.4 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.964 1.306 . . . . 0.0 111.613 179.202 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -123.82 6.17 8.74 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.291 0.636 . . . . 0.0 112.273 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 62.44 41.63 99.76 Favored Glycine 0 CA--C 1.53 0.99 0 N-CA-C 111.698 -0.561 . . . . 0.0 111.698 -175.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 95.2 t -63.38 94.3 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 124.852 1.261 . . . . 0.0 107.963 173.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 1.6 pmm? -73.77 -30.72 62.93 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 125.235 1.414 . . . . 0.0 112.452 -175.325 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 52.0 m -147.42 175.0 11.16 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 126.067 1.747 . . . . 0.0 109.653 -172.221 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 42.8 pt -137.2 154.87 76.02 Favored Pre-proline 0 CA--C 1.546 0.813 0 C-N-CA 125.045 1.338 . . . . 0.0 108.631 175.211 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -67.93 141.54 60.19 Favored 'Cis proline' 0 N--CA 1.458 -0.612 0 CA-C-N 120.467 1.203 . . . . 0.0 110.493 -4.215 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 18.4 m -135.88 137.51 41.51 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 175.016 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -114.79 133.39 55.96 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 -173.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -120.78 116.49 25.34 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 103.18 -2.896 . . . . 0.0 103.18 176.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.4 t -91.79 121.36 42.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 103.723 -2.695 . . . . 0.0 103.723 173.431 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.4 mp -110.51 155.28 22.48 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 175.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 26.4 ttpp -133.7 115.05 14.13 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 105.677 -1.971 . . . . 0.0 105.677 176.387 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 27.6 t0 50.09 39.98 20.55 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.675 1.19 . . . . 0.0 112.461 176.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 103.59 -4.22 46.82 Favored Glycine 0 CA--C 1.529 0.958 0 CA-C-O 118.184 -1.342 . . . . 0.0 115.345 168.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -132.27 150.2 52.21 Favored 'General case' 0 C--N 1.34 0.155 0 CA-C-N 120.056 1.928 . . . . 0.0 110.32 -178.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 22.1 t -62.99 134.66 28.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 -179.352 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.3 p -117.97 -27.67 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 C-N-CA 125.016 1.326 . . . . 0.0 110.169 174.393 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 40.8 mm-40 -150.22 163.14 39.01 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 120.201 1.364 . . . . 0.0 110.177 172.281 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 17.9 m -141.04 145.08 35.4 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.057 1.343 . . . . 0.0 108.44 176.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 20.0 m -144.74 151.99 39.7 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.389 1.476 . . . . 0.0 108.845 175.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 59.2 t -132.44 142.96 41.24 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 -177.059 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 79.14 179.5 52.02 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 123.876 0.751 . . . . 0.0 111.815 -178.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -57.96 144.76 38.29 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 123.391 0.676 . . . . 0.0 110.511 178.219 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -149.64 134.93 9.7 Favored Pre-proline 0 N--CA 1.453 -0.303 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 -175.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -74.39 156.81 45.7 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 122.12 1.88 . . . . 0.0 110.787 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 17.7 ptmt -56.9 -31.77 65.22 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 124.019 0.927 . . . . 0.0 112.266 177.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -66.09 -48.54 70.6 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 118.731 0.696 . . . . 0.0 110.011 179.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.94 -44.36 96.29 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 118.009 0.368 . . . . 0.0 110.335 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 83.3 mt -61.73 -42.68 99.27 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-O 119.465 -0.303 . . . . 0.0 110.505 178.391 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -61.62 -39.85 92.75 Favored 'General case' 0 C--O 1.222 -0.343 0 CA-C-O 118.132 -0.937 . . . . 0.0 111.268 175.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -64.11 -41.9 97.09 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 119.822 1.192 . . . . 0.0 110.421 178.385 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 88.8 mt -63.54 -38.63 91.87 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 122.904 0.482 . . . . 0.0 111.165 178.129 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 49.7 t -63.33 -51.26 73.26 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 C-N-CA 123.676 0.79 . . . . 0.0 109.542 171.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -59.63 -40.76 88.69 Favored 'General case' 0 C--N 1.332 -0.153 0 C-N-CA 125.907 1.683 . . . . 0.0 111.503 -169.407 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 13.7 ptmm? -69.5 -6.63 31.89 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 118.155 -0.926 . . . . 0.0 113.16 -177.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 93.6 m-70 -124.96 -15.4 6.4 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 177.105 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 19.7 mt . . . . . 0 C--O 1.249 1.076 0 CA-C-N 119.563 1.074 . . . . 0.0 109.371 169.404 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.6 mt . . . . . 0 C--O 1.236 0.39 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 21.4 t -133.95 159.56 42.31 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 C-N-CA 126.221 1.808 . . . . 0.0 106.498 -176.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -115.2 128.44 56.17 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 105.428 -2.064 . . . . 0.0 105.428 178.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -138.5 166.76 23.48 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 121.576 0.703 . . . . 0.0 112.313 -173.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.448 HG22 HD21 ' A' ' 60' ' ' ASN . 36.4 p -137.09 179.24 6.5 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 125.648 1.579 . . . . 0.0 107.715 171.105 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -49.14 -29.8 5.85 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.25 1.02 . . . . 0.0 112.706 170.18 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -63.04 -27.54 69.47 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.007 1.323 . . . . 0.0 112.805 179.341 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 13.6 p -132.08 -20.22 2.48 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 -167.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 56.4 t80 -51.98 -47.52 64.81 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 124.767 1.227 . . . . 0.0 112.534 -169.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.3 m -64.6 -38.57 91.47 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 122.666 0.386 . . . . 0.0 111.665 -175.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -68.04 -45.01 75.12 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 176.567 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 -62.9 -36.5 83.58 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 119.301 -0.38 . . . . 0.0 111.082 -177.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.8 p -83.75 -0.04 49.24 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 113.526 0.936 . . . . 0.0 113.526 -177.059 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 70.3 m -102.6 31.34 4.14 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.986 0.914 . . . . 0.0 111.494 -175.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -132.35 53.04 2.03 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.181 0.992 . . . . 0.0 110.781 -175.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 99.62 -156.21 19.79 Favored Glycine 0 C--N 1.338 0.655 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 176.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 90.0 t -70.18 136.43 26.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 167.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 60.6 t -139.59 147.13 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 N-CA-C 105.576 -2.009 . . . . 0.0 105.576 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.1 tt -125.17 99.0 5.89 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 -175.557 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -80.26 147.44 31.19 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 123.258 0.623 . . . . 0.0 109.548 -179.162 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -129.44 93.94 3.66 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 126.126 1.77 . . . . 0.0 108.163 -174.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -75.17 112.58 11.58 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 106.321 -1.733 . . . . 0.0 106.321 174.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -149.46 -176.57 5.44 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.775 1.23 . . . . 0.0 108.218 -173.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -156.67 149.1 17.86 Favored Pre-proline 0 CA--C 1.531 0.239 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 167.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -60.85 -19.13 60.57 Favored 'Trans proline' 0 N--CA 1.46 -0.47 0 C-N-CA 121.568 1.512 . . . . 0.0 115.43 179.134 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 48.5 p-90 -69.72 -20.06 63.54 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 119.926 1.239 . . . . 0.0 111.927 173.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 25.4 t -59.62 147.83 35.88 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.932 1.293 . . . . 0.0 111.072 -172.217 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -96.91 -63.62 0.92 Allowed Glycine 0 CA--C 1.529 0.94 0 CA-C-O 118.479 -1.178 . . . . 0.0 110.862 171.376 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -62.68 -26.2 75.38 Favored 'Trans proline' 0 C--N 1.349 0.605 0 CA-C-N 120.314 2.057 . . . . 0.0 113.543 -174.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 35.1 m -57.65 -34.34 69.26 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 118.653 0.66 . . . . 0.0 111.471 174.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.9 mmtp -67.88 -25.28 65.44 Favored 'General case' 0 CA--C 1.531 0.236 0 O-C-N 121.553 -0.717 . . . . 0.0 110.921 -179.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 31.0 mtm -71.91 -42.81 66.28 Favored 'General case' 0 C--N 1.34 0.16 0 CA-C-N 118.696 0.68 . . . . 0.0 110.444 176.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 13.5 tt -84.05 -21.73 8.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-O 118.826 -0.607 . . . . 0.0 111.56 -175.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -48.82 -51.8 51.25 Favored Pre-proline 0 CA--C 1.546 0.819 0 CA-C-N 119.994 1.27 . . . . 0.0 113.643 177.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -67.27 -29.0 39.4 Favored 'Trans proline' 0 C--N 1.351 0.682 0 CA-C-N 121.756 1.663 . . . . 0.0 112.555 176.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 31.4 t -65.48 -40.24 87.61 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 174.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 76.9 mt -67.78 -35.54 78.86 Favored 'General case' 0 C--O 1.224 -0.238 0 CA-C-N 119.299 0.954 . . . . 0.0 111.482 173.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -62.38 -42.27 99.28 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 119.549 1.068 . . . . 0.0 110.736 172.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -65.03 -39.38 93.3 Favored 'General case' 0 CA--C 1.532 0.265 0 O-C-N 121.28 -0.887 . . . . 0.0 110.505 175.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.24 -46.37 90.02 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.638 0.775 . . . . 0.0 109.348 175.486 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -58.88 -42.94 90.69 Favored 'General case' 0 CA--C 1.521 -0.144 0 C-N-CA 123.833 0.853 . . . . 0.0 111.279 179.386 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -70.79 -10.47 59.58 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.428 0.691 . . . . 0.0 112.607 179.338 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 58.2 mt-10 -106.16 -30.62 9.12 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 125.601 1.56 . . . . 0.0 111.46 -177.511 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 91.6 mmm -127.62 -5.38 5.83 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 -171.511 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.81 -10.69 14.21 Favored Glycine 0 CA--C 1.531 1.036 0 CA-C-N 119.828 1.194 . . . . 0.0 114.854 -174.106 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -65.41 -28.48 69.28 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 118.509 1.154 . . . . 0.0 111.51 171.502 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -123.31 -25.84 4.38 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 125.427 1.491 . . . . 0.0 111.639 -179.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 31.6 tp -100.07 161.61 13.5 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 124.306 1.042 . . . . 0.0 110.385 -170.244 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -135.95 144.6 45.53 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 104.447 -2.427 . . . . 0.0 104.447 168.066 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 59.9 mt -116.65 139.32 43.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 105.489 -2.041 . . . . 0.0 105.489 176.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 93.2 t -132.98 96.31 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 -169.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -74.39 138.02 43.1 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 178.175 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 13.4 tt -141.4 128.73 21.32 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 177.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 64.6 t0 -87.94 106.68 18.27 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.603 1.161 . . . . 0.0 109.797 -169.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 31.3 m -62.08 -19.02 20.92 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 CA-C-O 118.693 -0.67 . . . . 0.0 112.473 -176.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -67.2 -15.72 63.87 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 119.685 1.129 . . . . 0.0 112.105 176.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -127.21 1.86 6.42 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.306 1.042 . . . . 0.0 111.863 179.155 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.448 HD21 HG22 ' A' ' 7' ' ' THR . 63.8 m-80 -137.63 40.52 2.39 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.732 0.813 . . . . 0.0 111.447 -169.235 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 5.5 mp0 -54.41 -32.58 57.59 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.056 0.542 . . . . 0.0 111.781 174.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 32.9 mm-40 -65.73 -48.96 70.17 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 118.514 0.597 . . . . 0.0 110.136 -179.07 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.39 -37.82 80.76 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.036 0.534 . . . . 0.0 109.927 -178.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.4 -48.59 81.08 Favored 'General case' 0 CA--C 1.535 0.372 0 O-C-N 121.064 -1.022 . . . . 0.0 110.363 172.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -60.62 -27.67 66.58 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 124.225 0.916 . . . . 0.0 112.334 177.535 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 47.3 tttp -55.52 -29.11 58.29 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.84 1.256 . . . . 0.0 111.726 178.415 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -123.54 10.8 9.15 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.554 0.742 . . . . 0.0 111.732 179.242 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 64.12 30.44 77.78 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 123.649 0.642 . . . . 0.0 112.629 -176.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 61.5 t -65.44 125.8 23.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 171.038 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 67.0 mtt -136.36 3.84 2.86 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.811 1.244 . . . . 0.0 111.465 -179.209 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 24.2 m -144.05 161.79 37.88 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 126.591 1.957 . . . . 0.0 107.697 179.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 42.5 pt -141.56 154.51 66.59 Favored Pre-proline 0 CA--C 1.545 0.774 0 C-N-CA 124.424 1.09 . . . . 0.0 108.811 176.141 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -67.42 140.02 50.34 Favored 'Cis proline' 0 C--N 1.349 0.586 0 CA-C-N 120.356 1.163 . . . . 0.0 110.385 -4.278 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 42.4 m -132.71 142.24 48.96 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 173.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 91.6 mt -125.21 129.46 50.15 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 107.37 -1.345 . . . . 0.0 107.37 -169.259 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -119.84 118.49 30.92 Favored 'General case' 0 CA--C 1.513 -0.476 0 N-CA-C 103.27 -2.863 . . . . 0.0 103.27 178.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 4.5 t -88.6 122.83 40.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 103.007 -2.96 . . . . 0.0 103.007 172.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.2 mp -112.05 157.42 20.78 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 174.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 89.1 tttt -136.42 124.51 22.96 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 106.304 -1.739 . . . . 0.0 106.304 169.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.0 t70 49.22 38.02 12.48 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.909 1.284 . . . . 0.0 112.389 175.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 100.87 -2.4 55.55 Favored Glycine 0 CA--C 1.53 0.979 0 CA-C-O 118.15 -1.361 . . . . 0.0 115.167 169.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -131.96 152.54 51.04 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 120.174 1.987 . . . . 0.0 110.284 -179.15 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 22.0 t -62.92 134.52 28.12 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 -179.252 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.5 p -120.14 -24.23 3.03 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 C-N-CA 125.471 1.508 . . . . 0.0 109.958 176.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -158.79 172.2 18.68 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 120.262 1.392 . . . . 0.0 109.601 173.656 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 26.5 m -148.87 153.15 37.65 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 120.555 -1.34 . . . . 0.0 109.543 -179.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 48.4 m -150.22 154.44 37.95 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.218 1.407 . . . . 0.0 109.051 169.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 40.9 t -133.59 142.17 42.32 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 -177.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 75.69 -177.9 48.92 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 123.43 0.538 . . . . 0.0 111.838 -178.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 59.2 t80 -59.52 143.97 48.62 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 123.238 0.615 . . . . 0.0 110.683 179.212 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -150.27 137.12 11.23 Favored Pre-proline 0 C--O 1.234 0.267 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 -176.502 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -73.12 153.83 51.97 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 122.009 1.806 . . . . 0.0 110.486 176.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 57.6 pttt -60.79 -31.61 70.97 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 118.897 -0.573 . . . . 0.0 111.818 -178.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -66.45 -42.5 87.53 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.279 0.632 . . . . 0.0 110.438 -179.179 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.18 -44.48 88.32 Favored 'General case' 0 C--O 1.232 0.16 0 O-C-N 121.961 -0.462 . . . . 0.0 109.898 179.148 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 92.0 mt -62.61 -40.22 96.25 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.582 177.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -60.4 -41.19 93.34 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-O 118.577 -0.725 . . . . 0.0 111.498 174.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -63.39 -42.71 98.83 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 118.924 0.784 . . . . 0.0 110.007 176.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 40.7 mt -63.65 -41.62 98.19 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 118.739 0.699 . . . . 0.0 111.382 177.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 43.1 t -57.51 -49.34 80.68 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 C-N-CA 123.546 0.738 . . . . 0.0 109.239 171.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -63.05 -31.44 72.58 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.403 1.481 . . . . 0.0 111.964 -173.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -58.67 -24.73 61.83 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 118.236 -0.888 . . . . 0.0 112.213 174.397 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 82.3 m-70 -125.69 -14.56 6.23 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 113.863 1.06 . . . . 0.0 113.863 -168.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 23.8 mt . . . . . 0 C--O 1.247 0.964 0 CA-C-N 119.692 1.133 . . . . 0.0 109.125 168.975 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 7.6 mt . . . . . 0 CA--C 1.536 0.405 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 38.7 t -135.0 164.1 34.68 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 C-N-CA 127.065 2.146 . . . . 0.0 106.082 -179.291 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 6.2 ttmt -120.85 146.22 46.79 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 175.016 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -146.48 167.78 22.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.335 0.588 . . . . 0.0 111.104 -176.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 16.0 p -132.57 170.62 14.91 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 126.394 1.878 . . . . 0.0 107.896 171.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -52.97 -29.76 30.95 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.034 0.933 . . . . 0.0 113.125 -179.096 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 56.6 mt-30 -62.47 -28.98 70.19 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.124 1.37 . . . . 0.0 112.933 179.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.6 m -136.33 -5.89 2.04 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 113.517 0.932 . . . . 0.0 113.517 -169.191 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 81.9 t80 -53.43 -44.01 68.46 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.174 0.99 . . . . 0.0 111.281 -178.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.2 m -62.89 -39.06 93.33 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.252 0.621 . . . . 0.0 111.935 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.77 -43.89 82.82 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 122.697 0.399 . . . . 0.0 109.993 178.299 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -64.53 -41.54 96.31 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 122.235 0.214 . . . . 0.0 110.709 -179.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.409 ' HA ' HG21 ' A' ' 20' ' ' VAL . 36.3 p -79.47 -3.65 47.59 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 124.308 1.043 . . . . 0.0 113.544 -176.567 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 74.7 m -75.07 -21.4 59.01 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 176.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -88.02 71.74 9.32 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 121.55 -0.719 . . . . 0.0 111.586 -169.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 84.13 -152.75 28.58 Favored Glycine 0 C--N 1.336 0.566 0 N-CA-C 110.304 -1.118 . . . . 0.0 110.304 173.303 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 63.2 t -70.7 134.36 30.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 169.114 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.409 HG21 ' HA ' ' A' ' 15' ' ' THR . 61.6 t -139.09 138.81 41.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 105.786 -1.931 . . . . 0.0 105.786 179.34 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.9 tt -117.37 104.31 11.0 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 -177.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -89.45 147.1 24.2 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 -177.308 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -127.42 94.13 3.9 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 125.551 1.54 . . . . 0.0 107.333 -175.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -74.46 112.77 10.96 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 105.68 -1.971 . . . . 0.0 105.68 174.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -149.41 -174.94 4.81 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 124.911 1.284 . . . . 0.0 108.095 -172.056 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -152.77 148.78 20.95 Favored Pre-proline 0 N--CA 1.453 -0.285 0 N-CA-C 105.83 -1.915 . . . . 0.0 105.83 167.174 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -68.21 -11.89 33.39 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 CA-C-N 121.101 1.429 . . . . 0.0 112.855 178.149 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 1.3 m95 -77.22 -12.34 59.94 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.775 0.83 . . . . 0.0 111.814 172.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 17.4 t -64.65 160.95 18.69 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.353 1.461 . . . . 0.0 110.834 -178.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -115.52 -58.02 0.34 Allowed Glycine 0 CA--C 1.531 1.046 0 CA-C-O 118.631 -1.094 . . . . 0.0 111.069 171.436 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -56.22 -33.63 91.29 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 123.506 2.804 . . . . 0.0 113.395 178.368 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 23.0 m -58.4 -33.71 69.94 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 121.705 -0.622 . . . . 0.0 111.555 176.34 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.5 mmtp -68.5 -22.24 64.55 Favored 'General case' 0 CA--C 1.531 0.238 0 O-C-N 121.499 -0.75 . . . . 0.0 111.086 -179.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 35.3 mtm -70.15 -43.27 71.23 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-N 118.731 0.696 . . . . 0.0 110.298 175.346 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 18.2 tt -85.2 -23.7 7.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-O 118.379 -0.82 . . . . 0.0 111.701 -176.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -49.04 -50.19 64.47 Favored Pre-proline 0 CA--C 1.549 0.914 0 CA-C-N 120.407 1.458 . . . . 0.0 114.516 179.038 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -66.13 -30.64 46.6 Favored 'Trans proline' 0 C--N 1.351 0.666 0 CA-C-N 121.636 1.62 . . . . 0.0 111.682 176.449 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.6 t -66.03 -39.81 85.55 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-O 118.305 -0.855 . . . . 0.0 109.449 174.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 94.7 mt -62.53 -37.66 86.95 Favored 'General case' 0 C--N 1.34 0.185 0 CA-C-N 119.916 1.235 . . . . 0.0 110.874 173.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -63.02 -45.4 92.5 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 119.411 1.005 . . . . 0.0 110.978 173.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 50.8 mm-40 -65.26 -37.33 86.87 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 120.923 -1.111 . . . . 0.0 110.83 178.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -63.94 -42.99 97.19 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 125.154 1.382 . . . . 0.0 109.392 176.156 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -58.5 -43.59 89.14 Favored 'General case' 0 CA--C 1.521 -0.137 0 C-N-CA 123.941 0.896 . . . . 0.0 111.203 176.014 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -70.26 -12.8 61.84 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -179.013 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -102.25 -33.38 9.64 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 125.228 1.411 . . . . 0.0 111.088 -179.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 79.5 mmm -119.49 -5.61 10.29 Favored 'General case' 0 N--CA 1.461 0.117 0 CA-C-O 118.584 -0.722 . . . . 0.0 112.837 -168.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -61.4 -8.01 11.86 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 124.583 1.087 . . . . 0.0 115.574 -173.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -75.53 -26.41 58.04 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 118.736 1.268 . . . . 0.0 111.365 171.497 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 50.8 mmtt -118.15 -24.29 7.04 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 125.503 1.521 . . . . 0.0 111.684 -176.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 47.4 tp -116.4 152.99 32.85 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 124.379 1.072 . . . . 0.0 112.056 -167.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -119.41 142.15 48.47 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 104.986 -2.227 . . . . 0.0 104.986 166.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 75.8 mt -110.94 140.28 30.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 105.667 -1.975 . . . . 0.0 105.667 172.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 97.3 t -131.79 98.35 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -175.095 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -75.09 140.48 43.48 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 174.435 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 13.7 tt -142.88 124.77 12.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 178.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -82.68 105.31 13.61 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 124.594 1.158 . . . . 0.0 108.832 -173.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 31.0 m -60.12 -25.58 33.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 118.536 -0.745 . . . . 0.0 111.959 -175.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -65.71 -18.01 65.02 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 119.597 1.089 . . . . 0.0 112.047 -177.252 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -118.69 3.51 11.68 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.893 1.277 . . . . 0.0 111.132 177.392 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -139.81 40.46 2.0 Allowed 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 124.563 1.145 . . . . 0.0 109.758 -170.179 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 50.5 mm-40 -55.54 -32.42 62.93 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.907 0.883 . . . . 0.0 111.024 176.388 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 33.1 mm-40 -65.33 -48.27 73.61 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 118.411 0.551 . . . . 0.0 110.255 178.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.43 -40.27 85.48 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.235 0.614 . . . . 0.0 109.927 -178.561 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.98 -47.33 86.27 Favored 'General case' 0 CA--C 1.533 0.293 0 O-C-N 121.541 -0.725 . . . . 0.0 110.76 173.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -62.9 -29.01 72.87 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 123.554 0.597 . . . . 0.0 111.944 177.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 17.9 ttmt -55.6 -29.87 59.9 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 125.837 1.655 . . . . 0.0 111.999 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -123.67 7.9 8.85 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 123.491 0.717 . . . . 0.0 112.197 -179.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 63.09 41.41 99.78 Favored Glycine 0 CA--C 1.53 0.996 0 CA-C-N 118.329 0.513 . . . . 0.0 111.857 -176.431 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 88.3 t -66.07 91.52 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 C-N-CA 124.71 1.204 . . . . 0.0 107.774 174.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 25.1 ptt? -73.57 -28.12 61.68 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 124.707 1.203 . . . . 0.0 112.94 -176.138 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 34.4 m -146.72 174.85 11.08 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 125.973 1.709 . . . . 0.0 109.491 -170.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 41.6 pt -139.49 156.56 71.42 Favored Pre-proline 0 CA--C 1.545 0.752 0 C-N-CA 125.169 1.388 . . . . 0.0 108.669 174.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -67.46 138.97 44.99 Favored 'Cis proline' 0 C--N 1.349 0.561 0 CA-C-N 120.577 1.242 . . . . 0.0 110.13 -5.08 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 23.4 m -132.91 135.23 45.43 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 176.194 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 10.8 mp -114.81 125.68 53.96 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 -169.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -115.41 122.63 46.4 Favored 'General case' 0 CA--C 1.515 -0.393 0 N-CA-C 103.708 -2.701 . . . . 0.0 103.708 177.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 4.3 t -92.87 125.7 45.41 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.481 0 N-CA-C 103.655 -2.72 . . . . 0.0 103.655 169.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.2 mp -114.08 152.17 31.44 Favored 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 172.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -137.96 126.16 23.03 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 174.414 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 32.2 t70 50.86 33.17 8.21 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.976 1.31 . . . . 0.0 112.264 178.139 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 100.65 0.06 55.41 Favored Glycine 0 CA--C 1.531 1.059 0 CA-C-O 118.207 -1.33 . . . . 0.0 114.965 169.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -128.51 150.46 50.16 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 120.002 1.901 . . . . 0.0 109.929 179.218 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 47.1 t -62.09 132.62 27.87 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 175.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.6 p -119.53 -21.75 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 C-N-CA 125.129 1.372 . . . . 0.0 109.79 178.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -159.65 165.01 33.57 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 120.184 1.356 . . . . 0.0 110.751 171.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 10.7 m -136.32 150.82 49.05 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.255 1.422 . . . . 0.0 108.916 176.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 73.3 m -150.67 156.83 42.12 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.885 1.674 . . . . 0.0 108.696 170.594 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 47.5 t -133.49 145.3 33.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 -176.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 79.43 178.32 51.06 Favored Glycine 0 CA--C 1.53 1.025 0 C-N-CA 123.928 0.775 . . . . 0.0 112.706 175.253 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -60.06 148.35 36.05 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 123.798 0.839 . . . . 0.0 111.017 179.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -149.29 136.7 11.15 Favored Pre-proline 0 CA--C 1.534 0.334 0 C-N-CA 125.492 1.517 . . . . 0.0 107.084 -178.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -69.3 158.98 55.52 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 122.019 1.813 . . . . 0.0 111.04 177.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -55.06 -43.19 73.64 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 124.799 1.24 . . . . 0.0 112.739 -178.031 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -61.49 -44.08 97.72 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.009 0.524 . . . . 0.0 110.257 178.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.49 -36.51 82.92 Favored 'General case' 0 CA--C 1.528 0.129 0 O-C-N 121.865 -0.522 . . . . 0.0 111.017 178.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 92.4 mt -62.98 -42.11 99.74 Favored 'General case' 0 N--CA 1.456 -0.14 0 O-C-N 122.134 -0.353 . . . . 0.0 110.91 173.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -60.55 -39.8 89.27 Favored 'General case' 0 C--O 1.224 -0.284 0 CA-C-O 118.712 -0.661 . . . . 0.0 110.178 175.18 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -65.75 -40.9 92.56 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 119.02 0.827 . . . . 0.0 110.601 178.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 60.4 tp -60.44 -37.51 81.18 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 125.406 1.482 . . . . 0.0 110.958 177.22 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 92.9 t -69.38 -51.63 40.64 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 123.509 0.724 . . . . 0.0 109.698 171.321 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -58.27 -38.14 76.37 Favored 'General case' 0 C--N 1.334 -0.101 0 C-N-CA 125.939 1.695 . . . . 0.0 112.099 -168.135 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -65.42 -8.49 19.11 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 113.342 0.867 . . . . 0.0 113.342 -178.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -120.91 -10.46 9.1 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 124.293 1.037 . . . . 0.0 113.062 178.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 55.8 mt . . . . . 0 C--O 1.248 0.996 0 CA-C-N 119.204 0.911 . . . . 0.0 109.314 173.562 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.9 mt . . . . . 0 CA--C 1.538 0.5 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 40.8 t -138.07 163.88 28.71 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 126.284 1.834 . . . . 0.0 107.345 -174.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -115.29 146.07 41.86 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 174.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -147.94 167.57 24.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.31 0.576 . . . . 0.0 111.253 -179.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 18.0 p -136.25 172.26 13.27 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 126.253 1.821 . . . . 0.0 106.98 168.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -49.88 -28.53 6.68 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.824 0.85 . . . . 0.0 113.073 174.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -56.86 -31.98 65.36 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.619 1.568 . . . . 0.0 112.933 178.447 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 14.8 m -142.26 -4.78 1.0 Allowed 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -169.223 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -54.35 -41.67 69.39 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.98 0.912 . . . . 0.0 111.724 -176.156 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.2 p -59.96 -45.73 91.72 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 124.01 0.924 . . . . 0.0 111.747 177.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.2 -43.72 94.17 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 122.719 0.408 . . . . 0.0 110.284 178.069 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -63.4 -35.85 81.77 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 119.475 -0.298 . . . . 0.0 111.076 -179.255 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 29.1 p -85.5 3.58 39.72 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.094 0.957 . . . . 0.0 113.253 -176.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 60.5 m -106.43 30.78 5.69 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.165 0.986 . . . . 0.0 111.684 -176.344 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -132.5 37.91 3.48 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.573 0.749 . . . . 0.0 112.313 -174.149 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 121.04 -153.52 16.6 Favored Glycine 0 C--N 1.335 0.52 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 175.421 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 53.5 t -74.45 133.95 30.5 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 N-CA-C 105.011 -2.218 . . . . 0.0 105.011 166.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 43.2 t -137.03 133.81 47.76 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 N-CA-C 105.896 -1.89 . . . . 0.0 105.896 -178.484 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 5.1 tt -116.89 101.18 8.31 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 106.138 -1.801 . . . . 0.0 106.138 -177.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -81.82 145.8 30.22 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.342 179.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -126.15 94.17 4.02 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 125.918 1.687 . . . . 0.0 107.444 -177.451 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -73.1 112.85 9.52 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 105.936 -1.875 . . . . 0.0 105.936 174.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -149.38 -176.68 5.48 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.88 1.272 . . . . 0.0 108.403 -172.207 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -151.95 147.92 20.7 Favored Pre-proline 0 C--O 1.233 0.213 0 N-CA-C 105.545 -2.02 . . . . 0.0 105.545 167.228 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -68.03 -11.64 32.67 Favored 'Trans proline' 0 CA--C 1.534 0.498 0 CA-C-N 121.1 1.429 . . . . 0.0 113.276 -178.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 1.6 m95 -75.77 -13.7 60.3 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.637 0.775 . . . . 0.0 111.803 172.35 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 23.0 t -63.4 158.21 21.21 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.438 1.495 . . . . 0.0 110.971 -178.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -113.22 -57.82 0.41 Allowed Glycine 0 CA--C 1.531 1.065 0 CA-C-O 118.581 -1.121 . . . . 0.0 111.05 171.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -55.96 -33.76 90.06 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 123.366 2.711 . . . . 0.0 113.575 178.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 23.4 m -58.04 -34.15 69.76 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.271 0.628 . . . . 0.0 111.537 176.372 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.4 mmtp -68.5 -22.6 64.53 Favored 'General case' 0 CA--C 1.531 0.242 0 O-C-N 121.471 -0.768 . . . . 0.0 111.094 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 33.4 mtm -71.07 -42.85 68.84 Favored 'General case' 0 C--N 1.34 0.172 0 CA-C-N 118.841 0.746 . . . . 0.0 110.33 176.339 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 16.6 tt -85.29 -24.64 6.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-O 118.557 -0.735 . . . . 0.0 111.701 -175.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -48.85 -50.27 62.47 Favored Pre-proline 0 CA--C 1.549 0.912 0 CA-C-N 120.062 1.301 . . . . 0.0 114.219 178.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -67.08 -28.94 40.68 Favored 'Trans proline' 0 C--N 1.35 0.626 0 CA-C-N 121.774 1.669 . . . . 0.0 111.977 176.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.1 t -66.43 -40.89 87.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 CA-C-O 118.614 -0.708 . . . . 0.0 109.27 173.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 94.6 mt -63.23 -37.27 86.59 Favored 'General case' 0 C--N 1.34 0.188 0 CA-C-N 119.504 1.047 . . . . 0.0 110.855 174.58 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -62.37 -43.78 98.01 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 119.356 0.98 . . . . 0.0 111.107 173.02 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -62.74 -39.04 92.86 Favored 'General case' 0 CA--C 1.535 0.374 0 O-C-N 121.185 -0.947 . . . . 0.0 110.286 175.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.96 -43.65 98.22 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 124.556 1.142 . . . . 0.0 110.069 177.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -59.43 -42.71 92.51 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 123.679 0.792 . . . . 0.0 110.842 176.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -71.49 -10.61 60.04 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -179.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -106.6 -28.35 10.3 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 125.517 1.527 . . . . 0.0 111.651 -178.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 23.0 mtp -130.48 1.76 4.55 Favored 'General case' 0 N--CA 1.462 0.156 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -169.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -56.93 -11.63 6.09 Favored Glycine 0 CA--C 1.533 1.19 0 N-CA-C 115.993 1.157 . . . . 0.0 115.993 -175.399 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -78.58 -25.99 45.43 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 118.893 1.347 . . . . 0.0 111.778 173.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 52.1 mmtt -117.13 -19.8 9.54 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 125.468 1.507 . . . . 0.0 111.734 -176.031 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 57.1 tp -124.97 144.85 50.15 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 124.68 1.192 . . . . 0.0 110.668 -168.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -116.75 145.87 43.2 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 105.183 -2.154 . . . . 0.0 105.183 167.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 68.1 mt -115.83 140.24 38.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 105.768 -1.938 . . . . 0.0 105.768 175.179 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 80.8 t -132.84 98.23 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 -171.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -74.17 140.33 45.08 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 174.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 13.6 tt -143.49 124.97 11.09 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 178.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 61.0 t0 -83.89 106.63 15.71 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 124.401 1.08 . . . . 0.0 108.883 -172.331 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 33.0 m -59.81 -25.11 31.28 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 CA-C-O 118.444 -0.788 . . . . 0.0 112.072 -175.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -65.29 -18.6 65.44 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 119.646 1.112 . . . . 0.0 112.026 -178.556 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -118.7 4.53 11.6 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.041 1.337 . . . . 0.0 110.948 177.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 68.6 m-80 -140.5 38.72 1.87 Allowed 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 124.383 1.073 . . . . 0.0 110.151 -169.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 55.1 mm-40 -56.05 -33.27 64.83 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.295 0.638 . . . . 0.0 110.849 174.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -66.52 -47.93 71.36 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 118.3 0.5 . . . . 0.0 110.284 178.127 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.96 -40.86 91.68 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 118.65 0.659 . . . . 0.0 110.0 -179.236 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.35 -50.35 74.29 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.361 0.664 . . . . 0.0 110.1 174.08 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -60.37 -28.39 67.11 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 123.879 0.752 . . . . 0.0 112.334 177.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 21.9 ttmt -55.05 -29.48 57.56 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 125.565 1.546 . . . . 0.0 111.898 178.16 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -124.12 11.07 8.82 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.846 0.858 . . . . 0.0 111.71 178.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 67.38 24.42 73.63 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 123.914 0.768 . . . . 0.0 113.214 -177.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 48.9 t -63.65 129.62 27.53 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 171.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 35.0 ttm -142.64 4.37 1.52 Allowed 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.269 1.028 . . . . 0.0 111.278 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 22.8 m -142.6 161.58 37.7 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 126.697 1.999 . . . . 0.0 107.539 178.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 43.0 pt -143.0 156.45 61.95 Favored Pre-proline 0 CA--C 1.545 0.76 0 C-N-CA 124.588 1.155 . . . . 0.0 108.921 178.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -66.9 139.18 44.28 Favored 'Cis proline' 0 C--N 1.348 0.547 0 CA-C-N 120.423 1.187 . . . . 0.0 110.18 -5.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 33.1 m -131.37 139.1 49.42 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 174.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 83.7 mt -119.82 128.55 53.8 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 -169.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -117.86 124.32 48.04 Favored 'General case' 0 CA--C 1.516 -0.354 0 N-CA-C 103.973 -2.603 . . . . 0.0 103.973 177.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 15.9 t -96.38 122.68 48.12 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 N-CA-C 104.118 -2.549 . . . . 0.0 104.118 173.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.9 mp -116.16 152.45 33.67 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 175.317 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 57.8 tttp -135.02 121.83 20.97 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 173.123 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.4 t70 48.66 37.13 8.83 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.889 1.275 . . . . 0.0 112.264 175.469 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 99.07 2.1 57.02 Favored Glycine 0 CA--C 1.53 0.971 0 CA-C-O 117.954 -1.47 . . . . 0.0 115.283 169.539 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -122.1 145.55 48.06 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 120.292 2.046 . . . . 0.0 109.323 175.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 58.5 t -65.79 130.85 31.47 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 170.218 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 35.4 m -119.45 -19.27 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 CA-C-O 117.717 -1.135 . . . . 0.0 111.314 175.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -155.21 167.93 28.75 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 120.444 1.475 . . . . 0.0 111.191 173.345 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 14.3 m -141.84 151.11 42.45 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.767 1.627 . . . . 0.0 108.698 177.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 58.8 m -150.16 156.27 41.31 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.514 1.525 . . . . 0.0 108.57 169.146 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 42.3 t -133.62 144.91 34.54 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 -178.237 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 78.22 -175.86 54.43 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 123.695 0.664 . . . . 0.0 111.817 179.102 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -62.56 147.17 49.9 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.371 0.669 . . . . 0.0 110.415 177.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 58.6 mttt -142.22 138.0 16.25 Favored Pre-proline 0 C--O 1.234 0.281 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 168.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -68.6 165.09 30.54 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 122.134 1.889 . . . . 0.0 111.029 177.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -53.77 -44.04 69.72 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 125.531 1.532 . . . . 0.0 112.698 -178.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -63.78 -43.71 95.53 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.097 177.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.77 -38.49 86.66 Favored 'General case' 0 C--N 1.339 0.12 0 O-C-N 121.776 -0.577 . . . . 0.0 110.58 -179.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 51.9 mt -62.22 -45.87 91.42 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 123.511 0.724 . . . . 0.0 110.746 175.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 11.3 mt-30 -58.92 -41.0 86.26 Favored 'General case' 0 C--O 1.225 -0.19 0 CA-C-N 118.383 0.538 . . . . 0.0 110.769 175.214 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -65.9 -39.92 91.03 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 118.875 0.761 . . . . 0.0 110.81 179.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 67.8 tp -62.54 -36.38 82.42 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.339 1.456 . . . . 0.0 111.181 177.096 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 84.2 t -69.11 -47.88 72.36 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-N 118.572 0.623 . . . . 0.0 109.857 169.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -57.18 -40.6 77.66 Favored 'General case' 0 CA--C 1.521 -0.155 0 C-N-CA 125.498 1.519 . . . . 0.0 111.893 -168.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -65.52 -6.44 10.75 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 -178.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -126.59 0.4 6.84 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 124.526 1.13 . . . . 0.0 113.426 176.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 54.7 mt . . . . . 0 C--O 1.247 0.955 0 CA-C-N 119.462 1.028 . . . . 0.0 109.004 171.35 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.6 mt . . . . . 0 CA--C 1.539 0.547 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 47.3 t -140.34 164.3 22.36 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 C-N-CA 127.049 2.14 . . . . 0.0 106.99 -173.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 3.7 tppp? -113.87 147.37 38.57 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 175.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -146.85 168.91 20.25 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 123.109 0.564 . . . . 0.0 110.535 175.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 33.2 p -136.03 177.73 7.61 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 125.929 1.691 . . . . 0.0 107.961 170.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -42.75 -37.85 1.9 Allowed 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.3 1.44 . . . . 0.0 112.836 169.666 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 50.8 mm-40 -73.88 -26.24 60.45 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.805 0.842 . . . . 0.0 113.03 -174.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 14.3 p -121.74 -19.77 6.68 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 -169.413 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -53.82 -45.85 70.97 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 124.54 1.136 . . . . 0.0 111.925 -171.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.6 m -65.7 -23.96 66.88 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 112.937 0.717 . . . . 0.0 112.937 -177.14 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -90.66 -28.68 18.21 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 124.086 0.954 . . . . 0.0 111.443 176.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 68.9 mm-40 -70.81 -32.63 69.77 Favored 'General case' 0 N--CA 1.453 -0.325 0 O-C-N 121.797 -0.564 . . . . 0.0 110.829 173.266 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 22.9 p -88.71 4.56 46.9 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 113.847 1.055 . . . . 0.0 113.847 -170.277 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 30.4 p -108.67 29.16 7.68 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.336 1.054 . . . . 0.0 112.339 -174.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -129.32 50.73 2.12 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.218 1.007 . . . . 0.0 110.954 -174.357 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 103.68 -155.37 17.82 Favored Glycine 0 C--N 1.337 0.625 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 178.26 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 45.1 t -71.53 138.22 22.12 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 N-CA-C 105.694 -1.965 . . . . 0.0 105.694 167.552 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 47.3 t -138.22 139.25 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 N-CA-C 105.739 -1.949 . . . . 0.0 105.739 179.316 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 61.1 tp -122.6 101.72 7.64 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 106.703 -1.592 . . . . 0.0 106.703 -176.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -83.27 151.28 25.68 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 179.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -130.4 94.21 3.62 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 126.482 1.913 . . . . 0.0 107.242 -178.51 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -74.2 114.46 12.57 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 105.704 -1.962 . . . . 0.0 105.704 174.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -149.46 -177.63 5.96 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.094 1.357 . . . . 0.0 108.521 -172.856 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -155.63 147.94 17.59 Favored Pre-proline 0 CA--C 1.532 0.255 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 168.062 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -61.2 -18.06 56.21 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 121.649 1.566 . . . . 0.0 115.72 -178.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 49.7 p-90 -69.02 -20.68 64.14 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 119.963 1.256 . . . . 0.0 111.878 173.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 30.6 t -59.22 146.33 39.56 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 125.146 1.379 . . . . 0.0 111.054 -172.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -95.22 -60.26 1.07 Allowed Glycine 0 CA--C 1.531 1.064 0 CA-C-O 118.795 -1.003 . . . . 0.0 111.36 169.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -66.04 -26.25 50.88 Favored 'Trans proline' 0 C--N 1.35 0.656 0 CA-C-N 120.293 2.047 . . . . 0.0 113.101 -172.693 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 30.8 m -57.53 -35.14 69.89 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 121.699 -0.625 . . . . 0.0 111.295 174.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.0 mmtp -67.3 -26.09 66.36 Favored 'General case' 0 CA--C 1.53 0.207 0 O-C-N 121.673 -0.642 . . . . 0.0 110.928 -179.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 29.8 mtm -71.85 -44.17 64.28 Favored 'General case' 0 C--N 1.34 0.173 0 CA-C-N 118.585 0.63 . . . . 0.0 110.426 177.615 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 15.5 tt -79.86 -22.16 11.95 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-O 118.574 -0.727 . . . . 0.0 111.351 -177.201 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -48.93 -52.32 47.71 Favored Pre-proline 0 CA--C 1.549 0.942 0 CA-C-N 120.424 1.466 . . . . 0.0 114.241 179.125 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -66.71 -26.92 45.29 Favored 'Trans proline' 0 C--N 1.35 0.607 0 CA-C-N 121.748 1.66 . . . . 0.0 112.454 176.512 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 6.1 t -69.82 -37.86 74.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 O-C-N 121.688 -0.633 . . . . 0.0 109.454 174.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 43.2 mt -65.66 -36.72 84.49 Favored 'General case' 0 C--O 1.224 -0.267 0 CA-C-N 119.286 0.948 . . . . 0.0 110.517 172.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -63.34 -43.73 96.89 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 119.198 0.908 . . . . 0.0 111.079 173.013 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -60.61 -44.98 95.68 Favored 'General case' 0 CA--C 1.531 0.241 0 O-C-N 121.243 -0.911 . . . . 0.0 110.186 175.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -62.16 -41.88 98.73 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 124.846 1.258 . . . . 0.0 109.942 179.397 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -60.24 -42.85 96.14 Favored 'General case' 0 CA--C 1.521 -0.168 0 C-N-CA 123.879 0.872 . . . . 0.0 110.905 176.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -71.54 -10.46 59.8 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 122.976 0.51 . . . . 0.0 112.337 -179.202 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -103.59 -34.0 8.8 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 125.205 1.402 . . . . 0.0 111.234 178.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 74.6 mmm -121.86 -5.63 9.08 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 113.364 0.876 . . . . 0.0 113.364 -168.512 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -57.83 -15.11 18.37 Favored Glycine 0 CA--C 1.532 1.133 0 CA-C-N 119.718 1.145 . . . . 0.0 115.135 -173.203 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -69.71 -30.48 68.12 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 118.441 1.12 . . . . 0.0 111.728 173.574 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 45.9 mmtm -112.82 -19.69 11.89 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 125.456 1.502 . . . . 0.0 111.676 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 30.1 tp -117.55 157.15 26.83 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.412 1.085 . . . . 0.0 111.214 -169.232 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 37.4 ttmt -128.3 141.32 51.48 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 103.893 -2.632 . . . . 0.0 103.893 166.453 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 62.2 mt -108.15 141.53 23.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 105.925 -1.88 . . . . 0.0 105.925 175.04 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 84.7 t -132.69 98.44 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 -173.494 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt -74.31 140.49 44.93 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 174.397 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 15.0 tt -142.35 126.81 16.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 176.671 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 49.2 t0 -83.42 103.49 12.83 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.795 1.238 . . . . 0.0 109.067 -173.076 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 28.2 m -60.1 -27.15 38.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 118.766 -0.635 . . . . 0.0 112.028 -174.686 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -66.31 -19.54 65.84 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 119.321 0.964 . . . . 0.0 111.73 -177.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -114.13 1.78 14.69 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.558 1.543 . . . . 0.0 110.893 178.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 69.0 m-80 -141.98 42.52 1.68 Allowed 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.387 1.075 . . . . 0.0 109.79 -169.515 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 45.2 mm-40 -56.22 -33.07 65.01 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.794 0.838 . . . . 0.0 111.236 178.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 36.0 mm-40 -65.78 -46.72 77.68 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 118.379 0.536 . . . . 0.0 110.389 179.074 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.45 -38.51 77.81 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 121.798 -0.564 . . . . 0.0 109.778 -178.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -58.78 -47.54 84.36 Favored 'General case' 0 CA--C 1.535 0.376 0 O-C-N 120.978 -1.076 . . . . 0.0 110.241 171.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -59.97 -28.93 66.9 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 124.087 0.851 . . . . 0.0 112.506 176.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 50.1 tptt -56.27 -29.05 60.61 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.602 1.161 . . . . 0.0 111.551 179.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -123.34 10.39 9.24 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.568 0.747 . . . . 0.0 111.664 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 62.31 33.31 85.72 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 123.558 0.599 . . . . 0.0 112.427 -176.176 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 57.5 t -64.94 121.06 13.29 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 173.001 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 26.1 mmt -132.45 2.64 3.85 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.96 1.304 . . . . 0.0 111.465 -179.009 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 30.0 m -144.82 161.48 39.17 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 126.953 2.101 . . . . 0.0 107.062 178.242 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 34.5 pt -144.21 155.18 58.18 Favored Pre-proline 0 CA--C 1.545 0.788 0 C-N-CA 124.772 1.229 . . . . 0.0 108.451 177.406 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -68.54 139.54 51.47 Favored 'Cis proline' 0 C--N 1.35 0.624 0 CA-C-N 120.651 1.268 . . . . 0.0 110.53 -2.474 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 32.0 m -132.89 132.57 42.21 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 177.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 6.9 mp -110.52 131.17 55.28 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 -171.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -122.38 128.35 50.86 Favored 'General case' 0 CA--C 1.508 -0.638 0 N-CA-C 103.388 -2.819 . . . . 0.0 103.388 179.132 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 1.5 t -110.61 127.13 67.86 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.751 0 N-CA-C 104.337 -2.468 . . . . 0.0 104.337 -176.255 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.3 mp -126.08 152.05 46.37 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 -174.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -138.04 125.47 21.94 Favored 'General case' 0 CA--C 1.513 -0.479 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 175.221 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 29.2 t70 49.84 33.12 6.02 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.959 1.303 . . . . 0.0 112.348 173.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 99.41 4.59 56.14 Favored Glycine 0 CA--C 1.53 1.018 0 CA-C-O 118.018 -1.434 . . . . 0.0 114.551 170.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -122.0 144.89 48.62 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 120.101 1.951 . . . . 0.0 109.043 174.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 14.3 p -68.74 129.71 33.43 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 169.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 27.7 m -115.62 -20.87 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 CA-C-O 117.577 -1.201 . . . . 0.0 111.052 179.586 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -159.42 166.36 31.19 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 120.734 1.606 . . . . 0.0 111.402 176.343 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 13.3 m -136.34 151.18 49.31 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.991 1.716 . . . . 0.0 108.519 175.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 74.1 m -150.26 158.11 43.81 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.882 1.673 . . . . 0.0 108.671 171.206 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 39.2 t -133.97 148.21 30.32 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 -177.01 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.68 177.24 51.86 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 123.973 0.797 . . . . 0.0 112.705 171.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 47.6 t80 -62.55 135.46 57.42 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.352 0.661 . . . . 0.0 109.59 175.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 13.0 mptt -136.05 136.2 22.58 Favored Pre-proline 0 CA--C 1.533 0.324 0 C-N-CA 126.429 1.892 . . . . 0.0 105.995 175.389 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -70.61 160.19 50.28 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 122.493 2.128 . . . . 0.0 110.591 176.18 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 41.5 pttt -59.34 -28.9 67.25 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -177.108 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -65.86 -48.86 70.15 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 122.839 0.456 . . . . 0.0 110.037 173.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.6 -37.9 89.06 Favored 'General case' 0 CA--C 1.529 0.162 0 O-C-N 121.898 -0.501 . . . . 0.0 110.711 178.296 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 79.3 mt -64.97 -41.56 95.34 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 119.355 -0.355 . . . . 0.0 111.255 176.267 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 15.6 mt-30 -59.32 -41.05 88.17 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 118.824 0.738 . . . . 0.0 110.086 174.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -64.77 -40.82 95.9 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 118.199 0.454 . . . . 0.0 110.365 178.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 63.3 tp -61.03 -43.77 98.4 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.733 1.213 . . . . 0.0 110.755 177.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 78.5 t -61.42 -46.43 96.61 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 123.651 0.78 . . . . 0.0 109.37 173.125 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -61.91 -25.73 67.75 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 125.017 1.327 . . . . 0.0 112.239 -173.086 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 49.2 mtpt -55.86 -24.58 37.73 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 118.658 -0.687 . . . . 0.0 112.576 172.327 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 80.9 m-70 -123.34 -8.2 8.13 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 -168.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 82.1 mt . . . . . 0 C--O 1.248 0.975 0 CA-C-N 119.155 0.889 . . . . 0.0 109.327 171.512 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.3 mt . . . . . 0 CA--C 1.534 0.351 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 41.3 t -135.32 163.72 35.05 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 C-N-CA 126.353 1.861 . . . . 0.0 106.251 -177.127 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 6.2 ttmt -118.99 144.83 46.28 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 174.69 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -145.12 166.49 25.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.393 0.615 . . . . 0.0 110.976 -177.027 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.9 p -133.09 169.92 16.15 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 126.254 1.822 . . . . 0.0 107.779 171.29 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -52.63 -29.71 27.61 Favored 'General case' 0 CA--C 1.535 0.365 0 C-N-CA 124.499 1.12 . . . . 0.0 113.23 -178.67 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 82.6 mm-40 -63.54 -29.0 70.33 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.788 1.235 . . . . 0.0 113.103 179.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.6 m -135.17 -6.85 2.31 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 -169.295 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -52.14 -42.98 63.8 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.439 1.096 . . . . 0.0 111.722 -178.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.6 m -62.74 -39.15 93.19 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.111 0.564 . . . . 0.0 111.83 -179.02 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -68.54 -43.89 75.7 Favored 'General case' 0 N--CA 1.452 -0.329 0 O-C-N 122.011 -0.431 . . . . 0.0 110.079 177.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 67.1 mm-40 -63.05 -34.52 77.76 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-O 119.618 -0.229 . . . . 0.0 111.085 -179.068 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 27.4 p -85.65 3.66 39.94 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 113.524 0.935 . . . . 0.0 113.524 -176.507 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 69.6 m -105.4 30.05 5.99 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.053 0.941 . . . . 0.0 112.07 -175.515 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -132.83 37.46 3.45 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.455 0.702 . . . . 0.0 112.702 -173.248 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 123.11 -152.47 16.93 Favored Glycine 0 N--CA 1.465 0.593 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 174.022 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 67.4 t -73.09 133.72 31.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 104.528 -2.397 . . . . 0.0 104.528 165.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 40.7 t -136.26 130.19 47.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.8 tt -110.9 99.49 8.39 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 105.865 -1.902 . . . . 0.0 105.865 -178.106 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -80.07 143.16 34.23 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 178.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -123.91 94.05 4.11 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 125.806 1.642 . . . . 0.0 107.159 -176.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -73.88 113.15 10.72 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 105.791 -1.929 . . . . 0.0 105.791 174.758 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -148.86 -177.05 5.58 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.785 1.234 . . . . 0.0 108.354 -173.125 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -156.07 149.06 18.27 Favored Pre-proline 0 CA--C 1.531 0.224 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 167.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -61.44 -18.17 57.83 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 121.707 1.605 . . . . 0.0 115.61 179.657 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 52.6 p-90 -70.56 -19.44 62.88 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 120.002 1.274 . . . . 0.0 111.901 173.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 19.5 t -60.03 151.99 25.08 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 124.944 1.298 . . . . 0.0 110.844 -174.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -105.88 -58.0 0.64 Allowed Glycine 0 CA--C 1.531 1.058 0 CA-C-O 118.842 -0.976 . . . . 0.0 111.017 171.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -56.91 -33.16 94.53 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 123.28 2.653 . . . . 0.0 113.518 -179.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 31.4 m -58.11 -34.05 69.77 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.202 0.601 . . . . 0.0 111.423 176.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.2 mmtp -68.42 -24.85 64.79 Favored 'General case' 0 CA--C 1.53 0.184 0 O-C-N 121.534 -0.729 . . . . 0.0 110.927 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 31.0 mtm -70.65 -43.21 69.65 Favored 'General case' 0 C--N 1.34 0.153 0 CA-C-N 118.735 0.698 . . . . 0.0 110.357 176.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 17.5 tt -83.08 -22.74 8.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-O 118.61 -0.709 . . . . 0.0 111.616 -176.355 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -49.28 -51.08 60.4 Favored Pre-proline 0 CA--C 1.547 0.853 0 CA-C-N 120.234 1.379 . . . . 0.0 114.261 178.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -66.49 -28.97 45.33 Favored 'Trans proline' 0 C--N 1.351 0.675 0 CA-C-N 121.675 1.634 . . . . 0.0 112.028 176.378 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.2 t -68.27 -36.67 76.0 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 O-C-N 121.645 -0.659 . . . . 0.0 109.703 175.08 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 87.9 mt -66.39 -36.06 81.89 Favored 'General case' 0 C--N 1.341 0.212 0 CA-C-N 119.654 1.115 . . . . 0.0 111.144 171.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -62.45 -42.94 99.83 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 119.376 0.989 . . . . 0.0 110.799 171.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -63.92 -39.98 95.41 Favored 'General case' 0 CA--C 1.532 0.272 0 O-C-N 121.199 -0.938 . . . . 0.0 110.466 176.273 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 44.8 tp -62.05 -42.96 99.74 Favored 'General case' 0 CA--C 1.528 0.098 0 C-N-CA 123.867 0.867 . . . . 0.0 109.992 176.295 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -60.39 -42.45 95.9 Favored 'General case' 0 CA--C 1.52 -0.185 0 C-N-CA 123.275 0.63 . . . . 0.0 110.845 178.412 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -71.69 -10.8 60.31 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.319 0.648 . . . . 0.0 112.511 -179.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -105.52 -31.98 8.72 Favored 'General case' 0 C--O 1.232 0.15 0 C-N-CA 125.486 1.514 . . . . 0.0 111.458 -179.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 80.0 mmm -125.47 -3.32 7.34 Favored 'General case' 0 N--CA 1.46 0.06 0 CA-C-O 118.407 -0.806 . . . . 0.0 113.113 -167.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -57.85 -10.91 7.18 Favored Glycine 0 CA--C 1.534 1.226 0 C-N-CA 124.826 1.203 . . . . 0.0 115.919 -173.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -75.22 -24.57 57.75 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 118.502 1.151 . . . . 0.0 111.881 173.458 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 50.6 mtmt -128.26 -16.01 4.54 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 125.757 1.623 . . . . 0.0 111.887 -173.014 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 58.9 tp -123.0 144.23 49.4 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 124.816 1.246 . . . . 0.0 110.283 -172.227 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -116.25 145.39 43.18 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 105.256 -2.127 . . . . 0.0 105.256 167.305 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 82.6 mt -115.12 137.9 47.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 105.298 -2.112 . . . . 0.0 105.298 175.477 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 95.2 t -132.06 96.9 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 -171.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -74.96 137.03 41.34 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 176.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 13.3 tt -140.43 126.73 21.47 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 178.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -83.63 106.53 15.42 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 124.462 1.105 . . . . 0.0 109.098 -172.355 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 34.6 m -58.97 -27.7 36.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 118.643 -0.694 . . . . 0.0 111.99 -176.03 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -65.69 -17.23 64.46 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 119.347 0.976 . . . . 0.0 112.204 -176.593 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -121.96 4.16 9.92 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.927 1.291 . . . . 0.0 111.225 179.484 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 68.7 m-80 -141.28 40.47 1.76 Allowed 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.197 0.999 . . . . 0.0 109.785 -170.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 53.7 mm-40 -54.42 -30.84 53.69 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.097 0.959 . . . . 0.0 111.09 175.375 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -66.16 -50.18 64.83 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 123.99 0.916 . . . . 0.0 110.167 -179.273 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.77 -38.96 80.4 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 -178.428 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -58.62 -48.29 81.5 Favored 'General case' 0 CA--C 1.534 0.342 0 O-C-N 121.298 -0.876 . . . . 0.0 110.357 172.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -61.23 -28.76 69.71 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 123.905 0.764 . . . . 0.0 112.213 177.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 19.9 tptm -56.19 -29.3 60.69 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.697 1.199 . . . . 0.0 111.509 179.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -123.73 10.82 9.03 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.552 0.741 . . . . 0.0 111.627 -179.394 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 64.35 30.81 78.88 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 123.616 0.627 . . . . 0.0 112.582 -177.226 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 61.0 t -65.96 122.44 16.92 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 171.06 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 26.1 mmt -132.65 3.5 3.84 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.784 1.233 . . . . 0.0 111.381 -178.312 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 23.7 m -144.66 162.23 37.19 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 126.652 1.981 . . . . 0.0 107.621 179.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 17.7 pt -142.42 155.14 64.31 Favored Pre-proline 0 CA--C 1.544 0.731 0 C-N-CA 124.663 1.185 . . . . 0.0 108.689 175.195 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -67.99 138.32 43.39 Favored 'Cis proline' 0 C--N 1.35 0.63 0 CA-C-N 120.469 1.203 . . . . 0.0 110.399 -3.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 44.9 m -131.33 140.61 49.77 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 174.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 83.4 mt -122.32 127.73 50.18 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 -169.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -117.84 125.4 50.46 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 103.984 -2.599 . . . . 0.0 103.984 178.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 10.0 t -97.05 123.58 49.45 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 N-CA-C 104.145 -2.539 . . . . 0.0 104.145 172.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.9 mp -115.19 151.69 33.96 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 175.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 21.0 tptm -133.55 119.37 19.41 Favored 'General case' 0 CA--C 1.516 -0.363 0 N-CA-C 106.229 -1.767 . . . . 0.0 106.229 174.402 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.2 t70 50.83 37.59 17.52 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.626 1.17 . . . . 0.0 112.483 175.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 103.73 -2.35 45.42 Favored Glycine 0 CA--C 1.527 0.826 0 CA-C-O 118.087 -1.396 . . . . 0.0 115.582 168.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -128.41 145.25 51.14 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 120.033 1.917 . . . . 0.0 109.773 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 61.4 t -61.63 132.52 27.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 173.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.4 p -119.49 -21.85 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.77 0 C-N-CA 124.413 1.085 . . . . 0.0 110.372 174.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -157.62 165.56 35.17 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 120.552 1.524 . . . . 0.0 111.053 175.269 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 11.7 m -137.57 151.21 48.12 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.219 1.408 . . . . 0.0 109.004 179.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 58.4 m -148.47 157.23 43.34 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 126.022 1.729 . . . . 0.0 108.561 169.399 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 36.6 t -133.71 146.71 31.38 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 -179.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 79.41 -175.97 54.86 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 123.504 0.573 . . . . 0.0 112.19 177.135 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -63.17 146.55 53.1 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.579 0.752 . . . . 0.0 110.618 178.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 66.7 mttt -143.9 136.17 13.29 Favored Pre-proline 0 CA--C 1.532 0.284 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 168.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -70.42 160.42 49.59 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 122.408 2.072 . . . . 0.0 110.086 174.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 49.0 pttt -58.4 -28.59 65.34 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 113.569 0.952 . . . . 0.0 113.569 -177.369 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -65.25 -50.34 66.17 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 118.61 0.641 . . . . 0.0 109.741 174.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.81 -39.84 95.53 Favored 'General case' 0 C--N 1.34 0.165 0 C-N-CA 122.89 0.476 . . . . 0.0 110.627 178.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 92.3 mt -64.08 -42.54 96.92 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 122.74 0.416 . . . . 0.0 111.344 177.276 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -61.8 -40.07 93.94 Favored 'General case' 0 C--O 1.223 -0.29 0 CA-C-N 118.592 0.633 . . . . 0.0 110.197 176.469 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -65.5 -41.92 92.7 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 118.729 0.695 . . . . 0.0 110.302 178.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 58.3 tp -60.55 -38.29 84.03 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.744 1.618 . . . . 0.0 111.22 177.115 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 71.5 t -68.01 -49.92 63.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 C-N-CA 123.822 0.849 . . . . 0.0 109.545 171.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 -58.63 -40.68 84.02 Favored 'General case' 0 C--N 1.333 -0.122 0 C-N-CA 125.344 1.458 . . . . 0.0 111.821 -168.403 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.421 ' HG3' ' CD2' ' A' ' 103' ' ' HIS . 22.0 ptmt -65.75 -8.31 20.45 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 -177.542 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . 0.421 ' CD2' ' HG3' ' A' ' 102' ' ' LYS . 94.7 m-70 -124.14 1.9 8.56 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 124.413 1.085 . . . . 0.0 113.695 179.605 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 55.8 mt . . . . . 0 C--O 1.248 1.025 0 CA-C-N 119.386 0.994 . . . . 0.0 109.227 172.519 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.8 mt . . . . . 0 CA--C 1.536 0.428 0 N-CA-C 106.97 -1.493 . . . . 0.0 106.97 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 20.2 t -138.59 163.95 27.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 126.621 1.968 . . . . 0.0 106.856 -176.664 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.48 ' HE2' ' H ' ' A' ' 6' ' ' ALA . 0.0 OUTLIER -125.25 136.49 53.59 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 105.618 -1.993 . . . . 0.0 105.618 177.011 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.48 ' H ' ' HE2' ' A' ' 5' ' ' LYS . . . -141.3 176.2 9.04 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 123.631 0.772 . . . . 0.0 112.473 -169.542 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.4 p -130.08 173.12 11.04 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 127.646 2.378 . . . . 0.0 107.924 175.094 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -45.95 -39.9 9.52 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 124.643 1.177 . . . . 0.0 113.521 177.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 80.8 mm-40 -90.43 -38.02 13.56 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 122.921 0.489 . . . . 0.0 111.727 -174.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 11.4 m -67.83 -33.63 75.15 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 118.143 0.429 . . . . 0.0 110.927 177.34 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 33.4 t80 -50.77 -45.96 59.24 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 126.143 1.777 . . . . 0.0 111.217 -176.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 9.7 m -64.86 -37.8 88.85 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 118.601 0.637 . . . . 0.0 111.876 -175.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -68.53 -45.68 71.56 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 175.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -64.21 -36.75 85.09 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 122.486 0.314 . . . . 0.0 111.252 -176.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.409 ' HA ' HG21 ' A' ' 20' ' ' VAL . 36.8 p -81.17 -4.1 54.3 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 124.071 0.948 . . . . 0.0 113.031 -176.688 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 70.0 m -94.66 28.64 2.57 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.937 0.895 . . . . 0.0 111.754 -177.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -134.01 66.84 1.53 Allowed 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.541 1.137 . . . . 0.0 110.229 -177.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 88.13 -156.56 27.37 Favored Glycine 0 C--N 1.337 0.59 0 N-CA-C 110.373 -1.091 . . . . 0.0 110.373 174.205 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 97.9 t -71.41 132.85 32.82 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 N-CA-C 106.889 -1.522 . . . . 0.0 106.889 168.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.409 HG21 ' HA ' ' A' ' 15' ' ' THR . 47.2 t -136.46 146.34 29.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 179.74 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 5.0 tt -128.06 100.56 5.93 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 -176.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -81.97 146.27 29.83 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.256 -179.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -124.56 94.42 4.19 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 126.113 1.765 . . . . 0.0 107.458 -176.394 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -74.44 112.42 10.6 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 106.05 -1.833 . . . . 0.0 106.05 175.505 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -149.24 -177.22 5.71 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.668 1.187 . . . . 0.0 108.575 -174.087 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -155.65 146.96 16.71 Favored Pre-proline 0 CA--C 1.532 0.277 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 167.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_exo -60.29 -18.21 51.2 Favored 'Trans proline' 0 N--CA 1.461 -0.439 0 C-N-CA 121.821 1.68 . . . . 0.0 115.86 -178.359 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 51.3 p-90 -69.35 -20.43 63.85 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 119.949 1.25 . . . . 0.0 111.937 173.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 34.2 t -59.31 148.21 33.05 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 125.065 1.346 . . . . 0.0 111.199 -172.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -97.61 -63.28 0.89 Allowed Glycine 0 CA--C 1.53 0.971 0 CA-C-O 118.403 -1.22 . . . . 0.0 110.974 171.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -62.24 -26.52 77.53 Favored 'Trans proline' 0 C--N 1.35 0.613 0 CA-C-N 120.424 2.112 . . . . 0.0 113.679 -174.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 33.8 m -57.39 -34.98 69.43 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 121.582 -0.698 . . . . 0.0 111.515 174.464 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.8 mmtp -67.53 -24.94 65.6 Favored 'General case' 0 CA--C 1.53 0.182 0 O-C-N 121.602 -0.686 . . . . 0.0 111.021 -179.613 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 31.3 mtm -71.22 -43.41 67.4 Favored 'General case' 0 C--N 1.34 0.182 0 CA-C-N 118.68 0.673 . . . . 0.0 110.421 176.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 14.1 tt -84.18 -23.48 7.76 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-O 118.705 -0.664 . . . . 0.0 111.727 -174.646 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -48.88 -51.47 54.44 Favored Pre-proline 0 CA--C 1.548 0.877 0 CA-C-N 119.911 1.232 . . . . 0.0 114.076 178.486 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -66.57 -29.67 43.8 Favored 'Trans proline' 0 C--N 1.35 0.65 0 CA-C-N 121.611 1.611 . . . . 0.0 112.194 176.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 5.4 t -66.46 -39.92 85.24 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 175.218 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 67.9 mt -64.99 -38.23 90.26 Favored 'General case' 0 C--N 1.34 0.169 0 CA-C-N 119.317 0.962 . . . . 0.0 110.858 174.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -61.6 -43.9 97.99 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 119.011 0.823 . . . . 0.0 111.122 172.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -62.34 -38.5 89.75 Favored 'General case' 0 CA--C 1.533 0.327 0 O-C-N 121.393 -0.817 . . . . 0.0 110.223 175.609 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.77 -44.48 96.08 Favored 'General case' 0 C--N 1.333 -0.114 0 C-N-CA 124.074 0.95 . . . . 0.0 110.391 177.097 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -60.24 -41.89 94.1 Favored 'General case' 0 CA--C 1.521 -0.165 0 C-N-CA 123.24 0.616 . . . . 0.0 110.92 177.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 -72.01 -11.03 60.58 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 -179.075 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -106.45 -32.69 7.99 Favored 'General case' 0 C--O 1.232 0.133 0 C-N-CA 125.226 1.411 . . . . 0.0 111.639 -179.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 87.4 mmm -125.75 -4.18 7.08 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-O 118.357 -0.83 . . . . 0.0 113.022 -168.284 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -58.39 -11.77 10.8 Favored Glycine 0 CA--C 1.533 1.188 0 CA-C-N 119.835 1.198 . . . . 0.0 114.811 -175.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -65.98 -27.95 68.53 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 118.418 1.109 . . . . 0.0 111.83 171.378 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.464 ' HA ' ' HE3' ' A' ' 49' ' ' LYS . 0.0 OUTLIER -121.28 -24.87 5.36 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 125.954 1.701 . . . . 0.0 111.81 179.333 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 45.9 tp -103.0 157.76 16.76 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 124.144 0.977 . . . . 0.0 111.036 -169.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -133.88 144.41 48.88 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 103.957 -2.608 . . . . 0.0 103.957 166.65 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 66.2 mt -118.56 140.54 41.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 105.61 -1.996 . . . . 0.0 105.61 178.305 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 74.0 t -133.0 97.21 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 -170.205 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 51.3 mtmt -74.35 134.46 42.5 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 177.294 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 20.2 tt -137.92 126.8 33.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 178.167 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 62.9 t0 -87.84 103.97 16.15 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 114.727 -1.124 . . . . 0.0 108.419 -171.599 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 23.0 m -61.7 -23.2 30.29 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 CA-C-O 118.766 -0.635 . . . . 0.0 112.208 -174.339 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -65.34 -22.67 66.84 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 119.25 0.932 . . . . 0.0 111.562 -179.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -117.28 1.71 12.47 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.926 1.29 . . . . 0.0 111.323 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 66.6 m-80 -139.36 43.34 2.02 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 125.167 1.387 . . . . 0.0 108.798 -171.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.411 ' CD ' ' H ' ' A' ' 61' ' ' GLN . 3.4 mp0 -60.64 -35.44 76.21 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.034 0.934 . . . . 0.0 109.825 -175.451 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 -62.64 -44.49 96.15 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 123.674 0.79 . . . . 0.0 110.218 179.174 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -66.7 -40.86 88.65 Favored 'General case' 0 C--O 1.225 -0.188 0 C-N-CA 123.467 0.707 . . . . 0.0 110.082 -178.061 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.38 -50.06 75.41 Favored 'General case' 0 CA--C 1.532 0.283 0 O-C-N 121.742 -0.598 . . . . 0.0 110.058 173.185 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -58.43 -29.77 63.96 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 123.558 0.599 . . . . 0.0 112.55 176.347 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 9.8 ttpt -58.05 -26.61 62.7 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 125.758 1.623 . . . . 0.0 111.994 -178.35 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -123.61 11.04 9.13 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.886 0.874 . . . . 0.0 111.944 176.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 65.89 29.05 74.24 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 123.567 0.603 . . . . 0.0 112.765 -177.173 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 61.8 t -65.65 125.26 22.37 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 170.14 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 98.7 mtp -135.25 3.41 3.11 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.747 1.219 . . . . 0.0 111.515 -179.131 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 24.0 m -144.1 162.05 37.26 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 126.588 1.955 . . . . 0.0 107.743 179.228 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 38.6 pt -142.11 154.39 64.64 Favored Pre-proline 0 CA--C 1.545 0.767 0 C-N-CA 124.534 1.134 . . . . 0.0 108.685 176.332 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -67.71 140.07 51.63 Favored 'Cis proline' 0 C--N 1.351 0.692 0 CA-C-N 120.437 1.192 . . . . 0.0 110.429 -3.149 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 35.8 m -131.74 143.52 50.3 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 173.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 88.3 mt -123.9 126.84 47.08 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 -169.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -115.87 121.71 43.18 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 103.17 -2.9 . . . . 0.0 103.17 177.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 4.6 t -94.21 129.14 44.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 103.641 -2.726 . . . . 0.0 103.641 174.43 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.7 mp -122.89 154.81 37.83 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 178.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -138.33 123.32 19.0 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 174.12 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.0 t70 49.86 37.41 13.45 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.07 1.348 . . . . 0.0 112.647 176.299 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 105.1 -4.23 41.29 Favored Glycine 0 CA--C 1.529 0.916 0 CA-C-O 118.184 -1.342 . . . . 0.0 115.271 168.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -131.92 150.68 52.08 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 120.056 1.928 . . . . 0.0 110.374 -177.221 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 44.6 t -62.2 132.14 27.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 178.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.8 p -120.44 -21.75 3.94 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 C-N-CA 125.436 1.494 . . . . 0.0 109.926 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -159.84 172.21 18.05 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 120.121 1.328 . . . . 0.0 109.873 174.034 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 25.9 m -146.53 151.41 37.29 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.708 1.203 . . . . 0.0 109.246 177.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 4.2 m -147.13 156.87 43.35 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 125.507 1.523 . . . . 0.0 109.14 170.174 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 35.5 t -134.85 143.32 37.82 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 -177.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 76.17 -173.89 53.65 Favored Glycine 0 CA--C 1.531 1.052 0 CA-C-O 121.509 0.505 . . . . 0.0 111.862 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 65.4 t80 -63.56 149.2 46.86 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.483 0.713 . . . . 0.0 110.871 179.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 27.4 mttp -144.71 136.92 13.2 Favored Pre-proline 0 CA--C 1.534 0.342 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 168.247 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -70.44 161.3 46.52 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 122.32 2.013 . . . . 0.0 110.228 174.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 46.5 pttt -59.15 -29.53 67.49 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 -177.429 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -64.86 -50.13 67.81 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 118.951 0.796 . . . . 0.0 109.737 175.096 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.62 -39.47 94.44 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 122.73 0.412 . . . . 0.0 110.821 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 77.1 mt -63.68 -44.46 93.66 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 122.949 0.5 . . . . 0.0 111.249 176.385 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 12.4 mt-30 -61.4 -39.44 90.73 Favored 'General case' 0 C--O 1.224 -0.243 0 CA-C-O 118.704 -0.665 . . . . 0.0 110.371 176.358 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -65.6 -40.46 92.69 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 118.915 0.78 . . . . 0.0 110.439 178.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 68.9 tp -62.93 -35.73 81.07 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.634 1.574 . . . . 0.0 111.451 177.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 76.9 t -69.04 -50.96 48.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 C-N-CA 123.638 0.775 . . . . 0.0 109.584 169.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -58.27 -38.5 77.08 Favored 'General case' 0 CA--C 1.522 -0.117 0 C-N-CA 126.013 1.725 . . . . 0.0 112.196 -168.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -64.68 -6.96 8.92 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 -179.096 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -123.25 -5.9 8.31 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 124.395 1.078 . . . . 0.0 113.276 176.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 57.6 mt . . . . . 0 C--O 1.246 0.911 0 CA-C-N 119.319 0.963 . . . . 0.0 109.223 172.678 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.1 mp . . . . . 0 N--CA 1.448 -0.557 0 N-CA-C 105.134 -2.172 . . . . 0.0 105.134 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 46.8 t -132.91 164.4 35.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 C-N-CA 127.165 2.186 . . . . 0.0 105.904 -175.251 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 6.3 ttmt -121.67 147.2 46.19 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 177.007 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -147.35 168.32 22.11 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 123.279 0.632 . . . . 0.0 110.449 179.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.407 HG22 HD21 ' A' ' 60' ' ' ASN . 33.8 p -134.68 179.78 6.08 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 125.595 1.558 . . . . 0.0 107.371 169.314 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -49.17 -29.74 5.9 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.842 0.857 . . . . 0.0 112.685 170.167 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -65.18 -27.15 68.5 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.265 1.426 . . . . 0.0 113.138 179.27 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.9 p -134.43 -16.9 2.06 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 114.66 1.356 . . . . 0.0 114.66 -167.097 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -55.11 -45.13 75.48 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 124.442 1.097 . . . . 0.0 111.85 -170.091 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.7 m -63.26 -39.0 93.35 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 122.747 0.419 . . . . 0.0 111.613 -178.014 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -68.43 -44.49 74.87 Favored 'General case' 0 N--CA 1.452 -0.361 0 O-C-N 122.119 -0.363 . . . . 0.0 110.076 177.398 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -63.34 -34.6 78.06 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-O 119.33 -0.367 . . . . 0.0 111.108 -178.442 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 35.0 p -86.83 3.48 45.12 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.192 0.997 . . . . 0.0 113.268 -176.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 69.5 m -105.36 32.29 4.36 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.252 1.021 . . . . 0.0 111.562 -177.035 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -132.3 53.74 1.98 Allowed 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.197 0.999 . . . . 0.0 110.798 -176.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 97.55 -157.17 20.79 Favored Glycine 0 C--N 1.339 0.703 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 177.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 91.1 t -70.17 137.11 24.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 167.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 61.9 t -138.16 144.94 29.42 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 N-CA-C 105.479 -2.045 . . . . 0.0 105.479 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 41.8 tp -122.97 99.42 6.37 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 106.611 -1.625 . . . . 0.0 106.611 -177.321 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -78.52 149.95 33.0 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 109.319 -0.622 . . . . 0.0 109.319 177.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -129.15 94.38 3.8 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 126.761 2.024 . . . . 0.0 106.821 -179.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -73.25 114.51 11.52 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 105.882 -1.896 . . . . 0.0 105.882 174.253 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -147.38 -177.85 5.92 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 125.507 1.523 . . . . 0.0 108.301 -171.154 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -155.72 148.69 18.19 Favored Pre-proline 0 C--O 1.235 0.303 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 168.058 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -67.56 -13.25 38.4 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 121.656 1.571 . . . . 0.0 114.469 -175.206 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 53.4 p-90 -71.1 -20.26 62.36 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 120.194 1.361 . . . . 0.0 112.283 170.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 34.7 t -61.0 153.66 24.63 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.078 1.351 . . . . 0.0 111.523 -172.117 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -103.26 -65.53 0.72 Allowed Glycine 0 CA--C 1.53 0.983 0 CA-C-O 118.385 -1.23 . . . . 0.0 110.91 174.479 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_exo -55.77 -30.03 74.38 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.965 2.444 . . . . 0.0 114.118 179.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 33.2 m -58.18 -30.34 66.33 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 121.321 -0.862 . . . . 0.0 111.977 175.222 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.5 mmtp -72.68 -38.26 67.64 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 123.314 0.646 . . . . 0.0 110.014 178.046 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 5.8 ptt? -72.76 -31.52 64.97 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 118.817 0.735 . . . . 0.0 111.639 -176.327 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 15.9 tt -78.26 -19.1 13.53 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-O 118.925 -0.56 . . . . 0.0 111.969 174.608 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -54.94 -49.33 92.59 Favored Pre-proline 0 CA--C 1.545 0.77 0 CA-C-N 120.272 1.397 . . . . 0.0 113.655 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -66.53 -26.58 46.94 Favored 'Trans proline' 0 C--N 1.351 0.696 0 CA-C-N 121.95 1.732 . . . . 0.0 112.344 175.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 11.7 t -67.19 -39.7 83.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 174.11 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 96.3 mt -67.02 -34.34 77.51 Favored 'General case' 0 C--N 1.339 0.122 0 CA-C-N 119.013 0.824 . . . . 0.0 111.579 173.431 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -64.68 -42.26 95.47 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 119.338 0.972 . . . . 0.0 110.859 172.318 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -62.64 -37.77 87.66 Favored 'General case' 0 CA--C 1.531 0.235 0 O-C-N 120.884 -1.135 . . . . 0.0 110.457 173.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 42.9 tp -63.99 -42.42 97.19 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 123.114 0.566 . . . . 0.0 110.314 177.361 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -57.8 -44.47 86.34 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 118.983 0.81 . . . . 0.0 110.881 173.418 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -68.99 -8.87 48.91 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -177.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -112.2 -30.05 7.35 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 125.787 1.635 . . . . 0.0 111.973 -179.096 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 87.1 mmm -129.1 -7.66 4.86 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -169.539 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -58.48 -15.93 26.74 Favored Glycine 0 CA--C 1.529 0.949 0 CA-C-N 119.906 1.23 . . . . 0.0 114.674 -171.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -65.75 -26.2 67.62 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.297 1.039 . . . . 0.0 111.653 174.221 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.458 ' HA ' ' HE3' ' A' ' 49' ' ' LYS . 0.0 OUTLIER -122.91 -19.91 5.99 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.932 1.693 . . . . 0.0 111.884 179.761 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 36.0 tp -110.37 154.5 23.46 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 124.113 0.965 . . . . 0.0 111.144 -169.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 36.1 ttmt -130.96 144.28 51.36 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 104.6 -2.37 . . . . 0.0 104.6 167.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 94.1 mt -115.75 136.54 52.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 105.305 -2.109 . . . . 0.0 105.305 179.393 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 95.8 t -132.35 98.77 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-N 119.11 0.868 . . . . 0.0 109.23 -169.252 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 29.6 mtpp -74.57 139.99 44.1 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 175.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 13.0 tt -141.61 128.08 19.76 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 176.632 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 60.4 t0 -85.21 104.6 15.23 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 124.554 1.142 . . . . 0.0 109.196 -171.232 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 31.1 m -58.91 -26.46 32.55 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-O 118.593 -0.718 . . . . 0.0 112.017 -175.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -65.29 -18.57 65.42 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 119.454 1.024 . . . . 0.0 112.18 -177.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -119.8 4.39 11.02 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.921 1.289 . . . . 0.0 111.071 177.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.407 HD21 HG22 ' A' ' 7' ' ' THR . 68.0 m-80 -139.24 39.92 2.09 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 124.456 1.102 . . . . 0.0 109.642 -170.533 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 49.9 mm-40 -55.67 -33.32 64.01 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.929 0.892 . . . . 0.0 111.112 177.523 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 -66.29 -49.04 68.43 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 118.353 0.524 . . . . 0.0 110.189 179.093 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.52 -39.66 88.75 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.351 0.661 . . . . 0.0 109.846 -179.006 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.64 -49.05 79.28 Favored 'General case' 0 CA--C 1.533 0.292 0 O-C-N 121.149 -0.97 . . . . 0.0 110.322 173.344 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -60.46 -28.49 67.5 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 123.916 0.77 . . . . 0.0 112.262 177.257 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 72.2 tttt -56.13 -29.03 60.14 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 125.068 1.347 . . . . 0.0 111.698 179.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -123.47 10.64 9.18 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.63 0.772 . . . . 0.0 111.703 179.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 64.1 31.15 79.87 Favored Glycine 0 CA--C 1.532 1.14 0 C-N-CA 123.708 0.67 . . . . 0.0 112.617 -176.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 61.8 t -65.94 121.6 15.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 171.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 26.1 mmt -132.47 2.17 3.8 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.797 1.239 . . . . 0.0 111.514 -178.583 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 31.5 m -145.65 161.74 39.16 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 126.789 2.036 . . . . 0.0 107.401 179.372 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 41.6 pt -142.62 156.79 63.03 Favored Pre-proline 0 CA--C 1.545 0.773 0 C-N-CA 124.734 1.214 . . . . 0.0 108.739 177.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -65.48 142.69 55.56 Favored 'Cis proline' 0 C--N 1.35 0.627 0 CA-C-N 120.413 1.183 . . . . 0.0 110.231 -5.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 18.6 m -135.62 132.86 37.61 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 175.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -110.02 134.59 51.97 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 -174.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -121.98 125.75 47.02 Favored 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 102.593 -3.114 . . . . 0.0 102.593 177.022 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 1.9 t -103.67 122.3 56.17 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 N-CA-C 103.605 -2.739 . . . . 0.0 103.605 -179.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.7 mp -119.45 155.8 31.37 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 -175.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -136.81 126.2 24.99 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 170.214 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.2 t70 48.36 36.02 6.5 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.93 1.292 . . . . 0.0 112.294 172.366 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 98.31 2.53 57.84 Favored Glycine 0 CA--C 1.533 1.189 0 CA-C-O 117.925 -1.486 . . . . 0.0 115.108 171.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -121.42 145.88 47.47 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 120.364 2.082 . . . . 0.0 109.569 175.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 67.6 t -66.32 130.03 31.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 169.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 35.5 m -114.42 -21.92 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 CA-C-O 117.666 -1.159 . . . . 0.0 110.985 174.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -156.36 168.23 27.98 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 120.605 1.548 . . . . 0.0 111.023 173.609 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 14.1 m -143.72 151.0 39.49 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.597 1.559 . . . . 0.0 109.186 -177.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 13.0 m -152.61 153.95 34.39 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.375 1.47 . . . . 0.0 109.221 168.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 61.0 t -132.69 142.33 42.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 -172.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 75.84 -172.32 54.12 Favored Glycine 0 CA--C 1.529 0.913 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 -173.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -60.08 148.86 34.3 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.566 0.698 . . . . 0.0 110.303 174.615 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 39.5 tptt -149.14 122.44 4.53 Favored Pre-proline 0 N--CA 1.45 -0.431 0 N-CA-C 105.717 -1.956 . . . . 0.0 105.717 -173.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -68.5 155.67 68.23 Favored 'Trans proline' 0 N--CA 1.454 -0.807 0 C-N-CA 121.369 1.379 . . . . 0.0 111.101 -174.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.434 ' HG2' HE21 ' A' ' 97' ' ' GLN . 38.9 ttpt -52.26 -46.88 65.97 Favored 'General case' 0 N--CA 1.461 0.121 0 C-N-CA 125.205 1.402 . . . . 0.0 112.021 -179.357 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -62.26 -40.39 96.04 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 122.95 0.5 . . . . 0.0 110.672 -179.104 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -69.45 -37.51 77.38 Favored 'General case' 0 N--CA 1.456 -0.162 0 O-C-N 121.796 -0.565 . . . . 0.0 110.798 179.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 98.5 mt -60.43 -43.4 96.82 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-O 119.285 -0.388 . . . . 0.0 110.18 173.389 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.434 HE21 ' HG2' ' A' ' 93' ' ' LYS . 65.4 mt-30 -62.11 -37.05 83.64 Favored 'General case' 0 N--CA 1.461 0.103 0 CA-C-N 118.431 0.56 . . . . 0.0 111.732 176.017 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -61.79 -48.74 79.26 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 118.429 0.559 . . . . 0.0 109.781 175.219 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 34.9 mt -62.47 -36.69 83.27 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 118.381 0.537 . . . . 0.0 111.431 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 56.1 t -61.48 -51.81 68.46 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 172.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -69.2 -22.04 63.92 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 -172.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 65.2 mttm -57.65 -26.36 61.51 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 118.213 -0.899 . . . . 0.0 111.548 170.115 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -126.13 -18.05 5.1 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 113.645 0.98 . . . . 0.0 113.645 -169.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 33.4 mt . . . . . 0 C--O 1.247 0.926 0 CA-C-N 119.935 1.243 . . . . 0.0 109.156 169.097 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.3 mt . . . . . 0 CA--C 1.537 0.48 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 23.4 t -136.55 162.99 34.41 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 C-N-CA 126.271 1.829 . . . . 0.0 106.94 -174.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.21 132.77 55.49 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 105.128 -2.175 . . . . 0.0 105.128 173.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -136.25 169.7 17.22 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 123.309 0.644 . . . . 0.0 110.976 -177.218 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.9 p -135.91 171.98 13.68 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 125.597 1.559 . . . . 0.0 107.505 169.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -51.79 -27.8 13.47 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.502 1.121 . . . . 0.0 112.946 178.061 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -57.97 -32.37 67.78 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 126.256 1.823 . . . . 0.0 112.809 178.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.0 m -141.22 -3.73 1.19 Allowed 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 113.383 0.883 . . . . 0.0 113.383 -169.166 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 78.3 t80 -53.51 -41.6 66.48 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.172 0.989 . . . . 0.0 111.633 -178.069 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.1 p -60.67 -45.5 93.89 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 124.045 0.938 . . . . 0.0 111.774 177.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.03 -43.62 95.02 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 122.737 0.415 . . . . 0.0 110.284 178.175 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 65.4 mm-40 -63.4 -37.24 86.53 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-O 119.414 -0.326 . . . . 0.0 110.962 -179.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.4 ' HA ' HG21 ' A' ' 20' ' ' VAL . 31.6 p -83.98 3.26 35.04 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.221 1.008 . . . . 0.0 113.277 -177.26 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 63.4 m -104.13 31.47 4.55 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.296 1.038 . . . . 0.0 111.459 -177.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -134.51 64.02 1.61 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.297 1.039 . . . . 0.0 110.229 -177.486 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 88.89 -158.33 28.13 Favored Glycine 0 C--N 1.337 0.603 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 177.483 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 59.1 t -69.94 135.5 28.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 168.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.4 HG21 ' HA ' ' A' ' 15' ' ' THR . 46.8 t -137.35 140.17 42.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 N-CA-C 105.763 -1.94 . . . . 0.0 105.763 179.26 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 52.3 tp -118.98 99.58 6.82 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 106.622 -1.622 . . . . 0.0 106.622 -178.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -79.67 149.35 31.27 Favored 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 178.025 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -130.43 93.99 3.57 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 126.532 1.933 . . . . 0.0 107.596 -177.02 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -74.44 113.82 12.11 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 105.821 -1.918 . . . . 0.0 105.821 175.275 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -149.9 -175.82 5.19 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 124.667 1.187 . . . . 0.0 108.455 -172.28 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -151.82 147.74 20.53 Favored Pre-proline 0 C--O 1.233 0.199 0 N-CA-C 105.64 -1.985 . . . . 0.0 105.64 167.19 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -67.1 -13.05 38.39 Favored 'Trans proline' 0 CA--C 1.535 0.533 0 CA-C-N 121.093 1.426 . . . . 0.0 113.104 -179.073 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 1.3 m95 -76.4 -13.51 60.12 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.841 0.856 . . . . 0.0 111.907 173.074 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 31.4 t -63.87 154.37 33.9 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 125.387 1.475 . . . . 0.0 111.076 -176.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -104.74 -65.4 0.68 Allowed Glycine 0 CA--C 1.53 0.997 0 CA-C-O 118.324 -1.265 . . . . 0.0 110.589 172.213 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -53.26 -32.02 58.78 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 123.4 2.733 . . . . 0.0 114.633 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 33.2 m -57.91 -34.37 69.77 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 121.574 -0.704 . . . . 0.0 111.721 176.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.0 mmtp -67.76 -23.17 65.2 Favored 'General case' 0 CA--C 1.53 0.188 0 O-C-N 121.492 -0.755 . . . . 0.0 111.074 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 32.2 mtm -70.83 -43.52 68.39 Favored 'General case' 0 C--N 1.339 0.143 0 CA-C-N 118.784 0.72 . . . . 0.0 110.357 176.018 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 17.3 tt -83.61 -22.61 8.33 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-O 118.75 -0.643 . . . . 0.0 111.698 -176.387 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -48.94 -51.43 55.29 Favored Pre-proline 0 CA--C 1.547 0.861 0 CA-C-N 120.032 1.287 . . . . 0.0 114.035 178.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -67.56 -25.16 41.16 Favored 'Trans proline' 0 C--N 1.351 0.688 0 CA-C-N 121.78 1.672 . . . . 0.0 112.367 176.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.4 t -72.07 -35.1 52.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 O-C-N 121.506 -0.746 . . . . 0.0 109.613 175.249 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 69.6 mt -67.97 -35.98 79.28 Favored 'General case' 0 C--N 1.338 0.095 0 CA-C-N 119.329 0.968 . . . . 0.0 111.036 170.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -62.4 -41.61 98.8 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 119.058 0.845 . . . . 0.0 110.818 170.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -61.99 -42.38 99.08 Favored 'General case' 0 C--N 1.331 -0.23 0 O-C-N 121.182 -0.948 . . . . 0.0 110.27 174.185 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 46.3 tp -61.62 -40.65 95.61 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.993 0.917 . . . . 0.0 110.642 178.586 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -60.98 -41.47 96.47 Favored 'General case' 0 C--N 1.334 -0.099 0 C-N-CA 123.108 0.563 . . . . 0.0 110.821 174.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -75.55 -11.08 59.95 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.023 0.529 . . . . 0.0 112.362 178.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -91.44 -50.45 5.79 Favored 'General case' 0 C--O 1.232 0.15 0 C-N-CA 124.928 1.291 . . . . 0.0 109.636 178.117 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 24.9 mtm -140.49 21.3 2.37 Favored 'General case' 0 N--CA 1.465 0.275 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -170.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -56.34 -11.7 5.28 Favored Glycine 0 CA--C 1.538 1.473 0 CA-C-N 120.197 1.362 . . . . 0.0 114.591 174.16 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -72.77 -28.7 62.76 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 118.694 1.247 . . . . 0.0 111.723 171.454 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -107.9 -24.92 11.45 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 125.922 1.689 . . . . 0.0 111.302 -179.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 48.8 tp -114.42 157.54 22.75 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 124.498 1.119 . . . . 0.0 111.307 -168.664 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -128.7 143.42 50.93 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 104.214 -2.513 . . . . 0.0 104.214 166.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 82.3 mt -117.44 138.5 47.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 105.367 -2.086 . . . . 0.0 105.367 178.199 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 98.8 t -132.59 98.74 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 -170.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 52.6 mtmt -70.93 141.6 51.11 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 107.848 -1.168 . . . . 0.0 107.848 173.323 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 16.5 tt -144.05 125.2 9.73 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 174.221 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 54.1 t0 -83.82 105.65 14.89 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.362 1.065 . . . . 0.0 108.629 -173.489 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 30.9 m -59.31 -26.25 33.25 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-O 118.538 -0.744 . . . . 0.0 111.939 -174.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -65.11 -18.27 65.16 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 119.453 1.024 . . . . 0.0 112.179 -177.401 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -119.69 3.82 11.11 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.915 1.286 . . . . 0.0 111.134 178.046 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 68.2 m-80 -139.5 39.82 2.05 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.438 1.095 . . . . 0.0 109.761 -170.453 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 52.1 mm-40 -55.41 -32.61 62.82 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.75 0.82 . . . . 0.0 111.092 176.37 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 33.4 mm-40 -65.99 -47.67 73.78 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 118.373 0.533 . . . . 0.0 110.324 178.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.49 -39.83 85.2 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 118.581 0.628 . . . . 0.0 109.993 -178.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.49 -49.39 77.96 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 121.621 -0.674 . . . . 0.0 110.453 173.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -61.75 -28.67 70.4 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 123.764 0.697 . . . . 0.0 112.131 178.367 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 17.2 ttmt -54.97 -29.47 56.9 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 125.772 1.629 . . . . 0.0 112.009 178.346 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -123.65 10.5 9.05 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.794 0.837 . . . . 0.0 111.831 178.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 65.25 28.27 73.37 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 123.825 0.726 . . . . 0.0 112.94 -177.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 56.7 t -62.35 127.49 22.45 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 172.084 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 42.3 ttp -137.29 0.79 2.36 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.532 1.133 . . . . 0.0 110.966 -176.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 24.4 m -144.95 162.74 36.15 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 126.535 1.934 . . . . 0.0 107.634 179.557 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 41.0 pt -143.29 156.55 60.92 Favored Pre-proline 0 CA--C 1.545 0.754 0 C-N-CA 124.897 1.279 . . . . 0.0 108.583 176.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -66.89 139.6 46.36 Favored 'Cis proline' 0 C--N 1.349 0.575 0 CA-C-N 120.522 1.222 . . . . 0.0 110.207 -5.097 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 31.9 m -132.11 138.59 48.16 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 176.198 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 88.5 mt -116.09 128.5 55.73 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 -171.367 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -119.23 125.54 49.41 Favored 'General case' 0 CA--C 1.509 -0.626 0 N-CA-C 102.551 -3.129 . . . . 0.0 102.551 177.459 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 1.7 t -105.64 122.6 59.31 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 N-CA-C 103.609 -2.737 . . . . 0.0 103.609 -179.387 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.8 mp -120.23 153.52 36.2 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 -176.57 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -136.63 124.97 23.28 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 171.501 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.5 t70 48.62 36.04 7.04 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.016 1.327 . . . . 0.0 112.284 174.026 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 99.8 2.34 56.23 Favored Glycine 0 CA--C 1.532 1.113 0 CA-C-O 117.92 -1.489 . . . . 0.0 114.98 170.055 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -122.36 146.75 47.04 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 120.273 2.037 . . . . 0.0 109.571 176.122 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 62.0 t -66.82 130.01 31.83 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 N-CA-C 107.405 -1.332 . . . . 0.0 107.405 170.216 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 30.7 m -118.29 -17.19 7.36 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 C-N-CA 124.641 1.177 . . . . 0.0 111.338 176.21 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -156.4 167.55 30.09 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 120.547 1.521 . . . . 0.0 110.61 172.477 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 19.1 m -146.42 142.62 28.35 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.589 1.156 . . . . 0.0 108.706 174.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 49.5 m -144.58 156.71 44.27 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.025 1.33 . . . . 0.0 108.734 176.672 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 39.8 t -134.23 146.38 31.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 -174.657 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 76.32 -175.95 52.36 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 123.532 0.587 . . . . 0.0 112.436 177.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -63.29 148.78 47.31 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.989 0.915 . . . . 0.0 111.286 -179.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -148.84 142.13 15.85 Favored Pre-proline 0 CA--C 1.534 0.335 0 C-N-CA 125.626 1.57 . . . . 0.0 107.24 167.816 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -72.26 160.8 46.23 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 122.871 2.381 . . . . 0.0 110.787 175.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 40.5 pttt -59.31 -30.12 68.12 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 -176.275 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -65.22 -49.72 68.62 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 118.355 0.525 . . . . 0.0 109.639 174.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.74 -37.86 88.93 Favored 'General case' 0 CA--C 1.528 0.118 0 O-C-N 122.063 -0.398 . . . . 0.0 110.853 179.22 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 84.5 mt -63.77 -44.62 92.88 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 122.722 0.409 . . . . 0.0 111.289 175.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -60.7 -41.95 96.23 Favored 'General case' 0 C--O 1.223 -0.291 0 CA-C-O 118.903 -0.57 . . . . 0.0 109.838 176.07 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -64.24 -40.93 97.05 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 118.383 0.538 . . . . 0.0 110.777 -179.535 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 56.3 tp -61.0 -44.89 96.75 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 124.965 1.306 . . . . 0.0 110.715 176.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 75.4 t -62.15 -43.83 98.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 123.602 0.761 . . . . 0.0 109.621 173.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -62.6 -24.05 67.37 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 125.186 1.395 . . . . 0.0 112.203 -173.296 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -54.85 -26.1 33.08 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 118.611 -0.709 . . . . 0.0 112.222 171.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 86.1 m-70 -123.8 -11.62 7.67 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 113.423 0.897 . . . . 0.0 113.423 -168.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 70.4 mt . . . . . 0 C--O 1.249 1.045 0 CA-C-N 119.16 0.891 . . . . 0.0 109.292 171.678 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.1 ttm . . . . . 0 N--CA 1.484 1.247 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -68.64 -20.89 64.49 Favored 'General case' 0 CA--C 1.509 -0.611 0 N-CA-C 115.699 1.74 . . . . 0.0 115.699 -175.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 7.6 mt -87.55 133.63 29.83 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 -172.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 10.4 t -135.71 158.8 39.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 106.441 -1.688 . . . . 0.0 106.441 -172.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 14.1 mtpt -119.99 125.14 47.66 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 105.793 -1.928 . . . . 0.0 105.793 -177.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -136.65 166.46 23.49 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.485 0.66 . . . . 0.0 111.422 -173.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 22.9 p -132.38 176.23 8.6 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 126.013 1.725 . . . . 0.0 107.819 172.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -53.58 -29.49 37.67 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.859 0.863 . . . . 0.0 112.465 177.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 54.2 mt-30 -66.53 -29.35 69.41 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.048 1.339 . . . . 0.0 112.915 179.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 23.5 p -123.3 -15.65 7.13 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.565 1.146 . . . . 0.0 113.416 -169.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -52.88 -48.15 67.34 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 124.53 1.132 . . . . 0.0 112.048 -172.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.9 m -63.92 -39.38 94.03 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.013 0.525 . . . . 0.0 111.779 -177.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.84 -43.78 87.48 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 178.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -66.08 -43.3 87.76 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 122.425 0.29 . . . . 0.0 110.747 -179.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 37.6 p -77.51 -5.32 49.61 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 -175.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 73.1 m -73.27 -21.88 60.5 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 177.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -87.98 72.18 9.29 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 118.75 0.705 . . . . 0.0 111.527 -169.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 85.09 -151.73 26.2 Favored Glycine 0 C--N 1.336 0.573 0 N-CA-C 110.479 -1.049 . . . . 0.0 110.479 172.1 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 97.6 t -72.18 132.95 32.69 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 168.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 49.6 t -138.2 143.96 31.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 N-CA-C 105.756 -1.942 . . . . 0.0 105.756 179.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 5.6 tt -122.85 101.6 7.53 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 106.303 -1.74 . . . . 0.0 106.303 -178.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -81.78 147.06 29.6 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.659 -179.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -125.43 93.8 3.96 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 126.588 1.955 . . . . 0.0 107.194 -175.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -75.8 112.79 12.55 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 175.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -149.94 -176.04 5.28 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.432 1.093 . . . . 0.0 108.644 -172.013 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -152.79 147.69 19.52 Favored Pre-proline 0 CA--C 1.531 0.236 0 N-CA-C 106.085 -1.821 . . . . 0.0 106.085 167.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -59.11 -18.29 43.06 Favored 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 121.848 1.699 . . . . 0.0 114.595 177.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 2.0 m95 -75.19 -14.22 60.52 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 118.818 0.735 . . . . 0.0 111.865 176.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 25.0 t -64.32 153.33 38.68 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.499 1.519 . . . . 0.0 111.063 -177.059 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -103.26 -65.14 0.71 Allowed Glycine 0 CA--C 1.53 0.982 0 CA-C-O 118.424 -1.209 . . . . 0.0 110.514 171.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_exo -53.22 -31.7 56.93 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 123.525 2.816 . . . . 0.0 114.608 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 34.3 m -58.63 -32.59 69.17 Favored 'General case' 0 CA--C 1.537 0.451 0 O-C-N 121.509 -0.744 . . . . 0.0 111.857 176.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.3 mmtp -68.36 -23.83 64.73 Favored 'General case' 0 CA--C 1.531 0.244 0 O-C-N 121.273 -0.892 . . . . 0.0 110.888 179.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 28.9 mtm -71.57 -40.93 69.61 Favored 'General case' 0 C--N 1.339 0.148 0 CA-C-N 118.79 0.723 . . . . 0.0 110.636 176.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 19.2 tt -83.14 -21.37 8.98 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-O 118.918 -0.563 . . . . 0.0 111.529 -176.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -49.79 -50.62 66.46 Favored Pre-proline 0 CA--C 1.55 0.952 0 CA-C-N 120.14 1.336 . . . . 0.0 114.003 177.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -66.46 -26.39 47.59 Favored 'Trans proline' 0 C--N 1.351 0.701 0 CA-C-N 121.688 1.639 . . . . 0.0 112.451 175.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 6.0 t -67.63 -40.08 83.43 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-N 118.907 0.776 . . . . 0.0 109.136 173.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 91.3 mt -64.3 -34.21 77.6 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 119.462 1.028 . . . . 0.0 111.224 172.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -66.32 -38.14 86.99 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 119.606 1.094 . . . . 0.0 111.385 171.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -63.78 -36.09 82.76 Favored 'General case' 0 C--N 1.33 -0.248 0 O-C-N 120.299 -1.501 . . . . 0.0 110.115 172.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 18.7 mt -66.58 -37.25 84.52 Favored 'General case' 0 C--N 1.334 -0.097 0 CA-C-O 117.892 -1.051 . . . . 0.0 112.087 173.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -54.1 -47.05 72.18 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 120.569 1.532 . . . . 0.0 109.65 168.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 44.1 mt-30 -74.49 -13.67 60.72 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 113.283 0.846 . . . . 0.0 113.283 -174.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 61.7 mt-10 -120.93 -24.27 5.67 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 124.417 1.087 . . . . 0.0 113.01 -170.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 17.5 mtp -131.99 -5.2 3.53 Favored 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 -175.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -58.43 -12.17 12.16 Favored Glycine 0 CA--C 1.538 1.472 0 CA-C-N 120.488 1.494 . . . . 0.0 115.393 -172.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -74.83 -25.99 59.39 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.326 1.45 . . . . 0.0 112.226 174.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.479 ' HA ' ' HE3' ' A' ' 49' ' ' LYS . 0.0 OUTLIER -123.67 -18.16 6.19 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 125.575 1.55 . . . . 0.0 112.144 -177.504 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 55.7 tp -118.13 150.71 38.91 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 124.167 0.987 . . . . 0.0 110.552 -169.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -124.02 145.0 49.5 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 104.821 -2.289 . . . . 0.0 104.821 167.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 90.0 mt -120.59 129.32 75.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 104.395 -2.446 . . . . 0.0 104.395 -177.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 98.7 t -126.23 98.45 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 CA-C-N 119.217 0.917 . . . . 0.0 109.403 -170.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -73.47 137.62 44.62 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 176.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 15.1 tt -141.34 125.43 16.79 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 C-N-CA 123.769 0.827 . . . . 0.0 108.79 176.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 60.6 t0 -83.47 104.2 13.42 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 124.62 1.168 . . . . 0.0 108.953 -172.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 30.3 m -58.81 -27.05 33.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 118.713 -0.66 . . . . 0.0 111.959 -174.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -65.57 -17.75 64.81 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 119.346 0.975 . . . . 0.0 112.171 -176.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -120.57 3.44 10.7 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.869 1.268 . . . . 0.0 111.222 178.011 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 69.0 m-80 -139.11 40.02 2.12 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.43 1.092 . . . . 0.0 109.814 -169.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 51.8 mm-40 -55.46 -32.09 62.49 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.122 0.969 . . . . 0.0 111.257 176.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 36.8 mm-40 -66.25 -48.45 70.47 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 118.493 0.588 . . . . 0.0 110.357 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.15 -39.46 82.63 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 118.408 0.549 . . . . 0.0 109.556 -178.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -58.95 -48.69 80.6 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 121.31 -0.869 . . . . 0.0 110.327 173.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -61.19 -28.66 69.45 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 123.985 0.802 . . . . 0.0 112.202 177.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 44.9 tttp -55.97 -29.24 59.94 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.965 1.306 . . . . 0.0 111.686 179.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -122.88 10.43 9.54 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.705 0.802 . . . . 0.0 111.739 179.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 64.95 28.37 73.41 Favored Glycine 0 CA--C 1.533 1.186 0 CA-C-O 119.39 -0.672 . . . . 0.0 112.892 -177.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 61.4 t -62.27 125.56 18.87 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 171.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 12.0 tpt -136.53 1.28 2.59 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.608 1.163 . . . . 0.0 111.085 -175.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 24.6 m -144.82 163.11 35.07 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 126.626 1.97 . . . . 0.0 107.481 179.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 38.5 pt -142.88 156.26 62.4 Favored Pre-proline 0 CA--C 1.545 0.765 0 C-N-CA 124.574 1.15 . . . . 0.0 108.847 175.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -66.65 138.9 42.11 Favored 'Cis proline' 0 N--CA 1.458 -0.582 0 CA-C-N 120.361 1.164 . . . . 0.0 110.179 -5.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 32.3 m -129.77 142.71 50.65 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 174.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 88.4 mt -123.39 126.52 46.95 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 -168.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -118.41 119.39 34.46 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 103.969 -2.604 . . . . 0.0 103.969 179.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 5.1 t -90.23 123.15 42.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 103.565 -2.754 . . . . 0.0 103.565 171.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.2 mp -111.61 153.64 26.03 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 173.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -136.15 124.32 23.07 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 105.916 -1.883 . . . . 0.0 105.916 174.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 31.9 t70 50.96 34.13 10.06 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.573 1.149 . . . . 0.0 112.251 177.143 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 98.55 0.86 57.84 Favored Glycine 0 CA--C 1.531 1.038 0 CA-C-O 118.227 -1.318 . . . . 0.0 114.956 169.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -128.38 150.32 50.16 Favored 'General case' 0 C--N 1.34 0.153 0 CA-C-N 119.999 1.9 . . . . 0.0 109.916 178.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 47.9 t -62.26 133.24 28.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 176.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.6 p -117.92 -24.73 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 C-N-CA 125.087 1.355 . . . . 0.0 109.58 177.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -158.79 164.98 35.31 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 120.035 1.289 . . . . 0.0 110.506 175.041 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 10.6 m -136.26 150.88 49.14 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.709 1.204 . . . . 0.0 108.891 177.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 62.3 m -150.52 159.3 44.58 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.622 1.569 . . . . 0.0 108.768 169.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 40.7 t -133.77 147.73 30.66 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 -176.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 76.93 -178.03 51.51 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 123.637 0.637 . . . . 0.0 112.423 176.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -64.73 150.29 47.59 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.886 0.874 . . . . 0.0 110.826 178.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -149.02 145.53 19.7 Favored Pre-proline 0 C--O 1.235 0.321 0 C-N-CA 125.677 1.591 . . . . 0.0 106.93 167.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -70.84 161.19 46.94 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 122.649 2.233 . . . . 0.0 110.462 174.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 63.5 pttt -58.71 -31.74 68.54 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -175.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -68.02 -45.49 73.85 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 118.244 0.475 . . . . 0.0 109.859 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.7 -40.43 95.36 Favored 'General case' 0 C--O 1.232 0.159 0 O-C-N 122.039 -0.413 . . . . 0.0 110.339 177.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 97.4 mt -64.57 -40.6 95.84 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 122.307 0.243 . . . . 0.0 111.313 176.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 18.9 mt-30 -59.83 -39.3 84.61 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 118.759 -0.638 . . . . 0.0 110.108 175.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -68.14 -40.35 82.45 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 118.941 0.791 . . . . 0.0 110.808 178.122 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 43.9 tp -60.34 -37.89 82.08 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.312 1.445 . . . . 0.0 111.313 176.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 99.4 t -68.74 -49.75 61.41 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 C-N-CA 123.756 0.823 . . . . 0.0 109.578 170.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -58.09 -39.25 78.11 Favored 'General case' 0 CA--C 1.519 -0.218 0 C-N-CA 125.453 1.501 . . . . 0.0 112.119 -168.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 13.3 ptmm? -65.44 -5.92 9.02 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 113.364 0.876 . . . . 0.0 113.364 -178.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -127.04 -3.48 6.38 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.548 1.139 . . . . 0.0 113.595 175.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 46.9 mt . . . . . 0 C--O 1.248 0.988 0 CA-C-N 119.413 1.006 . . . . 0.0 109.164 170.289 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 43.5 tpp . . . . . 0 N--CA 1.483 1.196 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -144.73 -174.09 4.24 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.535 1.134 . . . . 0.0 110.476 -170.244 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 7.5 mt -70.05 147.27 11.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 168.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 37.3 t -137.68 164.77 27.91 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 C-N-CA 127.106 2.162 . . . . 0.0 106.2 -179.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 8.1 ttmt -120.14 146.34 46.07 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 107.1 -1.445 . . . . 0.0 107.1 173.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -143.64 169.97 16.73 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.717 0.77 . . . . 0.0 111.029 -178.242 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 18.6 p -133.77 173.43 11.54 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 127.699 2.4 . . . . 0.0 107.863 176.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -54.93 -31.41 60.32 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 121.578 -0.701 . . . . 0.0 112.547 177.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 59.4 mt-30 -70.77 -27.62 64.06 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.113 1.365 . . . . 0.0 112.959 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 25.5 p -118.89 -18.95 8.74 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.425 1.09 . . . . 0.0 113.524 -168.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -52.99 -46.47 68.32 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 125.014 1.326 . . . . 0.0 111.942 -172.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.0 m -63.79 -38.39 90.92 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 122.79 0.436 . . . . 0.0 111.795 -176.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -68.54 -44.6 74.2 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 177.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 67.6 mm-40 -63.95 -34.46 78.02 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-O 119.545 -0.264 . . . . 0.0 111.223 -178.134 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 33.3 p -85.79 1.63 48.9 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.012 0.925 . . . . 0.0 113.427 -176.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 70.9 m -101.79 31.52 3.81 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.14 0.976 . . . . 0.0 111.601 -177.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -133.72 65.05 1.59 Allowed 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.44 1.096 . . . . 0.0 110.104 -177.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 89.84 -154.32 23.79 Favored Glycine 0 C--N 1.338 0.661 0 N-CA-C 110.294 -1.123 . . . . 0.0 110.294 175.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 48.5 t -71.71 135.7 27.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 N-CA-C 106.214 -1.772 . . . . 0.0 106.214 168.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 49.2 t -137.62 141.98 37.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 178.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 60.4 tp -122.96 98.79 6.06 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 -177.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -79.39 148.72 31.89 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 178.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -127.98 93.98 3.82 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 126.543 1.937 . . . . 0.0 107.443 -178.046 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -73.4 112.6 9.62 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 105.735 -1.95 . . . . 0.0 105.735 175.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -148.64 -177.2 5.65 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 124.847 1.259 . . . . 0.0 108.173 -172.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -156.01 149.35 18.69 Favored Pre-proline 0 N--CA 1.453 -0.29 0 N-CA-C 106.154 -1.795 . . . . 0.0 106.154 167.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -68.93 -13.18 36.19 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 CA-C-N 120.866 1.345 . . . . 0.0 113.96 -177.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 46.4 p-90 -69.74 -20.39 63.51 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 120.147 1.34 . . . . 0.0 111.975 169.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 29.1 t -59.17 148.33 31.94 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.06 1.344 . . . . 0.0 111.05 -171.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -97.09 -60.59 0.96 Allowed Glycine 0 CA--C 1.532 1.113 0 CA-C-O 118.722 -1.043 . . . . 0.0 111.335 169.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -66.37 -25.99 48.6 Favored 'Trans proline' 0 C--N 1.349 0.574 0 CA-C-N 120.387 2.093 . . . . 0.0 112.983 -173.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 24.5 m -58.26 -33.98 69.99 Favored 'General case' 0 CA--C 1.534 0.346 0 O-C-N 121.627 -0.671 . . . . 0.0 111.218 174.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.1 mmtp -68.24 -22.87 64.75 Favored 'General case' 0 CA--C 1.531 0.242 0 O-C-N 121.591 -0.693 . . . . 0.0 111.078 -179.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 35.3 mtm -71.34 -44.21 65.51 Favored 'General case' 0 C--N 1.34 0.184 0 CA-C-N 118.863 0.756 . . . . 0.0 110.323 175.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 17.2 tt -83.04 -22.73 8.61 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-O 118.628 -0.701 . . . . 0.0 111.555 -176.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -49.05 -52.04 50.81 Favored Pre-proline 0 CA--C 1.548 0.888 0 CA-C-N 120.28 1.4 . . . . 0.0 114.223 178.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -66.41 -29.9 44.94 Favored 'Trans proline' 0 C--N 1.351 0.667 0 CA-C-N 121.574 1.598 . . . . 0.0 111.985 176.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.0 t -66.49 -40.26 86.04 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-O 118.722 -0.656 . . . . 0.0 109.403 175.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 45.7 mt -64.54 -37.05 86.21 Favored 'General case' 0 C--O 1.224 -0.258 0 CA-C-N 119.507 1.049 . . . . 0.0 110.613 174.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -63.03 -44.47 95.85 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 119.104 0.866 . . . . 0.0 111.083 173.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -63.94 -39.79 94.97 Favored 'General case' 0 CA--C 1.534 0.334 0 O-C-N 121.166 -0.959 . . . . 0.0 110.451 177.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -63.68 -43.28 97.11 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 125.175 1.39 . . . . 0.0 109.641 177.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -58.74 -43.12 90.15 Favored 'General case' 0 CA--C 1.521 -0.143 0 C-N-CA 123.767 0.827 . . . . 0.0 110.917 176.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -70.5 -10.19 58.55 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -106.31 -27.58 10.92 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 125.735 1.614 . . . . 0.0 111.518 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 22.2 mtp -126.14 -2.47 7.01 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 113.51 0.929 . . . . 0.0 113.51 -169.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.82 -7.3 6.17 Favored Glycine 0 CA--C 1.533 1.215 0 CA-C-N 119.591 1.087 . . . . 0.0 115.538 -176.1 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -75.71 -27.64 58.29 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 118.597 1.198 . . . . 0.0 111.638 171.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 45.0 mmtm -121.03 -20.51 6.81 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 125.514 1.526 . . . . 0.0 112.347 -175.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 48.8 tp -119.83 151.91 38.11 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.131 0.972 . . . . 0.0 111.546 -168.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -120.41 143.84 48.25 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 105.011 -2.218 . . . . 0.0 105.011 166.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 58.6 mt -112.56 140.2 33.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 105.497 -2.038 . . . . 0.0 105.497 173.036 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 95.1 t -132.75 98.96 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 -172.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 47.6 mtpt -73.9 140.43 45.65 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 175.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 13.0 tt -141.01 126.16 18.57 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 175.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -83.79 101.86 11.9 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 124.728 1.211 . . . . 0.0 108.786 -173.082 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 24.9 m -59.95 -25.63 33.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 118.667 -0.683 . . . . 0.0 111.961 -174.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -65.05 -18.45 65.31 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 119.464 1.029 . . . . 0.0 112.143 -177.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -120.22 4.02 10.84 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.809 1.244 . . . . 0.0 111.072 177.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -139.2 40.56 2.1 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.607 1.163 . . . . 0.0 109.592 -170.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 48.0 mm-40 -55.84 -32.55 63.7 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.184 0.993 . . . . 0.0 111.257 177.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -65.74 -46.27 79.51 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 118.385 0.539 . . . . 0.0 110.425 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.13 -39.19 79.03 Favored 'General case' 0 C--O 1.223 -0.317 0 CA-C-N 118.457 0.571 . . . . 0.0 109.618 -179.246 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.06 -48.36 81.89 Favored 'General case' 0 CA--C 1.533 0.326 0 O-C-N 121.256 -0.902 . . . . 0.0 110.25 173.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -60.68 -28.75 68.49 Favored Glycine 0 CA--C 1.529 0.938 0 C-N-CA 124.079 0.847 . . . . 0.0 112.36 177.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 47.3 tttp -55.94 -29.32 59.96 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 124.861 1.265 . . . . 0.0 111.709 179.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -123.2 10.63 9.35 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.621 0.768 . . . . 0.0 111.767 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 63.6 31.57 81.21 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 123.641 0.639 . . . . 0.0 112.636 -176.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 55.1 t -65.83 121.87 15.73 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 171.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 98.5 mmm -131.59 2.64 4.14 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.898 1.279 . . . . 0.0 111.382 -178.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 24.5 m -144.83 161.17 39.94 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 126.652 1.981 . . . . 0.0 107.565 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 38.7 pt -142.69 154.36 62.69 Favored Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 124.726 1.211 . . . . 0.0 108.41 176.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -68.26 140.14 53.89 Favored 'Cis proline' 0 C--N 1.349 0.601 0 CA-C-N 120.495 1.212 . . . . 0.0 110.541 -3.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 33.9 m -131.86 142.83 49.81 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 175.067 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 83.0 mt -121.24 127.4 51.39 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 -170.006 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -120.64 124.63 45.7 Favored 'General case' 0 CA--C 1.508 -0.637 0 N-CA-C 102.851 -3.018 . . . . 0.0 102.851 178.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 1.3 t -106.04 125.87 61.58 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 N-CA-C 103.872 -2.64 . . . . 0.0 103.872 -178.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.7 mp -122.08 152.9 39.34 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 -175.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -135.71 116.71 14.27 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 106.522 -1.659 . . . . 0.0 106.522 178.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.1 t70 49.58 38.42 14.79 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.915 1.286 . . . . 0.0 112.571 176.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 104.14 -2.87 43.99 Favored Glycine 0 CA--C 1.529 0.92 0 CA-C-O 118.056 -1.414 . . . . 0.0 115.418 168.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -126.57 147.17 49.91 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 120.129 1.964 . . . . 0.0 109.995 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 61.0 t -62.58 131.43 27.94 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 174.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 9.9 p -119.3 -20.67 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.732 0 C-N-CA 125.006 1.322 . . . . 0.0 110.093 178.102 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -159.96 166.75 29.46 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 120.58 1.536 . . . . 0.0 110.272 172.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 17.4 m -136.75 151.34 49.1 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.647 1.579 . . . . 0.0 108.798 176.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 46.3 m -148.35 157.4 43.46 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.871 1.669 . . . . 0.0 108.595 169.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 39.4 t -133.8 146.24 32.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 -178.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 79.58 -175.87 54.88 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 123.646 0.641 . . . . 0.0 112.296 176.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -62.46 145.28 54.56 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.577 0.751 . . . . 0.0 110.563 178.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 68.9 mttt -143.72 134.31 12.23 Favored Pre-proline 0 CA--C 1.532 0.258 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 168.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -69.5 160.76 48.56 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.306 2.004 . . . . 0.0 109.907 174.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 49.7 pttt -59.24 -28.3 66.57 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 -176.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -65.54 -47.89 74.35 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 118.444 0.565 . . . . 0.0 109.975 174.116 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.53 -37.65 88.28 Favored 'General case' 0 CA--C 1.529 0.173 0 O-C-N 121.859 -0.526 . . . . 0.0 110.619 177.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 83.0 mt -65.19 -42.12 93.89 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-O 119.285 -0.388 . . . . 0.0 111.383 176.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 15.8 mt-30 -59.3 -42.87 92.35 Favored 'General case' 0 C--O 1.225 -0.214 0 CA-C-N 118.697 0.681 . . . . 0.0 109.643 175.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -65.99 -38.6 88.91 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 118.017 0.371 . . . . 0.0 110.683 -179.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 65.9 tp -61.15 -47.25 87.06 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 125.025 1.33 . . . . 0.0 110.328 176.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 97.3 t -61.55 -43.26 96.64 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 123.902 0.881 . . . . 0.0 110.045 174.041 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -61.51 -26.05 67.67 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 125.18 1.392 . . . . 0.0 112.136 -172.088 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 82.3 mttt -55.15 -24.88 28.62 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 118.774 -0.632 . . . . 0.0 112.617 172.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 43.3 m-70 -121.74 -10.67 8.71 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 -167.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 78.7 mt . . . . . 0 C--O 1.249 1.077 0 CA-C-N 118.565 0.62 . . . . 0.0 109.457 172.586 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.0 mmt . . . . . 0 N--CA 1.485 1.281 0 CA-C-O 120.766 0.317 . . . . 0.0 110.148 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -150.44 -176.98 5.7 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.135 1.374 . . . . 0.0 109.201 -175.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.9 mt -73.79 144.93 12.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 167.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 29.0 t -136.47 163.97 32.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 C-N-CA 126.724 2.01 . . . . 0.0 106.273 -178.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.52 133.78 49.81 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 104.923 -2.251 . . . . 0.0 104.923 176.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -135.22 175.11 9.89 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 123.875 0.87 . . . . 0.0 111.37 -171.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 31.3 p -137.87 178.56 7.02 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 125.244 1.418 . . . . 0.0 107.779 169.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -49.3 -30.34 7.27 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.895 0.878 . . . . 0.0 112.4 169.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -64.81 -27.47 68.91 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.003 1.321 . . . . 0.0 112.776 -179.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 14.1 p -130.83 -17.55 3.16 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 114.298 1.222 . . . . 0.0 114.298 -167.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 56.8 t80 -52.2 -47.28 65.67 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 124.463 1.105 . . . . 0.0 112.259 -170.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.2 m -64.56 -37.9 89.15 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 122.62 0.368 . . . . 0.0 111.849 -176.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -69.09 -44.56 72.24 Favored 'General case' 0 N--CA 1.452 -0.343 0 O-C-N 122.017 -0.427 . . . . 0.0 109.96 176.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 68.9 mm-40 -63.22 -35.82 81.59 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 122.529 0.331 . . . . 0.0 110.921 -178.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.407 ' HA ' HG21 ' A' ' 20' ' ' VAL . 29.3 p -82.85 0.62 43.22 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 -176.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 70.7 m -102.04 29.21 5.2 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.972 0.909 . . . . 0.0 112.068 -175.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -135.2 55.24 1.89 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.831 0.853 . . . . 0.0 111.387 -173.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 107.39 -152.06 16.91 Favored Glycine 0 C--N 1.337 0.614 0 N-CA-C 109.954 -1.258 . . . . 0.0 109.954 173.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.2 t -74.83 135.75 26.65 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 N-CA-C 104.88 -2.267 . . . . 0.0 104.88 166.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.407 HG21 ' HA ' ' A' ' 15' ' ' THR . 34.3 t -136.15 139.47 45.61 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 N-CA-C 106.441 -1.688 . . . . 0.0 106.441 178.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.8 tt -124.17 100.11 6.56 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 106.131 -1.803 . . . . 0.0 106.131 -177.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -81.33 145.67 30.75 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.236 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -124.52 94.02 4.08 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 125.899 1.68 . . . . 0.0 107.619 -176.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -74.22 112.51 10.45 Favored 'General case' 0 C--O 1.24 0.58 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 175.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -148.96 -176.51 5.37 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.966 1.306 . . . . 0.0 108.548 -172.581 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -156.44 146.74 15.9 Favored Pre-proline 0 CA--C 1.533 0.296 0 N-CA-C 106.16 -1.793 . . . . 0.0 106.16 168.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -60.76 -17.95 53.04 Favored 'Trans proline' 0 CA--C 1.534 0.495 0 C-N-CA 121.662 1.575 . . . . 0.0 115.799 -178.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 50.5 p-90 -69.23 -20.56 63.95 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 119.99 1.268 . . . . 0.0 112.011 173.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 34.1 t -58.9 146.9 35.99 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 125.055 1.342 . . . . 0.0 111.231 -172.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -95.4 -62.43 0.99 Allowed Glycine 0 CA--C 1.531 1.082 0 CA-C-O 118.647 -1.085 . . . . 0.0 111.163 170.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -64.43 -26.53 62.9 Favored 'Trans proline' 0 C--N 1.35 0.634 0 CA-C-N 120.257 2.029 . . . . 0.0 113.387 -173.1 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 30.2 m -57.29 -34.7 68.95 Favored 'General case' 0 CA--C 1.537 0.456 0 O-C-N 121.63 -0.669 . . . . 0.0 111.479 174.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.9 mmtp -67.91 -24.49 65.21 Favored 'General case' 0 CA--C 1.531 0.25 0 O-C-N 121.645 -0.659 . . . . 0.0 111.057 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 32.3 mtm -71.25 -44.04 66.07 Favored 'General case' 0 C--N 1.34 0.18 0 CA-C-N 118.654 0.661 . . . . 0.0 110.411 177.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 14.5 tt -82.21 -23.69 9.33 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-O 118.745 -0.645 . . . . 0.0 111.523 -176.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -48.59 -51.46 52.33 Favored Pre-proline 0 CA--C 1.548 0.888 0 CA-C-N 120.062 1.301 . . . . 0.0 114.262 179.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -66.93 -28.08 42.53 Favored 'Trans proline' 0 C--N 1.35 0.649 0 CA-C-N 121.807 1.681 . . . . 0.0 112.407 176.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.6 t -67.8 -37.92 79.32 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 O-C-N 121.584 -0.698 . . . . 0.0 109.313 174.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 95.0 mt -67.16 -35.4 79.6 Favored 'General case' 0 C--N 1.34 0.166 0 CA-C-N 119.516 1.053 . . . . 0.0 111.328 172.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -61.96 -43.07 99.6 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 119.548 1.067 . . . . 0.0 110.755 171.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -63.38 -41.35 98.79 Favored 'General case' 0 CA--C 1.53 0.179 0 O-C-N 121.279 -0.888 . . . . 0.0 110.421 175.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 35.3 tp -60.82 -42.21 97.23 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 123.494 0.718 . . . . 0.0 110.24 177.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -60.54 -43.82 96.79 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 123.347 0.659 . . . . 0.0 110.728 177.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 -71.4 -10.72 60.21 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.29 0.636 . . . . 0.0 112.629 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -105.59 -28.09 10.97 Favored 'General case' 0 C--O 1.232 0.172 0 C-N-CA 125.46 1.504 . . . . 0.0 111.42 -178.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 22.8 mtp -131.44 0.27 4.04 Favored 'General case' 0 N--CA 1.461 0.105 0 N-CA-C 113.658 0.985 . . . . 0.0 113.658 -169.002 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -55.82 -10.31 3.35 Favored Glycine 0 CA--C 1.535 1.343 0 C-N-CA 124.747 1.165 . . . . 0.0 115.926 -176.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -72.86 -29.14 62.97 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.597 1.159 . . . . 0.0 112.049 172.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 42.3 mmtm -126.37 -14.9 5.79 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 125.732 1.613 . . . . 0.0 112.842 -175.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 58.9 tp -120.3 142.59 48.95 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 124.144 0.978 . . . . 0.0 109.925 -170.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -117.73 145.48 44.43 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 104.899 -2.26 . . . . 0.0 104.899 167.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 73.7 mt -116.19 138.19 47.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 105.399 -2.075 . . . . 0.0 105.399 176.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 93.1 t -132.59 96.47 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -169.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 54.4 mtpt -74.24 139.05 44.07 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 177.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 17.3 tt -141.41 125.62 16.89 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 176.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 39.4 t0 -82.35 104.89 12.99 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 124.737 1.215 . . . . 0.0 108.428 -175.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 30.5 m -60.47 -25.8 35.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 C-N-CA 123.464 0.705 . . . . 0.0 112.194 -173.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -64.83 -26.54 68.38 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 119.188 0.904 . . . . 0.0 111.468 -177.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -108.97 6.38 25.14 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.098 1.359 . . . . 0.0 110.791 -179.205 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 68.3 m-80 -146.69 39.66 1.06 Allowed 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.536 1.135 . . . . 0.0 110.137 -168.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -57.84 -29.6 65.1 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.448 1.099 . . . . 0.0 110.541 179.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 48.1 mp0 -65.4 -51.35 60.93 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 124.7 1.2 . . . . 0.0 109.923 177.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.12 -38.55 85.79 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.536 0.734 . . . . 0.0 109.748 -178.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.1 -48.62 80.95 Favored 'General case' 0 CA--C 1.534 0.34 0 O-C-N 121.105 -0.997 . . . . 0.0 110.255 172.185 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -60.59 -28.92 68.52 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 123.887 0.756 . . . . 0.0 112.397 177.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 73.7 tttt -55.82 -29.28 59.52 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 125.047 1.339 . . . . 0.0 111.674 179.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -123.64 10.17 9.03 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.647 0.779 . . . . 0.0 111.87 179.288 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 64.37 28.75 73.5 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 123.736 0.684 . . . . 0.0 112.839 -176.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 51.0 t -62.08 125.65 18.81 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 172.054 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 12.0 tpt -137.6 0.71 2.28 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.567 1.147 . . . . 0.0 111.15 -176.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 28.0 m -144.87 162.67 36.24 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 126.594 1.957 . . . . 0.0 107.439 179.031 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 40.2 pt -142.97 154.44 61.89 Favored Pre-proline 0 CA--C 1.546 0.809 0 C-N-CA 124.502 1.121 . . . . 0.0 108.916 177.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -68.03 138.49 44.33 Favored 'Cis proline' 0 C--N 1.35 0.628 0 CA-C-N 120.427 1.188 . . . . 0.0 110.376 -3.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 26.0 m -129.42 141.55 51.01 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 173.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 86.7 mt -122.82 127.17 48.71 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 -169.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -115.99 123.63 48.5 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 103.683 -2.71 . . . . 0.0 103.683 177.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 6.2 t -99.24 125.13 52.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 103.993 -2.595 . . . . 0.0 103.993 177.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.7 mp -122.5 153.67 38.86 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 4.5 tmtp? -135.19 120.24 18.72 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 106.306 -1.739 . . . . 0.0 106.306 175.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.5 t70 50.69 36.88 15.15 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.901 1.28 . . . . 0.0 112.559 175.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 106.24 -4.26 38.04 Favored Glycine 0 CA--C 1.526 0.779 0 CA-C-O 118.104 -1.387 . . . . 0.0 115.326 168.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -130.87 147.72 52.55 Favored 'General case' 0 C--N 1.339 0.132 0 CA-C-N 120.085 1.942 . . . . 0.0 110.205 -177.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 53.0 t -63.26 132.86 29.24 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 178.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 5.2 p -119.21 -20.39 4.99 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 C-N-CA 124.823 1.249 . . . . 0.0 110.795 174.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -158.23 168.73 26.23 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 120.544 1.52 . . . . 0.0 110.903 173.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 10.3 m -138.26 150.94 47.16 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.399 1.48 . . . . 0.0 108.497 175.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 2.7 m -146.54 157.16 43.69 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 125.761 1.624 . . . . 0.0 108.653 169.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 39.5 t -133.67 147.14 30.92 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 176.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 78.47 -176.94 54.07 Favored Glycine 0 CA--C 1.53 0.973 0 CA-C-O 121.638 0.577 . . . . 0.0 112.406 177.101 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 60.0 t80 -65.91 145.03 56.4 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.921 0.888 . . . . 0.0 110.896 -179.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -141.93 140.57 19.96 Favored Pre-proline 0 CA--C 1.535 0.37 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 167.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -72.11 162.5 41.55 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 122.68 2.254 . . . . 0.0 110.781 175.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 31.9 pttt -58.91 -30.99 68.23 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 -177.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -66.94 -49.76 64.5 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 118.336 0.516 . . . . 0.0 109.969 176.194 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.24 -39.4 94.5 Favored 'General case' 0 CA--C 1.529 0.146 0 O-C-N 121.923 -0.486 . . . . 0.0 110.512 179.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 59.3 mt -62.48 -45.22 94.01 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 123.345 0.658 . . . . 0.0 111.013 176.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 19.2 mt-30 -58.79 -42.15 88.39 Favored 'General case' 0 C--O 1.225 -0.214 0 CA-C-N 118.311 0.505 . . . . 0.0 110.262 176.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -66.89 -38.62 86.62 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 118.488 0.586 . . . . 0.0 110.817 -179.079 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 64.8 tp -63.67 -38.32 90.68 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.869 1.267 . . . . 0.0 110.956 176.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 96.4 t -68.54 -46.38 80.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-N 119.083 0.856 . . . . 0.0 109.787 172.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -56.79 -41.96 78.61 Favored 'General case' 0 CA--C 1.519 -0.219 0 C-N-CA 125.449 1.499 . . . . 0.0 111.802 -168.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -68.39 -5.62 20.05 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -175.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 83.5 m-70 -123.72 2.56 8.86 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.311 1.044 . . . . 0.0 112.8 178.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 53.9 mt . . . . . 0 C--O 1.249 1.058 0 CA-C-N 119.306 0.957 . . . . 0.0 109.545 174.449 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.472 ' HG3' ' H ' ' A' ' 2' ' ' ALA 0.252 20.8 ptm . . . . . 0 N--CA 1.48 1.067 0 CA-C-O 118.778 -0.63 . . . . 0.0 112.033 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.472 ' H ' ' HG3' ' A' ' 1' ' ' MET . . . -158.33 -176.31 5.83 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 125.264 1.426 . . . . 0.0 109.034 -170.12 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.9 mt -75.56 145.63 10.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 167.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 29.5 t -139.53 163.72 25.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 C-N-CA 126.426 1.89 . . . . 0.0 107.138 -174.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -113.74 146.03 40.47 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 174.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -145.25 168.02 21.43 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 123.086 0.554 . . . . 0.0 110.077 175.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 31.7 p -132.42 178.57 6.72 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 168.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -53.29 -28.14 26.51 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.385 0.674 . . . . 0.0 112.292 174.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 -66.05 -29.01 69.28 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.294 1.838 . . . . 0.0 112.832 179.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 16.6 p -129.62 -14.61 4.1 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 -167.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -52.61 -47.03 67.22 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 124.453 1.101 . . . . 0.0 111.987 -172.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.8 m -63.84 -38.88 92.73 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 122.855 0.462 . . . . 0.0 111.787 -177.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -67.56 -44.79 77.4 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 177.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -64.02 -35.76 81.78 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 122.392 0.277 . . . . 0.0 111.062 -178.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 29.0 p -84.12 0.18 49.49 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.868 0.867 . . . . 0.0 113.251 -176.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 70.1 m -99.41 30.0 3.74 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.127 0.971 . . . . 0.0 111.758 -177.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -132.95 56.75 1.83 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.255 1.022 . . . . 0.0 110.543 -176.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 97.14 -155.36 20.66 Favored Glycine 0 C--N 1.336 0.572 0 N-CA-C 110.043 -1.223 . . . . 0.0 110.043 175.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 65.5 t -71.42 133.09 32.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 168.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 46.9 t -137.25 141.59 39.57 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 N-CA-C 105.907 -1.886 . . . . 0.0 105.907 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 3.8 tt -122.81 100.21 6.79 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 106.208 -1.775 . . . . 0.0 106.208 -175.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -82.09 146.22 29.75 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.402 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -125.63 94.2 4.06 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 126.101 1.761 . . . . 0.0 107.323 -178.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -73.54 113.46 10.68 Favored 'General case' 0 C--O 1.24 0.563 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 174.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -149.01 -177.33 5.75 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.842 1.257 . . . . 0.0 108.595 -172.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -156.21 148.3 17.46 Favored Pre-proline 0 CA--C 1.532 0.268 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 167.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -60.61 -18.63 55.97 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 121.796 1.664 . . . . 0.0 115.68 -179.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 50.6 p-90 -69.69 -20.14 63.56 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 119.987 1.267 . . . . 0.0 112.01 173.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 33.7 t -59.56 148.37 33.61 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 124.975 1.31 . . . . 0.0 111.185 -172.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -97.78 -63.36 0.89 Allowed Glycine 0 CA--C 1.529 0.962 0 CA-C-O 118.503 -1.165 . . . . 0.0 110.92 171.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -62.34 -26.57 77.1 Favored 'Trans proline' 0 C--N 1.351 0.704 0 CA-C-N 120.367 2.084 . . . . 0.0 113.73 -174.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 34.3 m -57.08 -35.59 69.57 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 121.653 -0.654 . . . . 0.0 111.513 174.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.0 mmtp -67.32 -25.54 66.07 Favored 'General case' 0 CA--C 1.53 0.208 0 O-C-N 121.63 -0.669 . . . . 0.0 110.977 -179.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 31.4 mtm -70.86 -44.24 66.81 Favored 'General case' 0 C--N 1.341 0.222 0 CA-C-N 118.619 0.645 . . . . 0.0 110.313 177.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 15.4 tt -83.32 -23.65 8.24 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 CA-C-O 118.685 -0.674 . . . . 0.0 111.831 -174.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -48.78 -51.45 53.84 Favored Pre-proline 0 CA--C 1.547 0.843 0 CA-C-N 119.941 1.246 . . . . 0.0 114.072 179.027 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -66.78 -29.22 42.65 Favored 'Trans proline' 0 C--N 1.35 0.642 0 CA-C-N 121.737 1.656 . . . . 0.0 112.24 176.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.2 t -67.91 -36.83 77.07 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 O-C-N 121.545 -0.722 . . . . 0.0 109.579 175.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 55.2 mt -68.15 -35.25 77.76 Favored 'General case' 0 C--O 1.226 -0.178 0 CA-C-N 119.43 1.014 . . . . 0.0 111.07 173.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -61.96 -42.83 99.56 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 119.196 0.907 . . . . 0.0 110.803 170.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -64.76 -38.71 91.9 Favored 'General case' 0 CA--C 1.532 0.277 0 O-C-N 121.092 -1.005 . . . . 0.0 110.686 176.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 43.5 tp -61.82 -42.92 99.63 Favored 'General case' 0 C--N 1.335 -0.032 0 C-N-CA 123.625 0.77 . . . . 0.0 109.95 175.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -60.23 -42.2 94.7 Favored 'General case' 0 CA--C 1.522 -0.119 0 C-N-CA 123.041 0.536 . . . . 0.0 110.728 178.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 -72.34 -10.92 60.4 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 112.573 0.582 . . . . 0.0 112.573 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -105.36 -32.86 8.38 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 125.353 1.461 . . . . 0.0 111.545 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 82.1 mmm -126.16 -5.7 6.67 Favored 'General case' 0 C--O 1.227 -0.127 0 CA-C-O 118.226 -0.892 . . . . 0.0 113.097 -167.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -57.82 -13.95 14.65 Favored Glycine 0 CA--C 1.532 1.155 0 CA-C-N 120.027 1.285 . . . . 0.0 114.873 -174.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -66.73 -27.32 67.52 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.508 1.123 . . . . 0.0 112.011 172.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.471 ' HA ' ' HE3' ' A' ' 49' ' ' LYS . 0.0 OUTLIER -120.93 -21.61 6.48 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 126.094 1.757 . . . . 0.0 111.84 179.787 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 35.9 tp -109.49 157.67 18.74 Favored 'General case' 0 C--O 1.232 0.169 0 C-N-CA 123.994 0.918 . . . . 0.0 111.428 -169.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -131.27 143.19 50.36 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 103.846 -2.65 . . . . 0.0 103.846 166.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 73.6 mt -116.01 140.38 38.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 105.517 -2.031 . . . . 0.0 105.517 176.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 81.3 t -132.53 98.36 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 -172.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -74.3 140.34 44.83 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 174.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 14.9 tt -142.63 126.91 15.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 N-CA-C 108.679 -0.859 . . . . 0.0 108.679 176.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 62.2 t0 -84.4 105.36 15.18 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 124.609 1.163 . . . . 0.0 109.057 -173.11 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 31.4 m -59.61 -26.14 33.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 118.664 -0.684 . . . . 0.0 112.023 -175.113 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -65.18 -18.6 65.44 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 119.407 1.003 . . . . 0.0 112.143 -176.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -119.87 3.71 11.03 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.916 1.287 . . . . 0.0 111.173 178.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -139.39 40.29 2.07 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 124.528 1.131 . . . . 0.0 109.82 -169.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 51.4 mm-40 -56.04 -33.05 64.58 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.997 0.919 . . . . 0.0 111.227 178.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -66.08 -46.53 77.37 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 118.509 0.595 . . . . 0.0 110.549 179.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.19 -39.03 78.93 Favored 'General case' 0 C--O 1.223 -0.32 0 O-C-N 121.816 -0.553 . . . . 0.0 109.721 -179.296 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -58.79 -47.95 82.96 Favored 'General case' 0 CA--C 1.534 0.346 0 O-C-N 121.062 -1.024 . . . . 0.0 110.244 172.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -60.38 -28.47 67.26 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 124.171 0.891 . . . . 0.0 112.421 177.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 48.2 tptt -56.2 -29.07 60.42 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.546 1.139 . . . . 0.0 111.491 179.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -123.99 10.26 8.82 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.511 0.724 . . . . 0.0 111.661 -179.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 63.36 30.51 77.77 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 123.693 0.663 . . . . 0.0 112.572 -176.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 61.5 t -61.37 122.34 11.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 173.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 25.8 ptp -129.9 -12.4 4.22 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 124.923 1.289 . . . . 0.0 112.748 -171.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 23.0 m -139.9 165.23 27.87 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 127.396 2.278 . . . . 0.0 108.124 178.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 36.7 pt -142.13 154.79 65.05 Favored Pre-proline 0 CA--C 1.545 0.772 0 C-N-CA 124.845 1.258 . . . . 0.0 108.567 177.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -67.94 139.87 51.34 Favored 'Cis proline' 0 C--N 1.351 0.664 0 CA-C-N 120.481 1.208 . . . . 0.0 110.414 -2.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 22.7 m -130.99 139.12 49.96 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 174.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 85.5 mt -119.46 126.1 50.51 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 106.819 -1.548 . . . . 0.0 106.819 -169.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -117.01 119.28 34.82 Favored 'General case' 0 CA--C 1.511 -0.535 0 N-CA-C 103.755 -2.683 . . . . 0.0 103.755 177.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.4 t -92.34 124.29 44.75 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 N-CA-C 103.582 -2.747 . . . . 0.0 103.582 173.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.3 mp -115.03 155.12 27.58 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 174.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -136.73 123.75 21.53 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 171.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 27.9 t70 49.45 38.03 13.37 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.008 1.323 . . . . 0.0 112.456 177.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 101.64 -2.72 53.05 Favored Glycine 0 CA--C 1.528 0.865 0 CA-C-O 118.108 -1.384 . . . . 0.0 115.395 168.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -131.47 151.74 51.3 Favored 'General case' 0 CA--C 1.528 0.109 0 CA-C-N 120.063 1.931 . . . . 0.0 110.185 -178.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 38.8 t -62.85 133.32 28.7 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.9 p -120.61 -20.28 4.57 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 C-N-CA 125.324 1.45 . . . . 0.0 109.872 177.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -161.02 168.73 23.91 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 120.315 1.416 . . . . 0.0 110.47 171.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 10.5 m -140.46 151.03 44.54 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.078 1.351 . . . . 0.0 108.741 175.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 58.7 m -150.45 157.21 42.77 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.283 1.433 . . . . 0.0 108.835 169.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 43.7 t -133.89 144.56 35.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 -178.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 79.24 -175.07 55.21 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 123.434 0.54 . . . . 0.0 112.153 178.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -63.58 148.77 47.97 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.742 0.817 . . . . 0.0 111.031 -179.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 45.6 mttm -144.14 135.54 12.68 Favored Pre-proline 0 C--O 1.233 0.234 0 N-CA-C 106.406 -1.702 . . . . 0.0 106.406 168.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -70.0 162.37 42.46 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 122.154 1.903 . . . . 0.0 110.266 173.155 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 18.2 ptmt -55.98 -31.02 62.63 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.424 1.09 . . . . 0.0 113.533 -179.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -67.43 -49.69 62.62 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 118.528 0.604 . . . . 0.0 109.767 176.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.04 -39.38 94.56 Favored 'General case' 0 C--N 1.34 0.173 0 C-N-CA 122.896 0.478 . . . . 0.0 110.72 179.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 86.2 mt -62.95 -45.39 92.69 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.111 0.564 . . . . 0.0 111.166 176.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -61.07 -41.14 96.08 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-O 118.944 -0.551 . . . . 0.0 110.353 176.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -63.72 -41.62 98.04 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 118.427 0.558 . . . . 0.0 110.275 179.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 67.8 tp -61.73 -41.49 97.71 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 124.729 1.212 . . . . 0.0 110.98 177.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 75.1 t -62.39 -47.72 91.7 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 CA-C-N 118.757 0.708 . . . . 0.0 109.365 171.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 -61.76 -26.53 68.14 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 125.504 1.522 . . . . 0.0 112.291 -171.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -53.83 -26.87 26.42 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 123.604 0.761 . . . . 0.0 112.416 172.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 72.8 m-70 -123.49 -6.09 8.16 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 113.852 1.056 . . . . 0.0 113.852 -167.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 79.9 mt . . . . . 0 C--O 1.249 1.062 0 CA-C-N 118.814 0.733 . . . . 0.0 109.286 171.851 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.7 tpt . . . . . 0 N--CA 1.479 1.007 0 CA-C-O 118.949 -0.548 . . . . 0.0 110.248 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -163.87 -174.46 3.64 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.541 1.537 . . . . 0.0 108.205 -172.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.2 mt -75.3 142.62 14.31 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 N-CA-C 106.225 -1.769 . . . . 0.0 106.225 166.302 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 43.4 t -134.2 163.07 38.01 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 C-N-CA 126.89 2.076 . . . . 0.0 106.0 -178.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 1.4 tmtt? -129.01 131.54 47.41 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 104.247 -2.501 . . . . 0.0 104.247 179.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -142.6 173.46 11.51 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 123.732 0.813 . . . . 0.0 110.973 -169.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 23.6 p -136.91 174.01 11.08 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 125.066 1.347 . . . . 0.0 107.573 169.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -51.13 -27.97 9.79 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.726 1.21 . . . . 0.0 112.976 176.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -57.99 -30.59 66.18 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.103 1.761 . . . . 0.0 112.767 178.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.0 m -139.55 -7.4 1.3 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.837 0.855 . . . . 0.0 113.277 -169.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 69.2 t80 -51.45 -44.0 62.25 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.409 1.084 . . . . 0.0 111.925 -177.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.7 m -63.58 -38.39 90.96 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 122.991 0.516 . . . . 0.0 111.804 -178.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -68.32 -44.82 74.54 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 176.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 67.7 mm-40 -62.43 -36.83 83.62 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 122.67 0.388 . . . . 0.0 111.124 -178.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.7 p -83.13 0.7 43.98 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.072 0.949 . . . . 0.0 113.46 -177.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 68.0 m -105.15 33.33 3.71 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.206 1.002 . . . . 0.0 111.125 -176.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -132.8 60.25 1.71 Allowed 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.253 1.021 . . . . 0.0 109.966 -178.243 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 92.11 -153.71 22.0 Favored Glycine 0 C--N 1.337 0.633 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 177.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 82.9 t -74.06 137.01 24.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 168.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 48.1 t -139.21 145.96 26.54 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 N-CA-C 105.952 -1.87 . . . . 0.0 105.952 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.3 tt -125.01 99.09 5.97 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 106.448 -1.686 . . . . 0.0 106.448 -176.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -79.51 144.63 33.78 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 123.572 0.749 . . . . 0.0 109.17 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -126.92 94.35 4.01 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 126.045 1.738 . . . . 0.0 107.643 -176.316 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -74.49 113.46 11.76 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 173.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -147.22 -171.47 3.79 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.128 1.371 . . . . 0.0 108.225 -175.449 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -161.32 148.0 11.52 Favored Pre-proline 0 CA--C 1.533 0.306 0 N-CA-C 105.996 -1.853 . . . . 0.0 105.996 166.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -60.58 -18.07 52.47 Favored 'Trans proline' 0 CA--C 1.534 0.477 0 C-N-CA 121.776 1.651 . . . . 0.0 115.745 -178.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 50.7 p-90 -69.76 -20.57 63.49 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 120.029 1.286 . . . . 0.0 111.998 173.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 26.9 t -59.89 148.74 33.8 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 124.902 1.281 . . . . 0.0 111.096 -172.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -100.6 -63.97 0.79 Allowed Glycine 0 CA--C 1.529 0.938 0 CA-C-O 118.501 -1.166 . . . . 0.0 110.492 172.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_exo -53.77 -32.4 65.9 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 123.244 2.629 . . . . 0.0 114.495 -179.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 35.9 m -57.55 -34.82 69.57 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.326 0.651 . . . . 0.0 111.635 176.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.5 mmtp -67.93 -25.49 65.5 Favored 'General case' 0 CA--C 1.531 0.248 0 O-C-N 121.589 -0.694 . . . . 0.0 110.836 -179.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 30.0 mtm -71.25 -42.46 68.79 Favored 'General case' 0 C--N 1.341 0.213 0 CA-C-N 118.67 0.668 . . . . 0.0 110.444 176.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 17.1 tt -84.07 -22.48 8.11 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-O 118.807 -0.616 . . . . 0.0 111.53 -175.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -48.99 -51.21 57.58 Favored Pre-proline 0 CA--C 1.547 0.862 0 CA-C-N 120.028 1.285 . . . . 0.0 113.971 178.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -67.07 -28.37 41.33 Favored 'Trans proline' 0 C--N 1.35 0.614 0 CA-C-N 121.724 1.652 . . . . 0.0 112.303 176.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 13.0 t -66.45 -39.3 83.69 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 174.269 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 87.4 mt -67.06 -34.7 78.25 Favored 'General case' 0 C--N 1.34 0.165 0 CA-C-N 119.22 0.918 . . . . 0.0 111.323 173.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -62.5 -44.36 96.56 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 119.571 1.078 . . . . 0.0 110.746 171.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -64.42 -38.31 90.6 Favored 'General case' 0 CA--C 1.532 0.271 0 O-C-N 121.233 -0.917 . . . . 0.0 110.7 176.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 61.5 tp -63.22 -44.26 95.79 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.619 0.768 . . . . 0.0 110.015 176.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -59.31 -41.73 89.73 Favored 'General case' 0 CA--C 1.521 -0.153 0 C-N-CA 123.41 0.684 . . . . 0.0 111.009 177.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -72.06 -10.38 59.7 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.075 0.55 . . . . 0.0 112.464 -179.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 -104.77 -33.43 8.44 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 125.208 1.403 . . . . 0.0 111.662 179.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 74.8 mmm -121.29 -4.44 9.43 Favored 'General case' 0 C--O 1.224 -0.242 0 CA-C-O 118.18 -0.914 . . . . 0.0 112.658 -168.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -58.22 -14.09 17.58 Favored Glycine 0 CA--C 1.531 1.075 0 CA-C-N 120.07 1.305 . . . . 0.0 115.23 -173.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -70.14 -25.14 63.33 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 118.533 1.167 . . . . 0.0 111.775 172.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.428 ' HA ' ' HE2' ' A' ' 49' ' ' LYS . 9.7 mmpt? -123.67 -17.43 6.41 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 126.519 1.928 . . . . 0.0 111.628 -175.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 28.0 tp -118.94 159.39 23.9 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 124.718 1.207 . . . . 0.0 111.021 -169.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 37.2 ttmt -134.82 145.2 48.12 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 104.108 -2.552 . . . . 0.0 104.108 167.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 62.3 mt -115.81 141.11 34.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 175.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 69.1 t -132.83 96.81 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 -172.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -75.96 131.91 39.88 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 177.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 15.9 tt -140.34 135.49 36.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -97.78 115.57 28.28 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 123.875 0.87 . . . . 0.0 111.049 -168.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 35.7 m -60.96 -19.62 20.15 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 O-C-N 121.582 -0.699 . . . . 0.0 112.321 -178.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -63.39 -21.75 66.47 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.757 1.223 . . . . 0.0 113.004 179.092 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -131.79 1.76 4.01 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.655 0.782 . . . . 0.0 112.625 178.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 63.4 m-80 -129.88 39.41 3.7 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.683 0.793 . . . . 0.0 110.896 -170.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.2 mp0 -54.97 -31.88 61.11 Favored 'General case' 0 C--N 1.34 0.178 0 C-N-CA 123.707 0.803 . . . . 0.0 111.896 176.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 27.4 tp10 -67.31 -47.08 71.63 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 123.979 0.912 . . . . 0.0 110.556 -178.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.72 -39.46 76.84 Favored 'General case' 0 CA--C 1.535 0.395 0 O-C-N 121.728 -0.607 . . . . 0.0 109.561 179.316 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.29 -47.45 85.34 Favored 'General case' 0 CA--C 1.533 0.312 0 O-C-N 121.423 -0.798 . . . . 0.0 110.56 174.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -62.66 -27.11 69.3 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 124.055 0.836 . . . . 0.0 111.876 178.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 5.8 tppt? -55.67 -28.44 55.54 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.568 1.147 . . . . 0.0 111.877 177.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -124.22 11.39 8.78 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.81 0.844 . . . . 0.0 111.572 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 63.77 30.48 77.79 Favored Glycine 0 CA--C 1.532 1.094 0 C-N-CA 123.72 0.676 . . . . 0.0 112.761 -177.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 60.9 t -65.86 125.66 23.45 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 172.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 66.8 mtt -136.75 3.98 2.77 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.821 1.249 . . . . 0.0 111.448 -179.275 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 23.4 m -144.05 162.62 35.75 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 126.676 1.991 . . . . 0.0 107.768 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 44.2 pt -141.72 155.48 66.44 Favored Pre-proline 0 CA--C 1.545 0.78 0 C-N-CA 124.445 1.098 . . . . 0.0 108.796 175.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -67.38 139.62 48.1 Favored 'Cis proline' 0 C--N 1.35 0.607 0 CA-C-N 120.209 1.11 . . . . 0.0 110.209 -5.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 50.9 m -132.65 140.69 48.29 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 174.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 87.8 mt -123.62 129.18 50.76 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 -169.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -120.94 122.9 41.18 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 103.431 -2.803 . . . . 0.0 103.431 177.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 1.8 t -100.22 120.17 49.3 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 N-CA-C 103.899 -2.63 . . . . 0.0 103.899 176.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.3 mp -112.03 155.16 24.24 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 -178.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 57.8 tttp -134.59 115.59 14.04 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 105.785 -1.932 . . . . 0.0 105.785 177.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.0 t70 49.87 39.17 17.72 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.893 1.277 . . . . 0.0 112.374 176.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 104.79 -5.62 43.39 Favored Glycine 0 CA--C 1.529 0.955 0 CA-C-O 118.139 -1.367 . . . . 0.0 115.295 169.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -131.29 149.27 52.63 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 120.054 1.927 . . . . 0.0 110.527 -177.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 39.2 t -63.59 134.49 28.57 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 -179.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 8.7 p -118.94 -26.41 2.51 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 C-N-CA 125.065 1.346 . . . . 0.0 110.504 172.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -149.9 165.28 33.06 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 120.689 1.586 . . . . 0.0 110.046 173.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 17.2 m -140.86 151.18 44.1 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.442 1.497 . . . . 0.0 108.025 178.116 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 37.3 m -151.25 157.06 42.1 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.415 1.486 . . . . 0.0 109.265 169.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 30.6 t -135.62 145.65 31.14 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 -176.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 75.81 -176.75 50.65 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 123.896 0.76 . . . . 0.0 111.893 178.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 47.4 t80 -62.06 137.58 58.27 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 173.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 64.6 tttt -149.94 137.68 11.76 Favored Pre-proline 0 C--O 1.235 0.316 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 -178.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -70.7 153.73 64.45 Favored 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 121.628 1.552 . . . . 0.0 111.959 -172.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 29.2 ttpp -52.18 -45.39 65.11 Favored 'General case' 0 CA--C 1.518 -0.256 0 C-N-CA 125.805 1.642 . . . . 0.0 112.313 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -62.92 -43.31 99.14 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 -176.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.98 -43.1 96.73 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 122.421 0.288 . . . . 0.0 110.499 179.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 76.8 mt -62.32 -44.08 97.32 Favored 'General case' 0 C--O 1.231 0.095 0 CA-C-N 117.535 0.152 . . . . 0.0 110.911 178.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -74.24 -29.27 61.62 Favored 'General case' 0 N--CA 1.451 -0.42 0 O-C-N 122.178 -0.326 . . . . 0.0 110.892 -175.544 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 31.9 tp10 -70.23 -37.72 75.07 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 124.566 1.146 . . . . 0.0 110.543 173.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 53.6 mt -60.86 -50.32 73.89 Favored 'General case' 0 C--O 1.224 -0.246 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 172.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 33.0 t -52.22 -46.33 44.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 122.853 0.461 . . . . 0.0 109.949 173.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -62.77 -38.43 90.56 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 123.974 0.909 . . . . 0.0 112.258 -171.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 16.9 ptmt -67.13 -18.25 65.22 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 118.125 -0.94 . . . . 0.0 112.644 -175.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 25.2 p80 -127.13 -8.41 5.93 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 115.002 1.482 . . . . 0.0 115.002 -174.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 10.2 mt . . . . . 0 C--O 1.248 0.997 0 CA-C-O 118.029 -0.986 . . . . 0.0 109.368 167.433 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.6 ttm . . . . . 0 N--CA 1.483 1.212 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -157.23 -163.62 1.42 Allowed 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.311 1.444 . . . . 0.0 108.828 -172.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.8 mt -72.82 145.58 11.75 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 166.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 14.7 t -138.53 162.12 29.91 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 126.395 1.878 . . . . 0.0 106.805 -175.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -116.5 144.05 44.82 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 106.03 -1.841 . . . . 0.0 106.03 172.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -144.36 157.66 44.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.385 0.612 . . . . 0.0 111.566 -176.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 16.1 p -105.3 171.07 7.52 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 126.292 1.837 . . . . 0.0 107.646 168.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -47.26 -43.85 22.44 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 124.72 1.208 . . . . 0.0 113.112 176.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 66.9 mm-40 -79.93 -35.04 38.35 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 122.654 0.382 . . . . 0.0 111.533 -175.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.2 m -71.81 -32.38 67.53 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 122.772 0.429 . . . . 0.0 111.315 176.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -52.72 -46.74 67.53 Favored 'General case' 0 N--CA 1.457 -0.116 0 C-N-CA 125.128 1.371 . . . . 0.0 112.245 -169.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 9.5 m -63.75 -38.4 90.98 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 118.105 0.412 . . . . 0.0 111.86 -176.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -68.81 -44.31 73.81 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 176.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 69.0 mm-40 -63.94 -37.21 86.56 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 122.451 0.3 . . . . 0.0 110.925 -178.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.423 ' HA ' HG21 ' A' ' 20' ' ' VAL . 28.8 p -80.52 0.1 35.2 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.992 0.917 . . . . 0.0 113.332 -177.552 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 70.8 m -98.13 28.76 3.84 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.097 0.959 . . . . 0.0 112.16 -177.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -136.73 81.06 1.85 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.209 1.004 . . . . 0.0 110.023 -178.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 82.64 -156.66 35.17 Favored Glycine 0 C--N 1.338 0.65 0 N-CA-C 110.722 -0.951 . . . . 0.0 110.722 173.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 44.9 t -74.17 135.4 27.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 N-CA-C 106.034 -1.839 . . . . 0.0 106.034 168.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.423 HG21 ' HA ' ' A' ' 15' ' ' THR . 40.2 t -135.57 136.85 50.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 179.158 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.2 tt -120.01 111.36 17.8 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 106.198 -1.778 . . . . 0.0 106.198 -179.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -94.31 144.92 25.12 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 123.854 0.862 . . . . 0.0 109.104 -175.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -124.16 93.73 4.0 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 125.56 1.544 . . . . 0.0 107.469 -176.115 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -73.77 113.44 10.91 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 105.815 -1.92 . . . . 0.0 105.815 174.095 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -150.41 -176.57 5.53 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.727 1.211 . . . . 0.0 108.227 -171.156 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -152.13 149.15 22.58 Favored Pre-proline 0 C--N 1.331 -0.215 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 167.069 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -67.95 -12.65 35.95 Favored 'Trans proline' 0 N--CA 1.459 -0.543 0 CA-C-N 121.179 1.457 . . . . 0.0 113.071 -179.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 1.5 m95 -76.27 -12.84 60.15 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.665 0.786 . . . . 0.0 111.876 172.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 29.7 t -64.07 153.62 36.92 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.317 1.447 . . . . 0.0 111.089 -176.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.403 ' H ' ' HD2' ' A' ' 31' ' ' PRO . . . -101.51 -62.98 0.76 Allowed Glycine 0 CA--C 1.532 1.137 0 C-N-CA 124.723 1.154 . . . . 0.0 111.268 170.319 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.403 ' HD2' ' H ' ' A' ' 30' ' ' GLY . 25.3 Cg_endo -64.88 -25.96 59.72 Favored 'Trans proline' 0 C--N 1.35 0.611 0 CA-C-N 120.472 2.136 . . . . 0.0 113.266 -173.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 25.7 m -57.59 -34.43 69.23 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 121.537 -0.727 . . . . 0.0 111.433 174.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.4 mmtp -67.7 -22.79 65.25 Favored 'General case' 0 CA--C 1.531 0.22 0 O-C-N 121.663 -0.648 . . . . 0.0 111.199 -179.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 34.0 mtm -71.15 -43.64 67.12 Favored 'General case' 0 C--N 1.34 0.179 0 CA-C-N 118.723 0.692 . . . . 0.0 110.359 176.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 13.4 tt -84.21 -23.32 7.78 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-O 118.817 -0.611 . . . . 0.0 111.691 -175.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -48.4 -51.17 53.19 Favored Pre-proline 0 CA--C 1.548 0.889 0 CA-C-N 119.959 1.254 . . . . 0.0 114.27 178.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -66.59 -29.36 44.08 Favored 'Trans proline' 0 C--N 1.351 0.685 0 CA-C-N 121.628 1.617 . . . . 0.0 112.108 176.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 5.1 t -68.06 -36.59 76.01 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 O-C-N 121.585 -0.697 . . . . 0.0 109.751 175.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 74.1 mt -67.21 -36.05 80.9 Favored 'General case' 0 C--N 1.34 0.166 0 CA-C-N 119.518 1.053 . . . . 0.0 111.153 172.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -62.1 -42.66 99.45 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 119.227 0.921 . . . . 0.0 110.808 171.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -63.91 -39.44 94.19 Favored 'General case' 0 CA--C 1.533 0.298 0 O-C-N 121.078 -1.014 . . . . 0.0 110.381 175.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 36.9 tp -62.81 -42.36 99.68 Favored 'General case' 0 CA--C 1.527 0.088 0 C-N-CA 123.754 0.822 . . . . 0.0 110.237 176.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -59.09 -43.15 91.83 Favored 'General case' 0 CA--C 1.522 -0.13 0 C-N-CA 123.363 0.665 . . . . 0.0 110.657 176.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -71.44 -10.67 60.14 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.327 0.651 . . . . 0.0 112.645 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 23.9 mm-40 -106.63 -28.41 10.24 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 125.419 1.487 . . . . 0.0 111.759 -178.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 23.1 mtp -131.73 -1.7 3.79 Favored 'General case' 0 N--CA 1.461 0.118 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 -169.126 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -54.69 -15.6 6.39 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 124.777 1.179 . . . . 0.0 115.616 -174.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -69.7 -28.91 66.24 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.842 1.257 . . . . 0.0 112.016 175.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 41.7 mmtm -123.88 -16.06 6.73 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 125.757 1.623 . . . . 0.0 112.39 -177.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 58.5 tp -119.28 139.04 52.56 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 123.982 0.913 . . . . 0.0 110.289 -170.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -111.69 145.67 38.87 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 105.009 -2.219 . . . . 0.0 105.009 168.074 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 90.4 mt -116.99 138.93 46.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 105.747 -1.946 . . . . 0.0 105.747 174.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 98.3 t -132.75 98.87 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 -171.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 54.2 mtpt -74.28 140.25 44.82 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 174.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 14.3 tt -142.71 128.05 16.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 177.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 64.6 t0 -87.57 107.22 18.49 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 124.4 1.08 . . . . 0.0 109.323 -169.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 29.0 m -61.69 -20.81 24.15 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 CA-C-O 118.737 -0.649 . . . . 0.0 112.143 -177.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -69.04 -14.06 62.81 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 119.691 1.132 . . . . 0.0 112.112 178.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -127.06 0.52 6.52 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.1 0.96 . . . . 0.0 111.997 178.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 67.8 m-80 -138.39 41.92 2.21 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.735 0.814 . . . . 0.0 111.104 -169.247 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 5.4 mp0 -54.62 -31.66 57.57 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.376 0.67 . . . . 0.0 112.104 176.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 -64.72 -46.69 81.23 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 118.471 0.578 . . . . 0.0 110.411 -178.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.6 -38.49 73.99 Favored 'General case' 0 C--O 1.223 -0.303 0 C-N-CA 123.162 0.585 . . . . 0.0 109.503 -178.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -58.09 -47.9 81.8 Favored 'General case' 0 CA--C 1.535 0.376 0 O-C-N 121.28 -0.888 . . . . 0.0 110.236 172.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -61.34 -29.02 70.33 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 124.117 0.865 . . . . 0.0 112.265 177.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 74.3 tttt -55.7 -28.73 57.26 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.774 1.23 . . . . 0.0 111.873 178.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -123.2 9.94 9.28 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.69 0.796 . . . . 0.0 111.956 178.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 63.57 31.71 81.71 Favored Glycine 0 CA--C 1.533 1.218 0 CA-C-O 119.459 -0.634 . . . . 0.0 112.578 -176.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 61.3 t -64.19 124.59 19.26 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 172.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 78.2 mtm -137.06 3.53 2.66 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.924 1.29 . . . . 0.0 111.522 -178.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 39.1 m -141.48 163.87 31.76 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 126.767 2.027 . . . . 0.0 107.532 175.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 41.1 pt -142.99 155.12 62.49 Favored Pre-proline 0 CA--C 1.546 0.806 0 C-N-CA 124.596 1.158 . . . . 0.0 108.626 174.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -67.62 137.68 39.15 Favored 'Cis proline' 0 C--N 1.349 0.587 0 CA-C-N 120.5 1.214 . . . . 0.0 110.204 -4.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 35.9 m -129.96 134.17 47.28 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 106.97 -1.493 . . . . 0.0 106.97 175.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 10.9 mp -114.47 126.54 55.07 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 -169.238 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -114.73 147.72 39.3 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 104.583 -2.377 . . . . 0.0 104.583 175.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.4 t -126.79 128.79 71.24 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.624 0 N-CA-C 104.706 -2.331 . . . . 0.0 104.706 -177.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.4 mp -130.22 147.89 52.0 Favored 'General case' 0 N--CA 1.445 -0.725 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 -172.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 21.4 tptm -133.74 118.32 17.95 Favored 'General case' 0 CA--C 1.514 -0.439 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 29.2 t70 51.15 33.89 10.17 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.486 1.515 . . . . 0.0 112.55 174.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 110.72 -3.48 29.07 Favored Glycine 0 CA--C 1.527 0.806 0 CA-C-O 118.062 -1.41 . . . . 0.0 114.869 169.063 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -130.2 144.78 51.56 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 120.027 1.914 . . . . 0.0 110.164 -177.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 13.6 p -65.55 133.23 30.94 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 176.339 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 8.0 p -126.28 -19.02 2.78 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-O 117.653 -1.165 . . . . 0.0 111.239 -179.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -156.48 169.96 23.42 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 121.116 1.78 . . . . 0.0 111.529 177.538 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 15.6 m -147.11 151.73 37.31 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.454 1.501 . . . . 0.0 108.907 178.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 65.1 m -152.25 157.39 41.35 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 126.18 1.792 . . . . 0.0 108.321 171.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 28.7 t -134.06 142.76 40.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 -176.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.56 -176.81 53.56 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 123.58 0.61 . . . . 0.0 112.44 177.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 66.1 t80 -63.17 150.4 42.98 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.39 1.076 . . . . 0.0 110.939 178.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -146.97 146.14 24.91 Favored Pre-proline 0 N--CA 1.467 0.384 0 C-N-CA 125.355 1.462 . . . . 0.0 107.4 168.034 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -71.24 157.66 56.62 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 122.444 2.096 . . . . 0.0 110.219 170.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 48.5 pttt -58.48 -30.29 66.87 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -178.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -67.18 -45.12 77.92 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 118.508 0.594 . . . . 0.0 109.946 178.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.47 -38.12 89.93 Favored 'General case' 0 CA--C 1.529 0.165 0 O-C-N 121.845 -0.534 . . . . 0.0 110.57 176.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 95.0 mt -64.34 -42.74 96.12 Favored 'General case' 0 C--O 1.226 -0.146 0 CA-C-O 119.26 -0.4 . . . . 0.0 111.327 176.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 15.8 mt-30 -58.11 -42.16 85.13 Favored 'General case' 0 C--O 1.226 -0.139 0 CA-C-N 118.584 0.629 . . . . 0.0 109.971 174.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -65.08 -40.09 94.15 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 118.115 0.416 . . . . 0.0 110.579 -179.414 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 68.9 tp -61.97 -43.74 98.21 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.44 1.096 . . . . 0.0 110.712 176.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 93.3 t -62.56 -43.44 98.43 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 123.585 0.754 . . . . 0.0 109.743 174.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -60.28 -27.67 67.47 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 125.101 1.36 . . . . 0.0 112.055 -172.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -56.07 -24.07 37.65 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.549 0.74 . . . . 0.0 112.668 174.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 47.4 m-70 -125.37 -3.42 7.39 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 -168.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 84.2 mt . . . . . 0 C--O 1.25 1.083 0 CA-C-N 118.785 0.721 . . . . 0.0 109.184 172.65 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.199 0 CA-C-O 118.391 -0.814 . . . . 0.0 113.017 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -152.07 177.98 9.94 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 119.888 1.222 . . . . 0.0 109.952 -172.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.5 mt -75.64 147.46 8.09 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 167.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 18.2 t -138.36 161.97 30.62 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 C-N-CA 126.157 1.783 . . . . 0.0 106.887 -175.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 3.7 tppp? -116.33 142.04 47.37 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 106.001 -1.852 . . . . 0.0 106.001 172.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -146.36 166.33 26.66 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.399 0.619 . . . . 0.0 111.053 -177.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.442 HG22 HD21 ' A' ' 60' ' ' ASN . 28.5 p -135.47 174.36 10.7 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 126.444 1.897 . . . . 0.0 107.578 170.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -48.53 -29.78 4.57 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.851 1.26 . . . . 0.0 113.149 173.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -59.35 -29.84 67.95 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.071 1.348 . . . . 0.0 113.052 178.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 14.4 m -141.22 -7.1 1.04 Allowed 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 -169.355 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 77.8 t80 -53.75 -43.64 69.31 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 124.009 0.923 . . . . 0.0 111.772 -174.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.7 m -63.35 -38.91 92.98 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.086 0.554 . . . . 0.0 111.762 -179.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -68.13 -44.26 76.48 Favored 'General case' 0 N--CA 1.453 -0.313 0 O-C-N 122.05 -0.406 . . . . 0.0 109.954 177.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 67.3 mm-40 -63.11 -36.47 83.7 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 122.367 0.267 . . . . 0.0 110.985 -178.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 25.6 p -82.93 1.21 40.75 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.049 0.939 . . . . 0.0 113.367 -177.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 67.4 m -101.63 31.01 3.98 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.204 1.002 . . . . 0.0 111.746 -176.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -132.66 62.09 1.66 Allowed 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.198 0.999 . . . . 0.0 110.206 -178.234 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 91.54 -156.24 23.86 Favored Glycine 0 C--N 1.339 0.715 0 N-CA-C 109.899 -1.281 . . . . 0.0 109.899 176.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 94.4 t -70.81 135.32 28.32 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 168.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 55.7 t -137.51 142.95 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 N-CA-C 105.742 -1.947 . . . . 0.0 105.742 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.2 tt -122.94 100.87 7.11 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 -176.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -83.29 146.03 28.76 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.376 -179.162 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -124.46 94.08 4.1 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 125.906 1.682 . . . . 0.0 107.356 -177.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -73.91 112.79 10.37 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 105.891 -1.892 . . . . 0.0 105.891 175.157 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -148.56 -178.91 6.59 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.95 1.3 . . . . 0.0 108.475 -172.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -158.34 147.76 14.91 Favored Pre-proline 0 CA--C 1.531 0.245 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 167.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -62.87 -12.0 27.06 Favored 'Trans proline' 0 CA--C 1.535 0.573 0 CA-C-N 121.53 1.582 . . . . 0.0 116.086 -178.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 54.2 p-90 -70.72 -19.33 62.76 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 120.731 1.605 . . . . 0.0 111.784 171.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 15.3 t -61.2 162.58 7.3 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.41 1.484 . . . . 0.0 111.187 -177.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -119.94 -59.19 0.25 Allowed Glycine 0 CA--C 1.531 1.049 0 CA-C-O 118.513 -1.159 . . . . 0.0 110.694 171.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -54.13 -31.46 65.41 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 123.832 3.021 . . . . 0.0 114.118 179.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 79.8 m -52.37 -37.0 55.14 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.694 1.198 . . . . 0.0 111.915 174.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 75.2 mttt -83.06 -14.69 53.32 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.381 0.672 . . . . 0.0 110.861 -175.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 26.8 mtm -73.1 -43.71 61.39 Favored 'General case' 0 C--N 1.341 0.197 0 CA-C-N 118.886 0.767 . . . . 0.0 109.541 169.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 16.3 tt -80.37 -23.95 11.4 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-O 118.609 -0.71 . . . . 0.0 111.431 -178.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -48.39 -51.16 53.11 Favored Pre-proline 0 CA--C 1.548 0.881 0 CA-C-N 120.359 1.436 . . . . 0.0 114.315 179.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -66.9 -25.76 44.81 Favored 'Trans proline' 0 C--N 1.349 0.59 0 CA-C-N 121.958 1.735 . . . . 0.0 112.597 176.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.5 t -71.4 -35.77 58.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 O-C-N 121.454 -0.779 . . . . 0.0 109.589 174.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 95.7 mt -66.78 -35.26 79.67 Favored 'General case' 0 C--N 1.341 0.202 0 CA-C-N 119.515 1.052 . . . . 0.0 111.233 170.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -63.09 -42.13 99.55 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 119.566 1.075 . . . . 0.0 110.83 171.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -60.73 -44.86 96.11 Favored 'General case' 0 CA--C 1.53 0.174 0 O-C-N 121.505 -0.747 . . . . 0.0 110.021 173.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 34.0 tp -60.7 -41.85 96.02 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.668 0.787 . . . . 0.0 110.355 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -60.97 -43.5 98.7 Favored 'General case' 0 CA--C 1.521 -0.172 0 C-N-CA 123.264 0.626 . . . . 0.0 110.82 177.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -72.41 -10.71 60.13 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.276 0.63 . . . . 0.0 112.502 179.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -104.44 -28.57 11.25 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 125.31 1.444 . . . . 0.0 111.367 -178.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 25.4 mtp -133.69 -2.66 2.98 Favored 'General case' 0 C--N 1.339 0.146 0 N-CA-C 113.966 1.099 . . . . 0.0 113.966 -169.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -55.05 -17.2 9.44 Favored Glycine 0 CA--C 1.534 1.259 0 CA-C-N 120.148 1.34 . . . . 0.0 115.234 -173.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -67.14 -30.7 70.75 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.727 1.211 . . . . 0.0 111.934 174.093 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 40.3 mmtm -117.21 -17.41 10.22 Favored 'General case' 0 N--CA 1.462 0.149 0 C-N-CA 125.989 1.716 . . . . 0.0 111.938 -178.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 46.8 tp -116.75 154.66 30.27 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.2 1.0 . . . . 0.0 110.599 -169.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -130.12 144.56 51.42 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 104.11 -2.552 . . . . 0.0 104.11 167.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 75.8 mt -117.7 138.27 48.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 105.266 -2.124 . . . . 0.0 105.266 177.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 96.9 t -133.09 98.2 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 -169.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 52.6 mtpt -74.11 139.57 44.67 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 175.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 13.5 tt -141.76 127.16 18.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 176.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -85.27 103.73 14.48 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.615 1.166 . . . . 0.0 108.901 -171.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 29.7 m -59.85 -25.63 33.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 118.614 -0.708 . . . . 0.0 112.003 -174.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -65.41 -17.82 64.83 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 119.494 1.043 . . . . 0.0 112.055 -178.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -120.65 5.31 10.56 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.103 1.361 . . . . 0.0 111.037 178.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.442 HD21 HG22 ' A' ' 7' ' ' THR . 66.5 m-80 -141.39 40.28 1.74 Allowed 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.588 1.155 . . . . 0.0 109.665 -171.016 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 51.2 mm-40 -55.2 -31.29 61.31 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.854 0.861 . . . . 0.0 110.893 175.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -65.91 -50.42 64.5 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 124.056 0.943 . . . . 0.0 109.941 179.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.9 -38.8 83.42 Favored 'General case' 0 C--O 1.223 -0.299 0 C-N-CA 123.37 0.668 . . . . 0.0 109.643 -178.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -58.99 -48.03 83.05 Favored 'General case' 0 CA--C 1.533 0.299 0 O-C-N 121.061 -1.024 . . . . 0.0 110.305 172.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -60.95 -28.77 69.2 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 123.901 0.762 . . . . 0.0 112.331 177.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 47.8 tptt -56.33 -29.2 60.99 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.723 1.209 . . . . 0.0 111.471 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -124.16 10.91 8.77 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.507 0.723 . . . . 0.0 111.679 -179.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 63.75 31.16 79.85 Favored Glycine 0 CA--C 1.532 1.14 0 C-N-CA 123.643 0.639 . . . . 0.0 112.584 -176.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 49.3 t -65.7 123.78 19.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 171.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 67.1 mtt -136.07 3.64 2.92 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.693 1.197 . . . . 0.0 111.463 -178.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 25.6 m -143.93 161.53 38.46 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 126.849 2.06 . . . . 0.0 107.302 178.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 39.0 pt -143.25 156.11 61.23 Favored Pre-proline 0 CA--C 1.545 0.761 0 C-N-CA 124.636 1.175 . . . . 0.0 108.76 177.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -67.15 139.1 44.69 Favored 'Cis proline' 0 C--N 1.35 0.629 0 CA-C-N 120.347 1.16 . . . . 0.0 110.168 -4.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 26.6 m -130.14 140.76 50.74 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 174.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 89.8 mt -120.08 125.0 47.2 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 106.546 -1.65 . . . . 0.0 106.546 -169.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -114.86 119.83 37.93 Favored 'General case' 0 CA--C 1.512 -0.509 0 N-CA-C 103.663 -2.717 . . . . 0.0 103.663 177.064 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.8 t -90.58 123.18 42.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 103.217 -2.883 . . . . 0.0 103.217 172.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.1 mp -114.66 155.84 25.85 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 173.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -137.91 122.75 18.84 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 173.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.0 t70 49.55 37.33 12.15 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.034 1.334 . . . . 0.0 112.471 176.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 103.91 -4.27 45.66 Favored Glycine 0 CA--C 1.529 0.918 0 CA-C-O 118.217 -1.324 . . . . 0.0 115.202 168.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -131.85 152.81 50.76 Favored 'General case' 0 C--N 1.339 0.137 0 CA-C-N 120.054 1.927 . . . . 0.0 110.209 -177.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 40.8 t -63.14 134.15 28.5 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.5 p -119.02 -20.81 4.8 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 C-N-CA 125.377 1.471 . . . . 0.0 110.006 176.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -161.04 169.15 23.06 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 120.23 1.377 . . . . 0.0 110.685 169.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 8.9 m -136.14 150.83 49.24 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.369 1.468 . . . . 0.0 108.288 173.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 63.7 m -151.07 159.11 44.71 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.483 1.513 . . . . 0.0 108.559 169.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 40.4 t -133.84 148.54 30.38 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 N-CA-C 107.929 -1.138 . . . . 0.0 107.929 -177.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 76.86 -174.88 54.08 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 123.45 0.548 . . . . 0.0 112.404 175.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -64.78 148.62 50.85 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.001 0.92 . . . . 0.0 110.935 -179.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.75 142.18 16.41 Favored Pre-proline 0 CA--C 1.533 0.322 0 C-N-CA 125.455 1.502 . . . . 0.0 107.093 167.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -72.45 161.44 44.23 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 122.747 2.298 . . . . 0.0 110.635 175.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 41.5 pttt -59.25 -29.99 67.95 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 -178.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -66.38 -49.7 65.95 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 118.418 0.554 . . . . 0.0 109.908 176.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.57 -39.96 95.73 Favored 'General case' 0 CA--C 1.528 0.132 0 O-C-N 122.026 -0.421 . . . . 0.0 110.599 179.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 78.4 mt -62.94 -43.55 98.47 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.021 0.528 . . . . 0.0 111.188 177.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -59.16 -41.78 89.19 Favored 'General case' 0 C--O 1.225 -0.189 0 CA-C-N 118.342 0.519 . . . . 0.0 109.981 176.057 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -66.78 -38.98 87.6 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 118.624 0.647 . . . . 0.0 110.876 -179.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 67.4 tp -62.47 -36.64 83.12 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.842 1.257 . . . . 0.0 110.972 176.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 94.2 t -70.48 -49.32 53.84 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 CA-C-N 119.178 0.899 . . . . 0.0 109.501 171.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -56.46 -40.55 75.03 Favored 'General case' 0 CA--C 1.52 -0.204 0 C-N-CA 125.901 1.68 . . . . 0.0 111.854 -168.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -67.37 -6.21 17.92 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 -176.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 90.4 m-70 -120.89 -7.54 9.49 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.346 1.058 . . . . 0.0 112.686 177.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 60.6 mt . . . . . 0 C--O 1.248 0.99 0 CA-C-N 119.239 0.927 . . . . 0.0 109.15 173.811 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.8 mpp? . . . . . 0 N--CA 1.482 1.151 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -149.93 -173.38 4.41 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.518 1.527 . . . . 0.0 108.805 -177.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.2 mt -75.25 145.09 11.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 167.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 31.9 t -136.33 163.48 33.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 126.192 1.797 . . . . 0.0 106.877 -175.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -118.05 142.84 46.96 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 105.919 -1.882 . . . . 0.0 105.919 174.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -144.52 166.4 25.26 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.407 0.622 . . . . 0.0 111.027 -177.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 18.3 p -134.09 171.21 14.54 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 126.448 1.899 . . . . 0.0 107.731 171.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -52.73 -29.42 26.88 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.611 1.164 . . . . 0.0 113.046 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 56.7 mt-30 -62.87 -28.98 70.4 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.216 1.406 . . . . 0.0 113.004 179.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.4 m -136.27 -6.63 2.04 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 113.517 0.932 . . . . 0.0 113.517 -169.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -52.19 -43.97 64.44 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.431 1.092 . . . . 0.0 111.677 -178.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.5 m -63.21 -38.95 93.19 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.063 0.545 . . . . 0.0 111.857 -179.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -67.98 -44.35 76.87 Favored 'General case' 0 N--CA 1.452 -0.344 0 O-C-N 122.02 -0.425 . . . . 0.0 110.066 177.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 66.7 mm-40 -63.22 -35.87 81.75 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 122.416 0.286 . . . . 0.0 110.946 -178.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 27.5 p -83.51 1.37 42.22 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.044 0.938 . . . . 0.0 113.377 -177.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 68.1 m -102.02 30.97 4.13 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.18 0.992 . . . . 0.0 111.802 -176.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -132.68 57.79 1.78 Allowed 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.1 0.96 . . . . 0.0 110.526 -177.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 98.65 -153.43 19.88 Favored Glycine 0 C--N 1.337 0.636 0 N-CA-C 110.084 -1.206 . . . . 0.0 110.084 174.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 55.0 t -72.05 135.06 28.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 N-CA-C 105.744 -1.947 . . . . 0.0 105.744 167.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 46.6 t -137.5 142.96 35.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 105.908 -1.886 . . . . 0.0 105.908 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.6 tt -125.27 101.42 6.97 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 106.03 -1.841 . . . . 0.0 106.03 -177.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -82.55 144.64 30.23 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.275 -179.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -121.18 93.79 4.13 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 125.955 1.702 . . . . 0.0 107.166 -178.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -72.7 111.6 7.99 Favored 'General case' 0 C--O 1.239 0.545 0 N-CA-C 105.689 -1.967 . . . . 0.0 105.689 174.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -146.86 -177.46 5.67 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 125.241 1.417 . . . . 0.0 108.168 -171.643 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -155.73 149.59 19.25 Favored Pre-proline 0 C--N 1.33 -0.265 0 N-CA-C 106.405 -1.702 . . . . 0.0 106.405 168.078 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -68.53 -12.58 35.17 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 121.378 1.386 . . . . 0.0 114.231 -176.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 52.0 p-90 -71.02 -19.69 62.48 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 120.233 1.378 . . . . 0.0 112.192 169.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 27.8 t -60.36 153.25 23.23 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.964 1.306 . . . . 0.0 111.419 -172.004 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.405 ' H ' ' HD2' ' A' ' 31' ' ' PRO . . . -102.46 -61.2 0.73 Allowed Glycine 0 CA--C 1.533 1.195 0 C-N-CA 124.585 1.088 . . . . 0.0 111.626 171.49 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.405 ' HD2' ' H ' ' A' ' 30' ' ' GLY . 28.5 Cg_endo -66.95 -25.57 44.63 Favored 'Trans proline' 0 C--N 1.348 0.517 0 CA-C-N 120.46 2.13 . . . . 0.0 112.702 -174.582 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 24.6 m -56.41 -35.51 67.87 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 121.235 -0.916 . . . . 0.0 111.023 172.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.6 mmtp -69.31 -26.21 64.61 Favored 'General case' 0 CA--C 1.529 0.155 0 O-C-N 121.564 -0.71 . . . . 0.0 111.296 -178.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 5.1 ptt? -85.7 -31.55 22.41 Favored 'General case' 0 C--N 1.34 0.188 0 CA-C-N 118.961 0.8 . . . . 0.0 111.414 -176.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 18.2 tt -77.57 -25.26 14.78 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-O 118.591 -0.718 . . . . 0.0 111.537 170.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -49.71 -49.57 72.23 Favored Pre-proline 0 CA--C 1.547 0.839 0 CA-C-N 120.379 1.445 . . . . 0.0 114.367 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -66.35 -28.88 46.55 Favored 'Trans proline' 0 C--N 1.349 0.601 0 CA-C-N 122.038 1.763 . . . . 0.0 112.122 176.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.1 t -67.82 -37.26 78.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 O-C-N 121.666 -0.646 . . . . 0.0 109.553 174.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 96.1 mt -66.74 -34.82 78.69 Favored 'General case' 0 C--N 1.34 0.175 0 CA-C-N 119.46 1.027 . . . . 0.0 111.422 171.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -63.05 -42.33 99.7 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 119.556 1.071 . . . . 0.0 110.716 171.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -63.94 -39.49 94.27 Favored 'General case' 0 CA--C 1.531 0.24 0 O-C-N 121.243 -0.911 . . . . 0.0 110.421 175.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 42.8 tp -62.4 -43.04 99.77 Favored 'General case' 0 CA--C 1.527 0.077 0 C-N-CA 123.643 0.777 . . . . 0.0 110.205 175.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -60.06 -42.36 94.34 Favored 'General case' 0 CA--C 1.521 -0.137 0 C-N-CA 123.453 0.701 . . . . 0.0 110.805 178.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 -71.98 -10.8 60.28 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.263 0.625 . . . . 0.0 112.481 -179.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -105.54 -32.53 8.46 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 125.265 1.426 . . . . 0.0 111.415 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 71.5 mmm -125.77 -3.14 7.18 Favored 'General case' 0 C--O 1.226 -0.138 0 CA-C-O 118.414 -0.803 . . . . 0.0 113.152 -167.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -57.63 -13.59 12.48 Favored Glycine 0 CA--C 1.533 1.185 0 CA-C-N 119.769 1.168 . . . . 0.0 115.847 -172.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -77.1 -24.98 51.73 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 118.462 1.131 . . . . 0.0 111.721 174.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 51.1 mmtt -117.38 -21.08 8.85 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 125.648 1.579 . . . . 0.0 111.445 -177.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 52.2 tp -122.26 148.45 44.98 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 125.16 1.384 . . . . 0.0 110.223 -169.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -120.64 145.42 47.42 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 105.116 -2.179 . . . . 0.0 105.116 167.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 77.3 mt -115.01 138.01 46.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 105.637 -1.986 . . . . 0.0 105.637 176.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 93.5 t -133.56 98.6 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-N 118.879 0.763 . . . . 0.0 109.236 -170.193 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 52.9 mtpt -73.89 140.37 45.63 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 176.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 13.9 tt -142.72 127.87 16.39 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 176.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 50.6 t0 -84.02 103.43 13.25 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 124.732 1.213 . . . . 0.0 109.004 -172.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 28.3 m -59.36 -28.36 39.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 118.819 -0.61 . . . . 0.0 111.888 -174.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -66.64 -19.3 65.73 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 119.258 0.935 . . . . 0.0 111.846 -177.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -114.62 1.41 14.23 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.547 1.539 . . . . 0.0 110.828 178.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 68.3 m-80 -141.67 42.42 1.72 Allowed 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 124.4 1.08 . . . . 0.0 109.54 -169.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 45.0 mm-40 -55.81 -32.57 63.67 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.041 0.936 . . . . 0.0 111.269 178.239 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 -66.08 -47.58 73.8 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 118.384 0.538 . . . . 0.0 110.47 179.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.94 -39.41 79.59 Favored 'General case' 0 C--O 1.223 -0.327 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 -178.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -58.99 -47.81 83.83 Favored 'General case' 0 CA--C 1.533 0.325 0 O-C-N 121.207 -0.933 . . . . 0.0 110.264 173.097 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -60.85 -28.72 68.87 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 124.062 0.839 . . . . 0.0 112.405 177.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 24.4 tptp -56.18 -29.21 60.53 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.68 1.192 . . . . 0.0 111.47 179.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -124.27 10.73 8.69 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.557 0.743 . . . . 0.0 111.61 -179.1 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 63.71 31.36 80.51 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 123.728 0.68 . . . . 0.0 112.588 -177.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 53.7 t -65.55 123.67 18.94 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 172.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 99.0 mtp -135.99 3.49 2.93 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.757 1.223 . . . . 0.0 111.486 -179.121 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 24.5 m -143.89 160.96 39.88 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 126.656 1.983 . . . . 0.0 107.409 178.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 41.9 pt -143.14 154.9 61.89 Favored Pre-proline 0 CA--C 1.545 0.781 0 C-N-CA 124.468 1.107 . . . . 0.0 108.93 177.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -67.1 139.69 47.54 Favored 'Cis proline' 0 C--N 1.35 0.626 0 CA-C-N 120.373 1.169 . . . . 0.0 110.42 -4.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 24.6 m -130.36 140.8 50.59 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 174.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 86.2 mt -121.28 123.57 42.52 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 -169.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -114.06 122.45 46.93 Favored 'General case' 0 CA--C 1.512 -0.513 0 N-CA-C 103.627 -2.731 . . . . 0.0 103.627 178.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.2 t -96.02 127.18 48.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 N-CA-C 104.002 -2.592 . . . . 0.0 104.002 174.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.0 mp -119.66 155.05 33.09 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 177.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -137.05 119.47 15.82 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 106.376 -1.713 . . . . 0.0 106.376 176.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.0 t70 49.52 38.2 14.04 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.97 1.308 . . . . 0.0 112.482 177.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 104.67 -5.1 43.31 Favored Glycine 0 CA--C 1.529 0.944 0 CA-C-O 118.148 -1.362 . . . . 0.0 115.46 168.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -130.81 150.57 51.92 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 120.006 1.903 . . . . 0.0 110.276 -177.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 42.9 t -62.73 133.29 28.6 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.4 p -119.25 -21.03 4.61 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 125.19 1.396 . . . . 0.0 110.36 176.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -158.51 168.59 26.51 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 120.582 1.537 . . . . 0.0 110.317 173.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 18.1 m -146.37 143.31 28.99 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.385 1.074 . . . . 0.0 109.063 175.23 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 49.5 m -144.62 156.23 44.02 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.561 1.544 . . . . 0.0 108.66 176.213 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 41.2 t -133.76 146.44 31.77 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 -175.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 75.21 -174.25 52.12 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 123.292 0.473 . . . . 0.0 112.271 178.185 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 67.4 t80 -65.3 148.66 51.31 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.674 0.79 . . . . 0.0 111.347 -178.175 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.29 140.18 14.64 Favored Pre-proline 0 CA--C 1.534 0.349 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 167.383 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -72.05 161.66 44.07 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 122.718 2.279 . . . . 0.0 110.497 175.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 49.3 pttt -58.51 -29.34 66.19 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 113.571 0.952 . . . . 0.0 113.571 -178.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -65.91 -50.34 64.8 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 118.595 0.634 . . . . 0.0 109.559 176.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.53 -39.07 93.46 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 122.721 0.409 . . . . 0.0 110.821 178.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 87.8 mt -63.49 -44.06 95.47 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 122.985 0.514 . . . . 0.0 111.156 176.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 -61.17 -41.95 97.68 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-N 118.426 0.557 . . . . 0.0 110.153 176.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -63.31 -41.18 98.91 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 118.15 0.432 . . . . 0.0 110.238 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 61.3 tp -61.71 -46.01 91.5 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.705 1.202 . . . . 0.0 110.674 176.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 72.8 t -58.32 -44.86 89.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 CA-C-N 118.75 0.705 . . . . 0.0 109.462 173.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -62.59 -25.29 68.0 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.905 1.282 . . . . 0.0 112.153 -174.017 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -57.61 -22.14 43.42 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 118.506 -0.759 . . . . 0.0 112.452 172.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 70.8 m-70 -124.09 -8.26 7.69 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 -168.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 77.3 mt . . . . . 0 C--O 1.246 0.886 0 CA-C-O 118.363 -0.827 . . . . 0.0 109.416 171.54 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.3 mtt . . . . . 0 N--CA 1.483 1.19 0 CA-C-O 118.985 -0.531 . . . . 0.0 111.154 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -67.2 -20.62 65.73 Favored 'General case' 0 CA--C 1.51 -0.581 0 N-CA-C 116.844 2.164 . . . . 0.0 116.844 -169.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 12.0 mt -82.12 137.61 20.84 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.192 0 CA-C-N 114.312 -1.313 . . . . 0.0 108.901 -168.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 5.4 t -137.45 160.85 34.87 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 C-N-CA 126.702 2.001 . . . . 0.0 106.472 -174.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.34 133.07 50.12 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 105.358 -2.09 . . . . 0.0 105.358 176.506 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -142.8 174.96 10.19 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 123.611 0.764 . . . . 0.0 111.421 -170.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.3 p -138.14 171.74 13.94 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 126.732 2.013 . . . . 0.0 106.661 168.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -50.45 -27.95 7.42 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 175.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -55.06 -31.33 61.05 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.732 1.613 . . . . 0.0 112.756 177.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.1 m -139.67 -10.1 1.21 Allowed 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 124.035 0.934 . . . . 0.0 113.059 -170.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -53.57 -42.08 67.2 Favored 'General case' 0 C--O 1.231 0.117 0 C-N-CA 124.472 1.109 . . . . 0.0 111.316 -177.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.4 m -63.38 -36.9 85.27 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.16 0.584 . . . . 0.0 112.027 179.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -69.7 -44.25 70.79 Favored 'General case' 0 N--CA 1.453 -0.313 0 O-C-N 121.998 -0.439 . . . . 0.0 110.005 177.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -62.8 -40.88 98.74 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 122.827 0.451 . . . . 0.0 110.463 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.434 ' HA ' HG21 ' A' ' 20' ' ' VAL . 26.0 p -77.3 1.84 17.53 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.867 0.867 . . . . 0.0 113.252 -179.484 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 63.5 m -105.18 32.76 4.02 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.531 1.132 . . . . 0.0 111.206 179.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -130.97 51.48 2.13 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.2 1.0 . . . . 0.0 110.51 -178.125 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 97.27 -156.7 20.85 Favored Glycine 0 C--N 1.337 0.588 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 179.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 74.4 t -70.94 136.59 25.59 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 168.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.434 HG21 ' HA ' ' A' ' 15' ' ' THR . 54.6 t -137.84 135.55 45.66 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 N-CA-C 106.039 -1.838 . . . . 0.0 106.039 -179.084 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.0 tt -113.25 99.95 8.2 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 105.754 -1.943 . . . . 0.0 105.754 -176.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -83.07 146.62 28.6 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 179.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -127.21 94.17 3.93 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 126.236 1.814 . . . . 0.0 107.66 -176.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -74.5 114.07 12.47 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 106.109 -1.811 . . . . 0.0 106.109 175.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -149.99 -177.04 5.68 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.918 1.287 . . . . 0.0 108.778 -171.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -152.86 147.16 18.77 Favored Pre-proline 0 CA--C 1.531 0.245 0 N-CA-C 105.936 -1.875 . . . . 0.0 105.936 167.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -58.81 -18.39 41.4 Favored 'Trans proline' 0 CA--C 1.531 0.36 0 C-N-CA 121.933 1.755 . . . . 0.0 114.844 178.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 1.9 m95 -74.28 -14.65 60.94 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 118.91 0.777 . . . . 0.0 111.908 176.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 34.9 t -63.95 152.54 39.69 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.41 1.484 . . . . 0.0 111.14 -175.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -100.5 -64.4 0.8 Allowed Glycine 0 CA--C 1.53 1.002 0 CA-C-O 118.446 -1.197 . . . . 0.0 110.997 171.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -62.3 -26.28 77.08 Favored 'Trans proline' 0 C--N 1.35 0.646 0 CA-C-N 120.44 2.12 . . . . 0.0 113.675 -174.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 33.7 m -57.01 -34.41 68.15 Favored 'General case' 0 CA--C 1.537 0.446 0 O-C-N 121.577 -0.702 . . . . 0.0 111.627 174.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.2 mmtp -67.53 -24.36 65.55 Favored 'General case' 0 CA--C 1.531 0.226 0 O-C-N 121.529 -0.732 . . . . 0.0 111.118 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 30.8 mtm -72.45 -42.7 64.72 Favored 'General case' 0 C--N 1.34 0.159 0 CA-C-N 118.581 0.628 . . . . 0.0 110.439 177.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 17.1 tt -83.48 -22.12 8.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-O 118.726 -0.654 . . . . 0.0 111.7 -175.117 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -50.24 -52.18 56.3 Favored Pre-proline 0 CA--C 1.549 0.915 0 CA-C-N 120.059 1.3 . . . . 0.0 113.674 177.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -66.84 -27.62 43.71 Favored 'Trans proline' 0 C--N 1.351 0.675 0 CA-C-N 121.606 1.609 . . . . 0.0 112.305 176.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 22.0 t -68.1 -39.19 80.97 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 O-C-N 121.541 -0.724 . . . . 0.0 109.5 175.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 53.2 mt -65.31 -36.3 83.62 Favored 'General case' 0 C--N 1.34 0.16 0 CA-C-N 119.265 0.939 . . . . 0.0 111.085 172.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -63.62 -38.5 91.36 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 118.803 0.729 . . . . 0.0 111.178 172.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -66.63 -35.42 80.15 Favored 'General case' 0 CA--C 1.531 0.244 0 O-C-N 120.35 -1.469 . . . . 0.0 110.691 173.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.58 -44.84 92.88 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.594 0.758 . . . . 0.0 109.733 177.014 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 53.2 t0 -53.66 -48.22 69.64 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 124.972 1.309 . . . . 0.0 110.397 172.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -68.43 -8.11 37.67 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -178.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 77.7 mt-10 -109.6 -36.64 5.9 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.996 1.319 . . . . 0.0 112.265 -176.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 6.2 ptp -145.12 22.96 1.53 Allowed 'General case' 0 C--N 1.341 0.212 0 N-CA-C 114.865 1.432 . . . . 0.0 114.865 178.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -60.84 -5.68 5.69 Favored Glycine 0 CA--C 1.537 1.46 0 CA-C-N 119.996 1.271 . . . . 0.0 115.221 177.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -78.6 -33.17 47.68 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.586 1.154 . . . . 0.0 111.296 170.035 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -95.45 -35.23 11.79 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 124.844 1.258 . . . . 0.0 110.659 178.425 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 60.8 tp -105.14 153.06 22.03 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.452 1.101 . . . . 0.0 111.745 -169.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 14.4 ttmm -121.85 144.46 48.82 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 104.426 -2.435 . . . . 0.0 104.426 166.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 79.3 mt -120.66 135.62 60.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 104.872 -2.269 . . . . 0.0 104.872 179.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 99.3 t -130.0 98.61 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 -172.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 52.4 mtmt -71.47 138.88 49.36 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 172.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 17.1 tt -142.28 123.59 12.24 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 177.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 59.3 t0 -83.32 106.98 15.53 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 124.282 1.033 . . . . 0.0 108.566 -173.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 31.7 m -60.07 -24.68 30.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 118.551 -0.737 . . . . 0.0 112.043 -175.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -64.75 -19.73 65.95 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 119.659 1.118 . . . . 0.0 112.002 -179.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -116.44 4.44 13.34 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.069 1.347 . . . . 0.0 110.85 178.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 68.4 m-80 -141.35 39.16 1.73 Allowed 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 124.537 1.135 . . . . 0.0 110.169 -169.141 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 53.4 mm-40 -56.48 -34.8 67.26 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.358 0.663 . . . . 0.0 110.851 176.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -65.34 -46.18 81.26 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 122.78 0.432 . . . . 0.0 110.305 177.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.29 -40.62 86.12 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.482 0.713 . . . . 0.0 110.043 -178.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -58.26 -49.49 76.91 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.389 0.675 . . . . 0.0 110.109 172.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -59.67 -29.57 67.31 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 123.958 0.789 . . . . 0.0 112.432 177.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 22.6 ttmt -55.39 -28.91 57.11 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.497 1.519 . . . . 0.0 112.042 178.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -123.61 9.49 8.98 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 123.868 0.867 . . . . 0.0 111.948 178.053 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 65.14 28.77 73.94 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 123.819 0.723 . . . . 0.0 112.935 -176.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 54.5 t -61.67 128.99 24.07 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 172.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 22.4 ttt -137.93 0.37 2.17 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.573 1.149 . . . . 0.0 111.145 -177.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 25.2 m -145.08 163.95 32.72 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 126.558 1.943 . . . . 0.0 107.612 179.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 39.5 pt -143.41 155.82 60.77 Favored Pre-proline 0 CA--C 1.547 0.832 0 C-N-CA 124.603 1.161 . . . . 0.0 108.85 176.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -67.24 138.66 42.8 Favored 'Cis proline' 0 C--N 1.351 0.671 0 CA-C-N 120.453 1.197 . . . . 0.0 110.288 -4.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 32.8 m -130.22 141.1 50.66 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 175.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 83.0 mt -122.62 128.47 50.71 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 -167.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -122.54 118.36 28.06 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 104.013 -2.588 . . . . 0.0 104.013 -178.302 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 14.7 t -92.92 119.28 40.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 N-CA-C 104.108 -2.553 . . . . 0.0 104.108 173.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.8 mp -109.74 153.91 23.65 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 172.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -134.34 125.06 26.84 Favored 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 170.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.0 t70 48.48 35.02 5.31 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.234 1.414 . . . . 0.0 112.181 173.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 101.69 0.67 52.7 Favored Glycine 0 CA--C 1.532 1.146 0 CA-C-O 117.876 -1.513 . . . . 0.0 115.289 170.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -123.29 146.42 47.9 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 120.491 2.145 . . . . 0.0 109.5 176.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 11.4 p -68.67 132.48 32.89 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 170.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 33.7 m -119.91 -21.0 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 124.439 1.096 . . . . 0.0 110.996 178.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -155.75 162.86 40.45 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 120.44 1.473 . . . . 0.0 110.851 174.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 9.0 m -139.13 151.06 46.36 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.673 1.189 . . . . 0.0 108.708 177.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 48.6 m -151.55 159.32 44.17 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.408 1.483 . . . . 0.0 108.874 169.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 42.7 t -133.93 144.67 34.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 -176.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 77.87 177.97 48.06 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 123.639 0.638 . . . . 0.0 112.494 176.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 55.2 t80 -61.35 145.14 52.53 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 123.866 0.866 . . . . 0.0 111.089 -179.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.37 141.27 14.91 Favored Pre-proline 0 CA--C 1.535 0.403 0 C-N-CA 126.206 1.802 . . . . 0.0 106.843 177.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -72.35 156.79 54.38 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 122.409 2.073 . . . . 0.0 110.722 176.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 42.2 pttt -57.5 -32.54 67.13 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 -175.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -68.77 -43.04 76.59 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 118.5 0.591 . . . . 0.0 109.504 178.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.47 -42.05 98.6 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 118.354 0.525 . . . . 0.0 110.517 176.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 97.1 mt -60.86 -48.84 79.99 Favored 'General case' 0 N--CA 1.461 0.095 0 CA-C-O 121.08 0.467 . . . . 0.0 110.686 178.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -71.57 -28.29 63.74 Favored 'General case' 0 N--CA 1.451 -0.381 0 O-C-N 122.037 -0.414 . . . . 0.0 110.866 -175.038 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -70.03 -37.25 75.55 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 118.404 0.547 . . . . 0.0 111.355 170.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 8.7 tp -62.79 -34.5 77.4 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.5 1.12 . . . . 0.0 110.274 174.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 48.9 t -69.99 -45.97 74.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 123.836 0.854 . . . . 0.0 110.066 169.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -59.91 -36.58 77.3 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 124.73 1.212 . . . . 0.0 111.937 -172.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 11.0 ptmm? -67.06 -6.25 16.5 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 178.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -123.35 -18.07 6.36 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.136 0.974 . . . . 0.0 113.363 175.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 31.7 mt . . . . . 0 C--O 1.249 1.034 0 CA-C-N 119.913 1.233 . . . . 0.0 109.459 171.784 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.5 ttt . . . . . 0 N--CA 1.479 0.993 0 CA-C-O 119.082 -0.485 . . . . 0.0 110.076 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -165.23 -175.62 3.72 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 126.096 1.759 . . . . 0.0 107.876 -171.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.1 mt -76.15 142.67 14.09 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 165.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 44.6 t -138.79 164.03 26.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 126.494 1.917 . . . . 0.0 106.733 -174.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 4.7 mtpt -117.01 142.84 46.45 Favored 'General case' 0 CA--C 1.517 -0.31 0 C-N-CA 125.345 1.458 . . . . 0.0 107.373 173.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -142.81 165.62 26.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.422 0.63 . . . . 0.0 110.525 178.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 17.5 p -132.55 172.25 12.75 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 126.254 1.822 . . . . 0.0 107.664 170.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -52.39 -29.53 24.59 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.238 1.015 . . . . 0.0 113.111 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 56.1 mt-30 -63.47 -28.96 70.32 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.12 1.368 . . . . 0.0 113.174 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.2 m -136.88 -5.49 1.92 Allowed 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 113.842 1.053 . . . . 0.0 113.842 -168.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -52.39 -44.07 65.12 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.166 0.987 . . . . 0.0 111.65 -177.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.5 m -63.23 -38.57 91.68 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.129 0.572 . . . . 0.0 111.849 -179.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -68.1 -44.34 76.45 Favored 'General case' 0 N--CA 1.452 -0.337 0 O-C-N 121.994 -0.442 . . . . 0.0 110.023 177.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 66.1 mm-40 -63.61 -35.76 81.56 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 122.391 0.276 . . . . 0.0 110.979 -178.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 26.4 p -83.91 1.44 43.36 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.029 0.931 . . . . 0.0 113.329 -177.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 69.1 m -100.17 30.27 3.89 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.23 1.012 . . . . 0.0 111.742 -177.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -133.26 61.95 1.67 Allowed 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.297 1.039 . . . . 0.0 110.195 -177.081 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 92.24 -156.53 23.52 Favored Glycine 0 C--N 1.338 0.694 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 175.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 59.1 t -71.31 134.23 30.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 N-CA-C 106.506 -1.665 . . . . 0.0 106.506 168.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 47.1 t -136.99 141.11 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 105.915 -1.883 . . . . 0.0 105.915 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 3.7 tt -122.19 100.3 6.89 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 106.255 -1.757 . . . . 0.0 106.255 -176.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -83.25 145.42 29.14 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.293 -179.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -123.95 94.12 4.13 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 126.083 1.753 . . . . 0.0 107.196 -177.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -74.13 112.26 10.09 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 105.884 -1.895 . . . . 0.0 105.884 174.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -148.3 -177.12 5.59 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.704 1.201 . . . . 0.0 108.608 -172.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -155.87 146.98 16.55 Favored Pre-proline 0 CA--C 1.531 0.232 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 168.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -60.75 -17.27 48.98 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 121.818 1.679 . . . . 0.0 116.01 -177.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 54.0 p-90 -70.04 -20.12 63.26 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 120.03 1.286 . . . . 0.0 111.914 173.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 29.0 t -59.58 150.97 25.66 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.991 1.316 . . . . 0.0 110.971 -174.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -104.99 -58.61 0.67 Allowed Glycine 0 CA--C 1.531 1.062 0 CA-C-O 118.704 -1.053 . . . . 0.0 110.97 172.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -56.54 -33.08 91.88 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 123.217 2.611 . . . . 0.0 113.712 -179.288 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 29.7 m -57.82 -34.57 69.81 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.441 0.696 . . . . 0.0 111.403 176.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.4 mmtp -68.38 -24.54 64.79 Favored 'General case' 0 CA--C 1.531 0.22 0 O-C-N 121.5 -0.75 . . . . 0.0 111.063 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 31.1 mtm -70.8 -42.27 70.52 Favored 'General case' 0 C--N 1.34 0.186 0 CA-C-N 118.742 0.701 . . . . 0.0 110.405 176.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 19.1 tt -85.0 -23.76 7.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 CA-C-O 118.53 -0.748 . . . . 0.0 111.782 -175.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -49.38 -50.52 64.55 Favored Pre-proline 0 CA--C 1.548 0.867 0 CA-C-N 120.088 1.313 . . . . 0.0 114.191 178.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -66.93 -27.76 42.83 Favored 'Trans proline' 0 C--N 1.351 0.674 0 CA-C-N 121.779 1.671 . . . . 0.0 112.069 176.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.8 t -68.94 -37.12 76.87 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 O-C-N 121.589 -0.694 . . . . 0.0 109.769 173.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 95.6 mt -65.5 -34.69 78.87 Favored 'General case' 0 C--N 1.339 0.135 0 CA-C-N 119.743 1.156 . . . . 0.0 111.025 172.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -61.97 -43.79 98.1 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 119.376 0.989 . . . . 0.0 110.944 170.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -63.67 -40.18 96.18 Favored 'General case' 0 CA--C 1.531 0.218 0 O-C-N 121.172 -0.955 . . . . 0.0 110.711 175.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 39.8 tp -61.98 -41.96 98.61 Favored 'General case' 0 C--N 1.334 -0.105 0 C-N-CA 124.372 1.069 . . . . 0.0 109.919 178.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -60.82 -42.96 98.73 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 122.949 0.499 . . . . 0.0 110.696 175.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -71.97 -10.4 59.72 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 112.6 0.592 . . . . 0.0 112.6 179.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -105.36 -28.38 10.91 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 125.437 1.495 . . . . 0.0 111.377 -178.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 26.8 mtp -134.3 -1.56 2.88 Favored 'General case' 0 N--CA 1.462 0.146 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 -168.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -56.91 -13.91 9.26 Favored Glycine 0 CA--C 1.532 1.126 0 CA-C-N 119.913 1.233 . . . . 0.0 115.434 -173.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -69.73 -29.93 67.42 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 118.674 1.237 . . . . 0.0 111.73 173.121 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 45.6 mmtm -115.7 -20.27 10.17 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 125.512 1.525 . . . . 0.0 111.889 -178.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 36.6 tp -112.57 157.17 21.51 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 123.984 0.914 . . . . 0.0 111.41 -168.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -132.34 144.51 50.6 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 103.806 -2.665 . . . . 0.0 103.806 166.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 83.0 mt -118.02 139.43 45.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 105.274 -2.121 . . . . 0.0 105.274 177.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 81.9 t -132.26 98.78 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 -170.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 52.4 mtmt -74.2 136.69 42.79 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 175.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 15.3 tt -139.98 124.82 19.88 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 176.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -82.79 105.08 13.51 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 124.717 1.207 . . . . 0.0 108.784 -174.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 27.7 m -60.37 -27.06 38.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 118.684 -0.674 . . . . 0.0 111.898 -174.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -66.1 -19.83 65.97 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 119.423 1.011 . . . . 0.0 111.773 -177.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -113.83 1.59 14.84 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.534 1.534 . . . . 0.0 110.891 178.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 68.7 m-80 -141.68 41.77 1.72 Allowed 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.27 1.028 . . . . 0.0 109.889 -169.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 46.7 mm-40 -56.03 -32.37 63.96 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.806 0.842 . . . . 0.0 111.262 177.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 35.0 mm-40 -65.72 -47.21 76.1 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 118.407 0.549 . . . . 0.0 110.5 179.199 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.2 -39.04 78.86 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 121.801 -0.562 . . . . 0.0 109.634 -178.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -58.79 -48.28 81.82 Favored 'General case' 0 CA--C 1.534 0.343 0 O-C-N 121.142 -0.974 . . . . 0.0 110.171 172.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -60.45 -28.67 67.74 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 124.078 0.847 . . . . 0.0 112.438 177.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 47.7 tptt -56.23 -29.28 60.79 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.629 1.171 . . . . 0.0 111.425 179.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -124.0 10.7 8.85 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.671 0.788 . . . . 0.0 111.598 -179.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 64.41 28.52 73.21 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 123.819 0.723 . . . . 0.0 112.802 -177.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 49.1 t -62.86 125.94 20.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 172.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 40.3 ttp -138.49 1.86 2.19 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.487 1.115 . . . . 0.0 111.036 -177.092 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 24.8 m -144.31 161.98 37.58 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 126.789 2.036 . . . . 0.0 107.374 178.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 40.7 pt -143.13 155.91 61.7 Favored Pre-proline 0 CA--C 1.544 0.721 0 C-N-CA 124.631 1.173 . . . . 0.0 108.768 177.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -67.05 139.54 46.66 Favored 'Cis proline' 0 C--N 1.349 0.588 0 CA-C-N 120.459 1.2 . . . . 0.0 110.26 -4.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 28.1 m -130.81 139.95 50.24 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 174.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 88.0 mt -120.33 124.49 45.69 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 -169.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -115.18 119.7 37.27 Favored 'General case' 0 CA--C 1.512 -0.509 0 N-CA-C 103.578 -2.749 . . . . 0.0 103.578 177.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.2 t -93.1 123.31 45.14 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 N-CA-C 103.432 -2.803 . . . . 0.0 103.432 173.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.1 mp -114.86 155.25 27.16 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 174.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -137.94 123.38 19.55 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 172.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.2 t70 49.36 36.87 10.46 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.084 1.354 . . . . 0.0 112.537 176.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 103.4 -2.83 46.59 Favored Glycine 0 CA--C 1.529 0.92 0 CA-C-O 118.122 -1.377 . . . . 0.0 115.285 168.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -128.62 149.98 50.41 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 120.074 1.937 . . . . 0.0 110.077 -179.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 44.3 t -62.0 131.53 27.25 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 175.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.1 p -117.44 -22.94 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 C-N-CA 125.102 1.361 . . . . 0.0 109.406 179.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -162.3 168.04 22.9 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 120.463 1.483 . . . . 0.0 110.097 169.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 14.0 m -136.56 151.07 48.98 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.363 1.465 . . . . 0.0 108.796 177.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 58.3 m -148.38 157.28 43.38 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.631 1.573 . . . . 0.0 108.649 169.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 42.6 t -133.6 145.33 33.77 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 -178.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 78.27 -176.29 54.24 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 123.553 0.597 . . . . 0.0 111.877 179.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -63.72 148.91 47.91 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.484 0.714 . . . . 0.0 110.41 178.003 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 42.9 mttt -142.4 138.24 16.28 Favored Pre-proline 0 C--O 1.235 0.311 0 N-CA-C 106.352 -1.722 . . . . 0.0 106.352 168.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -66.57 160.03 47.97 Favored 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 121.88 1.72 . . . . 0.0 110.925 178.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 33.7 tttm -48.85 -46.72 42.68 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 126.071 1.748 . . . . 0.0 112.987 -178.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 27.4 mm-40 -72.98 -35.94 66.99 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.207 -176.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.64 -36.6 84.78 Favored 'General case' 0 C--N 1.341 0.233 0 CA-C-N 118.979 0.808 . . . . 0.0 111.054 173.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 87.1 mt -64.53 -45.78 85.72 Favored 'General case' 0 N--CA 1.456 -0.137 0 CA-C-O 119.197 -0.43 . . . . 0.0 110.665 176.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 8.9 mt-30 -57.99 -42.44 85.16 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-N 118.501 0.591 . . . . 0.0 110.787 173.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -64.61 -39.58 93.98 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 118.016 0.371 . . . . 0.0 110.508 -178.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 57.8 tp -61.86 -44.0 97.72 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 124.636 1.174 . . . . 0.0 110.568 176.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 86.6 t -61.22 -44.13 97.78 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-N 118.821 0.737 . . . . 0.0 109.39 173.023 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -60.58 -28.34 68.4 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 125.019 1.328 . . . . 0.0 112.15 -173.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -56.4 -24.12 42.71 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 123.402 0.681 . . . . 0.0 112.498 174.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 72.2 m-70 -123.18 -9.18 8.16 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 -168.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 74.5 mt . . . . . 0 C--O 1.249 1.045 0 CA-C-N 118.948 0.794 . . . . 0.0 109.333 171.298 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 46.4 tpp . . . . . 0 N--CA 1.484 1.235 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -143.58 -179.26 6.33 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.728 1.211 . . . . 0.0 110.353 -172.465 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.8 mt -72.26 148.8 9.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 168.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 21.5 t -134.88 160.87 41.01 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 C-N-CA 126.68 1.992 . . . . 0.0 106.521 -176.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.23 139.1 50.7 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 105.368 -2.086 . . . . 0.0 105.368 169.284 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -140.68 168.94 18.6 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 121.296 0.569 . . . . 0.0 110.886 -178.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 17.4 p -133.19 169.67 16.54 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 126.334 1.854 . . . . 0.0 107.987 175.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -53.42 -29.31 34.53 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.443 1.097 . . . . 0.0 113.039 -178.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 57.0 mt-30 -61.28 -29.26 69.75 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.164 1.386 . . . . 0.0 112.944 178.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.6 m -136.86 -7.19 1.87 Allowed 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 -169.45 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -53.25 -43.65 67.52 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.349 1.06 . . . . 0.0 111.516 -177.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.8 m -62.86 -39.87 95.74 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.058 0.543 . . . . 0.0 111.76 179.518 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.66 -43.38 84.73 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 122.71 0.404 . . . . 0.0 110.074 177.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 68.5 mm-40 -64.09 -42.82 96.8 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 122.265 0.226 . . . . 0.0 110.551 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.423 ' HA ' HG21 ' A' ' 20' ' ' VAL . 35.5 p -77.89 -5.86 52.4 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 124.262 1.025 . . . . 0.0 113.568 -176.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 72.7 m -74.72 -20.26 59.91 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 177.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -87.41 69.23 9.87 Favored 'General case' 0 CA--C 1.537 0.451 0 O-C-N 121.483 -0.761 . . . . 0.0 111.581 -170.012 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 85.28 -151.51 25.75 Favored Glycine 0 C--N 1.337 0.612 0 N-CA-C 109.993 -1.243 . . . . 0.0 109.993 173.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 58.0 t -71.17 137.11 24.43 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 168.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.423 HG21 ' HA ' ' A' ' 15' ' ' THR . 57.7 t -140.37 146.99 23.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 105.777 -1.935 . . . . 0.0 105.777 179.08 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.5 tt -124.96 99.35 6.09 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 -176.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -81.43 147.86 29.56 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.732 -179.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -126.48 95.21 4.29 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 126.145 1.778 . . . . 0.0 107.27 -178.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -73.81 115.36 13.16 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 174.455 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -149.16 -178.06 6.17 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.351 1.46 . . . . 0.0 108.553 -173.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -156.12 149.65 18.97 Favored Pre-proline 0 CA--C 1.531 0.238 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 167.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_exo -59.62 -19.16 51.51 Favored 'Trans proline' 0 CA--C 1.534 0.504 0 C-N-CA 122.323 2.015 . . . . 0.0 115.775 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 52.4 p-90 -70.85 -20.11 62.57 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 119.933 1.242 . . . . 0.0 112.035 174.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 23.9 t -61.45 152.35 30.13 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 125.025 1.33 . . . . 0.0 111.344 -172.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -101.63 -66.59 0.78 Allowed Glycine 0 CA--C 1.529 0.963 0 CA-C-O 118.424 -1.209 . . . . 0.0 110.528 173.03 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -54.75 -30.42 67.06 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 123.12 2.547 . . . . 0.0 114.275 -179.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 39.4 m -56.26 -34.87 66.82 Favored 'General case' 0 CA--C 1.538 0.495 0 O-C-N 121.467 -0.77 . . . . 0.0 111.551 175.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.4 mmtp -68.94 -29.61 67.89 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 123.427 0.691 . . . . 0.0 110.944 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 5.0 ptt? -85.55 -30.03 23.7 Favored 'General case' 0 C--N 1.34 0.153 0 CA-C-N 118.809 0.731 . . . . 0.0 111.539 -177.002 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 19.5 tt -77.87 -20.77 13.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-O 118.626 -0.702 . . . . 0.0 111.56 169.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -51.7 -49.61 82.14 Favored Pre-proline 0 CA--C 1.548 0.887 0 CA-C-N 120.83 1.65 . . . . 0.0 113.852 178.232 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -66.18 -28.3 48.31 Favored 'Trans proline' 0 C--N 1.35 0.631 0 CA-C-N 121.922 1.722 . . . . 0.0 112.285 175.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 23.9 t -66.93 -39.23 83.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 174.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 95.1 mt -64.6 -37.0 86.08 Favored 'General case' 0 C--N 1.341 0.239 0 CA-C-N 119.531 1.06 . . . . 0.0 111.155 171.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -64.66 -40.79 96.04 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 119.385 0.993 . . . . 0.0 110.857 174.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -63.02 -40.02 96.49 Favored 'General case' 0 CA--C 1.531 0.232 0 O-C-N 121.067 -1.021 . . . . 0.0 110.187 174.158 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.35 -47.28 84.31 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.885 0.874 . . . . 0.0 109.746 175.499 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -59.01 -40.57 85.36 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 123.62 0.768 . . . . 0.0 111.03 179.262 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 -73.92 -10.71 59.93 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.303 0.641 . . . . 0.0 112.377 -179.395 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -103.44 -33.88 8.91 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 124.954 1.302 . . . . 0.0 111.791 178.292 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 86.6 mmm -125.08 -3.77 7.53 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 113.237 0.829 . . . . 0.0 113.237 -168.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -62.63 -3.57 5.82 Favored Glycine 0 CA--C 1.532 1.147 0 CA-C-N 119.853 1.206 . . . . 0.0 115.342 -175.415 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -73.96 -27.68 61.12 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 118.519 1.16 . . . . 0.0 111.201 169.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.3 -23.07 3.3 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 125.289 1.435 . . . . 0.0 111.59 -171.313 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 45.0 tp -111.24 151.61 28.1 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 124.878 1.271 . . . . 0.0 110.169 -169.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -118.82 144.8 46.12 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 105.541 -2.022 . . . . 0.0 105.541 168.322 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 73.1 mt -116.53 136.96 51.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 105.384 -2.08 . . . . 0.0 105.384 175.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 97.3 t -133.06 97.08 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 -169.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -73.97 139.48 44.86 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 107.648 -1.242 . . . . 0.0 107.648 175.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 11.5 tt -141.05 129.27 23.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.395 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 178.265 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 61.7 t0 -87.83 105.44 17.41 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 124.809 1.243 . . . . 0.0 110.06 -169.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 27.0 m -62.58 -18.46 20.69 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 CA-C-O 118.539 -0.743 . . . . 0.0 112.449 -177.347 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -67.54 -15.5 63.69 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 119.863 1.211 . . . . 0.0 112.023 176.591 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -127.18 1.03 6.45 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.236 1.014 . . . . 0.0 111.89 178.323 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 67.0 m-80 -137.55 41.0 2.4 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.737 0.815 . . . . 0.0 111.209 -169.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 5.3 mp0 -54.11 -32.08 53.94 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.203 0.601 . . . . 0.0 111.76 174.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -66.3 -47.44 73.59 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 118.423 0.556 . . . . 0.0 110.498 -177.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.07 -39.26 79.2 Favored 'General case' 0 CA--C 1.534 0.345 0 O-C-N 121.836 -0.54 . . . . 0.0 109.591 -179.416 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -58.53 -48.45 80.81 Favored 'General case' 0 CA--C 1.534 0.338 0 O-C-N 121.244 -0.91 . . . . 0.0 110.463 173.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -61.92 -28.15 69.83 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 124.179 0.895 . . . . 0.0 112.166 178.015 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 71.7 tttt -55.66 -28.76 57.23 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.853 1.261 . . . . 0.0 111.683 178.057 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -123.17 10.58 9.37 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.775 0.83 . . . . 0.0 111.803 179.252 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 65.38 27.46 72.5 Favored Glycine 0 CA--C 1.534 1.239 0 C-N-CA 123.85 0.738 . . . . 0.0 113.024 -177.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 60.4 t -62.72 127.63 23.17 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 171.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 22.6 ttt -137.16 0.49 2.35 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.612 1.165 . . . . 0.0 111.05 -176.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 25.2 m -144.92 162.51 36.67 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 126.514 1.926 . . . . 0.0 107.719 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 41.1 pt -142.8 156.79 62.47 Favored Pre-proline 0 CA--C 1.544 0.747 0 C-N-CA 124.858 1.263 . . . . 0.0 108.615 177.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -66.74 140.7 51.32 Favored 'Cis proline' 0 C--N 1.349 0.594 0 CA-C-N 120.464 1.201 . . . . 0.0 110.416 -5.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 32.2 m -135.2 135.96 41.41 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 176.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -115.4 132.11 56.72 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 -172.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -120.22 121.87 39.67 Favored 'General case' 0 CA--C 1.513 -0.443 0 N-CA-C 103.545 -2.761 . . . . 0.0 103.545 177.343 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 8.3 t -92.67 123.36 44.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 103.331 -2.84 . . . . 0.0 103.331 172.227 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.2 mp -113.09 155.7 24.44 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 175.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 60.8 tttp -135.65 124.62 24.2 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 105.854 -1.906 . . . . 0.0 105.854 173.479 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 30.8 t70 50.64 34.73 10.23 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.693 1.197 . . . . 0.0 112.119 176.199 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 100.38 -1.13 55.86 Favored Glycine 0 CA--C 1.529 0.951 0 CA-C-O 118.27 -1.294 . . . . 0.0 114.92 169.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -132.28 152.37 51.39 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 120.072 1.936 . . . . 0.0 110.24 -179.487 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 29.0 t -62.31 135.14 27.17 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 -178.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.9 p -120.59 -25.84 2.44 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 125.16 1.384 . . . . 0.0 110.237 175.135 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -155.95 170.24 22.59 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 120.22 1.373 . . . . 0.0 109.792 177.404 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 30.0 m -152.43 153.73 34.13 Favored 'General case' 0 CA--C 1.541 0.612 0 O-C-N 120.747 -1.221 . . . . 0.0 110.271 -176.197 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 41.7 m -150.22 154.45 37.98 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.561 1.544 . . . . 0.0 108.981 168.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 43.4 t -132.9 141.0 46.06 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 N-CA-C 107.03 -1.471 . . . . 0.0 107.03 -177.113 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 76.67 179.19 47.34 Favored Glycine 0 CA--C 1.53 0.992 0 N-CA-C 111.436 -0.665 . . . . 0.0 111.436 -177.131 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 36.1 t80 -63.18 132.62 52.36 Favored 'General case' 0 C--O 1.231 0.129 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 175.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 13.1 mptt -135.47 147.4 61.65 Favored Pre-proline 0 CA--C 1.536 0.419 0 C-N-CA 126.676 1.99 . . . . 0.0 106.176 174.262 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -71.53 158.07 54.67 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 122.513 2.142 . . . . 0.0 110.521 178.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 20.7 pttp -58.25 -29.25 65.63 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -62.4 -42.84 99.74 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.215 0.606 . . . . 0.0 110.433 176.368 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.62 -47.38 78.78 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 118.544 0.611 . . . . 0.0 110.09 -178.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 10.1 mp -56.09 -47.44 78.03 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.577 0.751 . . . . 0.0 109.912 176.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 14.7 mt-30 -61.73 -39.9 93.18 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-O 118.729 -0.653 . . . . 0.0 112.058 178.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -64.69 -42.83 95.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 119.073 0.852 . . . . 0.0 110.029 178.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 31.0 mt -66.92 -35.3 79.68 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 118.586 0.63 . . . . 0.0 111.562 179.034 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 44.0 t -60.99 -50.99 78.29 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 170.024 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -61.26 -33.65 73.88 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 125.383 1.473 . . . . 0.0 111.862 -173.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 59.1 mtpt -56.36 -27.93 57.54 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 118.332 -0.842 . . . . 0.0 112.212 174.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -128.92 -5.47 5.06 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 114.688 1.366 . . . . 0.0 114.688 -167.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 17.5 mt . . . . . 0 C--O 1.25 1.082 0 CA-C-N 119.655 1.116 . . . . 0.0 108.725 168.569 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.8 tpp . . . . . 0 N--CA 1.478 0.973 0 CA-C-O 118.912 -0.566 . . . . 0.0 110.251 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -164.56 -175.57 3.92 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 125.588 1.555 . . . . 0.0 108.366 -173.423 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.3 mt -75.92 143.78 12.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 166.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 20.7 t -135.77 161.37 38.54 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 126.696 1.998 . . . . 0.0 106.103 -176.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.62 138.89 50.62 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 105.652 -1.981 . . . . 0.0 105.652 169.149 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -139.2 171.39 14.36 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 123.453 0.701 . . . . 0.0 110.852 -178.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.0 p -136.18 171.66 14.15 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 125.768 1.627 . . . . 0.0 108.454 175.29 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -38.82 -39.93 0.57 Allowed 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 126.415 1.886 . . . . 0.0 113.525 170.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 43.5 mm-40 -68.62 -26.03 65.14 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.095 0.958 . . . . 0.0 113.088 -173.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.1 m -134.18 -8.95 2.62 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 113.585 0.958 . . . . 0.0 113.585 -169.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 67.4 t80 -54.03 -45.17 71.49 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 124.363 1.065 . . . . 0.0 111.44 -176.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 9.3 m -63.25 -37.42 87.18 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.041 0.536 . . . . 0.0 111.729 -178.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -68.41 -44.77 74.32 Favored 'General case' 0 N--CA 1.454 -0.272 0 O-C-N 122.036 -0.415 . . . . 0.0 110.055 177.143 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 67.0 mm-40 -63.21 -35.78 81.46 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 122.414 0.286 . . . . 0.0 110.955 -178.6 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.9 p -83.98 1.36 44.04 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.2 1.0 . . . . 0.0 113.496 -177.471 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 66.5 m -102.15 32.58 3.43 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.099 0.959 . . . . 0.0 111.403 -177.105 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -132.78 58.18 1.77 Allowed 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.354 1.062 . . . . 0.0 110.155 -178.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 93.97 -154.08 21.42 Favored Glycine 0 C--N 1.339 0.728 0 N-CA-C 110.084 -1.206 . . . . 0.0 110.084 176.269 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 84.7 t -71.19 134.84 29.24 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 168.142 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 58.8 t -139.07 142.07 34.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 105.639 -1.985 . . . . 0.0 105.639 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 3.4 tt -120.51 99.37 6.52 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 -174.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -81.33 146.83 30.16 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 179.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -126.09 94.14 4.01 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 125.983 1.713 . . . . 0.0 106.961 -177.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -73.95 113.97 11.73 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 106.179 -1.786 . . . . 0.0 106.179 174.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -149.75 -175.85 5.19 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 125.107 1.363 . . . . 0.0 107.883 -172.23 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -155.84 148.36 17.8 Favored Pre-proline 0 N--CA 1.451 -0.376 0 N-CA-C 106.106 -1.813 . . . . 0.0 106.106 167.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -68.35 -12.92 36.34 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 CA-C-N 120.871 1.347 . . . . 0.0 113.923 -178.45 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 42.6 p-90 -69.88 -20.94 63.37 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 120.221 1.373 . . . . 0.0 111.978 169.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 26.8 t -59.3 149.19 29.51 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.117 1.367 . . . . 0.0 111.123 -171.165 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -97.02 -60.39 0.97 Allowed Glycine 0 CA--C 1.533 1.19 0 CA-C-O 118.715 -1.047 . . . . 0.0 111.418 170.016 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -66.77 -25.9 45.7 Favored 'Trans proline' 0 C--N 1.349 0.576 0 CA-C-N 120.444 2.122 . . . . 0.0 112.813 -173.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 22.5 m -58.73 -32.23 69.02 Favored 'General case' 0 CA--C 1.536 0.41 0 O-C-N 121.524 -0.735 . . . . 0.0 111.401 174.392 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.7 mmtp -69.03 -23.01 64.02 Favored 'General case' 0 CA--C 1.532 0.257 0 O-C-N 121.373 -0.829 . . . . 0.0 111.109 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 34.0 mtm -71.52 -42.65 67.71 Favored 'General case' 0 C--N 1.34 0.194 0 CA-C-N 118.763 0.711 . . . . 0.0 110.404 175.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 16.5 tt -84.0 -22.12 8.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-O 118.741 -0.647 . . . . 0.0 111.599 -176.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -49.39 -51.16 60.38 Favored Pre-proline 0 CA--C 1.547 0.845 0 CA-C-N 120.009 1.277 . . . . 0.0 113.894 177.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -67.59 -25.98 40.29 Favored 'Trans proline' 0 C--N 1.351 0.66 0 CA-C-N 121.828 1.689 . . . . 0.0 112.528 176.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 15.2 t -70.05 -37.01 71.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 O-C-N 121.555 -0.715 . . . . 0.0 109.49 174.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 93.6 mt -67.41 -36.72 81.83 Favored 'General case' 0 C--O 1.226 -0.152 0 CA-C-N 119.576 1.08 . . . . 0.0 111.267 171.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -62.43 -41.59 98.82 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 119.385 0.993 . . . . 0.0 110.686 172.27 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 30.9 mm-40 -60.08 -45.91 91.33 Favored 'General case' 0 N--CA 1.455 -0.18 0 O-C-N 121.401 -0.812 . . . . 0.0 110.139 173.286 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.13 -44.09 92.03 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.886 0.874 . . . . 0.0 109.576 179.513 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -60.46 -42.78 96.88 Favored 'General case' 0 CA--C 1.522 -0.117 0 C-N-CA 123.559 0.743 . . . . 0.0 111.245 178.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -72.6 -10.22 59.53 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.366 0.666 . . . . 0.0 112.459 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -103.13 -33.75 9.11 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 125.315 1.446 . . . . 0.0 110.723 -179.203 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 88.4 mmm -130.12 -4.05 4.46 Favored 'General case' 0 C--N 1.341 0.203 0 N-CA-C 113.869 1.063 . . . . 0.0 113.869 -167.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.61 -11.41 15.51 Favored Glycine 0 CA--C 1.532 1.095 0 CA-C-N 119.954 1.252 . . . . 0.0 114.993 -173.575 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -67.05 -28.23 68.04 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 118.434 1.117 . . . . 0.0 111.595 172.012 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -120.8 -25.16 5.5 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 125.56 1.544 . . . . 0.0 111.686 -178.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 35.3 tp -102.58 159.6 15.31 Favored 'General case' 0 C--O 1.232 0.149 0 C-N-CA 124.202 1.001 . . . . 0.0 110.504 -170.216 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -132.68 143.54 49.71 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 104.326 -2.472 . . . . 0.0 104.326 167.403 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 67.5 mt -117.09 138.76 46.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 105.28 -2.118 . . . . 0.0 105.28 177.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 97.7 t -132.9 94.22 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 -169.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 27.9 mtpp -73.43 141.07 46.92 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 176.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 11.8 tt -142.73 126.86 15.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 178.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 57.4 t0 -86.25 104.61 15.95 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 124.783 1.233 . . . . 0.0 109.253 -170.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 26.1 m -61.79 -20.74 24.19 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-O 118.625 -0.702 . . . . 0.0 112.271 -176.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -67.6 -13.83 62.41 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 119.723 1.147 . . . . 0.0 111.958 177.345 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -124.23 3.28 8.54 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.666 1.187 . . . . 0.0 111.506 175.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 65.0 m-80 -141.65 41.25 1.72 Allowed 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 124.13 0.972 . . . . 0.0 111.29 -169.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 3.7 mp0 -52.89 -31.55 40.31 Favored 'General case' 0 CA--C 1.531 0.25 0 O-C-N 121.972 -0.455 . . . . 0.0 111.716 172.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -65.05 -50.76 64.92 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 123.905 0.882 . . . . 0.0 109.77 -178.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.34 -36.95 77.42 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.33 0.652 . . . . 0.0 109.839 -178.471 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.41 -45.99 89.96 Favored 'General case' 0 CA--C 1.534 0.365 0 O-C-N 120.834 -1.167 . . . . 0.0 110.669 171.295 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -63.5 -28.12 71.92 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 123.906 0.765 . . . . 0.0 112.189 177.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 74.0 tttt -56.15 -29.17 60.4 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.964 1.306 . . . . 0.0 111.613 179.202 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -123.82 6.17 8.74 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.291 0.636 . . . . 0.0 112.273 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 62.44 41.63 99.76 Favored Glycine 0 CA--C 1.53 0.99 0 N-CA-C 111.698 -0.561 . . . . 0.0 111.698 -175.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 95.2 t -63.38 94.3 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 124.852 1.261 . . . . 0.0 107.963 173.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 1.6 pmm? -73.77 -30.72 62.93 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 125.235 1.414 . . . . 0.0 112.452 -175.325 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 52.0 m -147.42 175.0 11.16 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 126.067 1.747 . . . . 0.0 109.653 -172.221 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 42.8 pt -137.2 154.87 76.02 Favored Pre-proline 0 CA--C 1.546 0.813 0 C-N-CA 125.045 1.338 . . . . 0.0 108.631 175.211 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -67.93 141.54 60.19 Favored 'Cis proline' 0 N--CA 1.458 -0.612 0 CA-C-N 120.467 1.203 . . . . 0.0 110.493 -4.215 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 18.4 m -135.88 137.51 41.51 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 175.016 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -114.79 133.39 55.96 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 -173.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -120.78 116.49 25.34 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 103.18 -2.896 . . . . 0.0 103.18 176.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.4 t -91.79 121.36 42.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 103.723 -2.695 . . . . 0.0 103.723 173.431 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.4 mp -110.51 155.28 22.48 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 175.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 26.4 ttpp -133.7 115.05 14.13 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 105.677 -1.971 . . . . 0.0 105.677 176.387 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 27.6 t0 50.09 39.98 20.55 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.675 1.19 . . . . 0.0 112.461 176.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 103.59 -4.22 46.82 Favored Glycine 0 CA--C 1.529 0.958 0 CA-C-O 118.184 -1.342 . . . . 0.0 115.345 168.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -132.27 150.2 52.21 Favored 'General case' 0 C--N 1.34 0.155 0 CA-C-N 120.056 1.928 . . . . 0.0 110.32 -178.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 22.1 t -62.99 134.66 28.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 -179.352 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.3 p -117.97 -27.67 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 C-N-CA 125.016 1.326 . . . . 0.0 110.169 174.393 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 40.8 mm-40 -150.22 163.14 39.01 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 120.201 1.364 . . . . 0.0 110.177 172.281 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 17.9 m -141.04 145.08 35.4 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.057 1.343 . . . . 0.0 108.44 176.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 20.0 m -144.74 151.99 39.7 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.389 1.476 . . . . 0.0 108.845 175.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 59.2 t -132.44 142.96 41.24 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 -177.059 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 79.14 179.5 52.02 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 123.876 0.751 . . . . 0.0 111.815 -178.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -57.96 144.76 38.29 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 123.391 0.676 . . . . 0.0 110.511 178.219 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -149.64 134.93 9.7 Favored Pre-proline 0 N--CA 1.453 -0.303 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 -175.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -74.39 156.81 45.7 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 122.12 1.88 . . . . 0.0 110.787 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 17.7 ptmt -56.9 -31.77 65.22 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 124.019 0.927 . . . . 0.0 112.266 177.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -66.09 -48.54 70.6 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 118.731 0.696 . . . . 0.0 110.011 179.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.94 -44.36 96.29 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 118.009 0.368 . . . . 0.0 110.335 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 83.3 mt -61.73 -42.68 99.27 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-O 119.465 -0.303 . . . . 0.0 110.505 178.391 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -61.62 -39.85 92.75 Favored 'General case' 0 C--O 1.222 -0.343 0 CA-C-O 118.132 -0.937 . . . . 0.0 111.268 175.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -64.11 -41.9 97.09 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 119.822 1.192 . . . . 0.0 110.421 178.385 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 88.8 mt -63.54 -38.63 91.87 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 122.904 0.482 . . . . 0.0 111.165 178.129 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 49.7 t -63.33 -51.26 73.26 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 C-N-CA 123.676 0.79 . . . . 0.0 109.542 171.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -59.63 -40.76 88.69 Favored 'General case' 0 C--N 1.332 -0.153 0 C-N-CA 125.907 1.683 . . . . 0.0 111.503 -169.407 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 13.7 ptmm? -69.5 -6.63 31.89 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 118.155 -0.926 . . . . 0.0 113.16 -177.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 93.6 m-70 -124.96 -15.4 6.4 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 177.105 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 19.7 mt . . . . . 0 C--O 1.249 1.076 0 CA-C-N 119.563 1.074 . . . . 0.0 109.371 169.404 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.0 mtt . . . . . 0 N--CA 1.479 1.004 0 CA-C-O 118.981 -0.533 . . . . 0.0 109.907 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -161.17 -172.43 3.42 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.607 1.563 . . . . 0.0 108.436 -174.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.6 mt -74.95 143.54 13.23 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 166.45 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 21.4 t -133.95 159.56 42.31 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 C-N-CA 126.221 1.808 . . . . 0.0 106.498 -176.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -115.2 128.44 56.17 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 105.428 -2.064 . . . . 0.0 105.428 178.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -138.5 166.76 23.48 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 121.576 0.703 . . . . 0.0 112.313 -173.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.448 HG22 HD21 ' A' ' 60' ' ' ASN . 36.4 p -137.09 179.24 6.5 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 125.648 1.579 . . . . 0.0 107.715 171.105 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -49.14 -29.8 5.85 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.25 1.02 . . . . 0.0 112.706 170.18 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -63.04 -27.54 69.47 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.007 1.323 . . . . 0.0 112.805 179.341 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 13.6 p -132.08 -20.22 2.48 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 -167.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 56.4 t80 -51.98 -47.52 64.81 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 124.767 1.227 . . . . 0.0 112.534 -169.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.3 m -64.6 -38.57 91.47 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 122.666 0.386 . . . . 0.0 111.665 -175.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -68.04 -45.01 75.12 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 176.567 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 -62.9 -36.5 83.58 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 119.301 -0.38 . . . . 0.0 111.082 -177.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.8 p -83.75 -0.04 49.24 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 113.526 0.936 . . . . 0.0 113.526 -177.059 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 70.3 m -102.6 31.34 4.14 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.986 0.914 . . . . 0.0 111.494 -175.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -132.35 53.04 2.03 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.181 0.992 . . . . 0.0 110.781 -175.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 99.62 -156.21 19.79 Favored Glycine 0 C--N 1.338 0.655 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 176.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 90.0 t -70.18 136.43 26.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 167.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 60.6 t -139.59 147.13 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 N-CA-C 105.576 -2.009 . . . . 0.0 105.576 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.1 tt -125.17 99.0 5.89 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 -175.557 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -80.26 147.44 31.19 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 123.258 0.623 . . . . 0.0 109.548 -179.162 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -129.44 93.94 3.66 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 126.126 1.77 . . . . 0.0 108.163 -174.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -75.17 112.58 11.58 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 106.321 -1.733 . . . . 0.0 106.321 174.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -149.46 -176.57 5.44 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.775 1.23 . . . . 0.0 108.218 -173.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -156.67 149.1 17.86 Favored Pre-proline 0 CA--C 1.531 0.239 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 167.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -60.85 -19.13 60.57 Favored 'Trans proline' 0 N--CA 1.46 -0.47 0 C-N-CA 121.568 1.512 . . . . 0.0 115.43 179.134 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 48.5 p-90 -69.72 -20.06 63.54 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 119.926 1.239 . . . . 0.0 111.927 173.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 25.4 t -59.62 147.83 35.88 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.932 1.293 . . . . 0.0 111.072 -172.217 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -96.91 -63.62 0.92 Allowed Glycine 0 CA--C 1.529 0.94 0 CA-C-O 118.479 -1.178 . . . . 0.0 110.862 171.376 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -62.68 -26.2 75.38 Favored 'Trans proline' 0 C--N 1.349 0.605 0 CA-C-N 120.314 2.057 . . . . 0.0 113.543 -174.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 35.1 m -57.65 -34.34 69.26 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 118.653 0.66 . . . . 0.0 111.471 174.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.9 mmtp -67.88 -25.28 65.44 Favored 'General case' 0 CA--C 1.531 0.236 0 O-C-N 121.553 -0.717 . . . . 0.0 110.921 -179.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 31.0 mtm -71.91 -42.81 66.28 Favored 'General case' 0 C--N 1.34 0.16 0 CA-C-N 118.696 0.68 . . . . 0.0 110.444 176.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 13.5 tt -84.05 -21.73 8.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-O 118.826 -0.607 . . . . 0.0 111.56 -175.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -48.82 -51.8 51.25 Favored Pre-proline 0 CA--C 1.546 0.819 0 CA-C-N 119.994 1.27 . . . . 0.0 113.643 177.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -67.27 -29.0 39.4 Favored 'Trans proline' 0 C--N 1.351 0.682 0 CA-C-N 121.756 1.663 . . . . 0.0 112.555 176.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 31.4 t -65.48 -40.24 87.61 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 174.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 76.9 mt -67.78 -35.54 78.86 Favored 'General case' 0 C--O 1.224 -0.238 0 CA-C-N 119.299 0.954 . . . . 0.0 111.482 173.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -62.38 -42.27 99.28 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 119.549 1.068 . . . . 0.0 110.736 172.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -65.03 -39.38 93.3 Favored 'General case' 0 CA--C 1.532 0.265 0 O-C-N 121.28 -0.887 . . . . 0.0 110.505 175.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.24 -46.37 90.02 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.638 0.775 . . . . 0.0 109.348 175.486 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -58.88 -42.94 90.69 Favored 'General case' 0 CA--C 1.521 -0.144 0 C-N-CA 123.833 0.853 . . . . 0.0 111.279 179.386 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -70.79 -10.47 59.58 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.428 0.691 . . . . 0.0 112.607 179.338 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 58.2 mt-10 -106.16 -30.62 9.12 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 125.601 1.56 . . . . 0.0 111.46 -177.511 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 91.6 mmm -127.62 -5.38 5.83 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 -171.511 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.81 -10.69 14.21 Favored Glycine 0 CA--C 1.531 1.036 0 CA-C-N 119.828 1.194 . . . . 0.0 114.854 -174.106 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -65.41 -28.48 69.28 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 118.509 1.154 . . . . 0.0 111.51 171.502 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -123.31 -25.84 4.38 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 125.427 1.491 . . . . 0.0 111.639 -179.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 31.6 tp -100.07 161.61 13.5 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 124.306 1.042 . . . . 0.0 110.385 -170.244 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -135.95 144.6 45.53 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 104.447 -2.427 . . . . 0.0 104.447 168.066 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 59.9 mt -116.65 139.32 43.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 105.489 -2.041 . . . . 0.0 105.489 176.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 93.2 t -132.98 96.31 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 -169.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -74.39 138.02 43.1 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 178.175 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 13.4 tt -141.4 128.73 21.32 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 177.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 64.6 t0 -87.94 106.68 18.27 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.603 1.161 . . . . 0.0 109.797 -169.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 31.3 m -62.08 -19.02 20.92 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 CA-C-O 118.693 -0.67 . . . . 0.0 112.473 -176.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -67.2 -15.72 63.87 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 119.685 1.129 . . . . 0.0 112.105 176.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -127.21 1.86 6.42 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.306 1.042 . . . . 0.0 111.863 179.155 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.448 HD21 HG22 ' A' ' 7' ' ' THR . 63.8 m-80 -137.63 40.52 2.39 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.732 0.813 . . . . 0.0 111.447 -169.235 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 5.5 mp0 -54.41 -32.58 57.59 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.056 0.542 . . . . 0.0 111.781 174.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 32.9 mm-40 -65.73 -48.96 70.17 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 118.514 0.597 . . . . 0.0 110.136 -179.07 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.39 -37.82 80.76 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.036 0.534 . . . . 0.0 109.927 -178.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.4 -48.59 81.08 Favored 'General case' 0 CA--C 1.535 0.372 0 O-C-N 121.064 -1.022 . . . . 0.0 110.363 172.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -60.62 -27.67 66.58 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 124.225 0.916 . . . . 0.0 112.334 177.535 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 47.3 tttp -55.52 -29.11 58.29 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.84 1.256 . . . . 0.0 111.726 178.415 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -123.54 10.8 9.15 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.554 0.742 . . . . 0.0 111.732 179.242 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 64.12 30.44 77.78 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 123.649 0.642 . . . . 0.0 112.629 -176.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 61.5 t -65.44 125.8 23.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 171.038 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 67.0 mtt -136.36 3.84 2.86 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.811 1.244 . . . . 0.0 111.465 -179.209 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 24.2 m -144.05 161.79 37.88 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 126.591 1.957 . . . . 0.0 107.697 179.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 42.5 pt -141.56 154.51 66.59 Favored Pre-proline 0 CA--C 1.545 0.774 0 C-N-CA 124.424 1.09 . . . . 0.0 108.811 176.141 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -67.42 140.02 50.34 Favored 'Cis proline' 0 C--N 1.349 0.586 0 CA-C-N 120.356 1.163 . . . . 0.0 110.385 -4.278 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 42.4 m -132.71 142.24 48.96 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 173.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 91.6 mt -125.21 129.46 50.15 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 107.37 -1.345 . . . . 0.0 107.37 -169.259 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -119.84 118.49 30.92 Favored 'General case' 0 CA--C 1.513 -0.476 0 N-CA-C 103.27 -2.863 . . . . 0.0 103.27 178.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 4.5 t -88.6 122.83 40.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 103.007 -2.96 . . . . 0.0 103.007 172.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.2 mp -112.05 157.42 20.78 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 174.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 89.1 tttt -136.42 124.51 22.96 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 106.304 -1.739 . . . . 0.0 106.304 169.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.0 t70 49.22 38.02 12.48 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.909 1.284 . . . . 0.0 112.389 175.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 100.87 -2.4 55.55 Favored Glycine 0 CA--C 1.53 0.979 0 CA-C-O 118.15 -1.361 . . . . 0.0 115.167 169.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -131.96 152.54 51.04 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 120.174 1.987 . . . . 0.0 110.284 -179.15 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 22.0 t -62.92 134.52 28.12 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 -179.252 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.5 p -120.14 -24.23 3.03 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 C-N-CA 125.471 1.508 . . . . 0.0 109.958 176.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -158.79 172.2 18.68 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 120.262 1.392 . . . . 0.0 109.601 173.656 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 26.5 m -148.87 153.15 37.65 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 120.555 -1.34 . . . . 0.0 109.543 -179.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 48.4 m -150.22 154.44 37.95 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.218 1.407 . . . . 0.0 109.051 169.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 40.9 t -133.59 142.17 42.32 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 -177.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 75.69 -177.9 48.92 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 123.43 0.538 . . . . 0.0 111.838 -178.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 59.2 t80 -59.52 143.97 48.62 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 123.238 0.615 . . . . 0.0 110.683 179.212 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -150.27 137.12 11.23 Favored Pre-proline 0 C--O 1.234 0.267 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 -176.502 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -73.12 153.83 51.97 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 122.009 1.806 . . . . 0.0 110.486 176.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 57.6 pttt -60.79 -31.61 70.97 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 118.897 -0.573 . . . . 0.0 111.818 -178.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -66.45 -42.5 87.53 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.279 0.632 . . . . 0.0 110.438 -179.179 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.18 -44.48 88.32 Favored 'General case' 0 C--O 1.232 0.16 0 O-C-N 121.961 -0.462 . . . . 0.0 109.898 179.148 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 92.0 mt -62.61 -40.22 96.25 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.582 177.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -60.4 -41.19 93.34 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-O 118.577 -0.725 . . . . 0.0 111.498 174.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -63.39 -42.71 98.83 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 118.924 0.784 . . . . 0.0 110.007 176.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 40.7 mt -63.65 -41.62 98.19 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 118.739 0.699 . . . . 0.0 111.382 177.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 43.1 t -57.51 -49.34 80.68 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 C-N-CA 123.546 0.738 . . . . 0.0 109.239 171.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -63.05 -31.44 72.58 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.403 1.481 . . . . 0.0 111.964 -173.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -58.67 -24.73 61.83 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 118.236 -0.888 . . . . 0.0 112.213 174.397 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 82.3 m-70 -125.69 -14.56 6.23 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 113.863 1.06 . . . . 0.0 113.863 -168.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 23.8 mt . . . . . 0 C--O 1.247 0.964 0 CA-C-N 119.692 1.133 . . . . 0.0 109.125 168.975 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 44.7 tpp . . . . . 0 N--CA 1.483 1.185 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -143.82 -173.73 4.06 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.536 1.134 . . . . 0.0 110.527 -170.001 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 7.6 mt -69.95 145.6 12.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 168.34 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 38.7 t -135.0 164.1 34.68 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 C-N-CA 127.065 2.146 . . . . 0.0 106.082 -179.291 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 6.2 ttmt -120.85 146.22 46.79 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 175.016 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -146.48 167.78 22.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.335 0.588 . . . . 0.0 111.104 -176.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 16.0 p -132.57 170.62 14.91 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 126.394 1.878 . . . . 0.0 107.896 171.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -52.97 -29.76 30.95 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.034 0.933 . . . . 0.0 113.125 -179.096 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 56.6 mt-30 -62.47 -28.98 70.19 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.124 1.37 . . . . 0.0 112.933 179.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.6 m -136.33 -5.89 2.04 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 113.517 0.932 . . . . 0.0 113.517 -169.191 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 81.9 t80 -53.43 -44.01 68.46 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.174 0.99 . . . . 0.0 111.281 -178.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.2 m -62.89 -39.06 93.33 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.252 0.621 . . . . 0.0 111.935 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.77 -43.89 82.82 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 122.697 0.399 . . . . 0.0 109.993 178.299 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -64.53 -41.54 96.31 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 122.235 0.214 . . . . 0.0 110.709 -179.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.409 ' HA ' HG21 ' A' ' 20' ' ' VAL . 36.3 p -79.47 -3.65 47.59 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 124.308 1.043 . . . . 0.0 113.544 -176.567 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 74.7 m -75.07 -21.4 59.01 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 176.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -88.02 71.74 9.32 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 121.55 -0.719 . . . . 0.0 111.586 -169.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 84.13 -152.75 28.58 Favored Glycine 0 C--N 1.336 0.566 0 N-CA-C 110.304 -1.118 . . . . 0.0 110.304 173.303 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 63.2 t -70.7 134.36 30.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 169.114 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.409 HG21 ' HA ' ' A' ' 15' ' ' THR . 61.6 t -139.09 138.81 41.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 105.786 -1.931 . . . . 0.0 105.786 179.34 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.9 tt -117.37 104.31 11.0 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 -177.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -89.45 147.1 24.2 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 -177.308 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -127.42 94.13 3.9 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 125.551 1.54 . . . . 0.0 107.333 -175.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -74.46 112.77 10.96 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 105.68 -1.971 . . . . 0.0 105.68 174.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -149.41 -174.94 4.81 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 124.911 1.284 . . . . 0.0 108.095 -172.056 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -152.77 148.78 20.95 Favored Pre-proline 0 N--CA 1.453 -0.285 0 N-CA-C 105.83 -1.915 . . . . 0.0 105.83 167.174 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -68.21 -11.89 33.39 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 CA-C-N 121.101 1.429 . . . . 0.0 112.855 178.149 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 1.3 m95 -77.22 -12.34 59.94 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.775 0.83 . . . . 0.0 111.814 172.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 17.4 t -64.65 160.95 18.69 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.353 1.461 . . . . 0.0 110.834 -178.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -115.52 -58.02 0.34 Allowed Glycine 0 CA--C 1.531 1.046 0 CA-C-O 118.631 -1.094 . . . . 0.0 111.069 171.436 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -56.22 -33.63 91.29 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 123.506 2.804 . . . . 0.0 113.395 178.368 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 23.0 m -58.4 -33.71 69.94 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 121.705 -0.622 . . . . 0.0 111.555 176.34 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.5 mmtp -68.5 -22.24 64.55 Favored 'General case' 0 CA--C 1.531 0.238 0 O-C-N 121.499 -0.75 . . . . 0.0 111.086 -179.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 35.3 mtm -70.15 -43.27 71.23 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-N 118.731 0.696 . . . . 0.0 110.298 175.346 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 18.2 tt -85.2 -23.7 7.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-O 118.379 -0.82 . . . . 0.0 111.701 -176.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -49.04 -50.19 64.47 Favored Pre-proline 0 CA--C 1.549 0.914 0 CA-C-N 120.407 1.458 . . . . 0.0 114.516 179.038 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -66.13 -30.64 46.6 Favored 'Trans proline' 0 C--N 1.351 0.666 0 CA-C-N 121.636 1.62 . . . . 0.0 111.682 176.449 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.6 t -66.03 -39.81 85.55 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-O 118.305 -0.855 . . . . 0.0 109.449 174.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 94.7 mt -62.53 -37.66 86.95 Favored 'General case' 0 C--N 1.34 0.185 0 CA-C-N 119.916 1.235 . . . . 0.0 110.874 173.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -63.02 -45.4 92.5 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 119.411 1.005 . . . . 0.0 110.978 173.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 50.8 mm-40 -65.26 -37.33 86.87 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 120.923 -1.111 . . . . 0.0 110.83 178.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -63.94 -42.99 97.19 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 125.154 1.382 . . . . 0.0 109.392 176.156 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -58.5 -43.59 89.14 Favored 'General case' 0 CA--C 1.521 -0.137 0 C-N-CA 123.941 0.896 . . . . 0.0 111.203 176.014 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -70.26 -12.8 61.84 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -179.013 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -102.25 -33.38 9.64 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 125.228 1.411 . . . . 0.0 111.088 -179.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 79.5 mmm -119.49 -5.61 10.29 Favored 'General case' 0 N--CA 1.461 0.117 0 CA-C-O 118.584 -0.722 . . . . 0.0 112.837 -168.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -61.4 -8.01 11.86 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 124.583 1.087 . . . . 0.0 115.574 -173.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -75.53 -26.41 58.04 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 118.736 1.268 . . . . 0.0 111.365 171.497 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 50.8 mmtt -118.15 -24.29 7.04 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 125.503 1.521 . . . . 0.0 111.684 -176.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 47.4 tp -116.4 152.99 32.85 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 124.379 1.072 . . . . 0.0 112.056 -167.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -119.41 142.15 48.47 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 104.986 -2.227 . . . . 0.0 104.986 166.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 75.8 mt -110.94 140.28 30.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 105.667 -1.975 . . . . 0.0 105.667 172.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 97.3 t -131.79 98.35 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -175.095 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -75.09 140.48 43.48 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 174.435 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 13.7 tt -142.88 124.77 12.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 178.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -82.68 105.31 13.61 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 124.594 1.158 . . . . 0.0 108.832 -173.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 31.0 m -60.12 -25.58 33.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 118.536 -0.745 . . . . 0.0 111.959 -175.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -65.71 -18.01 65.02 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 119.597 1.089 . . . . 0.0 112.047 -177.252 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -118.69 3.51 11.68 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.893 1.277 . . . . 0.0 111.132 177.392 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -139.81 40.46 2.0 Allowed 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 124.563 1.145 . . . . 0.0 109.758 -170.179 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 50.5 mm-40 -55.54 -32.42 62.93 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.907 0.883 . . . . 0.0 111.024 176.388 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 33.1 mm-40 -65.33 -48.27 73.61 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 118.411 0.551 . . . . 0.0 110.255 178.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.43 -40.27 85.48 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.235 0.614 . . . . 0.0 109.927 -178.561 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.98 -47.33 86.27 Favored 'General case' 0 CA--C 1.533 0.293 0 O-C-N 121.541 -0.725 . . . . 0.0 110.76 173.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -62.9 -29.01 72.87 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 123.554 0.597 . . . . 0.0 111.944 177.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 17.9 ttmt -55.6 -29.87 59.9 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 125.837 1.655 . . . . 0.0 111.999 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -123.67 7.9 8.85 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 123.491 0.717 . . . . 0.0 112.197 -179.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 63.09 41.41 99.78 Favored Glycine 0 CA--C 1.53 0.996 0 CA-C-N 118.329 0.513 . . . . 0.0 111.857 -176.431 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 88.3 t -66.07 91.52 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 C-N-CA 124.71 1.204 . . . . 0.0 107.774 174.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 25.1 ptt? -73.57 -28.12 61.68 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 124.707 1.203 . . . . 0.0 112.94 -176.138 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 34.4 m -146.72 174.85 11.08 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 125.973 1.709 . . . . 0.0 109.491 -170.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 41.6 pt -139.49 156.56 71.42 Favored Pre-proline 0 CA--C 1.545 0.752 0 C-N-CA 125.169 1.388 . . . . 0.0 108.669 174.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -67.46 138.97 44.99 Favored 'Cis proline' 0 C--N 1.349 0.561 0 CA-C-N 120.577 1.242 . . . . 0.0 110.13 -5.08 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 23.4 m -132.91 135.23 45.43 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 176.194 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 10.8 mp -114.81 125.68 53.96 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 -169.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -115.41 122.63 46.4 Favored 'General case' 0 CA--C 1.515 -0.393 0 N-CA-C 103.708 -2.701 . . . . 0.0 103.708 177.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 4.3 t -92.87 125.7 45.41 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.481 0 N-CA-C 103.655 -2.72 . . . . 0.0 103.655 169.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.2 mp -114.08 152.17 31.44 Favored 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 172.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -137.96 126.16 23.03 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 174.414 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 32.2 t70 50.86 33.17 8.21 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.976 1.31 . . . . 0.0 112.264 178.139 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 100.65 0.06 55.41 Favored Glycine 0 CA--C 1.531 1.059 0 CA-C-O 118.207 -1.33 . . . . 0.0 114.965 169.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -128.51 150.46 50.16 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 120.002 1.901 . . . . 0.0 109.929 179.218 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 47.1 t -62.09 132.62 27.87 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 175.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.6 p -119.53 -21.75 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 C-N-CA 125.129 1.372 . . . . 0.0 109.79 178.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -159.65 165.01 33.57 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 120.184 1.356 . . . . 0.0 110.751 171.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 10.7 m -136.32 150.82 49.05 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.255 1.422 . . . . 0.0 108.916 176.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 73.3 m -150.67 156.83 42.12 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.885 1.674 . . . . 0.0 108.696 170.594 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 47.5 t -133.49 145.3 33.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 -176.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 79.43 178.32 51.06 Favored Glycine 0 CA--C 1.53 1.025 0 C-N-CA 123.928 0.775 . . . . 0.0 112.706 175.253 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -60.06 148.35 36.05 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 123.798 0.839 . . . . 0.0 111.017 179.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -149.29 136.7 11.15 Favored Pre-proline 0 CA--C 1.534 0.334 0 C-N-CA 125.492 1.517 . . . . 0.0 107.084 -178.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -69.3 158.98 55.52 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 122.019 1.813 . . . . 0.0 111.04 177.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -55.06 -43.19 73.64 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 124.799 1.24 . . . . 0.0 112.739 -178.031 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -61.49 -44.08 97.72 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.009 0.524 . . . . 0.0 110.257 178.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.49 -36.51 82.92 Favored 'General case' 0 CA--C 1.528 0.129 0 O-C-N 121.865 -0.522 . . . . 0.0 111.017 178.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 92.4 mt -62.98 -42.11 99.74 Favored 'General case' 0 N--CA 1.456 -0.14 0 O-C-N 122.134 -0.353 . . . . 0.0 110.91 173.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -60.55 -39.8 89.27 Favored 'General case' 0 C--O 1.224 -0.284 0 CA-C-O 118.712 -0.661 . . . . 0.0 110.178 175.18 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -65.75 -40.9 92.56 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 119.02 0.827 . . . . 0.0 110.601 178.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 60.4 tp -60.44 -37.51 81.18 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 125.406 1.482 . . . . 0.0 110.958 177.22 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 92.9 t -69.38 -51.63 40.64 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 123.509 0.724 . . . . 0.0 109.698 171.321 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -58.27 -38.14 76.37 Favored 'General case' 0 C--N 1.334 -0.101 0 C-N-CA 125.939 1.695 . . . . 0.0 112.099 -168.135 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -65.42 -8.49 19.11 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 113.342 0.867 . . . . 0.0 113.342 -178.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -120.91 -10.46 9.1 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 124.293 1.037 . . . . 0.0 113.062 178.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 55.8 mt . . . . . 0 C--O 1.248 0.996 0 CA-C-N 119.204 0.911 . . . . 0.0 109.314 173.562 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.1 mmt . . . . . 0 N--CA 1.484 1.233 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -151.97 -174.59 4.91 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.041 1.336 . . . . 0.0 109.211 -174.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.9 mt -75.67 143.79 12.77 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 167.146 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 40.8 t -138.07 163.88 28.71 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 126.284 1.834 . . . . 0.0 107.345 -174.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -115.29 146.07 41.86 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 174.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -147.94 167.57 24.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.31 0.576 . . . . 0.0 111.253 -179.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 18.0 p -136.25 172.26 13.27 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 126.253 1.821 . . . . 0.0 106.98 168.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -49.88 -28.53 6.68 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.824 0.85 . . . . 0.0 113.073 174.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -56.86 -31.98 65.36 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.619 1.568 . . . . 0.0 112.933 178.447 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 14.8 m -142.26 -4.78 1.0 Allowed 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -169.223 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -54.35 -41.67 69.39 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.98 0.912 . . . . 0.0 111.724 -176.156 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.2 p -59.96 -45.73 91.72 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 124.01 0.924 . . . . 0.0 111.747 177.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.2 -43.72 94.17 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 122.719 0.408 . . . . 0.0 110.284 178.069 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -63.4 -35.85 81.77 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 119.475 -0.298 . . . . 0.0 111.076 -179.255 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 29.1 p -85.5 3.58 39.72 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.094 0.957 . . . . 0.0 113.253 -176.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 60.5 m -106.43 30.78 5.69 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.165 0.986 . . . . 0.0 111.684 -176.344 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -132.5 37.91 3.48 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.573 0.749 . . . . 0.0 112.313 -174.149 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 121.04 -153.52 16.6 Favored Glycine 0 C--N 1.335 0.52 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 175.421 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 53.5 t -74.45 133.95 30.5 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 N-CA-C 105.011 -2.218 . . . . 0.0 105.011 166.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 43.2 t -137.03 133.81 47.76 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 N-CA-C 105.896 -1.89 . . . . 0.0 105.896 -178.484 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 5.1 tt -116.89 101.18 8.31 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 106.138 -1.801 . . . . 0.0 106.138 -177.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -81.82 145.8 30.22 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.342 179.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -126.15 94.17 4.02 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 125.918 1.687 . . . . 0.0 107.444 -177.451 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -73.1 112.85 9.52 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 105.936 -1.875 . . . . 0.0 105.936 174.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -149.38 -176.68 5.48 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.88 1.272 . . . . 0.0 108.403 -172.207 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -151.95 147.92 20.7 Favored Pre-proline 0 C--O 1.233 0.213 0 N-CA-C 105.545 -2.02 . . . . 0.0 105.545 167.228 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -68.03 -11.64 32.67 Favored 'Trans proline' 0 CA--C 1.534 0.498 0 CA-C-N 121.1 1.429 . . . . 0.0 113.276 -178.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 1.6 m95 -75.77 -13.7 60.3 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.637 0.775 . . . . 0.0 111.803 172.35 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 23.0 t -63.4 158.21 21.21 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.438 1.495 . . . . 0.0 110.971 -178.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -113.22 -57.82 0.41 Allowed Glycine 0 CA--C 1.531 1.065 0 CA-C-O 118.581 -1.121 . . . . 0.0 111.05 171.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -55.96 -33.76 90.06 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 123.366 2.711 . . . . 0.0 113.575 178.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 23.4 m -58.04 -34.15 69.76 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.271 0.628 . . . . 0.0 111.537 176.372 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.4 mmtp -68.5 -22.6 64.53 Favored 'General case' 0 CA--C 1.531 0.242 0 O-C-N 121.471 -0.768 . . . . 0.0 111.094 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 33.4 mtm -71.07 -42.85 68.84 Favored 'General case' 0 C--N 1.34 0.172 0 CA-C-N 118.841 0.746 . . . . 0.0 110.33 176.339 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 16.6 tt -85.29 -24.64 6.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-O 118.557 -0.735 . . . . 0.0 111.701 -175.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -48.85 -50.27 62.47 Favored Pre-proline 0 CA--C 1.549 0.912 0 CA-C-N 120.062 1.301 . . . . 0.0 114.219 178.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -67.08 -28.94 40.68 Favored 'Trans proline' 0 C--N 1.35 0.626 0 CA-C-N 121.774 1.669 . . . . 0.0 111.977 176.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.1 t -66.43 -40.89 87.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 CA-C-O 118.614 -0.708 . . . . 0.0 109.27 173.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 94.6 mt -63.23 -37.27 86.59 Favored 'General case' 0 C--N 1.34 0.188 0 CA-C-N 119.504 1.047 . . . . 0.0 110.855 174.58 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -62.37 -43.78 98.01 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 119.356 0.98 . . . . 0.0 111.107 173.02 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -62.74 -39.04 92.86 Favored 'General case' 0 CA--C 1.535 0.374 0 O-C-N 121.185 -0.947 . . . . 0.0 110.286 175.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.96 -43.65 98.22 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 124.556 1.142 . . . . 0.0 110.069 177.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -59.43 -42.71 92.51 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 123.679 0.792 . . . . 0.0 110.842 176.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -71.49 -10.61 60.04 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -179.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -106.6 -28.35 10.3 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 125.517 1.527 . . . . 0.0 111.651 -178.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 23.0 mtp -130.48 1.76 4.55 Favored 'General case' 0 N--CA 1.462 0.156 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -169.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -56.93 -11.63 6.09 Favored Glycine 0 CA--C 1.533 1.19 0 N-CA-C 115.993 1.157 . . . . 0.0 115.993 -175.399 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -78.58 -25.99 45.43 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 118.893 1.347 . . . . 0.0 111.778 173.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 52.1 mmtt -117.13 -19.8 9.54 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 125.468 1.507 . . . . 0.0 111.734 -176.031 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 57.1 tp -124.97 144.85 50.15 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 124.68 1.192 . . . . 0.0 110.668 -168.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -116.75 145.87 43.2 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 105.183 -2.154 . . . . 0.0 105.183 167.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 68.1 mt -115.83 140.24 38.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 105.768 -1.938 . . . . 0.0 105.768 175.179 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 80.8 t -132.84 98.23 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 -171.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -74.17 140.33 45.08 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 174.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 13.6 tt -143.49 124.97 11.09 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 178.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 61.0 t0 -83.89 106.63 15.71 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 124.401 1.08 . . . . 0.0 108.883 -172.331 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 33.0 m -59.81 -25.11 31.28 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 CA-C-O 118.444 -0.788 . . . . 0.0 112.072 -175.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -65.29 -18.6 65.44 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 119.646 1.112 . . . . 0.0 112.026 -178.556 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -118.7 4.53 11.6 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.041 1.337 . . . . 0.0 110.948 177.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 68.6 m-80 -140.5 38.72 1.87 Allowed 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 124.383 1.073 . . . . 0.0 110.151 -169.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 55.1 mm-40 -56.05 -33.27 64.83 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.295 0.638 . . . . 0.0 110.849 174.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -66.52 -47.93 71.36 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 118.3 0.5 . . . . 0.0 110.284 178.127 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.96 -40.86 91.68 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 118.65 0.659 . . . . 0.0 110.0 -179.236 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.35 -50.35 74.29 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.361 0.664 . . . . 0.0 110.1 174.08 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -60.37 -28.39 67.11 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 123.879 0.752 . . . . 0.0 112.334 177.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 21.9 ttmt -55.05 -29.48 57.56 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 125.565 1.546 . . . . 0.0 111.898 178.16 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -124.12 11.07 8.82 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.846 0.858 . . . . 0.0 111.71 178.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 67.38 24.42 73.63 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 123.914 0.768 . . . . 0.0 113.214 -177.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 48.9 t -63.65 129.62 27.53 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 171.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 35.0 ttm -142.64 4.37 1.52 Allowed 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.269 1.028 . . . . 0.0 111.278 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 22.8 m -142.6 161.58 37.7 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 126.697 1.999 . . . . 0.0 107.539 178.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 43.0 pt -143.0 156.45 61.95 Favored Pre-proline 0 CA--C 1.545 0.76 0 C-N-CA 124.588 1.155 . . . . 0.0 108.921 178.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -66.9 139.18 44.28 Favored 'Cis proline' 0 C--N 1.348 0.547 0 CA-C-N 120.423 1.187 . . . . 0.0 110.18 -5.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 33.1 m -131.37 139.1 49.42 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 174.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 83.7 mt -119.82 128.55 53.8 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 -169.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -117.86 124.32 48.04 Favored 'General case' 0 CA--C 1.516 -0.354 0 N-CA-C 103.973 -2.603 . . . . 0.0 103.973 177.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 15.9 t -96.38 122.68 48.12 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 N-CA-C 104.118 -2.549 . . . . 0.0 104.118 173.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.9 mp -116.16 152.45 33.67 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 175.317 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 57.8 tttp -135.02 121.83 20.97 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 173.123 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.4 t70 48.66 37.13 8.83 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.889 1.275 . . . . 0.0 112.264 175.469 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 99.07 2.1 57.02 Favored Glycine 0 CA--C 1.53 0.971 0 CA-C-O 117.954 -1.47 . . . . 0.0 115.283 169.539 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -122.1 145.55 48.06 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 120.292 2.046 . . . . 0.0 109.323 175.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 58.5 t -65.79 130.85 31.47 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 170.218 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 35.4 m -119.45 -19.27 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 CA-C-O 117.717 -1.135 . . . . 0.0 111.314 175.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -155.21 167.93 28.75 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 120.444 1.475 . . . . 0.0 111.191 173.345 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 14.3 m -141.84 151.11 42.45 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.767 1.627 . . . . 0.0 108.698 177.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 58.8 m -150.16 156.27 41.31 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.514 1.525 . . . . 0.0 108.57 169.146 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 42.3 t -133.62 144.91 34.54 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 -178.237 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 78.22 -175.86 54.43 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 123.695 0.664 . . . . 0.0 111.817 179.102 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -62.56 147.17 49.9 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.371 0.669 . . . . 0.0 110.415 177.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 58.6 mttt -142.22 138.0 16.25 Favored Pre-proline 0 C--O 1.234 0.281 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 168.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -68.6 165.09 30.54 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 122.134 1.889 . . . . 0.0 111.029 177.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -53.77 -44.04 69.72 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 125.531 1.532 . . . . 0.0 112.698 -178.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -63.78 -43.71 95.53 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.097 177.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.77 -38.49 86.66 Favored 'General case' 0 C--N 1.339 0.12 0 O-C-N 121.776 -0.577 . . . . 0.0 110.58 -179.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 51.9 mt -62.22 -45.87 91.42 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 123.511 0.724 . . . . 0.0 110.746 175.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 11.3 mt-30 -58.92 -41.0 86.26 Favored 'General case' 0 C--O 1.225 -0.19 0 CA-C-N 118.383 0.538 . . . . 0.0 110.769 175.214 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -65.9 -39.92 91.03 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 118.875 0.761 . . . . 0.0 110.81 179.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 67.8 tp -62.54 -36.38 82.42 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.339 1.456 . . . . 0.0 111.181 177.096 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 84.2 t -69.11 -47.88 72.36 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-N 118.572 0.623 . . . . 0.0 109.857 169.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -57.18 -40.6 77.66 Favored 'General case' 0 CA--C 1.521 -0.155 0 C-N-CA 125.498 1.519 . . . . 0.0 111.893 -168.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -65.52 -6.44 10.75 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 -178.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -126.59 0.4 6.84 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 124.526 1.13 . . . . 0.0 113.426 176.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 54.7 mt . . . . . 0 C--O 1.247 0.955 0 CA-C-N 119.462 1.028 . . . . 0.0 109.004 171.35 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.4 ptt? . . . . . 0 N--CA 1.481 1.104 0 CA-C-O 118.563 -0.732 . . . . 0.0 112.762 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -158.04 -175.64 5.47 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 119.799 1.181 . . . . 0.0 109.413 -169.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.6 mt -75.89 144.34 12.05 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 167.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 47.3 t -140.34 164.3 22.36 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 C-N-CA 127.049 2.14 . . . . 0.0 106.99 -173.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 3.7 tppp? -113.87 147.37 38.57 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 175.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -146.85 168.91 20.25 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 123.109 0.564 . . . . 0.0 110.535 175.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 33.2 p -136.03 177.73 7.61 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 125.929 1.691 . . . . 0.0 107.961 170.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -42.75 -37.85 1.9 Allowed 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.3 1.44 . . . . 0.0 112.836 169.666 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 50.8 mm-40 -73.88 -26.24 60.45 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.805 0.842 . . . . 0.0 113.03 -174.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 14.3 p -121.74 -19.77 6.68 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 -169.413 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -53.82 -45.85 70.97 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 124.54 1.136 . . . . 0.0 111.925 -171.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.6 m -65.7 -23.96 66.88 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 112.937 0.717 . . . . 0.0 112.937 -177.14 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -90.66 -28.68 18.21 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 124.086 0.954 . . . . 0.0 111.443 176.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 68.9 mm-40 -70.81 -32.63 69.77 Favored 'General case' 0 N--CA 1.453 -0.325 0 O-C-N 121.797 -0.564 . . . . 0.0 110.829 173.266 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 22.9 p -88.71 4.56 46.9 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 113.847 1.055 . . . . 0.0 113.847 -170.277 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 30.4 p -108.67 29.16 7.68 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.336 1.054 . . . . 0.0 112.339 -174.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -129.32 50.73 2.12 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.218 1.007 . . . . 0.0 110.954 -174.357 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 103.68 -155.37 17.82 Favored Glycine 0 C--N 1.337 0.625 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 178.26 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 45.1 t -71.53 138.22 22.12 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 N-CA-C 105.694 -1.965 . . . . 0.0 105.694 167.552 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 47.3 t -138.22 139.25 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 N-CA-C 105.739 -1.949 . . . . 0.0 105.739 179.316 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 61.1 tp -122.6 101.72 7.64 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 106.703 -1.592 . . . . 0.0 106.703 -176.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -83.27 151.28 25.68 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 179.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -130.4 94.21 3.62 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 126.482 1.913 . . . . 0.0 107.242 -178.51 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -74.2 114.46 12.57 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 105.704 -1.962 . . . . 0.0 105.704 174.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -149.46 -177.63 5.96 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.094 1.357 . . . . 0.0 108.521 -172.856 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -155.63 147.94 17.59 Favored Pre-proline 0 CA--C 1.532 0.255 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 168.062 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -61.2 -18.06 56.21 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 121.649 1.566 . . . . 0.0 115.72 -178.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 49.7 p-90 -69.02 -20.68 64.14 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 119.963 1.256 . . . . 0.0 111.878 173.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 30.6 t -59.22 146.33 39.56 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 125.146 1.379 . . . . 0.0 111.054 -172.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -95.22 -60.26 1.07 Allowed Glycine 0 CA--C 1.531 1.064 0 CA-C-O 118.795 -1.003 . . . . 0.0 111.36 169.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -66.04 -26.25 50.88 Favored 'Trans proline' 0 C--N 1.35 0.656 0 CA-C-N 120.293 2.047 . . . . 0.0 113.101 -172.693 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 30.8 m -57.53 -35.14 69.89 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 121.699 -0.625 . . . . 0.0 111.295 174.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.0 mmtp -67.3 -26.09 66.36 Favored 'General case' 0 CA--C 1.53 0.207 0 O-C-N 121.673 -0.642 . . . . 0.0 110.928 -179.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 29.8 mtm -71.85 -44.17 64.28 Favored 'General case' 0 C--N 1.34 0.173 0 CA-C-N 118.585 0.63 . . . . 0.0 110.426 177.615 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 15.5 tt -79.86 -22.16 11.95 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-O 118.574 -0.727 . . . . 0.0 111.351 -177.201 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -48.93 -52.32 47.71 Favored Pre-proline 0 CA--C 1.549 0.942 0 CA-C-N 120.424 1.466 . . . . 0.0 114.241 179.125 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -66.71 -26.92 45.29 Favored 'Trans proline' 0 C--N 1.35 0.607 0 CA-C-N 121.748 1.66 . . . . 0.0 112.454 176.512 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 6.1 t -69.82 -37.86 74.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 O-C-N 121.688 -0.633 . . . . 0.0 109.454 174.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 43.2 mt -65.66 -36.72 84.49 Favored 'General case' 0 C--O 1.224 -0.267 0 CA-C-N 119.286 0.948 . . . . 0.0 110.517 172.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -63.34 -43.73 96.89 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 119.198 0.908 . . . . 0.0 111.079 173.013 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -60.61 -44.98 95.68 Favored 'General case' 0 CA--C 1.531 0.241 0 O-C-N 121.243 -0.911 . . . . 0.0 110.186 175.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -62.16 -41.88 98.73 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 124.846 1.258 . . . . 0.0 109.942 179.397 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -60.24 -42.85 96.14 Favored 'General case' 0 CA--C 1.521 -0.168 0 C-N-CA 123.879 0.872 . . . . 0.0 110.905 176.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -71.54 -10.46 59.8 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 122.976 0.51 . . . . 0.0 112.337 -179.202 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -103.59 -34.0 8.8 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 125.205 1.402 . . . . 0.0 111.234 178.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 74.6 mmm -121.86 -5.63 9.08 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 113.364 0.876 . . . . 0.0 113.364 -168.512 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -57.83 -15.11 18.37 Favored Glycine 0 CA--C 1.532 1.133 0 CA-C-N 119.718 1.145 . . . . 0.0 115.135 -173.203 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -69.71 -30.48 68.12 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 118.441 1.12 . . . . 0.0 111.728 173.574 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 45.9 mmtm -112.82 -19.69 11.89 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 125.456 1.502 . . . . 0.0 111.676 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 30.1 tp -117.55 157.15 26.83 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.412 1.085 . . . . 0.0 111.214 -169.232 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 37.4 ttmt -128.3 141.32 51.48 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 103.893 -2.632 . . . . 0.0 103.893 166.453 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 62.2 mt -108.15 141.53 23.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 105.925 -1.88 . . . . 0.0 105.925 175.04 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 84.7 t -132.69 98.44 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 -173.494 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt -74.31 140.49 44.93 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 174.397 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 15.0 tt -142.35 126.81 16.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 176.671 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 49.2 t0 -83.42 103.49 12.83 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.795 1.238 . . . . 0.0 109.067 -173.076 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 28.2 m -60.1 -27.15 38.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 118.766 -0.635 . . . . 0.0 112.028 -174.686 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -66.31 -19.54 65.84 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 119.321 0.964 . . . . 0.0 111.73 -177.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -114.13 1.78 14.69 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.558 1.543 . . . . 0.0 110.893 178.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 69.0 m-80 -141.98 42.52 1.68 Allowed 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.387 1.075 . . . . 0.0 109.79 -169.515 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 45.2 mm-40 -56.22 -33.07 65.01 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.794 0.838 . . . . 0.0 111.236 178.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 36.0 mm-40 -65.78 -46.72 77.68 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 118.379 0.536 . . . . 0.0 110.389 179.074 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.45 -38.51 77.81 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 121.798 -0.564 . . . . 0.0 109.778 -178.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -58.78 -47.54 84.36 Favored 'General case' 0 CA--C 1.535 0.376 0 O-C-N 120.978 -1.076 . . . . 0.0 110.241 171.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -59.97 -28.93 66.9 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 124.087 0.851 . . . . 0.0 112.506 176.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 50.1 tptt -56.27 -29.05 60.61 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.602 1.161 . . . . 0.0 111.551 179.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -123.34 10.39 9.24 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.568 0.747 . . . . 0.0 111.664 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 62.31 33.31 85.72 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 123.558 0.599 . . . . 0.0 112.427 -176.176 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 57.5 t -64.94 121.06 13.29 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 173.001 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 26.1 mmt -132.45 2.64 3.85 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.96 1.304 . . . . 0.0 111.465 -179.009 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 30.0 m -144.82 161.48 39.17 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 126.953 2.101 . . . . 0.0 107.062 178.242 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 34.5 pt -144.21 155.18 58.18 Favored Pre-proline 0 CA--C 1.545 0.788 0 C-N-CA 124.772 1.229 . . . . 0.0 108.451 177.406 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -68.54 139.54 51.47 Favored 'Cis proline' 0 C--N 1.35 0.624 0 CA-C-N 120.651 1.268 . . . . 0.0 110.53 -2.474 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 32.0 m -132.89 132.57 42.21 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 177.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 6.9 mp -110.52 131.17 55.28 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 -171.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -122.38 128.35 50.86 Favored 'General case' 0 CA--C 1.508 -0.638 0 N-CA-C 103.388 -2.819 . . . . 0.0 103.388 179.132 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 1.5 t -110.61 127.13 67.86 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.751 0 N-CA-C 104.337 -2.468 . . . . 0.0 104.337 -176.255 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.3 mp -126.08 152.05 46.37 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 -174.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -138.04 125.47 21.94 Favored 'General case' 0 CA--C 1.513 -0.479 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 175.221 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 29.2 t70 49.84 33.12 6.02 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.959 1.303 . . . . 0.0 112.348 173.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 99.41 4.59 56.14 Favored Glycine 0 CA--C 1.53 1.018 0 CA-C-O 118.018 -1.434 . . . . 0.0 114.551 170.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -122.0 144.89 48.62 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 120.101 1.951 . . . . 0.0 109.043 174.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 14.3 p -68.74 129.71 33.43 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 169.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 27.7 m -115.62 -20.87 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 CA-C-O 117.577 -1.201 . . . . 0.0 111.052 179.586 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -159.42 166.36 31.19 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 120.734 1.606 . . . . 0.0 111.402 176.343 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 13.3 m -136.34 151.18 49.31 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.991 1.716 . . . . 0.0 108.519 175.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 74.1 m -150.26 158.11 43.81 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.882 1.673 . . . . 0.0 108.671 171.206 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 39.2 t -133.97 148.21 30.32 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 -177.01 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.68 177.24 51.86 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 123.973 0.797 . . . . 0.0 112.705 171.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 47.6 t80 -62.55 135.46 57.42 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.352 0.661 . . . . 0.0 109.59 175.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 13.0 mptt -136.05 136.2 22.58 Favored Pre-proline 0 CA--C 1.533 0.324 0 C-N-CA 126.429 1.892 . . . . 0.0 105.995 175.389 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -70.61 160.19 50.28 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 122.493 2.128 . . . . 0.0 110.591 176.18 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 41.5 pttt -59.34 -28.9 67.25 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -177.108 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -65.86 -48.86 70.15 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 122.839 0.456 . . . . 0.0 110.037 173.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.6 -37.9 89.06 Favored 'General case' 0 CA--C 1.529 0.162 0 O-C-N 121.898 -0.501 . . . . 0.0 110.711 178.296 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 79.3 mt -64.97 -41.56 95.34 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 119.355 -0.355 . . . . 0.0 111.255 176.267 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 15.6 mt-30 -59.32 -41.05 88.17 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 118.824 0.738 . . . . 0.0 110.086 174.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -64.77 -40.82 95.9 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 118.199 0.454 . . . . 0.0 110.365 178.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 63.3 tp -61.03 -43.77 98.4 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.733 1.213 . . . . 0.0 110.755 177.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 78.5 t -61.42 -46.43 96.61 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 123.651 0.78 . . . . 0.0 109.37 173.125 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -61.91 -25.73 67.75 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 125.017 1.327 . . . . 0.0 112.239 -173.086 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 49.2 mtpt -55.86 -24.58 37.73 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 118.658 -0.687 . . . . 0.0 112.576 172.327 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 80.9 m-70 -123.34 -8.2 8.13 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 -168.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 82.1 mt . . . . . 0 C--O 1.248 0.975 0 CA-C-N 119.155 0.889 . . . . 0.0 109.327 171.512 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.8 mmt . . . . . 0 N--CA 1.483 1.224 0 N-CA-C 110.051 -0.351 . . . . 0.0 110.051 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -151.74 -175.47 5.22 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 125.006 1.322 . . . . 0.0 109.373 -174.548 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.3 mt -75.34 142.12 14.96 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 166.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 41.3 t -135.32 163.72 35.05 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 C-N-CA 126.353 1.861 . . . . 0.0 106.251 -177.127 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 6.2 ttmt -118.99 144.83 46.28 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 174.69 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -145.12 166.49 25.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.393 0.615 . . . . 0.0 110.976 -177.027 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.9 p -133.09 169.92 16.15 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 126.254 1.822 . . . . 0.0 107.779 171.29 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -52.63 -29.71 27.61 Favored 'General case' 0 CA--C 1.535 0.365 0 C-N-CA 124.499 1.12 . . . . 0.0 113.23 -178.67 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 82.6 mm-40 -63.54 -29.0 70.33 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.788 1.235 . . . . 0.0 113.103 179.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.6 m -135.17 -6.85 2.31 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 -169.295 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -52.14 -42.98 63.8 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.439 1.096 . . . . 0.0 111.722 -178.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.6 m -62.74 -39.15 93.19 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.111 0.564 . . . . 0.0 111.83 -179.02 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -68.54 -43.89 75.7 Favored 'General case' 0 N--CA 1.452 -0.329 0 O-C-N 122.011 -0.431 . . . . 0.0 110.079 177.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 67.1 mm-40 -63.05 -34.52 77.76 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-O 119.618 -0.229 . . . . 0.0 111.085 -179.068 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 27.4 p -85.65 3.66 39.94 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 113.524 0.935 . . . . 0.0 113.524 -176.507 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 69.6 m -105.4 30.05 5.99 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.053 0.941 . . . . 0.0 112.07 -175.515 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -132.83 37.46 3.45 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.455 0.702 . . . . 0.0 112.702 -173.248 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 123.11 -152.47 16.93 Favored Glycine 0 N--CA 1.465 0.593 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 174.022 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 67.4 t -73.09 133.72 31.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 104.528 -2.397 . . . . 0.0 104.528 165.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 40.7 t -136.26 130.19 47.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 4.8 tt -110.9 99.49 8.39 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 105.865 -1.902 . . . . 0.0 105.865 -178.106 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -80.07 143.16 34.23 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 178.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -123.91 94.05 4.11 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 125.806 1.642 . . . . 0.0 107.159 -176.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -73.88 113.15 10.72 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 105.791 -1.929 . . . . 0.0 105.791 174.758 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -148.86 -177.05 5.58 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.785 1.234 . . . . 0.0 108.354 -173.125 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -156.07 149.06 18.27 Favored Pre-proline 0 CA--C 1.531 0.224 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 167.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -61.44 -18.17 57.83 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 121.707 1.605 . . . . 0.0 115.61 179.657 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 52.6 p-90 -70.56 -19.44 62.88 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 120.002 1.274 . . . . 0.0 111.901 173.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 19.5 t -60.03 151.99 25.08 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 124.944 1.298 . . . . 0.0 110.844 -174.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -105.88 -58.0 0.64 Allowed Glycine 0 CA--C 1.531 1.058 0 CA-C-O 118.842 -0.976 . . . . 0.0 111.017 171.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -56.91 -33.16 94.53 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 123.28 2.653 . . . . 0.0 113.518 -179.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 31.4 m -58.11 -34.05 69.77 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.202 0.601 . . . . 0.0 111.423 176.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.2 mmtp -68.42 -24.85 64.79 Favored 'General case' 0 CA--C 1.53 0.184 0 O-C-N 121.534 -0.729 . . . . 0.0 110.927 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 31.0 mtm -70.65 -43.21 69.65 Favored 'General case' 0 C--N 1.34 0.153 0 CA-C-N 118.735 0.698 . . . . 0.0 110.357 176.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 17.5 tt -83.08 -22.74 8.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-O 118.61 -0.709 . . . . 0.0 111.616 -176.355 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -49.28 -51.08 60.4 Favored Pre-proline 0 CA--C 1.547 0.853 0 CA-C-N 120.234 1.379 . . . . 0.0 114.261 178.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -66.49 -28.97 45.33 Favored 'Trans proline' 0 C--N 1.351 0.675 0 CA-C-N 121.675 1.634 . . . . 0.0 112.028 176.378 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.2 t -68.27 -36.67 76.0 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 O-C-N 121.645 -0.659 . . . . 0.0 109.703 175.08 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 87.9 mt -66.39 -36.06 81.89 Favored 'General case' 0 C--N 1.341 0.212 0 CA-C-N 119.654 1.115 . . . . 0.0 111.144 171.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -62.45 -42.94 99.83 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 119.376 0.989 . . . . 0.0 110.799 171.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -63.92 -39.98 95.41 Favored 'General case' 0 CA--C 1.532 0.272 0 O-C-N 121.199 -0.938 . . . . 0.0 110.466 176.273 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 44.8 tp -62.05 -42.96 99.74 Favored 'General case' 0 CA--C 1.528 0.098 0 C-N-CA 123.867 0.867 . . . . 0.0 109.992 176.295 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -60.39 -42.45 95.9 Favored 'General case' 0 CA--C 1.52 -0.185 0 C-N-CA 123.275 0.63 . . . . 0.0 110.845 178.412 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -71.69 -10.8 60.31 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.319 0.648 . . . . 0.0 112.511 -179.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -105.52 -31.98 8.72 Favored 'General case' 0 C--O 1.232 0.15 0 C-N-CA 125.486 1.514 . . . . 0.0 111.458 -179.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 80.0 mmm -125.47 -3.32 7.34 Favored 'General case' 0 N--CA 1.46 0.06 0 CA-C-O 118.407 -0.806 . . . . 0.0 113.113 -167.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -57.85 -10.91 7.18 Favored Glycine 0 CA--C 1.534 1.226 0 C-N-CA 124.826 1.203 . . . . 0.0 115.919 -173.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -75.22 -24.57 57.75 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 118.502 1.151 . . . . 0.0 111.881 173.458 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 50.6 mtmt -128.26 -16.01 4.54 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 125.757 1.623 . . . . 0.0 111.887 -173.014 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 58.9 tp -123.0 144.23 49.4 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 124.816 1.246 . . . . 0.0 110.283 -172.227 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -116.25 145.39 43.18 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 105.256 -2.127 . . . . 0.0 105.256 167.305 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 82.6 mt -115.12 137.9 47.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 105.298 -2.112 . . . . 0.0 105.298 175.477 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 95.2 t -132.06 96.9 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 -171.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -74.96 137.03 41.34 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 176.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 13.3 tt -140.43 126.73 21.47 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 178.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -83.63 106.53 15.42 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 124.462 1.105 . . . . 0.0 109.098 -172.355 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 34.6 m -58.97 -27.7 36.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 118.643 -0.694 . . . . 0.0 111.99 -176.03 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -65.69 -17.23 64.46 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 119.347 0.976 . . . . 0.0 112.204 -176.593 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -121.96 4.16 9.92 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.927 1.291 . . . . 0.0 111.225 179.484 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 68.7 m-80 -141.28 40.47 1.76 Allowed 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.197 0.999 . . . . 0.0 109.785 -170.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 53.7 mm-40 -54.42 -30.84 53.69 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.097 0.959 . . . . 0.0 111.09 175.375 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -66.16 -50.18 64.83 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 123.99 0.916 . . . . 0.0 110.167 -179.273 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.77 -38.96 80.4 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 -178.428 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -58.62 -48.29 81.5 Favored 'General case' 0 CA--C 1.534 0.342 0 O-C-N 121.298 -0.876 . . . . 0.0 110.357 172.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -61.23 -28.76 69.71 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 123.905 0.764 . . . . 0.0 112.213 177.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 19.9 tptm -56.19 -29.3 60.69 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.697 1.199 . . . . 0.0 111.509 179.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -123.73 10.82 9.03 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.552 0.741 . . . . 0.0 111.627 -179.394 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 64.35 30.81 78.88 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 123.616 0.627 . . . . 0.0 112.582 -177.226 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 61.0 t -65.96 122.44 16.92 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 171.06 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 26.1 mmt -132.65 3.5 3.84 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.784 1.233 . . . . 0.0 111.381 -178.312 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 23.7 m -144.66 162.23 37.19 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 126.652 1.981 . . . . 0.0 107.621 179.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 17.7 pt -142.42 155.14 64.31 Favored Pre-proline 0 CA--C 1.544 0.731 0 C-N-CA 124.663 1.185 . . . . 0.0 108.689 175.195 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -67.99 138.32 43.39 Favored 'Cis proline' 0 C--N 1.35 0.63 0 CA-C-N 120.469 1.203 . . . . 0.0 110.399 -3.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 44.9 m -131.33 140.61 49.77 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 174.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 83.4 mt -122.32 127.73 50.18 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 -169.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -117.84 125.4 50.46 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 103.984 -2.599 . . . . 0.0 103.984 178.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 10.0 t -97.05 123.58 49.45 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 N-CA-C 104.145 -2.539 . . . . 0.0 104.145 172.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.9 mp -115.19 151.69 33.96 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 175.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 21.0 tptm -133.55 119.37 19.41 Favored 'General case' 0 CA--C 1.516 -0.363 0 N-CA-C 106.229 -1.767 . . . . 0.0 106.229 174.402 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.2 t70 50.83 37.59 17.52 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.626 1.17 . . . . 0.0 112.483 175.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 103.73 -2.35 45.42 Favored Glycine 0 CA--C 1.527 0.826 0 CA-C-O 118.087 -1.396 . . . . 0.0 115.582 168.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -128.41 145.25 51.14 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 120.033 1.917 . . . . 0.0 109.773 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 61.4 t -61.63 132.52 27.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 173.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.4 p -119.49 -21.85 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.77 0 C-N-CA 124.413 1.085 . . . . 0.0 110.372 174.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -157.62 165.56 35.17 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 120.552 1.524 . . . . 0.0 111.053 175.269 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 11.7 m -137.57 151.21 48.12 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.219 1.408 . . . . 0.0 109.004 179.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 58.4 m -148.47 157.23 43.34 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 126.022 1.729 . . . . 0.0 108.561 169.399 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 36.6 t -133.71 146.71 31.38 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 -179.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 79.41 -175.97 54.86 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 123.504 0.573 . . . . 0.0 112.19 177.135 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -63.17 146.55 53.1 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.579 0.752 . . . . 0.0 110.618 178.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 66.7 mttt -143.9 136.17 13.29 Favored Pre-proline 0 CA--C 1.532 0.284 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 168.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -70.42 160.42 49.59 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 122.408 2.072 . . . . 0.0 110.086 174.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 49.0 pttt -58.4 -28.59 65.34 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 113.569 0.952 . . . . 0.0 113.569 -177.369 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -65.25 -50.34 66.17 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 118.61 0.641 . . . . 0.0 109.741 174.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.81 -39.84 95.53 Favored 'General case' 0 C--N 1.34 0.165 0 C-N-CA 122.89 0.476 . . . . 0.0 110.627 178.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 92.3 mt -64.08 -42.54 96.92 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 122.74 0.416 . . . . 0.0 111.344 177.276 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -61.8 -40.07 93.94 Favored 'General case' 0 C--O 1.223 -0.29 0 CA-C-N 118.592 0.633 . . . . 0.0 110.197 176.469 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -65.5 -41.92 92.7 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 118.729 0.695 . . . . 0.0 110.302 178.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 58.3 tp -60.55 -38.29 84.03 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.744 1.618 . . . . 0.0 111.22 177.115 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 71.5 t -68.01 -49.92 63.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 C-N-CA 123.822 0.849 . . . . 0.0 109.545 171.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 -58.63 -40.68 84.02 Favored 'General case' 0 C--N 1.333 -0.122 0 C-N-CA 125.344 1.458 . . . . 0.0 111.821 -168.403 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.421 ' HG3' ' CD2' ' A' ' 103' ' ' HIS . 22.0 ptmt -65.75 -8.31 20.45 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 -177.542 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . 0.421 ' CD2' ' HG3' ' A' ' 102' ' ' LYS . 94.7 m-70 -124.14 1.9 8.56 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 124.413 1.085 . . . . 0.0 113.695 179.605 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 55.8 mt . . . . . 0 C--O 1.248 1.025 0 CA-C-N 119.386 0.994 . . . . 0.0 109.227 172.519 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.2 tmm? . . . . . 0 N--CA 1.48 1.031 0 CA-C-O 118.628 -0.701 . . . . 0.0 109.877 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -163.62 -173.58 3.35 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.622 1.569 . . . . 0.0 108.386 -178.429 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.8 mt -75.2 146.32 9.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 N-CA-C 106.97 -1.493 . . . . 0.0 106.97 166.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 20.2 t -138.59 163.95 27.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 126.621 1.968 . . . . 0.0 106.856 -176.664 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.48 ' HE2' ' H ' ' A' ' 6' ' ' ALA . 0.0 OUTLIER -125.25 136.49 53.59 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 105.618 -1.993 . . . . 0.0 105.618 177.011 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.48 ' H ' ' HE2' ' A' ' 5' ' ' LYS . . . -141.3 176.2 9.04 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 123.631 0.772 . . . . 0.0 112.473 -169.542 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.4 p -130.08 173.12 11.04 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 127.646 2.378 . . . . 0.0 107.924 175.094 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -45.95 -39.9 9.52 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 124.643 1.177 . . . . 0.0 113.521 177.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 80.8 mm-40 -90.43 -38.02 13.56 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 122.921 0.489 . . . . 0.0 111.727 -174.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 11.4 m -67.83 -33.63 75.15 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 118.143 0.429 . . . . 0.0 110.927 177.34 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 33.4 t80 -50.77 -45.96 59.24 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 126.143 1.777 . . . . 0.0 111.217 -176.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 9.7 m -64.86 -37.8 88.85 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 118.601 0.637 . . . . 0.0 111.876 -175.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -68.53 -45.68 71.56 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 175.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -64.21 -36.75 85.09 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 122.486 0.314 . . . . 0.0 111.252 -176.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.409 ' HA ' HG21 ' A' ' 20' ' ' VAL . 36.8 p -81.17 -4.1 54.3 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 124.071 0.948 . . . . 0.0 113.031 -176.688 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 70.0 m -94.66 28.64 2.57 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.937 0.895 . . . . 0.0 111.754 -177.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -134.01 66.84 1.53 Allowed 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.541 1.137 . . . . 0.0 110.229 -177.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 88.13 -156.56 27.37 Favored Glycine 0 C--N 1.337 0.59 0 N-CA-C 110.373 -1.091 . . . . 0.0 110.373 174.205 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 97.9 t -71.41 132.85 32.82 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 N-CA-C 106.889 -1.522 . . . . 0.0 106.889 168.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.409 HG21 ' HA ' ' A' ' 15' ' ' THR . 47.2 t -136.46 146.34 29.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 179.74 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 5.0 tt -128.06 100.56 5.93 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 -176.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -81.97 146.27 29.83 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.256 -179.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -124.56 94.42 4.19 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 126.113 1.765 . . . . 0.0 107.458 -176.394 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -74.44 112.42 10.6 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 106.05 -1.833 . . . . 0.0 106.05 175.505 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -149.24 -177.22 5.71 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.668 1.187 . . . . 0.0 108.575 -174.087 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -155.65 146.96 16.71 Favored Pre-proline 0 CA--C 1.532 0.277 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 167.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_exo -60.29 -18.21 51.2 Favored 'Trans proline' 0 N--CA 1.461 -0.439 0 C-N-CA 121.821 1.68 . . . . 0.0 115.86 -178.359 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 51.3 p-90 -69.35 -20.43 63.85 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 119.949 1.25 . . . . 0.0 111.937 173.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 34.2 t -59.31 148.21 33.05 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 125.065 1.346 . . . . 0.0 111.199 -172.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -97.61 -63.28 0.89 Allowed Glycine 0 CA--C 1.53 0.971 0 CA-C-O 118.403 -1.22 . . . . 0.0 110.974 171.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -62.24 -26.52 77.53 Favored 'Trans proline' 0 C--N 1.35 0.613 0 CA-C-N 120.424 2.112 . . . . 0.0 113.679 -174.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 33.8 m -57.39 -34.98 69.43 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 121.582 -0.698 . . . . 0.0 111.515 174.464 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.8 mmtp -67.53 -24.94 65.6 Favored 'General case' 0 CA--C 1.53 0.182 0 O-C-N 121.602 -0.686 . . . . 0.0 111.021 -179.613 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 31.3 mtm -71.22 -43.41 67.4 Favored 'General case' 0 C--N 1.34 0.182 0 CA-C-N 118.68 0.673 . . . . 0.0 110.421 176.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 14.1 tt -84.18 -23.48 7.76 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-O 118.705 -0.664 . . . . 0.0 111.727 -174.646 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -48.88 -51.47 54.44 Favored Pre-proline 0 CA--C 1.548 0.877 0 CA-C-N 119.911 1.232 . . . . 0.0 114.076 178.486 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -66.57 -29.67 43.8 Favored 'Trans proline' 0 C--N 1.35 0.65 0 CA-C-N 121.611 1.611 . . . . 0.0 112.194 176.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 5.4 t -66.46 -39.92 85.24 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 175.218 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 67.9 mt -64.99 -38.23 90.26 Favored 'General case' 0 C--N 1.34 0.169 0 CA-C-N 119.317 0.962 . . . . 0.0 110.858 174.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -61.6 -43.9 97.99 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 119.011 0.823 . . . . 0.0 111.122 172.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -62.34 -38.5 89.75 Favored 'General case' 0 CA--C 1.533 0.327 0 O-C-N 121.393 -0.817 . . . . 0.0 110.223 175.609 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.77 -44.48 96.08 Favored 'General case' 0 C--N 1.333 -0.114 0 C-N-CA 124.074 0.95 . . . . 0.0 110.391 177.097 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -60.24 -41.89 94.1 Favored 'General case' 0 CA--C 1.521 -0.165 0 C-N-CA 123.24 0.616 . . . . 0.0 110.92 177.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 -72.01 -11.03 60.58 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 -179.075 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -106.45 -32.69 7.99 Favored 'General case' 0 C--O 1.232 0.133 0 C-N-CA 125.226 1.411 . . . . 0.0 111.639 -179.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 87.4 mmm -125.75 -4.18 7.08 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-O 118.357 -0.83 . . . . 0.0 113.022 -168.284 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -58.39 -11.77 10.8 Favored Glycine 0 CA--C 1.533 1.188 0 CA-C-N 119.835 1.198 . . . . 0.0 114.811 -175.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -65.98 -27.95 68.53 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 118.418 1.109 . . . . 0.0 111.83 171.378 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.464 ' HA ' ' HE3' ' A' ' 49' ' ' LYS . 0.0 OUTLIER -121.28 -24.87 5.36 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 125.954 1.701 . . . . 0.0 111.81 179.333 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 45.9 tp -103.0 157.76 16.76 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 124.144 0.977 . . . . 0.0 111.036 -169.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -133.88 144.41 48.88 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 103.957 -2.608 . . . . 0.0 103.957 166.65 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 66.2 mt -118.56 140.54 41.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 105.61 -1.996 . . . . 0.0 105.61 178.305 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 74.0 t -133.0 97.21 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 -170.205 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 51.3 mtmt -74.35 134.46 42.5 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 177.294 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 20.2 tt -137.92 126.8 33.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 178.167 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 62.9 t0 -87.84 103.97 16.15 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 114.727 -1.124 . . . . 0.0 108.419 -171.599 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 23.0 m -61.7 -23.2 30.29 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 CA-C-O 118.766 -0.635 . . . . 0.0 112.208 -174.339 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -65.34 -22.67 66.84 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 119.25 0.932 . . . . 0.0 111.562 -179.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -117.28 1.71 12.47 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.926 1.29 . . . . 0.0 111.323 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 66.6 m-80 -139.36 43.34 2.02 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 125.167 1.387 . . . . 0.0 108.798 -171.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.411 ' CD ' ' H ' ' A' ' 61' ' ' GLN . 3.4 mp0 -60.64 -35.44 76.21 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.034 0.934 . . . . 0.0 109.825 -175.451 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 -62.64 -44.49 96.15 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 123.674 0.79 . . . . 0.0 110.218 179.174 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -66.7 -40.86 88.65 Favored 'General case' 0 C--O 1.225 -0.188 0 C-N-CA 123.467 0.707 . . . . 0.0 110.082 -178.061 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.38 -50.06 75.41 Favored 'General case' 0 CA--C 1.532 0.283 0 O-C-N 121.742 -0.598 . . . . 0.0 110.058 173.185 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -58.43 -29.77 63.96 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 123.558 0.599 . . . . 0.0 112.55 176.347 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 9.8 ttpt -58.05 -26.61 62.7 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 125.758 1.623 . . . . 0.0 111.994 -178.35 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -123.61 11.04 9.13 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.886 0.874 . . . . 0.0 111.944 176.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 65.89 29.05 74.24 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 123.567 0.603 . . . . 0.0 112.765 -177.173 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 61.8 t -65.65 125.26 22.37 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 170.14 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 98.7 mtp -135.25 3.41 3.11 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.747 1.219 . . . . 0.0 111.515 -179.131 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 24.0 m -144.1 162.05 37.26 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 126.588 1.955 . . . . 0.0 107.743 179.228 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 38.6 pt -142.11 154.39 64.64 Favored Pre-proline 0 CA--C 1.545 0.767 0 C-N-CA 124.534 1.134 . . . . 0.0 108.685 176.332 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -67.71 140.07 51.63 Favored 'Cis proline' 0 C--N 1.351 0.692 0 CA-C-N 120.437 1.192 . . . . 0.0 110.429 -3.149 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 35.8 m -131.74 143.52 50.3 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 173.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 88.3 mt -123.9 126.84 47.08 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 -169.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -115.87 121.71 43.18 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 103.17 -2.9 . . . . 0.0 103.17 177.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 4.6 t -94.21 129.14 44.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 103.641 -2.726 . . . . 0.0 103.641 174.43 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.7 mp -122.89 154.81 37.83 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 178.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -138.33 123.32 19.0 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 174.12 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.0 t70 49.86 37.41 13.45 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.07 1.348 . . . . 0.0 112.647 176.299 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 105.1 -4.23 41.29 Favored Glycine 0 CA--C 1.529 0.916 0 CA-C-O 118.184 -1.342 . . . . 0.0 115.271 168.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -131.92 150.68 52.08 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 120.056 1.928 . . . . 0.0 110.374 -177.221 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 44.6 t -62.2 132.14 27.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 178.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 1.8 p -120.44 -21.75 3.94 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 C-N-CA 125.436 1.494 . . . . 0.0 109.926 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -159.84 172.21 18.05 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 120.121 1.328 . . . . 0.0 109.873 174.034 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 25.9 m -146.53 151.41 37.29 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.708 1.203 . . . . 0.0 109.246 177.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 4.2 m -147.13 156.87 43.35 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 125.507 1.523 . . . . 0.0 109.14 170.174 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 35.5 t -134.85 143.32 37.82 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 -177.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 76.17 -173.89 53.65 Favored Glycine 0 CA--C 1.531 1.052 0 CA-C-O 121.509 0.505 . . . . 0.0 111.862 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 65.4 t80 -63.56 149.2 46.86 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.483 0.713 . . . . 0.0 110.871 179.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 27.4 mttp -144.71 136.92 13.2 Favored Pre-proline 0 CA--C 1.534 0.342 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 168.247 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -70.44 161.3 46.52 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 122.32 2.013 . . . . 0.0 110.228 174.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 46.5 pttt -59.15 -29.53 67.49 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 -177.429 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -64.86 -50.13 67.81 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 118.951 0.796 . . . . 0.0 109.737 175.096 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.62 -39.47 94.44 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 122.73 0.412 . . . . 0.0 110.821 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 77.1 mt -63.68 -44.46 93.66 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 122.949 0.5 . . . . 0.0 111.249 176.385 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 12.4 mt-30 -61.4 -39.44 90.73 Favored 'General case' 0 C--O 1.224 -0.243 0 CA-C-O 118.704 -0.665 . . . . 0.0 110.371 176.358 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -65.6 -40.46 92.69 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 118.915 0.78 . . . . 0.0 110.439 178.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 68.9 tp -62.93 -35.73 81.07 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.634 1.574 . . . . 0.0 111.451 177.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 76.9 t -69.04 -50.96 48.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 C-N-CA 123.638 0.775 . . . . 0.0 109.584 169.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -58.27 -38.5 77.08 Favored 'General case' 0 CA--C 1.522 -0.117 0 C-N-CA 126.013 1.725 . . . . 0.0 112.196 -168.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -64.68 -6.96 8.92 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 -179.096 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -123.25 -5.9 8.31 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 124.395 1.078 . . . . 0.0 113.276 176.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 57.6 mt . . . . . 0 C--O 1.246 0.911 0 CA-C-N 119.319 0.963 . . . . 0.0 109.223 172.678 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 78.5 mtm . . . . . 0 N--CA 1.481 1.12 0 CA-C-O 120.399 0.143 . . . . 0.0 110.884 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 68.87 167.14 0.27 Allowed 'General case' 0 C--O 1.237 0.42 0 C-N-CA 128.776 2.831 . . . . 0.0 114.756 169.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.1 mp -87.01 141.88 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 N-CA-C 105.134 -2.172 . . . . 0.0 105.134 169.301 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 46.8 t -132.91 164.4 35.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 C-N-CA 127.165 2.186 . . . . 0.0 105.904 -175.251 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 6.3 ttmt -121.67 147.2 46.19 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 177.007 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -147.35 168.32 22.11 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 123.279 0.632 . . . . 0.0 110.449 179.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.407 HG22 HD21 ' A' ' 60' ' ' ASN . 33.8 p -134.68 179.78 6.08 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 125.595 1.558 . . . . 0.0 107.371 169.314 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -49.17 -29.74 5.9 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.842 0.857 . . . . 0.0 112.685 170.167 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -65.18 -27.15 68.5 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.265 1.426 . . . . 0.0 113.138 179.27 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.9 p -134.43 -16.9 2.06 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 114.66 1.356 . . . . 0.0 114.66 -167.097 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -55.11 -45.13 75.48 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 124.442 1.097 . . . . 0.0 111.85 -170.091 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.7 m -63.26 -39.0 93.35 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 122.747 0.419 . . . . 0.0 111.613 -178.014 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -68.43 -44.49 74.87 Favored 'General case' 0 N--CA 1.452 -0.361 0 O-C-N 122.119 -0.363 . . . . 0.0 110.076 177.398 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -63.34 -34.6 78.06 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-O 119.33 -0.367 . . . . 0.0 111.108 -178.442 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 35.0 p -86.83 3.48 45.12 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.192 0.997 . . . . 0.0 113.268 -176.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 69.5 m -105.36 32.29 4.36 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.252 1.021 . . . . 0.0 111.562 -177.035 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -132.3 53.74 1.98 Allowed 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.197 0.999 . . . . 0.0 110.798 -176.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 97.55 -157.17 20.79 Favored Glycine 0 C--N 1.339 0.703 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 177.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 91.1 t -70.17 137.11 24.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 167.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 61.9 t -138.16 144.94 29.42 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 N-CA-C 105.479 -2.045 . . . . 0.0 105.479 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 41.8 tp -122.97 99.42 6.37 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 106.611 -1.625 . . . . 0.0 106.611 -177.321 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -78.52 149.95 33.0 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 109.319 -0.622 . . . . 0.0 109.319 177.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -129.15 94.38 3.8 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 126.761 2.024 . . . . 0.0 106.821 -179.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -73.25 114.51 11.52 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 105.882 -1.896 . . . . 0.0 105.882 174.253 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -147.38 -177.85 5.92 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 125.507 1.523 . . . . 0.0 108.301 -171.154 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -155.72 148.69 18.19 Favored Pre-proline 0 C--O 1.235 0.303 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 168.058 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -67.56 -13.25 38.4 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 121.656 1.571 . . . . 0.0 114.469 -175.206 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 53.4 p-90 -71.1 -20.26 62.36 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 120.194 1.361 . . . . 0.0 112.283 170.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 34.7 t -61.0 153.66 24.63 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.078 1.351 . . . . 0.0 111.523 -172.117 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -103.26 -65.53 0.72 Allowed Glycine 0 CA--C 1.53 0.983 0 CA-C-O 118.385 -1.23 . . . . 0.0 110.91 174.479 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_exo -55.77 -30.03 74.38 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.965 2.444 . . . . 0.0 114.118 179.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 33.2 m -58.18 -30.34 66.33 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 121.321 -0.862 . . . . 0.0 111.977 175.222 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.5 mmtp -72.68 -38.26 67.64 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 123.314 0.646 . . . . 0.0 110.014 178.046 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 5.8 ptt? -72.76 -31.52 64.97 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 118.817 0.735 . . . . 0.0 111.639 -176.327 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 15.9 tt -78.26 -19.1 13.53 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-O 118.925 -0.56 . . . . 0.0 111.969 174.608 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -54.94 -49.33 92.59 Favored Pre-proline 0 CA--C 1.545 0.77 0 CA-C-N 120.272 1.397 . . . . 0.0 113.655 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -66.53 -26.58 46.94 Favored 'Trans proline' 0 C--N 1.351 0.696 0 CA-C-N 121.95 1.732 . . . . 0.0 112.344 175.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 11.7 t -67.19 -39.7 83.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 174.11 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 96.3 mt -67.02 -34.34 77.51 Favored 'General case' 0 C--N 1.339 0.122 0 CA-C-N 119.013 0.824 . . . . 0.0 111.579 173.431 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -64.68 -42.26 95.47 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 119.338 0.972 . . . . 0.0 110.859 172.318 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -62.64 -37.77 87.66 Favored 'General case' 0 CA--C 1.531 0.235 0 O-C-N 120.884 -1.135 . . . . 0.0 110.457 173.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 42.9 tp -63.99 -42.42 97.19 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 123.114 0.566 . . . . 0.0 110.314 177.361 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -57.8 -44.47 86.34 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 118.983 0.81 . . . . 0.0 110.881 173.418 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -68.99 -8.87 48.91 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -177.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -112.2 -30.05 7.35 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 125.787 1.635 . . . . 0.0 111.973 -179.096 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 87.1 mmm -129.1 -7.66 4.86 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -169.539 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -58.48 -15.93 26.74 Favored Glycine 0 CA--C 1.529 0.949 0 CA-C-N 119.906 1.23 . . . . 0.0 114.674 -171.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -65.75 -26.2 67.62 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.297 1.039 . . . . 0.0 111.653 174.221 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.458 ' HA ' ' HE3' ' A' ' 49' ' ' LYS . 0.0 OUTLIER -122.91 -19.91 5.99 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.932 1.693 . . . . 0.0 111.884 179.761 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 36.0 tp -110.37 154.5 23.46 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 124.113 0.965 . . . . 0.0 111.144 -169.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 36.1 ttmt -130.96 144.28 51.36 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 104.6 -2.37 . . . . 0.0 104.6 167.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 94.1 mt -115.75 136.54 52.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 105.305 -2.109 . . . . 0.0 105.305 179.393 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 95.8 t -132.35 98.77 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-N 119.11 0.868 . . . . 0.0 109.23 -169.252 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 29.6 mtpp -74.57 139.99 44.1 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 175.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 13.0 tt -141.61 128.08 19.76 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 176.632 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 60.4 t0 -85.21 104.6 15.23 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 124.554 1.142 . . . . 0.0 109.196 -171.232 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 31.1 m -58.91 -26.46 32.55 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-O 118.593 -0.718 . . . . 0.0 112.017 -175.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -65.29 -18.57 65.42 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 119.454 1.024 . . . . 0.0 112.18 -177.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -119.8 4.39 11.02 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.921 1.289 . . . . 0.0 111.071 177.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.407 HD21 HG22 ' A' ' 7' ' ' THR . 68.0 m-80 -139.24 39.92 2.09 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 124.456 1.102 . . . . 0.0 109.642 -170.533 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 49.9 mm-40 -55.67 -33.32 64.01 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.929 0.892 . . . . 0.0 111.112 177.523 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 -66.29 -49.04 68.43 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 118.353 0.524 . . . . 0.0 110.189 179.093 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.52 -39.66 88.75 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.351 0.661 . . . . 0.0 109.846 -179.006 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.64 -49.05 79.28 Favored 'General case' 0 CA--C 1.533 0.292 0 O-C-N 121.149 -0.97 . . . . 0.0 110.322 173.344 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -60.46 -28.49 67.5 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 123.916 0.77 . . . . 0.0 112.262 177.257 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 72.2 tttt -56.13 -29.03 60.14 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 125.068 1.347 . . . . 0.0 111.698 179.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -123.47 10.64 9.18 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.63 0.772 . . . . 0.0 111.703 179.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 64.1 31.15 79.87 Favored Glycine 0 CA--C 1.532 1.14 0 C-N-CA 123.708 0.67 . . . . 0.0 112.617 -176.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 61.8 t -65.94 121.6 15.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 171.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 26.1 mmt -132.47 2.17 3.8 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.797 1.239 . . . . 0.0 111.514 -178.583 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 31.5 m -145.65 161.74 39.16 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 126.789 2.036 . . . . 0.0 107.401 179.372 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 41.6 pt -142.62 156.79 63.03 Favored Pre-proline 0 CA--C 1.545 0.773 0 C-N-CA 124.734 1.214 . . . . 0.0 108.739 177.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -65.48 142.69 55.56 Favored 'Cis proline' 0 C--N 1.35 0.627 0 CA-C-N 120.413 1.183 . . . . 0.0 110.231 -5.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 18.6 m -135.62 132.86 37.61 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 175.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -110.02 134.59 51.97 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 -174.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -121.98 125.75 47.02 Favored 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 102.593 -3.114 . . . . 0.0 102.593 177.022 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 1.9 t -103.67 122.3 56.17 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 N-CA-C 103.605 -2.739 . . . . 0.0 103.605 -179.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.7 mp -119.45 155.8 31.37 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 -175.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -136.81 126.2 24.99 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 170.214 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.2 t70 48.36 36.02 6.5 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.93 1.292 . . . . 0.0 112.294 172.366 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 98.31 2.53 57.84 Favored Glycine 0 CA--C 1.533 1.189 0 CA-C-O 117.925 -1.486 . . . . 0.0 115.108 171.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -121.42 145.88 47.47 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 120.364 2.082 . . . . 0.0 109.569 175.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 67.6 t -66.32 130.03 31.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 169.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 35.5 m -114.42 -21.92 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 CA-C-O 117.666 -1.159 . . . . 0.0 110.985 174.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -156.36 168.23 27.98 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 120.605 1.548 . . . . 0.0 111.023 173.609 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 14.1 m -143.72 151.0 39.49 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.597 1.559 . . . . 0.0 109.186 -177.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 13.0 m -152.61 153.95 34.39 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.375 1.47 . . . . 0.0 109.221 168.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 61.0 t -132.69 142.33 42.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 -172.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 75.84 -172.32 54.12 Favored Glycine 0 CA--C 1.529 0.913 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 -173.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -60.08 148.86 34.3 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.566 0.698 . . . . 0.0 110.303 174.615 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 39.5 tptt -149.14 122.44 4.53 Favored Pre-proline 0 N--CA 1.45 -0.431 0 N-CA-C 105.717 -1.956 . . . . 0.0 105.717 -173.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -68.5 155.67 68.23 Favored 'Trans proline' 0 N--CA 1.454 -0.807 0 C-N-CA 121.369 1.379 . . . . 0.0 111.101 -174.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.434 ' HG2' HE21 ' A' ' 97' ' ' GLN . 38.9 ttpt -52.26 -46.88 65.97 Favored 'General case' 0 N--CA 1.461 0.121 0 C-N-CA 125.205 1.402 . . . . 0.0 112.021 -179.357 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -62.26 -40.39 96.04 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 122.95 0.5 . . . . 0.0 110.672 -179.104 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -69.45 -37.51 77.38 Favored 'General case' 0 N--CA 1.456 -0.162 0 O-C-N 121.796 -0.565 . . . . 0.0 110.798 179.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 98.5 mt -60.43 -43.4 96.82 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-O 119.285 -0.388 . . . . 0.0 110.18 173.389 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.434 HE21 ' HG2' ' A' ' 93' ' ' LYS . 65.4 mt-30 -62.11 -37.05 83.64 Favored 'General case' 0 N--CA 1.461 0.103 0 CA-C-N 118.431 0.56 . . . . 0.0 111.732 176.017 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -61.79 -48.74 79.26 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 118.429 0.559 . . . . 0.0 109.781 175.219 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 34.9 mt -62.47 -36.69 83.27 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 118.381 0.537 . . . . 0.0 111.431 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 56.1 t -61.48 -51.81 68.46 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 172.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -69.2 -22.04 63.92 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 -172.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 65.2 mttm -57.65 -26.36 61.51 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 118.213 -0.899 . . . . 0.0 111.548 170.115 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -126.13 -18.05 5.1 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 113.645 0.98 . . . . 0.0 113.645 -169.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 33.4 mt . . . . . 0 C--O 1.247 0.926 0 CA-C-N 119.935 1.243 . . . . 0.0 109.156 169.097 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.3 mpt? . . . . . 0 N--CA 1.478 0.962 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -162.47 -175.3 4.43 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 126.137 1.775 . . . . 0.0 107.805 -177.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.3 mt -76.02 144.37 11.97 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 166.058 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 23.4 t -136.55 162.99 34.41 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 C-N-CA 126.271 1.829 . . . . 0.0 106.94 -174.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.21 132.77 55.49 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 105.128 -2.175 . . . . 0.0 105.128 173.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -136.25 169.7 17.22 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 123.309 0.644 . . . . 0.0 110.976 -177.218 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.9 p -135.91 171.98 13.68 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 125.597 1.559 . . . . 0.0 107.505 169.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -51.79 -27.8 13.47 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.502 1.121 . . . . 0.0 112.946 178.061 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -57.97 -32.37 67.78 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 126.256 1.823 . . . . 0.0 112.809 178.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.0 m -141.22 -3.73 1.19 Allowed 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 113.383 0.883 . . . . 0.0 113.383 -169.166 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 78.3 t80 -53.51 -41.6 66.48 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.172 0.989 . . . . 0.0 111.633 -178.069 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.1 p -60.67 -45.5 93.89 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 124.045 0.938 . . . . 0.0 111.774 177.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.03 -43.62 95.02 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 122.737 0.415 . . . . 0.0 110.284 178.175 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 65.4 mm-40 -63.4 -37.24 86.53 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-O 119.414 -0.326 . . . . 0.0 110.962 -179.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.4 ' HA ' HG21 ' A' ' 20' ' ' VAL . 31.6 p -83.98 3.26 35.04 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.221 1.008 . . . . 0.0 113.277 -177.26 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 63.4 m -104.13 31.47 4.55 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.296 1.038 . . . . 0.0 111.459 -177.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -134.51 64.02 1.61 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.297 1.039 . . . . 0.0 110.229 -177.486 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 88.89 -158.33 28.13 Favored Glycine 0 C--N 1.337 0.603 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 177.483 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 59.1 t -69.94 135.5 28.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 168.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.4 HG21 ' HA ' ' A' ' 15' ' ' THR . 46.8 t -137.35 140.17 42.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 N-CA-C 105.763 -1.94 . . . . 0.0 105.763 179.26 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 52.3 tp -118.98 99.58 6.82 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 106.622 -1.622 . . . . 0.0 106.622 -178.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -79.67 149.35 31.27 Favored 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 178.025 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -130.43 93.99 3.57 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 126.532 1.933 . . . . 0.0 107.596 -177.02 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -74.44 113.82 12.11 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 105.821 -1.918 . . . . 0.0 105.821 175.275 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -149.9 -175.82 5.19 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 124.667 1.187 . . . . 0.0 108.455 -172.28 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -151.82 147.74 20.53 Favored Pre-proline 0 C--O 1.233 0.199 0 N-CA-C 105.64 -1.985 . . . . 0.0 105.64 167.19 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -67.1 -13.05 38.39 Favored 'Trans proline' 0 CA--C 1.535 0.533 0 CA-C-N 121.093 1.426 . . . . 0.0 113.104 -179.073 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 1.3 m95 -76.4 -13.51 60.12 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.841 0.856 . . . . 0.0 111.907 173.074 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 31.4 t -63.87 154.37 33.9 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 125.387 1.475 . . . . 0.0 111.076 -176.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -104.74 -65.4 0.68 Allowed Glycine 0 CA--C 1.53 0.997 0 CA-C-O 118.324 -1.265 . . . . 0.0 110.589 172.213 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -53.26 -32.02 58.78 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 123.4 2.733 . . . . 0.0 114.633 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 33.2 m -57.91 -34.37 69.77 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 121.574 -0.704 . . . . 0.0 111.721 176.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.0 mmtp -67.76 -23.17 65.2 Favored 'General case' 0 CA--C 1.53 0.188 0 O-C-N 121.492 -0.755 . . . . 0.0 111.074 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 32.2 mtm -70.83 -43.52 68.39 Favored 'General case' 0 C--N 1.339 0.143 0 CA-C-N 118.784 0.72 . . . . 0.0 110.357 176.018 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 17.3 tt -83.61 -22.61 8.33 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-O 118.75 -0.643 . . . . 0.0 111.698 -176.387 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -48.94 -51.43 55.29 Favored Pre-proline 0 CA--C 1.547 0.861 0 CA-C-N 120.032 1.287 . . . . 0.0 114.035 178.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -67.56 -25.16 41.16 Favored 'Trans proline' 0 C--N 1.351 0.688 0 CA-C-N 121.78 1.672 . . . . 0.0 112.367 176.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.4 t -72.07 -35.1 52.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 O-C-N 121.506 -0.746 . . . . 0.0 109.613 175.249 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 69.6 mt -67.97 -35.98 79.28 Favored 'General case' 0 C--N 1.338 0.095 0 CA-C-N 119.329 0.968 . . . . 0.0 111.036 170.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -62.4 -41.61 98.8 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 119.058 0.845 . . . . 0.0 110.818 170.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -61.99 -42.38 99.08 Favored 'General case' 0 C--N 1.331 -0.23 0 O-C-N 121.182 -0.948 . . . . 0.0 110.27 174.185 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 46.3 tp -61.62 -40.65 95.61 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.993 0.917 . . . . 0.0 110.642 178.586 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -60.98 -41.47 96.47 Favored 'General case' 0 C--N 1.334 -0.099 0 C-N-CA 123.108 0.563 . . . . 0.0 110.821 174.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -75.55 -11.08 59.95 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.023 0.529 . . . . 0.0 112.362 178.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -91.44 -50.45 5.79 Favored 'General case' 0 C--O 1.232 0.15 0 C-N-CA 124.928 1.291 . . . . 0.0 109.636 178.117 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 24.9 mtm -140.49 21.3 2.37 Favored 'General case' 0 N--CA 1.465 0.275 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -170.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -56.34 -11.7 5.28 Favored Glycine 0 CA--C 1.538 1.473 0 CA-C-N 120.197 1.362 . . . . 0.0 114.591 174.16 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -72.77 -28.7 62.76 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 118.694 1.247 . . . . 0.0 111.723 171.454 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -107.9 -24.92 11.45 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 125.922 1.689 . . . . 0.0 111.302 -179.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 48.8 tp -114.42 157.54 22.75 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 124.498 1.119 . . . . 0.0 111.307 -168.664 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -128.7 143.42 50.93 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 104.214 -2.513 . . . . 0.0 104.214 166.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 82.3 mt -117.44 138.5 47.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 105.367 -2.086 . . . . 0.0 105.367 178.199 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 98.8 t -132.59 98.74 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 -170.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 52.6 mtmt -70.93 141.6 51.11 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 107.848 -1.168 . . . . 0.0 107.848 173.323 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 16.5 tt -144.05 125.2 9.73 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 174.221 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 54.1 t0 -83.82 105.65 14.89 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.362 1.065 . . . . 0.0 108.629 -173.489 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 30.9 m -59.31 -26.25 33.25 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-O 118.538 -0.744 . . . . 0.0 111.939 -174.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -65.11 -18.27 65.16 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 119.453 1.024 . . . . 0.0 112.179 -177.401 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -119.69 3.82 11.11 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.915 1.286 . . . . 0.0 111.134 178.046 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 68.2 m-80 -139.5 39.82 2.05 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.438 1.095 . . . . 0.0 109.761 -170.453 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 52.1 mm-40 -55.41 -32.61 62.82 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.75 0.82 . . . . 0.0 111.092 176.37 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 33.4 mm-40 -65.99 -47.67 73.78 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 118.373 0.533 . . . . 0.0 110.324 178.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.49 -39.83 85.2 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 118.581 0.628 . . . . 0.0 109.993 -178.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.49 -49.39 77.96 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 121.621 -0.674 . . . . 0.0 110.453 173.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -61.75 -28.67 70.4 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 123.764 0.697 . . . . 0.0 112.131 178.367 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 17.2 ttmt -54.97 -29.47 56.9 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 125.772 1.629 . . . . 0.0 112.009 178.346 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -123.65 10.5 9.05 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.794 0.837 . . . . 0.0 111.831 178.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 65.25 28.27 73.37 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 123.825 0.726 . . . . 0.0 112.94 -177.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 56.7 t -62.35 127.49 22.45 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 172.084 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 42.3 ttp -137.29 0.79 2.36 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.532 1.133 . . . . 0.0 110.966 -176.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 24.4 m -144.95 162.74 36.15 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 126.535 1.934 . . . . 0.0 107.634 179.557 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 41.0 pt -143.29 156.55 60.92 Favored Pre-proline 0 CA--C 1.545 0.754 0 C-N-CA 124.897 1.279 . . . . 0.0 108.583 176.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -66.89 139.6 46.36 Favored 'Cis proline' 0 C--N 1.349 0.575 0 CA-C-N 120.522 1.222 . . . . 0.0 110.207 -5.097 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 31.9 m -132.11 138.59 48.16 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 176.198 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 88.5 mt -116.09 128.5 55.73 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 -171.367 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -119.23 125.54 49.41 Favored 'General case' 0 CA--C 1.509 -0.626 0 N-CA-C 102.551 -3.129 . . . . 0.0 102.551 177.459 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 1.7 t -105.64 122.6 59.31 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 N-CA-C 103.609 -2.737 . . . . 0.0 103.609 -179.387 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.8 mp -120.23 153.52 36.2 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 -176.57 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -136.63 124.97 23.28 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 171.501 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.5 t70 48.62 36.04 7.04 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.016 1.327 . . . . 0.0 112.284 174.026 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 99.8 2.34 56.23 Favored Glycine 0 CA--C 1.532 1.113 0 CA-C-O 117.92 -1.489 . . . . 0.0 114.98 170.055 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -122.36 146.75 47.04 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 120.273 2.037 . . . . 0.0 109.571 176.122 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 62.0 t -66.82 130.01 31.83 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 N-CA-C 107.405 -1.332 . . . . 0.0 107.405 170.216 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 30.7 m -118.29 -17.19 7.36 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 C-N-CA 124.641 1.177 . . . . 0.0 111.338 176.21 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -156.4 167.55 30.09 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 120.547 1.521 . . . . 0.0 110.61 172.477 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 19.1 m -146.42 142.62 28.35 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.589 1.156 . . . . 0.0 108.706 174.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 49.5 m -144.58 156.71 44.27 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.025 1.33 . . . . 0.0 108.734 176.672 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 39.8 t -134.23 146.38 31.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 -174.657 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 76.32 -175.95 52.36 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 123.532 0.587 . . . . 0.0 112.436 177.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -63.29 148.78 47.31 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.989 0.915 . . . . 0.0 111.286 -179.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -148.84 142.13 15.85 Favored Pre-proline 0 CA--C 1.534 0.335 0 C-N-CA 125.626 1.57 . . . . 0.0 107.24 167.816 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -72.26 160.8 46.23 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 122.871 2.381 . . . . 0.0 110.787 175.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 40.5 pttt -59.31 -30.12 68.12 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 -176.275 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -65.22 -49.72 68.62 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 118.355 0.525 . . . . 0.0 109.639 174.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.74 -37.86 88.93 Favored 'General case' 0 CA--C 1.528 0.118 0 O-C-N 122.063 -0.398 . . . . 0.0 110.853 179.22 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 84.5 mt -63.77 -44.62 92.88 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 122.722 0.409 . . . . 0.0 111.289 175.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -60.7 -41.95 96.23 Favored 'General case' 0 C--O 1.223 -0.291 0 CA-C-O 118.903 -0.57 . . . . 0.0 109.838 176.07 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -64.24 -40.93 97.05 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 118.383 0.538 . . . . 0.0 110.777 -179.535 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 56.3 tp -61.0 -44.89 96.75 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 124.965 1.306 . . . . 0.0 110.715 176.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 75.4 t -62.15 -43.83 98.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 123.602 0.761 . . . . 0.0 109.621 173.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -62.6 -24.05 67.37 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 125.186 1.395 . . . . 0.0 112.203 -173.296 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -54.85 -26.1 33.08 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 118.611 -0.709 . . . . 0.0 112.222 171.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 86.1 m-70 -123.8 -11.62 7.67 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 113.423 0.897 . . . . 0.0 113.423 -168.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 70.4 mt . . . . . 0 C--O 1.249 1.045 0 CA-C-N 119.16 0.891 . . . . 0.0 109.292 171.678 . . . . . . . . 0 0 . 1 stop_ save_